id	sid	tid	token	lemma	pos
10_1101-2021_01_06_425584	1	1	37271726	37271726	CD
10_1101-2021_01_06_425584	1	2	1	1	CD
10_1101-2021_01_06_425584	1	3	Comprehensive	comprehensive	JJ
10_1101-2021_01_06_425584	1	4	multi	multi	NN
10_1101-2021_01_06_425584	1	5	-	-	HYPH
10_1101-2021_01_06_425584	1	6	omics	omics	JJ
10_1101-2021_01_06_425584	1	7	study	study	NN
10_1101-2021_01_06_425584	1	8	of	of	IN
10_1101-2021_01_06_425584	1	9	the	the	DT
10_1101-2021_01_06_425584	1	10	molecular	molecular	JJ
10_1101-2021_01_06_425584	1	11	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	1	12	1	1	CD
10_1101-2021_01_06_425584	1	13	induced	induce	VBN
10_1101-2021_01_06_425584	1	14	by	by	IN
10_1101-2021_01_06_425584	1	15	simulated	simulated	JJ
10_1101-2021_01_06_425584	1	16	diabetes	diabete	NNS
10_1101-2021_01_06_425584	1	17	on	on	IN
10_1101-2021_01_06_425584	1	18	coronary	coronary	JJ
10_1101-2021_01_06_425584	1	19	artery	artery	NN
10_1101-2021_01_06_425584	1	20	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	1	21	cells	cell	NNS
10_1101-2021_01_06_425584	1	22	2	2	CD
10_1101-2021_01_06_425584	1	23	3	3	CD
10_1101-2021_01_06_425584	1	24	Aldo	Aldo	NNP
10_1101-2021_01_06_425584	1	25	Moreno	Moreno	NNP
10_1101-2021_01_06_425584	1	26	-	-	HYPH
10_1101-2021_01_06_425584	1	27	Ulloa1,2	Ulloa1,2	NNP
10_1101-2021_01_06_425584	1	28	*	*	NFP
10_1101-2021_01_06_425584	1	29	,	,	,
10_1101-2021_01_06_425584	1	30	Hilda	Hilda	NNP
10_1101-2021_01_06_425584	1	31	Carolina	Carolina	NNP
10_1101-2021_01_06_425584	1	32	Delgado	Delgado	NNP
10_1101-2021_01_06_425584	1	33	-	-	HYPH
10_1101-2021_01_06_425584	1	34	De	De	NNP
10_1101-2021_01_06_425584	1	35	la	la	NNP
10_1101-2021_01_06_425584	1	36	Herrán1,3	Herrán1,3	NNP
10_1101-2021_01_06_425584	1	37	,	,	,
10_1101-2021_01_06_425584	1	38	Carolina	Carolina	NNP
10_1101-2021_01_06_425584	1	39	Álvarez	Álvarez	NNP
10_1101-2021_01_06_425584	1	40	-	-	HYPH
10_1101-2021_01_06_425584	1	41	Delgado3	Delgado3	NNP
10_1101-2021_01_06_425584	1	42	,	,	,
10_1101-2021_01_06_425584	1	43	4	4	CD
10_1101-2021_01_06_425584	1	44	Omar	Omar	NNP
10_1101-2021_01_06_425584	1	45	Mendoza	Mendoza	NNP
10_1101-2021_01_06_425584	1	46	-	-	HYPH
10_1101-2021_01_06_425584	1	47	Porras4	Porras4	NNP
10_1101-2021_01_06_425584	1	48	,	,	,
10_1101-2021_01_06_425584	1	49	Rommel	Rommel	NNP
10_1101-2021_01_06_425584	1	50	A.	A.	NNP
10_1101-2021_01_06_425584	1	51	Carballo	Carballo	NNP
10_1101-2021_01_06_425584	1	52	-	-	HYPH
10_1101-2021_01_06_425584	1	53	Castañeda1	Castañeda1	NNP
10_1101-2021_01_06_425584	1	54	and	and	CC
10_1101-2021_01_06_425584	1	55	Francisco	Francisco	NNP
10_1101-2021_01_06_425584	1	56	Villarreal5,6	villarreal5,6	CD
10_1101-2021_01_06_425584	1	57	5	5	CD
10_1101-2021_01_06_425584	1	58	6	6	CD
10_1101-2021_01_06_425584	1	59	1MS2	1ms2	CD
10_1101-2021_01_06_425584	1	60	laboratory	laboratory	NN
10_1101-2021_01_06_425584	1	61	,	,	,
10_1101-2021_01_06_425584	1	62	Biomedical	Biomedical	NNP
10_1101-2021_01_06_425584	1	63	Innovation	Innovation	NNP
10_1101-2021_01_06_425584	1	64	Department	Department	NNP
10_1101-2021_01_06_425584	1	65	,	,	,
10_1101-2021_01_06_425584	1	66	Center	Center	NNP
10_1101-2021_01_06_425584	1	67	for	for	IN
10_1101-2021_01_06_425584	1	68	Scientific	Scientific	NNP
10_1101-2021_01_06_425584	1	69	Research	Research	NNP
10_1101-2021_01_06_425584	1	70	and	and	CC
10_1101-2021_01_06_425584	1	71	Higher	Higher	NNP
10_1101-2021_01_06_425584	1	72	7	7	NNP
10_1101-2021_01_06_425584	1	73	Education	Education	NNP
10_1101-2021_01_06_425584	1	74	of	of	IN
10_1101-2021_01_06_425584	1	75	Ensenada	Ensenada	NNP
10_1101-2021_01_06_425584	1	76	(	(	-LRB-
10_1101-2021_01_06_425584	1	77	CICESE	CICESE	NNP
10_1101-2021_01_06_425584	1	78	)	)	-RRB-
10_1101-2021_01_06_425584	1	79	,	,	,
10_1101-2021_01_06_425584	1	80	Baja	Baja	NNP
10_1101-2021_01_06_425584	1	81	California	California	NNP
10_1101-2021_01_06_425584	1	82	,	,	,
10_1101-2021_01_06_425584	1	83	México	México	NNP
10_1101-2021_01_06_425584	1	84	8	8	CD
10_1101-2021_01_06_425584	1	85	2Specialized	2Specialized	NNP
10_1101-2021_01_06_425584	1	86	Laboratory	Laboratory	NNP
10_1101-2021_01_06_425584	1	87	in	in	IN
10_1101-2021_01_06_425584	1	88	Metabolomics	Metabolomics	NNPS
10_1101-2021_01_06_425584	1	89	and	and	CC
10_1101-2021_01_06_425584	1	90	Proteomics	Proteomics	NNP
10_1101-2021_01_06_425584	1	91	(	(	-LRB-
10_1101-2021_01_06_425584	1	92	MetPro	MetPro	NNP
10_1101-2021_01_06_425584	1	93	)	)	-RRB-
10_1101-2021_01_06_425584	1	94	,	,	,
10_1101-2021_01_06_425584	1	95	CICESE	CICESE	NNP
10_1101-2021_01_06_425584	1	96	,	,	,
10_1101-2021_01_06_425584	1	97	México	México	NNP
10_1101-2021_01_06_425584	1	98	9	9	CD
10_1101-2021_01_06_425584	1	99	3Mitochondrial	3Mitochondrial	NNP
10_1101-2021_01_06_425584	1	100	Biology	Biology	NNP
10_1101-2021_01_06_425584	1	101	Laboratory	Laboratory	NNP
10_1101-2021_01_06_425584	1	102	,	,	,
10_1101-2021_01_06_425584	1	103	Biomedical	Biomedical	NNP
10_1101-2021_01_06_425584	1	104	Innovation	Innovation	NNP
10_1101-2021_01_06_425584	1	105	Department	Department	NNP
10_1101-2021_01_06_425584	1	106	,	,	,
10_1101-2021_01_06_425584	1	107	Center	Center	NNP
10_1101-2021_01_06_425584	1	108	for	for	IN
10_1101-2021_01_06_425584	1	109	Scientific	Scientific	NNP
10_1101-2021_01_06_425584	1	110	10	10	CD
10_1101-2021_01_06_425584	1	111	Research	Research	NNP
10_1101-2021_01_06_425584	1	112	and	and	CC
10_1101-2021_01_06_425584	1	113	Higher	Higher	NNP
10_1101-2021_01_06_425584	1	114	Education	Education	NNP
10_1101-2021_01_06_425584	1	115	of	of	IN
10_1101-2021_01_06_425584	1	116	Ensenada	Ensenada	NNP
10_1101-2021_01_06_425584	1	117	(	(	-LRB-
10_1101-2021_01_06_425584	1	118	CICESE	CICESE	NNP
10_1101-2021_01_06_425584	1	119	)	)	-RRB-
10_1101-2021_01_06_425584	1	120	,	,	,
10_1101-2021_01_06_425584	1	121	Baja	Baja	NNP
10_1101-2021_01_06_425584	1	122	California	California	NNP
10_1101-2021_01_06_425584	1	123	,	,	,
10_1101-2021_01_06_425584	1	124	México	México	NNP
10_1101-2021_01_06_425584	1	125	11	11	CD
10_1101-2021_01_06_425584	1	126	4CSIRO	4csiro	CD
10_1101-2021_01_06_425584	1	127	Livestock	Livestock	NNP
10_1101-2021_01_06_425584	1	128	and	and	CC
10_1101-2021_01_06_425584	1	129	Aquaculture	Aquaculture	NNP
10_1101-2021_01_06_425584	1	130	,	,	,
10_1101-2021_01_06_425584	1	131	Queensland	Queensland	NNP
10_1101-2021_01_06_425584	1	132	Bioscience	Bioscience	NNP
10_1101-2021_01_06_425584	1	133	Precinct	Precinct	NNP
10_1101-2021_01_06_425584	1	134	,	,	,
10_1101-2021_01_06_425584	1	135	306	306	CD
10_1101-2021_01_06_425584	1	136	Carmody	carmody	NN
10_1101-2021_01_06_425584	1	137	Rd	Rd	NNP
10_1101-2021_01_06_425584	1	138	,	,	,
10_1101-2021_01_06_425584	1	139	St	St	NNP
10_1101-2021_01_06_425584	1	140	12	12	CD
10_1101-2021_01_06_425584	1	141	Lucia	Lucia	NNP
10_1101-2021_01_06_425584	1	142	,	,	,
10_1101-2021_01_06_425584	1	143	QLD	QLD	NNP
10_1101-2021_01_06_425584	1	144	,	,	,
10_1101-2021_01_06_425584	1	145	Australia	Australia	NNP
10_1101-2021_01_06_425584	1	146	13	13	CD
10_1101-2021_01_06_425584	1	147	5School	5school	CD
10_1101-2021_01_06_425584	1	148	of	of	IN
10_1101-2021_01_06_425584	1	149	Medicine	Medicine	NNP
10_1101-2021_01_06_425584	1	150	,	,	,
10_1101-2021_01_06_425584	1	151	University	University	NNP
10_1101-2021_01_06_425584	1	152	of	of	IN
10_1101-2021_01_06_425584	1	153	California	California	NNP
10_1101-2021_01_06_425584	1	154	,	,	,
10_1101-2021_01_06_425584	1	155	San	San	NNP
10_1101-2021_01_06_425584	1	156	Diego	Diego	NNP
10_1101-2021_01_06_425584	1	157	,	,	,
10_1101-2021_01_06_425584	1	158	CA	CA	NNP
10_1101-2021_01_06_425584	1	159	,	,	,
10_1101-2021_01_06_425584	1	160	USA	USA	NNP
10_1101-2021_01_06_425584	1	161	14	14	CD
10_1101-2021_01_06_425584	1	162	6San	6san	CD
10_1101-2021_01_06_425584	1	163	Diego	Diego	NNP
10_1101-2021_01_06_425584	1	164	VA	VA	NNP
10_1101-2021_01_06_425584	1	165	Healthcare	Healthcare	NNP
10_1101-2021_01_06_425584	1	166	System	System	NNP
10_1101-2021_01_06_425584	1	167	15	15	CD
10_1101-2021_01_06_425584	1	168	16	16	CD
10_1101-2021_01_06_425584	1	169	17	17	CD
10_1101-2021_01_06_425584	1	170	18	18	CD
10_1101-2021_01_06_425584	1	171	*	*	NFP
10_1101-2021_01_06_425584	1	172	To	to	IN
10_1101-2021_01_06_425584	1	173	whom	whom	WP
10_1101-2021_01_06_425584	1	174	correspondence	correspondence	NN
10_1101-2021_01_06_425584	1	175	should	should	MD
10_1101-2021_01_06_425584	1	176	be	be	VB
10_1101-2021_01_06_425584	1	177	addressed	address	VBN
10_1101-2021_01_06_425584	1	178	:	:	:
10_1101-2021_01_06_425584	1	179	Biomedical	Biomedical	NNP
10_1101-2021_01_06_425584	1	180	Innovation	Innovation	NNP
10_1101-2021_01_06_425584	1	181	Department	Department	NNP
10_1101-2021_01_06_425584	1	182	,	,	,
10_1101-2021_01_06_425584	1	183	CICESE	CICESE	NNP
10_1101-2021_01_06_425584	1	184	19	19	CD
10_1101-2021_01_06_425584	1	185	Carretera	Carretera	NNP
10_1101-2021_01_06_425584	1	186	Ensenada	Ensenada	NNP
10_1101-2021_01_06_425584	1	187	-	-	HYPH
10_1101-2021_01_06_425584	1	188	Tijuana	Tijuana	NNP
10_1101-2021_01_06_425584	1	189	No	no	NN
10_1101-2021_01_06_425584	1	190	.	.	.
10_1101-2021_01_06_425584	2	1	3918	3918	CD
10_1101-2021_01_06_425584	2	2	,	,	,
10_1101-2021_01_06_425584	2	3	Zona	Zona	NNP
10_1101-2021_01_06_425584	2	4	Playitas	Playitas	NNP
10_1101-2021_01_06_425584	2	5	,	,	,
10_1101-2021_01_06_425584	2	6	CP	CP	NNP
10_1101-2021_01_06_425584	2	7	.	.	.
10_1101-2021_01_06_425584	3	1	22860	22860	CD
10_1101-2021_01_06_425584	3	2	,	,	,
10_1101-2021_01_06_425584	3	3	Ensenada	Ensenada	NNP
10_1101-2021_01_06_425584	3	4	,	,	,
10_1101-2021_01_06_425584	3	5	B.C.	B.C.	NNP
10_1101-2021_01_06_425584	4	1	Mexico	Mexico	NNP
10_1101-2021_01_06_425584	4	2	,	,	,
10_1101-2021_01_06_425584	4	3	20	20	CD
10_1101-2021_01_06_425584	4	4	Phone	phone	NN
10_1101-2021_01_06_425584	4	5	:	:	:
10_1101-2021_01_06_425584	4	6	+52(646)175	+52(646)175	NNP
10_1101-2021_01_06_425584	4	7	-	-	HYPH
10_1101-2021_01_06_425584	4	8	05	05	CD
10_1101-2021_01_06_425584	4	9	-	-	HYPH
10_1101-2021_01_06_425584	4	10	00	00	NFP
10_1101-2021_01_06_425584	4	11	ext	ext	NN
10_1101-2021_01_06_425584	4	12	.	.	.
10_1101-2021_01_06_425584	5	1	2721	2721	CD
10_1101-2021_01_06_425584	5	2	,	,	,
10_1101-2021_01_06_425584	5	3	E	e	NN
10_1101-2021_01_06_425584	5	4	-	-	NN
10_1101-2021_01_06_425584	5	5	mail	mail	NN
10_1101-2021_01_06_425584	5	6	:	:	:
10_1101-2021_01_06_425584	5	7	amoreno@cicese.mx	amoreno@cicese.mx	CD
10_1101-2021_01_06_425584	5	8	21	21	CD
10_1101-2021_01_06_425584	5	9	22	22	CD
10_1101-2021_01_06_425584	5	10	23	23	CD
10_1101-2021_01_06_425584	5	11	24	24	CD
10_1101-2021_01_06_425584	5	12	.CC	.CC	:
10_1101-2021_01_06_425584	5	13	-	-	HYPH
10_1101-2021_01_06_425584	5	14	BY	by	IN
10_1101-2021_01_06_425584	5	15	-	-	HYPH
10_1101-2021_01_06_425584	5	16	NC	NC	NNP
10_1101-2021_01_06_425584	5	17	-	-	HYPH
10_1101-2021_01_06_425584	5	18	ND	ND	NNP
10_1101-2021_01_06_425584	5	19	4.0	4.0	CD
10_1101-2021_01_06_425584	5	20	International	International	NNP
10_1101-2021_01_06_425584	5	21	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	5	22	under	under	IN
10_1101-2021_01_06_425584	5	23	a	a	DT
10_1101-2021_01_06_425584	5	24	(	(	-LRB-
10_1101-2021_01_06_425584	5	25	which	which	WDT
10_1101-2021_01_06_425584	5	26	was	be	VBD
10_1101-2021_01_06_425584	5	27	not	not	RB
10_1101-2021_01_06_425584	5	28	certified	certify	VBN
10_1101-2021_01_06_425584	5	29	by	by	IN
10_1101-2021_01_06_425584	5	30	peer	peer	NN
10_1101-2021_01_06_425584	5	31	review	review	NN
10_1101-2021_01_06_425584	5	32	)	)	-RRB-
10_1101-2021_01_06_425584	5	33	is	be	VBZ
10_1101-2021_01_06_425584	5	34	the	the	DT
10_1101-2021_01_06_425584	5	35	author	author	NN
10_1101-2021_01_06_425584	5	36	/	/	SYM
10_1101-2021_01_06_425584	5	37	funder	funder	NN
10_1101-2021_01_06_425584	5	38	,	,	,
10_1101-2021_01_06_425584	5	39	who	who	WP
10_1101-2021_01_06_425584	5	40	has	have	VBZ
10_1101-2021_01_06_425584	5	41	granted	grant	VBN
10_1101-2021_01_06_425584	5	42	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	5	43	a	a	DT
10_1101-2021_01_06_425584	5	44	license	license	NN
10_1101-2021_01_06_425584	5	45	to	to	TO
10_1101-2021_01_06_425584	5	46	display	display	VB
10_1101-2021_01_06_425584	5	47	the	the	DT
10_1101-2021_01_06_425584	5	48	preprint	preprint	NN
10_1101-2021_01_06_425584	5	49	in	in	IN
10_1101-2021_01_06_425584	5	50	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	5	51	.	.	.
10_1101-2021_01_06_425584	6	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	6	2	is	be	VBZ
10_1101-2021_01_06_425584	6	3	made	make	VBN
10_1101-2021_01_06_425584	6	4	The	the	DT
10_1101-2021_01_06_425584	6	5	copyright	copyright	NN
10_1101-2021_01_06_425584	6	6	holder	holder	NN
10_1101-2021_01_06_425584	6	7	for	for	IN
10_1101-2021_01_06_425584	6	8	this	this	DT
10_1101-2021_01_06_425584	6	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	6	10	version	version	NN
10_1101-2021_01_06_425584	6	11	posted	post	VBD
10_1101-2021_01_06_425584	6	12	January	January	NNP
10_1101-2021_01_06_425584	6	13	8	8	CD
10_1101-2021_01_06_425584	6	14	,	,	,
10_1101-2021_01_06_425584	6	15	2021	2021	CD
10_1101-2021_01_06_425584	6	16	.	.	.
10_1101-2021_01_06_425584	6	17	;	;	:
10_1101-2021_01_06_425584	6	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	6	19	:	:	:
10_1101-2021_01_06_425584	6	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	6	21	preprint	preprint	NN
10_1101-2021_01_06_425584	6	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	6	23	-	-	:
10_1101-2021_01_06_425584	6	24	BY	by	IN
10_1101-2021_01_06_425584	6	25	-	-	HYPH
10_1101-2021_01_06_425584	6	26	NC	NC	NNP
10_1101-2021_01_06_425584	6	27	-	-	HYPH
10_1101-2021_01_06_425584	6	28	ND	ND	NNP
10_1101-2021_01_06_425584	6	29	4.0	4.0	CD
10_1101-2021_01_06_425584	6	30	International	International	NNP
10_1101-2021_01_06_425584	6	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	6	32	under	under	IN
10_1101-2021_01_06_425584	6	33	a	a	DT
10_1101-2021_01_06_425584	6	34	(	(	-LRB-
10_1101-2021_01_06_425584	6	35	which	which	WDT
10_1101-2021_01_06_425584	6	36	was	be	VBD
10_1101-2021_01_06_425584	6	37	not	not	RB
10_1101-2021_01_06_425584	6	38	certified	certify	VBN
10_1101-2021_01_06_425584	6	39	by	by	IN
10_1101-2021_01_06_425584	6	40	peer	peer	NN
10_1101-2021_01_06_425584	6	41	review	review	NN
10_1101-2021_01_06_425584	6	42	)	)	-RRB-
10_1101-2021_01_06_425584	6	43	is	be	VBZ
10_1101-2021_01_06_425584	6	44	the	the	DT
10_1101-2021_01_06_425584	6	45	author	author	NN
10_1101-2021_01_06_425584	6	46	/	/	SYM
10_1101-2021_01_06_425584	6	47	funder	funder	NN
10_1101-2021_01_06_425584	6	48	,	,	,
10_1101-2021_01_06_425584	6	49	who	who	WP
10_1101-2021_01_06_425584	6	50	has	have	VBZ
10_1101-2021_01_06_425584	6	51	granted	grant	VBN
10_1101-2021_01_06_425584	6	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	6	53	a	a	DT
10_1101-2021_01_06_425584	6	54	license	license	NN
10_1101-2021_01_06_425584	6	55	to	to	TO
10_1101-2021_01_06_425584	6	56	display	display	VB
10_1101-2021_01_06_425584	6	57	the	the	DT
10_1101-2021_01_06_425584	6	58	preprint	preprint	NN
10_1101-2021_01_06_425584	6	59	in	in	IN
10_1101-2021_01_06_425584	6	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	6	61	.	.	.
10_1101-2021_01_06_425584	7	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	7	2	is	be	VBZ
10_1101-2021_01_06_425584	7	3	made	make	VBN
10_1101-2021_01_06_425584	7	4	The	the	DT
10_1101-2021_01_06_425584	7	5	copyright	copyright	NN
10_1101-2021_01_06_425584	7	6	holder	holder	NN
10_1101-2021_01_06_425584	7	7	for	for	IN
10_1101-2021_01_06_425584	7	8	this	this	DT
10_1101-2021_01_06_425584	7	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	7	10	version	version	NN
10_1101-2021_01_06_425584	7	11	posted	post	VBD
10_1101-2021_01_06_425584	7	12	January	January	NNP
10_1101-2021_01_06_425584	7	13	8	8	CD
10_1101-2021_01_06_425584	7	14	,	,	,
10_1101-2021_01_06_425584	7	15	2021	2021	CD
10_1101-2021_01_06_425584	7	16	.	.	.
10_1101-2021_01_06_425584	7	17	;	;	:
10_1101-2021_01_06_425584	7	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	7	19	:	:	:
10_1101-2021_01_06_425584	7	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	7	21	preprint	preprint	NN
10_1101-2021_01_06_425584	7	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	7	23	-	-	:
10_1101-2021_01_06_425584	7	24	BY	by	IN
10_1101-2021_01_06_425584	7	25	-	-	HYPH
10_1101-2021_01_06_425584	7	26	NC	NC	NNP
10_1101-2021_01_06_425584	7	27	-	-	HYPH
10_1101-2021_01_06_425584	7	28	ND	ND	NNP
10_1101-2021_01_06_425584	7	29	4.0	4.0	CD
10_1101-2021_01_06_425584	7	30	International	International	NNP
10_1101-2021_01_06_425584	7	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	7	32	under	under	IN
10_1101-2021_01_06_425584	7	33	a	a	DT
10_1101-2021_01_06_425584	7	34	(	(	-LRB-
10_1101-2021_01_06_425584	7	35	which	which	WDT
10_1101-2021_01_06_425584	7	36	was	be	VBD
10_1101-2021_01_06_425584	7	37	not	not	RB
10_1101-2021_01_06_425584	7	38	certified	certify	VBN
10_1101-2021_01_06_425584	7	39	by	by	IN
10_1101-2021_01_06_425584	7	40	peer	peer	NN
10_1101-2021_01_06_425584	7	41	review	review	NN
10_1101-2021_01_06_425584	7	42	)	)	-RRB-
10_1101-2021_01_06_425584	7	43	is	be	VBZ
10_1101-2021_01_06_425584	7	44	the	the	DT
10_1101-2021_01_06_425584	7	45	author	author	NN
10_1101-2021_01_06_425584	7	46	/	/	SYM
10_1101-2021_01_06_425584	7	47	funder	funder	NN
10_1101-2021_01_06_425584	7	48	,	,	,
10_1101-2021_01_06_425584	7	49	who	who	WP
10_1101-2021_01_06_425584	7	50	has	have	VBZ
10_1101-2021_01_06_425584	7	51	granted	grant	VBN
10_1101-2021_01_06_425584	7	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	7	53	a	a	DT
10_1101-2021_01_06_425584	7	54	license	license	NN
10_1101-2021_01_06_425584	7	55	to	to	TO
10_1101-2021_01_06_425584	7	56	display	display	VB
10_1101-2021_01_06_425584	7	57	the	the	DT
10_1101-2021_01_06_425584	7	58	preprint	preprint	NN
10_1101-2021_01_06_425584	7	59	in	in	IN
10_1101-2021_01_06_425584	7	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	7	61	.	.	.
10_1101-2021_01_06_425584	8	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	8	2	is	be	VBZ
10_1101-2021_01_06_425584	8	3	made	make	VBN
10_1101-2021_01_06_425584	8	4	The	the	DT
10_1101-2021_01_06_425584	8	5	copyright	copyright	NN
10_1101-2021_01_06_425584	8	6	holder	holder	NN
10_1101-2021_01_06_425584	8	7	for	for	IN
10_1101-2021_01_06_425584	8	8	this	this	DT
10_1101-2021_01_06_425584	8	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	8	10	version	version	NN
10_1101-2021_01_06_425584	8	11	posted	post	VBD
10_1101-2021_01_06_425584	8	12	January	January	NNP
10_1101-2021_01_06_425584	8	13	8	8	CD
10_1101-2021_01_06_425584	8	14	,	,	,
10_1101-2021_01_06_425584	8	15	2021	2021	CD
10_1101-2021_01_06_425584	8	16	.	.	.
10_1101-2021_01_06_425584	8	17	;	;	:
10_1101-2021_01_06_425584	8	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	8	19	:	:	:
10_1101-2021_01_06_425584	8	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	8	21	preprint	preprint	NN
10_1101-2021_01_06_425584	8	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	8	23	-	-	:
10_1101-2021_01_06_425584	8	24	BY	by	IN
10_1101-2021_01_06_425584	8	25	-	-	HYPH
10_1101-2021_01_06_425584	8	26	NC	NC	NNP
10_1101-2021_01_06_425584	8	27	-	-	HYPH
10_1101-2021_01_06_425584	8	28	ND	ND	NNP
10_1101-2021_01_06_425584	8	29	4.0	4.0	CD
10_1101-2021_01_06_425584	8	30	International	International	NNP
10_1101-2021_01_06_425584	8	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	8	32	under	under	IN
10_1101-2021_01_06_425584	8	33	a	a	DT
10_1101-2021_01_06_425584	8	34	(	(	-LRB-
10_1101-2021_01_06_425584	8	35	which	which	WDT
10_1101-2021_01_06_425584	8	36	was	be	VBD
10_1101-2021_01_06_425584	8	37	not	not	RB
10_1101-2021_01_06_425584	8	38	certified	certify	VBN
10_1101-2021_01_06_425584	8	39	by	by	IN
10_1101-2021_01_06_425584	8	40	peer	peer	NN
10_1101-2021_01_06_425584	8	41	review	review	NN
10_1101-2021_01_06_425584	8	42	)	)	-RRB-
10_1101-2021_01_06_425584	8	43	is	be	VBZ
10_1101-2021_01_06_425584	8	44	the	the	DT
10_1101-2021_01_06_425584	8	45	author	author	NN
10_1101-2021_01_06_425584	8	46	/	/	SYM
10_1101-2021_01_06_425584	8	47	funder	funder	NN
10_1101-2021_01_06_425584	8	48	,	,	,
10_1101-2021_01_06_425584	8	49	who	who	WP
10_1101-2021_01_06_425584	8	50	has	have	VBZ
10_1101-2021_01_06_425584	8	51	granted	grant	VBN
10_1101-2021_01_06_425584	8	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	8	53	a	a	DT
10_1101-2021_01_06_425584	8	54	license	license	NN
10_1101-2021_01_06_425584	8	55	to	to	TO
10_1101-2021_01_06_425584	8	56	display	display	VB
10_1101-2021_01_06_425584	8	57	the	the	DT
10_1101-2021_01_06_425584	8	58	preprint	preprint	NN
10_1101-2021_01_06_425584	8	59	in	in	IN
10_1101-2021_01_06_425584	8	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	8	61	.	.	.
10_1101-2021_01_06_425584	9	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	9	2	is	be	VBZ
10_1101-2021_01_06_425584	9	3	made	make	VBN
10_1101-2021_01_06_425584	9	4	The	the	DT
10_1101-2021_01_06_425584	9	5	copyright	copyright	NN
10_1101-2021_01_06_425584	9	6	holder	holder	NN
10_1101-2021_01_06_425584	9	7	for	for	IN
10_1101-2021_01_06_425584	9	8	this	this	DT
10_1101-2021_01_06_425584	9	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	9	10	version	version	NN
10_1101-2021_01_06_425584	9	11	posted	post	VBD
10_1101-2021_01_06_425584	9	12	January	January	NNP
10_1101-2021_01_06_425584	9	13	8	8	CD
10_1101-2021_01_06_425584	9	14	,	,	,
10_1101-2021_01_06_425584	9	15	2021	2021	CD
10_1101-2021_01_06_425584	9	16	.	.	.
10_1101-2021_01_06_425584	9	17	;	;	:
10_1101-2021_01_06_425584	9	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	9	19	:	:	:
10_1101-2021_01_06_425584	9	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	9	21	preprint	preprint	NN
10_1101-2021_01_06_425584	9	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	9	23	-	-	:
10_1101-2021_01_06_425584	9	24	BY	by	IN
10_1101-2021_01_06_425584	9	25	-	-	HYPH
10_1101-2021_01_06_425584	9	26	NC	NC	NNP
10_1101-2021_01_06_425584	9	27	-	-	HYPH
10_1101-2021_01_06_425584	9	28	ND	ND	NNP
10_1101-2021_01_06_425584	9	29	4.0	4.0	CD
10_1101-2021_01_06_425584	9	30	International	International	NNP
10_1101-2021_01_06_425584	9	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	9	32	under	under	IN
10_1101-2021_01_06_425584	9	33	a	a	DT
10_1101-2021_01_06_425584	9	34	(	(	-LRB-
10_1101-2021_01_06_425584	9	35	which	which	WDT
10_1101-2021_01_06_425584	9	36	was	be	VBD
10_1101-2021_01_06_425584	9	37	not	not	RB
10_1101-2021_01_06_425584	9	38	certified	certify	VBN
10_1101-2021_01_06_425584	9	39	by	by	IN
10_1101-2021_01_06_425584	9	40	peer	peer	NN
10_1101-2021_01_06_425584	9	41	review	review	NN
10_1101-2021_01_06_425584	9	42	)	)	-RRB-
10_1101-2021_01_06_425584	9	43	is	be	VBZ
10_1101-2021_01_06_425584	9	44	the	the	DT
10_1101-2021_01_06_425584	9	45	author	author	NN
10_1101-2021_01_06_425584	9	46	/	/	SYM
10_1101-2021_01_06_425584	9	47	funder	funder	NN
10_1101-2021_01_06_425584	9	48	,	,	,
10_1101-2021_01_06_425584	9	49	who	who	WP
10_1101-2021_01_06_425584	9	50	has	have	VBZ
10_1101-2021_01_06_425584	9	51	granted	grant	VBN
10_1101-2021_01_06_425584	9	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	9	53	a	a	DT
10_1101-2021_01_06_425584	9	54	license	license	NN
10_1101-2021_01_06_425584	9	55	to	to	TO
10_1101-2021_01_06_425584	9	56	display	display	VB
10_1101-2021_01_06_425584	9	57	the	the	DT
10_1101-2021_01_06_425584	9	58	preprint	preprint	NN
10_1101-2021_01_06_425584	9	59	in	in	IN
10_1101-2021_01_06_425584	9	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	9	61	.	.	.
10_1101-2021_01_06_425584	10	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	10	2	is	be	VBZ
10_1101-2021_01_06_425584	10	3	made	make	VBN
10_1101-2021_01_06_425584	10	4	The	the	DT
10_1101-2021_01_06_425584	10	5	copyright	copyright	NN
10_1101-2021_01_06_425584	10	6	holder	holder	NN
10_1101-2021_01_06_425584	10	7	for	for	IN
10_1101-2021_01_06_425584	10	8	this	this	DT
10_1101-2021_01_06_425584	10	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	10	10	version	version	NN
10_1101-2021_01_06_425584	10	11	posted	post	VBD
10_1101-2021_01_06_425584	10	12	January	January	NNP
10_1101-2021_01_06_425584	10	13	8	8	CD
10_1101-2021_01_06_425584	10	14	,	,	,
10_1101-2021_01_06_425584	10	15	2021	2021	CD
10_1101-2021_01_06_425584	10	16	.	.	.
10_1101-2021_01_06_425584	10	17	;	;	:
10_1101-2021_01_06_425584	10	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	10	19	:	:	:
10_1101-2021_01_06_425584	10	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	10	21	preprint	preprint	NN
10_1101-2021_01_06_425584	10	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	10	23	-	-	:
10_1101-2021_01_06_425584	10	24	BY	by	IN
10_1101-2021_01_06_425584	10	25	-	-	HYPH
10_1101-2021_01_06_425584	10	26	NC	NC	NNP
10_1101-2021_01_06_425584	10	27	-	-	HYPH
10_1101-2021_01_06_425584	10	28	ND	ND	NNP
10_1101-2021_01_06_425584	10	29	4.0	4.0	CD
10_1101-2021_01_06_425584	10	30	International	International	NNP
10_1101-2021_01_06_425584	10	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	10	32	under	under	IN
10_1101-2021_01_06_425584	10	33	a	a	DT
10_1101-2021_01_06_425584	10	34	(	(	-LRB-
10_1101-2021_01_06_425584	10	35	which	which	WDT
10_1101-2021_01_06_425584	10	36	was	be	VBD
10_1101-2021_01_06_425584	10	37	not	not	RB
10_1101-2021_01_06_425584	10	38	certified	certify	VBN
10_1101-2021_01_06_425584	10	39	by	by	IN
10_1101-2021_01_06_425584	10	40	peer	peer	NN
10_1101-2021_01_06_425584	10	41	review	review	NN
10_1101-2021_01_06_425584	10	42	)	)	-RRB-
10_1101-2021_01_06_425584	10	43	is	be	VBZ
10_1101-2021_01_06_425584	10	44	the	the	DT
10_1101-2021_01_06_425584	10	45	author	author	NN
10_1101-2021_01_06_425584	10	46	/	/	SYM
10_1101-2021_01_06_425584	10	47	funder	funder	NN
10_1101-2021_01_06_425584	10	48	,	,	,
10_1101-2021_01_06_425584	10	49	who	who	WP
10_1101-2021_01_06_425584	10	50	has	have	VBZ
10_1101-2021_01_06_425584	10	51	granted	grant	VBN
10_1101-2021_01_06_425584	10	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	10	53	a	a	DT
10_1101-2021_01_06_425584	10	54	license	license	NN
10_1101-2021_01_06_425584	10	55	to	to	TO
10_1101-2021_01_06_425584	10	56	display	display	VB
10_1101-2021_01_06_425584	10	57	the	the	DT
10_1101-2021_01_06_425584	10	58	preprint	preprint	NN
10_1101-2021_01_06_425584	10	59	in	in	IN
10_1101-2021_01_06_425584	10	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	10	61	.	.	.
10_1101-2021_01_06_425584	11	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	11	2	is	be	VBZ
10_1101-2021_01_06_425584	11	3	made	make	VBN
10_1101-2021_01_06_425584	11	4	The	the	DT
10_1101-2021_01_06_425584	11	5	copyright	copyright	NN
10_1101-2021_01_06_425584	11	6	holder	holder	NN
10_1101-2021_01_06_425584	11	7	for	for	IN
10_1101-2021_01_06_425584	11	8	this	this	DT
10_1101-2021_01_06_425584	11	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	11	10	version	version	NN
10_1101-2021_01_06_425584	11	11	posted	post	VBD
10_1101-2021_01_06_425584	11	12	January	January	NNP
10_1101-2021_01_06_425584	11	13	8	8	CD
10_1101-2021_01_06_425584	11	14	,	,	,
10_1101-2021_01_06_425584	11	15	2021	2021	CD
10_1101-2021_01_06_425584	11	16	.	.	.
10_1101-2021_01_06_425584	11	17	;	;	:
10_1101-2021_01_06_425584	11	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	11	19	:	:	:
10_1101-2021_01_06_425584	11	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	11	21	preprint	preprint	NN
10_1101-2021_01_06_425584	11	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	11	23	-	-	:
10_1101-2021_01_06_425584	11	24	BY	by	IN
10_1101-2021_01_06_425584	11	25	-	-	HYPH
10_1101-2021_01_06_425584	11	26	NC	NC	NNP
10_1101-2021_01_06_425584	11	27	-	-	HYPH
10_1101-2021_01_06_425584	11	28	ND	ND	NNP
10_1101-2021_01_06_425584	11	29	4.0	4.0	CD
10_1101-2021_01_06_425584	11	30	International	International	NNP
10_1101-2021_01_06_425584	11	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	11	32	under	under	IN
10_1101-2021_01_06_425584	11	33	a	a	DT
10_1101-2021_01_06_425584	11	34	(	(	-LRB-
10_1101-2021_01_06_425584	11	35	which	which	WDT
10_1101-2021_01_06_425584	11	36	was	be	VBD
10_1101-2021_01_06_425584	11	37	not	not	RB
10_1101-2021_01_06_425584	11	38	certified	certify	VBN
10_1101-2021_01_06_425584	11	39	by	by	IN
10_1101-2021_01_06_425584	11	40	peer	peer	NN
10_1101-2021_01_06_425584	11	41	review	review	NN
10_1101-2021_01_06_425584	11	42	)	)	-RRB-
10_1101-2021_01_06_425584	11	43	is	be	VBZ
10_1101-2021_01_06_425584	11	44	the	the	DT
10_1101-2021_01_06_425584	11	45	author	author	NN
10_1101-2021_01_06_425584	11	46	/	/	SYM
10_1101-2021_01_06_425584	11	47	funder	funder	NN
10_1101-2021_01_06_425584	11	48	,	,	,
10_1101-2021_01_06_425584	11	49	who	who	WP
10_1101-2021_01_06_425584	11	50	has	have	VBZ
10_1101-2021_01_06_425584	11	51	granted	grant	VBN
10_1101-2021_01_06_425584	11	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	11	53	a	a	DT
10_1101-2021_01_06_425584	11	54	license	license	NN
10_1101-2021_01_06_425584	11	55	to	to	TO
10_1101-2021_01_06_425584	11	56	display	display	VB
10_1101-2021_01_06_425584	11	57	the	the	DT
10_1101-2021_01_06_425584	11	58	preprint	preprint	NN
10_1101-2021_01_06_425584	11	59	in	in	IN
10_1101-2021_01_06_425584	11	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	11	61	.	.	.
10_1101-2021_01_06_425584	12	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	12	2	is	be	VBZ
10_1101-2021_01_06_425584	12	3	made	make	VBN
10_1101-2021_01_06_425584	12	4	The	the	DT
10_1101-2021_01_06_425584	12	5	copyright	copyright	NN
10_1101-2021_01_06_425584	12	6	holder	holder	NN
10_1101-2021_01_06_425584	12	7	for	for	IN
10_1101-2021_01_06_425584	12	8	this	this	DT
10_1101-2021_01_06_425584	12	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	12	10	version	version	NN
10_1101-2021_01_06_425584	12	11	posted	post	VBD
10_1101-2021_01_06_425584	12	12	January	January	NNP
10_1101-2021_01_06_425584	12	13	8	8	CD
10_1101-2021_01_06_425584	12	14	,	,	,
10_1101-2021_01_06_425584	12	15	2021	2021	CD
10_1101-2021_01_06_425584	12	16	.	.	.
10_1101-2021_01_06_425584	12	17	;	;	:
10_1101-2021_01_06_425584	12	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	12	19	:	:	:
10_1101-2021_01_06_425584	12	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	12	21	preprint	preprint	NN
10_1101-2021_01_06_425584	12	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	12	23	-	-	:
10_1101-2021_01_06_425584	12	24	BY	by	IN
10_1101-2021_01_06_425584	12	25	-	-	HYPH
10_1101-2021_01_06_425584	12	26	NC	NC	NNP
10_1101-2021_01_06_425584	12	27	-	-	HYPH
10_1101-2021_01_06_425584	12	28	ND	ND	NNP
10_1101-2021_01_06_425584	12	29	4.0	4.0	CD
10_1101-2021_01_06_425584	12	30	International	International	NNP
10_1101-2021_01_06_425584	12	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	12	32	under	under	IN
10_1101-2021_01_06_425584	12	33	a	a	DT
10_1101-2021_01_06_425584	12	34	(	(	-LRB-
10_1101-2021_01_06_425584	12	35	which	which	WDT
10_1101-2021_01_06_425584	12	36	was	be	VBD
10_1101-2021_01_06_425584	12	37	not	not	RB
10_1101-2021_01_06_425584	12	38	certified	certify	VBN
10_1101-2021_01_06_425584	12	39	by	by	IN
10_1101-2021_01_06_425584	12	40	peer	peer	NN
10_1101-2021_01_06_425584	12	41	review	review	NN
10_1101-2021_01_06_425584	12	42	)	)	-RRB-
10_1101-2021_01_06_425584	12	43	is	be	VBZ
10_1101-2021_01_06_425584	12	44	the	the	DT
10_1101-2021_01_06_425584	12	45	author	author	NN
10_1101-2021_01_06_425584	12	46	/	/	SYM
10_1101-2021_01_06_425584	12	47	funder	funder	NN
10_1101-2021_01_06_425584	12	48	,	,	,
10_1101-2021_01_06_425584	12	49	who	who	WP
10_1101-2021_01_06_425584	12	50	has	have	VBZ
10_1101-2021_01_06_425584	12	51	granted	grant	VBN
10_1101-2021_01_06_425584	12	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	12	53	a	a	DT
10_1101-2021_01_06_425584	12	54	license	license	NN
10_1101-2021_01_06_425584	12	55	to	to	TO
10_1101-2021_01_06_425584	12	56	display	display	VB
10_1101-2021_01_06_425584	12	57	the	the	DT
10_1101-2021_01_06_425584	12	58	preprint	preprint	NN
10_1101-2021_01_06_425584	12	59	in	in	IN
10_1101-2021_01_06_425584	12	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	12	61	.	.	.
10_1101-2021_01_06_425584	13	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	13	2	is	be	VBZ
10_1101-2021_01_06_425584	13	3	made	make	VBN
10_1101-2021_01_06_425584	13	4	The	the	DT
10_1101-2021_01_06_425584	13	5	copyright	copyright	NN
10_1101-2021_01_06_425584	13	6	holder	holder	NN
10_1101-2021_01_06_425584	13	7	for	for	IN
10_1101-2021_01_06_425584	13	8	this	this	DT
10_1101-2021_01_06_425584	13	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	13	10	version	version	NN
10_1101-2021_01_06_425584	13	11	posted	post	VBD
10_1101-2021_01_06_425584	13	12	January	January	NNP
10_1101-2021_01_06_425584	13	13	8	8	CD
10_1101-2021_01_06_425584	13	14	,	,	,
10_1101-2021_01_06_425584	13	15	2021	2021	CD
10_1101-2021_01_06_425584	13	16	.	.	.
10_1101-2021_01_06_425584	13	17	;	;	:
10_1101-2021_01_06_425584	13	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	13	19	:	:	:
10_1101-2021_01_06_425584	13	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	13	21	preprint	preprint	NN
10_1101-2021_01_06_425584	13	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	13	23	-	-	:
10_1101-2021_01_06_425584	13	24	BY	by	IN
10_1101-2021_01_06_425584	13	25	-	-	HYPH
10_1101-2021_01_06_425584	13	26	NC	NC	NNP
10_1101-2021_01_06_425584	13	27	-	-	HYPH
10_1101-2021_01_06_425584	13	28	ND	ND	NNP
10_1101-2021_01_06_425584	13	29	4.0	4.0	CD
10_1101-2021_01_06_425584	13	30	International	International	NNP
10_1101-2021_01_06_425584	13	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	13	32	under	under	IN
10_1101-2021_01_06_425584	13	33	a	a	DT
10_1101-2021_01_06_425584	13	34	(	(	-LRB-
10_1101-2021_01_06_425584	13	35	which	which	WDT
10_1101-2021_01_06_425584	13	36	was	be	VBD
10_1101-2021_01_06_425584	13	37	not	not	RB
10_1101-2021_01_06_425584	13	38	certified	certify	VBN
10_1101-2021_01_06_425584	13	39	by	by	IN
10_1101-2021_01_06_425584	13	40	peer	peer	NN
10_1101-2021_01_06_425584	13	41	review	review	NN
10_1101-2021_01_06_425584	13	42	)	)	-RRB-
10_1101-2021_01_06_425584	13	43	is	be	VBZ
10_1101-2021_01_06_425584	13	44	the	the	DT
10_1101-2021_01_06_425584	13	45	author	author	NN
10_1101-2021_01_06_425584	13	46	/	/	SYM
10_1101-2021_01_06_425584	13	47	funder	funder	NN
10_1101-2021_01_06_425584	13	48	,	,	,
10_1101-2021_01_06_425584	13	49	who	who	WP
10_1101-2021_01_06_425584	13	50	has	have	VBZ
10_1101-2021_01_06_425584	13	51	granted	grant	VBN
10_1101-2021_01_06_425584	13	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	13	53	a	a	DT
10_1101-2021_01_06_425584	13	54	license	license	NN
10_1101-2021_01_06_425584	13	55	to	to	TO
10_1101-2021_01_06_425584	13	56	display	display	VB
10_1101-2021_01_06_425584	13	57	the	the	DT
10_1101-2021_01_06_425584	13	58	preprint	preprint	NN
10_1101-2021_01_06_425584	13	59	in	in	IN
10_1101-2021_01_06_425584	13	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	13	61	.	.	.
10_1101-2021_01_06_425584	14	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	14	2	is	be	VBZ
10_1101-2021_01_06_425584	14	3	made	make	VBN
10_1101-2021_01_06_425584	14	4	The	the	DT
10_1101-2021_01_06_425584	14	5	copyright	copyright	NN
10_1101-2021_01_06_425584	14	6	holder	holder	NN
10_1101-2021_01_06_425584	14	7	for	for	IN
10_1101-2021_01_06_425584	14	8	this	this	DT
10_1101-2021_01_06_425584	14	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	14	10	version	version	NN
10_1101-2021_01_06_425584	14	11	posted	post	VBD
10_1101-2021_01_06_425584	14	12	January	January	NNP
10_1101-2021_01_06_425584	14	13	8	8	CD
10_1101-2021_01_06_425584	14	14	,	,	,
10_1101-2021_01_06_425584	14	15	2021	2021	CD
10_1101-2021_01_06_425584	14	16	.	.	.
10_1101-2021_01_06_425584	14	17	;	;	:
10_1101-2021_01_06_425584	14	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	14	19	:	:	:
10_1101-2021_01_06_425584	14	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	14	21	preprint	preprint	NN
10_1101-2021_01_06_425584	14	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	14	23	-	-	:
10_1101-2021_01_06_425584	14	24	BY	by	IN
10_1101-2021_01_06_425584	14	25	-	-	HYPH
10_1101-2021_01_06_425584	14	26	NC	NC	NNP
10_1101-2021_01_06_425584	14	27	-	-	HYPH
10_1101-2021_01_06_425584	14	28	ND	ND	NNP
10_1101-2021_01_06_425584	14	29	4.0	4.0	CD
10_1101-2021_01_06_425584	14	30	International	International	NNP
10_1101-2021_01_06_425584	14	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	14	32	under	under	IN
10_1101-2021_01_06_425584	14	33	a	a	DT
10_1101-2021_01_06_425584	14	34	(	(	-LRB-
10_1101-2021_01_06_425584	14	35	which	which	WDT
10_1101-2021_01_06_425584	14	36	was	be	VBD
10_1101-2021_01_06_425584	14	37	not	not	RB
10_1101-2021_01_06_425584	14	38	certified	certify	VBN
10_1101-2021_01_06_425584	14	39	by	by	IN
10_1101-2021_01_06_425584	14	40	peer	peer	NN
10_1101-2021_01_06_425584	14	41	review	review	NN
10_1101-2021_01_06_425584	14	42	)	)	-RRB-
10_1101-2021_01_06_425584	14	43	is	be	VBZ
10_1101-2021_01_06_425584	14	44	the	the	DT
10_1101-2021_01_06_425584	14	45	author	author	NN
10_1101-2021_01_06_425584	14	46	/	/	SYM
10_1101-2021_01_06_425584	14	47	funder	funder	NN
10_1101-2021_01_06_425584	14	48	,	,	,
10_1101-2021_01_06_425584	14	49	who	who	WP
10_1101-2021_01_06_425584	14	50	has	have	VBZ
10_1101-2021_01_06_425584	14	51	granted	grant	VBN
10_1101-2021_01_06_425584	14	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	14	53	a	a	DT
10_1101-2021_01_06_425584	14	54	license	license	NN
10_1101-2021_01_06_425584	14	55	to	to	TO
10_1101-2021_01_06_425584	14	56	display	display	VB
10_1101-2021_01_06_425584	14	57	the	the	DT
10_1101-2021_01_06_425584	14	58	preprint	preprint	NN
10_1101-2021_01_06_425584	14	59	in	in	IN
10_1101-2021_01_06_425584	14	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	14	61	.	.	.
10_1101-2021_01_06_425584	15	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	15	2	is	be	VBZ
10_1101-2021_01_06_425584	15	3	made	make	VBN
10_1101-2021_01_06_425584	15	4	The	the	DT
10_1101-2021_01_06_425584	15	5	copyright	copyright	NN
10_1101-2021_01_06_425584	15	6	holder	holder	NN
10_1101-2021_01_06_425584	15	7	for	for	IN
10_1101-2021_01_06_425584	15	8	this	this	DT
10_1101-2021_01_06_425584	15	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	15	10	version	version	NN
10_1101-2021_01_06_425584	15	11	posted	post	VBD
10_1101-2021_01_06_425584	15	12	January	January	NNP
10_1101-2021_01_06_425584	15	13	8	8	CD
10_1101-2021_01_06_425584	15	14	,	,	,
10_1101-2021_01_06_425584	15	15	2021	2021	CD
10_1101-2021_01_06_425584	15	16	.	.	.
10_1101-2021_01_06_425584	15	17	;	;	:
10_1101-2021_01_06_425584	15	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	15	19	:	:	:
10_1101-2021_01_06_425584	15	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	15	21	preprint	preprint	NN
10_1101-2021_01_06_425584	15	22	.CC	.CC	NFP
10_1101-2021_01_06_425584	15	23	-	-	:
10_1101-2021_01_06_425584	15	24	BY	by	IN
10_1101-2021_01_06_425584	15	25	-	-	HYPH
10_1101-2021_01_06_425584	15	26	NC	NC	NNP
10_1101-2021_01_06_425584	15	27	-	-	HYPH
10_1101-2021_01_06_425584	15	28	ND	ND	NNP
10_1101-2021_01_06_425584	15	29	4.0	4.0	CD
10_1101-2021_01_06_425584	15	30	International	International	NNP
10_1101-2021_01_06_425584	15	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	15	32	under	under	IN
10_1101-2021_01_06_425584	15	33	a	a	DT
10_1101-2021_01_06_425584	15	34	(	(	-LRB-
10_1101-2021_01_06_425584	15	35	which	which	WDT
10_1101-2021_01_06_425584	15	36	was	be	VBD
10_1101-2021_01_06_425584	15	37	not	not	RB
10_1101-2021_01_06_425584	15	38	certified	certify	VBN
10_1101-2021_01_06_425584	15	39	by	by	IN
10_1101-2021_01_06_425584	15	40	peer	peer	NN
10_1101-2021_01_06_425584	15	41	review	review	NN
10_1101-2021_01_06_425584	15	42	)	)	-RRB-
10_1101-2021_01_06_425584	15	43	is	be	VBZ
10_1101-2021_01_06_425584	15	44	the	the	DT
10_1101-2021_01_06_425584	15	45	author	author	NN
10_1101-2021_01_06_425584	15	46	/	/	SYM
10_1101-2021_01_06_425584	15	47	funder	funder	NN
10_1101-2021_01_06_425584	15	48	,	,	,
10_1101-2021_01_06_425584	15	49	who	who	WP
10_1101-2021_01_06_425584	15	50	has	have	VBZ
10_1101-2021_01_06_425584	15	51	granted	grant	VBN
10_1101-2021_01_06_425584	15	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	15	53	a	a	DT
10_1101-2021_01_06_425584	15	54	license	license	NN
10_1101-2021_01_06_425584	15	55	to	to	TO
10_1101-2021_01_06_425584	15	56	display	display	VB
10_1101-2021_01_06_425584	15	57	the	the	DT
10_1101-2021_01_06_425584	15	58	preprint	preprint	NN
10_1101-2021_01_06_425584	15	59	in	in	IN
10_1101-2021_01_06_425584	15	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	15	61	.	.	.
10_1101-2021_01_06_425584	16	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	16	2	is	be	VBZ
10_1101-2021_01_06_425584	16	3	made	make	VBN
10_1101-2021_01_06_425584	16	4	The	the	DT
10_1101-2021_01_06_425584	16	5	copyright	copyright	NN
10_1101-2021_01_06_425584	16	6	holder	holder	NN
10_1101-2021_01_06_425584	16	7	for	for	IN
10_1101-2021_01_06_425584	16	8	this	this	DT
10_1101-2021_01_06_425584	16	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	16	10	version	version	NN
10_1101-2021_01_06_425584	16	11	posted	post	VBD
10_1101-2021_01_06_425584	16	12	January	January	NNP
10_1101-2021_01_06_425584	16	13	8	8	CD
10_1101-2021_01_06_425584	16	14	,	,	,
10_1101-2021_01_06_425584	16	15	2021	2021	CD
10_1101-2021_01_06_425584	16	16	.	.	.
10_1101-2021_01_06_425584	16	17	;	;	:
10_1101-2021_01_06_425584	16	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	16	19	:	:	:
10_1101-2021_01_06_425584	16	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	16	21	preprint	preprint	NN
10_1101-2021_01_06_425584	16	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	24	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	25	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	26	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	27	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	28	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	29	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	30	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	31	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	32	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	33	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	34	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	35	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	36	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	37	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	38	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	39	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	40	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	41	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	42	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	16	43	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	16	44	2	2	CD
10_1101-2021_01_06_425584	16	45	Abstract	Abstract	NNP
10_1101-2021_01_06_425584	16	46	25	25	CD
10_1101-2021_01_06_425584	16	47	Coronary	coronary	JJ
10_1101-2021_01_06_425584	16	48	artery	artery	NN
10_1101-2021_01_06_425584	16	49	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	16	50	cells	cell	NNS
10_1101-2021_01_06_425584	16	51	(	(	-LRB-
10_1101-2021_01_06_425584	16	52	CAEC	caec	NN
10_1101-2021_01_06_425584	16	53	)	)	-RRB-
10_1101-2021_01_06_425584	16	54	exert	exert	VBP
10_1101-2021_01_06_425584	16	55	an	an	DT
10_1101-2021_01_06_425584	16	56	important	important	JJ
10_1101-2021_01_06_425584	16	57	role	role	NN
10_1101-2021_01_06_425584	16	58	in	in	IN
10_1101-2021_01_06_425584	16	59	the	the	DT
10_1101-2021_01_06_425584	16	60	development	development	NN
10_1101-2021_01_06_425584	16	61	of	of	IN
10_1101-2021_01_06_425584	16	62	26	26	CD
10_1101-2021_01_06_425584	16	63	cardiovascular	cardiovascular	JJ
10_1101-2021_01_06_425584	16	64	disease	disease	NN
10_1101-2021_01_06_425584	16	65	.	.	.
10_1101-2021_01_06_425584	17	1	Dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	17	2	of	of	IN
10_1101-2021_01_06_425584	17	3	CAEC	CAEC	NNP
10_1101-2021_01_06_425584	17	4	is	be	VBZ
10_1101-2021_01_06_425584	17	5	associated	associate	VBN
10_1101-2021_01_06_425584	17	6	with	with	IN
10_1101-2021_01_06_425584	17	7	cardiovascular	cardiovascular	JJ
10_1101-2021_01_06_425584	17	8	disease	disease	NN
10_1101-2021_01_06_425584	17	9	in	in	IN
10_1101-2021_01_06_425584	17	10	27	27	CD
10_1101-2021_01_06_425584	17	11	subjects	subject	NNS
10_1101-2021_01_06_425584	17	12	with	with	IN
10_1101-2021_01_06_425584	17	13	type	type	NN
10_1101-2021_01_06_425584	17	14	2	2	CD
10_1101-2021_01_06_425584	17	15	diabetes	diabetes	NN
10_1101-2021_01_06_425584	17	16	mellitus	mellitus	NN
10_1101-2021_01_06_425584	17	17	(	(	-LRB-
10_1101-2021_01_06_425584	17	18	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	17	19	)	)	-RRB-
10_1101-2021_01_06_425584	17	20	.	.	.
10_1101-2021_01_06_425584	18	1	However	however	RB
10_1101-2021_01_06_425584	18	2	,	,	,
10_1101-2021_01_06_425584	18	3	comprehensive	comprehensive	JJ
10_1101-2021_01_06_425584	18	4	studies	study	NNS
10_1101-2021_01_06_425584	18	5	of	of	IN
10_1101-2021_01_06_425584	18	6	the	the	DT
10_1101-2021_01_06_425584	18	7	effects	effect	NNS
10_1101-2021_01_06_425584	18	8	28	28	CD
10_1101-2021_01_06_425584	18	9	that	that	IN
10_1101-2021_01_06_425584	18	10	a	a	DT
10_1101-2021_01_06_425584	18	11	diabetic	diabetic	JJ
10_1101-2021_01_06_425584	18	12	environment	environment	NN
10_1101-2021_01_06_425584	18	13	exerts	exert	NNS
10_1101-2021_01_06_425584	18	14	on	on	IN
10_1101-2021_01_06_425584	18	15	this	this	DT
10_1101-2021_01_06_425584	18	16	cellular	cellular	JJ
10_1101-2021_01_06_425584	18	17	type	type	NN
10_1101-2021_01_06_425584	18	18	scarce	scarce	JJ
10_1101-2021_01_06_425584	18	19	.	.	.
10_1101-2021_01_06_425584	19	1	The	the	DT
10_1101-2021_01_06_425584	19	2	present	present	JJ
10_1101-2021_01_06_425584	19	3	study	study	NN
10_1101-2021_01_06_425584	19	4	characterized	characterize	VBD
10_1101-2021_01_06_425584	19	5	29	29	CD
10_1101-2021_01_06_425584	19	6	the	the	DT
10_1101-2021_01_06_425584	19	7	molecular	molecular	JJ
10_1101-2021_01_06_425584	19	8	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	19	9	occurring	occur	VBG
10_1101-2021_01_06_425584	19	10	on	on	IN
10_1101-2021_01_06_425584	19	11	cultured	cultured	JJ
10_1101-2021_01_06_425584	19	12	bovine	bovine	NN
10_1101-2021_01_06_425584	19	13	CAEC	caec	NN
10_1101-2021_01_06_425584	19	14	subjected	subject	VBN
10_1101-2021_01_06_425584	19	15	to	to	IN
10_1101-2021_01_06_425584	19	16	a	a	DT
10_1101-2021_01_06_425584	19	17	prolonged	prolong	VBN
10_1101-2021_01_06_425584	19	18	diabetic	diabetic	JJ
10_1101-2021_01_06_425584	19	19	30	30	CD
10_1101-2021_01_06_425584	19	20	environment	environment	NN
10_1101-2021_01_06_425584	19	21	(	(	-LRB-
10_1101-2021_01_06_425584	19	22	high	high	JJ
10_1101-2021_01_06_425584	19	23	glucose	glucose	NN
10_1101-2021_01_06_425584	19	24	[	[	-LRB-
10_1101-2021_01_06_425584	19	25	HG	HG	NNP
10_1101-2021_01_06_425584	19	26	]	]	-RRB-
10_1101-2021_01_06_425584	19	27	and	and	CC
10_1101-2021_01_06_425584	19	28	high	high	JJ
10_1101-2021_01_06_425584	19	29	insulin	insulin	NN
10_1101-2021_01_06_425584	19	30	[	[	-LRB-
10_1101-2021_01_06_425584	19	31	HI	HI	NNP
10_1101-2021_01_06_425584	19	32	]	]	-RRB-
10_1101-2021_01_06_425584	19	33	)	)	-RRB-
10_1101-2021_01_06_425584	19	34	.	.	.
10_1101-2021_01_06_425584	20	1	Changes	change	NNS
10_1101-2021_01_06_425584	20	2	at	at	IN
10_1101-2021_01_06_425584	20	3	the	the	DT
10_1101-2021_01_06_425584	20	4	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	20	5	and	and	CC
10_1101-2021_01_06_425584	20	6	peptide	peptide	JJ
10_1101-2021_01_06_425584	20	7	31	31	CD
10_1101-2021_01_06_425584	20	8	level	level	NN
10_1101-2021_01_06_425584	20	9	were	be	VBD
10_1101-2021_01_06_425584	20	10	assessed	assess	VBN
10_1101-2021_01_06_425584	20	11	by	by	IN
10_1101-2021_01_06_425584	20	12	untargeted	untargeted	JJ
10_1101-2021_01_06_425584	20	13	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	20	14	and	and	CC
10_1101-2021_01_06_425584	20	15	chemoinformatics	chemoinformatic	NNS
10_1101-2021_01_06_425584	20	16	,	,	,
10_1101-2021_01_06_425584	20	17	and	and	CC
10_1101-2021_01_06_425584	20	18	the	the	DT
10_1101-2021_01_06_425584	20	19	results	result	NNS
10_1101-2021_01_06_425584	20	20	were	be	VBD
10_1101-2021_01_06_425584	20	21	32	32	CD
10_1101-2021_01_06_425584	20	22	integrated	integrate	VBN
10_1101-2021_01_06_425584	20	23	with	with	IN
10_1101-2021_01_06_425584	20	24	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	20	25	data	datum	NNS
10_1101-2021_01_06_425584	20	26	using	use	VBG
10_1101-2021_01_06_425584	20	27	published	publish	VBN
10_1101-2021_01_06_425584	20	28	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	20	29	-	-	HYPH
10_1101-2021_01_06_425584	20	30	based	base	VBN
10_1101-2021_01_06_425584	20	31	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	20	32	on	on	IN
10_1101-2021_01_06_425584	20	33	the	the	DT
10_1101-2021_01_06_425584	20	34	same	same	JJ
10_1101-2021_01_06_425584	20	35	in	in	FW
10_1101-2021_01_06_425584	20	36	vitro	vitro	FW
10_1101-2021_01_06_425584	20	37	33	33	CD
10_1101-2021_01_06_425584	20	38	model	model	NN
10_1101-2021_01_06_425584	20	39	.	.	.
10_1101-2021_01_06_425584	21	1	Our	-PRON-	PRP$
10_1101-2021_01_06_425584	21	2	findings	finding	NNS
10_1101-2021_01_06_425584	21	3	were	be	VBD
10_1101-2021_01_06_425584	21	4	consistent	consistent	JJ
10_1101-2021_01_06_425584	21	5	with	with	IN
10_1101-2021_01_06_425584	21	6	reports	report	NNS
10_1101-2021_01_06_425584	21	7	on	on	IN
10_1101-2021_01_06_425584	21	8	other	other	JJ
10_1101-2021_01_06_425584	21	9	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	21	10	cell	cell	NN
10_1101-2021_01_06_425584	21	11	types	type	NNS
10_1101-2021_01_06_425584	21	12	,	,	,
10_1101-2021_01_06_425584	21	13	but	but	CC
10_1101-2021_01_06_425584	21	14	also	also	RB
10_1101-2021_01_06_425584	21	15	identified	identify	VBD
10_1101-2021_01_06_425584	21	16	34	34	CD
10_1101-2021_01_06_425584	21	17	novel	novel	JJ
10_1101-2021_01_06_425584	21	18	signatures	signature	NNS
10_1101-2021_01_06_425584	21	19	of	of	IN
10_1101-2021_01_06_425584	21	20	DNA	DNA	NNP
10_1101-2021_01_06_425584	21	21	/	/	SYM
10_1101-2021_01_06_425584	21	22	RNA	RNA	NNP
10_1101-2021_01_06_425584	21	23	,	,	,
10_1101-2021_01_06_425584	21	24	aminoacid	aminoacid	NN
10_1101-2021_01_06_425584	21	25	,	,	,
10_1101-2021_01_06_425584	21	26	peptide	peptide	NN
10_1101-2021_01_06_425584	21	27	,	,	,
10_1101-2021_01_06_425584	21	28	and	and	CC
10_1101-2021_01_06_425584	21	29	lipid	lipid	VB
10_1101-2021_01_06_425584	21	30	metabolism	metabolism	NN
10_1101-2021_01_06_425584	21	31	in	in	IN
10_1101-2021_01_06_425584	21	32	cells	cell	NNS
10_1101-2021_01_06_425584	21	33	under	under	IN
10_1101-2021_01_06_425584	21	34	a	a	DT
10_1101-2021_01_06_425584	21	35	diabetic	diabetic	JJ
10_1101-2021_01_06_425584	21	36	35	35	CD
10_1101-2021_01_06_425584	21	37	environment	environment	NN
10_1101-2021_01_06_425584	21	38	.	.	.
10_1101-2021_01_06_425584	22	1	Manual	manual	JJ
10_1101-2021_01_06_425584	22	2	data	datum	NNS
10_1101-2021_01_06_425584	22	3	inspection	inspection	NN
10_1101-2021_01_06_425584	22	4	revealed	reveal	VBD
10_1101-2021_01_06_425584	22	5	disturbances	disturbance	NNS
10_1101-2021_01_06_425584	22	6	on	on	IN
10_1101-2021_01_06_425584	22	7	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	22	8	catabolism	catabolism	NN
10_1101-2021_01_06_425584	22	9	and	and	CC
10_1101-2021_01_06_425584	22	10	36	36	CD
10_1101-2021_01_06_425584	22	11	biosynthesis	biosynthesis	NN
10_1101-2021_01_06_425584	22	12	of	of	IN
10_1101-2021_01_06_425584	22	13	phenylalanine	phenylalanine	NN
10_1101-2021_01_06_425584	22	14	-	-	HYPH
10_1101-2021_01_06_425584	22	15	based	base	VBN
10_1101-2021_01_06_425584	22	16	,	,	,
10_1101-2021_01_06_425584	22	17	glutathione	glutathione	NN
10_1101-2021_01_06_425584	22	18	-	-	HYPH
10_1101-2021_01_06_425584	22	19	based	base	VBN
10_1101-2021_01_06_425584	22	20	,	,	,
10_1101-2021_01_06_425584	22	21	and	and	CC
10_1101-2021_01_06_425584	22	22	proline	proline	NN
10_1101-2021_01_06_425584	22	23	-	-	HYPH
10_1101-2021_01_06_425584	22	24	based	base	VBN
10_1101-2021_01_06_425584	22	25	peptide	peptide	NN
10_1101-2021_01_06_425584	22	26	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	22	27	.	.	.
10_1101-2021_01_06_425584	23	1	37	37	CD
10_1101-2021_01_06_425584	23	2	Fluorescence	fluorescence	NN
10_1101-2021_01_06_425584	23	3	microscopy	microscopy	NN
10_1101-2021_01_06_425584	23	4	detected	detect	VBD
10_1101-2021_01_06_425584	23	5	an	an	DT
10_1101-2021_01_06_425584	23	6	increase	increase	NN
10_1101-2021_01_06_425584	23	7	in	in	IN
10_1101-2021_01_06_425584	23	8	binucleation	binucleation	NN
10_1101-2021_01_06_425584	23	9	in	in	IN
10_1101-2021_01_06_425584	23	10	cells	cell	NNS
10_1101-2021_01_06_425584	23	11	under	under	IN
10_1101-2021_01_06_425584	23	12	treatment	treatment	NN
10_1101-2021_01_06_425584	23	13	that	that	WDT
10_1101-2021_01_06_425584	23	14	also	also	RB
10_1101-2021_01_06_425584	23	15	38	38	CD
10_1101-2021_01_06_425584	23	16	occurred	occur	VBD
10_1101-2021_01_06_425584	23	17	when	when	WRB
10_1101-2021_01_06_425584	23	18	human	human	NN
10_1101-2021_01_06_425584	23	19	CAEC	CAEC	NNP
10_1101-2021_01_06_425584	23	20	were	be	VBD
10_1101-2021_01_06_425584	23	21	used	use	VBN
10_1101-2021_01_06_425584	23	22	.	.	.
10_1101-2021_01_06_425584	24	1	This	this	DT
10_1101-2021_01_06_425584	24	2	multi	multi	JJ
10_1101-2021_01_06_425584	24	3	-	-	HYPH
10_1101-2021_01_06_425584	24	4	omics	omics	JJ
10_1101-2021_01_06_425584	24	5	study	study	NN
10_1101-2021_01_06_425584	24	6	identified	identify	VBD
10_1101-2021_01_06_425584	24	7	particular	particular	JJ
10_1101-2021_01_06_425584	24	8	molecular	molecular	JJ
10_1101-2021_01_06_425584	24	9	39	39	CD
10_1101-2021_01_06_425584	24	10	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	24	11	in	in	IN
10_1101-2021_01_06_425584	24	12	an	an	DT
10_1101-2021_01_06_425584	24	13	induced	induce	VBN
10_1101-2021_01_06_425584	24	14	diabetic	diabetic	JJ
10_1101-2021_01_06_425584	24	15	environment	environment	NN
10_1101-2021_01_06_425584	24	16	that	that	WDT
10_1101-2021_01_06_425584	24	17	could	could	MD
10_1101-2021_01_06_425584	24	18	help	help	VB
10_1101-2021_01_06_425584	24	19	unravel	unravel	VB
10_1101-2021_01_06_425584	24	20	the	the	DT
10_1101-2021_01_06_425584	24	21	mechanisms	mechanism	NNS
10_1101-2021_01_06_425584	24	22	40	40	CD
10_1101-2021_01_06_425584	24	23	underlying	underlie	VBG
10_1101-2021_01_06_425584	24	24	the	the	DT
10_1101-2021_01_06_425584	24	25	development	development	NN
10_1101-2021_01_06_425584	24	26	of	of	IN
10_1101-2021_01_06_425584	24	27	cardiovascular	cardiovascular	JJ
10_1101-2021_01_06_425584	24	28	disease	disease	NN
10_1101-2021_01_06_425584	24	29	in	in	IN
10_1101-2021_01_06_425584	24	30	subjects	subject	NNS
10_1101-2021_01_06_425584	24	31	with	with	IN
10_1101-2021_01_06_425584	24	32	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	24	33	.	.	.
10_1101-2021_01_06_425584	25	1	41	41	CD
10_1101-2021_01_06_425584	25	2	42	42	CD
10_1101-2021_01_06_425584	25	3	43	43	CD
10_1101-2021_01_06_425584	25	4	Keywords	keyword	NNS
10_1101-2021_01_06_425584	25	5	:	:	:
10_1101-2021_01_06_425584	25	6	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	25	7	-	-	HYPH
10_1101-2021_01_06_425584	25	8	Proteomics	Proteomics	NNP
10_1101-2021_01_06_425584	25	9	;	;	:
10_1101-2021_01_06_425584	25	10	Metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	25	11	;	;	:
10_1101-2021_01_06_425584	25	12	Type	type	NN
10_1101-2021_01_06_425584	25	13	2	2	NNP
10_1101-2021_01_06_425584	25	14	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	25	15	Mellitus	Mellitus	NNP
10_1101-2021_01_06_425584	25	16	;	;	:
10_1101-2021_01_06_425584	25	17	Endothelial	endothelial	JJ
10_1101-2021_01_06_425584	25	18	cells	cell	NNS
10_1101-2021_01_06_425584	25	19	;	;	:
10_1101-2021_01_06_425584	25	20	44	44	CD
10_1101-2021_01_06_425584	25	21	Feature	feature	NN
10_1101-2021_01_06_425584	25	22	-	-	HYPH
10_1101-2021_01_06_425584	25	23	Based	base	VBN
10_1101-2021_01_06_425584	25	24	Molecular	Molecular	NNP
10_1101-2021_01_06_425584	25	25	Networking	Networking	NNP
10_1101-2021_01_06_425584	25	26	45	45	CD
10_1101-2021_01_06_425584	25	27	46	46	CD
10_1101-2021_01_06_425584	25	28	47	47	CD
10_1101-2021_01_06_425584	25	29	48	48	CD
10_1101-2021_01_06_425584	25	30	.CC	.cc	CD
10_1101-2021_01_06_425584	25	31	-	-	HYPH
10_1101-2021_01_06_425584	25	32	BY	by	IN
10_1101-2021_01_06_425584	25	33	-	-	HYPH
10_1101-2021_01_06_425584	25	34	NC	NC	NNP
10_1101-2021_01_06_425584	25	35	-	-	HYPH
10_1101-2021_01_06_425584	25	36	ND	ND	NNP
10_1101-2021_01_06_425584	25	37	4.0	4.0	CD
10_1101-2021_01_06_425584	25	38	International	International	NNP
10_1101-2021_01_06_425584	25	39	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	25	40	under	under	IN
10_1101-2021_01_06_425584	25	41	a	a	DT
10_1101-2021_01_06_425584	25	42	(	(	-LRB-
10_1101-2021_01_06_425584	25	43	which	which	WDT
10_1101-2021_01_06_425584	25	44	was	be	VBD
10_1101-2021_01_06_425584	25	45	not	not	RB
10_1101-2021_01_06_425584	25	46	certified	certify	VBN
10_1101-2021_01_06_425584	25	47	by	by	IN
10_1101-2021_01_06_425584	25	48	peer	peer	NN
10_1101-2021_01_06_425584	25	49	review	review	NN
10_1101-2021_01_06_425584	25	50	)	)	-RRB-
10_1101-2021_01_06_425584	25	51	is	be	VBZ
10_1101-2021_01_06_425584	25	52	the	the	DT
10_1101-2021_01_06_425584	25	53	author	author	NN
10_1101-2021_01_06_425584	25	54	/	/	SYM
10_1101-2021_01_06_425584	25	55	funder	funder	NN
10_1101-2021_01_06_425584	25	56	,	,	,
10_1101-2021_01_06_425584	25	57	who	who	WP
10_1101-2021_01_06_425584	25	58	has	have	VBZ
10_1101-2021_01_06_425584	25	59	granted	grant	VBN
10_1101-2021_01_06_425584	25	60	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	25	61	a	a	DT
10_1101-2021_01_06_425584	25	62	license	license	NN
10_1101-2021_01_06_425584	25	63	to	to	TO
10_1101-2021_01_06_425584	25	64	display	display	VB
10_1101-2021_01_06_425584	25	65	the	the	DT
10_1101-2021_01_06_425584	25	66	preprint	preprint	NN
10_1101-2021_01_06_425584	25	67	in	in	IN
10_1101-2021_01_06_425584	25	68	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	25	69	.	.	.
10_1101-2021_01_06_425584	26	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	26	2	is	be	VBZ
10_1101-2021_01_06_425584	26	3	made	make	VBN
10_1101-2021_01_06_425584	26	4	The	the	DT
10_1101-2021_01_06_425584	26	5	copyright	copyright	NN
10_1101-2021_01_06_425584	26	6	holder	holder	NN
10_1101-2021_01_06_425584	26	7	for	for	IN
10_1101-2021_01_06_425584	26	8	this	this	DT
10_1101-2021_01_06_425584	26	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	26	10	version	version	NN
10_1101-2021_01_06_425584	26	11	posted	post	VBD
10_1101-2021_01_06_425584	26	12	January	January	NNP
10_1101-2021_01_06_425584	26	13	8	8	CD
10_1101-2021_01_06_425584	26	14	,	,	,
10_1101-2021_01_06_425584	26	15	2021	2021	CD
10_1101-2021_01_06_425584	26	16	.	.	.
10_1101-2021_01_06_425584	26	17	;	;	:
10_1101-2021_01_06_425584	26	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	26	19	:	:	:
10_1101-2021_01_06_425584	26	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	26	21	preprint	preprint	NN
10_1101-2021_01_06_425584	26	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	26	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	26	24	3	3	CD
10_1101-2021_01_06_425584	26	25	1	1	CD
10_1101-2021_01_06_425584	26	26	.	.	.
10_1101-2021_01_06_425584	27	1	Introduction	introduction	NN
10_1101-2021_01_06_425584	27	2	49	49	CD
10_1101-2021_01_06_425584	27	3	Damage	damage	NN
10_1101-2021_01_06_425584	27	4	to	to	IN
10_1101-2021_01_06_425584	27	5	coronary	coronary	JJ
10_1101-2021_01_06_425584	27	6	artery	artery	NN
10_1101-2021_01_06_425584	27	7	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	27	8	cells	cell	NNS
10_1101-2021_01_06_425584	27	9	(	(	-LRB-
10_1101-2021_01_06_425584	27	10	CAEC	caec	NN
10_1101-2021_01_06_425584	27	11	)	)	-RRB-
10_1101-2021_01_06_425584	27	12	leads	lead	VBZ
10_1101-2021_01_06_425584	27	13	to	to	IN
10_1101-2021_01_06_425584	27	14	coronary	coronary	JJ
10_1101-2021_01_06_425584	27	15	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	27	16	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	27	17	,	,	,
10_1101-2021_01_06_425584	27	18	50	50	CD
10_1101-2021_01_06_425584	27	19	which	which	WDT
10_1101-2021_01_06_425584	27	20	is	be	VBZ
10_1101-2021_01_06_425584	27	21	associated	associate	VBN
10_1101-2021_01_06_425584	27	22	with	with	IN
10_1101-2021_01_06_425584	27	23	the	the	DT
10_1101-2021_01_06_425584	27	24	development	development	NN
10_1101-2021_01_06_425584	27	25	of	of	IN
10_1101-2021_01_06_425584	27	26	cardiac	cardiac	JJ
10_1101-2021_01_06_425584	27	27	pathologies	pathology	NNS
10_1101-2021_01_06_425584	27	28	in	in	IN
10_1101-2021_01_06_425584	27	29	subjects	subject	NNS
10_1101-2021_01_06_425584	27	30	with	with	IN
10_1101-2021_01_06_425584	27	31	and	and	CC
10_1101-2021_01_06_425584	27	32	without	without	IN
10_1101-2021_01_06_425584	27	33	51	51	CD
10_1101-2021_01_06_425584	27	34	coronary	coronary	JJ
10_1101-2021_01_06_425584	27	35	atherosclerosis	atherosclerosis	NN
10_1101-2021_01_06_425584	27	36	(	(	-LRB-
10_1101-2021_01_06_425584	27	37	1	1	CD
10_1101-2021_01_06_425584	27	38	)	)	-RRB-
10_1101-2021_01_06_425584	27	39	.	.	.
10_1101-2021_01_06_425584	28	1	Subjects	subject	NNS
10_1101-2021_01_06_425584	28	2	with	with	IN
10_1101-2021_01_06_425584	28	3	type	type	NN
10_1101-2021_01_06_425584	28	4	2	2	CD
10_1101-2021_01_06_425584	28	5	diabetes	diabetes	NN
10_1101-2021_01_06_425584	28	6	mellitus	mellitus	NN
10_1101-2021_01_06_425584	28	7	(	(	-LRB-
10_1101-2021_01_06_425584	28	8	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	28	9	)	)	-RRB-
10_1101-2021_01_06_425584	28	10	are	be	VBP
10_1101-2021_01_06_425584	28	11	particularly	particularly	RB
10_1101-2021_01_06_425584	28	12	at	at	IN
10_1101-2021_01_06_425584	28	13	52	52	CD
10_1101-2021_01_06_425584	28	14	increased	increase	VBN
10_1101-2021_01_06_425584	28	15	risk	risk	NN
10_1101-2021_01_06_425584	28	16	of	of	IN
10_1101-2021_01_06_425584	28	17	myocardial	myocardial	JJ
10_1101-2021_01_06_425584	28	18	infarction	infarction	NN
10_1101-2021_01_06_425584	28	19	(	(	-LRB-
10_1101-2021_01_06_425584	28	20	2	2	CD
10_1101-2021_01_06_425584	28	21	)	)	-RRB-
10_1101-2021_01_06_425584	28	22	and	and	CC
10_1101-2021_01_06_425584	28	23	coronary	coronary	JJ
10_1101-2021_01_06_425584	28	24	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	28	25	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	28	26	has	have	VBZ
10_1101-2021_01_06_425584	28	27	been	be	VBN
10_1101-2021_01_06_425584	28	28	53	53	CD
10_1101-2021_01_06_425584	28	29	implicated	implicate	VBN
10_1101-2021_01_06_425584	28	30	in	in	IN
10_1101-2021_01_06_425584	28	31	the	the	DT
10_1101-2021_01_06_425584	28	32	prognosis	prognosis	NN
10_1101-2021_01_06_425584	28	33	(	(	-LRB-
10_1101-2021_01_06_425584	28	34	3	3	CD
10_1101-2021_01_06_425584	28	35	)	)	-RRB-
10_1101-2021_01_06_425584	28	36	.	.	.
10_1101-2021_01_06_425584	29	1	A	a	DT
10_1101-2021_01_06_425584	29	2	high	high	JJ
10_1101-2021_01_06_425584	29	3	-	-	HYPH
10_1101-2021_01_06_425584	29	4	glucose	glucose	NN
10_1101-2021_01_06_425584	29	5	(	(	-LRB-
10_1101-2021_01_06_425584	29	6	HG	HG	NNP
10_1101-2021_01_06_425584	29	7	)	)	-RRB-
10_1101-2021_01_06_425584	29	8	environment	environment	NN
10_1101-2021_01_06_425584	29	9	—	—	:
10_1101-2021_01_06_425584	29	10	hallmark	hallmark	NN
10_1101-2021_01_06_425584	29	11	of	of	IN
10_1101-2021_01_06_425584	29	12	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	29	13	—	—	:
10_1101-2021_01_06_425584	29	14	leads	lead	VBZ
10_1101-2021_01_06_425584	29	15	to	to	IN
10_1101-2021_01_06_425584	29	16	54	54	CD
10_1101-2021_01_06_425584	29	17	nitric	nitric	JJ
10_1101-2021_01_06_425584	29	18	oxide	oxide	NN
10_1101-2021_01_06_425584	29	19	signaling	signaling	NN
10_1101-2021_01_06_425584	29	20	,	,	,
10_1101-2021_01_06_425584	29	21	cell	cell	NN
10_1101-2021_01_06_425584	29	22	cycle	cycle	NN
10_1101-2021_01_06_425584	29	23	(	(	-LRB-
10_1101-2021_01_06_425584	29	24	4	4	CD
10_1101-2021_01_06_425584	29	25	)	)	-RRB-
10_1101-2021_01_06_425584	29	26	,	,	,
10_1101-2021_01_06_425584	29	27	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	29	28	(	(	-LRB-
10_1101-2021_01_06_425584	29	29	5	5	CD
10_1101-2021_01_06_425584	29	30	)	)	-RRB-
10_1101-2021_01_06_425584	29	31	,	,	,
10_1101-2021_01_06_425584	29	32	angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	29	33	(	(	-LRB-
10_1101-2021_01_06_425584	29	34	6	6	CD
10_1101-2021_01_06_425584	29	35	)	)	-RRB-
10_1101-2021_01_06_425584	29	36	,	,	,
10_1101-2021_01_06_425584	29	37	and	and	CC
10_1101-2021_01_06_425584	29	38	DNA	dna	NN
10_1101-2021_01_06_425584	29	39	structure	structure	NN
10_1101-2021_01_06_425584	29	40	impairment	impairment	NN
10_1101-2021_01_06_425584	29	41	55	55	CD
10_1101-2021_01_06_425584	29	42	(	(	-LRB-
10_1101-2021_01_06_425584	29	43	7	7	CD
10_1101-2021_01_06_425584	29	44	)	)	-RRB-
10_1101-2021_01_06_425584	29	45	.	.	.
10_1101-2021_01_06_425584	30	1	However	however	RB
10_1101-2021_01_06_425584	30	2	,	,	,
10_1101-2021_01_06_425584	30	3	given	give	VBN
10_1101-2021_01_06_425584	30	4	the	the	DT
10_1101-2021_01_06_425584	30	5	intrinsic	intrinsic	JJ
10_1101-2021_01_06_425584	30	6	heterogeneity	heterogeneity	NN
10_1101-2021_01_06_425584	30	7	of	of	IN
10_1101-2021_01_06_425584	30	8	the	the	DT
10_1101-2021_01_06_425584	30	9	endothelium	endothelium	NN
10_1101-2021_01_06_425584	30	10	,	,	,
10_1101-2021_01_06_425584	30	11	the	the	DT
10_1101-2021_01_06_425584	30	12	molecular	molecular	JJ
10_1101-2021_01_06_425584	30	13	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	30	14	56	56	CD
10_1101-2021_01_06_425584	30	15	caused	cause	VBN
10_1101-2021_01_06_425584	30	16	by	by	IN
10_1101-2021_01_06_425584	30	17	HG	HG	NNP
10_1101-2021_01_06_425584	30	18	vary	vary	VBP
10_1101-2021_01_06_425584	30	19	accordingly	accordingly	RB
10_1101-2021_01_06_425584	30	20	with	with	IN
10_1101-2021_01_06_425584	30	21	the	the	DT
10_1101-2021_01_06_425584	30	22	type	type	NN
10_1101-2021_01_06_425584	30	23	of	of	IN
10_1101-2021_01_06_425584	30	24	studied	study	VBN
10_1101-2021_01_06_425584	30	25	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	30	26	cells	cell	NNS
10_1101-2021_01_06_425584	30	27	(	(	-LRB-
10_1101-2021_01_06_425584	30	28	8	8	CD
10_1101-2021_01_06_425584	30	29	,	,	,
10_1101-2021_01_06_425584	30	30	9	9	CD
10_1101-2021_01_06_425584	30	31	)	)	-RRB-
10_1101-2021_01_06_425584	30	32	.	.	.
10_1101-2021_01_06_425584	31	1	For	for	IN
10_1101-2021_01_06_425584	31	2	instance	instance	NN
10_1101-2021_01_06_425584	31	3	,	,	,
10_1101-2021_01_06_425584	31	4	57	57	CD
10_1101-2021_01_06_425584	31	5	human	human	JJ
10_1101-2021_01_06_425584	31	6	microvascular	microvascular	JJ
10_1101-2021_01_06_425584	31	7	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	31	8	cells	cell	NNS
10_1101-2021_01_06_425584	31	9	showed	show	VBD
10_1101-2021_01_06_425584	31	10	increased	increase	VBN
10_1101-2021_01_06_425584	31	11	gene	gene	NN
10_1101-2021_01_06_425584	31	12	expression	expression	NN
10_1101-2021_01_06_425584	31	13	of	of	IN
10_1101-2021_01_06_425584	31	14	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	31	15	nitric	nitric	NN
10_1101-2021_01_06_425584	31	16	58	58	CD
10_1101-2021_01_06_425584	31	17	oxide	oxide	NN
10_1101-2021_01_06_425584	31	18	synthase	synthase	NN
10_1101-2021_01_06_425584	31	19	,	,	,
10_1101-2021_01_06_425584	31	20	superoxide	superoxide	NNP
10_1101-2021_01_06_425584	31	21	dismutase	dismutase	JJ
10_1101-2021_01_06_425584	31	22	1	1	CD
10_1101-2021_01_06_425584	31	23	,	,	,
10_1101-2021_01_06_425584	31	24	glutathione	glutathione	NNP
10_1101-2021_01_06_425584	31	25	peroxidase	peroxidase	VB
10_1101-2021_01_06_425584	31	26	1	1	CD
10_1101-2021_01_06_425584	31	27	,	,	,
10_1101-2021_01_06_425584	31	28	thioredoxin	thioredoxin	NN
10_1101-2021_01_06_425584	31	29	reductase	reductase	NN
10_1101-2021_01_06_425584	31	30	1	1	CD
10_1101-2021_01_06_425584	31	31	and	and	CC
10_1101-2021_01_06_425584	31	32	59	59	CD
10_1101-2021_01_06_425584	31	33	2	2	CD
10_1101-2021_01_06_425584	31	34	compared	compare	VBN
10_1101-2021_01_06_425584	31	35	to	to	IN
10_1101-2021_01_06_425584	31	36	the	the	DT
10_1101-2021_01_06_425584	31	37	regulation	regulation	NN
10_1101-2021_01_06_425584	31	38	observed	observe	VBN
10_1101-2021_01_06_425584	31	39	in	in	IN
10_1101-2021_01_06_425584	31	40	human	human	JJ
10_1101-2021_01_06_425584	31	41	umbilical	umbilical	JJ
10_1101-2021_01_06_425584	31	42	vein	vein	NN
10_1101-2021_01_06_425584	31	43	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	31	44	cells	cell	NNS
10_1101-2021_01_06_425584	31	45	(	(	-LRB-
10_1101-2021_01_06_425584	31	46	HUVEC	HUVEC	NNP
10_1101-2021_01_06_425584	31	47	)	)	-RRB-
10_1101-2021_01_06_425584	31	48	when	when	WRB
10_1101-2021_01_06_425584	31	49	60	60	CD
10_1101-2021_01_06_425584	31	50	cultured	culture	VBN
10_1101-2021_01_06_425584	31	51	in	in	IN
10_1101-2021_01_06_425584	31	52	HG	HG	NNP
10_1101-2021_01_06_425584	31	53	for	for	IN
10_1101-2021_01_06_425584	31	54	24	24	CD
10_1101-2021_01_06_425584	31	55	h.	h.	NNS
10_1101-2021_01_06_425584	31	56	Furthermore	furthermore	RB
10_1101-2021_01_06_425584	31	57	,	,	,
10_1101-2021_01_06_425584	31	58	the	the	DT
10_1101-2021_01_06_425584	31	59	response	response	NN
10_1101-2021_01_06_425584	31	60	of	of	IN
10_1101-2021_01_06_425584	31	61	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	31	62	cells	cell	NNS
10_1101-2021_01_06_425584	31	63	to	to	IN
10_1101-2021_01_06_425584	31	64	HG	HG	NNP
10_1101-2021_01_06_425584	31	65	is	be	VBZ
10_1101-2021_01_06_425584	31	66	influenced	influence	VBN
10_1101-2021_01_06_425584	31	67	by	by	IN
10_1101-2021_01_06_425584	31	68	the	the	DT
10_1101-2021_01_06_425584	31	69	61	61	CD
10_1101-2021_01_06_425584	31	70	duration	duration	NN
10_1101-2021_01_06_425584	31	71	of	of	IN
10_1101-2021_01_06_425584	31	72	exposure	exposure	NN
10_1101-2021_01_06_425584	31	73	(	(	-LRB-
10_1101-2021_01_06_425584	31	74	10	10	CD
10_1101-2021_01_06_425584	31	75	,	,	,
10_1101-2021_01_06_425584	31	76	11	11	CD
10_1101-2021_01_06_425584	31	77	)	)	-RRB-
10_1101-2021_01_06_425584	31	78	as	as	IN
10_1101-2021_01_06_425584	31	79	demonstrated	demonstrate	VBN
10_1101-2021_01_06_425584	31	80	in	in	IN
10_1101-2021_01_06_425584	31	81	bovine	bovine	JJ
10_1101-2021_01_06_425584	31	82	aortic	aortic	JJ
10_1101-2021_01_06_425584	31	83	and	and	CC
10_1101-2021_01_06_425584	31	84	human	human	JJ
10_1101-2021_01_06_425584	31	85	microvascular	microvascular	JJ
10_1101-2021_01_06_425584	31	86	62	62	CD
10_1101-2021_01_06_425584	31	87	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	31	88	cells	cell	NNS
10_1101-2021_01_06_425584	31	89	where	where	WRB
10_1101-2021_01_06_425584	31	90	cell	cell	NN
10_1101-2021_01_06_425584	31	91	proliferation	proliferation	NN
10_1101-2021_01_06_425584	31	92	and	and	CC
10_1101-2021_01_06_425584	31	93	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	31	94	were	be	VBD
10_1101-2021_01_06_425584	31	95	higher	high	JJR
10_1101-2021_01_06_425584	31	96	at	at	IN
10_1101-2021_01_06_425584	31	97	<	<	XX
10_1101-2021_01_06_425584	31	98	48	48	CD
10_1101-2021_01_06_425584	31	99	h	h	NNS
10_1101-2021_01_06_425584	31	100	compared	compare	VBN
10_1101-2021_01_06_425584	31	101	to	to	IN
10_1101-2021_01_06_425584	31	102	8	8	CD
10_1101-2021_01_06_425584	31	103	weeks	week	NNS
10_1101-2021_01_06_425584	31	104	63	63	CD
10_1101-2021_01_06_425584	31	105	of	of	IN
10_1101-2021_01_06_425584	31	106	exposure	exposure	NN
10_1101-2021_01_06_425584	31	107	(	(	-LRB-
10_1101-2021_01_06_425584	31	108	10	10	CD
10_1101-2021_01_06_425584	31	109	)	)	-RRB-
10_1101-2021_01_06_425584	31	110	.	.	.
10_1101-2021_01_06_425584	32	1	In	in	IN
10_1101-2021_01_06_425584	32	2	another	another	DT
10_1101-2021_01_06_425584	32	3	example	example	NN
10_1101-2021_01_06_425584	32	4	of	of	IN
10_1101-2021_01_06_425584	32	5	time	time	NN
10_1101-2021_01_06_425584	32	6	-	-	HYPH
10_1101-2021_01_06_425584	32	7	dependent	dependent	JJ
10_1101-2021_01_06_425584	32	8	response	response	NN
10_1101-2021_01_06_425584	32	9	,	,	,
10_1101-2021_01_06_425584	32	10	increased	increased	JJ
10_1101-2021_01_06_425584	32	11	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	32	12	(	(	-LRB-
10_1101-2021_01_06_425584	32	13	derived	derive	VBN
10_1101-2021_01_06_425584	32	14	64	64	CD
10_1101-2021_01_06_425584	32	15	from	from	IN
10_1101-2021_01_06_425584	32	16	DNA	dna	NN
10_1101-2021_01_06_425584	32	17	fragmentation	fragmentation	NN
10_1101-2021_01_06_425584	32	18	)	)	-RRB-
10_1101-2021_01_06_425584	32	19	and	and	CC
10_1101-2021_01_06_425584	32	20	tumor	tumor	NN
10_1101-2021_01_06_425584	32	21	necrosis	necrosis	NNP
10_1101-2021_01_06_425584	32	22	factor	factor	NN
10_1101-2021_01_06_425584	32	23	alpha	alpha	NN
10_1101-2021_01_06_425584	32	24	protein	protein	NN
10_1101-2021_01_06_425584	32	25	levels	level	NNS
10_1101-2021_01_06_425584	32	26	were	be	VBD
10_1101-2021_01_06_425584	32	27	reported	report	VBN
10_1101-2021_01_06_425584	32	28	in	in	IN
10_1101-2021_01_06_425584	32	29	human	human	JJ
10_1101-2021_01_06_425584	32	30	65	65	CD
10_1101-2021_01_06_425584	32	31	coronary	coronary	JJ
10_1101-2021_01_06_425584	32	32	artery	artery	NN
10_1101-2021_01_06_425584	32	33	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	32	34	cells	cell	NNS
10_1101-2021_01_06_425584	32	35	(	(	-LRB-
10_1101-2021_01_06_425584	32	36	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	32	37	)	)	-RRB-
10_1101-2021_01_06_425584	32	38	after	after	IN
10_1101-2021_01_06_425584	32	39	only	only	RB
10_1101-2021_01_06_425584	32	40	24	24	CD
10_1101-2021_01_06_425584	32	41	h	h	NN
10_1101-2021_01_06_425584	32	42	of	of	IN
10_1101-2021_01_06_425584	32	43	incubation	incubation	NN
10_1101-2021_01_06_425584	32	44	with	with	IN
10_1101-2021_01_06_425584	32	45	HG	HG	NNP
10_1101-2021_01_06_425584	32	46	(	(	-LRB-
10_1101-2021_01_06_425584	32	47	5	5	CD
10_1101-2021_01_06_425584	32	48	)	)	-RRB-
10_1101-2021_01_06_425584	32	49	.	.	.
10_1101-2021_01_06_425584	33	1	Hence	hence	RB
10_1101-2021_01_06_425584	33	2	,	,	,
10_1101-2021_01_06_425584	33	3	the	the	DT
10_1101-2021_01_06_425584	33	4	66	66	CD
10_1101-2021_01_06_425584	33	5	molecular	molecular	JJ
10_1101-2021_01_06_425584	33	6	response	response	NN
10_1101-2021_01_06_425584	33	7	to	to	IN
10_1101-2021_01_06_425584	33	8	HG	HG	NNP
10_1101-2021_01_06_425584	33	9	can	can	MD
10_1101-2021_01_06_425584	33	10	not	not	RB
10_1101-2021_01_06_425584	33	11	be	be	VB
10_1101-2021_01_06_425584	33	12	generalized	generalize	VBN
10_1101-2021_01_06_425584	33	13	among	among	IN
10_1101-2021_01_06_425584	33	14	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	33	15	cell	cell	NN
10_1101-2021_01_06_425584	33	16	types	type	NNS
10_1101-2021_01_06_425584	33	17	.	.	.
10_1101-2021_01_06_425584	34	1	Previously	previously	RB
10_1101-2021_01_06_425584	34	2	we	-PRON-	PRP
10_1101-2021_01_06_425584	34	3	67	67	CD
10_1101-2021_01_06_425584	34	4	reported	report	VBD
10_1101-2021_01_06_425584	34	5	impaired	impaired	JJ
10_1101-2021_01_06_425584	34	6	mitochondrial	mitochondrial	NN
10_1101-2021_01_06_425584	34	7	function	function	NN
10_1101-2021_01_06_425584	34	8	/	/	SYM
10_1101-2021_01_06_425584	34	9	structure	structure	NN
10_1101-2021_01_06_425584	34	10	and	and	CC
10_1101-2021_01_06_425584	34	11	nitric	nitric	JJ
10_1101-2021_01_06_425584	34	12	oxide	oxide	NN
10_1101-2021_01_06_425584	34	13	signaling	signal	VBG
10_1101-2021_01_06_425584	34	14	in	in	IN
10_1101-2021_01_06_425584	34	15	HG	HG	NNP
10_1101-2021_01_06_425584	34	16	treated	treat	VBN
10_1101-2021_01_06_425584	34	17	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	34	18	68	68	CD
10_1101-2021_01_06_425584	34	19	for	for	IN
10_1101-2021_01_06_425584	34	20	48	48	CD
10_1101-2021_01_06_425584	34	21	h	h	NNS
10_1101-2021_01_06_425584	34	22	(	(	-LRB-
10_1101-2021_01_06_425584	34	23	12	12	CD
10_1101-2021_01_06_425584	34	24	)	)	-RRB-
10_1101-2021_01_06_425584	34	25	.	.	.
10_1101-2021_01_06_425584	35	1	However	however	RB
10_1101-2021_01_06_425584	35	2	,	,	,
10_1101-2021_01_06_425584	35	3	a	a	DT
10_1101-2021_01_06_425584	35	4	72	72	CD
10_1101-2021_01_06_425584	35	5	h	h	NN
10_1101-2021_01_06_425584	35	6	study	study	NN
10_1101-2021_01_06_425584	35	7	documented	document	VBD
10_1101-2021_01_06_425584	35	8	an	an	DT
10_1101-2021_01_06_425584	35	9	increased	increase	VBN
10_1101-2021_01_06_425584	35	10	in	in	IN
10_1101-2021_01_06_425584	35	11	pro	pro	JJ
10_1101-2021_01_06_425584	35	12	-	-	JJ
10_1101-2021_01_06_425584	35	13	inflammatory	inflammatory	JJ
10_1101-2021_01_06_425584	35	14	cytokines	cytokine	NNS
10_1101-2021_01_06_425584	35	15	(	(	-LRB-
10_1101-2021_01_06_425584	35	16	13	13	CD
10_1101-2021_01_06_425584	35	17	)	)	-RRB-
10_1101-2021_01_06_425584	35	18	69	69	CD
10_1101-2021_01_06_425584	35	19	and	and	CC
10_1101-2021_01_06_425584	35	20	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	35	21	stress	stress	NN
10_1101-2021_01_06_425584	35	22	in	in	IN
10_1101-2021_01_06_425584	35	23	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	35	24	(	(	-LRB-
10_1101-2021_01_06_425584	35	25	14	14	CD
10_1101-2021_01_06_425584	35	26	)	)	-RRB-
10_1101-2021_01_06_425584	35	27	.	.	.
10_1101-2021_01_06_425584	36	1	The	the	DT
10_1101-2021_01_06_425584	36	2	long	long	JJ
10_1101-2021_01_06_425584	36	3	-	-	HYPH
10_1101-2021_01_06_425584	36	4	term	term	NN
10_1101-2021_01_06_425584	36	5	(	(	-LRB-
10_1101-2021_01_06_425584	36	6	>	>	NFP
10_1101-2021_01_06_425584	36	7	72	72	CD
10_1101-2021_01_06_425584	36	8	h	h	NNP
10_1101-2021_01_06_425584	36	9	)	)	-RRB-
10_1101-2021_01_06_425584	36	10	effect	effect	NN
10_1101-2021_01_06_425584	36	11	of	of	IN
10_1101-2021_01_06_425584	36	12	HG	HG	NNP
10_1101-2021_01_06_425584	36	13	in	in	IN
10_1101-2021_01_06_425584	36	14	CAEC	caec	NN
10_1101-2021_01_06_425584	36	15	has	have	VBZ
10_1101-2021_01_06_425584	36	16	not	not	RB
10_1101-2021_01_06_425584	36	17	been	be	VBN
10_1101-2021_01_06_425584	36	18	70	70	CD
10_1101-2021_01_06_425584	36	19	as	as	IN
10_1101-2021_01_06_425584	36	20	extensively	extensively	RB
10_1101-2021_01_06_425584	36	21	documented	document	VBN
10_1101-2021_01_06_425584	36	22	compared	compare	VBN
10_1101-2021_01_06_425584	36	23	to	to	IN
10_1101-2021_01_06_425584	36	24	other	other	JJ
10_1101-2021_01_06_425584	36	25	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	36	26	cell	cell	NN
10_1101-2021_01_06_425584	36	27	types	type	NNS
10_1101-2021_01_06_425584	36	28	.	.	.
10_1101-2021_01_06_425584	37	1	Characterizing	characterize	VBG
10_1101-2021_01_06_425584	37	2	the	the	DT
10_1101-2021_01_06_425584	37	3	effect	effect	NN
10_1101-2021_01_06_425584	37	4	of	of	IN
10_1101-2021_01_06_425584	37	5	71	71	CD
10_1101-2021_01_06_425584	37	6	HG	HG	NNP
10_1101-2021_01_06_425584	37	7	on	on	IN
10_1101-2021_01_06_425584	37	8	CAEC	CAEC	NNP
10_1101-2021_01_06_425584	37	9	may	may	MD
10_1101-2021_01_06_425584	37	10	allow	allow	VB
10_1101-2021_01_06_425584	37	11	us	-PRON-	PRP
10_1101-2021_01_06_425584	37	12	to	to	TO
10_1101-2021_01_06_425584	37	13	identify	identify	VB
10_1101-2021_01_06_425584	37	14	key	key	JJ
10_1101-2021_01_06_425584	37	15	signaling	signal	VBG
10_1101-2021_01_06_425584	37	16	pathways	pathway	NNS
10_1101-2021_01_06_425584	37	17	(	(	-LRB-
10_1101-2021_01_06_425584	37	18	or	or	CC
10_1101-2021_01_06_425584	37	19	specific	specific	JJ
10_1101-2021_01_06_425584	37	20	biomolecules	biomolecule	NNS
10_1101-2021_01_06_425584	37	21	)	)	-RRB-
10_1101-2021_01_06_425584	37	22	72	72	CD
10_1101-2021_01_06_425584	37	23	associated	associate	VBN
10_1101-2021_01_06_425584	37	24	with	with	IN
10_1101-2021_01_06_425584	37	25	the	the	DT
10_1101-2021_01_06_425584	37	26	development	development	NN
10_1101-2021_01_06_425584	37	27	of	of	IN
10_1101-2021_01_06_425584	37	28	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	37	29	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	37	30	and	and	CC
10_1101-2021_01_06_425584	37	31	cardiac	cardiac	JJ
10_1101-2021_01_06_425584	37	32	pathologies	pathology	NNS
10_1101-2021_01_06_425584	37	33	.	.	.
10_1101-2021_01_06_425584	38	1	73	73	CD
10_1101-2021_01_06_425584	38	2	Here	here	RB
10_1101-2021_01_06_425584	38	3	,	,	,
10_1101-2021_01_06_425584	38	4	liquid	liquid	JJ
10_1101-2021_01_06_425584	38	5	chromatography	chromatography	NN
10_1101-2021_01_06_425584	38	6	coupled	couple	VBN
10_1101-2021_01_06_425584	38	7	to	to	IN
10_1101-2021_01_06_425584	38	8	mass	mass	NNP
10_1101-2021_01_06_425584	38	9	spectrometry	spectrometry	NNP
10_1101-2021_01_06_425584	38	10	(	(	-LRB-
10_1101-2021_01_06_425584	38	11	LC	LC	NNP
10_1101-2021_01_06_425584	38	12	-	-	HYPH
10_1101-2021_01_06_425584	38	13	MS2)-based	MS2)-based	NNP
10_1101-2021_01_06_425584	38	14	untargeted	untargeted	JJ
10_1101-2021_01_06_425584	38	15	74	74	CD
10_1101-2021_01_06_425584	38	16	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	38	17	and	and	CC
10_1101-2021_01_06_425584	38	18	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	38	19	-	-	HYPH
10_1101-2021_01_06_425584	38	20	based	base	VBN
10_1101-2021_01_06_425584	38	21	quantitative	quantitative	JJ
10_1101-2021_01_06_425584	38	22	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	38	23	data	datum	NNS
10_1101-2021_01_06_425584	38	24	,	,	,
10_1101-2021_01_06_425584	38	25	as	as	RB
10_1101-2021_01_06_425584	38	26	well	well	RB
10_1101-2021_01_06_425584	38	27	as	as	IN
10_1101-2021_01_06_425584	38	28	bio-	bio-	NN
10_1101-2021_01_06_425584	38	29	and	and	CC
10_1101-2021_01_06_425584	38	30	chemo-75	chemo-75	NN
10_1101-2021_01_06_425584	38	31	informatics	informatic	NNS
10_1101-2021_01_06_425584	38	32	were	be	VBD
10_1101-2021_01_06_425584	38	33	used	use	VBN
10_1101-2021_01_06_425584	38	34	to	to	TO
10_1101-2021_01_06_425584	38	35	characterize	characterize	VB
10_1101-2021_01_06_425584	38	36	the	the	DT
10_1101-2021_01_06_425584	38	37	molecular	molecular	JJ
10_1101-2021_01_06_425584	38	38	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	38	39	occurring	occur	VBG
10_1101-2021_01_06_425584	38	40	in	in	IN
10_1101-2021_01_06_425584	38	41	Bovine	Bovine	NNP
10_1101-2021_01_06_425584	38	42	Coronary	Coronary	NNP
10_1101-2021_01_06_425584	38	43	76	76	CD
10_1101-2021_01_06_425584	38	44	Artery	Artery	NNP
10_1101-2021_01_06_425584	38	45	Endothelial	Endothelial	NNP
10_1101-2021_01_06_425584	38	46	Cells	Cells	NNPS
10_1101-2021_01_06_425584	38	47	(	(	-LRB-
10_1101-2021_01_06_425584	38	48	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	38	49	)	)	-RRB-
10_1101-2021_01_06_425584	38	50	under	under	IN
10_1101-2021_01_06_425584	38	51	a	a	DT
10_1101-2021_01_06_425584	38	52	prolonged	prolong	VBN
10_1101-2021_01_06_425584	38	53	diabetic	diabetic	JJ
10_1101-2021_01_06_425584	38	54	environment	environment	NN
10_1101-2021_01_06_425584	38	55	.	.	.
10_1101-2021_01_06_425584	39	1	77	77	CD
10_1101-2021_01_06_425584	39	2	78	78	CD
10_1101-2021_01_06_425584	39	3	2	2	CD
10_1101-2021_01_06_425584	39	4	.	.	.
10_1101-2021_01_06_425584	40	1	Methods	method	NNS
10_1101-2021_01_06_425584	40	2	79	79	CD
10_1101-2021_01_06_425584	40	3	2.1	2.1	CD
10_1101-2021_01_06_425584	40	4	Chemical	chemical	NN
10_1101-2021_01_06_425584	40	5	and	and	CC
10_1101-2021_01_06_425584	40	6	reagents	reagent	NNS
10_1101-2021_01_06_425584	40	7	80	80	CD
10_1101-2021_01_06_425584	40	8	Recombinant	recombinant	JJ
10_1101-2021_01_06_425584	40	9	human	human	JJ
10_1101-2021_01_06_425584	40	10	insulin	insulin	NN
10_1101-2021_01_06_425584	40	11	was	be	VBD
10_1101-2021_01_06_425584	40	12	purchased	purchase	VBN
10_1101-2021_01_06_425584	40	13	from	from	IN
10_1101-2021_01_06_425584	40	14	Sigma	Sigma	NNP
10_1101-2021_01_06_425584	40	15	Aldrich	Aldrich	NNP
10_1101-2021_01_06_425584	40	16	(	(	-LRB-
10_1101-2021_01_06_425584	40	17	St.	St.	NNP
10_1101-2021_01_06_425584	40	18	Louis	Louis	NNP
10_1101-2021_01_06_425584	40	19	,	,	,
10_1101-2021_01_06_425584	40	20	MO	MO	NNP
10_1101-2021_01_06_425584	40	21	,	,	,
10_1101-2021_01_06_425584	40	22	USA	USA	NNP
10_1101-2021_01_06_425584	40	23	)	)	-RRB-
10_1101-2021_01_06_425584	40	24	.	.	.
10_1101-2021_01_06_425584	41	1	Antibiotic-81	Antibiotic-81	NNP
10_1101-2021_01_06_425584	41	2	antimitotic	antimitotic	JJ
10_1101-2021_01_06_425584	41	3	solution	solution	NN
10_1101-2021_01_06_425584	41	4	,	,	,
10_1101-2021_01_06_425584	41	5	trypsin	trypsin	NNP
10_1101-2021_01_06_425584	41	6	-	-	HYPH
10_1101-2021_01_06_425584	41	7	EDTA	EDTA	NNP
10_1101-2021_01_06_425584	41	8	solution	solution	NN
10_1101-2021_01_06_425584	41	9	0.25	0.25	CD
10_1101-2021_01_06_425584	41	10	%	%	NN
10_1101-2021_01_06_425584	41	11	,	,	,
10_1101-2021_01_06_425584	41	12	Hank	Hank	NNP
10_1101-2021_01_06_425584	41	13	’s	’s	POS
10_1101-2021_01_06_425584	41	14	Balanced	Balanced	NNP
10_1101-2021_01_06_425584	41	15	Salt	Salt	NNP
10_1101-2021_01_06_425584	41	16	Solution	Solution	NNP
10_1101-2021_01_06_425584	41	17	(	(	-LRB-
10_1101-2021_01_06_425584	41	18	HBSS	HBSS	NNP
10_1101-2021_01_06_425584	41	19	)	)	-RRB-
10_1101-2021_01_06_425584	41	20	without	without	IN
10_1101-2021_01_06_425584	41	21	82	82	CD
10_1101-2021_01_06_425584	41	22	.CC	.CC	:
10_1101-2021_01_06_425584	41	23	-	-	HYPH
10_1101-2021_01_06_425584	41	24	BY	by	IN
10_1101-2021_01_06_425584	41	25	-	-	HYPH
10_1101-2021_01_06_425584	41	26	NC	NC	NNP
10_1101-2021_01_06_425584	41	27	-	-	HYPH
10_1101-2021_01_06_425584	41	28	ND	ND	NNP
10_1101-2021_01_06_425584	41	29	4.0	4.0	CD
10_1101-2021_01_06_425584	41	30	International	International	NNP
10_1101-2021_01_06_425584	41	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	41	32	under	under	IN
10_1101-2021_01_06_425584	41	33	a	a	DT
10_1101-2021_01_06_425584	41	34	(	(	-LRB-
10_1101-2021_01_06_425584	41	35	which	which	WDT
10_1101-2021_01_06_425584	41	36	was	be	VBD
10_1101-2021_01_06_425584	41	37	not	not	RB
10_1101-2021_01_06_425584	41	38	certified	certify	VBN
10_1101-2021_01_06_425584	41	39	by	by	IN
10_1101-2021_01_06_425584	41	40	peer	peer	NN
10_1101-2021_01_06_425584	41	41	review	review	NN
10_1101-2021_01_06_425584	41	42	)	)	-RRB-
10_1101-2021_01_06_425584	41	43	is	be	VBZ
10_1101-2021_01_06_425584	41	44	the	the	DT
10_1101-2021_01_06_425584	41	45	author	author	NN
10_1101-2021_01_06_425584	41	46	/	/	SYM
10_1101-2021_01_06_425584	41	47	funder	funder	NN
10_1101-2021_01_06_425584	41	48	,	,	,
10_1101-2021_01_06_425584	41	49	who	who	WP
10_1101-2021_01_06_425584	41	50	has	have	VBZ
10_1101-2021_01_06_425584	41	51	granted	grant	VBN
10_1101-2021_01_06_425584	41	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	41	53	a	a	DT
10_1101-2021_01_06_425584	41	54	license	license	NN
10_1101-2021_01_06_425584	41	55	to	to	TO
10_1101-2021_01_06_425584	41	56	display	display	VB
10_1101-2021_01_06_425584	41	57	the	the	DT
10_1101-2021_01_06_425584	41	58	preprint	preprint	NN
10_1101-2021_01_06_425584	41	59	in	in	IN
10_1101-2021_01_06_425584	41	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	41	61	.	.	.
10_1101-2021_01_06_425584	42	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	42	2	is	be	VBZ
10_1101-2021_01_06_425584	42	3	made	make	VBN
10_1101-2021_01_06_425584	42	4	The	the	DT
10_1101-2021_01_06_425584	42	5	copyright	copyright	NN
10_1101-2021_01_06_425584	42	6	holder	holder	NN
10_1101-2021_01_06_425584	42	7	for	for	IN
10_1101-2021_01_06_425584	42	8	this	this	DT
10_1101-2021_01_06_425584	42	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	42	10	version	version	NN
10_1101-2021_01_06_425584	42	11	posted	post	VBD
10_1101-2021_01_06_425584	42	12	January	January	NNP
10_1101-2021_01_06_425584	42	13	8	8	CD
10_1101-2021_01_06_425584	42	14	,	,	,
10_1101-2021_01_06_425584	42	15	2021	2021	CD
10_1101-2021_01_06_425584	42	16	.	.	.
10_1101-2021_01_06_425584	42	17	;	;	:
10_1101-2021_01_06_425584	42	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	42	19	:	:	:
10_1101-2021_01_06_425584	42	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	42	21	preprint	preprint	NN
10_1101-2021_01_06_425584	42	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	42	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	42	24	4	4	CD
10_1101-2021_01_06_425584	42	25	phenol	phenol	NN
10_1101-2021_01_06_425584	42	26	red	red	NN
10_1101-2021_01_06_425584	42	27	,	,	,
10_1101-2021_01_06_425584	42	28	Dulbecco	Dulbecco	NNP
10_1101-2021_01_06_425584	42	29	’s	’s	POS
10_1101-2021_01_06_425584	42	30	Modified	Modified	NNP
10_1101-2021_01_06_425584	42	31	Eagle	Eagle	NNP
10_1101-2021_01_06_425584	42	32	’s	’s	POS
10_1101-2021_01_06_425584	42	33	Media	Media	NNP
10_1101-2021_01_06_425584	42	34	(	(	-LRB-
10_1101-2021_01_06_425584	42	35	DMEM	DMEM	NNP
10_1101-2021_01_06_425584	42	36	)	)	-RRB-
10_1101-2021_01_06_425584	42	37	with	with	IN
10_1101-2021_01_06_425584	42	38	glutamine	glutamine	NN
10_1101-2021_01_06_425584	42	39	,	,	,
10_1101-2021_01_06_425584	42	40	Fetal	Fetal	NNP
10_1101-2021_01_06_425584	42	41	Bovine	Bovine	NNP
10_1101-2021_01_06_425584	42	42	Serum	Serum	NNP
10_1101-2021_01_06_425584	42	43	83	83	CD
10_1101-2021_01_06_425584	42	44	(	(	-LRB-
10_1101-2021_01_06_425584	42	45	FBS	FBS	NNP
10_1101-2021_01_06_425584	42	46	)	)	-RRB-
10_1101-2021_01_06_425584	42	47	,	,	,
10_1101-2021_01_06_425584	42	48	Hoechst	Hoechst	NNP
10_1101-2021_01_06_425584	42	49	33258	33258	CD
10_1101-2021_01_06_425584	42	50	,	,	,
10_1101-2021_01_06_425584	42	51	Pentahydrate	Pentahydrate	NNP
10_1101-2021_01_06_425584	42	52	(	(	-LRB-
10_1101-2021_01_06_425584	42	53	bis	bis	JJ
10_1101-2021_01_06_425584	42	54	-	-	HYPH
10_1101-2021_01_06_425584	42	55	Benzimide)-FluoroPure	Benzimide)-FluoroPure	NNP
10_1101-2021_01_06_425584	42	56	™	™	NN
10_1101-2021_01_06_425584	42	57	,	,	,
10_1101-2021_01_06_425584	42	58	and	and	CC
10_1101-2021_01_06_425584	42	59	methanol	methanol	NN
10_1101-2021_01_06_425584	42	60	-	-	HYPH
10_1101-2021_01_06_425584	42	61	free	free	JJ
10_1101-2021_01_06_425584	42	62	84	84	CD
10_1101-2021_01_06_425584	42	63	formaldehyde	formaldehyde	NN
10_1101-2021_01_06_425584	42	64	(	(	-LRB-
10_1101-2021_01_06_425584	42	65	16	16	CD
10_1101-2021_01_06_425584	42	66	%	%	NN
10_1101-2021_01_06_425584	42	67	solution	solution	NN
10_1101-2021_01_06_425584	42	68	)	)	-RRB-
10_1101-2021_01_06_425584	42	69	were	be	VBD
10_1101-2021_01_06_425584	42	70	obtained	obtain	VBN
10_1101-2021_01_06_425584	42	71	from	from	IN
10_1101-2021_01_06_425584	42	72	Thermo	Thermo	NNP
10_1101-2021_01_06_425584	42	73	Fisher	Fisher	NNP
10_1101-2021_01_06_425584	42	74	Scientific	Scientific	NNP
10_1101-2021_01_06_425584	42	75	(	(	-LRB-
10_1101-2021_01_06_425584	42	76	Waltham	Waltham	NNP
10_1101-2021_01_06_425584	42	77	,	,	,
10_1101-2021_01_06_425584	42	78	MA	MA	NNP
10_1101-2021_01_06_425584	42	79	,	,	,
10_1101-2021_01_06_425584	42	80	USA	USA	NNP
10_1101-2021_01_06_425584	42	81	)	)	-RRB-
10_1101-2021_01_06_425584	42	82	.	.	.
10_1101-2021_01_06_425584	43	1	85	85	CD
10_1101-2021_01_06_425584	43	2	Methanol	Methanol	NNP
10_1101-2021_01_06_425584	43	3	,	,	,
10_1101-2021_01_06_425584	43	4	Acetonitrile	Acetonitrile	NNP
10_1101-2021_01_06_425584	43	5	,	,	,
10_1101-2021_01_06_425584	43	6	and	and	CC
10_1101-2021_01_06_425584	43	7	water	water	NN
10_1101-2021_01_06_425584	43	8	were	be	VBD
10_1101-2021_01_06_425584	43	9	Optima	Optima	NNP
10_1101-2021_01_06_425584	43	10	™	™	CD
10_1101-2021_01_06_425584	43	11	LC	LC	NNP
10_1101-2021_01_06_425584	43	12	-	-	HYPH
10_1101-2021_01_06_425584	43	13	MS	MS	NNP
10_1101-2021_01_06_425584	43	14	Grade	Grade	NNP
10_1101-2021_01_06_425584	43	15	and	and	CC
10_1101-2021_01_06_425584	43	16	obtained	obtain	VBN
10_1101-2021_01_06_425584	43	17	from	from	IN
10_1101-2021_01_06_425584	43	18	Fisher	Fisher	NNP
10_1101-2021_01_06_425584	43	19	86	86	CD
10_1101-2021_01_06_425584	43	20	Scientific	Scientific	NNP
10_1101-2021_01_06_425584	43	21	(	(	-LRB-
10_1101-2021_01_06_425584	43	22	Hampton	Hampton	NNP
10_1101-2021_01_06_425584	43	23	,	,	,
10_1101-2021_01_06_425584	43	24	NH	NH	NNP
10_1101-2021_01_06_425584	43	25	,	,	,
10_1101-2021_01_06_425584	43	26	USA	USA	NNP
10_1101-2021_01_06_425584	43	27	)	)	-RRB-
10_1101-2021_01_06_425584	43	28	.	.	.
10_1101-2021_01_06_425584	44	1	Ethanol	ethanol	NN
10_1101-2021_01_06_425584	44	2	LiChrosolv	LiChrosolv	NNP
10_1101-2021_01_06_425584	44	3	®	®	NNP
10_1101-2021_01_06_425584	44	4	Grade	Grade	NNP
10_1101-2021_01_06_425584	44	5	was	be	VBD
10_1101-2021_01_06_425584	44	6	obtained	obtain	VBN
10_1101-2021_01_06_425584	44	7	from	from	IN
10_1101-2021_01_06_425584	44	8	Merck	Merck	NNP
10_1101-2021_01_06_425584	44	9	KGaA	KGaA	NNP
10_1101-2021_01_06_425584	44	10	87	87	CD
10_1101-2021_01_06_425584	44	11	(	(	-LRB-
10_1101-2021_01_06_425584	44	12	Darmstadt	Darmstadt	NNP
10_1101-2021_01_06_425584	44	13	,	,	,
10_1101-2021_01_06_425584	44	14	Germany	Germany	NNP
10_1101-2021_01_06_425584	44	15	)	)	-RRB-
10_1101-2021_01_06_425584	44	16	.	.	.
10_1101-2021_01_06_425584	45	1	Rabbit	rabbit	NN
10_1101-2021_01_06_425584	45	2	anti	anti	JJ
10_1101-2021_01_06_425584	45	3	-	-	JJ
10_1101-2021_01_06_425584	45	4	Von	Von	NNP
10_1101-2021_01_06_425584	45	5	Willebrand	Willebrand	NNP
10_1101-2021_01_06_425584	45	6	factor	factor	NN
10_1101-2021_01_06_425584	45	7	(	(	-LRB-
10_1101-2021_01_06_425584	45	8	vWf	vWf	NNS
10_1101-2021_01_06_425584	45	9	)	)	-RRB-
10_1101-2021_01_06_425584	45	10	antibody	antibody	NN
10_1101-2021_01_06_425584	45	11	and	and	CC
10_1101-2021_01_06_425584	45	12	goat	goat	NN
10_1101-2021_01_06_425584	45	13	anti	anti	JJ
10_1101-2021_01_06_425584	45	14	-	-	JJ
10_1101-2021_01_06_425584	45	15	rabbit	rabbit	JJ
10_1101-2021_01_06_425584	45	16	IgG	IgG	NNP
10_1101-2021_01_06_425584	45	17	88	88	CD
10_1101-2021_01_06_425584	45	18	conjugated	conjugate	VBD
10_1101-2021_01_06_425584	45	19	to	to	IN
10_1101-2021_01_06_425584	45	20	Alexa	Alexa	NNP
10_1101-2021_01_06_425584	45	21	Fluor	Fluor	NNP
10_1101-2021_01_06_425584	45	22	488	488	CD
10_1101-2021_01_06_425584	45	23	were	be	VBD
10_1101-2021_01_06_425584	45	24	obtained	obtain	VBN
10_1101-2021_01_06_425584	45	25	from	from	IN
10_1101-2021_01_06_425584	45	26	Abcam	Abcam	NNP
10_1101-2021_01_06_425584	45	27	(	(	-LRB-
10_1101-2021_01_06_425584	45	28	Cambridge	Cambridge	NNP
10_1101-2021_01_06_425584	45	29	,	,	,
10_1101-2021_01_06_425584	45	30	MA	MA	NNP
10_1101-2021_01_06_425584	45	31	,	,	,
10_1101-2021_01_06_425584	45	32	USA	USA	NNP
10_1101-2021_01_06_425584	45	33	)	)	-RRB-
10_1101-2021_01_06_425584	45	34	.	.	.
10_1101-2021_01_06_425584	46	1	89	89	CD
10_1101-2021_01_06_425584	46	2	90	90	CD
10_1101-2021_01_06_425584	46	3	2.2	2.2	CD
10_1101-2021_01_06_425584	46	4	Cell	cell	NN
10_1101-2021_01_06_425584	46	5	culture	culture	NN
10_1101-2021_01_06_425584	46	6	91	91	CD
10_1101-2021_01_06_425584	46	7	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	46	8	were	be	VBD
10_1101-2021_01_06_425584	46	9	purchased	purchase	VBN
10_1101-2021_01_06_425584	46	10	from	from	IN
10_1101-2021_01_06_425584	46	11	Cell	Cell	NNP
10_1101-2021_01_06_425584	46	12	applications	application	NNS
10_1101-2021_01_06_425584	46	13	,	,	,
10_1101-2021_01_06_425584	46	14	Inc.	Inc.	NNP
10_1101-2021_01_06_425584	46	15	(	(	-LRB-
10_1101-2021_01_06_425584	46	16	San	San	NNP
10_1101-2021_01_06_425584	46	17	Diego	Diego	NNP
10_1101-2021_01_06_425584	46	18	,	,	,
10_1101-2021_01_06_425584	46	19	CA	CA	NNP
10_1101-2021_01_06_425584	46	20	,	,	,
10_1101-2021_01_06_425584	46	21	USA	USA	NNP
10_1101-2021_01_06_425584	46	22	)	)	-RRB-
10_1101-2021_01_06_425584	46	23	and	and	CC
10_1101-2021_01_06_425584	46	24	grown	grow	VBN
10_1101-2021_01_06_425584	46	25	as	as	IN
10_1101-2021_01_06_425584	46	26	92	92	CD
10_1101-2021_01_06_425584	46	27	previously	previously	RB
10_1101-2021_01_06_425584	46	28	described	describe	VBN
10_1101-2021_01_06_425584	46	29	(	(	-LRB-
10_1101-2021_01_06_425584	46	30	15	15	CD
10_1101-2021_01_06_425584	46	31	)	)	-RRB-
10_1101-2021_01_06_425584	46	32	.	.	.
10_1101-2021_01_06_425584	47	1	In	in	IN
10_1101-2021_01_06_425584	47	2	brief	brief	JJ
10_1101-2021_01_06_425584	47	3	,	,	,
10_1101-2021_01_06_425584	47	4	cells	cell	NNS
10_1101-2021_01_06_425584	47	5	were	be	VBD
10_1101-2021_01_06_425584	47	6	grown	grow	VBN
10_1101-2021_01_06_425584	47	7	with	with	IN
10_1101-2021_01_06_425584	47	8	DMEM	DMEM	NNP
10_1101-2021_01_06_425584	47	9	(	(	-LRB-
10_1101-2021_01_06_425584	47	10	5.5	5.5	CD
10_1101-2021_01_06_425584	47	11	mmol	mmol	NN
10_1101-2021_01_06_425584	47	12	/	/	SYM
10_1101-2021_01_06_425584	47	13	L	L	NNP
10_1101-2021_01_06_425584	47	14	glucose	glucose	NN
10_1101-2021_01_06_425584	47	15	,	,	,
10_1101-2021_01_06_425584	47	16	93	93	CD
10_1101-2021_01_06_425584	47	17	supplemented	supplement	VBN
10_1101-2021_01_06_425584	47	18	with	with	IN
10_1101-2021_01_06_425584	47	19	10	10	CD
10_1101-2021_01_06_425584	47	20	%	%	NN
10_1101-2021_01_06_425584	47	21	FBS	FBS	NNP
10_1101-2021_01_06_425584	47	22	and	and	CC
10_1101-2021_01_06_425584	47	23	1	1	CD
10_1101-2021_01_06_425584	47	24	%	%	NN
10_1101-2021_01_06_425584	47	25	antibiotic	antibiotic	JJ
10_1101-2021_01_06_425584	47	26	-	-	HYPH
10_1101-2021_01_06_425584	47	27	antimitotic	antimitotic	JJ
10_1101-2021_01_06_425584	47	28	solution	solution	NN
10_1101-2021_01_06_425584	47	29	)	)	-RRB-
10_1101-2021_01_06_425584	47	30	at	at	IN
10_1101-2021_01_06_425584	47	31	37	37	CD
10_1101-2021_01_06_425584	47	32	oC	oC	NNP
10_1101-2021_01_06_425584	47	33	in	in	IN
10_1101-2021_01_06_425584	47	34	an	an	DT
10_1101-2021_01_06_425584	47	35	incubator	incubator	NN
10_1101-2021_01_06_425584	47	36	with	with	IN
10_1101-2021_01_06_425584	47	37	94	94	CD
10_1101-2021_01_06_425584	47	38	a	a	DT
10_1101-2021_01_06_425584	47	39	humidified	humidified	JJ
10_1101-2021_01_06_425584	47	40	atmosphere	atmosphere	NN
10_1101-2021_01_06_425584	47	41	of	of	IN
10_1101-2021_01_06_425584	47	42	5	5	CD
10_1101-2021_01_06_425584	47	43	%	%	NN
10_1101-2021_01_06_425584	47	44	CO2	CO2	NNP
10_1101-2021_01_06_425584	47	45	.	.	.
10_1101-2021_01_06_425584	48	1	Before	before	IN
10_1101-2021_01_06_425584	48	2	experiments	experiment	NNS
10_1101-2021_01_06_425584	48	3	,	,	,
10_1101-2021_01_06_425584	48	4	cells	cell	NNS
10_1101-2021_01_06_425584	48	5	were	be	VBD
10_1101-2021_01_06_425584	48	6	switched	switch	VBN
10_1101-2021_01_06_425584	48	7	to	to	IN
10_1101-2021_01_06_425584	48	8	DMEM	DMEM	NNP
10_1101-2021_01_06_425584	48	9	with	with	IN
10_1101-2021_01_06_425584	48	10	1	1	CD
10_1101-2021_01_06_425584	48	11	%	%	NN
10_1101-2021_01_06_425584	48	12	95	95	CD
10_1101-2021_01_06_425584	48	13	FBS	fbs	NN
10_1101-2021_01_06_425584	48	14	for	for	IN
10_1101-2021_01_06_425584	48	15	12	12	CD
10_1101-2021_01_06_425584	48	16	h	h	NN
10_1101-2021_01_06_425584	48	17	to	to	TO
10_1101-2021_01_06_425584	48	18	maintain	maintain	VB
10_1101-2021_01_06_425584	48	19	the	the	DT
10_1101-2021_01_06_425584	48	20	cells	cell	NNS
10_1101-2021_01_06_425584	48	21	under	under	IN
10_1101-2021_01_06_425584	48	22	a	a	DT
10_1101-2021_01_06_425584	48	23	quiescent	quiescent	JJ
10_1101-2021_01_06_425584	48	24	state	state	NN
10_1101-2021_01_06_425584	48	25	.	.	.
10_1101-2021_01_06_425584	49	1	The	the	DT
10_1101-2021_01_06_425584	49	2	model	model	NN
10_1101-2021_01_06_425584	49	3	to	to	TO
10_1101-2021_01_06_425584	49	4	simulate	simulate	VB
10_1101-2021_01_06_425584	49	5	diabetes	diabetes	NN
10_1101-2021_01_06_425584	49	6	is	be	VBZ
10_1101-2021_01_06_425584	49	7	96	96	CD
10_1101-2021_01_06_425584	49	8	described	describe	VBN
10_1101-2021_01_06_425584	49	9	in	in	IN
10_1101-2021_01_06_425584	49	10	(	(	-LRB-
10_1101-2021_01_06_425584	49	11	15	15	CD
10_1101-2021_01_06_425584	49	12	)	)	-RRB-
10_1101-2021_01_06_425584	49	13	(	(	-LRB-
10_1101-2021_01_06_425584	49	14	Figure	figure	NN
10_1101-2021_01_06_425584	49	15	1	1	CD
10_1101-2021_01_06_425584	49	16	)	)	-RRB-
10_1101-2021_01_06_425584	49	17	.	.	.
10_1101-2021_01_06_425584	50	1	Endothelial	endothelial	JJ
10_1101-2021_01_06_425584	50	2	cells	cell	NNS
10_1101-2021_01_06_425584	50	3	were	be	VBD
10_1101-2021_01_06_425584	50	4	cultured	culture	VBN
10_1101-2021_01_06_425584	50	5	for	for	IN
10_1101-2021_01_06_425584	50	6	12	12	CD
10_1101-2021_01_06_425584	50	7	days	day	NNS
10_1101-2021_01_06_425584	50	8	to	to	TO
10_1101-2021_01_06_425584	50	9	determine	determine	VB
10_1101-2021_01_06_425584	50	10	the	the	DT
10_1101-2021_01_06_425584	50	11	chronic	chronic	JJ
10_1101-2021_01_06_425584	50	12	97	97	CD
10_1101-2021_01_06_425584	50	13	molecular	molecular	JJ
10_1101-2021_01_06_425584	50	14	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	50	15	caused	cause	VBN
10_1101-2021_01_06_425584	50	16	by	by	IN
10_1101-2021_01_06_425584	50	17	simulated	simulated	JJ
10_1101-2021_01_06_425584	50	18	diabetes	diabetes	NN
10_1101-2021_01_06_425584	50	19	and	and	CC
10_1101-2021_01_06_425584	50	20	to	to	TO
10_1101-2021_01_06_425584	50	21	avoid	avoid	VB
10_1101-2021_01_06_425584	50	22	the	the	DT
10_1101-2021_01_06_425584	50	23	early	early	JJ
10_1101-2021_01_06_425584	50	24	(	(	-LRB-
10_1101-2021_01_06_425584	50	25	within	within	IN
10_1101-2021_01_06_425584	50	26	48	48	CD
10_1101-2021_01_06_425584	50	27	h	h	NN
10_1101-2021_01_06_425584	50	28	)	)	-RRB-
10_1101-2021_01_06_425584	50	29	cell	cell	NN
10_1101-2021_01_06_425584	50	30	98	98	CD
10_1101-2021_01_06_425584	50	31	proliferation	proliferation	NN
10_1101-2021_01_06_425584	50	32	effects	effect	NNS
10_1101-2021_01_06_425584	50	33	caused	cause	VBN
10_1101-2021_01_06_425584	50	34	by	by	IN
10_1101-2021_01_06_425584	50	35	HG	HG	NNP
10_1101-2021_01_06_425584	50	36	(	(	-LRB-
10_1101-2021_01_06_425584	50	37	10	10	CD
10_1101-2021_01_06_425584	50	38	,	,	,
10_1101-2021_01_06_425584	50	39	16	16	CD
10_1101-2021_01_06_425584	50	40	)	)	-RRB-
10_1101-2021_01_06_425584	50	41	.	.	.
10_1101-2021_01_06_425584	51	1	In	in	IN
10_1101-2021_01_06_425584	51	2	brief	brief	JJ
10_1101-2021_01_06_425584	51	3	,	,	,
10_1101-2021_01_06_425584	51	4	cells	cell	NNS
10_1101-2021_01_06_425584	51	5	were	be	VBD
10_1101-2021_01_06_425584	51	6	first	first	RB
10_1101-2021_01_06_425584	51	7	treated	treat	VBN
10_1101-2021_01_06_425584	51	8	with	with	IN
10_1101-2021_01_06_425584	51	9	100	100	CD
10_1101-2021_01_06_425584	51	10	nmol	nmol	JJ
10_1101-2021_01_06_425584	51	11	/	/	SYM
10_1101-2021_01_06_425584	51	12	L	L	NNP
10_1101-2021_01_06_425584	51	13	insulin	insulin	NN
10_1101-2021_01_06_425584	51	14	99	99	CD
10_1101-2021_01_06_425584	51	15	(	(	-LRB-
10_1101-2021_01_06_425584	51	16	high	high	JJ
10_1101-2021_01_06_425584	51	17	-	-	HYPH
10_1101-2021_01_06_425584	51	18	insulin	insulin	NN
10_1101-2021_01_06_425584	51	19	,	,	,
10_1101-2021_01_06_425584	51	20	HI	HI	NNP
10_1101-2021_01_06_425584	51	21	)	)	-RRB-
10_1101-2021_01_06_425584	51	22	in	in	IN
10_1101-2021_01_06_425584	51	23	normal	normal	JJ
10_1101-2021_01_06_425584	51	24	glucose	glucose	NN
10_1101-2021_01_06_425584	51	25	(	(	-LRB-
10_1101-2021_01_06_425584	51	26	NG	NG	NNP
10_1101-2021_01_06_425584	51	27	,	,	,
10_1101-2021_01_06_425584	51	28	5.5	5.5	CD
10_1101-2021_01_06_425584	51	29	mmol	mmol	NN
10_1101-2021_01_06_425584	51	30	/	/	SYM
10_1101-2021_01_06_425584	51	31	L	l	NN
10_1101-2021_01_06_425584	51	32	in	in	IN
10_1101-2021_01_06_425584	51	33	DMEM	DMEM	NNP
10_1101-2021_01_06_425584	51	34	)	)	-RRB-
10_1101-2021_01_06_425584	51	35	for	for	IN
10_1101-2021_01_06_425584	51	36	3	3	CD
10_1101-2021_01_06_425584	51	37	days	day	NNS
10_1101-2021_01_06_425584	51	38	(	(	-LRB-
10_1101-2021_01_06_425584	51	39	17	17	CD
10_1101-2021_01_06_425584	51	40	)	)	-RRB-
10_1101-2021_01_06_425584	51	41	and	and	CC
10_1101-2021_01_06_425584	51	42	then	then	RB
10_1101-2021_01_06_425584	51	43	100	100	CD
10_1101-2021_01_06_425584	51	44	maintained	maintain	VBN
10_1101-2021_01_06_425584	51	45	in	in	IN
10_1101-2021_01_06_425584	51	46	high	high	JJ
10_1101-2021_01_06_425584	51	47	-	-	HYPH
10_1101-2021_01_06_425584	51	48	glucose	glucose	NN
10_1101-2021_01_06_425584	51	49	(	(	-LRB-
10_1101-2021_01_06_425584	51	50	HG	HG	NNP
10_1101-2021_01_06_425584	51	51	,	,	,
10_1101-2021_01_06_425584	51	52	20	20	CD
10_1101-2021_01_06_425584	51	53	mmol	mmol	NN
10_1101-2021_01_06_425584	51	54	/	/	SYM
10_1101-2021_01_06_425584	51	55	L	l	NN
10_1101-2021_01_06_425584	51	56	in	in	IN
10_1101-2021_01_06_425584	51	57	DMEM	DMEM	NNP
10_1101-2021_01_06_425584	51	58	)	)	-RRB-
10_1101-2021_01_06_425584	51	59	and	and	CC
10_1101-2021_01_06_425584	51	60	constant	constant	JJ
10_1101-2021_01_06_425584	51	61	HI	HI	NNP
10_1101-2021_01_06_425584	51	62	for	for	IN
10_1101-2021_01_06_425584	51	63	9	9	CD
10_1101-2021_01_06_425584	51	64	days	day	NNS
10_1101-2021_01_06_425584	51	65	.	.	.
10_1101-2021_01_06_425584	52	1	This	this	DT
10_1101-2021_01_06_425584	52	2	sequential	sequential	JJ
10_1101-2021_01_06_425584	52	3	101	101	CD
10_1101-2021_01_06_425584	52	4	scheme	scheme	NN
10_1101-2021_01_06_425584	52	5	tried	try	VBD
10_1101-2021_01_06_425584	52	6	to	to	TO
10_1101-2021_01_06_425584	52	7	mimic	mimic	VB
10_1101-2021_01_06_425584	52	8	the	the	DT
10_1101-2021_01_06_425584	52	9	pathophysiological	pathophysiological	JJ
10_1101-2021_01_06_425584	52	10	conditions	condition	NNS
10_1101-2021_01_06_425584	52	11	that	that	WDT
10_1101-2021_01_06_425584	52	12	occur	occur	VBP
10_1101-2021_01_06_425584	52	13	in	in	IN
10_1101-2021_01_06_425584	52	14	T2DM	t2dm	NN
10_1101-2021_01_06_425584	52	15	patients	patient	NNS
10_1101-2021_01_06_425584	52	16	,	,	,
10_1101-2021_01_06_425584	52	17	wherein	wherein	WRB
10_1101-2021_01_06_425584	52	18	102	102	CD
10_1101-2021_01_06_425584	52	19	hyperinsulinemia	hyperinsulinemia	NN
10_1101-2021_01_06_425584	52	20	precedes	precede	NNS
10_1101-2021_01_06_425584	52	21	hyperglycemia	hyperglycemia	NNP
10_1101-2021_01_06_425584	52	22	(	(	-LRB-
10_1101-2021_01_06_425584	52	23	18	18	CD
10_1101-2021_01_06_425584	52	24	)	)	-RRB-
10_1101-2021_01_06_425584	52	25	.	.	.
10_1101-2021_01_06_425584	53	1	Cells	cell	NNS
10_1101-2021_01_06_425584	53	2	were	be	VBD
10_1101-2021_01_06_425584	53	3	used	use	VBN
10_1101-2021_01_06_425584	53	4	at	at	IN
10_1101-2021_01_06_425584	53	5	passages	passage	NNS
10_1101-2021_01_06_425584	53	6	between	between	IN
10_1101-2021_01_06_425584	53	7	6	6	CD
10_1101-2021_01_06_425584	53	8	to	to	TO
10_1101-2021_01_06_425584	53	9	12	12	CD
10_1101-2021_01_06_425584	53	10	.	.	.
10_1101-2021_01_06_425584	54	1	103	103	CD
10_1101-2021_01_06_425584	54	2	The	the	DT
10_1101-2021_01_06_425584	54	3	control	control	NN
10_1101-2021_01_06_425584	54	4	group	group	NN
10_1101-2021_01_06_425584	54	5	did	do	VBD
10_1101-2021_01_06_425584	54	6	not	not	RB
10_1101-2021_01_06_425584	54	7	receive	receive	VB
10_1101-2021_01_06_425584	54	8	HI	HI	NNP
10_1101-2021_01_06_425584	54	9	nor	nor	CC
10_1101-2021_01_06_425584	54	10	HG	HG	NNP
10_1101-2021_01_06_425584	54	11	treatment	treatment	NN
10_1101-2021_01_06_425584	54	12	.	.	.
10_1101-2021_01_06_425584	55	1	For	for	IN
10_1101-2021_01_06_425584	55	2	selected	select	VBN
10_1101-2021_01_06_425584	55	3	experiments	experiment	NNS
10_1101-2021_01_06_425584	55	4	(	(	-LRB-
10_1101-2021_01_06_425584	55	5	binucleation	binucleation	NNP
10_1101-2021_01_06_425584	55	6	104	104	CD
10_1101-2021_01_06_425584	55	7	analysis	analysis	NN
10_1101-2021_01_06_425584	55	8	)	)	-RRB-
10_1101-2021_01_06_425584	55	9	,	,	,
10_1101-2021_01_06_425584	55	10	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	55	11	(	(	-LRB-
10_1101-2021_01_06_425584	55	12	55	55	CD
10_1101-2021_01_06_425584	55	13	years	year	NNS
10_1101-2021_01_06_425584	55	14	old	old	JJ
10_1101-2021_01_06_425584	55	15	Caucasian	caucasian	JJ
10_1101-2021_01_06_425584	55	16	male	male	NN
10_1101-2021_01_06_425584	55	17	,	,	,
10_1101-2021_01_06_425584	55	18	history	history	NN
10_1101-2021_01_06_425584	55	19	of	of	IN
10_1101-2021_01_06_425584	55	20	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	55	21	for	for	IN
10_1101-2021_01_06_425584	55	22	>	>	NN
10_1101-2021_01_06_425584	55	23	5	5	CD
10_1101-2021_01_06_425584	55	24	years	year	NNS
10_1101-2021_01_06_425584	55	25	)	)	-RRB-
10_1101-2021_01_06_425584	55	26	were	be	VBD
10_1101-2021_01_06_425584	55	27	purchased	purchase	VBN
10_1101-2021_01_06_425584	55	28	105	105	CD
10_1101-2021_01_06_425584	55	29	from	from	IN
10_1101-2021_01_06_425584	55	30	Cell	Cell	NNP
10_1101-2021_01_06_425584	55	31	Applications	Applications	NNP
10_1101-2021_01_06_425584	55	32	,	,	,
10_1101-2021_01_06_425584	55	33	Inc.	Inc.	NNP
10_1101-2021_01_06_425584	55	34	and	and	CC
10_1101-2021_01_06_425584	55	35	subjected	subject	VBN
10_1101-2021_01_06_425584	55	36	to	to	IN
10_1101-2021_01_06_425584	55	37	the	the	DT
10_1101-2021_01_06_425584	55	38	same	same	JJ
10_1101-2021_01_06_425584	55	39	conditions	condition	NNS
10_1101-2021_01_06_425584	55	40	as	as	IN
10_1101-2021_01_06_425584	55	41	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	55	42	but	but	CC
10_1101-2021_01_06_425584	55	43	using	use	VBG
10_1101-2021_01_06_425584	55	44	MesoEndo	MesoEndo	NNP
10_1101-2021_01_06_425584	55	45	106	106	CD
10_1101-2021_01_06_425584	55	46	Growth	growth	NN
10_1101-2021_01_06_425584	55	47	Medium	medium	NN
10_1101-2021_01_06_425584	55	48	(	(	-LRB-
10_1101-2021_01_06_425584	55	49	Cell	Cell	NNP
10_1101-2021_01_06_425584	55	50	Applications	Applications	NNP
10_1101-2021_01_06_425584	55	51	,	,	,
10_1101-2021_01_06_425584	55	52	Inc.	Inc.	NNP
10_1101-2021_01_06_425584	55	53	)	)	-RRB-
10_1101-2021_01_06_425584	55	54	to	to	TO
10_1101-2021_01_06_425584	55	55	induce	induce	VB
10_1101-2021_01_06_425584	55	56	proliferation	proliferation	NN
10_1101-2021_01_06_425584	55	57	.	.	.
10_1101-2021_01_06_425584	56	1	For	for	IN
10_1101-2021_01_06_425584	56	2	simulated	simulated	JJ
10_1101-2021_01_06_425584	56	3	diabetes	diabete	NNS
10_1101-2021_01_06_425584	56	4	,	,	,
10_1101-2021_01_06_425584	56	5	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	56	6	107	107	CD
10_1101-2021_01_06_425584	56	7	were	be	VBD
10_1101-2021_01_06_425584	56	8	treated	treat	VBN
10_1101-2021_01_06_425584	56	9	with	with	IN
10_1101-2021_01_06_425584	56	10	HI	HI	NNP
10_1101-2021_01_06_425584	56	11	and	and	CC
10_1101-2021_01_06_425584	56	12	HG	HG	NNP
10_1101-2021_01_06_425584	56	13	as	as	IN
10_1101-2021_01_06_425584	56	14	with	with	IN
10_1101-2021_01_06_425584	56	15	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	56	16	but	but	CC
10_1101-2021_01_06_425584	56	17	,	,	,
10_1101-2021_01_06_425584	56	18	MesoEndo	MesoEndo	NNP
10_1101-2021_01_06_425584	56	19	Growht	Growht	NNP
10_1101-2021_01_06_425584	56	20	Medium	Medium	NNP
10_1101-2021_01_06_425584	56	21	was	be	VBD
10_1101-2021_01_06_425584	56	22	used	use	VBN
10_1101-2021_01_06_425584	56	23	instead	instead	RB
10_1101-2021_01_06_425584	56	24	.	.	.
10_1101-2021_01_06_425584	57	1	108	108	CD
10_1101-2021_01_06_425584	57	2	For	for	IN
10_1101-2021_01_06_425584	57	3	consistency	consistency	NN
10_1101-2021_01_06_425584	57	4	,	,	,
10_1101-2021_01_06_425584	57	5	the	the	DT
10_1101-2021_01_06_425584	57	6	group	group	NN
10_1101-2021_01_06_425584	57	7	that	that	WDT
10_1101-2021_01_06_425584	57	8	underwent	undergo	VBD
10_1101-2021_01_06_425584	57	9	simulated	simulated	JJ
10_1101-2021_01_06_425584	57	10	diabetes	diabetes	NN
10_1101-2021_01_06_425584	57	11	(	(	-LRB-
10_1101-2021_01_06_425584	57	12	HG	HG	NNP
10_1101-2021_01_06_425584	57	13	+	+	CC
10_1101-2021_01_06_425584	57	14	HI	HI	NNP
10_1101-2021_01_06_425584	57	15	)	)	-RRB-
10_1101-2021_01_06_425584	57	16	will	will	MD
10_1101-2021_01_06_425584	57	17	be	be	VB
10_1101-2021_01_06_425584	57	18	referred	refer	VBN
10_1101-2021_01_06_425584	57	19	to	to	IN
10_1101-2021_01_06_425584	57	20	as	as	IN
10_1101-2021_01_06_425584	57	21	the	the	DT
10_1101-2021_01_06_425584	57	22	109	109	CD
10_1101-2021_01_06_425584	57	23	“	"	``
10_1101-2021_01_06_425584	57	24	experimental	experimental	JJ
10_1101-2021_01_06_425584	57	25	group	group	NN
10_1101-2021_01_06_425584	57	26	”	"	''
10_1101-2021_01_06_425584	57	27	.	.	.
10_1101-2021_01_06_425584	58	1	All	all	DT
10_1101-2021_01_06_425584	58	2	experiments	experiment	NNS
10_1101-2021_01_06_425584	58	3	were	be	VBD
10_1101-2021_01_06_425584	58	4	carried	carry	VBN
10_1101-2021_01_06_425584	58	5	out	out	RP
10_1101-2021_01_06_425584	58	6	in	in	IN
10_1101-2021_01_06_425584	58	7	triplicate	triplicate	NN
10_1101-2021_01_06_425584	58	8	.	.	.
10_1101-2021_01_06_425584	59	1	110	110	CD
10_1101-2021_01_06_425584	59	2	111	111	CD
10_1101-2021_01_06_425584	59	3	2.3	2.3	CD
10_1101-2021_01_06_425584	59	4	Immunofluorescence	immunofluorescence	NN
10_1101-2021_01_06_425584	59	5	112	112	CD
10_1101-2021_01_06_425584	59	6	As	as	RB
10_1101-2021_01_06_425584	59	7	previously	previously	RB
10_1101-2021_01_06_425584	59	8	described	describe	VBN
10_1101-2021_01_06_425584	59	9	(	(	-LRB-
10_1101-2021_01_06_425584	59	10	15	15	CD
10_1101-2021_01_06_425584	59	11	)	)	-RRB-
10_1101-2021_01_06_425584	59	12	,	,	,
10_1101-2021_01_06_425584	59	13	100,000	100,000	CD
10_1101-2021_01_06_425584	59	14	cells	cell	NNS
10_1101-2021_01_06_425584	59	15	per	per	IN
10_1101-2021_01_06_425584	59	16	well	well	RB
10_1101-2021_01_06_425584	59	17	were	be	VBD
10_1101-2021_01_06_425584	59	18	seeded	seed	VBN
10_1101-2021_01_06_425584	59	19	onto	onto	IN
10_1101-2021_01_06_425584	59	20	12-well	12-well	CD
10_1101-2021_01_06_425584	59	21	plates	plate	NNS
10_1101-2021_01_06_425584	59	22	(	(	-LRB-
10_1101-2021_01_06_425584	59	23	Corning	corn	VBG
10_1101-2021_01_06_425584	59	24	®	®	NNPS
10_1101-2021_01_06_425584	59	25	113	113	CD
10_1101-2021_01_06_425584	59	26	CellBIND	CellBIND	NNP
10_1101-2021_01_06_425584	59	27	®	®	:
10_1101-2021_01_06_425584	59	28	)	)	-RRB-
10_1101-2021_01_06_425584	59	29	and	and	CC
10_1101-2021_01_06_425584	59	30	exposed	expose	VBN
10_1101-2021_01_06_425584	59	31	to	to	IN
10_1101-2021_01_06_425584	59	32	simulated	simulate	VBN
10_1101-2021_01_06_425584	59	33	diabetes	diabete	NNS
10_1101-2021_01_06_425584	59	34	.	.	.
10_1101-2021_01_06_425584	60	1	Thereafter	thereafter	RB
10_1101-2021_01_06_425584	60	2	,	,	,
10_1101-2021_01_06_425584	60	3	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	60	4	and	and	CC
10_1101-2021_01_06_425584	60	5	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	60	6	were	be	VBD
10_1101-2021_01_06_425584	60	7	washed	wash	VBN
10_1101-2021_01_06_425584	60	8	114	114	CD
10_1101-2021_01_06_425584	60	9	with	with	IN
10_1101-2021_01_06_425584	60	10	PBS	PBS	NNP
10_1101-2021_01_06_425584	60	11	to	to	TO
10_1101-2021_01_06_425584	60	12	remove	remove	VB
10_1101-2021_01_06_425584	60	13	dead	dead	JJ
10_1101-2021_01_06_425584	60	14	cells	cell	NNS
10_1101-2021_01_06_425584	60	15	and	and	CC
10_1101-2021_01_06_425584	60	16	debris	debris	NN
10_1101-2021_01_06_425584	60	17	.	.	.
10_1101-2021_01_06_425584	61	1	Cells	cell	NNS
10_1101-2021_01_06_425584	61	2	were	be	VBD
10_1101-2021_01_06_425584	61	3	fixed	fix	VBN
10_1101-2021_01_06_425584	61	4	,	,	,
10_1101-2021_01_06_425584	61	5	permeabilized	permeabilize	VBN
10_1101-2021_01_06_425584	61	6	,	,	,
10_1101-2021_01_06_425584	61	7	and	and	CC
10_1101-2021_01_06_425584	61	8	blocked	block	VBD
10_1101-2021_01_06_425584	61	9	as	as	IN
10_1101-2021_01_06_425584	61	10	115	115	CD
10_1101-2021_01_06_425584	61	11	described	describe	VBN
10_1101-2021_01_06_425584	61	12	before	before	IN
10_1101-2021_01_06_425584	61	13	(	(	-LRB-
10_1101-2021_01_06_425584	61	14	19	19	CD
10_1101-2021_01_06_425584	61	15	)	)	-RRB-
10_1101-2021_01_06_425584	61	16	.	.	.
10_1101-2021_01_06_425584	62	1	Cells	cell	NNS
10_1101-2021_01_06_425584	62	2	were	be	VBD
10_1101-2021_01_06_425584	62	3	then	then	RB
10_1101-2021_01_06_425584	62	4	incubated	incubate	VBN
10_1101-2021_01_06_425584	62	5	with	with	IN
10_1101-2021_01_06_425584	62	6	a	a	DT
10_1101-2021_01_06_425584	62	7	polyclonal	polyclonal	JJ
10_1101-2021_01_06_425584	62	8	antibody	antibody	NN
10_1101-2021_01_06_425584	62	9	against	against	IN
10_1101-2021_01_06_425584	62	10	the	the	DT
10_1101-2021_01_06_425584	62	11	vWf	vWf	NNP
10_1101-2021_01_06_425584	62	12	116	116	CD
10_1101-2021_01_06_425584	62	13	.CC	.CC	NFP
10_1101-2021_01_06_425584	62	14	-	-	HYPH
10_1101-2021_01_06_425584	62	15	BY	by	IN
10_1101-2021_01_06_425584	62	16	-	-	HYPH
10_1101-2021_01_06_425584	62	17	NC	NC	NNP
10_1101-2021_01_06_425584	62	18	-	-	HYPH
10_1101-2021_01_06_425584	62	19	ND	ND	NNP
10_1101-2021_01_06_425584	62	20	4.0	4.0	CD
10_1101-2021_01_06_425584	62	21	International	International	NNP
10_1101-2021_01_06_425584	62	22	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	62	23	under	under	IN
10_1101-2021_01_06_425584	62	24	a	a	DT
10_1101-2021_01_06_425584	62	25	(	(	-LRB-
10_1101-2021_01_06_425584	62	26	which	which	WDT
10_1101-2021_01_06_425584	62	27	was	be	VBD
10_1101-2021_01_06_425584	62	28	not	not	RB
10_1101-2021_01_06_425584	62	29	certified	certify	VBN
10_1101-2021_01_06_425584	62	30	by	by	IN
10_1101-2021_01_06_425584	62	31	peer	peer	NN
10_1101-2021_01_06_425584	62	32	review	review	NN
10_1101-2021_01_06_425584	62	33	)	)	-RRB-
10_1101-2021_01_06_425584	62	34	is	be	VBZ
10_1101-2021_01_06_425584	62	35	the	the	DT
10_1101-2021_01_06_425584	62	36	author	author	NN
10_1101-2021_01_06_425584	62	37	/	/	SYM
10_1101-2021_01_06_425584	62	38	funder	funder	NN
10_1101-2021_01_06_425584	62	39	,	,	,
10_1101-2021_01_06_425584	62	40	who	who	WP
10_1101-2021_01_06_425584	62	41	has	have	VBZ
10_1101-2021_01_06_425584	62	42	granted	grant	VBN
10_1101-2021_01_06_425584	62	43	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	62	44	a	a	DT
10_1101-2021_01_06_425584	62	45	license	license	NN
10_1101-2021_01_06_425584	62	46	to	to	TO
10_1101-2021_01_06_425584	62	47	display	display	VB
10_1101-2021_01_06_425584	62	48	the	the	DT
10_1101-2021_01_06_425584	62	49	preprint	preprint	NN
10_1101-2021_01_06_425584	62	50	in	in	IN
10_1101-2021_01_06_425584	62	51	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	62	52	.	.	.
10_1101-2021_01_06_425584	63	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	63	2	is	be	VBZ
10_1101-2021_01_06_425584	63	3	made	make	VBN
10_1101-2021_01_06_425584	63	4	The	the	DT
10_1101-2021_01_06_425584	63	5	copyright	copyright	NN
10_1101-2021_01_06_425584	63	6	holder	holder	NN
10_1101-2021_01_06_425584	63	7	for	for	IN
10_1101-2021_01_06_425584	63	8	this	this	DT
10_1101-2021_01_06_425584	63	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	63	10	version	version	NN
10_1101-2021_01_06_425584	63	11	posted	post	VBD
10_1101-2021_01_06_425584	63	12	January	January	NNP
10_1101-2021_01_06_425584	63	13	8	8	CD
10_1101-2021_01_06_425584	63	14	,	,	,
10_1101-2021_01_06_425584	63	15	2021	2021	CD
10_1101-2021_01_06_425584	63	16	.	.	.
10_1101-2021_01_06_425584	63	17	;	;	:
10_1101-2021_01_06_425584	63	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	63	19	:	:	:
10_1101-2021_01_06_425584	63	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	63	21	preprint	preprint	NN
10_1101-2021_01_06_425584	63	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	63	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	63	24	5	5	CD
10_1101-2021_01_06_425584	63	25	(	(	-LRB-
10_1101-2021_01_06_425584	63	26	1:400	1:400	CD
10_1101-2021_01_06_425584	63	27	,	,	,
10_1101-2021_01_06_425584	63	28	3	3	CD
10_1101-2021_01_06_425584	63	29	%	%	NN
10_1101-2021_01_06_425584	63	30	BSA	BSA	NNP
10_1101-2021_01_06_425584	63	31	in	in	IN
10_1101-2021_01_06_425584	63	32	PBS	PBS	NNP
10_1101-2021_01_06_425584	63	33	)	)	-RRB-
10_1101-2021_01_06_425584	63	34	overnight	overnight	RB
10_1101-2021_01_06_425584	63	35	at	at	IN
10_1101-2021_01_06_425584	63	36	4oC	4oc	CD
10_1101-2021_01_06_425584	63	37	and	and	CC
10_1101-2021_01_06_425584	63	38	thereafter	thereafter	RB
10_1101-2021_01_06_425584	63	39	washed	wash	VBD
10_1101-2021_01_06_425584	63	40	3x	3x	CD
10_1101-2021_01_06_425584	63	41	with	with	IN
10_1101-2021_01_06_425584	63	42	PBS	PBS	NNP
10_1101-2021_01_06_425584	63	43	.	.	.
10_1101-2021_01_06_425584	64	1	Alexa	Alexa	NNP
10_1101-2021_01_06_425584	64	2	Fluor	Fluor	NNP
10_1101-2021_01_06_425584	64	3	488	488	CD
10_1101-2021_01_06_425584	64	4	-	-	SYM
10_1101-2021_01_06_425584	64	5	117	117	CD
10_1101-2021_01_06_425584	64	6	labeled	label	VBD
10_1101-2021_01_06_425584	64	7	anti	anti	JJ
10_1101-2021_01_06_425584	64	8	-	-	NN
10_1101-2021_01_06_425584	64	9	rabbit	rabbit	JJ
10_1101-2021_01_06_425584	64	10	(	(	-LRB-
10_1101-2021_01_06_425584	64	11	1:400	1:400	CD
10_1101-2021_01_06_425584	64	12	in	in	IN
10_1101-2021_01_06_425584	64	13	PBS	PBS	NNP
10_1101-2021_01_06_425584	64	14	)	)	-RRB-
10_1101-2021_01_06_425584	64	15	was	be	VBD
10_1101-2021_01_06_425584	64	16	then	then	RB
10_1101-2021_01_06_425584	64	17	used	use	VBN
10_1101-2021_01_06_425584	64	18	as	as	IN
10_1101-2021_01_06_425584	64	19	a	a	DT
10_1101-2021_01_06_425584	64	20	secondary	secondary	JJ
10_1101-2021_01_06_425584	64	21	antibody	antibody	NN
10_1101-2021_01_06_425584	64	22	for	for	IN
10_1101-2021_01_06_425584	64	23	1	1	CD
10_1101-2021_01_06_425584	64	24	h	h	NN
10_1101-2021_01_06_425584	64	25	at	at	IN
10_1101-2021_01_06_425584	64	26	RT	RT	NNP
10_1101-2021_01_06_425584	64	27	and	and	CC
10_1101-2021_01_06_425584	64	28	118	118	CD
10_1101-2021_01_06_425584	64	29	washed	wash	VBD
10_1101-2021_01_06_425584	64	30	3x	3x	CD
10_1101-2021_01_06_425584	64	31	with	with	IN
10_1101-2021_01_06_425584	64	32	PBS	PBS	NNP
10_1101-2021_01_06_425584	64	33	.	.	.
10_1101-2021_01_06_425584	65	1	As	as	IN
10_1101-2021_01_06_425584	65	2	a	a	DT
10_1101-2021_01_06_425584	65	3	negative	negative	JJ
10_1101-2021_01_06_425584	65	4	control	control	NN
10_1101-2021_01_06_425584	65	5	,	,	,
10_1101-2021_01_06_425584	65	6	cells	cell	NNS
10_1101-2021_01_06_425584	65	7	were	be	VBD
10_1101-2021_01_06_425584	65	8	incubated	incubate	VBN
10_1101-2021_01_06_425584	65	9	only	only	RB
10_1101-2021_01_06_425584	65	10	with	with	IN
10_1101-2021_01_06_425584	65	11	secondary	secondary	JJ
10_1101-2021_01_06_425584	65	12	antibody	antibody	NN
10_1101-2021_01_06_425584	65	13	to	to	IN
10_1101-2021_01_06_425584	65	14	119	119	CD
10_1101-2021_01_06_425584	65	15	assess	assess	NN
10_1101-2021_01_06_425584	65	16	for	for	IN
10_1101-2021_01_06_425584	65	17	non	non	JJ
10_1101-2021_01_06_425584	65	18	-	-	JJ
10_1101-2021_01_06_425584	65	19	specific	specific	JJ
10_1101-2021_01_06_425584	65	20	binding	binding	NN
10_1101-2021_01_06_425584	65	21	.	.	.
10_1101-2021_01_06_425584	66	1	Cell	cell	NN
10_1101-2021_01_06_425584	66	2	nuclei	nucleus	NNS
10_1101-2021_01_06_425584	66	3	were	be	VBD
10_1101-2021_01_06_425584	66	4	stained	stain	VBN
10_1101-2021_01_06_425584	66	5	with	with	IN
10_1101-2021_01_06_425584	66	6	Hoechst	Hoechst	NNP
10_1101-2021_01_06_425584	66	7	33258	33258	CD
10_1101-2021_01_06_425584	66	8	(	(	-LRB-
10_1101-2021_01_06_425584	66	9	2	2	CD
10_1101-2021_01_06_425584	66	10	µg	µg	NN
10_1101-2021_01_06_425584	66	11	/	/	SYM
10_1101-2021_01_06_425584	66	12	ml	ml	NN
10_1101-2021_01_06_425584	66	13	in	in	IN
10_1101-2021_01_06_425584	66	14	HBSS	HBSS	NNP
10_1101-2021_01_06_425584	66	15	)	)	-RRB-
10_1101-2021_01_06_425584	66	16	120	120	CD
10_1101-2021_01_06_425584	66	17	for	for	IN
10_1101-2021_01_06_425584	66	18	30	30	CD
10_1101-2021_01_06_425584	66	19	min	min	NN
10_1101-2021_01_06_425584	66	20	and	and	CC
10_1101-2021_01_06_425584	66	21	washed	wash	VBD
10_1101-2021_01_06_425584	66	22	3x	3x	CD
10_1101-2021_01_06_425584	66	23	with	with	IN
10_1101-2021_01_06_425584	66	24	PBS	PBS	NNP
10_1101-2021_01_06_425584	66	25	.	.	.
10_1101-2021_01_06_425584	67	1	Fluorescent	fluorescent	NN
10_1101-2021_01_06_425584	67	2	images	image	NNS
10_1101-2021_01_06_425584	67	3	were	be	VBD
10_1101-2021_01_06_425584	67	4	taken	take	VBN
10_1101-2021_01_06_425584	67	5	in	in	RP
10_1101-2021_01_06_425584	67	6	at	at	RB
10_1101-2021_01_06_425584	67	7	least	least	RBS
10_1101-2021_01_06_425584	67	8	three	three	CD
10_1101-2021_01_06_425584	67	9	random	random	JJ
10_1101-2021_01_06_425584	67	10	121	121	CD
10_1101-2021_01_06_425584	67	11	fields	field	NNS
10_1101-2021_01_06_425584	67	12	per	per	IN
10_1101-2021_01_06_425584	67	13	condition	condition	NN
10_1101-2021_01_06_425584	67	14	using	use	VBG
10_1101-2021_01_06_425584	67	15	an	an	DT
10_1101-2021_01_06_425584	67	16	EVOS	evos	NN
10_1101-2021_01_06_425584	67	17	®	®	.
10_1101-2021_01_06_425584	67	18	FLoid	floid	NN
10_1101-2021_01_06_425584	67	19	®	®	:
10_1101-2021_01_06_425584	67	20	Cell	Cell	NNP
10_1101-2021_01_06_425584	67	21	Imaging	Imaging	NNP
10_1101-2021_01_06_425584	67	22	Station	Station	NNP
10_1101-2021_01_06_425584	67	23	with	with	IN
10_1101-2021_01_06_425584	67	24	a	a	DT
10_1101-2021_01_06_425584	67	25	fixed	fix	VBN
10_1101-2021_01_06_425584	67	26	20x	20x	NNS
10_1101-2021_01_06_425584	67	27	air	air	NN
10_1101-2021_01_06_425584	67	28	objective	objective	NN
10_1101-2021_01_06_425584	67	29	.	.	.
10_1101-2021_01_06_425584	68	1	122	122	CD
10_1101-2021_01_06_425584	68	2	Image	image	NN
10_1101-2021_01_06_425584	68	3	analysis	analysis	NN
10_1101-2021_01_06_425584	68	4	was	be	VBD
10_1101-2021_01_06_425584	68	5	performed	perform	VBN
10_1101-2021_01_06_425584	68	6	through	through	IN
10_1101-2021_01_06_425584	68	7	ImageJ	ImageJ	NNP
10_1101-2021_01_06_425584	68	8	software	software	NN
10_1101-2021_01_06_425584	68	9	(	(	-LRB-
10_1101-2021_01_06_425584	68	10	version	version	NN
10_1101-2021_01_06_425584	68	11	2.0.0	2.0.0	CD
10_1101-2021_01_06_425584	68	12	)	)	-RRB-
10_1101-2021_01_06_425584	68	13	.	.	.
10_1101-2021_01_06_425584	69	1	123	123	CD
10_1101-2021_01_06_425584	69	2	124	124	CD
10_1101-2021_01_06_425584	69	3	2.4	2.4	CD
10_1101-2021_01_06_425584	69	4	Metabolite	Metabolite	NNP
10_1101-2021_01_06_425584	69	5	extraction	extraction	NN
10_1101-2021_01_06_425584	69	6	125	125	CD
10_1101-2021_01_06_425584	69	7	Cells	cell	NNS
10_1101-2021_01_06_425584	69	8	were	be	VBD
10_1101-2021_01_06_425584	69	9	seeded	seed	VBN
10_1101-2021_01_06_425584	69	10	at	at	IN
10_1101-2021_01_06_425584	69	11	300,000	300,000	CD
10_1101-2021_01_06_425584	69	12	cells	cell	NNS
10_1101-2021_01_06_425584	69	13	per	per	IN
10_1101-2021_01_06_425584	69	14	well	well	NN
10_1101-2021_01_06_425584	69	15	in	in	IN
10_1101-2021_01_06_425584	69	16	6-well	6-well	CD
10_1101-2021_01_06_425584	69	17	plates	plate	NNS
10_1101-2021_01_06_425584	69	18	(	(	-LRB-
10_1101-2021_01_06_425584	69	19	Corning	corn	VBG
10_1101-2021_01_06_425584	69	20	®	®	NN
10_1101-2021_01_06_425584	69	21	CellBIND	CellBIND	NNP
10_1101-2021_01_06_425584	69	22	®	®	:
10_1101-2021_01_06_425584	69	23	)	)	-RRB-
10_1101-2021_01_06_425584	69	24	and	and	CC
10_1101-2021_01_06_425584	69	25	treated	treat	VBN
10_1101-2021_01_06_425584	69	26	as	as	IN
10_1101-2021_01_06_425584	69	27	126	126	CD
10_1101-2021_01_06_425584	69	28	above	above	RB
10_1101-2021_01_06_425584	69	29	.	.	.
10_1101-2021_01_06_425584	70	1	After	after	IN
10_1101-2021_01_06_425584	70	2	HG	HG	NNP
10_1101-2021_01_06_425584	70	3	and	and	CC
10_1101-2021_01_06_425584	70	4	HI	HI	NNP
10_1101-2021_01_06_425584	70	5	conditions	condition	NNS
10_1101-2021_01_06_425584	70	6	,	,	,
10_1101-2021_01_06_425584	70	7	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	70	8	were	be	VBD
10_1101-2021_01_06_425584	70	9	extracted	extract	VBN
10_1101-2021_01_06_425584	70	10	following	follow	VBG
10_1101-2021_01_06_425584	70	11	a	a	DT
10_1101-2021_01_06_425584	70	12	published	publish	VBN
10_1101-2021_01_06_425584	70	13	protocol	protocol	NN
10_1101-2021_01_06_425584	70	14	for	for	IN
10_1101-2021_01_06_425584	70	15	127	127	CD
10_1101-2021_01_06_425584	70	16	adherent	adherent	JJ
10_1101-2021_01_06_425584	70	17	cells	cell	NNS
10_1101-2021_01_06_425584	70	18	with	with	IN
10_1101-2021_01_06_425584	70	19	some	some	DT
10_1101-2021_01_06_425584	70	20	modifications	modification	NNS
10_1101-2021_01_06_425584	70	21	(	(	-LRB-
10_1101-2021_01_06_425584	70	22	20	20	CD
10_1101-2021_01_06_425584	70	23	)	)	-RRB-
10_1101-2021_01_06_425584	70	24	(	(	-LRB-
10_1101-2021_01_06_425584	70	25	Figure	figure	NN
10_1101-2021_01_06_425584	70	26	1	1	CD
10_1101-2021_01_06_425584	70	27	)	)	-RRB-
10_1101-2021_01_06_425584	70	28	.	.	.
10_1101-2021_01_06_425584	71	1	In	in	IN
10_1101-2021_01_06_425584	71	2	brief	brief	NN
10_1101-2021_01_06_425584	71	3	,	,	,
10_1101-2021_01_06_425584	71	4	after	after	IN
10_1101-2021_01_06_425584	71	5	washing	wash	VBG
10_1101-2021_01_06_425584	71	6	the	the	DT
10_1101-2021_01_06_425584	71	7	cells	cell	NNS
10_1101-2021_01_06_425584	71	8	3	3	CD
10_1101-2021_01_06_425584	71	9	x	x	NN
10_1101-2021_01_06_425584	71	10	with	with	IN
10_1101-2021_01_06_425584	71	11	128	128	CD
10_1101-2021_01_06_425584	71	12	PBS	PBS	NNP
10_1101-2021_01_06_425584	71	13	,	,	,
10_1101-2021_01_06_425584	71	14	500	500	CD
10_1101-2021_01_06_425584	71	15	µL	µL	NNP
10_1101-2021_01_06_425584	71	16	of	of	IN
10_1101-2021_01_06_425584	71	17	a	a	DT
10_1101-2021_01_06_425584	71	18	cold	cold	JJ
10_1101-2021_01_06_425584	71	19	mixture	mixture	NN
10_1101-2021_01_06_425584	71	20	of	of	IN
10_1101-2021_01_06_425584	71	21	methanol	methanol	NN
10_1101-2021_01_06_425584	71	22	:	:	:
10_1101-2021_01_06_425584	71	23	ethanol	ethanol	NN
10_1101-2021_01_06_425584	71	24	(	(	-LRB-
10_1101-2021_01_06_425584	71	25	50:50	50:50	CD
10_1101-2021_01_06_425584	71	26	,	,	,
10_1101-2021_01_06_425584	71	27	v	v	NN
10_1101-2021_01_06_425584	71	28	:	:	:
10_1101-2021_01_06_425584	71	29	v	v	LS
10_1101-2021_01_06_425584	71	30	)	)	-RRB-
10_1101-2021_01_06_425584	71	31	were	be	VBD
10_1101-2021_01_06_425584	71	32	added	add	VBN
10_1101-2021_01_06_425584	71	33	to	to	IN
10_1101-2021_01_06_425584	71	34	each	each	DT
10_1101-2021_01_06_425584	71	35	well	well	RB
10_1101-2021_01_06_425584	71	36	,	,	,
10_1101-2021_01_06_425584	71	37	covered	cover	VBD
10_1101-2021_01_06_425584	71	38	129	129	CD
10_1101-2021_01_06_425584	71	39	with	with	IN
10_1101-2021_01_06_425584	71	40	aluminum	aluminum	NN
10_1101-2021_01_06_425584	71	41	foil	foil	NN
10_1101-2021_01_06_425584	71	42	,	,	,
10_1101-2021_01_06_425584	71	43	and	and	CC
10_1101-2021_01_06_425584	71	44	incubated	incubate	VBD
10_1101-2021_01_06_425584	71	45	at	at	IN
10_1101-2021_01_06_425584	71	46	-800C	-800C	NNP
10_1101-2021_01_06_425584	71	47	for	for	IN
10_1101-2021_01_06_425584	71	48	4	4	CD
10_1101-2021_01_06_425584	71	49	h.	h.	NN
10_1101-2021_01_06_425584	71	50	Cells	cell	NNS
10_1101-2021_01_06_425584	71	51	were	be	VBD
10_1101-2021_01_06_425584	71	52	then	then	RB
10_1101-2021_01_06_425584	71	53	scrapped	scrap	VBN
10_1101-2021_01_06_425584	71	54	using	use	VBG
10_1101-2021_01_06_425584	71	55	a	a	DT
10_1101-2021_01_06_425584	71	56	lifter	lifter	NN
10_1101-2021_01_06_425584	71	57	(	(	-LRB-
10_1101-2021_01_06_425584	71	58	Fisher	Fisher	NNP
10_1101-2021_01_06_425584	71	59	130	130	CD
10_1101-2021_01_06_425584	71	60	Scientific	Scientific	NNP
10_1101-2021_01_06_425584	71	61	,	,	,
10_1101-2021_01_06_425584	71	62	Hampton	Hampton	NNP
10_1101-2021_01_06_425584	71	63	,	,	,
10_1101-2021_01_06_425584	71	64	NH	NH	NNP
10_1101-2021_01_06_425584	71	65	,	,	,
10_1101-2021_01_06_425584	71	66	USA	USA	NNP
10_1101-2021_01_06_425584	71	67	)	)	-RRB-
10_1101-2021_01_06_425584	71	68	,	,	,
10_1101-2021_01_06_425584	71	69	and	and	CC
10_1101-2021_01_06_425584	71	70	the	the	DT
10_1101-2021_01_06_425584	71	71	supernatant	supernatant	JJ
10_1101-2021_01_06_425584	71	72	was	be	VBD
10_1101-2021_01_06_425584	71	73	transferred	transfer	VBN
10_1101-2021_01_06_425584	71	74	to	to	IN
10_1101-2021_01_06_425584	71	75	Eppendorf	Eppendorf	NNP
10_1101-2021_01_06_425584	71	76	tubes	tube	NNS
10_1101-2021_01_06_425584	71	77	before	before	IN
10_1101-2021_01_06_425584	71	78	131	131	CD
10_1101-2021_01_06_425584	71	79	centrifugation	centrifugation	NN
10_1101-2021_01_06_425584	71	80	for	for	IN
10_1101-2021_01_06_425584	71	81	10	10	CD
10_1101-2021_01_06_425584	71	82	min	min	NN
10_1101-2021_01_06_425584	71	83	at	at	IN
10_1101-2021_01_06_425584	71	84	14,000	14,000	CD
10_1101-2021_01_06_425584	71	85	rpm	rpm	NN
10_1101-2021_01_06_425584	71	86	at	at	IN
10_1101-2021_01_06_425584	71	87	40C.	40c.	CD
10_1101-2021_01_06_425584	72	1	The	the	DT
10_1101-2021_01_06_425584	72	2	supernatant	supernatant	JJ
10_1101-2021_01_06_425584	72	3	was	be	VBD
10_1101-2021_01_06_425584	72	4	transferred	transfer	VBN
10_1101-2021_01_06_425584	72	5	to	to	IN
10_1101-2021_01_06_425584	72	6	another	another	DT
10_1101-2021_01_06_425584	72	7	tube	tube	NN
10_1101-2021_01_06_425584	72	8	132	132	CD
10_1101-2021_01_06_425584	72	9	and	and	CC
10_1101-2021_01_06_425584	72	10	dried	dry	VBN
10_1101-2021_01_06_425584	72	11	down	down	RP
10_1101-2021_01_06_425584	72	12	by	by	IN
10_1101-2021_01_06_425584	72	13	SpeedVac	SpeedVac	NNP
10_1101-2021_01_06_425584	72	14	™	™	CD
10_1101-2021_01_06_425584	72	15	System	System	NNP
10_1101-2021_01_06_425584	72	16	(	(	-LRB-
10_1101-2021_01_06_425584	72	17	Thermo	Thermo	NNP
10_1101-2021_01_06_425584	72	18	Fisher	Fisher	NNP
10_1101-2021_01_06_425584	72	19	Scientific	Scientific	NNP
10_1101-2021_01_06_425584	72	20	,	,	,
10_1101-2021_01_06_425584	72	21	Waltham	Waltham	NNP
10_1101-2021_01_06_425584	72	22	,	,	,
10_1101-2021_01_06_425584	72	23	MA	MA	NNP
10_1101-2021_01_06_425584	72	24	,	,	,
10_1101-2021_01_06_425584	72	25	USA	USA	NNP
10_1101-2021_01_06_425584	72	26	)	)	-RRB-
10_1101-2021_01_06_425584	72	27	.	.	.
10_1101-2021_01_06_425584	73	1	Samples	sample	NNS
10_1101-2021_01_06_425584	73	2	133	133	CD
10_1101-2021_01_06_425584	73	3	were	be	VBD
10_1101-2021_01_06_425584	73	4	reconstituted	reconstitute	VBN
10_1101-2021_01_06_425584	73	5	in	in	IN
10_1101-2021_01_06_425584	73	6	water	water	NN
10_1101-2021_01_06_425584	73	7	/	/	SYM
10_1101-2021_01_06_425584	73	8	acetonitrile	acetonitrile	NN
10_1101-2021_01_06_425584	73	9	95:5	95:5	CD
10_1101-2021_01_06_425584	73	10	v	v	NN
10_1101-2021_01_06_425584	73	11	/	/	SYM
10_1101-2021_01_06_425584	73	12	v	v	NN
10_1101-2021_01_06_425584	73	13	with	with	IN
10_1101-2021_01_06_425584	73	14	0.1	0.1	CD
10_1101-2021_01_06_425584	73	15	%	%	NN
10_1101-2021_01_06_425584	73	16	formic	formic	NN
10_1101-2021_01_06_425584	73	17	,	,	,
10_1101-2021_01_06_425584	73	18	centrifuged	centrifuge	VBD
10_1101-2021_01_06_425584	73	19	at	at	IN
10_1101-2021_01_06_425584	73	20	14,000	14,000	CD
10_1101-2021_01_06_425584	73	21	rpm	rpm	NN
10_1101-2021_01_06_425584	73	22	for	for	IN
10_1101-2021_01_06_425584	73	23	134	134	CD
10_1101-2021_01_06_425584	73	24	10	10	CD
10_1101-2021_01_06_425584	73	25	min	min	NN
10_1101-2021_01_06_425584	73	26	at	at	IN
10_1101-2021_01_06_425584	73	27	4o	4o	CD
10_1101-2021_01_06_425584	73	28	C.	C.	NNP
10_1101-2021_01_06_425584	73	29	The	the	DT
10_1101-2021_01_06_425584	73	30	particle	particle	NN
10_1101-2021_01_06_425584	73	31	free	free	JJ
10_1101-2021_01_06_425584	73	32	supernatant	supernatant	NN
10_1101-2021_01_06_425584	73	33	was	be	VBD
10_1101-2021_01_06_425584	73	34	recovered	recover	VBN
10_1101-2021_01_06_425584	73	35	for	for	IN
10_1101-2021_01_06_425584	73	36	further	further	JJ
10_1101-2021_01_06_425584	73	37	LC	LC	NNP
10_1101-2021_01_06_425584	73	38	-	-	HYPH
10_1101-2021_01_06_425584	73	39	MS2	MS2	NNP
10_1101-2021_01_06_425584	73	40	analysis	analysis	NN
10_1101-2021_01_06_425584	73	41	.	.	.
10_1101-2021_01_06_425584	74	1	135	135	CD
10_1101-2021_01_06_425584	74	2	136	136	CD
10_1101-2021_01_06_425584	74	3	2.5	2.5	CD
10_1101-2021_01_06_425584	74	4	LC	LC	NNP
10_1101-2021_01_06_425584	74	5	-	-	HYPH
10_1101-2021_01_06_425584	74	6	MS2	MS2	NNP
10_1101-2021_01_06_425584	74	7	data	data	NN
10_1101-2021_01_06_425584	74	8	acquisition	acquisition	NN
10_1101-2021_01_06_425584	74	9	for	for	IN
10_1101-2021_01_06_425584	74	10	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	74	11	137	137	CD
10_1101-2021_01_06_425584	74	12	Metabolites	metabolite	NNS
10_1101-2021_01_06_425584	74	13	were	be	VBD
10_1101-2021_01_06_425584	74	14	loaded	load	VBN
10_1101-2021_01_06_425584	74	15	into	into	IN
10_1101-2021_01_06_425584	74	16	an	an	DT
10_1101-2021_01_06_425584	74	17	Eksigent	Eksigent	NNP
10_1101-2021_01_06_425584	74	18	nanoLCâ	nanoLCâ	NNP
10_1101-2021_01_06_425584	74	19	400	400	CD
10_1101-2021_01_06_425584	74	20	system	system	NN
10_1101-2021_01_06_425584	74	21	(	(	-LRB-
10_1101-2021_01_06_425584	74	22	AB	AB	NNP
10_1101-2021_01_06_425584	74	23	Sciex	Sciex	NNP
10_1101-2021_01_06_425584	74	24	,	,	,
10_1101-2021_01_06_425584	74	25	Foster	Foster	NNP
10_1101-2021_01_06_425584	74	26	City	City	NNP
10_1101-2021_01_06_425584	74	27	,	,	,
10_1101-2021_01_06_425584	74	28	CA	CA	NNP
10_1101-2021_01_06_425584	74	29	,	,	,
10_1101-2021_01_06_425584	74	30	USA	USA	NNP
10_1101-2021_01_06_425584	74	31	)	)	-RRB-
10_1101-2021_01_06_425584	74	32	138	138	CD
10_1101-2021_01_06_425584	74	33	with	with	IN
10_1101-2021_01_06_425584	74	34	a	a	DT
10_1101-2021_01_06_425584	74	35	HALO	HALO	NNP
10_1101-2021_01_06_425584	74	36	Phenyl	Phenyl	NNP
10_1101-2021_01_06_425584	74	37	-	-	HYPH
10_1101-2021_01_06_425584	74	38	Hexyl	Hexyl	NNP
10_1101-2021_01_06_425584	74	39	column	column	NN
10_1101-2021_01_06_425584	74	40	(	(	-LRB-
10_1101-2021_01_06_425584	74	41	0.5	0.5	CD
10_1101-2021_01_06_425584	74	42	x	x	SYM
10_1101-2021_01_06_425584	74	43	50	50	CD
10_1101-2021_01_06_425584	74	44	mm	mm	NN
10_1101-2021_01_06_425584	74	45	,	,	,
10_1101-2021_01_06_425584	74	46	2.7	2.7	CD
10_1101-2021_01_06_425584	74	47	µm	µm	NNP
10_1101-2021_01_06_425584	74	48	,	,	,
10_1101-2021_01_06_425584	74	49	90	90	CD
10_1101-2021_01_06_425584	74	50	Å	å	JJ
10_1101-2021_01_06_425584	74	51	pore	pore	NN
10_1101-2021_01_06_425584	74	52	size	size	NN
10_1101-2021_01_06_425584	74	53	,	,	,
10_1101-2021_01_06_425584	74	54	Eksigent	Eksigent	NNP
10_1101-2021_01_06_425584	74	55	AB	AB	NNP
10_1101-2021_01_06_425584	74	56	Sciex	Sciex	NNP
10_1101-2021_01_06_425584	74	57	,	,	,
10_1101-2021_01_06_425584	74	58	139	139	CD
10_1101-2021_01_06_425584	74	59	Foster	Foster	NNP
10_1101-2021_01_06_425584	74	60	City	City	NNP
10_1101-2021_01_06_425584	74	61	,	,	,
10_1101-2021_01_06_425584	74	62	CA	CA	NNP
10_1101-2021_01_06_425584	74	63	,	,	,
10_1101-2021_01_06_425584	74	64	USA	USA	NNP
10_1101-2021_01_06_425584	74	65	)	)	-RRB-
10_1101-2021_01_06_425584	74	66	for	for	IN
10_1101-2021_01_06_425584	74	67	data	datum	NNS
10_1101-2021_01_06_425584	74	68	acquisition	acquisition	NN
10_1101-2021_01_06_425584	74	69	using	use	VBG
10_1101-2021_01_06_425584	74	70	the	the	DT
10_1101-2021_01_06_425584	74	71	LC	LC	NNP
10_1101-2021_01_06_425584	74	72	-	-	HYPH
10_1101-2021_01_06_425584	74	73	MS	MS	NNP
10_1101-2021_01_06_425584	74	74	parameters	parameter	NNS
10_1101-2021_01_06_425584	74	75	previously	previously	RB
10_1101-2021_01_06_425584	74	76	described	describe	VBD
10_1101-2021_01_06_425584	74	77	with	with	IN
10_1101-2021_01_06_425584	74	78	140	140	CD
10_1101-2021_01_06_425584	74	79	some	some	DT
10_1101-2021_01_06_425584	74	80	modifications	modification	NNS
10_1101-2021_01_06_425584	74	81	(	(	-LRB-
10_1101-2021_01_06_425584	74	82	21	21	CD
10_1101-2021_01_06_425584	74	83	)	)	-RRB-
10_1101-2021_01_06_425584	74	84	.	.	.
10_1101-2021_01_06_425584	75	1	In	in	IN
10_1101-2021_01_06_425584	75	2	brief	brief	NN
10_1101-2021_01_06_425584	75	3	,	,	,
10_1101-2021_01_06_425584	75	4	the	the	DT
10_1101-2021_01_06_425584	75	5	separation	separation	NN
10_1101-2021_01_06_425584	75	6	of	of	IN
10_1101-2021_01_06_425584	75	7	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	75	8	was	be	VBD
10_1101-2021_01_06_425584	75	9	performed	perform	VBN
10_1101-2021_01_06_425584	75	10	using	use	VBG
10_1101-2021_01_06_425584	75	11	gradient	gradient	NNP
10_1101-2021_01_06_425584	75	12	141	141	CD
10_1101-2021_01_06_425584	75	13	elution	elution	NN
10_1101-2021_01_06_425584	75	14	with	with	IN
10_1101-2021_01_06_425584	75	15	0.1	0.1	CD
10_1101-2021_01_06_425584	75	16	%	%	NN
10_1101-2021_01_06_425584	75	17	formic	formic	NN
10_1101-2021_01_06_425584	75	18	acid	acid	NN
10_1101-2021_01_06_425584	75	19	in	in	IN
10_1101-2021_01_06_425584	75	20	water	water	NN
10_1101-2021_01_06_425584	75	21	(	(	-LRB-
10_1101-2021_01_06_425584	75	22	A	a	NN
10_1101-2021_01_06_425584	75	23	)	)	-RRB-
10_1101-2021_01_06_425584	75	24	and	and	CC
10_1101-2021_01_06_425584	75	25	0.1	0.1	CD
10_1101-2021_01_06_425584	75	26	%	%	NN
10_1101-2021_01_06_425584	75	27	formic	formic	NN
10_1101-2021_01_06_425584	75	28	acid	acid	NN
10_1101-2021_01_06_425584	75	29	in	in	IN
10_1101-2021_01_06_425584	75	30	ACN	ACN	NNP
10_1101-2021_01_06_425584	75	31	(	(	-LRB-
10_1101-2021_01_06_425584	75	32	B	B	NNP
10_1101-2021_01_06_425584	75	33	)	)	-RRB-
10_1101-2021_01_06_425584	75	34	as	as	IN
10_1101-2021_01_06_425584	75	35	mobile	mobile	JJ
10_1101-2021_01_06_425584	75	36	phases	phase	VBZ
10_1101-2021_01_06_425584	75	37	at	at	IN
10_1101-2021_01_06_425584	75	38	a	a	DT
10_1101-2021_01_06_425584	75	39	142	142	CD
10_1101-2021_01_06_425584	75	40	constant	constant	JJ
10_1101-2021_01_06_425584	75	41	flow	flow	NN
10_1101-2021_01_06_425584	75	42	rate	rate	NN
10_1101-2021_01_06_425584	75	43	of	of	IN
10_1101-2021_01_06_425584	75	44	5	5	CD
10_1101-2021_01_06_425584	75	45	µL	µL	NNP
10_1101-2021_01_06_425584	75	46	/	/	SYM
10_1101-2021_01_06_425584	75	47	min	min	NNP
10_1101-2021_01_06_425584	75	48	.	.	.
10_1101-2021_01_06_425584	76	1	The	the	DT
10_1101-2021_01_06_425584	76	2	gradient	gradient	NN
10_1101-2021_01_06_425584	76	3	started	start	VBD
10_1101-2021_01_06_425584	76	4	with	with	IN
10_1101-2021_01_06_425584	76	5	5	5	CD
10_1101-2021_01_06_425584	76	6	%	%	NN
10_1101-2021_01_06_425584	76	7	B	b	NN
10_1101-2021_01_06_425584	76	8	for	for	IN
10_1101-2021_01_06_425584	76	9	1	1	CD
10_1101-2021_01_06_425584	76	10	min	min	NN
10_1101-2021_01_06_425584	76	11	followed	follow	VBN
10_1101-2021_01_06_425584	76	12	by	by	IN
10_1101-2021_01_06_425584	76	13	a	a	DT
10_1101-2021_01_06_425584	76	14	stepped	step	VBN
10_1101-2021_01_06_425584	76	15	143	143	CD
10_1101-2021_01_06_425584	76	16	increase	increase	NN
10_1101-2021_01_06_425584	76	17	to	to	IN
10_1101-2021_01_06_425584	76	18	100	100	CD
10_1101-2021_01_06_425584	76	19	%	%	NN
10_1101-2021_01_06_425584	76	20	,	,	,
10_1101-2021_01_06_425584	76	21	B	b	NN
10_1101-2021_01_06_425584	76	22	over	over	IN
10_1101-2021_01_06_425584	76	23	26	26	CD
10_1101-2021_01_06_425584	76	24	min	min	NN
10_1101-2021_01_06_425584	76	25	and	and	CC
10_1101-2021_01_06_425584	76	26	held	hold	VBD
10_1101-2021_01_06_425584	76	27	constant	constant	JJ
10_1101-2021_01_06_425584	76	28	for	for	IN
10_1101-2021_01_06_425584	76	29	4	4	CD
10_1101-2021_01_06_425584	76	30	min	min	NN
10_1101-2021_01_06_425584	76	31	.	.	.
10_1101-2021_01_06_425584	77	1	Solvent	solvent	JJ
10_1101-2021_01_06_425584	77	2	composition	composition	NN
10_1101-2021_01_06_425584	77	3	was	be	VBD
10_1101-2021_01_06_425584	77	4	returned	return	VBN
10_1101-2021_01_06_425584	77	5	144	144	CD
10_1101-2021_01_06_425584	77	6	to	to	TO
10_1101-2021_01_06_425584	77	7	5	5	CD
10_1101-2021_01_06_425584	77	8	%	%	NN
10_1101-2021_01_06_425584	77	9	B	b	NN
10_1101-2021_01_06_425584	77	10	for	for	IN
10_1101-2021_01_06_425584	77	11	0.1	0.1	CD
10_1101-2021_01_06_425584	77	12	min	min	NN
10_1101-2021_01_06_425584	77	13	.	.	.
10_1101-2021_01_06_425584	78	1	Column	column	NN
10_1101-2021_01_06_425584	78	2	re	re	NN
10_1101-2021_01_06_425584	78	3	-	-	NN
10_1101-2021_01_06_425584	78	4	equilibration	equilibration	NN
10_1101-2021_01_06_425584	78	5	was	be	VBD
10_1101-2021_01_06_425584	78	6	carried	carry	VBN
10_1101-2021_01_06_425584	78	7	out	out	RP
10_1101-2021_01_06_425584	78	8	with	with	IN
10_1101-2021_01_06_425584	78	9	5	5	CD
10_1101-2021_01_06_425584	78	10	%	%	NN
10_1101-2021_01_06_425584	78	11	mobile	mobile	JJ
10_1101-2021_01_06_425584	78	12	phase	phase	NN
10_1101-2021_01_06_425584	78	13	B	b	NN
10_1101-2021_01_06_425584	78	14	for	for	IN
10_1101-2021_01_06_425584	78	15	4	4	CD
10_1101-2021_01_06_425584	78	16	minutes	minute	NNS
10_1101-2021_01_06_425584	78	17	.	.	.
10_1101-2021_01_06_425584	79	1	145	145	CD
10_1101-2021_01_06_425584	79	2	Potential	potential	JJ
10_1101-2021_01_06_425584	79	3	carryover	carryover	NN
10_1101-2021_01_06_425584	79	4	was	be	VBD
10_1101-2021_01_06_425584	79	5	minimized	minimize	VBN
10_1101-2021_01_06_425584	79	6	with	with	IN
10_1101-2021_01_06_425584	79	7	a	a	DT
10_1101-2021_01_06_425584	79	8	blank	blank	JJ
10_1101-2021_01_06_425584	79	9	run	run	NN
10_1101-2021_01_06_425584	79	10	(	(	-LRB-
10_1101-2021_01_06_425584	79	11	1	1	CD
10_1101-2021_01_06_425584	79	12	µL	µl	CD
10_1101-2021_01_06_425584	79	13	buffer	buffer	NN
10_1101-2021_01_06_425584	79	14	A	a	NN
10_1101-2021_01_06_425584	79	15	)	)	-RRB-
10_1101-2021_01_06_425584	79	16	between	between	IN
10_1101-2021_01_06_425584	79	17	sample	sample	NN
10_1101-2021_01_06_425584	79	18	experimental	experimental	JJ
10_1101-2021_01_06_425584	79	19	146	146	CD
10_1101-2021_01_06_425584	79	20	samples	sample	NNS
10_1101-2021_01_06_425584	79	21	.	.	.
10_1101-2021_01_06_425584	80	1	The	the	DT
10_1101-2021_01_06_425584	80	2	eluate	eluate	NN
10_1101-2021_01_06_425584	80	3	from	from	IN
10_1101-2021_01_06_425584	80	4	the	the	DT
10_1101-2021_01_06_425584	80	5	LC	LC	NNP
10_1101-2021_01_06_425584	80	6	was	be	VBD
10_1101-2021_01_06_425584	80	7	delivered	deliver	VBN
10_1101-2021_01_06_425584	80	8	directly	directly	RB
10_1101-2021_01_06_425584	80	9	to	to	IN
10_1101-2021_01_06_425584	80	10	the	the	DT
10_1101-2021_01_06_425584	80	11	TurboV	turbov	JJ
10_1101-2021_01_06_425584	80	12	source	source	NN
10_1101-2021_01_06_425584	80	13	of	of	IN
10_1101-2021_01_06_425584	80	14	a	a	DT
10_1101-2021_01_06_425584	80	15	TripleTOF	TripleTOF	NNP
10_1101-2021_01_06_425584	80	16	147	147	CD
10_1101-2021_01_06_425584	80	17	5600	5600	CD
10_1101-2021_01_06_425584	80	18	+	+	CC
10_1101-2021_01_06_425584	80	19	mass	mass	NN
10_1101-2021_01_06_425584	80	20	spectrometer	spectrometer	NN
10_1101-2021_01_06_425584	80	21	(	(	-LRB-
10_1101-2021_01_06_425584	80	22	AB	AB	NNP
10_1101-2021_01_06_425584	80	23	Sciex	Sciex	NNP
10_1101-2021_01_06_425584	80	24	,	,	,
10_1101-2021_01_06_425584	80	25	Foster	Foster	NNP
10_1101-2021_01_06_425584	80	26	City	City	NNP
10_1101-2021_01_06_425584	80	27	,	,	,
10_1101-2021_01_06_425584	80	28	CA	CA	NNP
10_1101-2021_01_06_425584	80	29	,	,	,
10_1101-2021_01_06_425584	80	30	USA	USA	NNP
10_1101-2021_01_06_425584	80	31	)	)	-RRB-
10_1101-2021_01_06_425584	80	32	using	use	VBG
10_1101-2021_01_06_425584	80	33	electrospray	electrospray	JJ
10_1101-2021_01_06_425584	80	34	ionization	ionization	NN
10_1101-2021_01_06_425584	80	35	(	(	-LRB-
10_1101-2021_01_06_425584	80	36	ESI	ESI	NNP
10_1101-2021_01_06_425584	80	37	)	)	-RRB-
10_1101-2021_01_06_425584	80	38	148	148	CD
10_1101-2021_01_06_425584	80	39	under	under	IN
10_1101-2021_01_06_425584	80	40	positive	positive	JJ
10_1101-2021_01_06_425584	80	41	mode	mode	NN
10_1101-2021_01_06_425584	80	42	.	.	.
10_1101-2021_01_06_425584	81	1	ESI	ESI	NNP
10_1101-2021_01_06_425584	81	2	source	source	NN
10_1101-2021_01_06_425584	81	3	conditions	condition	NNS
10_1101-2021_01_06_425584	81	4	were	be	VBD
10_1101-2021_01_06_425584	81	5	set	set	VBN
10_1101-2021_01_06_425584	81	6	as	as	IN
10_1101-2021_01_06_425584	81	7	follows	follow	VBZ
10_1101-2021_01_06_425584	81	8	:	:	:
10_1101-2021_01_06_425584	81	9	IonSpray	IonSpray	NNP
10_1101-2021_01_06_425584	81	10	Voltage	Voltage	NNP
10_1101-2021_01_06_425584	81	11	Floating	Floating	NNP
10_1101-2021_01_06_425584	81	12	,	,	,
10_1101-2021_01_06_425584	81	13	5500	5500	CD
10_1101-2021_01_06_425584	81	14	149	149	CD
10_1101-2021_01_06_425584	81	15	V	v	NN
10_1101-2021_01_06_425584	81	16	;	;	:
10_1101-2021_01_06_425584	81	17	Source	source	NN
10_1101-2021_01_06_425584	81	18	temperature	temperature	NN
10_1101-2021_01_06_425584	81	19	,	,	,
10_1101-2021_01_06_425584	81	20	350	350	CD
10_1101-2021_01_06_425584	81	21	°	°	,
10_1101-2021_01_06_425584	81	22	C	C	NNP
10_1101-2021_01_06_425584	81	23	;	;	:
10_1101-2021_01_06_425584	81	24	Curtain	curtain	JJ
10_1101-2021_01_06_425584	81	25	gas	gas	NN
10_1101-2021_01_06_425584	81	26	,	,	,
10_1101-2021_01_06_425584	81	27	20	20	CD
10_1101-2021_01_06_425584	81	28	psi	psi	NN
10_1101-2021_01_06_425584	81	29	;	;	:
10_1101-2021_01_06_425584	81	30	Ion	Ion	NNP
10_1101-2021_01_06_425584	81	31	source	source	NN
10_1101-2021_01_06_425584	81	32	gases	gas	VBZ
10_1101-2021_01_06_425584	81	33	1	1	CD
10_1101-2021_01_06_425584	81	34	and	and	CC
10_1101-2021_01_06_425584	81	35	2	2	CD
10_1101-2021_01_06_425584	81	36	were	be	VBD
10_1101-2021_01_06_425584	81	37	set	set	VBN
10_1101-2021_01_06_425584	81	38	to	to	IN
10_1101-2021_01_06_425584	81	39	40	40	CD
10_1101-2021_01_06_425584	81	40	and	and	CC
10_1101-2021_01_06_425584	81	41	150	150	CD
10_1101-2021_01_06_425584	81	42	.CC	.CC	:
10_1101-2021_01_06_425584	81	43	-	-	HYPH
10_1101-2021_01_06_425584	81	44	BY	by	IN
10_1101-2021_01_06_425584	81	45	-	-	HYPH
10_1101-2021_01_06_425584	81	46	NC	NC	NNP
10_1101-2021_01_06_425584	81	47	-	-	HYPH
10_1101-2021_01_06_425584	81	48	ND	ND	NNP
10_1101-2021_01_06_425584	81	49	4.0	4.0	CD
10_1101-2021_01_06_425584	81	50	International	International	NNP
10_1101-2021_01_06_425584	81	51	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	81	52	under	under	IN
10_1101-2021_01_06_425584	81	53	a	a	DT
10_1101-2021_01_06_425584	81	54	(	(	-LRB-
10_1101-2021_01_06_425584	81	55	which	which	WDT
10_1101-2021_01_06_425584	81	56	was	be	VBD
10_1101-2021_01_06_425584	81	57	not	not	RB
10_1101-2021_01_06_425584	81	58	certified	certify	VBN
10_1101-2021_01_06_425584	81	59	by	by	IN
10_1101-2021_01_06_425584	81	60	peer	peer	NN
10_1101-2021_01_06_425584	81	61	review	review	NN
10_1101-2021_01_06_425584	81	62	)	)	-RRB-
10_1101-2021_01_06_425584	81	63	is	be	VBZ
10_1101-2021_01_06_425584	81	64	the	the	DT
10_1101-2021_01_06_425584	81	65	author	author	NN
10_1101-2021_01_06_425584	81	66	/	/	SYM
10_1101-2021_01_06_425584	81	67	funder	funder	NN
10_1101-2021_01_06_425584	81	68	,	,	,
10_1101-2021_01_06_425584	81	69	who	who	WP
10_1101-2021_01_06_425584	81	70	has	have	VBZ
10_1101-2021_01_06_425584	81	71	granted	grant	VBN
10_1101-2021_01_06_425584	81	72	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	81	73	a	a	DT
10_1101-2021_01_06_425584	81	74	license	license	NN
10_1101-2021_01_06_425584	81	75	to	to	TO
10_1101-2021_01_06_425584	81	76	display	display	VB
10_1101-2021_01_06_425584	81	77	the	the	DT
10_1101-2021_01_06_425584	81	78	preprint	preprint	NN
10_1101-2021_01_06_425584	81	79	in	in	IN
10_1101-2021_01_06_425584	81	80	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	81	81	.	.	.
10_1101-2021_01_06_425584	82	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	82	2	is	be	VBZ
10_1101-2021_01_06_425584	82	3	made	make	VBN
10_1101-2021_01_06_425584	82	4	The	the	DT
10_1101-2021_01_06_425584	82	5	copyright	copyright	NN
10_1101-2021_01_06_425584	82	6	holder	holder	NN
10_1101-2021_01_06_425584	82	7	for	for	IN
10_1101-2021_01_06_425584	82	8	this	this	DT
10_1101-2021_01_06_425584	82	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	82	10	version	version	NN
10_1101-2021_01_06_425584	82	11	posted	post	VBD
10_1101-2021_01_06_425584	82	12	January	January	NNP
10_1101-2021_01_06_425584	82	13	8	8	CD
10_1101-2021_01_06_425584	82	14	,	,	,
10_1101-2021_01_06_425584	82	15	2021	2021	CD
10_1101-2021_01_06_425584	82	16	.	.	.
10_1101-2021_01_06_425584	82	17	;	;	:
10_1101-2021_01_06_425584	82	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	82	19	:	:	:
10_1101-2021_01_06_425584	82	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	82	21	preprint	preprint	NN
10_1101-2021_01_06_425584	82	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	82	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	82	24	6	6	CD
10_1101-2021_01_06_425584	82	25	45	45	CD
10_1101-2021_01_06_425584	82	26	psi	psi	NN
10_1101-2021_01_06_425584	82	27	;	;	:
10_1101-2021_01_06_425584	82	28	Declustering	declustere	VBG
10_1101-2021_01_06_425584	82	29	potential	potential	NN
10_1101-2021_01_06_425584	82	30	,	,	,
10_1101-2021_01_06_425584	82	31	100	100	CD
10_1101-2021_01_06_425584	82	32	V.	V.	NNP
10_1101-2021_01_06_425584	82	33	Data	Data	NNP
10_1101-2021_01_06_425584	82	34	was	be	VBD
10_1101-2021_01_06_425584	82	35	acquired	acquire	VBN
10_1101-2021_01_06_425584	82	36	using	use	VBG
10_1101-2021_01_06_425584	82	37	information	information	NN
10_1101-2021_01_06_425584	82	38	-	-	HYPH
10_1101-2021_01_06_425584	82	39	dependent	dependent	JJ
10_1101-2021_01_06_425584	82	40	acquisition	acquisition	NN
10_1101-2021_01_06_425584	82	41	151	151	CD
10_1101-2021_01_06_425584	82	42	(	(	-LRB-
10_1101-2021_01_06_425584	82	43	IDA	IDA	NNP
10_1101-2021_01_06_425584	82	44	)	)	-RRB-
10_1101-2021_01_06_425584	82	45	with	with	IN
10_1101-2021_01_06_425584	82	46	high	high	JJ
10_1101-2021_01_06_425584	82	47	sensitivity	sensitivity	NN
10_1101-2021_01_06_425584	82	48	mode	mode	NN
10_1101-2021_01_06_425584	82	49	selected	select	VBN
10_1101-2021_01_06_425584	82	50	,	,	,
10_1101-2021_01_06_425584	82	51	automatically	automatically	RB
10_1101-2021_01_06_425584	82	52	switching	switch	VBG
10_1101-2021_01_06_425584	82	53	between	between	IN
10_1101-2021_01_06_425584	82	54	full	full	JJ
10_1101-2021_01_06_425584	82	55	-	-	HYPH
10_1101-2021_01_06_425584	82	56	scan	scan	JJ
10_1101-2021_01_06_425584	82	57	MS	MS	NNP
10_1101-2021_01_06_425584	82	58	and	and	CC
10_1101-2021_01_06_425584	82	59	152	152	CD
10_1101-2021_01_06_425584	82	60	MS	MS	NNP
10_1101-2021_01_06_425584	82	61	/	/	SYM
10_1101-2021_01_06_425584	82	62	MS	MS	NNP
10_1101-2021_01_06_425584	82	63	.	.	.
10_1101-2021_01_06_425584	83	1	The	the	DT
10_1101-2021_01_06_425584	83	2	accumulation	accumulation	NN
10_1101-2021_01_06_425584	83	3	time	time	NN
10_1101-2021_01_06_425584	83	4	for	for	IN
10_1101-2021_01_06_425584	83	5	TOF	TOF	NNP
10_1101-2021_01_06_425584	83	6	MS	MS	NNP
10_1101-2021_01_06_425584	83	7	was	be	VBD
10_1101-2021_01_06_425584	83	8	0.25	0.25	CD
10_1101-2021_01_06_425584	83	9	s	s	NNPS
10_1101-2021_01_06_425584	83	10	/	/	SYM
10_1101-2021_01_06_425584	83	11	spectra	spectra	NNP
10_1101-2021_01_06_425584	83	12	over	over	IN
10_1101-2021_01_06_425584	83	13	the	the	DT
10_1101-2021_01_06_425584	83	14	m	m	NNP
10_1101-2021_01_06_425584	83	15	/	/	SYM
10_1101-2021_01_06_425584	83	16	z	z	NNP
10_1101-2021_01_06_425584	83	17	range	range	NN
10_1101-2021_01_06_425584	83	18	100	100	CD
10_1101-2021_01_06_425584	83	19	-	-	HYPH
10_1101-2021_01_06_425584	83	20	1500	1500	CD
10_1101-2021_01_06_425584	83	21	Da	Da	NNP
10_1101-2021_01_06_425584	83	22	153	153	CD
10_1101-2021_01_06_425584	83	23	and	and	CC
10_1101-2021_01_06_425584	83	24	for	for	IN
10_1101-2021_01_06_425584	83	25	MS	MS	NNP
10_1101-2021_01_06_425584	83	26	/	/	SYM
10_1101-2021_01_06_425584	83	27	MS	MS	NNP
10_1101-2021_01_06_425584	83	28	scan	scan	NNP
10_1101-2021_01_06_425584	83	29	was	be	VBD
10_1101-2021_01_06_425584	83	30	0.05	0.05	CD
10_1101-2021_01_06_425584	83	31	s	s	NNPS
10_1101-2021_01_06_425584	83	32	/	/	SYM
10_1101-2021_01_06_425584	83	33	spectra	spectra	NNP
10_1101-2021_01_06_425584	83	34	over	over	IN
10_1101-2021_01_06_425584	83	35	the	the	DT
10_1101-2021_01_06_425584	83	36	m	m	NNP
10_1101-2021_01_06_425584	83	37	/	/	SYM
10_1101-2021_01_06_425584	83	38	z	z	NNP
10_1101-2021_01_06_425584	83	39	50	50	CD
10_1101-2021_01_06_425584	83	40	-	-	SYM
10_1101-2021_01_06_425584	83	41	1500	1500	CD
10_1101-2021_01_06_425584	83	42	Da	Da	NNP
10_1101-2021_01_06_425584	83	43	.	.	.
10_1101-2021_01_06_425584	84	1	The	the	DT
10_1101-2021_01_06_425584	84	2	IDA	IDA	NNP
10_1101-2021_01_06_425584	84	3	settings	setting	NNS
10_1101-2021_01_06_425584	84	4	were	be	VBD
10_1101-2021_01_06_425584	84	5	as	as	IN
10_1101-2021_01_06_425584	84	6	154	154	CD
10_1101-2021_01_06_425584	84	7	follows	follow	VBZ
10_1101-2021_01_06_425584	84	8	charge	charge	NN
10_1101-2021_01_06_425584	84	9	state	state	NN
10_1101-2021_01_06_425584	84	10	+1	+1	NNS
10_1101-2021_01_06_425584	84	11	to	to	IN
10_1101-2021_01_06_425584	84	12	+2	+2	NNP
10_1101-2021_01_06_425584	84	13	,	,	,
10_1101-2021_01_06_425584	84	14	intensity	intensity	NN
10_1101-2021_01_06_425584	84	15	125	125	CD
10_1101-2021_01_06_425584	84	16	cps	cps	NN
10_1101-2021_01_06_425584	84	17	,	,	,
10_1101-2021_01_06_425584	84	18	exclude	exclude	VBP
10_1101-2021_01_06_425584	84	19	isotopes	isotope	VBZ
10_1101-2021_01_06_425584	84	20	within	within	IN
10_1101-2021_01_06_425584	84	21	6	6	CD
10_1101-2021_01_06_425584	84	22	Da	Da	NNP
10_1101-2021_01_06_425584	84	23	,	,	,
10_1101-2021_01_06_425584	84	24	mass	mass	NN
10_1101-2021_01_06_425584	84	25	tolerance	tolerance	NN
10_1101-2021_01_06_425584	84	26	50	50	CD
10_1101-2021_01_06_425584	84	27	155	155	CD
10_1101-2021_01_06_425584	84	28	mDa	mDa	NNS
10_1101-2021_01_06_425584	84	29	,	,	,
10_1101-2021_01_06_425584	84	30	and	and	CC
10_1101-2021_01_06_425584	84	31	a	a	DT
10_1101-2021_01_06_425584	84	32	maximum	maximum	JJ
10_1101-2021_01_06_425584	84	33	number	number	NN
10_1101-2021_01_06_425584	84	34	of	of	IN
10_1101-2021_01_06_425584	84	35	candidate	candidate	NN
10_1101-2021_01_06_425584	84	36	ions	ion	NNS
10_1101-2021_01_06_425584	84	37	20	20	CD
10_1101-2021_01_06_425584	84	38	.	.	.
10_1101-2021_01_06_425584	85	1	Under	under	IN
10_1101-2021_01_06_425584	85	2	IDA	IDA	NNP
10_1101-2021_01_06_425584	85	3	settings	setting	NNS
10_1101-2021_01_06_425584	85	4	,	,	,
10_1101-2021_01_06_425584	85	5	the	the	DT
10_1101-2021_01_06_425584	85	6	‘	'	``
10_1101-2021_01_06_425584	85	7	‘	'	``
10_1101-2021_01_06_425584	85	8	exclude	exclude	VB
10_1101-2021_01_06_425584	85	9	former	former	JJ
10_1101-2021_01_06_425584	85	10	156	156	CD
10_1101-2021_01_06_425584	85	11	target	target	NN
10_1101-2021_01_06_425584	85	12	ions	ion	NNS
10_1101-2021_01_06_425584	85	13	’	'	''
10_1101-2021_01_06_425584	85	14	’	'	''
10_1101-2021_01_06_425584	85	15	was	be	VBD
10_1101-2021_01_06_425584	85	16	set	set	VBN
10_1101-2021_01_06_425584	85	17	as	as	IN
10_1101-2021_01_06_425584	85	18	15	15	CD
10_1101-2021_01_06_425584	85	19	s	s	NN
10_1101-2021_01_06_425584	85	20	after	after	IN
10_1101-2021_01_06_425584	85	21	two	two	CD
10_1101-2021_01_06_425584	85	22	occurrences	occurrence	NNS
10_1101-2021_01_06_425584	85	23	and	and	CC
10_1101-2021_01_06_425584	85	24	‘	'	``
10_1101-2021_01_06_425584	85	25	‘	'	``
10_1101-2021_01_06_425584	85	26	dynamic	dynamic	JJ
10_1101-2021_01_06_425584	85	27	background	background	NN
10_1101-2021_01_06_425584	85	28	subtract	subtract	NN
10_1101-2021_01_06_425584	85	29	’	'	''
10_1101-2021_01_06_425584	85	30	’	'	''
10_1101-2021_01_06_425584	85	31	was	be	VBD
10_1101-2021_01_06_425584	85	32	157	157	CD
10_1101-2021_01_06_425584	85	33	selected	select	VBN
10_1101-2021_01_06_425584	85	34	.	.	.
10_1101-2021_01_06_425584	86	1	Manufacturer	manufacturer	NN
10_1101-2021_01_06_425584	86	2	rolling	roll	VBG
10_1101-2021_01_06_425584	86	3	collision	collision	NN
10_1101-2021_01_06_425584	86	4	energy	energy	NN
10_1101-2021_01_06_425584	86	5	(	(	-LRB-
10_1101-2021_01_06_425584	86	6	CE	CE	NNP
10_1101-2021_01_06_425584	86	7	)	)	-RRB-
10_1101-2021_01_06_425584	86	8	option	option	NN
10_1101-2021_01_06_425584	86	9	was	be	VBD
10_1101-2021_01_06_425584	86	10	used	use	VBN
10_1101-2021_01_06_425584	86	11	based	base	VBN
10_1101-2021_01_06_425584	86	12	on	on	IN
10_1101-2021_01_06_425584	86	13	the	the	DT
10_1101-2021_01_06_425584	86	14	size	size	NN
10_1101-2021_01_06_425584	86	15	and	and	CC
10_1101-2021_01_06_425584	86	16	158	158	CD
10_1101-2021_01_06_425584	86	17	charge	charge	NN
10_1101-2021_01_06_425584	86	18	of	of	IN
10_1101-2021_01_06_425584	86	19	the	the	DT
10_1101-2021_01_06_425584	86	20	precursor	precursor	NN
10_1101-2021_01_06_425584	86	21	ion	ion	NN
10_1101-2021_01_06_425584	86	22	using	use	VBG
10_1101-2021_01_06_425584	86	23	formula	formula	NN
10_1101-2021_01_06_425584	86	24	CE	CE	NNP
10_1101-2021_01_06_425584	86	25	=	=	SYM
10_1101-2021_01_06_425584	86	26	m	m	NNP
10_1101-2021_01_06_425584	86	27	/	/	SYM
10_1101-2021_01_06_425584	86	28	z	z	NNP
10_1101-2021_01_06_425584	86	29	x	x	SYM
10_1101-2021_01_06_425584	86	30	0.0575	0.0575	CD
10_1101-2021_01_06_425584	86	31	+	+	SYM
10_1101-2021_01_06_425584	86	32	9	9	CD
10_1101-2021_01_06_425584	86	33	.	.	.
10_1101-2021_01_06_425584	87	1	The	the	DT
10_1101-2021_01_06_425584	87	2	instrument	instrument	NN
10_1101-2021_01_06_425584	87	3	was	be	VBD
10_1101-2021_01_06_425584	87	4	automatically	automatically	RB
10_1101-2021_01_06_425584	87	5	159	159	CD
10_1101-2021_01_06_425584	87	6	calibrated	calibrate	VBN
10_1101-2021_01_06_425584	87	7	by	by	IN
10_1101-2021_01_06_425584	87	8	the	the	DT
10_1101-2021_01_06_425584	87	9	batch	batch	NN
10_1101-2021_01_06_425584	87	10	mode	mode	NN
10_1101-2021_01_06_425584	87	11	using	use	VBG
10_1101-2021_01_06_425584	87	12	appropriate	appropriate	JJ
10_1101-2021_01_06_425584	87	13	positive	positive	JJ
10_1101-2021_01_06_425584	87	14	TOF	TOF	NNP
10_1101-2021_01_06_425584	87	15	MS	MS	NNP
10_1101-2021_01_06_425584	87	16	and	and	CC
10_1101-2021_01_06_425584	87	17	MS	MS	NNP
10_1101-2021_01_06_425584	87	18	/	/	SYM
10_1101-2021_01_06_425584	87	19	MS	MS	NNP
10_1101-2021_01_06_425584	87	20	calibration	calibration	NN
10_1101-2021_01_06_425584	87	21	solutions	solution	VBZ
10_1101-2021_01_06_425584	87	22	160	160	CD
10_1101-2021_01_06_425584	87	23	before	before	IN
10_1101-2021_01_06_425584	87	24	sample	sample	NN
10_1101-2021_01_06_425584	87	25	injection	injection	NN
10_1101-2021_01_06_425584	87	26	and	and	CC
10_1101-2021_01_06_425584	87	27	after	after	IN
10_1101-2021_01_06_425584	87	28	injection	injection	NN
10_1101-2021_01_06_425584	87	29	of	of	IN
10_1101-2021_01_06_425584	87	30	two	two	CD
10_1101-2021_01_06_425584	87	31	samples	sample	NNS
10_1101-2021_01_06_425584	87	32	(	(	-LRB-
10_1101-2021_01_06_425584	87	33	<	<	XX
10_1101-2021_01_06_425584	87	34	3.5	3.5	CD
10_1101-2021_01_06_425584	87	35	working	work	VBG
10_1101-2021_01_06_425584	87	36	hours	hour	NNS
10_1101-2021_01_06_425584	87	37	)	)	-RRB-
10_1101-2021_01_06_425584	87	38	to	to	TO
10_1101-2021_01_06_425584	87	39	ensure	ensure	VB
10_1101-2021_01_06_425584	87	40	a	a	DT
10_1101-2021_01_06_425584	87	41	mass	mass	NN
10_1101-2021_01_06_425584	87	42	161	161	CD
10_1101-2021_01_06_425584	87	43	accuracy	accuracy	NN
10_1101-2021_01_06_425584	87	44	of	of	IN
10_1101-2021_01_06_425584	87	45	<	<	XX
10_1101-2021_01_06_425584	87	46	5	5	CD
10_1101-2021_01_06_425584	87	47	ppm	ppm	NN
10_1101-2021_01_06_425584	87	48	for	for	IN
10_1101-2021_01_06_425584	87	49	both	both	DT
10_1101-2021_01_06_425584	87	50	MS	MS	NNP
10_1101-2021_01_06_425584	87	51	and	and	CC
10_1101-2021_01_06_425584	87	52	MS	MS	NNP
10_1101-2021_01_06_425584	87	53	/	/	SYM
10_1101-2021_01_06_425584	87	54	MS	MS	NNP
10_1101-2021_01_06_425584	87	55	data	datum	NNS
10_1101-2021_01_06_425584	87	56	.	.	.
10_1101-2021_01_06_425584	88	1	Instrument	instrument	NN
10_1101-2021_01_06_425584	88	2	performance	performance	NN
10_1101-2021_01_06_425584	88	3	was	be	VBD
10_1101-2021_01_06_425584	88	4	monitored	monitor	VBN
10_1101-2021_01_06_425584	88	5	during	during	IN
10_1101-2021_01_06_425584	88	6	162	162	CD
10_1101-2021_01_06_425584	88	7	data	datum	NNS
10_1101-2021_01_06_425584	88	8	acquisition	acquisition	NN
10_1101-2021_01_06_425584	88	9	by	by	IN
10_1101-2021_01_06_425584	88	10	including	include	VBG
10_1101-2021_01_06_425584	88	11	QC	QC	NNP
10_1101-2021_01_06_425584	88	12	samples	sample	NNS
10_1101-2021_01_06_425584	88	13	(	(	-LRB-
10_1101-2021_01_06_425584	88	14	pooled	pool	VBN
10_1101-2021_01_06_425584	88	15	samples	sample	NNS
10_1101-2021_01_06_425584	88	16	of	of	IN
10_1101-2021_01_06_425584	88	17	equal	equal	JJ
10_1101-2021_01_06_425584	88	18	volume	volume	NN
10_1101-2021_01_06_425584	88	19	)	)	-RRB-
10_1101-2021_01_06_425584	88	20	every	every	DT
10_1101-2021_01_06_425584	88	21	4	4	CD
10_1101-2021_01_06_425584	88	22	experimental	experimental	JJ
10_1101-2021_01_06_425584	88	23	163	163	CD
10_1101-2021_01_06_425584	88	24	samples	sample	NNS
10_1101-2021_01_06_425584	88	25	.	.	.
10_1101-2021_01_06_425584	89	1	Data	datum	NNS
10_1101-2021_01_06_425584	89	2	acquisition	acquisition	NN
10_1101-2021_01_06_425584	89	3	of	of	IN
10_1101-2021_01_06_425584	89	4	experimental	experimental	JJ
10_1101-2021_01_06_425584	89	5	samples	sample	NNS
10_1101-2021_01_06_425584	89	6	was	be	VBD
10_1101-2021_01_06_425584	89	7	also	also	RB
10_1101-2021_01_06_425584	89	8	randomized	randomize	VBN
10_1101-2021_01_06_425584	89	9	.	.	.
10_1101-2021_01_06_425584	90	1	164	164	CD
10_1101-2021_01_06_425584	90	2	165	165	CD
10_1101-2021_01_06_425584	90	3	2.6	2.6	CD
10_1101-2021_01_06_425584	90	4	Metabolomics	Metabolomics	NNPS
10_1101-2021_01_06_425584	90	5	data	datum	NNS
10_1101-2021_01_06_425584	90	6	processing	process	VBG
10_1101-2021_01_06_425584	90	7	166	166	CD
10_1101-2021_01_06_425584	90	8	Mass	Mass	NNP
10_1101-2021_01_06_425584	90	9	detection	detection	NN
10_1101-2021_01_06_425584	90	10	,	,	,
10_1101-2021_01_06_425584	90	11	chromatogram	chromatogram	JJ
10_1101-2021_01_06_425584	90	12	building	building	NN
10_1101-2021_01_06_425584	90	13	and	and	CC
10_1101-2021_01_06_425584	90	14	deconvolution	deconvolution	NN
10_1101-2021_01_06_425584	90	15	,	,	,
10_1101-2021_01_06_425584	90	16	isotopic	isotopic	JJ
10_1101-2021_01_06_425584	90	17	assignment	assignment	NN
10_1101-2021_01_06_425584	90	18	,	,	,
10_1101-2021_01_06_425584	90	19	feature	feature	VBP
10_1101-2021_01_06_425584	90	20	167	167	CD
10_1101-2021_01_06_425584	90	21	alignment	alignment	NN
10_1101-2021_01_06_425584	90	22	,	,	,
10_1101-2021_01_06_425584	90	23	and	and	CC
10_1101-2021_01_06_425584	90	24	gap	gap	NN
10_1101-2021_01_06_425584	90	25	-	-	HYPH
10_1101-2021_01_06_425584	90	26	filling	filling	NN
10_1101-2021_01_06_425584	90	27	(	(	-LRB-
10_1101-2021_01_06_425584	90	28	to	to	TO
10_1101-2021_01_06_425584	90	29	detect	detect	VB
10_1101-2021_01_06_425584	90	30	features	feature	NNS
10_1101-2021_01_06_425584	90	31	missed	miss	VBN
10_1101-2021_01_06_425584	90	32	during	during	IN
10_1101-2021_01_06_425584	90	33	the	the	DT
10_1101-2021_01_06_425584	90	34	initial	initial	JJ
10_1101-2021_01_06_425584	90	35	alignment	alignment	NN
10_1101-2021_01_06_425584	90	36	)	)	-RRB-
10_1101-2021_01_06_425584	90	37	from	from	IN
10_1101-2021_01_06_425584	90	38	LC	LC	NNP
10_1101-2021_01_06_425584	90	39	-	-	HYPH
10_1101-2021_01_06_425584	90	40	MS2	MS2	NNP
10_1101-2021_01_06_425584	90	41	168	168	CD
10_1101-2021_01_06_425584	90	42	datasets	dataset	NNS
10_1101-2021_01_06_425584	90	43	was	be	VBD
10_1101-2021_01_06_425584	90	44	performed	perform	VBN
10_1101-2021_01_06_425584	90	45	using	use	VBG
10_1101-2021_01_06_425584	90	46	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	90	47	(	(	-LRB-
10_1101-2021_01_06_425584	90	48	https://xcmsonline.scripps.edu	https://xcmsonline.scripps.edu	NNP
10_1101-2021_01_06_425584	90	49	)	)	-RRB-
10_1101-2021_01_06_425584	90	50	(	(	-LRB-
10_1101-2021_01_06_425584	90	51	22	22	CD
10_1101-2021_01_06_425584	90	52	)	)	-RRB-
10_1101-2021_01_06_425584	90	53	and	and	CC
10_1101-2021_01_06_425584	90	54	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	90	55	(	(	-LRB-
10_1101-2021_01_06_425584	90	56	23	23	CD
10_1101-2021_01_06_425584	90	57	)	)	-RRB-
10_1101-2021_01_06_425584	90	58	169	169	CD
10_1101-2021_01_06_425584	90	59	software	software	NN
10_1101-2021_01_06_425584	90	60	.	.	.
10_1101-2021_01_06_425584	91	1	The	the	DT
10_1101-2021_01_06_425584	91	2	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	91	3	pipeline	pipeline	NN
10_1101-2021_01_06_425584	91	4	was	be	VBD
10_1101-2021_01_06_425584	91	5	used	use	VBN
10_1101-2021_01_06_425584	91	6	for	for	IN
10_1101-2021_01_06_425584	91	7	normalization	normalization	NN
10_1101-2021_01_06_425584	91	8	of	of	IN
10_1101-2021_01_06_425584	91	9	feature	feature	NN
10_1101-2021_01_06_425584	91	10	area	area	NN
10_1101-2021_01_06_425584	91	11	and	and	CC
10_1101-2021_01_06_425584	91	12	statistical	statistical	JJ
10_1101-2021_01_06_425584	91	13	analysis	analysis	NN
10_1101-2021_01_06_425584	91	14	.	.	.
10_1101-2021_01_06_425584	92	1	170	170	CD
10_1101-2021_01_06_425584	92	2	To	to	TO
10_1101-2021_01_06_425584	92	3	identify	identify	VB
10_1101-2021_01_06_425584	92	4	or	or	CC
10_1101-2021_01_06_425584	92	5	annotate	annotate	VB
10_1101-2021_01_06_425584	92	6	the	the	DT
10_1101-2021_01_06_425584	92	7	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	92	8	at	at	IN
10_1101-2021_01_06_425584	92	9	the	the	DT
10_1101-2021_01_06_425584	92	10	chemical	chemical	NN
10_1101-2021_01_06_425584	92	11	structure	structure	NN
10_1101-2021_01_06_425584	92	12	and	and	CC
10_1101-2021_01_06_425584	92	13	class	class	NN
10_1101-2021_01_06_425584	92	14	level	level	NN
10_1101-2021_01_06_425584	92	15	,	,	,
10_1101-2021_01_06_425584	92	16	the	the	DT
10_1101-2021_01_06_425584	92	17	MS2	MS2	NNP
10_1101-2021_01_06_425584	92	18	-	-	HYPH
10_1101-2021_01_06_425584	92	19	171	171	NNP
10_1101-2021_01_06_425584	92	20	containing	contain	VBG
10_1101-2021_01_06_425584	92	21	features	feature	NNS
10_1101-2021_01_06_425584	92	22	extracted	extract	VBN
10_1101-2021_01_06_425584	92	23	with	with	IN
10_1101-2021_01_06_425584	92	24	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	92	25	were	be	VBD
10_1101-2021_01_06_425584	92	26	further	further	RB
10_1101-2021_01_06_425584	92	27	analyzed	analyze	VBN
10_1101-2021_01_06_425584	92	28	using	use	VBG
10_1101-2021_01_06_425584	92	29	the	the	DT
10_1101-2021_01_06_425584	92	30	Global	Global	NNP
10_1101-2021_01_06_425584	92	31	Natural	Natural	NNP
10_1101-2021_01_06_425584	92	32	172	172	CD
10_1101-2021_01_06_425584	92	33	Products	Products	NNP
10_1101-2021_01_06_425584	92	34	Social	Social	NNP
10_1101-2021_01_06_425584	92	35	Molecular	Molecular	NNP
10_1101-2021_01_06_425584	92	36	Networking	Networking	NNP
10_1101-2021_01_06_425584	92	37	(	(	-LRB-
10_1101-2021_01_06_425584	92	38	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	92	39	)	)	-RRB-
10_1101-2021_01_06_425584	92	40	(	(	-LRB-
10_1101-2021_01_06_425584	92	41	24	24	CD
10_1101-2021_01_06_425584	92	42	)	)	-RRB-
10_1101-2021_01_06_425584	92	43	,	,	,
10_1101-2021_01_06_425584	92	44	Network	Network	NNP
10_1101-2021_01_06_425584	92	45	Annotation	Annotation	NNP
10_1101-2021_01_06_425584	92	46	Propagation	Propagation	NNP
10_1101-2021_01_06_425584	92	47	(	(	-LRB-
10_1101-2021_01_06_425584	92	48	NAP	NAP	NNP
10_1101-2021_01_06_425584	92	49	)	)	-RRB-
10_1101-2021_01_06_425584	92	50	(	(	-LRB-
10_1101-2021_01_06_425584	92	51	25	25	CD
10_1101-2021_01_06_425584	92	52	)	)	-RRB-
10_1101-2021_01_06_425584	92	53	173	173	CD
10_1101-2021_01_06_425584	92	54	and	and	CC
10_1101-2021_01_06_425584	92	55	MS2LDA	MS2LDA	NNP
10_1101-2021_01_06_425584	92	56	(	(	-LRB-
10_1101-2021_01_06_425584	92	57	26	26	CD
10_1101-2021_01_06_425584	92	58	)	)	-RRB-
10_1101-2021_01_06_425584	92	59	in	in	IN
10_1101-2021_01_06_425584	92	60	silico	silico	NN
10_1101-2021_01_06_425584	92	61	annotation	annotation	NN
10_1101-2021_01_06_425584	92	62	tools	tool	NNS
10_1101-2021_01_06_425584	92	63	,	,	,
10_1101-2021_01_06_425584	92	64	and	and	CC
10_1101-2021_01_06_425584	92	65	Classyfire	Classyfire	NNP
10_1101-2021_01_06_425584	92	66	automated	automate	VBD
10_1101-2021_01_06_425584	92	67	chemical	chemical	NN
10_1101-2021_01_06_425584	92	68	classification	classification	NN
10_1101-2021_01_06_425584	92	69	(	(	-LRB-
10_1101-2021_01_06_425584	92	70	27	27	CD
10_1101-2021_01_06_425584	92	71	)	)	-RRB-
10_1101-2021_01_06_425584	92	72	,	,	,
10_1101-2021_01_06_425584	92	73	174	174	CD
10_1101-2021_01_06_425584	92	74	as	as	RB
10_1101-2021_01_06_425584	92	75	previously	previously	RB
10_1101-2021_01_06_425584	92	76	described	describe	VBN
10_1101-2021_01_06_425584	92	77	(	(	-LRB-
10_1101-2021_01_06_425584	92	78	21	21	CD
10_1101-2021_01_06_425584	92	79	)	)	-RRB-
10_1101-2021_01_06_425584	92	80	with	with	IN
10_1101-2021_01_06_425584	92	81	some	some	DT
10_1101-2021_01_06_425584	92	82	modifications	modification	NNS
10_1101-2021_01_06_425584	92	83	.	.	.
10_1101-2021_01_06_425584	93	1	The	the	DT
10_1101-2021_01_06_425584	93	2	confidences	confidence	NNS
10_1101-2021_01_06_425584	93	3	of	of	IN
10_1101-2021_01_06_425584	93	4	such	such	JJ
10_1101-2021_01_06_425584	93	5	annotations	annotation	NNS
10_1101-2021_01_06_425584	93	6	are	be	VBP
10_1101-2021_01_06_425584	93	7	175	175	CD
10_1101-2021_01_06_425584	93	8	level	level	NN
10_1101-2021_01_06_425584	93	9	2	2	CD
10_1101-2021_01_06_425584	93	10	(	(	-LRB-
10_1101-2021_01_06_425584	93	11	probable	probable	JJ
10_1101-2021_01_06_425584	93	12	structure	structure	NN
10_1101-2021_01_06_425584	93	13	by	by	IN
10_1101-2021_01_06_425584	93	14	library	library	NN
10_1101-2021_01_06_425584	93	15	spectrum	spectrum	NN
10_1101-2021_01_06_425584	93	16	match	match	NN
10_1101-2021_01_06_425584	93	17	)	)	-RRB-
10_1101-2021_01_06_425584	93	18	and	and	CC
10_1101-2021_01_06_425584	93	19	level	level	NN
10_1101-2021_01_06_425584	93	20	3	3	CD
10_1101-2021_01_06_425584	93	21	(	(	-LRB-
10_1101-2021_01_06_425584	93	22	tentative	tentative	JJ
10_1101-2021_01_06_425584	93	23	candidates	candidate	NNS
10_1101-2021_01_06_425584	93	24	)	)	-RRB-
10_1101-2021_01_06_425584	93	25	in	in	IN
10_1101-2021_01_06_425584	93	26	176	176	CD
10_1101-2021_01_06_425584	93	27	agreement	agreement	NN
10_1101-2021_01_06_425584	93	28	with	with	IN
10_1101-2021_01_06_425584	93	29	the	the	DT
10_1101-2021_01_06_425584	93	30	Metabolomics	Metabolomics	NNPS
10_1101-2021_01_06_425584	93	31	Standards	Standards	NNPS
10_1101-2021_01_06_425584	93	32	Initiative	Initiative	NNP
10_1101-2021_01_06_425584	93	33	(	(	-LRB-
10_1101-2021_01_06_425584	93	34	MSI	MSI	NNP
10_1101-2021_01_06_425584	93	35	)	)	-RRB-
10_1101-2021_01_06_425584	93	36	classification	classification	NN
10_1101-2021_01_06_425584	93	37	(	(	-LRB-
10_1101-2021_01_06_425584	93	38	28	28	CD
10_1101-2021_01_06_425584	93	39	)	)	-RRB-
10_1101-2021_01_06_425584	93	40	.	.	.
10_1101-2021_01_06_425584	94	1	Molecular	molecular	JJ
10_1101-2021_01_06_425584	94	2	177	177	CD
10_1101-2021_01_06_425584	94	3	networking	networking	NN
10_1101-2021_01_06_425584	94	4	,	,	,
10_1101-2021_01_06_425584	94	5	NAP	NAP	NNP
10_1101-2021_01_06_425584	94	6	,	,	,
10_1101-2021_01_06_425584	94	7	and	and	CC
10_1101-2021_01_06_425584	94	8	Classyfire	Classyfire	NNP
10_1101-2021_01_06_425584	94	9	outputs	output	NNS
10_1101-2021_01_06_425584	94	10	were	be	VBD
10_1101-2021_01_06_425584	94	11	integrated	integrate	VBN
10_1101-2021_01_06_425584	94	12	using	use	VBG
10_1101-2021_01_06_425584	94	13	the	the	DT
10_1101-2021_01_06_425584	94	14	MolNetEnhancer	MolNetEnhancer	NNP
10_1101-2021_01_06_425584	94	15	workflow	workflow	NN
10_1101-2021_01_06_425584	94	16	178	178	CD
10_1101-2021_01_06_425584	94	17	(	(	-LRB-
10_1101-2021_01_06_425584	94	18	29	29	CD
10_1101-2021_01_06_425584	94	19	)	)	-RRB-
10_1101-2021_01_06_425584	94	20	.	.	.
10_1101-2021_01_06_425584	95	1	Molecular	molecular	JJ
10_1101-2021_01_06_425584	95	2	networks	network	NNS
10_1101-2021_01_06_425584	95	3	were	be	VBD
10_1101-2021_01_06_425584	95	4	visualized	visualize	VBN
10_1101-2021_01_06_425584	95	5	using	use	VBG
10_1101-2021_01_06_425584	95	6	Cytoscape	Cytoscape	NNP
10_1101-2021_01_06_425584	95	7	version	version	NN
10_1101-2021_01_06_425584	95	8	3.8.2	3.8.2	CD
10_1101-2021_01_06_425584	95	9	(	(	-LRB-
10_1101-2021_01_06_425584	95	10	30	30	CD
10_1101-2021_01_06_425584	95	11	)	)	-RRB-
10_1101-2021_01_06_425584	95	12	.	.	.
10_1101-2021_01_06_425584	96	1	In	in	IN
10_1101-2021_01_06_425584	96	2	addition	addition	NN
10_1101-2021_01_06_425584	96	3	,	,	,
10_1101-2021_01_06_425584	96	4	179	179	CD
10_1101-2021_01_06_425584	96	5	chemical	chemical	NN
10_1101-2021_01_06_425584	96	6	substructures	substructure	NNS
10_1101-2021_01_06_425584	96	7	(	(	-LRB-
10_1101-2021_01_06_425584	96	8	co	co	JJ
10_1101-2021_01_06_425584	96	9	-	-	JJ
10_1101-2021_01_06_425584	96	10	occurring	occurring	JJ
10_1101-2021_01_06_425584	96	11	fragments	fragment	NNS
10_1101-2021_01_06_425584	96	12	and	and	CC
10_1101-2021_01_06_425584	96	13	neutral	neutral	JJ
10_1101-2021_01_06_425584	96	14	losses	loss	NNS
10_1101-2021_01_06_425584	96	15	referred	refer	VBD
10_1101-2021_01_06_425584	96	16	to	to	IN
10_1101-2021_01_06_425584	96	17	as	as	IN
10_1101-2021_01_06_425584	96	18	“	"	``
10_1101-2021_01_06_425584	96	19	mass2motifs	mass2motifs	NNP
10_1101-2021_01_06_425584	96	20	”	"	''
10_1101-2021_01_06_425584	96	21	180	180	CD
10_1101-2021_01_06_425584	96	22	[	[	-LRB-
10_1101-2021_01_06_425584	96	23	M2	M2	NNP
10_1101-2021_01_06_425584	96	24	M	M	NNP
10_1101-2021_01_06_425584	96	25	]	]	-RRB-
10_1101-2021_01_06_425584	96	26	)	)	-RRB-
10_1101-2021_01_06_425584	96	27	were	be	VBD
10_1101-2021_01_06_425584	96	28	recognized	recognize	VBN
10_1101-2021_01_06_425584	96	29	using	use	VBG
10_1101-2021_01_06_425584	96	30	the	the	DT
10_1101-2021_01_06_425584	96	31	MS2LDA	MS2LDA	NNP
10_1101-2021_01_06_425584	96	32	web	web	NN
10_1101-2021_01_06_425584	96	33	pipeline	pipeline	NN
10_1101-2021_01_06_425584	96	34	(	(	-LRB-
10_1101-2021_01_06_425584	96	35	http://www.ms2lda.org	http://www.ms2lda.org	NNP
10_1101-2021_01_06_425584	96	36	)	)	-RRB-
10_1101-2021_01_06_425584	96	37	to	to	IN
10_1101-2021_01_06_425584	96	38	further	further	VB
10_1101-2021_01_06_425584	96	39	181	181	CD
10_1101-2021_01_06_425584	96	40	annotate	annotate	JJ
10_1101-2021_01_06_425584	96	41	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	96	42	(	(	-LRB-
10_1101-2021_01_06_425584	96	43	level	level	NN
10_1101-2021_01_06_425584	96	44	3	3	CD
10_1101-2021_01_06_425584	96	45	,	,	,
10_1101-2021_01_06_425584	96	46	MSI	MSI	NNP
10_1101-2021_01_06_425584	96	47	)	)	-RRB-
10_1101-2021_01_06_425584	96	48	.	.	.
10_1101-2021_01_06_425584	97	1	The	the	DT
10_1101-2021_01_06_425584	97	2	detailed	detailed	JJ
10_1101-2021_01_06_425584	97	3	processing	processing	NN
10_1101-2021_01_06_425584	97	4	parameters	parameter	NNS
10_1101-2021_01_06_425584	97	5	for	for	IN
10_1101-2021_01_06_425584	97	6	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	97	7	and	and	CC
10_1101-2021_01_06_425584	97	8	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	97	9	182	182	CD
10_1101-2021_01_06_425584	97	10	pipelines	pipeline	NNS
10_1101-2021_01_06_425584	97	11	are	be	VBP
10_1101-2021_01_06_425584	97	12	found	find	VBN
10_1101-2021_01_06_425584	97	13	in	in	IN
10_1101-2021_01_06_425584	97	14	the	the	DT
10_1101-2021_01_06_425584	97	15	supporting	support	VBG
10_1101-2021_01_06_425584	97	16	information	information	NN
10_1101-2021_01_06_425584	97	17	.	.	.
10_1101-2021_01_06_425584	98	1	183	183	CD
10_1101-2021_01_06_425584	98	2	184	184	CD
10_1101-2021_01_06_425584	98	3	.CC	.CC	:
10_1101-2021_01_06_425584	98	4	-	-	HYPH
10_1101-2021_01_06_425584	98	5	BY	by	IN
10_1101-2021_01_06_425584	98	6	-	-	HYPH
10_1101-2021_01_06_425584	98	7	NC	NC	NNP
10_1101-2021_01_06_425584	98	8	-	-	HYPH
10_1101-2021_01_06_425584	98	9	ND	ND	NNP
10_1101-2021_01_06_425584	98	10	4.0	4.0	CD
10_1101-2021_01_06_425584	98	11	International	International	NNP
10_1101-2021_01_06_425584	98	12	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	98	13	under	under	IN
10_1101-2021_01_06_425584	98	14	a	a	DT
10_1101-2021_01_06_425584	98	15	(	(	-LRB-
10_1101-2021_01_06_425584	98	16	which	which	WDT
10_1101-2021_01_06_425584	98	17	was	be	VBD
10_1101-2021_01_06_425584	98	18	not	not	RB
10_1101-2021_01_06_425584	98	19	certified	certify	VBN
10_1101-2021_01_06_425584	98	20	by	by	IN
10_1101-2021_01_06_425584	98	21	peer	peer	NN
10_1101-2021_01_06_425584	98	22	review	review	NN
10_1101-2021_01_06_425584	98	23	)	)	-RRB-
10_1101-2021_01_06_425584	98	24	is	be	VBZ
10_1101-2021_01_06_425584	98	25	the	the	DT
10_1101-2021_01_06_425584	98	26	author	author	NN
10_1101-2021_01_06_425584	98	27	/	/	SYM
10_1101-2021_01_06_425584	98	28	funder	funder	NN
10_1101-2021_01_06_425584	98	29	,	,	,
10_1101-2021_01_06_425584	98	30	who	who	WP
10_1101-2021_01_06_425584	98	31	has	have	VBZ
10_1101-2021_01_06_425584	98	32	granted	grant	VBN
10_1101-2021_01_06_425584	98	33	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	98	34	a	a	DT
10_1101-2021_01_06_425584	98	35	license	license	NN
10_1101-2021_01_06_425584	98	36	to	to	TO
10_1101-2021_01_06_425584	98	37	display	display	VB
10_1101-2021_01_06_425584	98	38	the	the	DT
10_1101-2021_01_06_425584	98	39	preprint	preprint	NN
10_1101-2021_01_06_425584	98	40	in	in	IN
10_1101-2021_01_06_425584	98	41	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	98	42	.	.	.
10_1101-2021_01_06_425584	99	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	99	2	is	be	VBZ
10_1101-2021_01_06_425584	99	3	made	make	VBN
10_1101-2021_01_06_425584	99	4	The	the	DT
10_1101-2021_01_06_425584	99	5	copyright	copyright	NN
10_1101-2021_01_06_425584	99	6	holder	holder	NN
10_1101-2021_01_06_425584	99	7	for	for	IN
10_1101-2021_01_06_425584	99	8	this	this	DT
10_1101-2021_01_06_425584	99	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	99	10	version	version	NN
10_1101-2021_01_06_425584	99	11	posted	post	VBD
10_1101-2021_01_06_425584	99	12	January	January	NNP
10_1101-2021_01_06_425584	99	13	8	8	CD
10_1101-2021_01_06_425584	99	14	,	,	,
10_1101-2021_01_06_425584	99	15	2021	2021	CD
10_1101-2021_01_06_425584	99	16	.	.	.
10_1101-2021_01_06_425584	99	17	;	;	:
10_1101-2021_01_06_425584	99	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	99	19	:	:	:
10_1101-2021_01_06_425584	99	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	99	21	preprint	preprint	NN
10_1101-2021_01_06_425584	99	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	99	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	99	24	7	7	CD
10_1101-2021_01_06_425584	99	25	2.7	2.7	CD
10_1101-2021_01_06_425584	99	26	Peptidomics	Peptidomics	NNP
10_1101-2021_01_06_425584	99	27	data	datum	NNS
10_1101-2021_01_06_425584	99	28	processing	process	VBG
10_1101-2021_01_06_425584	99	29	185	185	CD
10_1101-2021_01_06_425584	99	30	For	for	IN
10_1101-2021_01_06_425584	99	31	peptide	peptide	JJ
10_1101-2021_01_06_425584	99	32	identification	identification	NN
10_1101-2021_01_06_425584	99	33	,	,	,
10_1101-2021_01_06_425584	99	34	raw	raw	JJ
10_1101-2021_01_06_425584	99	35	.wiff	.wiff	NN
10_1101-2021_01_06_425584	99	36	and	and	CC
10_1101-2021_01_06_425584	99	37	.wiff.scan	.wiff.scan	JJ
10_1101-2021_01_06_425584	99	38	files	file	NNS
10_1101-2021_01_06_425584	99	39	(	(	-LRB-
10_1101-2021_01_06_425584	99	40	same	same	JJ
10_1101-2021_01_06_425584	99	41	files	file	NNS
10_1101-2021_01_06_425584	99	42	used	use	VBN
10_1101-2021_01_06_425584	99	43	for	for	IN
10_1101-2021_01_06_425584	99	44	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	99	45	and	and	CC
10_1101-2021_01_06_425584	99	46	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	99	47	)	)	-RRB-
10_1101-2021_01_06_425584	99	48	186	186	CD
10_1101-2021_01_06_425584	99	49	from	from	IN
10_1101-2021_01_06_425584	99	50	the	the	DT
10_1101-2021_01_06_425584	99	51	experimental	experimental	JJ
10_1101-2021_01_06_425584	99	52	and	and	CC
10_1101-2021_01_06_425584	99	53	control	control	NN
10_1101-2021_01_06_425584	99	54	groups	group	NNS
10_1101-2021_01_06_425584	99	55	were	be	VBD
10_1101-2021_01_06_425584	99	56	analyzed	analyze	VBN
10_1101-2021_01_06_425584	99	57	separately	separately	RB
10_1101-2021_01_06_425584	99	58	using	use	VBG
10_1101-2021_01_06_425584	99	59	ProteinPilot	ProteinPilot	NNP
10_1101-2021_01_06_425584	99	60	software	software	NN
10_1101-2021_01_06_425584	99	61	187	187	CD
10_1101-2021_01_06_425584	99	62	version	version	NN
10_1101-2021_01_06_425584	99	63	4.2	4.2	CD
10_1101-2021_01_06_425584	99	64	(	(	-LRB-
10_1101-2021_01_06_425584	99	65	Ab	Ab	NNP
10_1101-2021_01_06_425584	99	66	Sciex	Sciex	NNP
10_1101-2021_01_06_425584	99	67	,	,	,
10_1101-2021_01_06_425584	99	68	Foster	Foster	NNP
10_1101-2021_01_06_425584	99	69	City	City	NNP
10_1101-2021_01_06_425584	99	70	,	,	,
10_1101-2021_01_06_425584	99	71	CA	CA	NNP
10_1101-2021_01_06_425584	99	72	,	,	,
10_1101-2021_01_06_425584	99	73	USA	USA	NNP
10_1101-2021_01_06_425584	99	74	)	)	-RRB-
10_1101-2021_01_06_425584	99	75	with	with	IN
10_1101-2021_01_06_425584	99	76	the	the	DT
10_1101-2021_01_06_425584	99	77	Paragon	Paragon	NNP
10_1101-2021_01_06_425584	99	78	algorithm	algorithm	NN
10_1101-2021_01_06_425584	99	79	.	.	.
10_1101-2021_01_06_425584	100	1	MS1	MS1	NNP
10_1101-2021_01_06_425584	100	2	and	and	CC
10_1101-2021_01_06_425584	100	3	MS2	MS2	NNP
10_1101-2021_01_06_425584	100	4	data	datum	NNS
10_1101-2021_01_06_425584	100	5	were	be	VBD
10_1101-2021_01_06_425584	100	6	188	188	CD
10_1101-2021_01_06_425584	100	7	searched	search	VBN
10_1101-2021_01_06_425584	100	8	against	against	IN
10_1101-2021_01_06_425584	100	9	the	the	DT
10_1101-2021_01_06_425584	100	10	Bos	Bos	NNP
10_1101-2021_01_06_425584	100	11	taurus	taurus	CD
10_1101-2021_01_06_425584	100	12	SwissProt	SwissProt	NNP
10_1101-2021_01_06_425584	100	13	sequence	sequence	NN
10_1101-2021_01_06_425584	100	14	database	database	NN
10_1101-2021_01_06_425584	100	15	(	(	-LRB-
10_1101-2021_01_06_425584	100	16	6006	6006	CD
10_1101-2021_01_06_425584	100	17	reviewed	review	VBD
10_1101-2021_01_06_425584	100	18	189	189	CD
10_1101-2021_01_06_425584	100	19	proteins+common	proteins+common	NNP
10_1101-2021_01_06_425584	100	20	protein	protein	NN
10_1101-2021_01_06_425584	100	21	contaminants	contaminant	NNS
10_1101-2021_01_06_425584	100	22	,	,	,
10_1101-2021_01_06_425584	100	23	February	February	NNP
10_1101-2021_01_06_425584	100	24	2019	2019	CD
10_1101-2021_01_06_425584	100	25	release	release	NN
10_1101-2021_01_06_425584	100	26	)	)	-RRB-
10_1101-2021_01_06_425584	100	27	.	.	.
10_1101-2021_01_06_425584	101	1	The	the	DT
10_1101-2021_01_06_425584	101	2	parameters	parameter	NNS
10_1101-2021_01_06_425584	101	3	input	input	NN
10_1101-2021_01_06_425584	101	4	was	be	VBD
10_1101-2021_01_06_425584	101	5	:	:	:
10_1101-2021_01_06_425584	101	6	190	190	CD
10_1101-2021_01_06_425584	101	7	sample	sample	NN
10_1101-2021_01_06_425584	101	8	type	type	NN
10_1101-2021_01_06_425584	101	9	,	,	,
10_1101-2021_01_06_425584	101	10	identification	identification	NN
10_1101-2021_01_06_425584	101	11	;	;	:
10_1101-2021_01_06_425584	101	12	digestion	digestion	NN
10_1101-2021_01_06_425584	101	13	,	,	,
10_1101-2021_01_06_425584	101	14	none	none	NN
10_1101-2021_01_06_425584	101	15	;	;	:
10_1101-2021_01_06_425584	101	16	Cys	cys	NN
10_1101-2021_01_06_425584	101	17	alkylation	alkylation	NN
10_1101-2021_01_06_425584	101	18	,	,	,
10_1101-2021_01_06_425584	101	19	none	none	NN
10_1101-2021_01_06_425584	101	20	;	;	,
10_1101-2021_01_06_425584	101	21	instrument	instrument	NN
10_1101-2021_01_06_425584	101	22	,	,	,
10_1101-2021_01_06_425584	101	23	TripleTOF	TripleTOF	NNP
10_1101-2021_01_06_425584	101	24	5600	5600	CD
10_1101-2021_01_06_425584	101	25	;	;	:
10_1101-2021_01_06_425584	101	26	191	191	CD
10_1101-2021_01_06_425584	101	27	special	special	JJ
10_1101-2021_01_06_425584	101	28	factors	factor	NNS
10_1101-2021_01_06_425584	101	29	,	,	,
10_1101-2021_01_06_425584	101	30	none	none	NN
10_1101-2021_01_06_425584	101	31	;	;	:
10_1101-2021_01_06_425584	101	32	species	specie	NNS
10_1101-2021_01_06_425584	101	33	,	,	,
10_1101-2021_01_06_425584	101	34	Bos	Bos	NNP
10_1101-2021_01_06_425584	101	35	taurus	taurus	NNP
10_1101-2021_01_06_425584	101	36	;	;	:
10_1101-2021_01_06_425584	101	37	ID	ID	NNP
10_1101-2021_01_06_425584	101	38	focus	focus	VBP
10_1101-2021_01_06_425584	101	39	,	,	,
10_1101-2021_01_06_425584	101	40	biological	biological	JJ
10_1101-2021_01_06_425584	101	41	modifications	modification	NNS
10_1101-2021_01_06_425584	101	42	,	,	,
10_1101-2021_01_06_425584	101	43	and	and	CC
10_1101-2021_01_06_425584	101	44	amino	amino	NN
10_1101-2021_01_06_425584	101	45	acid	acid	NN
10_1101-2021_01_06_425584	101	46	192	192	CD
10_1101-2021_01_06_425584	101	47	substitutions	substitution	NNS
10_1101-2021_01_06_425584	101	48	;	;	:
10_1101-2021_01_06_425584	101	49	search	search	NN
10_1101-2021_01_06_425584	101	50	effort	effort	NN
10_1101-2021_01_06_425584	101	51	,	,	,
10_1101-2021_01_06_425584	101	52	thorough	thorough	JJ
10_1101-2021_01_06_425584	101	53	ID	ID	NNP
10_1101-2021_01_06_425584	101	54	.	.	.
10_1101-2021_01_06_425584	102	1	False	false	JJ
10_1101-2021_01_06_425584	102	2	discovery	discovery	NN
10_1101-2021_01_06_425584	102	3	rate	rate	NN
10_1101-2021_01_06_425584	102	4	analysis	analysis	NN
10_1101-2021_01_06_425584	102	5	was	be	VBD
10_1101-2021_01_06_425584	102	6	also	also	RB
10_1101-2021_01_06_425584	102	7	performed	perform	VBN
10_1101-2021_01_06_425584	102	8	.	.	.
10_1101-2021_01_06_425584	103	1	All	all	DT
10_1101-2021_01_06_425584	103	2	193	193	CD
10_1101-2021_01_06_425584	103	3	peptides	peptide	NNS
10_1101-2021_01_06_425584	103	4	were	be	VBD
10_1101-2021_01_06_425584	103	5	exported	export	VBN
10_1101-2021_01_06_425584	103	6	and	and	CC
10_1101-2021_01_06_425584	103	7	those	those	DT
10_1101-2021_01_06_425584	103	8	with	with	IN
10_1101-2021_01_06_425584	103	9	a	a	DT
10_1101-2021_01_06_425584	103	10	>	>	XX
10_1101-2021_01_06_425584	103	11	90	90	CD
10_1101-2021_01_06_425584	103	12	%	%	NN
10_1101-2021_01_06_425584	103	13	confidence	confidence	NN
10_1101-2021_01_06_425584	103	14	were	be	VBD
10_1101-2021_01_06_425584	103	15	linked	link	VBN
10_1101-2021_01_06_425584	103	16	to	to	IN
10_1101-2021_01_06_425584	103	17	the	the	DT
10_1101-2021_01_06_425584	103	18	corresponding	corresponding	JJ
10_1101-2021_01_06_425584	103	19	194	194	CD
10_1101-2021_01_06_425584	103	20	feature	feature	NN
10_1101-2021_01_06_425584	103	21	extracted	extract	VBN
10_1101-2021_01_06_425584	103	22	by	by	IN
10_1101-2021_01_06_425584	103	23	the	the	DT
10_1101-2021_01_06_425584	103	24	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	103	25	algorithm	algorithm	NN
10_1101-2021_01_06_425584	103	26	using	use	VBG
10_1101-2021_01_06_425584	103	27	their	-PRON-	PRP$
10_1101-2021_01_06_425584	103	28	accurate	accurate	JJ
10_1101-2021_01_06_425584	103	29	mass	mass	NN
10_1101-2021_01_06_425584	103	30	and	and	CC
10_1101-2021_01_06_425584	103	31	retention	retention	NN
10_1101-2021_01_06_425584	103	32	time	time	NN
10_1101-2021_01_06_425584	103	33	195	195	CD
10_1101-2021_01_06_425584	103	34	information	information	NN
10_1101-2021_01_06_425584	103	35	.	.	.
10_1101-2021_01_06_425584	104	1	For	for	IN
10_1101-2021_01_06_425584	104	2	peptide	peptide	JJ
10_1101-2021_01_06_425584	104	3	quantification	quantification	NN
10_1101-2021_01_06_425584	104	4	,	,	,
10_1101-2021_01_06_425584	104	5	we	-PRON-	PRP
10_1101-2021_01_06_425584	104	6	employed	employ	VBD
10_1101-2021_01_06_425584	104	7	the	the	DT
10_1101-2021_01_06_425584	104	8	normalized	normalized	JJ
10_1101-2021_01_06_425584	104	9	feature	feature	NN
10_1101-2021_01_06_425584	104	10	abundances	abundance	NNS
10_1101-2021_01_06_425584	104	11	(	(	-LRB-
10_1101-2021_01_06_425584	104	12	MS1	MS1	NNP
10_1101-2021_01_06_425584	104	13	196	196	CD
10_1101-2021_01_06_425584	104	14	level	level	NN
10_1101-2021_01_06_425584	104	15	)	)	-RRB-
10_1101-2021_01_06_425584	104	16	generated	generate	VBN
10_1101-2021_01_06_425584	104	17	by	by	IN
10_1101-2021_01_06_425584	104	18	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	104	19	.	.	.
10_1101-2021_01_06_425584	105	1	A	a	DT
10_1101-2021_01_06_425584	105	2	significance	significance	NN
10_1101-2021_01_06_425584	105	3	threshold	threshold	NN
10_1101-2021_01_06_425584	105	4	of	of	IN
10_1101-2021_01_06_425584	105	5	p<0.05	p<0.05	JJ
10_1101-2021_01_06_425584	105	6	(	(	-LRB-
10_1101-2021_01_06_425584	105	7	Welch	Welch	NNP
10_1101-2021_01_06_425584	105	8	’s	’s	POS
10_1101-2021_01_06_425584	105	9	t	t	NN
10_1101-2021_01_06_425584	105	10	test	test	NN
10_1101-2021_01_06_425584	105	11	)	)	-RRB-
10_1101-2021_01_06_425584	105	12	was	be	VBD
10_1101-2021_01_06_425584	105	13	utilized	utilize	VBN
10_1101-2021_01_06_425584	105	14	.	.	.
10_1101-2021_01_06_425584	106	1	197	197	CD
10_1101-2021_01_06_425584	106	2	198	198	CD
10_1101-2021_01_06_425584	106	3	2.8	2.8	CD
10_1101-2021_01_06_425584	106	4	Proteomics	Proteomics	NNP
10_1101-2021_01_06_425584	106	5	data	datum	NNS
10_1101-2021_01_06_425584	106	6	reprocessing	reprocess	VBG
10_1101-2021_01_06_425584	106	7	199	199	CD
10_1101-2021_01_06_425584	106	8	The	the	DT
10_1101-2021_01_06_425584	106	9	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	106	10	-	-	HYPH
10_1101-2021_01_06_425584	106	11	based	base	VBN
10_1101-2021_01_06_425584	106	12	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	106	13	data	datum	NNS
10_1101-2021_01_06_425584	106	14	(	(	-LRB-
10_1101-2021_01_06_425584	106	15	identifier	identifier	NNP
10_1101-2021_01_06_425584	106	16	PXD013643	PXD013643	NNP
10_1101-2021_01_06_425584	106	17	)	)	-RRB-
10_1101-2021_01_06_425584	106	18	,	,	,
10_1101-2021_01_06_425584	106	19	hosted	host	VBN
10_1101-2021_01_06_425584	106	20	in	in	IN
10_1101-2021_01_06_425584	106	21	ProteomeXchange	ProteomeXchange	NNP
10_1101-2021_01_06_425584	106	22	200	200	CD
10_1101-2021_01_06_425584	106	23	consortium	consortium	NN
10_1101-2021_01_06_425584	106	24	via	via	IN
10_1101-2021_01_06_425584	106	25	PRIDE	PRIDE	NNP
10_1101-2021_01_06_425584	106	26	(	(	-LRB-
10_1101-2021_01_06_425584	106	27	31	31	CD
10_1101-2021_01_06_425584	106	28	)	)	-RRB-
10_1101-2021_01_06_425584	106	29	,	,	,
10_1101-2021_01_06_425584	106	30	was	be	VBD
10_1101-2021_01_06_425584	106	31	reanalyzed	reanalyze	VBN
10_1101-2021_01_06_425584	106	32	with	with	IN
10_1101-2021_01_06_425584	106	33	some	some	DT
10_1101-2021_01_06_425584	106	34	modifications	modification	NNS
10_1101-2021_01_06_425584	106	35	.	.	.
10_1101-2021_01_06_425584	107	1	The	the	DT
10_1101-2021_01_06_425584	107	2	parameters	parameter	NNS
10_1101-2021_01_06_425584	107	3	used	use	VBD
10_1101-2021_01_06_425584	107	4	to	to	IN
10_1101-2021_01_06_425584	107	5	201	201	CD
10_1101-2021_01_06_425584	107	6	build	build	VB
10_1101-2021_01_06_425584	107	7	the	the	DT
10_1101-2021_01_06_425584	107	8	spectral	spectral	JJ
10_1101-2021_01_06_425584	107	9	library	library	NN
10_1101-2021_01_06_425584	107	10	remained	remain	VBD
10_1101-2021_01_06_425584	107	11	the	the	DT
10_1101-2021_01_06_425584	107	12	same	same	JJ
10_1101-2021_01_06_425584	107	13	(	(	-LRB-
10_1101-2021_01_06_425584	107	14	15	15	CD
10_1101-2021_01_06_425584	107	15	)	)	-RRB-
10_1101-2021_01_06_425584	107	16	,	,	,
10_1101-2021_01_06_425584	107	17	while	while	IN
10_1101-2021_01_06_425584	107	18	the	the	DT
10_1101-2021_01_06_425584	107	19	parameter	parameter	NN
10_1101-2021_01_06_425584	107	20	for	for	IN
10_1101-2021_01_06_425584	107	21	peptides	peptide	NNS
10_1101-2021_01_06_425584	107	22	per	per	IN
10_1101-2021_01_06_425584	107	23	protein	protein	NN
10_1101-2021_01_06_425584	107	24	202	202	CD
10_1101-2021_01_06_425584	107	25	was	be	VBD
10_1101-2021_01_06_425584	107	26	set	set	VBN
10_1101-2021_01_06_425584	107	27	to	to	IN
10_1101-2021_01_06_425584	107	28	100	100	CD
10_1101-2021_01_06_425584	107	29	in	in	IN
10_1101-2021_01_06_425584	107	30	the	the	DT
10_1101-2021_01_06_425584	107	31	software	software	NN
10_1101-2021_01_06_425584	107	32	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	107	33	®	®	NNPS
10_1101-2021_01_06_425584	107	34	Acquisition	Acquisition	NNP
10_1101-2021_01_06_425584	107	35	MicroApp	MicroApp	NNP
10_1101-2021_01_06_425584	107	36	2.0	2.0	CD
10_1101-2021_01_06_425584	107	37	in	in	IN
10_1101-2021_01_06_425584	107	38	PeakView	PeakView	NNP
10_1101-2021_01_06_425584	107	39	®	®	NNP
10_1101-2021_01_06_425584	107	40	version	version	NN
10_1101-2021_01_06_425584	107	41	1.2	1.2	CD
10_1101-2021_01_06_425584	107	42	(	(	-LRB-
10_1101-2021_01_06_425584	107	43	AB	AB	NNP
10_1101-2021_01_06_425584	107	44	203	203	CD
10_1101-2021_01_06_425584	107	45	Sciex	Sciex	NNP
10_1101-2021_01_06_425584	107	46	,	,	,
10_1101-2021_01_06_425584	107	47	Foster	Foster	NNP
10_1101-2021_01_06_425584	107	48	City	City	NNP
10_1101-2021_01_06_425584	107	49	,	,	,
10_1101-2021_01_06_425584	107	50	CA	CA	NNP
10_1101-2021_01_06_425584	107	51	,	,	,
10_1101-2021_01_06_425584	107	52	USA	USA	NNP
10_1101-2021_01_06_425584	107	53	)	)	-RRB-
10_1101-2021_01_06_425584	107	54	.	.	.
10_1101-2021_01_06_425584	108	1	The	the	DT
10_1101-2021_01_06_425584	108	2	obtained	obtain	VBN
10_1101-2021_01_06_425584	108	3	protein	protein	NN
10_1101-2021_01_06_425584	108	4	peak	peak	NN
10_1101-2021_01_06_425584	108	5	areas	area	NNS
10_1101-2021_01_06_425584	108	6	were	be	VBD
10_1101-2021_01_06_425584	108	7	exported	export	VBN
10_1101-2021_01_06_425584	108	8	to	to	TO
10_1101-2021_01_06_425584	108	9	Markerview	Markerview	NNP
10_1101-2021_01_06_425584	108	10	™	™	CD
10_1101-2021_01_06_425584	108	11	204	204	CD
10_1101-2021_01_06_425584	108	12	version	version	NN
10_1101-2021_01_06_425584	108	13	1.3	1.3	CD
10_1101-2021_01_06_425584	108	14	(	(	-LRB-
10_1101-2021_01_06_425584	108	15	AB	AB	NNP
10_1101-2021_01_06_425584	108	16	Sciex	Sciex	NNP
10_1101-2021_01_06_425584	108	17	,	,	,
10_1101-2021_01_06_425584	108	18	Foster	Foster	NNP
10_1101-2021_01_06_425584	108	19	City	City	NNP
10_1101-2021_01_06_425584	108	20	,	,	,
10_1101-2021_01_06_425584	108	21	CA	CA	NNP
10_1101-2021_01_06_425584	108	22	,	,	,
10_1101-2021_01_06_425584	108	23	USA	USA	NNP
10_1101-2021_01_06_425584	108	24	)	)	-RRB-
10_1101-2021_01_06_425584	108	25	for	for	IN
10_1101-2021_01_06_425584	108	26	further	further	JJ
10_1101-2021_01_06_425584	108	27	data	datum	NNS
10_1101-2021_01_06_425584	108	28	refinement	refinement	NN
10_1101-2021_01_06_425584	108	29	,	,	,
10_1101-2021_01_06_425584	108	30	including	include	VBG
10_1101-2021_01_06_425584	108	31	assignment	assignment	NN
10_1101-2021_01_06_425584	108	32	of	of	IN
10_1101-2021_01_06_425584	108	33	205	205	CD
10_1101-2021_01_06_425584	108	34	IDs	id	NNS
10_1101-2021_01_06_425584	108	35	to	to	IN
10_1101-2021_01_06_425584	108	36	files	file	NNS
10_1101-2021_01_06_425584	108	37	and	and	CC
10_1101-2021_01_06_425584	108	38	removal	removal	NN
10_1101-2021_01_06_425584	108	39	of	of	IN
10_1101-2021_01_06_425584	108	40	reversed	reversed	JJ
10_1101-2021_01_06_425584	108	41	and	and	CC
10_1101-2021_01_06_425584	108	42	common	common	JJ
10_1101-2021_01_06_425584	108	43	contaminants	contaminant	NNS
10_1101-2021_01_06_425584	108	44	.	.	.
10_1101-2021_01_06_425584	109	1	Peak	peak	NN
10_1101-2021_01_06_425584	109	2	areas	area	NNS
10_1101-2021_01_06_425584	109	3	were	be	VBD
10_1101-2021_01_06_425584	109	4	exported	export	VBN
10_1101-2021_01_06_425584	109	5	in	in	IN
10_1101-2021_01_06_425584	109	6	a	a	DT
10_1101-2021_01_06_425584	109	7	206	206	CD
10_1101-2021_01_06_425584	109	8	.tsv	.tsv	CD
10_1101-2021_01_06_425584	109	9	file	file	NN
10_1101-2021_01_06_425584	109	10	,	,	,
10_1101-2021_01_06_425584	109	11	and	and	CC
10_1101-2021_01_06_425584	109	12	normalized	normalize	VBD
10_1101-2021_01_06_425584	109	13	with	with	IN
10_1101-2021_01_06_425584	109	14	NormalyzerDE	NormalyzerDE	NNP
10_1101-2021_01_06_425584	109	15	online	online	JJ
10_1101-2021_01_06_425584	109	16	version	version	NN
10_1101-2021_01_06_425584	109	17	1.3.4	1.3.4	CD
10_1101-2021_01_06_425584	109	18	(	(	-LRB-
10_1101-2021_01_06_425584	109	19	32	32	CD
10_1101-2021_01_06_425584	109	20	)	)	-RRB-
10_1101-2021_01_06_425584	109	21	.	.	.
10_1101-2021_01_06_425584	110	1	The	the	DT
10_1101-2021_01_06_425584	110	2	NormalyzerDE	NormalyzerDE	NNP
10_1101-2021_01_06_425584	110	3	pipeline	pipeline	NN
10_1101-2021_01_06_425584	110	4	207	207	CD
10_1101-2021_01_06_425584	110	5	comprises	comprise	NNS
10_1101-2021_01_06_425584	110	6	8	8	CD
10_1101-2021_01_06_425584	110	7	different	different	JJ
10_1101-2021_01_06_425584	110	8	normalization	normalization	NN
10_1101-2021_01_06_425584	110	9	methods	method	NNS
10_1101-2021_01_06_425584	110	10	(	(	-LRB-
10_1101-2021_01_06_425584	110	11	Log2	log2	UH
10_1101-2021_01_06_425584	110	12	,	,	,
10_1101-2021_01_06_425584	110	13	variance	variance	NN
10_1101-2021_01_06_425584	110	14	stabilizing	stabilize	VBG
10_1101-2021_01_06_425584	110	15	normalization	normalization	NN
10_1101-2021_01_06_425584	110	16	,	,	,
10_1101-2021_01_06_425584	110	17	total	total	JJ
10_1101-2021_01_06_425584	110	18	208	208	CD
10_1101-2021_01_06_425584	110	19	intensity	intensity	NN
10_1101-2021_01_06_425584	110	20	,	,	,
10_1101-2021_01_06_425584	110	21	median	median	NNP
10_1101-2021_01_06_425584	110	22	,	,	,
10_1101-2021_01_06_425584	110	23	mean	mean	JJ
10_1101-2021_01_06_425584	110	24	,	,	,
10_1101-2021_01_06_425584	110	25	quantile	quantile	NNP
10_1101-2021_01_06_425584	110	26	,	,	,
10_1101-2021_01_06_425584	110	27	CycLoess	CycLoess	NNP
10_1101-2021_01_06_425584	110	28	,	,	,
10_1101-2021_01_06_425584	110	29	and	and	CC
10_1101-2021_01_06_425584	110	30	robust	robust	JJ
10_1101-2021_01_06_425584	110	31	linear	linear	JJ
10_1101-2021_01_06_425584	110	32	regression	regression	NN
10_1101-2021_01_06_425584	110	33	)	)	-RRB-
10_1101-2021_01_06_425584	110	34	.	.	.
10_1101-2021_01_06_425584	111	1	The	the	DT
10_1101-2021_01_06_425584	111	2	results	result	NNS
10_1101-2021_01_06_425584	111	3	of	of	IN
10_1101-2021_01_06_425584	111	4	209	209	CD
10_1101-2021_01_06_425584	111	5	qualitative	qualitative	JJ
10_1101-2021_01_06_425584	111	6	(	(	-LRB-
10_1101-2021_01_06_425584	111	7	MA	MA	NNP
10_1101-2021_01_06_425584	111	8	plots	plot	NNS
10_1101-2021_01_06_425584	111	9	,	,	,
10_1101-2021_01_06_425584	111	10	scatter	scatter	NN
10_1101-2021_01_06_425584	111	11	plots	plot	NNS
10_1101-2021_01_06_425584	111	12	,	,	,
10_1101-2021_01_06_425584	111	13	box	box	NN
10_1101-2021_01_06_425584	111	14	plots	plot	NNS
10_1101-2021_01_06_425584	111	15	,	,	,
10_1101-2021_01_06_425584	111	16	density	density	NN
10_1101-2021_01_06_425584	111	17	plots	plot	NNS
10_1101-2021_01_06_425584	111	18	)	)	-RRB-
10_1101-2021_01_06_425584	111	19	and	and	CC
10_1101-2021_01_06_425584	111	20	quantitative	quantitative	JJ
10_1101-2021_01_06_425584	111	21	(	(	-LRB-
10_1101-2021_01_06_425584	111	22	pooled	pool	VBN
10_1101-2021_01_06_425584	111	23	intragroup	intragroup	NNP
10_1101-2021_01_06_425584	111	24	210	210	CD
10_1101-2021_01_06_425584	111	25	coefficient	coefficient	NN
10_1101-2021_01_06_425584	111	26	of	of	IN
10_1101-2021_01_06_425584	111	27	variation	variation	NN
10_1101-2021_01_06_425584	111	28	[	[	-LRB-
10_1101-2021_01_06_425584	111	29	PCV	PCV	NNP
10_1101-2021_01_06_425584	111	30	]	]	-RRB-
10_1101-2021_01_06_425584	111	31	,	,	,
10_1101-2021_01_06_425584	111	32	median	median	JJ
10_1101-2021_01_06_425584	111	33	absolute	absolute	JJ
10_1101-2021_01_06_425584	111	34	deviation	deviation	NN
10_1101-2021_01_06_425584	111	35	[	[	-LRB-
10_1101-2021_01_06_425584	111	36	PMAD	PMAD	NNP
10_1101-2021_01_06_425584	111	37	]	]	-RRB-
10_1101-2021_01_06_425584	111	38	,	,	,
10_1101-2021_01_06_425584	111	39	estimate	estimate	NN
10_1101-2021_01_06_425584	111	40	of	of	IN
10_1101-2021_01_06_425584	111	41	variance	variance	NN
10_1101-2021_01_06_425584	111	42	[	[	-LRB-
10_1101-2021_01_06_425584	111	43	PEV	PEV	NNP
10_1101-2021_01_06_425584	111	44	]	]	-RRB-
10_1101-2021_01_06_425584	111	45	)	)	-RRB-
10_1101-2021_01_06_425584	111	46	211	211	CD
10_1101-2021_01_06_425584	111	47	parameters	parameter	NNS
10_1101-2021_01_06_425584	111	48	were	be	VBD
10_1101-2021_01_06_425584	111	49	compared	compare	VBN
10_1101-2021_01_06_425584	111	50	between	between	IN
10_1101-2021_01_06_425584	111	51	the	the	DT
10_1101-2021_01_06_425584	111	52	normalization	normalization	NN
10_1101-2021_01_06_425584	111	53	methods	method	NNS
10_1101-2021_01_06_425584	111	54	to	to	TO
10_1101-2021_01_06_425584	111	55	select	select	VB
10_1101-2021_01_06_425584	111	56	the	the	DT
10_1101-2021_01_06_425584	111	57	most	most	RBS
10_1101-2021_01_06_425584	111	58	appropriate	appropriate	JJ
10_1101-2021_01_06_425584	111	59	.	.	.
10_1101-2021_01_06_425584	112	1	212	212	CD
10_1101-2021_01_06_425584	112	2	213	213	CD
10_1101-2021_01_06_425584	112	3	2.9	2.9	CD
10_1101-2021_01_06_425584	112	4	Bioinformatic	bioinformatic	JJ
10_1101-2021_01_06_425584	112	5	analysis	analysis	NN
10_1101-2021_01_06_425584	112	6	of	of	IN
10_1101-2021_01_06_425584	112	7	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	112	8	data	datum	NNS
10_1101-2021_01_06_425584	112	9	214	214	CD
10_1101-2021_01_06_425584	112	10	Proteins	Proteins	NNPS
10_1101-2021_01_06_425584	112	11	that	that	WDT
10_1101-2021_01_06_425584	112	12	passed	pass	VBD
10_1101-2021_01_06_425584	112	13	the	the	DT
10_1101-2021_01_06_425584	112	14	significance	significance	NN
10_1101-2021_01_06_425584	112	15	threshold	threshold	NN
10_1101-2021_01_06_425584	112	16	were	be	VBD
10_1101-2021_01_06_425584	112	17	first	first	RB
10_1101-2021_01_06_425584	112	18	converted	convert	VBN
10_1101-2021_01_06_425584	112	19	to	to	IN
10_1101-2021_01_06_425584	112	20	their	-PRON-	PRP$
10_1101-2021_01_06_425584	112	21	corresponding	correspond	VBG
10_1101-2021_01_06_425584	112	22	Entrez	Entrez	NNP
10_1101-2021_01_06_425584	112	23	215	215	CD
10_1101-2021_01_06_425584	112	24	Gene	Gene	NNP
10_1101-2021_01_06_425584	112	25	(	(	-LRB-
10_1101-2021_01_06_425584	112	26	GeneID	GeneID	NNP
10_1101-2021_01_06_425584	112	27	)	)	-RRB-
10_1101-2021_01_06_425584	112	28	using	use	VBG
10_1101-2021_01_06_425584	112	29	https://www.uniprot.org/uploadlists/	https://www.uniprot.org/uploadlists/	NNP
10_1101-2021_01_06_425584	112	30	and	and	CC
10_1101-2021_01_06_425584	112	31	then	then	RB
10_1101-2021_01_06_425584	112	32	transformed	transform	VBD
10_1101-2021_01_06_425584	112	33	to	to	IN
10_1101-2021_01_06_425584	112	34	their	-PRON-	PRP$
10_1101-2021_01_06_425584	112	35	human	human	JJ
10_1101-2021_01_06_425584	112	36	216	216	CD
10_1101-2021_01_06_425584	112	37	equivalents	equivalent	NNS
10_1101-2021_01_06_425584	112	38	using	use	VBG
10_1101-2021_01_06_425584	112	39	the	the	DT
10_1101-2021_01_06_425584	112	40	ortholog	ortholog	NNP
10_1101-2021_01_06_425584	112	41	conversion	conversion	NN
10_1101-2021_01_06_425584	112	42	feature	feature	NN
10_1101-2021_01_06_425584	112	43	in	in	IN
10_1101-2021_01_06_425584	112	44	https://biodbnet-217	https://biodbnet-217	NNP
10_1101-2021_01_06_425584	112	45	abcc.ncifcrf.gov/db/dbOrtho.php	abcc.ncifcrf.gov/db/dbortho.php	ADD
10_1101-2021_01_06_425584	112	46	.	.	.
10_1101-2021_01_06_425584	113	1	Bioinformatic	bioinformatic	JJ
10_1101-2021_01_06_425584	113	2	analysis	analysis	NN
10_1101-2021_01_06_425584	113	3	was	be	VBD
10_1101-2021_01_06_425584	113	4	done	do	VBN
10_1101-2021_01_06_425584	113	5	on	on	IN
10_1101-2021_01_06_425584	113	6	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	113	7	website	website	NN
10_1101-2021_01_06_425584	113	8	platform	platform	NN
10_1101-2021_01_06_425584	113	9	218	218	CD
10_1101-2021_01_06_425584	113	10	.CC	.CC	:
10_1101-2021_01_06_425584	113	11	-	-	HYPH
10_1101-2021_01_06_425584	113	12	BY	by	IN
10_1101-2021_01_06_425584	113	13	-	-	HYPH
10_1101-2021_01_06_425584	113	14	NC	NC	NNP
10_1101-2021_01_06_425584	113	15	-	-	HYPH
10_1101-2021_01_06_425584	113	16	ND	ND	NNP
10_1101-2021_01_06_425584	113	17	4.0	4.0	CD
10_1101-2021_01_06_425584	113	18	International	International	NNP
10_1101-2021_01_06_425584	113	19	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	113	20	under	under	IN
10_1101-2021_01_06_425584	113	21	a	a	DT
10_1101-2021_01_06_425584	113	22	(	(	-LRB-
10_1101-2021_01_06_425584	113	23	which	which	WDT
10_1101-2021_01_06_425584	113	24	was	be	VBD
10_1101-2021_01_06_425584	113	25	not	not	RB
10_1101-2021_01_06_425584	113	26	certified	certify	VBN
10_1101-2021_01_06_425584	113	27	by	by	IN
10_1101-2021_01_06_425584	113	28	peer	peer	NN
10_1101-2021_01_06_425584	113	29	review	review	NN
10_1101-2021_01_06_425584	113	30	)	)	-RRB-
10_1101-2021_01_06_425584	113	31	is	be	VBZ
10_1101-2021_01_06_425584	113	32	the	the	DT
10_1101-2021_01_06_425584	113	33	author	author	NN
10_1101-2021_01_06_425584	113	34	/	/	SYM
10_1101-2021_01_06_425584	113	35	funder	funder	NN
10_1101-2021_01_06_425584	113	36	,	,	,
10_1101-2021_01_06_425584	113	37	who	who	WP
10_1101-2021_01_06_425584	113	38	has	have	VBZ
10_1101-2021_01_06_425584	113	39	granted	grant	VBN
10_1101-2021_01_06_425584	113	40	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	113	41	a	a	DT
10_1101-2021_01_06_425584	113	42	license	license	NN
10_1101-2021_01_06_425584	113	43	to	to	TO
10_1101-2021_01_06_425584	113	44	display	display	VB
10_1101-2021_01_06_425584	113	45	the	the	DT
10_1101-2021_01_06_425584	113	46	preprint	preprint	NN
10_1101-2021_01_06_425584	113	47	in	in	IN
10_1101-2021_01_06_425584	113	48	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	113	49	.	.	.
10_1101-2021_01_06_425584	114	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	114	2	is	be	VBZ
10_1101-2021_01_06_425584	114	3	made	make	VBN
10_1101-2021_01_06_425584	114	4	The	the	DT
10_1101-2021_01_06_425584	114	5	copyright	copyright	NN
10_1101-2021_01_06_425584	114	6	holder	holder	NN
10_1101-2021_01_06_425584	114	7	for	for	IN
10_1101-2021_01_06_425584	114	8	this	this	DT
10_1101-2021_01_06_425584	114	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	114	10	version	version	NN
10_1101-2021_01_06_425584	114	11	posted	post	VBD
10_1101-2021_01_06_425584	114	12	January	January	NNP
10_1101-2021_01_06_425584	114	13	8	8	CD
10_1101-2021_01_06_425584	114	14	,	,	,
10_1101-2021_01_06_425584	114	15	2021	2021	CD
10_1101-2021_01_06_425584	114	16	.	.	.
10_1101-2021_01_06_425584	114	17	;	;	:
10_1101-2021_01_06_425584	114	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	114	19	:	:	:
10_1101-2021_01_06_425584	114	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	114	21	preprint	preprint	NN
10_1101-2021_01_06_425584	114	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	114	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	114	24	8	8	CD
10_1101-2021_01_06_425584	114	25	(	(	-LRB-
10_1101-2021_01_06_425584	114	26	https://www.omicsnet.ca/	https://www.omicsnet.ca/	NN
10_1101-2021_01_06_425584	114	27	)	)	-RRB-
10_1101-2021_01_06_425584	114	28	(	(	-LRB-
10_1101-2021_01_06_425584	114	29	33	33	CD
10_1101-2021_01_06_425584	114	30	,	,	,
10_1101-2021_01_06_425584	114	31	34	34	CD
10_1101-2021_01_06_425584	114	32	)	)	-RRB-
10_1101-2021_01_06_425584	114	33	.	.	.
10_1101-2021_01_06_425584	115	1	First	first	RB
10_1101-2021_01_06_425584	115	2	,	,	,
10_1101-2021_01_06_425584	115	3	a	a	DT
10_1101-2021_01_06_425584	115	4	protein	protein	NN
10_1101-2021_01_06_425584	115	5	-	-	HYPH
10_1101-2021_01_06_425584	115	6	protein	protein	NN
10_1101-2021_01_06_425584	115	7	interaction	interaction	NN
10_1101-2021_01_06_425584	115	8	(	(	-LRB-
10_1101-2021_01_06_425584	115	9	PPI	PPI	NNP
10_1101-2021_01_06_425584	115	10	)	)	-RRB-
10_1101-2021_01_06_425584	115	11	molecular	molecular	JJ
10_1101-2021_01_06_425584	115	12	network	network	NN
10_1101-2021_01_06_425584	115	13	219	219	CD
10_1101-2021_01_06_425584	115	14	(	(	-LRB-
10_1101-2021_01_06_425584	115	15	first	first	JJ
10_1101-2021_01_06_425584	115	16	-	-	HYPH
10_1101-2021_01_06_425584	115	17	order	order	NN
10_1101-2021_01_06_425584	115	18	network	network	NN
10_1101-2021_01_06_425584	115	19	containing	contain	VBG
10_1101-2021_01_06_425584	115	20	query	query	NN
10_1101-2021_01_06_425584	115	21	or	or	CC
10_1101-2021_01_06_425584	115	22	seeds	seed	VBZ
10_1101-2021_01_06_425584	115	23	molecules	molecule	NNS
10_1101-2021_01_06_425584	115	24	and	and	CC
10_1101-2021_01_06_425584	115	25	their	-PRON-	PRP$
10_1101-2021_01_06_425584	115	26	immediate	immediate	JJ
10_1101-2021_01_06_425584	115	27	interacting	interact	VBG
10_1101-2021_01_06_425584	115	28	partners	partner	NNS
10_1101-2021_01_06_425584	115	29	)	)	-RRB-
10_1101-2021_01_06_425584	115	30	220	220	CD
10_1101-2021_01_06_425584	115	31	using	use	VBG
10_1101-2021_01_06_425584	115	32	STRING	STRING	NNP
10_1101-2021_01_06_425584	115	33	PPI	PPI	NNP
10_1101-2021_01_06_425584	115	34	database	database	NN
10_1101-2021_01_06_425584	115	35	was	be	VBD
10_1101-2021_01_06_425584	115	36	built	build	VBN
10_1101-2021_01_06_425584	115	37	(	(	-LRB-
10_1101-2021_01_06_425584	115	38	35	35	CD
10_1101-2021_01_06_425584	115	39	)	)	-RRB-
10_1101-2021_01_06_425584	115	40	and	and	CC
10_1101-2021_01_06_425584	115	41	then	then	RB
10_1101-2021_01_06_425584	115	42	pathway	pathway	NNP
10_1101-2021_01_06_425584	115	43	enrichment	enrichment	NN
10_1101-2021_01_06_425584	115	44	analysis	analysis	NN
10_1101-2021_01_06_425584	115	45	was	be	VBD
10_1101-2021_01_06_425584	115	46	performed	perform	VBN
10_1101-2021_01_06_425584	115	47	221	221	CD
10_1101-2021_01_06_425584	115	48	using	use	VBG
10_1101-2021_01_06_425584	115	49	the	the	DT
10_1101-2021_01_06_425584	115	50	built	build	VBN
10_1101-2021_01_06_425584	115	51	-	-	HYPH
10_1101-2021_01_06_425584	115	52	in	in	RP
10_1101-2021_01_06_425584	115	53	REACTOME	reactome	NN
10_1101-2021_01_06_425584	115	54	and	and	CC
10_1101-2021_01_06_425584	115	55	the	the	DT
10_1101-2021_01_06_425584	115	56	Kyoto	Kyoto	NNP
10_1101-2021_01_06_425584	115	57	Encyclopedia	Encyclopedia	NNP
10_1101-2021_01_06_425584	115	58	of	of	IN
10_1101-2021_01_06_425584	115	59	Genes	Genes	NNPS
10_1101-2021_01_06_425584	115	60	and	and	CC
10_1101-2021_01_06_425584	115	61	Genomes	Genomes	NNP
10_1101-2021_01_06_425584	115	62	(	(	-LRB-
10_1101-2021_01_06_425584	115	63	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	115	64	)	)	-RRB-
10_1101-2021_01_06_425584	115	65	222	222	CD
10_1101-2021_01_06_425584	115	66	databases	database	NNS
10_1101-2021_01_06_425584	115	67	.	.	.
10_1101-2021_01_06_425584	116	1	To	to	TO
10_1101-2021_01_06_425584	116	2	visualize	visualize	VB
10_1101-2021_01_06_425584	116	3	modules	module	NNS
10_1101-2021_01_06_425584	116	4	(	(	-LRB-
10_1101-2021_01_06_425584	116	5	functional	functional	JJ
10_1101-2021_01_06_425584	116	6	units	unit	NNS
10_1101-2021_01_06_425584	116	7	)	)	-RRB-
10_1101-2021_01_06_425584	116	8	contained	contain	VBN
10_1101-2021_01_06_425584	116	9	in	in	IN
10_1101-2021_01_06_425584	116	10	the	the	DT
10_1101-2021_01_06_425584	116	11	molecular	molecular	JJ
10_1101-2021_01_06_425584	116	12	network	network	NN
10_1101-2021_01_06_425584	116	13	the	the	DT
10_1101-2021_01_06_425584	116	14	223	223	CD
10_1101-2021_01_06_425584	116	15	WalkTrap	WalkTrap	NNP
10_1101-2021_01_06_425584	116	16	algorithm	algorithm	NN
10_1101-2021_01_06_425584	116	17	(	(	-LRB-
10_1101-2021_01_06_425584	116	18	within	within	IN
10_1101-2021_01_06_425584	116	19	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	116	20	platform	platform	NN
10_1101-2021_01_06_425584	116	21	)	)	-RRB-
10_1101-2021_01_06_425584	116	22	was	be	VBD
10_1101-2021_01_06_425584	116	23	employed	employ	VBN
10_1101-2021_01_06_425584	116	24	.	.	.
10_1101-2021_01_06_425584	117	1	Hypergeometric	hypergeometric	JJ
10_1101-2021_01_06_425584	117	2	test	test	NN
10_1101-2021_01_06_425584	117	3	was	be	VBD
10_1101-2021_01_06_425584	117	4	used	use	VBN
10_1101-2021_01_06_425584	117	5	to	to	IN
10_1101-2021_01_06_425584	117	6	224	224	CD
10_1101-2021_01_06_425584	117	7	compute	compute	JJ
10_1101-2021_01_06_425584	117	8	p	p	NN
10_1101-2021_01_06_425584	117	9	-	-	HYPH
10_1101-2021_01_06_425584	117	10	values	value	NNS
10_1101-2021_01_06_425584	117	11	.	.	.
10_1101-2021_01_06_425584	118	1	225	225	CD
10_1101-2021_01_06_425584	118	2	226	226	CD
10_1101-2021_01_06_425584	118	3	2.10	2.10	CD
10_1101-2021_01_06_425584	118	4	Integrative	integrative	JJ
10_1101-2021_01_06_425584	118	5	analysis	analysis	NN
10_1101-2021_01_06_425584	118	6	of	of	IN
10_1101-2021_01_06_425584	118	7	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	118	8	and	and	CC
10_1101-2021_01_06_425584	118	9	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	118	10	data	datum	NNS
10_1101-2021_01_06_425584	118	11	227	227	CD
10_1101-2021_01_06_425584	118	12	The	the	DT
10_1101-2021_01_06_425584	118	13	molecular	molecular	JJ
10_1101-2021_01_06_425584	118	14	interactions	interaction	NNS
10_1101-2021_01_06_425584	118	15	between	between	IN
10_1101-2021_01_06_425584	118	16	the	the	DT
10_1101-2021_01_06_425584	118	17	proteins	protein	NNS
10_1101-2021_01_06_425584	118	18	and	and	CC
10_1101-2021_01_06_425584	118	19	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	118	20	differentially	differentially	RB
10_1101-2021_01_06_425584	118	21	abundant	abundant	JJ
10_1101-2021_01_06_425584	118	22	between	between	IN
10_1101-2021_01_06_425584	118	23	228	228	CD
10_1101-2021_01_06_425584	118	24	HG	HG	NNP
10_1101-2021_01_06_425584	118	25	+	+	CC
10_1101-2021_01_06_425584	118	26	HI	HI	NNP
10_1101-2021_01_06_425584	118	27	and	and	CC
10_1101-2021_01_06_425584	118	28	NG	NG	NNP
10_1101-2021_01_06_425584	118	29	were	be	VBD
10_1101-2021_01_06_425584	118	30	determined	determine	VBN
10_1101-2021_01_06_425584	118	31	in	in	IN
10_1101-2021_01_06_425584	118	32	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	118	33	(	(	-LRB-
10_1101-2021_01_06_425584	118	34	32	32	CD
10_1101-2021_01_06_425584	118	35	,	,	,
10_1101-2021_01_06_425584	118	36	33	33	CD
10_1101-2021_01_06_425584	118	37	)	)	-RRB-
10_1101-2021_01_06_425584	118	38	.	.	.
10_1101-2021_01_06_425584	119	1	The	the	DT
10_1101-2021_01_06_425584	119	2	lists	list	NNS
10_1101-2021_01_06_425584	119	3	of	of	IN
10_1101-2021_01_06_425584	119	4	proteins	protein	NNS
10_1101-2021_01_06_425584	119	5	(	(	-LRB-
10_1101-2021_01_06_425584	119	6	EntrezGene	EntrezGene	NNP
10_1101-2021_01_06_425584	119	7	ID	ID	NNP
10_1101-2021_01_06_425584	119	8	)	)	-RRB-
10_1101-2021_01_06_425584	119	9	229	229	CD
10_1101-2021_01_06_425584	119	10	and	and	CC
10_1101-2021_01_06_425584	119	11	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	119	12	(	(	-LRB-
10_1101-2021_01_06_425584	119	13	HMDB	HMDB	NNP
10_1101-2021_01_06_425584	119	14	ID	ID	NNP
10_1101-2021_01_06_425584	119	15	)	)	-RRB-
10_1101-2021_01_06_425584	119	16	were	be	VBD
10_1101-2021_01_06_425584	119	17	loaded	load	VBN
10_1101-2021_01_06_425584	119	18	to	to	TO
10_1101-2021_01_06_425584	119	19	build	build	VB
10_1101-2021_01_06_425584	119	20	a	a	DT
10_1101-2021_01_06_425584	119	21	composite	composite	JJ
10_1101-2021_01_06_425584	119	22	network	network	NN
10_1101-2021_01_06_425584	119	23	using	use	VBG
10_1101-2021_01_06_425584	119	24	protein	protein	NN
10_1101-2021_01_06_425584	119	25	-	-	HYPH
10_1101-2021_01_06_425584	119	26	protein	protein	NN
10_1101-2021_01_06_425584	119	27	230	230	CD
10_1101-2021_01_06_425584	119	28	(	(	-LRB-
10_1101-2021_01_06_425584	119	29	STRING	string	NN
10_1101-2021_01_06_425584	119	30	database	database	NN
10_1101-2021_01_06_425584	119	31	selected	select	VBN
10_1101-2021_01_06_425584	119	32	)	)	-RRB-
10_1101-2021_01_06_425584	119	33	and	and	CC
10_1101-2021_01_06_425584	119	34	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	119	35	-	-	HYPH
10_1101-2021_01_06_425584	119	36	protein	protein	NN
10_1101-2021_01_06_425584	119	37	(	(	-LRB-
10_1101-2021_01_06_425584	119	38	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	119	39	database	database	NN
10_1101-2021_01_06_425584	119	40	selected	select	VBN
10_1101-2021_01_06_425584	119	41	)	)	-RRB-
10_1101-2021_01_06_425584	119	42	interaction	interaction	NN
10_1101-2021_01_06_425584	119	43	types	type	NNS
10_1101-2021_01_06_425584	119	44	.	.	.
10_1101-2021_01_06_425584	120	1	231	231	CD
10_1101-2021_01_06_425584	120	2	The	the	DT
10_1101-2021_01_06_425584	120	3	primary	primary	JJ
10_1101-2021_01_06_425584	120	4	network	network	NN
10_1101-2021_01_06_425584	120	5	relied	rely	VBN
10_1101-2021_01_06_425584	120	6	on	on	IN
10_1101-2021_01_06_425584	120	7	the	the	DT
10_1101-2021_01_06_425584	120	8	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	120	9	input	input	NN
10_1101-2021_01_06_425584	120	10	.	.	.
10_1101-2021_01_06_425584	121	1	Pathway	pathway	JJ
10_1101-2021_01_06_425584	121	2	enrichment	enrichment	NN
10_1101-2021_01_06_425584	121	3	analysis	analysis	NN
10_1101-2021_01_06_425584	121	4	was	be	VBD
10_1101-2021_01_06_425584	121	5	performed	perform	VBN
10_1101-2021_01_06_425584	121	6	232	232	CD
10_1101-2021_01_06_425584	121	7	using	use	VBG
10_1101-2021_01_06_425584	121	8	the	the	DT
10_1101-2021_01_06_425584	121	9	built	build	VBN
10_1101-2021_01_06_425584	121	10	-	-	HYPH
10_1101-2021_01_06_425584	121	11	in	in	RP
10_1101-2021_01_06_425584	121	12	REACTOME	reactome	NN
10_1101-2021_01_06_425584	121	13	and	and	CC
10_1101-2021_01_06_425584	121	14	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	121	15	databases	database	VBZ
10_1101-2021_01_06_425584	121	16	.	.	.
10_1101-2021_01_06_425584	122	1	Hypergeometric	hypergeometric	JJ
10_1101-2021_01_06_425584	122	2	test	test	NN
10_1101-2021_01_06_425584	122	3	was	be	VBD
10_1101-2021_01_06_425584	122	4	used	use	VBN
10_1101-2021_01_06_425584	122	5	to	to	TO
10_1101-2021_01_06_425584	122	6	compute	compute	VB
10_1101-2021_01_06_425584	122	7	233	233	CD
10_1101-2021_01_06_425584	122	8	p	p	NN
10_1101-2021_01_06_425584	122	9	-	-	HYPH
10_1101-2021_01_06_425584	122	10	values	value	NNS
10_1101-2021_01_06_425584	122	11	.	.	.
10_1101-2021_01_06_425584	123	1	234	234	CD
10_1101-2021_01_06_425584	123	2	235	235	CD
10_1101-2021_01_06_425584	123	3	2.11	2.11	CD
10_1101-2021_01_06_425584	123	4	Statistical	statistical	JJ
10_1101-2021_01_06_425584	123	5	analysis	analysis	NN
10_1101-2021_01_06_425584	123	6	236	236	CD
10_1101-2021_01_06_425584	123	7	All	all	DT
10_1101-2021_01_06_425584	123	8	experiments	experiment	NNS
10_1101-2021_01_06_425584	123	9	were	be	VBD
10_1101-2021_01_06_425584	123	10	performed	perform	VBN
10_1101-2021_01_06_425584	123	11	in	in	IN
10_1101-2021_01_06_425584	123	12	triplicate	triplicate	NN
10_1101-2021_01_06_425584	123	13	.	.	.
10_1101-2021_01_06_425584	124	1	Based	base	VBN
10_1101-2021_01_06_425584	124	2	on	on	IN
10_1101-2021_01_06_425584	124	3	the	the	DT
10_1101-2021_01_06_425584	124	4	accuracy	accuracy	NN
10_1101-2021_01_06_425584	124	5	(	(	-LRB-
10_1101-2021_01_06_425584	124	6	determination	determination	NN
10_1101-2021_01_06_425584	124	7	of	of	IN
10_1101-2021_01_06_425584	124	8	real	real	JJ
10_1101-2021_01_06_425584	124	9	fold-237	fold-237	NN
10_1101-2021_01_06_425584	124	10	changes	change	NNS
10_1101-2021_01_06_425584	124	11	)	)	-RRB-
10_1101-2021_01_06_425584	124	12	of	of	IN
10_1101-2021_01_06_425584	124	13	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	124	14	-	-	HYPH
10_1101-2021_01_06_425584	124	15	based	base	VBN
10_1101-2021_01_06_425584	124	16	quantification	quantification	NN
10_1101-2021_01_06_425584	124	17	(	(	-LRB-
10_1101-2021_01_06_425584	124	18	36	36	CD
10_1101-2021_01_06_425584	124	19	)	)	-RRB-
10_1101-2021_01_06_425584	124	20	,	,	,
10_1101-2021_01_06_425584	124	21	proteins	protein	VBZ
10_1101-2021_01_06_425584	124	22	with	with	IN
10_1101-2021_01_06_425584	124	23	a	a	DT
10_1101-2021_01_06_425584	124	24	fold	fold	JJ
10_1101-2021_01_06_425584	124	25	change	change	NN
10_1101-2021_01_06_425584	124	26	≥	≥	UH
10_1101-2021_01_06_425584	124	27	1.2	1.2	CD
10_1101-2021_01_06_425584	124	28	or	or	CC
10_1101-2021_01_06_425584	124	29	≤	≤	JJ
10_1101-2021_01_06_425584	124	30	1/1.2	1/1.2	NNS
10_1101-2021_01_06_425584	124	31	and	and	CC
10_1101-2021_01_06_425584	124	32	a	a	DT
10_1101-2021_01_06_425584	124	33	238	238	CD
10_1101-2021_01_06_425584	124	34	p	p	NN
10_1101-2021_01_06_425584	124	35	-	-	HYPH
10_1101-2021_01_06_425584	124	36	value	value	NN
10_1101-2021_01_06_425584	124	37	<	<	XX
10_1101-2021_01_06_425584	124	38	0.05	0.05	CD
10_1101-2021_01_06_425584	124	39	(	(	-LRB-
10_1101-2021_01_06_425584	124	40	Welch	Welch	NNP
10_1101-2021_01_06_425584	124	41	’s	’s	POS
10_1101-2021_01_06_425584	124	42	t	t	NN
10_1101-2021_01_06_425584	124	43	-	-	HYPH
10_1101-2021_01_06_425584	124	44	test	test	NN
10_1101-2021_01_06_425584	124	45	)	)	-RRB-
10_1101-2021_01_06_425584	124	46	were	be	VBD
10_1101-2021_01_06_425584	124	47	considered	consider	VBN
10_1101-2021_01_06_425584	124	48	as	as	RB
10_1101-2021_01_06_425584	124	49	differentially	differentially	RB
10_1101-2021_01_06_425584	124	50	abundant	abundant	JJ
10_1101-2021_01_06_425584	124	51	between	between	IN
10_1101-2021_01_06_425584	124	52	NG	NG	NNP
10_1101-2021_01_06_425584	124	53	and	and	CC
10_1101-2021_01_06_425584	124	54	HG	HG	NNP
10_1101-2021_01_06_425584	124	55	+	+	CC
10_1101-2021_01_06_425584	124	56	239	239	CD
10_1101-2021_01_06_425584	124	57	HI	HI	NNP
10_1101-2021_01_06_425584	124	58	conditions	condition	NNS
10_1101-2021_01_06_425584	124	59	.	.	.
10_1101-2021_01_06_425584	125	1	For	for	IN
10_1101-2021_01_06_425584	125	2	the	the	DT
10_1101-2021_01_06_425584	125	3	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	125	4	data	datum	NNS
10_1101-2021_01_06_425584	125	5	,	,	,
10_1101-2021_01_06_425584	125	6	features	feature	VBZ
10_1101-2021_01_06_425584	125	7	with	with	IN
10_1101-2021_01_06_425584	125	8	a	a	DT
10_1101-2021_01_06_425584	125	9	fold	fold	JJ
10_1101-2021_01_06_425584	125	10	change	change	NN
10_1101-2021_01_06_425584	125	11	≥	≥	NNP
10_1101-2021_01_06_425584	125	12	1.3	1.3	CD
10_1101-2021_01_06_425584	125	13	or	or	CC
10_1101-2021_01_06_425584	125	14	≤	≤	JJ
10_1101-2021_01_06_425584	125	15	1/1.3	1/1.3	NNS
10_1101-2021_01_06_425584	125	16	and	and	CC
10_1101-2021_01_06_425584	125	17	a	a	DT
10_1101-2021_01_06_425584	125	18	p-240	p-240	NNP
10_1101-2021_01_06_425584	125	19	value	value	NN
10_1101-2021_01_06_425584	125	20	<	<	XX
10_1101-2021_01_06_425584	125	21	0.05	0.05	CD
10_1101-2021_01_06_425584	125	22	(	(	-LRB-
10_1101-2021_01_06_425584	125	23	Welch	Welch	NNP
10_1101-2021_01_06_425584	125	24	’s	’s	POS
10_1101-2021_01_06_425584	125	25	t	t	NN
10_1101-2021_01_06_425584	125	26	-	-	HYPH
10_1101-2021_01_06_425584	125	27	test	test	NN
10_1101-2021_01_06_425584	125	28	)	)	-RRB-
10_1101-2021_01_06_425584	125	29	were	be	VBD
10_1101-2021_01_06_425584	125	30	considered	consider	VBN
10_1101-2021_01_06_425584	125	31	as	as	RB
10_1101-2021_01_06_425584	125	32	differentially	differentially	RB
10_1101-2021_01_06_425584	125	33	abundant	abundant	JJ
10_1101-2021_01_06_425584	125	34	.	.	.
10_1101-2021_01_06_425584	126	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	126	2	did	do	VBD
10_1101-2021_01_06_425584	126	3	not	not	RB
10_1101-2021_01_06_425584	126	4	apply	apply	VB
10_1101-2021_01_06_425584	126	5	multiple-241	multiple-241	NNP
10_1101-2021_01_06_425584	126	6	test	test	NN
10_1101-2021_01_06_425584	126	7	corrections	correction	NNS
10_1101-2021_01_06_425584	126	8	to	to	TO
10_1101-2021_01_06_425584	126	9	calculate	calculate	VB
10_1101-2021_01_06_425584	126	10	adjusted	adjusted	JJ
10_1101-2021_01_06_425584	126	11	p	p	NN
10_1101-2021_01_06_425584	126	12	-	-	HYPH
10_1101-2021_01_06_425584	126	13	values	value	NNS
10_1101-2021_01_06_425584	126	14	,	,	,
10_1101-2021_01_06_425584	126	15	because	because	IN
10_1101-2021_01_06_425584	126	16	this	this	DT
10_1101-2021_01_06_425584	126	17	process	process	NN
10_1101-2021_01_06_425584	126	18	could	could	MD
10_1101-2021_01_06_425584	126	19	obscure	obscure	VB
10_1101-2021_01_06_425584	126	20	proteins	protein	NNS
10_1101-2021_01_06_425584	126	21	or	or	CC
10_1101-2021_01_06_425584	126	22	242	242	CD
10_1101-2021_01_06_425584	126	23	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	126	24	with	with	IN
10_1101-2021_01_06_425584	126	25	real	real	JJ
10_1101-2021_01_06_425584	126	26	changes	change	NNS
10_1101-2021_01_06_425584	126	27	(	(	-LRB-
10_1101-2021_01_06_425584	126	28	true	true	JJ
10_1101-2021_01_06_425584	126	29	-	-	HYPH
10_1101-2021_01_06_425584	126	30	positives	positive	NNS
10_1101-2021_01_06_425584	126	31	)	)	-RRB-
10_1101-2021_01_06_425584	126	32	(	(	-LRB-
10_1101-2021_01_06_425584	126	33	37	37	CD
10_1101-2021_01_06_425584	126	34	)	)	-RRB-
10_1101-2021_01_06_425584	126	35	.	.	.
10_1101-2021_01_06_425584	127	1	Instead	instead	RB
10_1101-2021_01_06_425584	127	2	,	,	,
10_1101-2021_01_06_425584	127	3	the	the	DT
10_1101-2021_01_06_425584	127	4	analysis	analysis	NN
10_1101-2021_01_06_425584	127	5	was	be	VBD
10_1101-2021_01_06_425584	127	6	focused	focus	VBN
10_1101-2021_01_06_425584	127	7	on	on	IN
10_1101-2021_01_06_425584	127	8	top-243	top-243	NNP
10_1101-2021_01_06_425584	127	9	enriched	enrich	VBD
10_1101-2021_01_06_425584	127	10	signaling	signal	VBG
10_1101-2021_01_06_425584	127	11	pathways	pathway	NNS
10_1101-2021_01_06_425584	127	12	(	(	-LRB-
10_1101-2021_01_06_425584	127	13	adjusted	adjust	VBN
10_1101-2021_01_06_425584	127	14	p	p	NN
10_1101-2021_01_06_425584	127	15	-	-	HYPH
10_1101-2021_01_06_425584	127	16	value	value	NN
10_1101-2021_01_06_425584	127	17	<	<	XX
10_1101-2021_01_06_425584	127	18	0.01	0.01	XX
10_1101-2021_01_06_425584	127	19	)	)	-RRB-
10_1101-2021_01_06_425584	127	20	that	that	WDT
10_1101-2021_01_06_425584	127	21	allowed	allow	VBD
10_1101-2021_01_06_425584	127	22	us	-PRON-	PRP
10_1101-2021_01_06_425584	127	23	to	to	TO
10_1101-2021_01_06_425584	127	24	determine	determine	VB
10_1101-2021_01_06_425584	127	25	a	a	DT
10_1101-2021_01_06_425584	127	26	set	set	NN
10_1101-2021_01_06_425584	127	27	of	of	IN
10_1101-2021_01_06_425584	127	28	244	244	CD
10_1101-2021_01_06_425584	127	29	interacting	interact	VBG
10_1101-2021_01_06_425584	127	30	proteins	protein	NNS
10_1101-2021_01_06_425584	127	31	and	and	CC
10_1101-2021_01_06_425584	127	32	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	127	33	with	with	IN
10_1101-2021_01_06_425584	127	34	relevant	relevant	JJ
10_1101-2021_01_06_425584	127	35	biological	biological	JJ
10_1101-2021_01_06_425584	127	36	information	information	NN
10_1101-2021_01_06_425584	127	37	and	and	CC
10_1101-2021_01_06_425584	127	38	contributes	contribute	VBZ
10_1101-2021_01_06_425584	127	39	in	in	IN
10_1101-2021_01_06_425584	127	40	245	245	CD
10_1101-2021_01_06_425584	127	41	reducing	reduce	VBG
10_1101-2021_01_06_425584	127	42	false	false	JJ
10_1101-2021_01_06_425584	127	43	positives	positive	NNS
10_1101-2021_01_06_425584	127	44	.	.	.
10_1101-2021_01_06_425584	128	1	For	for	IN
10_1101-2021_01_06_425584	128	2	multivariate	multivariate	JJ
10_1101-2021_01_06_425584	128	3	statistical	statistical	JJ
10_1101-2021_01_06_425584	128	4	analysis	analysis	NN
10_1101-2021_01_06_425584	128	5	and	and	CC
10_1101-2021_01_06_425584	128	6	heatmap	heatmap	NNP
10_1101-2021_01_06_425584	128	7	visualization	visualization	NNP
10_1101-2021_01_06_425584	128	8	,	,	,
10_1101-2021_01_06_425584	128	9	246	246	CD
10_1101-2021_01_06_425584	128	10	Metaboanalyst	Metaboanalyst	NNP
10_1101-2021_01_06_425584	128	11	4.0	4.0	CD
10_1101-2021_01_06_425584	128	12	(	(	-LRB-
10_1101-2021_01_06_425584	128	13	https://www.metaboanalyst.ca	https://www.metaboanalyst.ca	NNP
10_1101-2021_01_06_425584	128	14	)	)	-RRB-
10_1101-2021_01_06_425584	128	15	was	be	VBD
10_1101-2021_01_06_425584	128	16	utilized	utilize	VBN
10_1101-2021_01_06_425584	128	17	.	.	.
10_1101-2021_01_06_425584	129	1	Principal	principal	JJ
10_1101-2021_01_06_425584	129	2	component	component	NN
10_1101-2021_01_06_425584	129	3	analysis	analysis	NN
10_1101-2021_01_06_425584	129	4	247	247	CD
10_1101-2021_01_06_425584	129	5	(	(	-LRB-
10_1101-2021_01_06_425584	129	6	PCA	PCA	NNP
10_1101-2021_01_06_425584	129	7	)	)	-RRB-
10_1101-2021_01_06_425584	129	8	was	be	VBD
10_1101-2021_01_06_425584	129	9	used	use	VBN
10_1101-2021_01_06_425584	129	10	to	to	TO
10_1101-2021_01_06_425584	129	11	assess	assess	VB
10_1101-2021_01_06_425584	129	12	for	for	IN
10_1101-2021_01_06_425584	129	13	sample	sample	NN
10_1101-2021_01_06_425584	129	14	clustering	cluster	VBG
10_1101-2021_01_06_425584	129	15	behavior	behavior	NN
10_1101-2021_01_06_425584	129	16	and	and	CC
10_1101-2021_01_06_425584	129	17	inter	inter	JJ
10_1101-2021_01_06_425584	129	18	-	-	JJ
10_1101-2021_01_06_425584	129	19	group	group	JJ
10_1101-2021_01_06_425584	129	20	variation	variation	NN
10_1101-2021_01_06_425584	129	21	.	.	.
10_1101-2021_01_06_425584	130	1	No	no	DT
10_1101-2021_01_06_425584	130	2	scaling	scale	VBG
10_1101-2021_01_06_425584	130	3	248	248	CD
10_1101-2021_01_06_425584	130	4	was	be	VBD
10_1101-2021_01_06_425584	130	5	used	use	VBN
10_1101-2021_01_06_425584	130	6	for	for	IN
10_1101-2021_01_06_425584	130	7	PCA	PCA	NNP
10_1101-2021_01_06_425584	130	8	and	and	CC
10_1101-2021_01_06_425584	130	9	heatmap	heatmap	NNP
10_1101-2021_01_06_425584	130	10	analysis	analysis	NN
10_1101-2021_01_06_425584	130	11	.	.	.
10_1101-2021_01_06_425584	131	1	Software	software	NN
10_1101-2021_01_06_425584	131	2	PRISM	prism	NN
10_1101-2021_01_06_425584	131	3	6.0	6.0	CD
10_1101-2021_01_06_425584	131	4	(	(	-LRB-
10_1101-2021_01_06_425584	131	5	GraphPad	GraphPad	NNP
10_1101-2021_01_06_425584	131	6	Software	Software	NNP
10_1101-2021_01_06_425584	131	7	,	,	,
10_1101-2021_01_06_425584	131	8	San	San	NNP
10_1101-2021_01_06_425584	131	9	Diego	Diego	NNP
10_1101-2021_01_06_425584	131	10	,	,	,
10_1101-2021_01_06_425584	131	11	249	249	CD
10_1101-2021_01_06_425584	131	12	CA	CA	NNP
10_1101-2021_01_06_425584	131	13	)	)	-RRB-
10_1101-2021_01_06_425584	131	14	was	be	VBD
10_1101-2021_01_06_425584	131	15	used	use	VBN
10_1101-2021_01_06_425584	131	16	for	for	IN
10_1101-2021_01_06_425584	131	17	the	the	DT
10_1101-2021_01_06_425584	131	18	creation	creation	NN
10_1101-2021_01_06_425584	131	19	of	of	IN
10_1101-2021_01_06_425584	131	20	volcano	volcano	NN
10_1101-2021_01_06_425584	131	21	plots	plot	NNS
10_1101-2021_01_06_425584	131	22	and	and	CC
10_1101-2021_01_06_425584	131	23	column	column	NN
10_1101-2021_01_06_425584	131	24	graphs	graphs	NN
10_1101-2021_01_06_425584	131	25	.	.	.
10_1101-2021_01_06_425584	132	1	250	250	CD
10_1101-2021_01_06_425584	132	2	251	251	CD
10_1101-2021_01_06_425584	132	3	2.12	2.12	CD
10_1101-2021_01_06_425584	132	4	Data	datum	NNS
10_1101-2021_01_06_425584	132	5	availability	availability	NN
10_1101-2021_01_06_425584	132	6	252	252	CD
10_1101-2021_01_06_425584	132	7	.CC	.CC	NFP
10_1101-2021_01_06_425584	132	8	-	-	:
10_1101-2021_01_06_425584	132	9	BY	by	IN
10_1101-2021_01_06_425584	132	10	-	-	HYPH
10_1101-2021_01_06_425584	132	11	NC	NC	NNP
10_1101-2021_01_06_425584	132	12	-	-	HYPH
10_1101-2021_01_06_425584	132	13	ND	ND	NNP
10_1101-2021_01_06_425584	132	14	4.0	4.0	CD
10_1101-2021_01_06_425584	132	15	International	International	NNP
10_1101-2021_01_06_425584	132	16	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	132	17	under	under	IN
10_1101-2021_01_06_425584	132	18	a	a	DT
10_1101-2021_01_06_425584	132	19	(	(	-LRB-
10_1101-2021_01_06_425584	132	20	which	which	WDT
10_1101-2021_01_06_425584	132	21	was	be	VBD
10_1101-2021_01_06_425584	132	22	not	not	RB
10_1101-2021_01_06_425584	132	23	certified	certify	VBN
10_1101-2021_01_06_425584	132	24	by	by	IN
10_1101-2021_01_06_425584	132	25	peer	peer	NN
10_1101-2021_01_06_425584	132	26	review	review	NN
10_1101-2021_01_06_425584	132	27	)	)	-RRB-
10_1101-2021_01_06_425584	132	28	is	be	VBZ
10_1101-2021_01_06_425584	132	29	the	the	DT
10_1101-2021_01_06_425584	132	30	author	author	NN
10_1101-2021_01_06_425584	132	31	/	/	SYM
10_1101-2021_01_06_425584	132	32	funder	funder	NN
10_1101-2021_01_06_425584	132	33	,	,	,
10_1101-2021_01_06_425584	132	34	who	who	WP
10_1101-2021_01_06_425584	132	35	has	have	VBZ
10_1101-2021_01_06_425584	132	36	granted	grant	VBN
10_1101-2021_01_06_425584	132	37	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	132	38	a	a	DT
10_1101-2021_01_06_425584	132	39	license	license	NN
10_1101-2021_01_06_425584	132	40	to	to	TO
10_1101-2021_01_06_425584	132	41	display	display	VB
10_1101-2021_01_06_425584	132	42	the	the	DT
10_1101-2021_01_06_425584	132	43	preprint	preprint	NN
10_1101-2021_01_06_425584	132	44	in	in	IN
10_1101-2021_01_06_425584	132	45	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	132	46	.	.	.
10_1101-2021_01_06_425584	133	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	133	2	is	be	VBZ
10_1101-2021_01_06_425584	133	3	made	make	VBN
10_1101-2021_01_06_425584	133	4	The	the	DT
10_1101-2021_01_06_425584	133	5	copyright	copyright	NN
10_1101-2021_01_06_425584	133	6	holder	holder	NN
10_1101-2021_01_06_425584	133	7	for	for	IN
10_1101-2021_01_06_425584	133	8	this	this	DT
10_1101-2021_01_06_425584	133	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	133	10	version	version	NN
10_1101-2021_01_06_425584	133	11	posted	post	VBD
10_1101-2021_01_06_425584	133	12	January	January	NNP
10_1101-2021_01_06_425584	133	13	8	8	CD
10_1101-2021_01_06_425584	133	14	,	,	,
10_1101-2021_01_06_425584	133	15	2021	2021	CD
10_1101-2021_01_06_425584	133	16	.	.	.
10_1101-2021_01_06_425584	133	17	;	;	:
10_1101-2021_01_06_425584	133	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	133	19	:	:	:
10_1101-2021_01_06_425584	133	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	133	21	preprint	preprint	NN
10_1101-2021_01_06_425584	133	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	133	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	133	24	9	9	CD
10_1101-2021_01_06_425584	133	25	The	the	DT
10_1101-2021_01_06_425584	133	26	raw	raw	JJ
10_1101-2021_01_06_425584	133	27	datasets	dataset	NNS
10_1101-2021_01_06_425584	133	28	supporting	support	VBG
10_1101-2021_01_06_425584	133	29	the	the	DT
10_1101-2021_01_06_425584	133	30	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	133	31	results	result	NNS
10_1101-2021_01_06_425584	133	32	are	be	VBP
10_1101-2021_01_06_425584	133	33	available	available	JJ
10_1101-2021_01_06_425584	133	34	in	in	IN
10_1101-2021_01_06_425584	133	35	the	the	DT
10_1101-2021_01_06_425584	133	36	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	133	37	/	/	SYM
10_1101-2021_01_06_425584	133	38	MassIVE	MassIVE	``
10_1101-2021_01_06_425584	133	39	public	public	JJ
10_1101-2021_01_06_425584	133	40	253	253	CD
10_1101-2021_01_06_425584	133	41	repository	repository	NN
10_1101-2021_01_06_425584	133	42	(	(	-LRB-
10_1101-2021_01_06_425584	133	43	38	38	CD
10_1101-2021_01_06_425584	133	44	)	)	-RRB-
10_1101-2021_01_06_425584	133	45	under	under	IN
10_1101-2021_01_06_425584	133	46	the	the	DT
10_1101-2021_01_06_425584	133	47	accession	accession	NN
10_1101-2021_01_06_425584	133	48	number	number	NN
10_1101-2021_01_06_425584	133	49	MSV000084307	MSV000084307	NNP
10_1101-2021_01_06_425584	133	50	.	.	.
10_1101-2021_01_06_425584	134	1	The	the	DT
10_1101-2021_01_06_425584	134	2	specific	specific	JJ
10_1101-2021_01_06_425584	134	3	parameters	parameter	NNS
10_1101-2021_01_06_425584	134	4	of	of	IN
10_1101-2021_01_06_425584	134	5	the	the	DT
10_1101-2021_01_06_425584	134	6	tools	tool	NNS
10_1101-2021_01_06_425584	134	7	254	254	CD
10_1101-2021_01_06_425584	134	8	employed	employ	VBN
10_1101-2021_01_06_425584	134	9	for	for	IN
10_1101-2021_01_06_425584	134	10	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	134	11	annotation	annotation	NN
10_1101-2021_01_06_425584	134	12	are	be	VBP
10_1101-2021_01_06_425584	134	13	available	available	JJ
10_1101-2021_01_06_425584	134	14	on	on	IN
10_1101-2021_01_06_425584	134	15	the	the	DT
10_1101-2021_01_06_425584	134	16	following	follow	VBG
10_1101-2021_01_06_425584	134	17	links	link	NNS
10_1101-2021_01_06_425584	134	18	:	:	:
10_1101-2021_01_06_425584	134	19	for	for	IN
10_1101-2021_01_06_425584	134	20	classical	classical	NNP
10_1101-2021_01_06_425584	134	21	molecular	molecular	NNP
10_1101-2021_01_06_425584	134	22	255	255	CD
10_1101-2021_01_06_425584	134	23	networking	networking	NN
10_1101-2021_01_06_425584	134	24	,	,	,
10_1101-2021_01_06_425584	134	25	256	256	CD
10_1101-2021_01_06_425584	134	26	https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=604b3d077e00430a9bc288eebf154b9b	https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=604b3d077e00430a9bc288eebf154b9b	NNP
10_1101-2021_01_06_425584	134	27	;	;	:
10_1101-2021_01_06_425584	134	28	for	for	IN
10_1101-2021_01_06_425584	134	29	257	257	CD
10_1101-2021_01_06_425584	134	30	FBMN	FBMN	NNP
10_1101-2021_01_06_425584	134	31	258	258	CD
10_1101-2021_01_06_425584	134	32	https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=5e2839037969442e868d9df21309d561	https://gnps.ucsd.edu/proteosafe/status.jsp?task=5e2839037969442e868d9df21309d561	NN
10_1101-2021_01_06_425584	134	33	;	;	:
10_1101-2021_01_06_425584	134	34	for	for	IN
10_1101-2021_01_06_425584	134	35	259	259	CD
10_1101-2021_01_06_425584	134	36	NAP	NAP	NNP
10_1101-2021_01_06_425584	134	37	,	,	,
10_1101-2021_01_06_425584	134	38	260	260	CD
10_1101-2021_01_06_425584	134	39	https://proteomics2.ucsd.edu/ProteoSAFe/status.jsp?task=96cda48c0df64d3398a8f9088907afb261	https://proteomics2.ucsd.edu/ProteoSAFe/status.jsp?task=96cda48c0df64d3398a8f9088907afb261	NNPS
10_1101-2021_01_06_425584	134	40	5	5	CD
10_1101-2021_01_06_425584	134	41	;	;	:
10_1101-2021_01_06_425584	134	42	for	for	IN
10_1101-2021_01_06_425584	134	43	MS2LDA	MS2LDA	NNP
10_1101-2021_01_06_425584	134	44	,	,	,
10_1101-2021_01_06_425584	134	45	http://ms2lda.org/basicviz/summary/1197/	http://ms2lda.org/basicviz/summary/1197/	ADD
10_1101-2021_01_06_425584	134	46	(	(	-LRB-
10_1101-2021_01_06_425584	134	47	need	need	VBP
10_1101-2021_01_06_425584	134	48	to	to	TO
10_1101-2021_01_06_425584	134	49	log	log	VB
10_1101-2021_01_06_425584	134	50	-	-	HYPH
10_1101-2021_01_06_425584	134	51	in	in	RP
10_1101-2021_01_06_425584	134	52	as	as	IN
10_1101-2021_01_06_425584	134	53	a	a	DT
10_1101-2021_01_06_425584	134	54	registered	registered	JJ
10_1101-2021_01_06_425584	134	55	or	or	CC
10_1101-2021_01_06_425584	134	56	guest	guest	NN
10_1101-2021_01_06_425584	134	57	262	262	CD
10_1101-2021_01_06_425584	134	58	user	user	NN
10_1101-2021_01_06_425584	134	59	)	)	-RRB-
10_1101-2021_01_06_425584	134	60	;	;	:
10_1101-2021_01_06_425584	134	61	for	for	IN
10_1101-2021_01_06_425584	134	62	MolNetEnhancer	MolNetEnhancer	NNP
10_1101-2021_01_06_425584	134	63	,	,	,
10_1101-2021_01_06_425584	134	64	263	263	CD
10_1101-2021_01_06_425584	134	65	https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=de80b9c765e042ffab7767a3101054fd	https://gnps.ucsd.edu/proteosafe/status.jsp?task=de80b9c765e042ffab7767a3101054fd	CD
10_1101-2021_01_06_425584	134	66	.	.	.
10_1101-2021_01_06_425584	135	1	The	the	DT
10_1101-2021_01_06_425584	135	2	264	264	CD
10_1101-2021_01_06_425584	135	3	quantitative	quantitative	JJ
10_1101-2021_01_06_425584	135	4	results	result	NNS
10_1101-2021_01_06_425584	135	5	generated	generate	VBN
10_1101-2021_01_06_425584	135	6	using	use	VBG
10_1101-2021_01_06_425584	135	7	the	the	DT
10_1101-2021_01_06_425584	135	8	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	135	9	platform	platform	NN
10_1101-2021_01_06_425584	135	10	can	can	MD
10_1101-2021_01_06_425584	135	11	be	be	VB
10_1101-2021_01_06_425584	135	12	accessed	access	VBN
10_1101-2021_01_06_425584	135	13	after	after	IN
10_1101-2021_01_06_425584	135	14	logging	log	VBG
10_1101-2021_01_06_425584	135	15	into	into	IN
10_1101-2021_01_06_425584	135	16	the	the	DT
10_1101-2021_01_06_425584	135	17	265	265	CD
10_1101-2021_01_06_425584	135	18	following	follow	VBG
10_1101-2021_01_06_425584	135	19	link	link	NN
10_1101-2021_01_06_425584	135	20	https://xcmsonline.scripps.edu	https://xcmsonline.scripps.edu	NNS
10_1101-2021_01_06_425584	135	21	and	and	CC
10_1101-2021_01_06_425584	135	22	searching	search	VBG
10_1101-2021_01_06_425584	135	23	for	for	IN
10_1101-2021_01_06_425584	135	24	the	the	DT
10_1101-2021_01_06_425584	135	25	job	job	NN
10_1101-2021_01_06_425584	135	26	number	number	NN
10_1101-2021_01_06_425584	135	27	1395724	1395724	CD
10_1101-2021_01_06_425584	135	28	.	.	.
10_1101-2021_01_06_425584	136	1	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	136	2	266	266	CD
10_1101-2021_01_06_425584	136	3	data	datum	NNS
10_1101-2021_01_06_425584	136	4	is	be	VBZ
10_1101-2021_01_06_425584	136	5	accessible	accessible	JJ
10_1101-2021_01_06_425584	136	6	on	on	IN
10_1101-2021_01_06_425584	136	7	the	the	DT
10_1101-2021_01_06_425584	136	8	ProteomeXchange	ProteomeXchange	NNP
10_1101-2021_01_06_425584	136	9	with	with	IN
10_1101-2021_01_06_425584	136	10	dataset	dataset	NN
10_1101-2021_01_06_425584	136	11	identifier	identifier	NN
10_1101-2021_01_06_425584	136	12	PXD013643	PXD013643	NNP
10_1101-2021_01_06_425584	136	13	.	.	.
10_1101-2021_01_06_425584	137	1	267	267	CD
10_1101-2021_01_06_425584	137	2	268	268	CD
10_1101-2021_01_06_425584	137	3	3	3	CD
10_1101-2021_01_06_425584	137	4	.	.	.
10_1101-2021_01_06_425584	138	1	Results	result	NNS
10_1101-2021_01_06_425584	138	2	269	269	CD
10_1101-2021_01_06_425584	138	3	270	270	CD
10_1101-2021_01_06_425584	138	4	Untargeted	untargeted	JJ
10_1101-2021_01_06_425584	138	5	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	138	6	271	271	CD
10_1101-2021_01_06_425584	138	7	Overall	overall	JJ
10_1101-2021_01_06_425584	138	8	5571	5571	CD
10_1101-2021_01_06_425584	138	9	features	feature	NNS
10_1101-2021_01_06_425584	138	10	or	or	CC
10_1101-2021_01_06_425584	138	11	potential	potential	JJ
10_1101-2021_01_06_425584	138	12	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	138	13	were	be	VBD
10_1101-2021_01_06_425584	138	14	detected	detect	VBN
10_1101-2021_01_06_425584	138	15	using	use	VBG
10_1101-2021_01_06_425584	138	16	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	138	17	and	and	CC
10_1101-2021_01_06_425584	138	18	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	138	19	,	,	,
10_1101-2021_01_06_425584	138	20	wherein	wherein	WRB
10_1101-2021_01_06_425584	138	21	272	272	CD
10_1101-2021_01_06_425584	138	22	957	957	CD
10_1101-2021_01_06_425584	138	23	(	(	-LRB-
10_1101-2021_01_06_425584	138	24	~18	~18	NFP
10_1101-2021_01_06_425584	138	25	%	%	NN
10_1101-2021_01_06_425584	138	26	)	)	-RRB-
10_1101-2021_01_06_425584	138	27	features	feature	NNS
10_1101-2021_01_06_425584	138	28	were	be	VBD
10_1101-2021_01_06_425584	138	29	commonly	commonly	RB
10_1101-2021_01_06_425584	138	30	identified	identify	VBN
10_1101-2021_01_06_425584	138	31	in	in	IN
10_1101-2021_01_06_425584	138	32	both	both	DT
10_1101-2021_01_06_425584	138	33	platforms	platform	NNS
10_1101-2021_01_06_425584	138	34	(	(	-LRB-
10_1101-2021_01_06_425584	138	35	Figure	Figure	NNP
10_1101-2021_01_06_425584	138	36	2A	2a	NN
10_1101-2021_01_06_425584	138	37	)	)	-RRB-
10_1101-2021_01_06_425584	138	38	.	.	.
10_1101-2021_01_06_425584	139	1	Based	base	VBN
10_1101-2021_01_06_425584	139	2	on	on	IN
10_1101-2021_01_06_425584	139	3	the	the	DT
10_1101-2021_01_06_425584	139	4	273	273	CD
10_1101-2021_01_06_425584	139	5	relative	relative	JJ
10_1101-2021_01_06_425584	139	6	quantification	quantification	NN
10_1101-2021_01_06_425584	139	7	using	use	VBG
10_1101-2021_01_06_425584	139	8	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	139	9	,	,	,
10_1101-2021_01_06_425584	139	10	140	140	CD
10_1101-2021_01_06_425584	139	11	and	and	CC
10_1101-2021_01_06_425584	139	12	82	82	CD
10_1101-2021_01_06_425584	139	13	features	feature	NNS
10_1101-2021_01_06_425584	139	14	were	be	VBD
10_1101-2021_01_06_425584	139	15	detected	detect	VBN
10_1101-2021_01_06_425584	139	16	with	with	IN
10_1101-2021_01_06_425584	139	17	reduced	reduced	JJ
10_1101-2021_01_06_425584	139	18	and	and	CC
10_1101-2021_01_06_425584	139	19	274	274	CD
10_1101-2021_01_06_425584	139	20	increased	increase	VBN
10_1101-2021_01_06_425584	139	21	abundances	abundance	NNS
10_1101-2021_01_06_425584	139	22	respectively	respectively	RB
10_1101-2021_01_06_425584	139	23	in	in	IN
10_1101-2021_01_06_425584	139	24	the	the	DT
10_1101-2021_01_06_425584	139	25	experimental	experimental	JJ
10_1101-2021_01_06_425584	139	26	group	group	NN
10_1101-2021_01_06_425584	139	27	compared	compare	VBN
10_1101-2021_01_06_425584	139	28	to	to	IN
10_1101-2021_01_06_425584	139	29	the	the	DT
10_1101-2021_01_06_425584	139	30	control	control	NN
10_1101-2021_01_06_425584	139	31	group	group	NN
10_1101-2021_01_06_425584	139	32	275	275	CD
10_1101-2021_01_06_425584	139	33	(	(	-LRB-
10_1101-2021_01_06_425584	139	34	Figure	figure	NN
10_1101-2021_01_06_425584	139	35	2B	2B	NNS
10_1101-2021_01_06_425584	139	36	)	)	-RRB-
10_1101-2021_01_06_425584	139	37	.	.	.
10_1101-2021_01_06_425584	140	1	The	the	DT
10_1101-2021_01_06_425584	140	2	effects	effect	NNS
10_1101-2021_01_06_425584	140	3	of	of	IN
10_1101-2021_01_06_425584	140	4	HG	HG	NNP
10_1101-2021_01_06_425584	140	5	and	and	CC
10_1101-2021_01_06_425584	140	6	HI	HI	NNP
10_1101-2021_01_06_425584	140	7	in	in	IN
10_1101-2021_01_06_425584	140	8	the	the	DT
10_1101-2021_01_06_425584	140	9	experimental	experimental	JJ
10_1101-2021_01_06_425584	140	10	group	group	NN
10_1101-2021_01_06_425584	140	11	are	be	VBP
10_1101-2021_01_06_425584	140	12	observed	observe	VBN
10_1101-2021_01_06_425584	140	13	by	by	IN
10_1101-2021_01_06_425584	140	14	PCA	PCA	NNP
10_1101-2021_01_06_425584	140	15	analysis	analysis	NN
10_1101-2021_01_06_425584	140	16	276	276	CD
10_1101-2021_01_06_425584	140	17	wherein	wherein	WRB
10_1101-2021_01_06_425584	140	18	the	the	DT
10_1101-2021_01_06_425584	140	19	experimental	experimental	JJ
10_1101-2021_01_06_425584	140	20	samples	sample	NNS
10_1101-2021_01_06_425584	140	21	clustered	cluster	VBN
10_1101-2021_01_06_425584	140	22	away	away	RB
10_1101-2021_01_06_425584	140	23	from	from	IN
10_1101-2021_01_06_425584	140	24	the	the	DT
10_1101-2021_01_06_425584	140	25	control	control	NN
10_1101-2021_01_06_425584	140	26	group	group	NN
10_1101-2021_01_06_425584	140	27	(	(	-LRB-
10_1101-2021_01_06_425584	140	28	Figure	figure	NN
10_1101-2021_01_06_425584	140	29	2C	2c	NN
10_1101-2021_01_06_425584	140	30	)	)	-RRB-
10_1101-2021_01_06_425584	140	31	.	.	.
10_1101-2021_01_06_425584	141	1	The	the	DT
10_1101-2021_01_06_425584	141	2	277	277	CD
10_1101-2021_01_06_425584	141	3	consistency	consistency	NN
10_1101-2021_01_06_425584	141	4	of	of	IN
10_1101-2021_01_06_425584	141	5	the	the	DT
10_1101-2021_01_06_425584	141	6	LC	LC	NNP
10_1101-2021_01_06_425584	141	7	-	-	HYPH
10_1101-2021_01_06_425584	141	8	MS	MS	NNP
10_1101-2021_01_06_425584	141	9	equipment	equipment	NN
10_1101-2021_01_06_425584	141	10	is	be	VBZ
10_1101-2021_01_06_425584	141	11	apparent	apparent	JJ
10_1101-2021_01_06_425584	141	12	by	by	IN
10_1101-2021_01_06_425584	141	13	the	the	DT
10_1101-2021_01_06_425584	141	14	clustering	clustering	NN
10_1101-2021_01_06_425584	141	15	of	of	IN
10_1101-2021_01_06_425584	141	16	the	the	DT
10_1101-2021_01_06_425584	141	17	QC	QC	NNP
10_1101-2021_01_06_425584	141	18	samples	sample	NNS
10_1101-2021_01_06_425584	141	19	(	(	-LRB-
10_1101-2021_01_06_425584	141	20	Figure	figure	NN
10_1101-2021_01_06_425584	141	21	278	278	CD
10_1101-2021_01_06_425584	141	22	2C	2c	NN
10_1101-2021_01_06_425584	141	23	)	)	-RRB-
10_1101-2021_01_06_425584	141	24	.	.	.
10_1101-2021_01_06_425584	142	1	Further	further	RB
10_1101-2021_01_06_425584	142	2	,	,	,
10_1101-2021_01_06_425584	142	3	the	the	DT
10_1101-2021_01_06_425584	142	4	heatmap	heatmap	NN
10_1101-2021_01_06_425584	142	5	visualization	visualization	NN
10_1101-2021_01_06_425584	142	6	of	of	IN
10_1101-2021_01_06_425584	142	7	the	the	DT
10_1101-2021_01_06_425584	142	8	top	top	JJ
10_1101-2021_01_06_425584	142	9	100-modulated	100-modulated	CD
10_1101-2021_01_06_425584	142	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	142	11	exhibited	exhibit	VBD
10_1101-2021_01_06_425584	142	12	the	the	DT
10_1101-2021_01_06_425584	142	13	279	279	CD
10_1101-2021_01_06_425584	142	14	different	different	JJ
10_1101-2021_01_06_425584	142	15	distribution	distribution	NN
10_1101-2021_01_06_425584	142	16	patterns	pattern	NNS
10_1101-2021_01_06_425584	142	17	among	among	IN
10_1101-2021_01_06_425584	142	18	groups	group	NNS
10_1101-2021_01_06_425584	142	19	(	(	-LRB-
10_1101-2021_01_06_425584	142	20	Figure	figure	NN
10_1101-2021_01_06_425584	142	21	2D	2d	NN
10_1101-2021_01_06_425584	142	22	)	)	-RRB-
10_1101-2021_01_06_425584	142	23	.	.	.
10_1101-2021_01_06_425584	143	1	Using	use	VBG
10_1101-2021_01_06_425584	143	2	the	the	DT
10_1101-2021_01_06_425584	143	3	GNPS	gnps	NN
10_1101-2021_01_06_425584	143	4	platform	platform	NN
10_1101-2021_01_06_425584	143	5	for	for	IN
10_1101-2021_01_06_425584	143	6	automatic	automatic	JJ
10_1101-2021_01_06_425584	143	7	280	280	CD
10_1101-2021_01_06_425584	143	8	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	143	9	annotation	annotation	NN
10_1101-2021_01_06_425584	143	10	,	,	,
10_1101-2021_01_06_425584	143	11	106	106	CD
10_1101-2021_01_06_425584	143	12	compounds	compound	NNS
10_1101-2021_01_06_425584	143	13	(	(	-LRB-
10_1101-2021_01_06_425584	143	14	excluding	exclude	VBG
10_1101-2021_01_06_425584	143	15	duplicates	duplicate	NNS
10_1101-2021_01_06_425584	143	16	and	and	CC
10_1101-2021_01_06_425584	143	17	contaminants	contaminant	NNS
10_1101-2021_01_06_425584	143	18	)	)	-RRB-
10_1101-2021_01_06_425584	143	19	were	be	VBD
10_1101-2021_01_06_425584	143	20	putatively	putatively	RB
10_1101-2021_01_06_425584	143	21	281	281	CD
10_1101-2021_01_06_425584	143	22	annotated	annotate	VBN
10_1101-2021_01_06_425584	143	23	with	with	IN
10_1101-2021_01_06_425584	143	24	a	a	DT
10_1101-2021_01_06_425584	143	25	level	level	NN
10_1101-2021_01_06_425584	143	26	2	2	CD
10_1101-2021_01_06_425584	143	27	confidence	confidence	NN
10_1101-2021_01_06_425584	143	28	annotation	annotation	NN
10_1101-2021_01_06_425584	143	29	(	(	-LRB-
10_1101-2021_01_06_425584	143	30	MS2	MS2	NNP
10_1101-2021_01_06_425584	143	31	spectral	spectral	JJ
10_1101-2021_01_06_425584	143	32	match	match	NN
10_1101-2021_01_06_425584	143	33	)	)	-RRB-
10_1101-2021_01_06_425584	143	34	(	(	-LRB-
10_1101-2021_01_06_425584	143	35	Table	table	NN
10_1101-2021_01_06_425584	143	36	S1	s1	NN
10_1101-2021_01_06_425584	143	37	)	)	-RRB-
10_1101-2021_01_06_425584	143	38	in	in	IN
10_1101-2021_01_06_425584	143	39	agreeance	agreeance	NN
10_1101-2021_01_06_425584	143	40	282	282	CD
10_1101-2021_01_06_425584	143	41	with	with	IN
10_1101-2021_01_06_425584	143	42	the	the	DT
10_1101-2021_01_06_425584	143	43	MSI	MSI	NNP
10_1101-2021_01_06_425584	143	44	classification	classification	NN
10_1101-2021_01_06_425584	143	45	(	(	-LRB-
10_1101-2021_01_06_425584	143	46	28	28	CD
10_1101-2021_01_06_425584	143	47	)	)	-RRB-
10_1101-2021_01_06_425584	143	48	.	.	.
10_1101-2021_01_06_425584	144	1	Some	some	DT
10_1101-2021_01_06_425584	144	2	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	144	3	identified	identify	VBN
10_1101-2021_01_06_425584	144	4	by	by	IN
10_1101-2021_01_06_425584	144	5	the	the	DT
10_1101-2021_01_06_425584	144	6	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	144	7	platform	platform	NN
10_1101-2021_01_06_425584	144	8	could	could	MD
10_1101-2021_01_06_425584	144	9	not	not	RB
10_1101-2021_01_06_425584	144	10	be	be	VB
10_1101-2021_01_06_425584	144	11	283	283	CD
10_1101-2021_01_06_425584	144	12	quantified	quantify	VBN
10_1101-2021_01_06_425584	144	13	because	because	IN
10_1101-2021_01_06_425584	144	14	they	-PRON-	PRP
10_1101-2021_01_06_425584	144	15	were	be	VBD
10_1101-2021_01_06_425584	144	16	not	not	RB
10_1101-2021_01_06_425584	144	17	detected	detect	VBN
10_1101-2021_01_06_425584	144	18	by	by	IN
10_1101-2021_01_06_425584	144	19	the	the	DT
10_1101-2021_01_06_425584	144	20	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	144	21	algorithm	algorithm	NN
10_1101-2021_01_06_425584	144	22	during	during	IN
10_1101-2021_01_06_425584	144	23	feature	feature	NN
10_1101-2021_01_06_425584	144	24	area	area	NN
10_1101-2021_01_06_425584	144	25	284	284	CD
10_1101-2021_01_06_425584	144	26	normalization	normalization	NN
10_1101-2021_01_06_425584	144	27	and	and	CC
10_1101-2021_01_06_425584	144	28	quantification	quantification	NN
10_1101-2021_01_06_425584	144	29	.	.	.
10_1101-2021_01_06_425584	145	1	Moreover	moreover	RB
10_1101-2021_01_06_425584	145	2	,	,	,
10_1101-2021_01_06_425584	145	3	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	145	4	Molecular	Molecular	NNP
10_1101-2021_01_06_425584	145	5	Networking	Networking	NNP
10_1101-2021_01_06_425584	145	6	aligned	align	VBD
10_1101-2021_01_06_425584	145	7	the	the	DT
10_1101-2021_01_06_425584	145	8	MS2	MS2	NNP
10_1101-2021_01_06_425584	145	9	-	-	HYPH
10_1101-2021_01_06_425584	145	10	285	285	NNP
10_1101-2021_01_06_425584	145	11	containing	contain	VBG
10_1101-2021_01_06_425584	145	12	features	feature	NNS
10_1101-2021_01_06_425584	145	13	(	(	-LRB-
10_1101-2021_01_06_425584	145	14	n=1,013	n=1,013	NNP
10_1101-2021_01_06_425584	145	15	)	)	-RRB-
10_1101-2021_01_06_425584	145	16	based	base	VBN
10_1101-2021_01_06_425584	145	17	on	on	IN
10_1101-2021_01_06_425584	145	18	their	-PRON-	PRP$
10_1101-2021_01_06_425584	145	19	structural	structural	JJ
10_1101-2021_01_06_425584	145	20	similarity	similarity	NN
10_1101-2021_01_06_425584	145	21	,	,	,
10_1101-2021_01_06_425584	145	22	creating	create	VBG
10_1101-2021_01_06_425584	145	23	118	118	CD
10_1101-2021_01_06_425584	145	24	independent	independent	JJ
10_1101-2021_01_06_425584	145	25	286	286	CD
10_1101-2021_01_06_425584	145	26	networks	network	NNS
10_1101-2021_01_06_425584	145	27	or	or	CC
10_1101-2021_01_06_425584	145	28	clusters	cluster	NNS
10_1101-2021_01_06_425584	145	29	with	with	IN
10_1101-2021_01_06_425584	145	30	at	at	RB
10_1101-2021_01_06_425584	145	31	least	least	RBS
10_1101-2021_01_06_425584	145	32	two	two	CD
10_1101-2021_01_06_425584	145	33	connected	connect	VBN
10_1101-2021_01_06_425584	145	34	nodes	node	NNS
10_1101-2021_01_06_425584	145	35	(	(	-LRB-
10_1101-2021_01_06_425584	145	36	Figure	Figure	NNP
10_1101-2021_01_06_425584	145	37	3A	3a	NN
10_1101-2021_01_06_425584	145	38	)	)	-RRB-
10_1101-2021_01_06_425584	145	39	.	.	.
10_1101-2021_01_06_425584	146	1	The	the	DT
10_1101-2021_01_06_425584	146	2	use	use	NN
10_1101-2021_01_06_425584	146	3	of	of	IN
10_1101-2021_01_06_425584	146	4	MolNetEnhancer	MolNetEnhancer	NNP
10_1101-2021_01_06_425584	146	5	287	287	CD
10_1101-2021_01_06_425584	146	6	.CC	.CC	NFP
10_1101-2021_01_06_425584	146	7	-	-	HYPH
10_1101-2021_01_06_425584	146	8	BY	by	IN
10_1101-2021_01_06_425584	146	9	-	-	HYPH
10_1101-2021_01_06_425584	146	10	NC	NC	NNP
10_1101-2021_01_06_425584	146	11	-	-	HYPH
10_1101-2021_01_06_425584	146	12	ND	ND	NNP
10_1101-2021_01_06_425584	146	13	4.0	4.0	CD
10_1101-2021_01_06_425584	146	14	International	International	NNP
10_1101-2021_01_06_425584	146	15	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	146	16	under	under	IN
10_1101-2021_01_06_425584	146	17	a	a	DT
10_1101-2021_01_06_425584	146	18	(	(	-LRB-
10_1101-2021_01_06_425584	146	19	which	which	WDT
10_1101-2021_01_06_425584	146	20	was	be	VBD
10_1101-2021_01_06_425584	146	21	not	not	RB
10_1101-2021_01_06_425584	146	22	certified	certify	VBN
10_1101-2021_01_06_425584	146	23	by	by	IN
10_1101-2021_01_06_425584	146	24	peer	peer	NN
10_1101-2021_01_06_425584	146	25	review	review	NN
10_1101-2021_01_06_425584	146	26	)	)	-RRB-
10_1101-2021_01_06_425584	146	27	is	be	VBZ
10_1101-2021_01_06_425584	146	28	the	the	DT
10_1101-2021_01_06_425584	146	29	author	author	NN
10_1101-2021_01_06_425584	146	30	/	/	SYM
10_1101-2021_01_06_425584	146	31	funder	funder	NN
10_1101-2021_01_06_425584	146	32	,	,	,
10_1101-2021_01_06_425584	146	33	who	who	WP
10_1101-2021_01_06_425584	146	34	has	have	VBZ
10_1101-2021_01_06_425584	146	35	granted	grant	VBN
10_1101-2021_01_06_425584	146	36	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	146	37	a	a	DT
10_1101-2021_01_06_425584	146	38	license	license	NN
10_1101-2021_01_06_425584	146	39	to	to	TO
10_1101-2021_01_06_425584	146	40	display	display	VB
10_1101-2021_01_06_425584	146	41	the	the	DT
10_1101-2021_01_06_425584	146	42	preprint	preprint	NN
10_1101-2021_01_06_425584	146	43	in	in	IN
10_1101-2021_01_06_425584	146	44	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	146	45	.	.	.
10_1101-2021_01_06_425584	147	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	147	2	is	be	VBZ
10_1101-2021_01_06_425584	147	3	made	make	VBN
10_1101-2021_01_06_425584	147	4	The	the	DT
10_1101-2021_01_06_425584	147	5	copyright	copyright	NN
10_1101-2021_01_06_425584	147	6	holder	holder	NN
10_1101-2021_01_06_425584	147	7	for	for	IN
10_1101-2021_01_06_425584	147	8	this	this	DT
10_1101-2021_01_06_425584	147	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	147	10	version	version	NN
10_1101-2021_01_06_425584	147	11	posted	post	VBD
10_1101-2021_01_06_425584	147	12	January	January	NNP
10_1101-2021_01_06_425584	147	13	8	8	CD
10_1101-2021_01_06_425584	147	14	,	,	,
10_1101-2021_01_06_425584	147	15	2021	2021	CD
10_1101-2021_01_06_425584	147	16	.	.	.
10_1101-2021_01_06_425584	147	17	;	;	:
10_1101-2021_01_06_425584	147	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	147	19	:	:	:
10_1101-2021_01_06_425584	147	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	147	21	preprint	preprint	NN
10_1101-2021_01_06_425584	147	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	147	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	147	24	10	10	CD
10_1101-2021_01_06_425584	147	25	workflow	workflow	NN
10_1101-2021_01_06_425584	147	26	allowed	allow	VBN
10_1101-2021_01_06_425584	147	27	to	to	TO
10_1101-2021_01_06_425584	147	28	putatively	putatively	RB
10_1101-2021_01_06_425584	147	29	identify	identify	VB
10_1101-2021_01_06_425584	147	30	chemical	chemical	NN
10_1101-2021_01_06_425584	147	31	classes	class	NNS
10_1101-2021_01_06_425584	147	32	(	(	-LRB-
10_1101-2021_01_06_425584	147	33	level	level	NN
10_1101-2021_01_06_425584	147	34	3	3	CD
10_1101-2021_01_06_425584	147	35	,	,	,
10_1101-2021_01_06_425584	147	36	MSI	MSI	NNP
10_1101-2021_01_06_425584	147	37	)	)	-RRB-
10_1101-2021_01_06_425584	147	38	for	for	IN
10_1101-2021_01_06_425584	147	39	56	56	CD
10_1101-2021_01_06_425584	147	40	of	of	IN
10_1101-2021_01_06_425584	147	41	the	the	DT
10_1101-2021_01_06_425584	147	42	118	118	CD
10_1101-2021_01_06_425584	147	43	288	288	CD
10_1101-2021_01_06_425584	147	44	independent	independent	JJ
10_1101-2021_01_06_425584	147	45	networks	network	NNS
10_1101-2021_01_06_425584	147	46	.	.	.
10_1101-2021_01_06_425584	148	1	The	the	DT
10_1101-2021_01_06_425584	148	2	top-10	top-10	JJ
10_1101-2021_01_06_425584	148	3	most	most	RBS
10_1101-2021_01_06_425584	148	4	abundant	abundant	JJ
10_1101-2021_01_06_425584	148	5	annotated	annotate	VBN
10_1101-2021_01_06_425584	148	6	chemical	chemical	NN
10_1101-2021_01_06_425584	148	7	classes	class	NNS
10_1101-2021_01_06_425584	148	8	and	and	CC
10_1101-2021_01_06_425584	148	9	associated	associate	VBD
10_1101-2021_01_06_425584	148	10	289	289	CD
10_1101-2021_01_06_425584	148	11	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	148	12	are	be	VBP
10_1101-2021_01_06_425584	148	13	shown	show	VBN
10_1101-2021_01_06_425584	148	14	in	in	IN
10_1101-2021_01_06_425584	148	15	Figure	figure	NN
10_1101-2021_01_06_425584	148	16	3A.	3a.	CD
10_1101-2021_01_06_425584	149	1	Three	three	CD
10_1101-2021_01_06_425584	149	2	-	-	HYPH
10_1101-2021_01_06_425584	149	3	clusters	cluster	NNS
10_1101-2021_01_06_425584	149	4	from	from	IN
10_1101-2021_01_06_425584	149	5	the	the	DT
10_1101-2021_01_06_425584	149	6	network	network	NN
10_1101-2021_01_06_425584	149	7	were	be	VBD
10_1101-2021_01_06_425584	149	8	further	further	RB
10_1101-2021_01_06_425584	149	9	analyzed	analyze	VBN
10_1101-2021_01_06_425584	149	10	290	290	CD
10_1101-2021_01_06_425584	149	11	because	because	IN
10_1101-2021_01_06_425584	149	12	they	-PRON-	PRP
10_1101-2021_01_06_425584	149	13	contained	contain	VBD
10_1101-2021_01_06_425584	149	14	annotated	annotate	VBN
10_1101-2021_01_06_425584	149	15	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	149	16	by	by	IN
10_1101-2021_01_06_425584	149	17	spectral	spectral	JJ
10_1101-2021_01_06_425584	149	18	matching	matching	NN
10_1101-2021_01_06_425584	149	19	,	,	,
10_1101-2021_01_06_425584	149	20	which	which	WDT
10_1101-2021_01_06_425584	149	21	facilitates	facilitate	VBZ
10_1101-2021_01_06_425584	149	22	the	the	DT
10_1101-2021_01_06_425584	149	23	291	291	CD
10_1101-2021_01_06_425584	149	24	annotation	annotation	NN
10_1101-2021_01_06_425584	149	25	of	of	IN
10_1101-2021_01_06_425584	149	26	other	other	JJ
10_1101-2021_01_06_425584	149	27	cluster	cluster	NN
10_1101-2021_01_06_425584	149	28	’s	’s	POS
10_1101-2021_01_06_425584	149	29	nodes	node	NNS
10_1101-2021_01_06_425584	149	30	.	.	.
10_1101-2021_01_06_425584	150	1	Cluster	Cluster	NNP
10_1101-2021_01_06_425584	150	2	1	1	CD
10_1101-2021_01_06_425584	150	3	revealed	reveal	VBD
10_1101-2021_01_06_425584	150	4	two	two	CD
10_1101-2021_01_06_425584	150	5	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	150	6	linked	link	VBN
10_1101-2021_01_06_425584	150	7	to	to	IN
10_1101-2021_01_06_425584	150	8	the	the	DT
10_1101-2021_01_06_425584	150	9	292	292	CD
10_1101-2021_01_06_425584	150	10	organonitrogen	organonitrogen	NNP
10_1101-2021_01_06_425584	150	11	compounds	compound	VBZ
10_1101-2021_01_06_425584	150	12	class	class	NN
10_1101-2021_01_06_425584	150	13	with	with	IN
10_1101-2021_01_06_425584	150	14	reduced	reduce	VBN
10_1101-2021_01_06_425584	150	15	abundance	abundance	NN
10_1101-2021_01_06_425584	150	16	in	in	IN
10_1101-2021_01_06_425584	150	17	the	the	DT
10_1101-2021_01_06_425584	150	18	experimental	experimental	JJ
10_1101-2021_01_06_425584	150	19	group	group	NN
10_1101-2021_01_06_425584	150	20	(	(	-LRB-
10_1101-2021_01_06_425584	150	21	Figure	Figure	NNP
10_1101-2021_01_06_425584	150	22	3B	3b	NN
10_1101-2021_01_06_425584	150	23	)	)	-RRB-
10_1101-2021_01_06_425584	150	24	.	.	.
10_1101-2021_01_06_425584	151	1	293	293	CD
10_1101-2021_01_06_425584	151	2	Library	library	JJ
10_1101-2021_01_06_425584	151	3	spectral	spectral	NN
10_1101-2021_01_06_425584	151	4	match	match	NN
10_1101-2021_01_06_425584	151	5	(	(	-LRB-
10_1101-2021_01_06_425584	151	6	level	level	NN
10_1101-2021_01_06_425584	151	7	2	2	CD
10_1101-2021_01_06_425584	151	8	,	,	,
10_1101-2021_01_06_425584	151	9	MSI	MSI	NNP
10_1101-2021_01_06_425584	151	10	)	)	-RRB-
10_1101-2021_01_06_425584	151	11	suggest	suggest	VBP
10_1101-2021_01_06_425584	151	12	PC(16:0/18:1(9Z	pc(16:0/18:1(9z	CD
10_1101-2021_01_06_425584	151	13	)	)	-RRB-
10_1101-2021_01_06_425584	151	14	)	)	-RRB-
10_1101-2021_01_06_425584	151	15	and	and	CC
10_1101-2021_01_06_425584	151	16	PC(18:0/18:2(9Z,12Z	PC(18:0/18:2(9Z,12Z	NNP
10_1101-2021_01_06_425584	151	17	)	)	-RRB-
10_1101-2021_01_06_425584	151	18	)	)	-RRB-
10_1101-2021_01_06_425584	151	19	as	as	IN
10_1101-2021_01_06_425584	151	20	294	294	CD
10_1101-2021_01_06_425584	151	21	putative	putative	JJ
10_1101-2021_01_06_425584	151	22	candidates	candidate	NNS
10_1101-2021_01_06_425584	151	23	,	,	,
10_1101-2021_01_06_425584	151	24	which	which	WDT
10_1101-2021_01_06_425584	151	25	was	be	VBD
10_1101-2021_01_06_425584	151	26	supported	support	VBN
10_1101-2021_01_06_425584	151	27	by	by	IN
10_1101-2021_01_06_425584	151	28	MS2LDA	MS2LDA	NNP
10_1101-2021_01_06_425584	151	29	phosphocholine	phosphocholine	NN
10_1101-2021_01_06_425584	151	30	-	-	HYPH
10_1101-2021_01_06_425584	151	31	substructure	substructure	NN
10_1101-2021_01_06_425584	151	32	recognition	recognition	NN
10_1101-2021_01_06_425584	151	33	295	295	CD
10_1101-2021_01_06_425584	151	34	(	(	-LRB-
10_1101-2021_01_06_425584	151	35	Figure	figure	NN
10_1101-2021_01_06_425584	151	36	3C	3c	NN
10_1101-2021_01_06_425584	151	37	)	)	-RRB-
10_1101-2021_01_06_425584	151	38	.	.	.
10_1101-2021_01_06_425584	152	1	In	in	IN
10_1101-2021_01_06_425584	152	2	cluster	cluster	NN
10_1101-2021_01_06_425584	152	3	2	2	CD
10_1101-2021_01_06_425584	152	4	,	,	,
10_1101-2021_01_06_425584	152	5	glutathione	glutathione	NN
10_1101-2021_01_06_425584	152	6	-	-	HYPH
10_1101-2021_01_06_425584	152	7	based	base	VBN
10_1101-2021_01_06_425584	152	8	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	152	9	(	(	-LRB-
10_1101-2021_01_06_425584	152	10	MSI	MSI	NNP
10_1101-2021_01_06_425584	152	11	level	level	NN
10_1101-2021_01_06_425584	152	12	3	3	CD
10_1101-2021_01_06_425584	152	13	)	)	-RRB-
10_1101-2021_01_06_425584	152	14	were	be	VBD
10_1101-2021_01_06_425584	152	15	detected	detect	VBN
10_1101-2021_01_06_425584	152	16	through	through	IN
10_1101-2021_01_06_425584	152	17	296	296	CD
10_1101-2021_01_06_425584	152	18	fragments	fragment	NNS
10_1101-2021_01_06_425584	152	19	m	m	NN
10_1101-2021_01_06_425584	152	20	/	/	SYM
10_1101-2021_01_06_425584	152	21	z	z	NNP
10_1101-2021_01_06_425584	152	22	308.0925	308.0925	NN
10_1101-2021_01_06_425584	152	23	,	,	,
10_1101-2021_01_06_425584	152	24	233.0575	233.0575	CD
10_1101-2021_01_06_425584	152	25	,	,	,
10_1101-2021_01_06_425584	152	26	179.0475	179.0475	UH
10_1101-2021_01_06_425584	152	27	,	,	,
10_1101-2021_01_06_425584	152	28	and	and	CC
10_1101-2021_01_06_425584	152	29	162.0225	162.0225	NN
10_1101-2021_01_06_425584	152	30	retrieved	retrieve	VBN
10_1101-2021_01_06_425584	152	31	by	by	IN
10_1101-2021_01_06_425584	152	32	the	the	DT
10_1101-2021_01_06_425584	152	33	M2M_453	M2M_453	NNP
10_1101-2021_01_06_425584	152	34	297	297	CD
10_1101-2021_01_06_425584	152	35	substructure	substructure	NN
10_1101-2021_01_06_425584	152	36	and	and	CC
10_1101-2021_01_06_425584	152	37	associated	associate	VBN
10_1101-2021_01_06_425584	152	38	with	with	IN
10_1101-2021_01_06_425584	152	39	glutathione	glutathione	NN
10_1101-2021_01_06_425584	152	40	structure	structure	NN
10_1101-2021_01_06_425584	152	41	using	use	VBG
10_1101-2021_01_06_425584	152	42	mzCloud	mzCloud	NNP
10_1101-2021_01_06_425584	152	43	in	in	IN
10_1101-2021_01_06_425584	152	44	silico	silico	NN
10_1101-2021_01_06_425584	152	45	predictions	prediction	NNS
10_1101-2021_01_06_425584	152	46	(	(	-LRB-
10_1101-2021_01_06_425584	152	47	Figure	Figure	NNP
10_1101-2021_01_06_425584	152	48	298	298	CD
10_1101-2021_01_06_425584	152	49	4A	4A	NNS
10_1101-2021_01_06_425584	152	50	)	)	-RRB-
10_1101-2021_01_06_425584	152	51	.	.	.
10_1101-2021_01_06_425584	153	1	The	the	DT
10_1101-2021_01_06_425584	153	2	precursor	precursor	NN
10_1101-2021_01_06_425584	153	3	ion	ion	NN
10_1101-2021_01_06_425584	153	4	at	at	IN
10_1101-2021_01_06_425584	153	5	m	m	NNP
10_1101-2021_01_06_425584	153	6	/	/	SYM
10_1101-2021_01_06_425584	153	7	z	z	NNP
10_1101-2021_01_06_425584	153	8	713.1472	713.1472	NN
10_1101-2021_01_06_425584	153	9	and	and	CC
10_1101-2021_01_06_425584	153	10	glutathione	glutathione	NN
10_1101-2021_01_06_425584	153	11	(	(	-LRB-
10_1101-2021_01_06_425584	153	12	annotated	annotate	VBN
10_1101-2021_01_06_425584	153	13	at	at	IN
10_1101-2021_01_06_425584	153	14	level	level	NN
10_1101-2021_01_06_425584	153	15	2	2	CD
10_1101-2021_01_06_425584	153	16	,	,	,
10_1101-2021_01_06_425584	153	17	MSI	MSI	NNP
10_1101-2021_01_06_425584	153	18	)	)	-RRB-
10_1101-2021_01_06_425584	153	19	were	be	VBD
10_1101-2021_01_06_425584	153	20	detected	detect	VBN
10_1101-2021_01_06_425584	153	21	299	299	CD
10_1101-2021_01_06_425584	153	22	with	with	IN
10_1101-2021_01_06_425584	153	23	increased	increase	VBN
10_1101-2021_01_06_425584	153	24	abundance	abundance	NN
10_1101-2021_01_06_425584	153	25	in	in	IN
10_1101-2021_01_06_425584	153	26	the	the	DT
10_1101-2021_01_06_425584	153	27	experimental	experimental	JJ
10_1101-2021_01_06_425584	153	28	group	group	NN
10_1101-2021_01_06_425584	153	29	.	.	.
10_1101-2021_01_06_425584	154	1	MS2LDA	MS2LDA	NNP
10_1101-2021_01_06_425584	154	2	visualization	visualization	NNP
10_1101-2021_01_06_425584	154	3	,	,	,
10_1101-2021_01_06_425584	154	4	at	at	IN
10_1101-2021_01_06_425584	154	5	the	the	DT
10_1101-2021_01_06_425584	154	6	M2	M2	NNP
10_1101-2021_01_06_425584	154	7	M	M	NNP
10_1101-2021_01_06_425584	154	8	level	level	NN
10_1101-2021_01_06_425584	154	9	,	,	,
10_1101-2021_01_06_425584	154	10	300	300	CD
10_1101-2021_01_06_425584	154	11	correlated	correlate	VBD
10_1101-2021_01_06_425584	154	12	with	with	IN
10_1101-2021_01_06_425584	154	13	the	the	DT
10_1101-2021_01_06_425584	154	14	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	154	15	molecular	molecular	JJ
10_1101-2021_01_06_425584	154	16	networking	networking	NN
10_1101-2021_01_06_425584	154	17	clustering	clustering	NN
10_1101-2021_01_06_425584	154	18	(	(	-LRB-
10_1101-2021_01_06_425584	154	19	Figure	figure	NN
10_1101-2021_01_06_425584	154	20	4B	4b	NN
10_1101-2021_01_06_425584	154	21	)	)	-RRB-
10_1101-2021_01_06_425584	154	22	.	.	.
10_1101-2021_01_06_425584	155	1	In	in	IN
10_1101-2021_01_06_425584	155	2	cluster	cluster	NN
10_1101-2021_01_06_425584	155	3	3	3	CD
10_1101-2021_01_06_425584	155	4	,	,	,
10_1101-2021_01_06_425584	155	5	various	various	JJ
10_1101-2021_01_06_425584	155	6	301	301	CD
10_1101-2021_01_06_425584	155	7	phenylalanine	phenylalanine	NN
10_1101-2021_01_06_425584	155	8	-	-	HYPH
10_1101-2021_01_06_425584	155	9	based	base	VBN
10_1101-2021_01_06_425584	155	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	155	11	were	be	VBD
10_1101-2021_01_06_425584	155	12	putatively	putatively	RB
10_1101-2021_01_06_425584	155	13	annotated	annotate	VBN
10_1101-2021_01_06_425584	155	14	aided	aid	VBN
10_1101-2021_01_06_425584	155	15	by	by	IN
10_1101-2021_01_06_425584	155	16	MS2LDA	ms2lda	NN
10_1101-2021_01_06_425584	155	17	substructure	substructure	VBP
10_1101-2021_01_06_425584	155	18	302	302	CD
10_1101-2021_01_06_425584	155	19	recognition	recognition	NN
10_1101-2021_01_06_425584	155	20	(	(	-LRB-
10_1101-2021_01_06_425584	155	21	Figure	figure	NN
10_1101-2021_01_06_425584	155	22	4C	4c	NN
10_1101-2021_01_06_425584	155	23	and	and	CC
10_1101-2021_01_06_425584	155	24	4D	4d	NN
10_1101-2021_01_06_425584	155	25	)	)	-RRB-
10_1101-2021_01_06_425584	155	26	.	.	.
10_1101-2021_01_06_425584	156	1	Within	within	IN
10_1101-2021_01_06_425584	156	2	this	this	DT
10_1101-2021_01_06_425584	156	3	cluster	cluster	NN
10_1101-2021_01_06_425584	156	4	,	,	,
10_1101-2021_01_06_425584	156	5	glutamyl	glutamyl	NNP
10_1101-2021_01_06_425584	156	6	-	-	HYPH
10_1101-2021_01_06_425584	156	7	phenylalanine	phenylalanine	NNP
10_1101-2021_01_06_425584	156	8	(	(	-LRB-
10_1101-2021_01_06_425584	156	9	annotated	annotate	VBN
10_1101-2021_01_06_425584	156	10	at	at	IN
10_1101-2021_01_06_425584	156	11	level	level	NN
10_1101-2021_01_06_425584	156	12	2	2	CD
10_1101-2021_01_06_425584	156	13	,	,	,
10_1101-2021_01_06_425584	156	14	303	303	CD
10_1101-2021_01_06_425584	156	15	MSI	MSI	NNP
10_1101-2021_01_06_425584	156	16	)	)	-RRB-
10_1101-2021_01_06_425584	156	17	and	and	CC
10_1101-2021_01_06_425584	156	18	the	the	DT
10_1101-2021_01_06_425584	156	19	precursor	precursor	NN
10_1101-2021_01_06_425584	156	20	ions	ion	NNS
10_1101-2021_01_06_425584	156	21	at	at	IN
10_1101-2021_01_06_425584	156	22	m	m	NNP
10_1101-2021_01_06_425584	156	23	/	/	SYM
10_1101-2021_01_06_425584	156	24	z	z	NNP
10_1101-2021_01_06_425584	156	25	297.1802	297.1802	NN
10_1101-2021_01_06_425584	156	26	and	and	CC
10_1101-2021_01_06_425584	156	27	487.1548	487.1548	NN
10_1101-2021_01_06_425584	156	28	presented	present	VBD
10_1101-2021_01_06_425584	156	29	with	with	IN
10_1101-2021_01_06_425584	156	30	increased	increase	VBN
10_1101-2021_01_06_425584	156	31	abundance	abundance	NN
10_1101-2021_01_06_425584	156	32	304	304	CD
10_1101-2021_01_06_425584	156	33	in	in	IN
10_1101-2021_01_06_425584	156	34	the	the	DT
10_1101-2021_01_06_425584	156	35	experimental	experimental	NNP
10_1101-2021_01_06_425584	156	36	vs.	vs.	FW
10_1101-2021_01_06_425584	156	37	control	control	NNP
10_1101-2021_01_06_425584	156	38	group	group	NNP
10_1101-2021_01_06_425584	156	39	.	.	.
10_1101-2021_01_06_425584	157	1	On	on	IN
10_1101-2021_01_06_425584	157	2	the	the	DT
10_1101-2021_01_06_425584	157	3	other	other	JJ
10_1101-2021_01_06_425584	157	4	hand	hand	NN
10_1101-2021_01_06_425584	157	5	,	,	,
10_1101-2021_01_06_425584	157	6	various	various	JJ
10_1101-2021_01_06_425584	157	7	aminoacids	aminoacid	NNS
10_1101-2021_01_06_425584	157	8	were	be	VBD
10_1101-2021_01_06_425584	157	9	annotated	annotate	VBN
10_1101-2021_01_06_425584	157	10	305	305	CD
10_1101-2021_01_06_425584	157	11	(	(	-LRB-
10_1101-2021_01_06_425584	157	12	level	level	NN
10_1101-2021_01_06_425584	157	13	2	2	CD
10_1101-2021_01_06_425584	157	14	,	,	,
10_1101-2021_01_06_425584	157	15	MSI	MSI	NNP
10_1101-2021_01_06_425584	157	16	)	)	-RRB-
10_1101-2021_01_06_425584	157	17	by	by	IN
10_1101-2021_01_06_425584	157	18	GNPS	gnps	NN
10_1101-2021_01_06_425584	157	19	spectral	spectral	NN
10_1101-2021_01_06_425584	157	20	matching	matching	NN
10_1101-2021_01_06_425584	157	21	and	and	CC
10_1101-2021_01_06_425584	157	22	manual	manual	JJ
10_1101-2021_01_06_425584	157	23	inspection	inspection	NN
10_1101-2021_01_06_425584	157	24	of	of	IN
10_1101-2021_01_06_425584	157	25	data	datum	NNS
10_1101-2021_01_06_425584	157	26	(	(	-LRB-
10_1101-2021_01_06_425584	157	27	Table	table	NN
10_1101-2021_01_06_425584	157	28	S2	S2	NNP
10_1101-2021_01_06_425584	157	29	)	)	-RRB-
10_1101-2021_01_06_425584	157	30	.	.	.
10_1101-2021_01_06_425584	158	1	Threonine	Threonine	NNP
10_1101-2021_01_06_425584	158	2	,	,	,
10_1101-2021_01_06_425584	158	3	306	306	CD
10_1101-2021_01_06_425584	158	4	valine	valine	NN
10_1101-2021_01_06_425584	158	5	,	,	,
10_1101-2021_01_06_425584	158	6	proline	proline	NN
10_1101-2021_01_06_425584	158	7	,	,	,
10_1101-2021_01_06_425584	158	8	leucine	leucine	NNP
10_1101-2021_01_06_425584	158	9	,	,	,
10_1101-2021_01_06_425584	158	10	serine	serine	NNP
10_1101-2021_01_06_425584	158	11	,	,	,
10_1101-2021_01_06_425584	158	12	glutamic	glutamic	JJ
10_1101-2021_01_06_425584	158	13	acid	acid	NN
10_1101-2021_01_06_425584	158	14	,	,	,
10_1101-2021_01_06_425584	158	15	methionine	methionine	NNP
10_1101-2021_01_06_425584	158	16	,	,	,
10_1101-2021_01_06_425584	158	17	and	and	CC
10_1101-2021_01_06_425584	158	18	tyrosine	tyrosine	NN
10_1101-2021_01_06_425584	158	19	presented	present	VBN
10_1101-2021_01_06_425584	158	20	increased	increase	VBD
10_1101-2021_01_06_425584	158	21	307	307	CD
10_1101-2021_01_06_425584	158	22	abundance	abundance	NN
10_1101-2021_01_06_425584	158	23	(	(	-LRB-
10_1101-2021_01_06_425584	158	24	fold	fold	VB
10_1101-2021_01_06_425584	158	25	change	change	NN
10_1101-2021_01_06_425584	158	26	range	range	NNP
10_1101-2021_01_06_425584	158	27	1.3	1.3	CD
10_1101-2021_01_06_425584	158	28	-	-	SYM
10_1101-2021_01_06_425584	158	29	1.7	1.7	CD
10_1101-2021_01_06_425584	158	30	,	,	,
10_1101-2021_01_06_425584	158	31	p<0.05	p<0.05	JJ
10_1101-2021_01_06_425584	158	32	)	)	-RRB-
10_1101-2021_01_06_425584	158	33	in	in	IN
10_1101-2021_01_06_425584	158	34	the	the	DT
10_1101-2021_01_06_425584	158	35	experimental	experimental	NNP
10_1101-2021_01_06_425584	158	36	vs.	vs.	FW
10_1101-2021_01_06_425584	158	37	control	control	NNP
10_1101-2021_01_06_425584	158	38	group	group	NNP
10_1101-2021_01_06_425584	158	39	.	.	.
10_1101-2021_01_06_425584	159	1	Particularly	particularly	RB
10_1101-2021_01_06_425584	159	2	,	,	,
10_1101-2021_01_06_425584	159	3	308	308	CD
10_1101-2021_01_06_425584	159	4	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	159	5	linked	link	VBN
10_1101-2021_01_06_425584	159	6	to	to	IN
10_1101-2021_01_06_425584	159	7	the	the	DT
10_1101-2021_01_06_425584	159	8	catabolism	catabolism	NN
10_1101-2021_01_06_425584	159	9	of	of	IN
10_1101-2021_01_06_425584	159	10	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	159	11	via	via	IN
10_1101-2021_01_06_425584	159	12	the	the	DT
10_1101-2021_01_06_425584	159	13	serotonin	serotonin	NNP
10_1101-2021_01_06_425584	159	14	and	and	CC
10_1101-2021_01_06_425584	159	15	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	159	16	pathway	pathway	NNP
10_1101-2021_01_06_425584	159	17	(	(	-LRB-
10_1101-2021_01_06_425584	159	18	39	39	CD
10_1101-2021_01_06_425584	159	19	)	)	-RRB-
10_1101-2021_01_06_425584	159	20	309	309	CD
10_1101-2021_01_06_425584	159	21	were	be	VBD
10_1101-2021_01_06_425584	159	22	annotated	annotate	VBN
10_1101-2021_01_06_425584	159	23	(	(	-LRB-
10_1101-2021_01_06_425584	159	24	level	level	NN
10_1101-2021_01_06_425584	159	25	2	2	CD
10_1101-2021_01_06_425584	159	26	,	,	,
10_1101-2021_01_06_425584	159	27	MSI	MSI	NNP
10_1101-2021_01_06_425584	159	28	)	)	-RRB-
10_1101-2021_01_06_425584	159	29	,	,	,
10_1101-2021_01_06_425584	159	30	including	include	VBG
10_1101-2021_01_06_425584	159	31	melatonin	melatonin	NNP
10_1101-2021_01_06_425584	159	32	,	,	,
10_1101-2021_01_06_425584	159	33	acetyl	acetyl	NNP
10_1101-2021_01_06_425584	159	34	serotonin	serotonin	NN
10_1101-2021_01_06_425584	159	35	,	,	,
10_1101-2021_01_06_425584	159	36	and	and	CC
10_1101-2021_01_06_425584	159	37	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	159	38	(	(	-LRB-
10_1101-2021_01_06_425584	159	39	Table	table	NN
10_1101-2021_01_06_425584	159	40	S1	S1	NNP
10_1101-2021_01_06_425584	159	41	)	)	-RRB-
10_1101-2021_01_06_425584	159	42	.	.	.
10_1101-2021_01_06_425584	160	1	310	310	CD
10_1101-2021_01_06_425584	160	2	However	however	RB
10_1101-2021_01_06_425584	160	3	,	,	,
10_1101-2021_01_06_425584	160	4	only	only	RB
10_1101-2021_01_06_425584	160	5	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	160	6	was	be	VBD
10_1101-2021_01_06_425584	160	7	significantly	significantly	RB
10_1101-2021_01_06_425584	160	8	elevated	elevate	VBN
10_1101-2021_01_06_425584	160	9	in	in	IN
10_1101-2021_01_06_425584	160	10	the	the	DT
10_1101-2021_01_06_425584	160	11	experimental	experimental	JJ
10_1101-2021_01_06_425584	160	12	group	group	NN
10_1101-2021_01_06_425584	160	13	.	.	.
10_1101-2021_01_06_425584	161	1	The	the	DT
10_1101-2021_01_06_425584	161	2	full	full	JJ
10_1101-2021_01_06_425584	161	3	list	list	NN
10_1101-2021_01_06_425584	161	4	of	of	IN
10_1101-2021_01_06_425584	161	5	311	311	CD
10_1101-2021_01_06_425584	161	6	annotated	annotate	VBN
10_1101-2021_01_06_425584	161	7	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	161	8	,	,	,
10_1101-2021_01_06_425584	161	9	differential	differential	NN
10_1101-2021_01_06_425584	161	10	abundances	abundance	NNS
10_1101-2021_01_06_425584	161	11	and	and	CC
10_1101-2021_01_06_425584	161	12	another	another	DT
10_1101-2021_01_06_425584	161	13	relevant	relevant	JJ
10_1101-2021_01_06_425584	161	14	feature	feature	NN
10_1101-2021_01_06_425584	161	15	information	information	NN
10_1101-2021_01_06_425584	161	16	is	be	VBZ
10_1101-2021_01_06_425584	161	17	shown	show	VBN
10_1101-2021_01_06_425584	161	18	312	312	CD
10_1101-2021_01_06_425584	161	19	in	in	IN
10_1101-2021_01_06_425584	161	20	Table	Table	NNP
10_1101-2021_01_06_425584	161	21	S2	S2	NNP
10_1101-2021_01_06_425584	161	22	.	.	.
10_1101-2021_01_06_425584	162	1	313	313	CD
10_1101-2021_01_06_425584	162	2	314	314	CD
10_1101-2021_01_06_425584	162	3	Peptidomics	Peptidomics	NNP
10_1101-2021_01_06_425584	162	4	315	315	CD
10_1101-2021_01_06_425584	162	5	Experimental	Experimental	NNP
10_1101-2021_01_06_425584	162	6	and	and	CC
10_1101-2021_01_06_425584	162	7	control	control	NN
10_1101-2021_01_06_425584	162	8	datasets	dataset	NNS
10_1101-2021_01_06_425584	162	9	were	be	VBD
10_1101-2021_01_06_425584	162	10	analyzed	analyze	VBN
10_1101-2021_01_06_425584	162	11	separately	separately	RB
10_1101-2021_01_06_425584	162	12	to	to	TO
10_1101-2021_01_06_425584	162	13	identify	identify	VB
10_1101-2021_01_06_425584	162	14	the	the	DT
10_1101-2021_01_06_425584	162	15	peptides	peptide	NNS
10_1101-2021_01_06_425584	162	16	and	and	CC
10_1101-2021_01_06_425584	162	17	their	-PRON-	PRP$
10_1101-2021_01_06_425584	162	18	316	316	CD
10_1101-2021_01_06_425584	162	19	biological	biological	JJ
10_1101-2021_01_06_425584	162	20	modifications	modification	NNS
10_1101-2021_01_06_425584	162	21	.	.	.
10_1101-2021_01_06_425584	163	1	The	the	DT
10_1101-2021_01_06_425584	163	2	complete	complete	JJ
10_1101-2021_01_06_425584	163	3	list	list	NN
10_1101-2021_01_06_425584	163	4	of	of	IN
10_1101-2021_01_06_425584	163	5	peptides	peptide	NNS
10_1101-2021_01_06_425584	163	6	identified	identify	VBN
10_1101-2021_01_06_425584	163	7	by	by	IN
10_1101-2021_01_06_425584	163	8	ProteinPilot	ProteinPilot	NNP
10_1101-2021_01_06_425584	163	9	between	between	IN
10_1101-2021_01_06_425584	163	10	the	the	DT
10_1101-2021_01_06_425584	163	11	317	317	CD
10_1101-2021_01_06_425584	163	12	experimental	experimental	JJ
10_1101-2021_01_06_425584	163	13	and	and	CC
10_1101-2021_01_06_425584	163	14	control	control	NN
10_1101-2021_01_06_425584	163	15	groups	group	NNS
10_1101-2021_01_06_425584	163	16	are	be	VBP
10_1101-2021_01_06_425584	163	17	described	describe	VBN
10_1101-2021_01_06_425584	163	18	in	in	IN
10_1101-2021_01_06_425584	163	19	Table	Table	NNP
10_1101-2021_01_06_425584	163	20	S3	S3	NNP
10_1101-2021_01_06_425584	163	21	.	.	.
10_1101-2021_01_06_425584	164	1	Proline	proline	JJ
10_1101-2021_01_06_425584	164	2	oxidation	oxidation	NN
10_1101-2021_01_06_425584	164	3	was	be	VBD
10_1101-2021_01_06_425584	164	4	the	the	DT
10_1101-2021_01_06_425584	164	5	most	most	RBS
10_1101-2021_01_06_425584	164	6	318	318	CD
10_1101-2021_01_06_425584	164	7	frequent	frequent	JJ
10_1101-2021_01_06_425584	164	8	biological	biological	JJ
10_1101-2021_01_06_425584	164	9	modification	modification	NN
10_1101-2021_01_06_425584	164	10	detected	detect	VBN
10_1101-2021_01_06_425584	164	11	in	in	IN
10_1101-2021_01_06_425584	164	12	the	the	DT
10_1101-2021_01_06_425584	164	13	experimental	experimental	JJ
10_1101-2021_01_06_425584	164	14	group	group	NN
10_1101-2021_01_06_425584	164	15	datasets	dataset	NNS
10_1101-2021_01_06_425584	164	16	.	.	.
10_1101-2021_01_06_425584	165	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	165	2	identified	identify	VBD
10_1101-2021_01_06_425584	165	3	8	8	CD
10_1101-2021_01_06_425584	165	4	and	and	CC
10_1101-2021_01_06_425584	165	5	319	319	CD
10_1101-2021_01_06_425584	165	6	12	12	CD
10_1101-2021_01_06_425584	165	7	peptides	peptide	NNS
10_1101-2021_01_06_425584	165	8	with	with	IN
10_1101-2021_01_06_425584	165	9	a	a	DT
10_1101-2021_01_06_425584	165	10	confidence	confidence	NN
10_1101-2021_01_06_425584	165	11	of	of	IN
10_1101-2021_01_06_425584	165	12	>	>	XX
10_1101-2021_01_06_425584	165	13	90	90	CD
10_1101-2021_01_06_425584	165	14	%	%	NN
10_1101-2021_01_06_425584	165	15	in	in	IN
10_1101-2021_01_06_425584	165	16	the	the	DT
10_1101-2021_01_06_425584	165	17	control	control	NN
10_1101-2021_01_06_425584	165	18	and	and	CC
10_1101-2021_01_06_425584	165	19	experimental	experimental	JJ
10_1101-2021_01_06_425584	165	20	group	group	NN
10_1101-2021_01_06_425584	165	21	,	,	,
10_1101-2021_01_06_425584	165	22	respectively	respectively	RB
10_1101-2021_01_06_425584	165	23	.	.	.
10_1101-2021_01_06_425584	166	1	320	320	CD
10_1101-2021_01_06_425584	166	2	Differential	differential	JJ
10_1101-2021_01_06_425584	166	3	abundance	abundance	NN
10_1101-2021_01_06_425584	166	4	of	of	IN
10_1101-2021_01_06_425584	166	5	2	2	CD
10_1101-2021_01_06_425584	166	6	proline	proline	JJ
10_1101-2021_01_06_425584	166	7	-	-	HYPH
10_1101-2021_01_06_425584	166	8	rich	rich	JJ
10_1101-2021_01_06_425584	166	9	peptides	peptide	NNS
10_1101-2021_01_06_425584	166	10	was	be	VBD
10_1101-2021_01_06_425584	166	11	observed	observe	VBN
10_1101-2021_01_06_425584	166	12	in	in	IN
10_1101-2021_01_06_425584	166	13	the	the	DT
10_1101-2021_01_06_425584	166	14	experimental	experimental	JJ
10_1101-2021_01_06_425584	166	15	group	group	NN
10_1101-2021_01_06_425584	166	16	321	321	CD
10_1101-2021_01_06_425584	166	17	.CC	.CC	,
10_1101-2021_01_06_425584	166	18	-	-	HYPH
10_1101-2021_01_06_425584	166	19	BY	by	IN
10_1101-2021_01_06_425584	166	20	-	-	HYPH
10_1101-2021_01_06_425584	166	21	NC	NC	NNP
10_1101-2021_01_06_425584	166	22	-	-	HYPH
10_1101-2021_01_06_425584	166	23	ND	ND	NNP
10_1101-2021_01_06_425584	166	24	4.0	4.0	CD
10_1101-2021_01_06_425584	166	25	International	International	NNP
10_1101-2021_01_06_425584	166	26	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	166	27	under	under	IN
10_1101-2021_01_06_425584	166	28	a	a	DT
10_1101-2021_01_06_425584	166	29	(	(	-LRB-
10_1101-2021_01_06_425584	166	30	which	which	WDT
10_1101-2021_01_06_425584	166	31	was	be	VBD
10_1101-2021_01_06_425584	166	32	not	not	RB
10_1101-2021_01_06_425584	166	33	certified	certify	VBN
10_1101-2021_01_06_425584	166	34	by	by	IN
10_1101-2021_01_06_425584	166	35	peer	peer	NN
10_1101-2021_01_06_425584	166	36	review	review	NN
10_1101-2021_01_06_425584	166	37	)	)	-RRB-
10_1101-2021_01_06_425584	166	38	is	be	VBZ
10_1101-2021_01_06_425584	166	39	the	the	DT
10_1101-2021_01_06_425584	166	40	author	author	NN
10_1101-2021_01_06_425584	166	41	/	/	SYM
10_1101-2021_01_06_425584	166	42	funder	funder	NN
10_1101-2021_01_06_425584	166	43	,	,	,
10_1101-2021_01_06_425584	166	44	who	who	WP
10_1101-2021_01_06_425584	166	45	has	have	VBZ
10_1101-2021_01_06_425584	166	46	granted	grant	VBN
10_1101-2021_01_06_425584	166	47	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	166	48	a	a	DT
10_1101-2021_01_06_425584	166	49	license	license	NN
10_1101-2021_01_06_425584	166	50	to	to	TO
10_1101-2021_01_06_425584	166	51	display	display	VB
10_1101-2021_01_06_425584	166	52	the	the	DT
10_1101-2021_01_06_425584	166	53	preprint	preprint	NN
10_1101-2021_01_06_425584	166	54	in	in	IN
10_1101-2021_01_06_425584	166	55	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	166	56	.	.	.
10_1101-2021_01_06_425584	167	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	167	2	is	be	VBZ
10_1101-2021_01_06_425584	167	3	made	make	VBN
10_1101-2021_01_06_425584	167	4	The	the	DT
10_1101-2021_01_06_425584	167	5	copyright	copyright	NN
10_1101-2021_01_06_425584	167	6	holder	holder	NN
10_1101-2021_01_06_425584	167	7	for	for	IN
10_1101-2021_01_06_425584	167	8	this	this	DT
10_1101-2021_01_06_425584	167	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	167	10	version	version	NN
10_1101-2021_01_06_425584	167	11	posted	post	VBD
10_1101-2021_01_06_425584	167	12	January	January	NNP
10_1101-2021_01_06_425584	167	13	8	8	CD
10_1101-2021_01_06_425584	167	14	,	,	,
10_1101-2021_01_06_425584	167	15	2021	2021	CD
10_1101-2021_01_06_425584	167	16	.	.	.
10_1101-2021_01_06_425584	167	17	;	;	:
10_1101-2021_01_06_425584	167	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	167	19	:	:	:
10_1101-2021_01_06_425584	167	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	167	21	preprint	preprint	NN
10_1101-2021_01_06_425584	167	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	167	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	167	24	11	11	CD
10_1101-2021_01_06_425584	167	25	compared	compare	VBN
10_1101-2021_01_06_425584	167	26	to	to	IN
10_1101-2021_01_06_425584	167	27	the	the	DT
10_1101-2021_01_06_425584	167	28	control	control	NN
10_1101-2021_01_06_425584	167	29	group	group	NN
10_1101-2021_01_06_425584	167	30	.	.	.
10_1101-2021_01_06_425584	168	1	An	an	DT
10_1101-2021_01_06_425584	168	2	additional	additional	JJ
10_1101-2021_01_06_425584	168	3	tripeptide	tripeptide	NN
10_1101-2021_01_06_425584	168	4	was	be	VBD
10_1101-2021_01_06_425584	168	5	manually	manually	RB
10_1101-2021_01_06_425584	168	6	annotated	annotate	VBN
10_1101-2021_01_06_425584	168	7	with	with	IN
10_1101-2021_01_06_425584	168	8	a	a	DT
10_1101-2021_01_06_425584	168	9	LPP	LPP	NNP
10_1101-2021_01_06_425584	168	10	322	322	CD
10_1101-2021_01_06_425584	168	11	sequence	sequence	NN
10_1101-2021_01_06_425584	168	12	(	(	-LRB-
10_1101-2021_01_06_425584	168	13	Table	Table	NNP
10_1101-2021_01_06_425584	168	14	S4	S4	NNP
10_1101-2021_01_06_425584	168	15	)	)	-RRB-
10_1101-2021_01_06_425584	168	16	.	.	.
10_1101-2021_01_06_425584	169	1	323	323	CD
10_1101-2021_01_06_425584	169	2	324	324	CD
10_1101-2021_01_06_425584	169	3	Proteomics	Proteomics	NNP
10_1101-2021_01_06_425584	169	4	325	325	CD
10_1101-2021_01_06_425584	169	5	The	the	DT
10_1101-2021_01_06_425584	169	6	re	re	NN
10_1101-2021_01_06_425584	169	7	-	-	NN
10_1101-2021_01_06_425584	169	8	analysis	analysis	NN
10_1101-2021_01_06_425584	169	9	of	of	IN
10_1101-2021_01_06_425584	169	10	the	the	DT
10_1101-2021_01_06_425584	169	11	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	169	12	data	datum	NNS
10_1101-2021_01_06_425584	169	13	(	(	-LRB-
10_1101-2021_01_06_425584	169	14	PXD013643	PXD013643	NNP
10_1101-2021_01_06_425584	169	15	dataset	dataset	NNP
10_1101-2021_01_06_425584	169	16	)	)	-RRB-
10_1101-2021_01_06_425584	169	17	facilitated	facilitate	VBD
10_1101-2021_01_06_425584	169	18	the	the	DT
10_1101-2021_01_06_425584	169	19	identification	identification	NN
10_1101-2021_01_06_425584	169	20	of	of	IN
10_1101-2021_01_06_425584	169	21	952	952	CD
10_1101-2021_01_06_425584	169	22	326	326	CD
10_1101-2021_01_06_425584	169	23	quantifiable	quantifiable	JJ
10_1101-2021_01_06_425584	169	24	proteins	protein	NNS
10_1101-2021_01_06_425584	169	25	(	(	-LRB-
10_1101-2021_01_06_425584	169	26	717	717	CD
10_1101-2021_01_06_425584	169	27	proteins	protein	NNS
10_1101-2021_01_06_425584	169	28	with	with	IN
10_1101-2021_01_06_425584	169	29	at	at	RB
10_1101-2021_01_06_425584	169	30	least	least	RBS
10_1101-2021_01_06_425584	169	31	2	2	CD
10_1101-2021_01_06_425584	169	32	unique	unique	JJ
10_1101-2021_01_06_425584	169	33	peptides	peptide	NNS
10_1101-2021_01_06_425584	169	34	,	,	,
10_1101-2021_01_06_425584	169	35	1	1	CD
10_1101-2021_01_06_425584	169	36	%	%	NN
10_1101-2021_01_06_425584	169	37	false	false	JJ
10_1101-2021_01_06_425584	169	38	discovery	discovery	NN
10_1101-2021_01_06_425584	169	39	rate	rate	NN
10_1101-2021_01_06_425584	169	40	)	)	-RRB-
10_1101-2021_01_06_425584	169	41	and	and	CC
10_1101-2021_01_06_425584	169	42	327	327	CD
10_1101-2021_01_06_425584	169	43	no	no	DT
10_1101-2021_01_06_425584	169	44	missing	miss	VBG
10_1101-2021_01_06_425584	169	45	values	value	NNS
10_1101-2021_01_06_425584	169	46	among	among	IN
10_1101-2021_01_06_425584	169	47	technical	technical	JJ
10_1101-2021_01_06_425584	169	48	and	and	CC
10_1101-2021_01_06_425584	169	49	biological	biological	JJ
10_1101-2021_01_06_425584	169	50	replicates	replicate	NNS
10_1101-2021_01_06_425584	169	51	(	(	-LRB-
10_1101-2021_01_06_425584	169	52	Table	table	NN
10_1101-2021_01_06_425584	169	53	S5	s5	NN
10_1101-2021_01_06_425584	169	54	)	)	-RRB-
10_1101-2021_01_06_425584	169	55	.	.	.
10_1101-2021_01_06_425584	170	1	Sample	sample	NN
10_1101-2021_01_06_425584	170	2	datasets	dataset	NNS
10_1101-2021_01_06_425584	170	3	were	be	VBD
10_1101-2021_01_06_425584	170	4	328	328	CD
10_1101-2021_01_06_425584	170	5	normalized	normalized	JJ
10_1101-2021_01_06_425584	170	6	using	use	VBG
10_1101-2021_01_06_425584	170	7	8	8	CD
10_1101-2021_01_06_425584	170	8	different	different	JJ
10_1101-2021_01_06_425584	170	9	methods	method	NNS
10_1101-2021_01_06_425584	170	10	to	to	TO
10_1101-2021_01_06_425584	170	11	select	select	VB
10_1101-2021_01_06_425584	170	12	the	the	DT
10_1101-2021_01_06_425584	170	13	most	most	RBS
10_1101-2021_01_06_425584	170	14	appropriate	appropriate	JJ
10_1101-2021_01_06_425584	170	15	based	base	VBN
10_1101-2021_01_06_425584	170	16	on	on	IN
10_1101-2021_01_06_425584	170	17	quantitative	quantitative	JJ
10_1101-2021_01_06_425584	170	18	and	and	CC
10_1101-2021_01_06_425584	170	19	329	329	CD
10_1101-2021_01_06_425584	170	20	qualitative	qualitative	JJ
10_1101-2021_01_06_425584	170	21	parameters	parameter	NNS
10_1101-2021_01_06_425584	170	22	on	on	IN
10_1101-2021_01_06_425584	170	23	our	-PRON-	PRP$
10_1101-2021_01_06_425584	170	24	dataset	dataset	NN
10_1101-2021_01_06_425584	170	25	.	.	.
10_1101-2021_01_06_425584	171	1	Quantile	Quantile	NNP
10_1101-2021_01_06_425584	171	2	normalization	normalization	NN
10_1101-2021_01_06_425584	171	3	produced	produce	VBD
10_1101-2021_01_06_425584	171	4	a	a	DT
10_1101-2021_01_06_425584	171	5	better	well	JJR
10_1101-2021_01_06_425584	171	6	qualitative	qualitative	JJ
10_1101-2021_01_06_425584	171	7	and	and	CC
10_1101-2021_01_06_425584	171	8	330	330	CD
10_1101-2021_01_06_425584	171	9	quantitative	quantitative	JJ
10_1101-2021_01_06_425584	171	10	profile	profile	NN
10_1101-2021_01_06_425584	171	11	and	and	CC
10_1101-2021_01_06_425584	171	12	was	be	VBD
10_1101-2021_01_06_425584	171	13	selected	select	VBN
10_1101-2021_01_06_425584	171	14	to	to	TO
10_1101-2021_01_06_425584	171	15	further	further	RB
10_1101-2021_01_06_425584	171	16	process	process	VB
10_1101-2021_01_06_425584	171	17	our	-PRON-	PRP$
10_1101-2021_01_06_425584	171	18	data	datum	NNS
10_1101-2021_01_06_425584	171	19	(	(	-LRB-
10_1101-2021_01_06_425584	171	20	Figure	figure	NN
10_1101-2021_01_06_425584	171	21	S1	s1	NN
10_1101-2021_01_06_425584	171	22	)	)	-RRB-
10_1101-2021_01_06_425584	171	23	.	.	.
10_1101-2021_01_06_425584	172	1	PCA	PCA	NNP
10_1101-2021_01_06_425584	172	2	analysis	analysis	NN
10_1101-2021_01_06_425584	172	3	of	of	IN
10_1101-2021_01_06_425584	172	4	331	331	CD
10_1101-2021_01_06_425584	172	5	normalized	normalized	JJ
10_1101-2021_01_06_425584	172	6	data	datum	NNS
10_1101-2021_01_06_425584	172	7	denoted	denote	VBD
10_1101-2021_01_06_425584	172	8	a	a	DT
10_1101-2021_01_06_425584	172	9	clear	clear	JJ
10_1101-2021_01_06_425584	172	10	separation	separation	NN
10_1101-2021_01_06_425584	172	11	of	of	IN
10_1101-2021_01_06_425584	172	12	the	the	DT
10_1101-2021_01_06_425584	172	13	groups	group	NNS
10_1101-2021_01_06_425584	172	14	suggesting	suggest	VBG
10_1101-2021_01_06_425584	172	15	overall	overall	JJ
10_1101-2021_01_06_425584	172	16	differences	difference	NNS
10_1101-2021_01_06_425584	172	17	in	in	IN
10_1101-2021_01_06_425584	172	18	their	-PRON-	PRP$
10_1101-2021_01_06_425584	172	19	332	332	CD
10_1101-2021_01_06_425584	172	20	proteomes	proteome	NNS
10_1101-2021_01_06_425584	172	21	(	(	-LRB-
10_1101-2021_01_06_425584	172	22	Figure	figure	NN
10_1101-2021_01_06_425584	172	23	5A	5a	RB
10_1101-2021_01_06_425584	172	24	)	)	-RRB-
10_1101-2021_01_06_425584	172	25	.	.	.
10_1101-2021_01_06_425584	173	1	Differential	differential	JJ
10_1101-2021_01_06_425584	173	2	abundance	abundance	NN
10_1101-2021_01_06_425584	173	3	analysis	analysis	NN
10_1101-2021_01_06_425584	173	4	revealed	reveal	VBD
10_1101-2021_01_06_425584	173	5	32	32	CD
10_1101-2021_01_06_425584	173	6	and	and	CC
10_1101-2021_01_06_425584	173	7	33	33	CD
10_1101-2021_01_06_425584	173	8	proteins	protein	NNS
10_1101-2021_01_06_425584	173	9	with	with	IN
10_1101-2021_01_06_425584	173	10	333	333	CD
10_1101-2021_01_06_425584	173	11	increased	increase	VBN
10_1101-2021_01_06_425584	173	12	and	and	CC
10_1101-2021_01_06_425584	173	13	decreased	decrease	VBD
10_1101-2021_01_06_425584	173	14	abundance	abundance	NN
10_1101-2021_01_06_425584	173	15	in	in	IN
10_1101-2021_01_06_425584	173	16	the	the	DT
10_1101-2021_01_06_425584	173	17	experimental	experimental	JJ
10_1101-2021_01_06_425584	173	18	group	group	NN
10_1101-2021_01_06_425584	173	19	(	(	-LRB-
10_1101-2021_01_06_425584	173	20	Figure	Figure	NNP
10_1101-2021_01_06_425584	173	21	5B	5b	NN
10_1101-2021_01_06_425584	173	22	)	)	-RRB-
10_1101-2021_01_06_425584	173	23	.	.	.
10_1101-2021_01_06_425584	174	1	Further	further	RB
10_1101-2021_01_06_425584	174	2	,	,	,
10_1101-2021_01_06_425584	174	3	the	the	DT
10_1101-2021_01_06_425584	174	4	334	334	CD
10_1101-2021_01_06_425584	174	5	heatmap	heatmap	NN
10_1101-2021_01_06_425584	174	6	visualization	visualization	NN
10_1101-2021_01_06_425584	174	7	of	of	IN
10_1101-2021_01_06_425584	174	8	the	the	DT
10_1101-2021_01_06_425584	174	9	top	top	JJ
10_1101-2021_01_06_425584	174	10	50-modulated	50-modulated	CD
10_1101-2021_01_06_425584	174	11	proteins	protein	NNS
10_1101-2021_01_06_425584	174	12	exhibited	exhibit	VBD
10_1101-2021_01_06_425584	174	13	the	the	DT
10_1101-2021_01_06_425584	174	14	different	different	JJ
10_1101-2021_01_06_425584	174	15	distribution	distribution	NN
10_1101-2021_01_06_425584	174	16	patterns	pattern	VBZ
10_1101-2021_01_06_425584	174	17	335	335	CD
10_1101-2021_01_06_425584	174	18	among	among	IN
10_1101-2021_01_06_425584	174	19	the	the	DT
10_1101-2021_01_06_425584	174	20	experimental	experimental	JJ
10_1101-2021_01_06_425584	174	21	and	and	CC
10_1101-2021_01_06_425584	174	22	control	control	NN
10_1101-2021_01_06_425584	174	23	groups	group	NNS
10_1101-2021_01_06_425584	174	24	(	(	-LRB-
10_1101-2021_01_06_425584	174	25	Figure	figure	NN
10_1101-2021_01_06_425584	174	26	5C	5c	NN
10_1101-2021_01_06_425584	174	27	)	)	-RRB-
10_1101-2021_01_06_425584	174	28	.	.	.
10_1101-2021_01_06_425584	175	1	To	to	TO
10_1101-2021_01_06_425584	175	2	obtain	obtain	VB
10_1101-2021_01_06_425584	175	3	a	a	DT
10_1101-2021_01_06_425584	175	4	molecular	molecular	JJ
10_1101-2021_01_06_425584	175	5	insight	insight	NN
10_1101-2021_01_06_425584	175	6	we	-PRON-	PRP
10_1101-2021_01_06_425584	175	7	336	336	CD
10_1101-2021_01_06_425584	175	8	performed	perform	VBD
10_1101-2021_01_06_425584	175	9	a	a	DT
10_1101-2021_01_06_425584	175	10	functional	functional	JJ
10_1101-2021_01_06_425584	175	11	enrichment	enrichment	NN
10_1101-2021_01_06_425584	175	12	analysis	analysis	NN
10_1101-2021_01_06_425584	175	13	using	use	VBG
10_1101-2021_01_06_425584	175	14	a	a	DT
10_1101-2021_01_06_425584	175	15	network	network	NN
10_1101-2021_01_06_425584	175	16	-	-	HYPH
10_1101-2021_01_06_425584	175	17	based	base	VBN
10_1101-2021_01_06_425584	175	18	approach	approach	NN
10_1101-2021_01_06_425584	175	19	.	.	.
10_1101-2021_01_06_425584	176	1	First	first	RB
10_1101-2021_01_06_425584	176	2	,	,	,
10_1101-2021_01_06_425584	176	3	we	-PRON-	PRP
10_1101-2021_01_06_425584	176	4	created	create	VBD
10_1101-2021_01_06_425584	176	5	a	a	DT
10_1101-2021_01_06_425584	176	6	337	337	CD
10_1101-2021_01_06_425584	176	7	composite	composite	JJ
10_1101-2021_01_06_425584	176	8	network	network	NN
10_1101-2021_01_06_425584	176	9	comprising	comprise	VBG
10_1101-2021_01_06_425584	176	10	PPI	PPI	NNP
10_1101-2021_01_06_425584	176	11	between	between	IN
10_1101-2021_01_06_425584	176	12	the	the	DT
10_1101-2021_01_06_425584	176	13	modulated	modulate	VBN
10_1101-2021_01_06_425584	176	14	proteins	protein	NNS
10_1101-2021_01_06_425584	176	15	by	by	IN
10_1101-2021_01_06_425584	176	16	simulated	simulated	JJ
10_1101-2021_01_06_425584	176	17	diabetes	diabete	NNS
10_1101-2021_01_06_425584	176	18	(	(	-LRB-
10_1101-2021_01_06_425584	176	19	seed	seed	NN
10_1101-2021_01_06_425584	176	20	338	338	CD
10_1101-2021_01_06_425584	176	21	proteins	protein	NNS
10_1101-2021_01_06_425584	176	22	)	)	-RRB-
10_1101-2021_01_06_425584	176	23	and	and	CC
10_1101-2021_01_06_425584	176	24	their	-PRON-	PRP$
10_1101-2021_01_06_425584	176	25	immediate	immediate	JJ
10_1101-2021_01_06_425584	176	26	interacting	interact	VBG
10_1101-2021_01_06_425584	176	27	partners	partner	NNS
10_1101-2021_01_06_425584	176	28	(	(	-LRB-
10_1101-2021_01_06_425584	176	29	highest	high	JJS
10_1101-2021_01_06_425584	176	30	confidence	confidence	NN
10_1101-2021_01_06_425584	176	31	>	>	NN
10_1101-2021_01_06_425584	176	32	0.9	0.9	CD
10_1101-2021_01_06_425584	176	33	)	)	-RRB-
10_1101-2021_01_06_425584	176	34	retrieved	retrieve	VBN
10_1101-2021_01_06_425584	176	35	from	from	IN
10_1101-2021_01_06_425584	176	36	339	339	CD
10_1101-2021_01_06_425584	176	37	STRING	STRING	NNP
10_1101-2021_01_06_425584	176	38	Database	Database	NNP
10_1101-2021_01_06_425584	176	39	(	(	-LRB-
10_1101-2021_01_06_425584	176	40	incorporated	incorporate	VBN
10_1101-2021_01_06_425584	176	41	in	in	IN
10_1101-2021_01_06_425584	176	42	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	176	43	platform	platform	NN
10_1101-2021_01_06_425584	176	44	)	)	-RRB-
10_1101-2021_01_06_425584	176	45	.	.	.
10_1101-2021_01_06_425584	177	1	The	the	DT
10_1101-2021_01_06_425584	177	2	principal	principal	JJ
10_1101-2021_01_06_425584	177	3	network	network	NN
10_1101-2021_01_06_425584	177	4	using	use	VBG
10_1101-2021_01_06_425584	177	5	the	the	DT
10_1101-2021_01_06_425584	177	6	up-340	up-340	NNP
10_1101-2021_01_06_425584	177	7	modulated	modulate	VBN
10_1101-2021_01_06_425584	177	8	proteins	protein	NNS
10_1101-2021_01_06_425584	177	9	consisted	consist	VBD
10_1101-2021_01_06_425584	177	10	of	of	IN
10_1101-2021_01_06_425584	177	11	461	461	CD
10_1101-2021_01_06_425584	177	12	proteins	protein	NNS
10_1101-2021_01_06_425584	177	13	,	,	,
10_1101-2021_01_06_425584	177	14	709	709	CD
10_1101-2021_01_06_425584	177	15	edges	edge	NNS
10_1101-2021_01_06_425584	177	16	and	and	CC
10_1101-2021_01_06_425584	177	17	18	18	CD
10_1101-2021_01_06_425584	177	18	seed	seed	NN
10_1101-2021_01_06_425584	177	19	proteins	protein	NNS
10_1101-2021_01_06_425584	177	20	(	(	-LRB-
10_1101-2021_01_06_425584	177	21	nodes	node	NNS
10_1101-2021_01_06_425584	177	22	with	with	IN
10_1101-2021_01_06_425584	177	23	blue	blue	JJ
10_1101-2021_01_06_425584	177	24	341	341	CD
10_1101-2021_01_06_425584	177	25	shadow	shadow	NN
10_1101-2021_01_06_425584	177	26	)	)	-RRB-
10_1101-2021_01_06_425584	177	27	and	and	CC
10_1101-2021_01_06_425584	177	28	is	be	VBZ
10_1101-2021_01_06_425584	177	29	illustrated	illustrate	VBN
10_1101-2021_01_06_425584	177	30	in	in	IN
10_1101-2021_01_06_425584	177	31	Figure	figure	NN
10_1101-2021_01_06_425584	177	32	5D.	5d.	NN
10_1101-2021_01_06_425584	178	1	Eight	eight	CD
10_1101-2021_01_06_425584	178	2	modules	module	NNS
10_1101-2021_01_06_425584	178	3	or	or	CC
10_1101-2021_01_06_425584	178	4	clusters	cluster	NNS
10_1101-2021_01_06_425584	178	5	were	be	VBD
10_1101-2021_01_06_425584	178	6	generated	generate	VBN
10_1101-2021_01_06_425584	178	7	,	,	,
10_1101-2021_01_06_425584	178	8	that	that	DT
10_1101-2021_01_06_425584	178	9	may	may	MD
10_1101-2021_01_06_425584	178	10	342	342	CD
10_1101-2021_01_06_425584	178	11	represent	represent	VB
10_1101-2021_01_06_425584	178	12	relevant	relevant	JJ
10_1101-2021_01_06_425584	178	13	complexes	complex	NNS
10_1101-2021_01_06_425584	178	14	or	or	CC
10_1101-2021_01_06_425584	178	15	functional	functional	JJ
10_1101-2021_01_06_425584	178	16	units	unit	NNS
10_1101-2021_01_06_425584	178	17	(	(	-LRB-
10_1101-2021_01_06_425584	178	18	40	40	CD
10_1101-2021_01_06_425584	178	19	)	)	-RRB-
10_1101-2021_01_06_425584	178	20	.	.	.
10_1101-2021_01_06_425584	179	1	The	the	DT
10_1101-2021_01_06_425584	179	2	5	5	CD
10_1101-2021_01_06_425584	179	3	most	most	RBS
10_1101-2021_01_06_425584	179	4	significant	significant	JJ
10_1101-2021_01_06_425584	179	5	(	(	-LRB-
10_1101-2021_01_06_425584	179	6	adjusted	adjust	VBN
10_1101-2021_01_06_425584	179	7	p	p	NN
10_1101-2021_01_06_425584	179	8	-	-	HYPH
10_1101-2021_01_06_425584	179	9	value	value	NN
10_1101-2021_01_06_425584	179	10	343	343	CD
10_1101-2021_01_06_425584	179	11	<	<	XX
10_1101-2021_01_06_425584	179	12	0.05	0.05	CD
10_1101-2021_01_06_425584	179	13	)	)	-RRB-
10_1101-2021_01_06_425584	179	14	REACTOME	reactome	NN
10_1101-2021_01_06_425584	179	15	and	and	CC
10_1101-2021_01_06_425584	179	16	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	179	17	pathways	pathway	NNS
10_1101-2021_01_06_425584	179	18	on	on	IN
10_1101-2021_01_06_425584	179	19	the	the	DT
10_1101-2021_01_06_425584	179	20	global	global	JJ
10_1101-2021_01_06_425584	179	21	network	network	NN
10_1101-2021_01_06_425584	179	22	are	be	VBP
10_1101-2021_01_06_425584	179	23	shown	show	VBN
10_1101-2021_01_06_425584	179	24	in	in	IN
10_1101-2021_01_06_425584	179	25	Table	table	NN
10_1101-2021_01_06_425584	179	26	1	1	CD
10_1101-2021_01_06_425584	179	27	.	.	.
10_1101-2021_01_06_425584	180	1	Two	two	CD
10_1101-2021_01_06_425584	180	2	344	344	CD
10_1101-2021_01_06_425584	180	3	modules	module	NNS
10_1101-2021_01_06_425584	180	4	contained	contain	VBD
10_1101-2021_01_06_425584	180	5	multiple	multiple	JJ
10_1101-2021_01_06_425584	180	6	seed	seed	NN
10_1101-2021_01_06_425584	180	7	proteins	protein	NNS
10_1101-2021_01_06_425584	180	8	and	and	CC
10_1101-2021_01_06_425584	180	9	were	be	VBD
10_1101-2021_01_06_425584	180	10	linked	link	VBN
10_1101-2021_01_06_425584	180	11	to	to	IN
10_1101-2021_01_06_425584	180	12	DNA	DNA	NNP
10_1101-2021_01_06_425584	180	13	/	/	SYM
10_1101-2021_01_06_425584	180	14	RNA	RNA	NNP
10_1101-2021_01_06_425584	180	15	and	and	CC
10_1101-2021_01_06_425584	180	16	protein	protein	NN
10_1101-2021_01_06_425584	180	17	metabolism	metabolism	NN
10_1101-2021_01_06_425584	180	18	345	345	CD
10_1101-2021_01_06_425584	180	19	pathways	pathway	NNS
10_1101-2021_01_06_425584	180	20	using	use	VBG
10_1101-2021_01_06_425584	180	21	the	the	DT
10_1101-2021_01_06_425584	180	22	WalkTrap	WalkTrap	NNP
10_1101-2021_01_06_425584	180	23	algorithm	algorithm	NN
10_1101-2021_01_06_425584	180	24	(	(	-LRB-
10_1101-2021_01_06_425584	180	25	Figure	Figure	NNP
10_1101-2021_01_06_425584	180	26	5D	5D	VBZ
10_1101-2021_01_06_425584	180	27	)	)	-RRB-
10_1101-2021_01_06_425584	180	28	.	.	.
10_1101-2021_01_06_425584	181	1	On	on	IN
10_1101-2021_01_06_425584	181	2	the	the	DT
10_1101-2021_01_06_425584	181	3	other	other	JJ
10_1101-2021_01_06_425584	181	4	hand	hand	NN
10_1101-2021_01_06_425584	181	5	,	,	,
10_1101-2021_01_06_425584	181	6	the	the	DT
10_1101-2021_01_06_425584	181	7	principal	principal	JJ
10_1101-2021_01_06_425584	181	8	network	network	NN
10_1101-2021_01_06_425584	181	9	346	346	CD
10_1101-2021_01_06_425584	181	10	using	use	VBG
10_1101-2021_01_06_425584	181	11	the	the	DT
10_1101-2021_01_06_425584	181	12	down	down	RB
10_1101-2021_01_06_425584	181	13	-	-	HYPH
10_1101-2021_01_06_425584	181	14	modulated	modulate	VBN
10_1101-2021_01_06_425584	181	15	proteins	protein	NNS
10_1101-2021_01_06_425584	181	16	consisted	consist	VBD
10_1101-2021_01_06_425584	181	17	of	of	IN
10_1101-2021_01_06_425584	181	18	488	488	CD
10_1101-2021_01_06_425584	181	19	proteins	protein	NNS
10_1101-2021_01_06_425584	181	20	,	,	,
10_1101-2021_01_06_425584	181	21	513	513	CD
10_1101-2021_01_06_425584	181	22	edges	edge	NNS
10_1101-2021_01_06_425584	181	23	and	and	CC
10_1101-2021_01_06_425584	181	24	18	18	CD
10_1101-2021_01_06_425584	181	25	seed	seed	NN
10_1101-2021_01_06_425584	181	26	proteins	protein	VBZ
10_1101-2021_01_06_425584	181	27	347	347	CD
10_1101-2021_01_06_425584	181	28	identified	identify	VBN
10_1101-2021_01_06_425584	181	29	eleven	eleven	CD
10_1101-2021_01_06_425584	181	30	modules	module	NNS
10_1101-2021_01_06_425584	181	31	wherein	wherein	WRB
10_1101-2021_01_06_425584	181	32	one	one	CD
10_1101-2021_01_06_425584	181	33	module	module	NN
10_1101-2021_01_06_425584	181	34	(	(	-LRB-
10_1101-2021_01_06_425584	181	35	with	with	IN
10_1101-2021_01_06_425584	181	36	2	2	CD
10_1101-2021_01_06_425584	181	37	seed	seed	NN
10_1101-2021_01_06_425584	181	38	proteins	protein	NNS
10_1101-2021_01_06_425584	181	39	)	)	-RRB-
10_1101-2021_01_06_425584	181	40	indicated	indicate	VBD
10_1101-2021_01_06_425584	181	41	associations	association	NNS
10_1101-2021_01_06_425584	181	42	with	with	IN
10_1101-2021_01_06_425584	181	43	348	348	CD
10_1101-2021_01_06_425584	181	44	mitochondrial	mitochondrial	NN
10_1101-2021_01_06_425584	181	45	function	function	NN
10_1101-2021_01_06_425584	181	46	pathways	pathway	NNS
10_1101-2021_01_06_425584	181	47	(	(	-LRB-
10_1101-2021_01_06_425584	181	48	Figure	figure	VB
10_1101-2021_01_06_425584	181	49	5E	5e	NN
10_1101-2021_01_06_425584	181	50	)	)	-RRB-
10_1101-2021_01_06_425584	181	51	.	.	.
10_1101-2021_01_06_425584	182	1	349	349	CD
10_1101-2021_01_06_425584	182	2	350	350	CD
10_1101-2021_01_06_425584	182	3	Integration	Integration	NNP
10_1101-2021_01_06_425584	182	4	of	of	IN
10_1101-2021_01_06_425584	182	5	Metabolomics	Metabolomics	NNPS
10_1101-2021_01_06_425584	182	6	and	and	CC
10_1101-2021_01_06_425584	182	7	Proteomics	Proteomics	NNP
10_1101-2021_01_06_425584	182	8	351	351	CD
10_1101-2021_01_06_425584	182	9	The	the	DT
10_1101-2021_01_06_425584	182	10	signaling	signal	VBG
10_1101-2021_01_06_425584	182	11	pathways	pathway	NNS
10_1101-2021_01_06_425584	182	12	perturbed	perturb	VBN
10_1101-2021_01_06_425584	182	13	by	by	IN
10_1101-2021_01_06_425584	182	14	simulated	simulated	JJ
10_1101-2021_01_06_425584	182	15	diabetes	diabete	NNS
10_1101-2021_01_06_425584	182	16	were	be	VBD
10_1101-2021_01_06_425584	182	17	identified	identify	VBN
10_1101-2021_01_06_425584	182	18	by	by	IN
10_1101-2021_01_06_425584	182	19	a	a	DT
10_1101-2021_01_06_425584	182	20	composite	composite	JJ
10_1101-2021_01_06_425584	182	21	network	network	NN
10_1101-2021_01_06_425584	182	22	352	352	CD
10_1101-2021_01_06_425584	182	23	of	of	IN
10_1101-2021_01_06_425584	182	24	interacting	interact	VBG
10_1101-2021_01_06_425584	182	25	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	182	26	and	and	CC
10_1101-2021_01_06_425584	182	27	proteins	protein	NNS
10_1101-2021_01_06_425584	182	28	using	use	VBG
10_1101-2021_01_06_425584	182	29	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	182	30	built	build	VBN
10_1101-2021_01_06_425584	182	31	-	-	HYPH
10_1101-2021_01_06_425584	182	32	in	in	RP
10_1101-2021_01_06_425584	182	33	databases	database	NNS
10_1101-2021_01_06_425584	182	34	.	.	.
10_1101-2021_01_06_425584	183	1	Figure	figure	NN
10_1101-2021_01_06_425584	183	2	6	6	CD
10_1101-2021_01_06_425584	183	3	illustrates	illustrate	VBZ
10_1101-2021_01_06_425584	183	4	the	the	DT
10_1101-2021_01_06_425584	183	5	353	353	CD
10_1101-2021_01_06_425584	183	6	composite	composite	JJ
10_1101-2021_01_06_425584	183	7	bi	bi	JJ
10_1101-2021_01_06_425584	183	8	-	-	JJ
10_1101-2021_01_06_425584	183	9	layered	layered	JJ
10_1101-2021_01_06_425584	183	10	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	183	11	-	-	HYPH
10_1101-2021_01_06_425584	183	12	PPI	PPI	NNP
10_1101-2021_01_06_425584	183	13	network	network	NN
10_1101-2021_01_06_425584	183	14	using	use	VBG
10_1101-2021_01_06_425584	183	15	the	the	DT
10_1101-2021_01_06_425584	183	16	up	up	RB
10_1101-2021_01_06_425584	183	17	-	-	HYPH
10_1101-2021_01_06_425584	183	18	modulated	modulate	VBN
10_1101-2021_01_06_425584	183	19	molecules	molecule	NNS
10_1101-2021_01_06_425584	183	20	(	(	-LRB-
10_1101-2021_01_06_425584	183	21	under	under	IN
10_1101-2021_01_06_425584	183	22	simulated	simulate	VBN
10_1101-2021_01_06_425584	183	23	354	354	CD
10_1101-2021_01_06_425584	183	24	diabetes	diabetes	NN
10_1101-2021_01_06_425584	183	25	)	)	-RRB-
10_1101-2021_01_06_425584	183	26	comprised	comprise	VBN
10_1101-2021_01_06_425584	183	27	of	of	IN
10_1101-2021_01_06_425584	183	28	9	9	CD
10_1101-2021_01_06_425584	183	29	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	183	30	(	(	-LRB-
10_1101-2021_01_06_425584	183	31	seed	seed	NN
10_1101-2021_01_06_425584	183	32	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	183	33	)	)	-RRB-
10_1101-2021_01_06_425584	183	34	,	,	,
10_1101-2021_01_06_425584	183	35	177	177	CD
10_1101-2021_01_06_425584	183	36	edges	edge	NNS
10_1101-2021_01_06_425584	183	37	,	,	,
10_1101-2021_01_06_425584	183	38	and	and	CC
10_1101-2021_01_06_425584	183	39	166	166	CD
10_1101-2021_01_06_425584	183	40	proteins	protein	NNS
10_1101-2021_01_06_425584	183	41	(	(	-LRB-
10_1101-2021_01_06_425584	183	42	5	5	CD
10_1101-2021_01_06_425584	183	43	seed	seed	NN
10_1101-2021_01_06_425584	183	44	355	355	CD
10_1101-2021_01_06_425584	183	45	.CC	.CC	:
10_1101-2021_01_06_425584	183	46	-	-	HYPH
10_1101-2021_01_06_425584	183	47	BY	by	IN
10_1101-2021_01_06_425584	183	48	-	-	HYPH
10_1101-2021_01_06_425584	183	49	NC	NC	NNP
10_1101-2021_01_06_425584	183	50	-	-	HYPH
10_1101-2021_01_06_425584	183	51	ND	ND	NNP
10_1101-2021_01_06_425584	183	52	4.0	4.0	CD
10_1101-2021_01_06_425584	183	53	International	International	NNP
10_1101-2021_01_06_425584	183	54	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	183	55	under	under	IN
10_1101-2021_01_06_425584	183	56	a	a	DT
10_1101-2021_01_06_425584	183	57	(	(	-LRB-
10_1101-2021_01_06_425584	183	58	which	which	WDT
10_1101-2021_01_06_425584	183	59	was	be	VBD
10_1101-2021_01_06_425584	183	60	not	not	RB
10_1101-2021_01_06_425584	183	61	certified	certify	VBN
10_1101-2021_01_06_425584	183	62	by	by	IN
10_1101-2021_01_06_425584	183	63	peer	peer	NN
10_1101-2021_01_06_425584	183	64	review	review	NN
10_1101-2021_01_06_425584	183	65	)	)	-RRB-
10_1101-2021_01_06_425584	183	66	is	be	VBZ
10_1101-2021_01_06_425584	183	67	the	the	DT
10_1101-2021_01_06_425584	183	68	author	author	NN
10_1101-2021_01_06_425584	183	69	/	/	SYM
10_1101-2021_01_06_425584	183	70	funder	funder	NN
10_1101-2021_01_06_425584	183	71	,	,	,
10_1101-2021_01_06_425584	183	72	who	who	WP
10_1101-2021_01_06_425584	183	73	has	have	VBZ
10_1101-2021_01_06_425584	183	74	granted	grant	VBN
10_1101-2021_01_06_425584	183	75	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	183	76	a	a	DT
10_1101-2021_01_06_425584	183	77	license	license	NN
10_1101-2021_01_06_425584	183	78	to	to	TO
10_1101-2021_01_06_425584	183	79	display	display	VB
10_1101-2021_01_06_425584	183	80	the	the	DT
10_1101-2021_01_06_425584	183	81	preprint	preprint	NN
10_1101-2021_01_06_425584	183	82	in	in	IN
10_1101-2021_01_06_425584	183	83	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	183	84	.	.	.
10_1101-2021_01_06_425584	184	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	184	2	is	be	VBZ
10_1101-2021_01_06_425584	184	3	made	make	VBN
10_1101-2021_01_06_425584	184	4	The	the	DT
10_1101-2021_01_06_425584	184	5	copyright	copyright	NN
10_1101-2021_01_06_425584	184	6	holder	holder	NN
10_1101-2021_01_06_425584	184	7	for	for	IN
10_1101-2021_01_06_425584	184	8	this	this	DT
10_1101-2021_01_06_425584	184	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	184	10	version	version	NN
10_1101-2021_01_06_425584	184	11	posted	post	VBD
10_1101-2021_01_06_425584	184	12	January	January	NNP
10_1101-2021_01_06_425584	184	13	8	8	CD
10_1101-2021_01_06_425584	184	14	,	,	,
10_1101-2021_01_06_425584	184	15	2021	2021	CD
10_1101-2021_01_06_425584	184	16	.	.	.
10_1101-2021_01_06_425584	184	17	;	;	:
10_1101-2021_01_06_425584	184	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	184	19	:	:	:
10_1101-2021_01_06_425584	184	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	184	21	preprint	preprint	NN
10_1101-2021_01_06_425584	184	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	184	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	184	24	12	12	CD
10_1101-2021_01_06_425584	184	25	proteins	protein	NNS
10_1101-2021_01_06_425584	184	26	)	)	-RRB-
10_1101-2021_01_06_425584	184	27	.	.	.
10_1101-2021_01_06_425584	185	1	The	the	DT
10_1101-2021_01_06_425584	185	2	10	10	CD
10_1101-2021_01_06_425584	185	3	top	top	JJ
10_1101-2021_01_06_425584	185	4	-	-	HYPH
10_1101-2021_01_06_425584	185	5	most	most	RBS
10_1101-2021_01_06_425584	185	6	enriched	enriched	JJ
10_1101-2021_01_06_425584	185	7	signaling	signal	VBG
10_1101-2021_01_06_425584	185	8	pathways	pathway	NNS
10_1101-2021_01_06_425584	185	9	identified	identify	VBN
10_1101-2021_01_06_425584	185	10	in	in	IN
10_1101-2021_01_06_425584	185	11	the	the	DT
10_1101-2021_01_06_425584	185	12	composite	composite	JJ
10_1101-2021_01_06_425584	185	13	network	network	NN
10_1101-2021_01_06_425584	185	14	are	be	VBP
10_1101-2021_01_06_425584	185	15	356	356	CD
10_1101-2021_01_06_425584	185	16	shown	show	VBN
10_1101-2021_01_06_425584	185	17	in	in	IN
10_1101-2021_01_06_425584	185	18	Table	table	NN
10_1101-2021_01_06_425584	185	19	2	2	CD
10_1101-2021_01_06_425584	185	20	.	.	.
10_1101-2021_01_06_425584	186	1	The	the	DT
10_1101-2021_01_06_425584	186	2	two	two	CD
10_1101-2021_01_06_425584	186	3	principal	principal	JJ
10_1101-2021_01_06_425584	186	4	modules	module	NNS
10_1101-2021_01_06_425584	186	5	highlighted	highlight	VBN
10_1101-2021_01_06_425584	186	6	by	by	IN
10_1101-2021_01_06_425584	186	7	the	the	DT
10_1101-2021_01_06_425584	186	8	WalkTrap	WalkTrap	NNP
10_1101-2021_01_06_425584	186	9	algorithm	algorithm	NN
10_1101-2021_01_06_425584	186	10	were	be	VBD
10_1101-2021_01_06_425584	186	11	linked	link	VBN
10_1101-2021_01_06_425584	186	12	357	357	CD
10_1101-2021_01_06_425584	186	13	to	to	IN
10_1101-2021_01_06_425584	186	14	glutathione	glutathione	NN
10_1101-2021_01_06_425584	186	15	and	and	CC
10_1101-2021_01_06_425584	186	16	amino	amino	NN
10_1101-2021_01_06_425584	186	17	acid	acid	NN
10_1101-2021_01_06_425584	186	18	metabolism	metabolism	NN
10_1101-2021_01_06_425584	186	19	.	.	.
10_1101-2021_01_06_425584	187	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	187	2	noted	note	VBD
10_1101-2021_01_06_425584	187	3	a	a	DT
10_1101-2021_01_06_425584	187	4	smaller	small	JJR
10_1101-2021_01_06_425584	187	5	interaction	interaction	NN
10_1101-2021_01_06_425584	187	6	between	between	IN
10_1101-2021_01_06_425584	187	7	Acyl	Acyl	NNP
10_1101-2021_01_06_425584	187	8	-	-	HYPH
10_1101-2021_01_06_425584	187	9	protein	protein	NN
10_1101-2021_01_06_425584	187	10	358	358	CD
10_1101-2021_01_06_425584	187	11	thioesterase	thioesterase	VBD
10_1101-2021_01_06_425584	187	12	1	1	CD
10_1101-2021_01_06_425584	187	13	(	(	-LRB-
10_1101-2021_01_06_425584	187	14	LYPLA1	LYPLA1	NNP
10_1101-2021_01_06_425584	187	15	)	)	-RRB-
10_1101-2021_01_06_425584	187	16	and	and	CC
10_1101-2021_01_06_425584	187	17	a	a	DT
10_1101-2021_01_06_425584	187	18	phosphatidylcholine	phosphatidylcholine	NN
10_1101-2021_01_06_425584	187	19	metabolite	metabolite	NN
10_1101-2021_01_06_425584	187	20	when	when	WRB
10_1101-2021_01_06_425584	187	21	simultaneously	simultaneously	RB
10_1101-2021_01_06_425584	187	22	analyzing	analyze	VBG
10_1101-2021_01_06_425584	187	23	359	359	CD
10_1101-2021_01_06_425584	187	24	up-	up-	CD
10_1101-2021_01_06_425584	187	25	and	and	CC
10_1101-2021_01_06_425584	187	26	down	down	RB
10_1101-2021_01_06_425584	187	27	-	-	HYPH
10_1101-2021_01_06_425584	187	28	modulated	modulate	VBN
10_1101-2021_01_06_425584	187	29	proteins	protein	NNS
10_1101-2021_01_06_425584	187	30	and	and	CC
10_1101-2021_01_06_425584	187	31	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	187	32	.	.	.
10_1101-2021_01_06_425584	188	1	No	no	DT
10_1101-2021_01_06_425584	188	2	significant	significant	JJ
10_1101-2021_01_06_425584	188	3	composite	composite	JJ
10_1101-2021_01_06_425584	188	4	network	network	NN
10_1101-2021_01_06_425584	188	5	was	be	VBD
10_1101-2021_01_06_425584	188	6	360	360	CD
10_1101-2021_01_06_425584	188	7	identified	identify	VBN
10_1101-2021_01_06_425584	188	8	using	use	VBG
10_1101-2021_01_06_425584	188	9	the	the	DT
10_1101-2021_01_06_425584	188	10	down	down	RB
10_1101-2021_01_06_425584	188	11	-	-	HYPH
10_1101-2021_01_06_425584	188	12	modulated	modulate	VBN
10_1101-2021_01_06_425584	188	13	proteins	protein	NNS
10_1101-2021_01_06_425584	188	14	and	and	CC
10_1101-2021_01_06_425584	188	15	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	188	16	.	.	.
10_1101-2021_01_06_425584	189	1	361	361	CD
10_1101-2021_01_06_425584	189	2	362	362	CD
10_1101-2021_01_06_425584	189	3	Cellular	Cellular	NNP
10_1101-2021_01_06_425584	189	4	morphology	morphology	NN
10_1101-2021_01_06_425584	189	5	363	363	CD
10_1101-2021_01_06_425584	189	6	To	to	TO
10_1101-2021_01_06_425584	189	7	better	well	RBR
10_1101-2021_01_06_425584	189	8	understand	understand	VB
10_1101-2021_01_06_425584	189	9	the	the	DT
10_1101-2021_01_06_425584	189	10	effects	effect	NNS
10_1101-2021_01_06_425584	189	11	that	that	WDT
10_1101-2021_01_06_425584	189	12	simulated	simulate	VBD
10_1101-2021_01_06_425584	189	13	diabetes	diabetes	NN
10_1101-2021_01_06_425584	189	14	exerts	exert	NNS
10_1101-2021_01_06_425584	189	15	on	on	IN
10_1101-2021_01_06_425584	189	16	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	189	17	cells	cell	NNS
10_1101-2021_01_06_425584	189	18	the	the	DT
10_1101-2021_01_06_425584	189	19	changes	change	NNS
10_1101-2021_01_06_425584	189	20	364	364	CD
10_1101-2021_01_06_425584	189	21	on	on	IN
10_1101-2021_01_06_425584	189	22	cellular	cellular	JJ
10_1101-2021_01_06_425584	189	23	structure	structure	NN
10_1101-2021_01_06_425584	189	24	endpoints	endpoint	NNS
10_1101-2021_01_06_425584	189	25	were	be	VBD
10_1101-2021_01_06_425584	189	26	evaluated	evaluate	VBN
10_1101-2021_01_06_425584	189	27	.	.	.
10_1101-2021_01_06_425584	190	1	The	the	DT
10_1101-2021_01_06_425584	190	2	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	190	3	nuclei	nuclei	NN
10_1101-2021_01_06_425584	190	4	morphology	morphology	NN
10_1101-2021_01_06_425584	190	5	in	in	IN
10_1101-2021_01_06_425584	190	6	the	the	DT
10_1101-2021_01_06_425584	190	7	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	190	8	365	365	CD
10_1101-2021_01_06_425584	190	9	control	control	NN
10_1101-2021_01_06_425584	190	10	and	and	CC
10_1101-2021_01_06_425584	190	11	experimental	experimental	JJ
10_1101-2021_01_06_425584	190	12	groups	group	NNS
10_1101-2021_01_06_425584	190	13	were	be	VBD
10_1101-2021_01_06_425584	190	14	evaluated	evaluate	VBN
10_1101-2021_01_06_425584	190	15	using	use	VBG
10_1101-2021_01_06_425584	190	16	fluorescent	fluorescent	NN
10_1101-2021_01_06_425584	190	17	-	-	HYPH
10_1101-2021_01_06_425584	190	18	staining	staining	NN
10_1101-2021_01_06_425584	190	19	and	and	CC
10_1101-2021_01_06_425584	190	20	image	image	NN
10_1101-2021_01_06_425584	190	21	analysis	analysis	NN
10_1101-2021_01_06_425584	190	22	.	.	.
10_1101-2021_01_06_425584	191	1	366	366	CD
10_1101-2021_01_06_425584	191	2	We	-PRON-	PRP
10_1101-2021_01_06_425584	191	3	also	also	RB
10_1101-2021_01_06_425584	191	4	evaluated	evaluate	VBD
10_1101-2021_01_06_425584	191	5	the	the	DT
10_1101-2021_01_06_425584	191	6	presence	presence	NN
10_1101-2021_01_06_425584	191	7	of	of	IN
10_1101-2021_01_06_425584	191	8	vWF	vWF	NNP
10_1101-2021_01_06_425584	191	9	(	(	-LRB-
10_1101-2021_01_06_425584	191	10	marker	marker	NN
10_1101-2021_01_06_425584	191	11	of	of	IN
10_1101-2021_01_06_425584	191	12	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	191	13	cells	cell	NNS
10_1101-2021_01_06_425584	191	14	)	)	-RRB-
10_1101-2021_01_06_425584	191	15	in	in	IN
10_1101-2021_01_06_425584	191	16	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	191	17	and	and	CC
10_1101-2021_01_06_425584	191	18	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	191	19	,	,	,
10_1101-2021_01_06_425584	191	20	to	to	IN
10_1101-2021_01_06_425584	191	21	367	367	CD
10_1101-2021_01_06_425584	191	22	reveal	reveal	VB
10_1101-2021_01_06_425584	191	23	the	the	DT
10_1101-2021_01_06_425584	191	24	cellular	cellular	JJ
10_1101-2021_01_06_425584	191	25	boundary	boundary	NN
10_1101-2021_01_06_425584	191	26	and	and	CC
10_1101-2021_01_06_425584	191	27	to	to	TO
10_1101-2021_01_06_425584	191	28	demonstrate	demonstrate	VB
10_1101-2021_01_06_425584	191	29	their	-PRON-	PRP$
10_1101-2021_01_06_425584	191	30	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	191	31	phenotype	phenotype	NN
10_1101-2021_01_06_425584	191	32	(	(	-LRB-
10_1101-2021_01_06_425584	191	33	41	41	CD
10_1101-2021_01_06_425584	191	34	)	)	-RRB-
10_1101-2021_01_06_425584	191	35	.	.	.
10_1101-2021_01_06_425584	192	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	192	2	noted	note	VBD
10_1101-2021_01_06_425584	192	3	an	an	DT
10_1101-2021_01_06_425584	192	4	368	368	CD
10_1101-2021_01_06_425584	192	5	increase	increase	NN
10_1101-2021_01_06_425584	192	6	in	in	IN
10_1101-2021_01_06_425584	192	7	the	the	DT
10_1101-2021_01_06_425584	192	8	percentage	percentage	NN
10_1101-2021_01_06_425584	192	9	of	of	IN
10_1101-2021_01_06_425584	192	10	binucleated	binucleated	JJ
10_1101-2021_01_06_425584	192	11	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	192	12	in	in	IN
10_1101-2021_01_06_425584	192	13	the	the	DT
10_1101-2021_01_06_425584	192	14	experimental	experimental	JJ
10_1101-2021_01_06_425584	192	15	group	group	NN
10_1101-2021_01_06_425584	192	16	compared	compare	VBN
10_1101-2021_01_06_425584	192	17	to	to	IN
10_1101-2021_01_06_425584	192	18	the	the	DT
10_1101-2021_01_06_425584	192	19	369	369	CD
10_1101-2021_01_06_425584	192	20	control	control	NN
10_1101-2021_01_06_425584	192	21	group	group	NN
10_1101-2021_01_06_425584	192	22	(	(	-LRB-
10_1101-2021_01_06_425584	192	23	top	top	JJ
10_1101-2021_01_06_425584	192	24	panel	panel	NN
10_1101-2021_01_06_425584	192	25	Figure	figure	NN
10_1101-2021_01_06_425584	192	26	7A	7a	NN
10_1101-2021_01_06_425584	192	27	and	and	CC
10_1101-2021_01_06_425584	192	28	7B	7b	NN
10_1101-2021_01_06_425584	192	29	)	)	-RRB-
10_1101-2021_01_06_425584	192	30	.	.	.
10_1101-2021_01_06_425584	193	1	A	a	DT
10_1101-2021_01_06_425584	193	2	similar	similar	JJ
10_1101-2021_01_06_425584	193	3	result	result	NN
10_1101-2021_01_06_425584	193	4	with	with	IN
10_1101-2021_01_06_425584	193	5	larger	large	JJR
10_1101-2021_01_06_425584	193	6	nuclei	nucleus	NNS
10_1101-2021_01_06_425584	193	7	,	,	,
10_1101-2021_01_06_425584	193	8	was	be	VBD
10_1101-2021_01_06_425584	193	9	observed	observe	VBN
10_1101-2021_01_06_425584	193	10	370	370	CD
10_1101-2021_01_06_425584	193	11	when	when	WRB
10_1101-2021_01_06_425584	193	12	using	use	VBG
10_1101-2021_01_06_425584	193	13	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	193	14	as	as	IN
10_1101-2021_01_06_425584	193	15	a	a	DT
10_1101-2021_01_06_425584	193	16	human	human	NN
10_1101-2021_01_06_425584	193	17	in	in	FW
10_1101-2021_01_06_425584	193	18	vitro	vitro	FW
10_1101-2021_01_06_425584	193	19	model	model	NN
10_1101-2021_01_06_425584	193	20	(	(	-LRB-
10_1101-2021_01_06_425584	193	21	bottom	bottom	JJ
10_1101-2021_01_06_425584	193	22	panel	panel	NN
10_1101-2021_01_06_425584	193	23	Figure	figure	NN
10_1101-2021_01_06_425584	193	24	7A	7a	NN
10_1101-2021_01_06_425584	193	25	and	and	CC
10_1101-2021_01_06_425584	193	26	7B	7b	NN
10_1101-2021_01_06_425584	193	27	)	)	-RRB-
10_1101-2021_01_06_425584	193	28	.	.	.
10_1101-2021_01_06_425584	194	1	Finally	finally	RB
10_1101-2021_01_06_425584	194	2	,	,	,
10_1101-2021_01_06_425584	194	3	as	as	IN
10_1101-2021_01_06_425584	194	4	371	371	CD
10_1101-2021_01_06_425584	194	5	expected	expect	VBN
10_1101-2021_01_06_425584	194	6	,	,	,
10_1101-2021_01_06_425584	194	7	we	-PRON-	PRP
10_1101-2021_01_06_425584	194	8	observed	observe	VBD
10_1101-2021_01_06_425584	194	9	a	a	DT
10_1101-2021_01_06_425584	194	10	typical	typical	JJ
10_1101-2021_01_06_425584	194	11	intracellular	intracellular	JJ
10_1101-2021_01_06_425584	194	12	localization	localization	NN
10_1101-2021_01_06_425584	194	13	of	of	IN
10_1101-2021_01_06_425584	194	14	vWF	vWF	NNP
10_1101-2021_01_06_425584	194	15	and	and	CC
10_1101-2021_01_06_425584	194	16	a	a	DT
10_1101-2021_01_06_425584	194	17	100	100	CD
10_1101-2021_01_06_425584	194	18	%	%	NN
10_1101-2021_01_06_425584	194	19	positivity	positivity	NN
10_1101-2021_01_06_425584	194	20	in	in	IN
10_1101-2021_01_06_425584	194	21	372	372	CD
10_1101-2021_01_06_425584	194	22	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	194	23	cells	cell	NNS
10_1101-2021_01_06_425584	194	24	.	.	.
10_1101-2021_01_06_425584	195	1	373	373	CD
10_1101-2021_01_06_425584	195	2	374	374	CD
10_1101-2021_01_06_425584	195	3	4	4	CD
10_1101-2021_01_06_425584	195	4	.	.	.
10_1101-2021_01_06_425584	196	1	Discussion	discussion	NN
10_1101-2021_01_06_425584	196	2	375	375	CD
10_1101-2021_01_06_425584	196	3	This	this	DT
10_1101-2021_01_06_425584	196	4	study	study	NN
10_1101-2021_01_06_425584	196	5	investigated	investigate	VBD
10_1101-2021_01_06_425584	196	6	the	the	DT
10_1101-2021_01_06_425584	196	7	molecular	molecular	JJ
10_1101-2021_01_06_425584	196	8	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	196	9	occurring	occur	VBG
10_1101-2021_01_06_425584	196	10	in	in	IN
10_1101-2021_01_06_425584	196	11	coronary	coronary	JJ
10_1101-2021_01_06_425584	196	12	endothelium	endothelium	NN
10_1101-2021_01_06_425584	196	13	cells	cell	NNS
10_1101-2021_01_06_425584	196	14	376	376	CD
10_1101-2021_01_06_425584	196	15	subjected	subject	VBN
10_1101-2021_01_06_425584	196	16	to	to	IN
10_1101-2021_01_06_425584	196	17	prolonged	prolonged	JJ
10_1101-2021_01_06_425584	196	18	simulated	simulated	JJ
10_1101-2021_01_06_425584	196	19	diabetes	diabete	NNS
10_1101-2021_01_06_425584	196	20	that	that	WDT
10_1101-2021_01_06_425584	196	21	facilitated	facilitate	VBD
10_1101-2021_01_06_425584	196	22	the	the	DT
10_1101-2021_01_06_425584	196	23	identification	identification	NN
10_1101-2021_01_06_425584	196	24	of	of	IN
10_1101-2021_01_06_425584	196	25	signaling	signal	VBG
10_1101-2021_01_06_425584	196	26	pathways	pathway	NNS
10_1101-2021_01_06_425584	196	27	377	377	CD
10_1101-2021_01_06_425584	196	28	and	and	CC
10_1101-2021_01_06_425584	196	29	specific	specific	JJ
10_1101-2021_01_06_425584	196	30	molecules	molecule	NNS
10_1101-2021_01_06_425584	196	31	that	that	WDT
10_1101-2021_01_06_425584	196	32	could	could	MD
10_1101-2021_01_06_425584	196	33	be	be	VB
10_1101-2021_01_06_425584	196	34	associated	associate	VBN
10_1101-2021_01_06_425584	196	35	with	with	IN
10_1101-2021_01_06_425584	196	36	the	the	DT
10_1101-2021_01_06_425584	196	37	development	development	NN
10_1101-2021_01_06_425584	196	38	of	of	IN
10_1101-2021_01_06_425584	196	39	cardiovascular	cardiovascular	JJ
10_1101-2021_01_06_425584	196	40	disease	disease	NN
10_1101-2021_01_06_425584	196	41	.	.	.
10_1101-2021_01_06_425584	197	1	378	378	CD
10_1101-2021_01_06_425584	197	2	To	to	TO
10_1101-2021_01_06_425584	197	3	achieve	achieve	VB
10_1101-2021_01_06_425584	197	4	this	this	DT
10_1101-2021_01_06_425584	197	5	,	,	,
10_1101-2021_01_06_425584	197	6	we	-PRON-	PRP
10_1101-2021_01_06_425584	197	7	employed	employ	VBD
10_1101-2021_01_06_425584	197	8	a	a	DT
10_1101-2021_01_06_425584	197	9	MS	MS	NNP
10_1101-2021_01_06_425584	197	10	-	-	HYPH
10_1101-2021_01_06_425584	197	11	based	base	VBN
10_1101-2021_01_06_425584	197	12	multi	multi	JJ
10_1101-2021_01_06_425584	197	13	-	-	HYPH
10_1101-2021_01_06_425584	197	14	omics	omics	JJ
10_1101-2021_01_06_425584	197	15	approach	approach	NN
10_1101-2021_01_06_425584	197	16	coupled	couple	VBN
10_1101-2021_01_06_425584	197	17	to	to	TO
10_1101-2021_01_06_425584	197	18	fluorescence	fluorescence	VB
10_1101-2021_01_06_425584	197	19	379	379	CD
10_1101-2021_01_06_425584	197	20	microscopy	microscopy	JJ
10_1101-2021_01_06_425584	197	21	to	to	TO
10_1101-2021_01_06_425584	197	22	detect	detect	VB
10_1101-2021_01_06_425584	197	23	structural	structural	JJ
10_1101-2021_01_06_425584	197	24	changes	change	NNS
10_1101-2021_01_06_425584	197	25	.	.	.
10_1101-2021_01_06_425584	198	1	Endothelial	endothelial	JJ
10_1101-2021_01_06_425584	198	2	cells	cell	NNS
10_1101-2021_01_06_425584	198	3	cover	cover	VBP
10_1101-2021_01_06_425584	198	4	the	the	DT
10_1101-2021_01_06_425584	198	5	inner	inner	JJ
10_1101-2021_01_06_425584	198	6	surface	surface	NN
10_1101-2021_01_06_425584	198	7	of	of	IN
10_1101-2021_01_06_425584	198	8	blood	blood	NN
10_1101-2021_01_06_425584	198	9	vessels	vessel	NNS
10_1101-2021_01_06_425584	198	10	380	380	CD
10_1101-2021_01_06_425584	198	11	and	and	CC
10_1101-2021_01_06_425584	198	12	are	be	VBP
10_1101-2021_01_06_425584	198	13	distributed	distribute	VBN
10_1101-2021_01_06_425584	198	14	across	across	IN
10_1101-2021_01_06_425584	198	15	the	the	DT
10_1101-2021_01_06_425584	198	16	body	body	NN
10_1101-2021_01_06_425584	198	17	.	.	.
10_1101-2021_01_06_425584	199	1	Their	-PRON-	PRP$
10_1101-2021_01_06_425584	199	2	functions	function	NNS
10_1101-2021_01_06_425584	199	3	include	include	VBP
10_1101-2021_01_06_425584	199	4	:	:	:
10_1101-2021_01_06_425584	199	5	acting	act	VBG
10_1101-2021_01_06_425584	199	6	as	as	IN
10_1101-2021_01_06_425584	199	7	a	a	DT
10_1101-2021_01_06_425584	199	8	mechanical	mechanical	JJ
10_1101-2021_01_06_425584	199	9	barrier	barrier	NN
10_1101-2021_01_06_425584	199	10	381	381	CD
10_1101-2021_01_06_425584	199	11	between	between	IN
10_1101-2021_01_06_425584	199	12	the	the	DT
10_1101-2021_01_06_425584	199	13	circulating	circulate	VBG
10_1101-2021_01_06_425584	199	14	blood	blood	NN
10_1101-2021_01_06_425584	199	15	and	and	CC
10_1101-2021_01_06_425584	199	16	adjacent	adjacent	JJ
10_1101-2021_01_06_425584	199	17	tissues	tissue	NNS
10_1101-2021_01_06_425584	199	18	as	as	RB
10_1101-2021_01_06_425584	199	19	well	well	RB
10_1101-2021_01_06_425584	199	20	as	as	IN
10_1101-2021_01_06_425584	199	21	modulating	modulate	VBG
10_1101-2021_01_06_425584	199	22	multiple	multiple	JJ
10_1101-2021_01_06_425584	199	23	functions	function	NNS
10_1101-2021_01_06_425584	199	24	in	in	IN
10_1101-2021_01_06_425584	199	25	382	382	CD
10_1101-2021_01_06_425584	199	26	distinct	distinct	JJ
10_1101-2021_01_06_425584	199	27	organs	organ	NNS
10_1101-2021_01_06_425584	199	28	(	(	-LRB-
10_1101-2021_01_06_425584	199	29	42	42	CD
10_1101-2021_01_06_425584	199	30	)	)	-RRB-
10_1101-2021_01_06_425584	199	31	.	.	.
10_1101-2021_01_06_425584	200	1	These	these	DT
10_1101-2021_01_06_425584	200	2	regulatory	regulatory	JJ
10_1101-2021_01_06_425584	200	3	functions	function	NNS
10_1101-2021_01_06_425584	200	4	vary	vary	VBP
10_1101-2021_01_06_425584	200	5	according	accord	VBG
10_1101-2021_01_06_425584	200	6	to	to	IN
10_1101-2021_01_06_425584	200	7	localization	localization	NN
10_1101-2021_01_06_425584	200	8	and	and	CC
10_1101-2021_01_06_425584	200	9	vascular	vascular	JJ
10_1101-2021_01_06_425584	200	10	bed-383	bed-383	NNP
10_1101-2021_01_06_425584	200	11	origin	origin	NN
10_1101-2021_01_06_425584	200	12	(	(	-LRB-
10_1101-2021_01_06_425584	200	13	43	43	CD
10_1101-2021_01_06_425584	200	14	)	)	-RRB-
10_1101-2021_01_06_425584	200	15	.	.	.
10_1101-2021_01_06_425584	201	1	HG	HG	NNP
10_1101-2021_01_06_425584	201	2	blood	blood	NN
10_1101-2021_01_06_425584	201	3	levels	level	NNS
10_1101-2021_01_06_425584	201	4	are	be	VBP
10_1101-2021_01_06_425584	201	5	detrimental	detrimental	JJ
10_1101-2021_01_06_425584	201	6	to	to	IN
10_1101-2021_01_06_425584	201	7	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	201	8	cells	cell	NNS
10_1101-2021_01_06_425584	201	9	function	function	NN
10_1101-2021_01_06_425584	201	10	in	in	IN
10_1101-2021_01_06_425584	201	11	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	201	12	leading	lead	VBG
10_1101-2021_01_06_425584	201	13	to	to	IN
10_1101-2021_01_06_425584	201	14	384	384	CD
10_1101-2021_01_06_425584	201	15	coronary	coronary	JJ
10_1101-2021_01_06_425584	201	16	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	201	17	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	201	18	and	and	CC
10_1101-2021_01_06_425584	201	19	development	development	NN
10_1101-2021_01_06_425584	201	20	of	of	IN
10_1101-2021_01_06_425584	201	21	CVD	CVD	NNP
10_1101-2021_01_06_425584	201	22	(	(	-LRB-
10_1101-2021_01_06_425584	201	23	44	44	CD
10_1101-2021_01_06_425584	201	24	,	,	,
10_1101-2021_01_06_425584	201	25	45	45	CD
10_1101-2021_01_06_425584	201	26	)	)	-RRB-
10_1101-2021_01_06_425584	201	27	.	.	.
10_1101-2021_01_06_425584	202	1	The	the	DT
10_1101-2021_01_06_425584	202	2	molecular	molecular	JJ
10_1101-2021_01_06_425584	202	3	effects	effect	NNS
10_1101-2021_01_06_425584	202	4	of	of	IN
10_1101-2021_01_06_425584	202	5	HG	HG	NNP
10_1101-2021_01_06_425584	202	6	385	385	CD
10_1101-2021_01_06_425584	202	7	on	on	IN
10_1101-2021_01_06_425584	202	8	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	202	9	cells	cell	NNS
10_1101-2021_01_06_425584	202	10	have	have	VBP
10_1101-2021_01_06_425584	202	11	been	be	VBN
10_1101-2021_01_06_425584	202	12	previously	previously	RB
10_1101-2021_01_06_425584	202	13	characterized	characterize	VBN
10_1101-2021_01_06_425584	202	14	(	(	-LRB-
10_1101-2021_01_06_425584	202	15	4	4	CD
10_1101-2021_01_06_425584	202	16	,	,	,
10_1101-2021_01_06_425584	202	17	6	6	CD
10_1101-2021_01_06_425584	202	18	,	,	,
10_1101-2021_01_06_425584	202	19	7	7	CD
10_1101-2021_01_06_425584	202	20	,	,	,
10_1101-2021_01_06_425584	202	21	10	10	CD
10_1101-2021_01_06_425584	202	22	,	,	,
10_1101-2021_01_06_425584	202	23	11	11	CD
10_1101-2021_01_06_425584	202	24	)	)	-RRB-
10_1101-2021_01_06_425584	202	25	;	;	:
10_1101-2021_01_06_425584	202	26	nevertheless	nevertheless	RB
10_1101-2021_01_06_425584	202	27	,	,	,
10_1101-2021_01_06_425584	202	28	the	the	DT
10_1101-2021_01_06_425584	202	29	386	386	CD
10_1101-2021_01_06_425584	202	30	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	202	31	cell	cell	NN
10_1101-2021_01_06_425584	202	32	types	type	NNS
10_1101-2021_01_06_425584	202	33	used	use	VBN
10_1101-2021_01_06_425584	202	34	in	in	IN
10_1101-2021_01_06_425584	202	35	these	these	DT
10_1101-2021_01_06_425584	202	36	studies	study	NNS
10_1101-2021_01_06_425584	202	37	are	be	VBP
10_1101-2021_01_06_425584	202	38	not	not	RB
10_1101-2021_01_06_425584	202	39	intrinsically	intrinsically	RB
10_1101-2021_01_06_425584	202	40	involved	involve	VBN
10_1101-2021_01_06_425584	202	41	in	in	IN
10_1101-2021_01_06_425584	202	42	CVD	CVD	NNP
10_1101-2021_01_06_425584	202	43	.	.	.
10_1101-2021_01_06_425584	203	1	The	the	DT
10_1101-2021_01_06_425584	203	2	present	present	JJ
10_1101-2021_01_06_425584	203	3	study	study	NN
10_1101-2021_01_06_425584	203	4	387	387	CD
10_1101-2021_01_06_425584	203	5	used	use	VBD
10_1101-2021_01_06_425584	203	6	an	an	DT
10_1101-2021_01_06_425584	203	7	in	in	FW
10_1101-2021_01_06_425584	203	8	vitro	vitro	FW
10_1101-2021_01_06_425584	203	9	model	model	NN
10_1101-2021_01_06_425584	203	10	involving	involve	VBG
10_1101-2021_01_06_425584	203	11	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	203	12	cells	cell	NNS
10_1101-2021_01_06_425584	203	13	that	that	WDT
10_1101-2021_01_06_425584	203	14	modulate	modulate	VBP
10_1101-2021_01_06_425584	203	15	the	the	DT
10_1101-2021_01_06_425584	203	16	heart	heart	NN
10_1101-2021_01_06_425584	203	17	function	function	NN
10_1101-2021_01_06_425584	203	18	,	,	,
10_1101-2021_01_06_425584	203	19	CAEC	CAEC	NNP
10_1101-2021_01_06_425584	203	20	(	(	-LRB-
10_1101-2021_01_06_425584	203	21	46	46	CD
10_1101-2021_01_06_425584	203	22	)	)	-RRB-
10_1101-2021_01_06_425584	203	23	.	.	.
10_1101-2021_01_06_425584	204	1	388	388	CD
10_1101-2021_01_06_425584	204	2	Our	-PRON-	PRP$
10_1101-2021_01_06_425584	204	3	model	model	NN
10_1101-2021_01_06_425584	204	4	not	not	RB
10_1101-2021_01_06_425584	204	5	only	only	RB
10_1101-2021_01_06_425584	204	6	used	use	VBN
10_1101-2021_01_06_425584	204	7	HG	HG	NNP
10_1101-2021_01_06_425584	204	8	(	(	-LRB-
10_1101-2021_01_06_425584	204	9	20	20	CD
10_1101-2021_01_06_425584	204	10	mmol	mmol	NN
10_1101-2021_01_06_425584	204	11	/	/	SYM
10_1101-2021_01_06_425584	204	12	L	l	NN
10_1101-2021_01_06_425584	204	13	)	)	-RRB-
10_1101-2021_01_06_425584	204	14	to	to	TO
10_1101-2021_01_06_425584	204	15	simulate	simulate	VB
10_1101-2021_01_06_425584	204	16	diabetes	diabete	NNS
10_1101-2021_01_06_425584	204	17	(	(	-LRB-
10_1101-2021_01_06_425584	204	18	4	4	CD
10_1101-2021_01_06_425584	204	19	,	,	,
10_1101-2021_01_06_425584	204	20	6	6	CD
10_1101-2021_01_06_425584	204	21	,	,	,
10_1101-2021_01_06_425584	204	22	7	7	CD
10_1101-2021_01_06_425584	204	23	,	,	,
10_1101-2021_01_06_425584	204	24	10	10	CD
10_1101-2021_01_06_425584	204	25	,	,	,
10_1101-2021_01_06_425584	204	26	11	11	CD
10_1101-2021_01_06_425584	204	27	)	)	-RRB-
10_1101-2021_01_06_425584	204	28	but	but	CC
10_1101-2021_01_06_425584	204	29	first	first	RB
10_1101-2021_01_06_425584	204	30	induced	induce	VBD
10_1101-2021_01_06_425584	204	31	389	389	CD
10_1101-2021_01_06_425584	204	32	.CC	.CC	:
10_1101-2021_01_06_425584	204	33	-	-	HYPH
10_1101-2021_01_06_425584	204	34	BY	by	IN
10_1101-2021_01_06_425584	204	35	-	-	HYPH
10_1101-2021_01_06_425584	204	36	NC	NC	NNP
10_1101-2021_01_06_425584	204	37	-	-	HYPH
10_1101-2021_01_06_425584	204	38	ND	ND	NNP
10_1101-2021_01_06_425584	204	39	4.0	4.0	CD
10_1101-2021_01_06_425584	204	40	International	International	NNP
10_1101-2021_01_06_425584	204	41	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	204	42	under	under	IN
10_1101-2021_01_06_425584	204	43	a	a	DT
10_1101-2021_01_06_425584	204	44	(	(	-LRB-
10_1101-2021_01_06_425584	204	45	which	which	WDT
10_1101-2021_01_06_425584	204	46	was	be	VBD
10_1101-2021_01_06_425584	204	47	not	not	RB
10_1101-2021_01_06_425584	204	48	certified	certify	VBN
10_1101-2021_01_06_425584	204	49	by	by	IN
10_1101-2021_01_06_425584	204	50	peer	peer	NN
10_1101-2021_01_06_425584	204	51	review	review	NN
10_1101-2021_01_06_425584	204	52	)	)	-RRB-
10_1101-2021_01_06_425584	204	53	is	be	VBZ
10_1101-2021_01_06_425584	204	54	the	the	DT
10_1101-2021_01_06_425584	204	55	author	author	NN
10_1101-2021_01_06_425584	204	56	/	/	SYM
10_1101-2021_01_06_425584	204	57	funder	funder	NN
10_1101-2021_01_06_425584	204	58	,	,	,
10_1101-2021_01_06_425584	204	59	who	who	WP
10_1101-2021_01_06_425584	204	60	has	have	VBZ
10_1101-2021_01_06_425584	204	61	granted	grant	VBN
10_1101-2021_01_06_425584	204	62	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	204	63	a	a	DT
10_1101-2021_01_06_425584	204	64	license	license	NN
10_1101-2021_01_06_425584	204	65	to	to	TO
10_1101-2021_01_06_425584	204	66	display	display	VB
10_1101-2021_01_06_425584	204	67	the	the	DT
10_1101-2021_01_06_425584	204	68	preprint	preprint	NN
10_1101-2021_01_06_425584	204	69	in	in	IN
10_1101-2021_01_06_425584	204	70	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	204	71	.	.	.
10_1101-2021_01_06_425584	205	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	205	2	is	be	VBZ
10_1101-2021_01_06_425584	205	3	made	make	VBN
10_1101-2021_01_06_425584	205	4	The	the	DT
10_1101-2021_01_06_425584	205	5	copyright	copyright	NN
10_1101-2021_01_06_425584	205	6	holder	holder	NN
10_1101-2021_01_06_425584	205	7	for	for	IN
10_1101-2021_01_06_425584	205	8	this	this	DT
10_1101-2021_01_06_425584	205	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	205	10	version	version	NN
10_1101-2021_01_06_425584	205	11	posted	post	VBD
10_1101-2021_01_06_425584	205	12	January	January	NNP
10_1101-2021_01_06_425584	205	13	8	8	CD
10_1101-2021_01_06_425584	205	14	,	,	,
10_1101-2021_01_06_425584	205	15	2021	2021	CD
10_1101-2021_01_06_425584	205	16	.	.	.
10_1101-2021_01_06_425584	205	17	;	;	:
10_1101-2021_01_06_425584	205	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	205	19	:	:	:
10_1101-2021_01_06_425584	205	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	205	21	preprint	preprint	NN
10_1101-2021_01_06_425584	205	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	205	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2021_01_06_425584	205	24	13	13	CD
10_1101-2021_01_06_425584	205	25	insulin	insulin	NN
10_1101-2021_01_06_425584	205	26	resistance	resistance	NN
10_1101-2021_01_06_425584	205	27	to	to	TO
10_1101-2021_01_06_425584	205	28	mimic	mimic	VB
10_1101-2021_01_06_425584	205	29	the	the	DT
10_1101-2021_01_06_425584	205	30	pathophysiological	pathophysiological	JJ
10_1101-2021_01_06_425584	205	31	conditions	condition	NNS
10_1101-2021_01_06_425584	205	32	that	that	WDT
10_1101-2021_01_06_425584	205	33	occur	occur	VBP
10_1101-2021_01_06_425584	205	34	in	in	IN
10_1101-2021_01_06_425584	205	35	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	205	36	wherein	wherein	WRB
10_1101-2021_01_06_425584	205	37	390	390	CD
10_1101-2021_01_06_425584	205	38	hyperinsulinemia	hyperinsulinemia	NN
10_1101-2021_01_06_425584	205	39	precedes	precedes	NNPS
10_1101-2021_01_06_425584	205	40	hyperglycemia	hyperglycemia	NNP
10_1101-2021_01_06_425584	205	41	(	(	-LRB-
10_1101-2021_01_06_425584	205	42	18	18	CD
10_1101-2021_01_06_425584	205	43	)	)	-RRB-
10_1101-2021_01_06_425584	205	44	.	.	.
10_1101-2021_01_06_425584	206	1	Diabetes	diabete	NNS
10_1101-2021_01_06_425584	206	2	was	be	VBD
10_1101-2021_01_06_425584	206	3	simulated	simulate	VBN
10_1101-2021_01_06_425584	206	4	for	for	IN
10_1101-2021_01_06_425584	206	5	up	up	IN
10_1101-2021_01_06_425584	206	6	to	to	TO
10_1101-2021_01_06_425584	206	7	12	12	CD
10_1101-2021_01_06_425584	206	8	days	day	NNS
10_1101-2021_01_06_425584	206	9	to	to	IN
10_1101-2021_01_06_425584	206	10	391	391	CD
10_1101-2021_01_06_425584	206	11	mimic	mimic	JJ
10_1101-2021_01_06_425584	206	12	chronic	chronic	JJ
10_1101-2021_01_06_425584	206	13	HG	HG	NNP
10_1101-2021_01_06_425584	206	14	exposure	exposure	NN
10_1101-2021_01_06_425584	206	15	and	and	CC
10_1101-2021_01_06_425584	206	16	to	to	TO
10_1101-2021_01_06_425584	206	17	prevent	prevent	VB
10_1101-2021_01_06_425584	206	18	measuring	measure	VBG
10_1101-2021_01_06_425584	206	19	cell	cell	NN
10_1101-2021_01_06_425584	206	20	proliferation	proliferation	NN
10_1101-2021_01_06_425584	206	21	known	know	VBN
10_1101-2021_01_06_425584	206	22	to	to	TO
10_1101-2021_01_06_425584	206	23	occur	occur	VB
10_1101-2021_01_06_425584	206	24	in	in	IN
10_1101-2021_01_06_425584	206	25	early	early	JJ
10_1101-2021_01_06_425584	206	26	392	392	CD
10_1101-2021_01_06_425584	206	27	HG	HG	NNS
10_1101-2021_01_06_425584	206	28	(	(	-LRB-
10_1101-2021_01_06_425584	206	29	10	10	CD
10_1101-2021_01_06_425584	206	30	,	,	,
10_1101-2021_01_06_425584	206	31	16	16	CD
10_1101-2021_01_06_425584	206	32	)	)	-RRB-
10_1101-2021_01_06_425584	206	33	.	.	.
10_1101-2021_01_06_425584	207	1	Despite	despite	IN
10_1101-2021_01_06_425584	207	2	a	a	DT
10_1101-2021_01_06_425584	207	3	lack	lack	NN
10_1101-2021_01_06_425584	207	4	of	of	IN
10_1101-2021_01_06_425584	207	5	apparent	apparent	JJ
10_1101-2021_01_06_425584	207	6	increase	increase	NN
10_1101-2021_01_06_425584	207	7	in	in	IN
10_1101-2021_01_06_425584	207	8	cell	cell	NN
10_1101-2021_01_06_425584	207	9	proliferation	proliferation	NN
10_1101-2021_01_06_425584	207	10	in	in	IN
10_1101-2021_01_06_425584	207	11	the	the	DT
10_1101-2021_01_06_425584	207	12	experimental	experimental	JJ
10_1101-2021_01_06_425584	207	13	group	group	NN
10_1101-2021_01_06_425584	207	14	393	393	CD
10_1101-2021_01_06_425584	207	15	compared	compare	VBN
10_1101-2021_01_06_425584	207	16	to	to	TO
10_1101-2021_01_06_425584	207	17	control	control	VB
10_1101-2021_01_06_425584	207	18	group	group	NN
10_1101-2021_01_06_425584	207	19	after	after	IN
10_1101-2021_01_06_425584	207	20	twelve	twelve	CD
10_1101-2021_01_06_425584	207	21	days	day	NNS
10_1101-2021_01_06_425584	207	22	,	,	,
10_1101-2021_01_06_425584	207	23	an	an	DT
10_1101-2021_01_06_425584	207	24	increase	increase	NN
10_1101-2021_01_06_425584	207	25	in	in	IN
10_1101-2021_01_06_425584	207	26	overall	overall	JJ
10_1101-2021_01_06_425584	207	27	protein	protein	NN
10_1101-2021_01_06_425584	207	28	abundance	abundance	NN
10_1101-2021_01_06_425584	207	29	was	be	VBD
10_1101-2021_01_06_425584	207	30	394	394	CD
10_1101-2021_01_06_425584	207	31	detected	detect	VBN
10_1101-2021_01_06_425584	207	32	by	by	IN
10_1101-2021_01_06_425584	207	33	Bradford	Bradford	NNP
10_1101-2021_01_06_425584	207	34	assay	assay	NNP
10_1101-2021_01_06_425584	207	35	(	(	-LRB-
10_1101-2021_01_06_425584	207	36	data	datum	NNS
10_1101-2021_01_06_425584	207	37	not	not	RB
10_1101-2021_01_06_425584	207	38	shown	show	VBN
10_1101-2021_01_06_425584	207	39	)	)	-RRB-
10_1101-2021_01_06_425584	207	40	and	and	CC
10_1101-2021_01_06_425584	207	41	inferred	infer	VBN
10_1101-2021_01_06_425584	207	42	from	from	IN
10_1101-2021_01_06_425584	207	43	total	total	JJ
10_1101-2021_01_06_425584	207	44	ion	ion	NN
10_1101-2021_01_06_425584	207	45	chromatogram	chromatogram	NNP
10_1101-2021_01_06_425584	207	46	(	(	-LRB-
10_1101-2021_01_06_425584	207	47	TIC	TIC	NNP
10_1101-2021_01_06_425584	207	48	)	)	-RRB-
10_1101-2021_01_06_425584	207	49	of	of	IN
10_1101-2021_01_06_425584	207	50	395	395	CD
10_1101-2021_01_06_425584	207	51	MS	MS	NNP
10_1101-2021_01_06_425584	207	52	(	(	-LRB-
10_1101-2021_01_06_425584	207	53	Figure	Figure	NNP
10_1101-2021_01_06_425584	207	54	S1A	s1a	NN
10_1101-2021_01_06_425584	207	55	)	)	-RRB-
10_1101-2021_01_06_425584	207	56	.	.	.
10_1101-2021_01_06_425584	208	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	208	2	suggest	suggest	VBP
10_1101-2021_01_06_425584	208	3	that	that	IN
10_1101-2021_01_06_425584	208	4	protein	protein	NN
10_1101-2021_01_06_425584	208	5	synthesis	synthesis	NN
10_1101-2021_01_06_425584	208	6	is	be	VBZ
10_1101-2021_01_06_425584	208	7	increased	increase	VBN
10_1101-2021_01_06_425584	208	8	as	as	IN
10_1101-2021_01_06_425584	208	9	a	a	DT
10_1101-2021_01_06_425584	208	10	consequence	consequence	NN
10_1101-2021_01_06_425584	208	11	of	of	IN
10_1101-2021_01_06_425584	208	12	the	the	DT
10_1101-2021_01_06_425584	208	13	higher	high	JJR
10_1101-2021_01_06_425584	208	14	396	396	CD
10_1101-2021_01_06_425584	208	15	presence	presence	NN
10_1101-2021_01_06_425584	208	16	of	of	IN
10_1101-2021_01_06_425584	208	17	bi	bi	JJ
10_1101-2021_01_06_425584	208	18	-	-	JJ
10_1101-2021_01_06_425584	208	19	nucleated	nucleate	VBN
10_1101-2021_01_06_425584	208	20	CAEC	CAEC	NNP
10_1101-2021_01_06_425584	208	21	(	(	-LRB-
10_1101-2021_01_06_425584	208	22	with	with	IN
10_1101-2021_01_06_425584	208	23	increased	increase	VBN
10_1101-2021_01_06_425584	208	24	DNA	DNA	NNP
10_1101-2021_01_06_425584	208	25	/	/	SYM
10_1101-2021_01_06_425584	208	26	RNA	RNA	NNP
10_1101-2021_01_06_425584	208	27	metabolism	metabolism	NN
10_1101-2021_01_06_425584	208	28	)	)	-RRB-
10_1101-2021_01_06_425584	208	29	under	under	IN
10_1101-2021_01_06_425584	208	30	HG	HG	NNP
10_1101-2021_01_06_425584	208	31	+	+	CC
10_1101-2021_01_06_425584	208	32	HI	HI	NNP
10_1101-2021_01_06_425584	208	33	compared	compare	VBN
10_1101-2021_01_06_425584	208	34	397	397	CD
10_1101-2021_01_06_425584	208	35	to	to	IN
10_1101-2021_01_06_425584	208	36	that	that	DT
10_1101-2021_01_06_425584	208	37	in	in	IN
10_1101-2021_01_06_425584	208	38	the	the	DT
10_1101-2021_01_06_425584	208	39	control	control	NN
10_1101-2021_01_06_425584	208	40	cohort	cohort	NN
10_1101-2021_01_06_425584	208	41	(	(	-LRB-
10_1101-2021_01_06_425584	208	42	Figure	figure	NN
10_1101-2021_01_06_425584	208	43	7A	7a	NN
10_1101-2021_01_06_425584	208	44	and	and	CC
10_1101-2021_01_06_425584	208	45	7B	7b	NN
10_1101-2021_01_06_425584	208	46	)	)	-RRB-
10_1101-2021_01_06_425584	208	47	.	.	.
10_1101-2021_01_06_425584	209	1	Previous	previous	JJ
10_1101-2021_01_06_425584	209	2	studies	study	NNS
10_1101-2021_01_06_425584	209	3	have	have	VBP
10_1101-2021_01_06_425584	209	4	shown	show	VBN
10_1101-2021_01_06_425584	209	5	reduced	reduce	VBN
10_1101-2021_01_06_425584	209	6	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	209	7	398	398	CD
10_1101-2021_01_06_425584	209	8	cell	cell	NN
10_1101-2021_01_06_425584	209	9	proliferation	proliferation	NN
10_1101-2021_01_06_425584	209	10	(	(	-LRB-
10_1101-2021_01_06_425584	209	11	mostly	mostly	RB
10_1101-2021_01_06_425584	209	12	in	in	IN
10_1101-2021_01_06_425584	209	13	HUVEC	HUVEC	NNP
10_1101-2021_01_06_425584	209	14	)	)	-RRB-
10_1101-2021_01_06_425584	209	15	after	after	IN
10_1101-2021_01_06_425584	209	16	long	long	JJ
10_1101-2021_01_06_425584	209	17	-	-	HYPH
10_1101-2021_01_06_425584	209	18	term	term	NN
10_1101-2021_01_06_425584	209	19	(	(	-LRB-
10_1101-2021_01_06_425584	209	20	7	7	CD
10_1101-2021_01_06_425584	209	21	-	-	SYM
10_1101-2021_01_06_425584	209	22	14	14	CD
10_1101-2021_01_06_425584	209	23	days	day	NNS
10_1101-2021_01_06_425584	209	24	)	)	-RRB-
10_1101-2021_01_06_425584	209	25	HG	HG	NNP
10_1101-2021_01_06_425584	209	26	exposure	exposure	NN
10_1101-2021_01_06_425584	209	27	(	(	-LRB-
10_1101-2021_01_06_425584	209	28	4	4	CD
10_1101-2021_01_06_425584	209	29	,	,	,
10_1101-2021_01_06_425584	209	30	11	11	CD
10_1101-2021_01_06_425584	209	31	,	,	,
10_1101-2021_01_06_425584	209	32	47	47	CD
10_1101-2021_01_06_425584	209	33	-	-	SYM
10_1101-2021_01_06_425584	209	34	53	53	CD
10_1101-2021_01_06_425584	209	35	)	)	-RRB-
10_1101-2021_01_06_425584	209	36	,	,	,
10_1101-2021_01_06_425584	209	37	399	399	CD
10_1101-2021_01_06_425584	209	38	accompanied	accompany	VBN
10_1101-2021_01_06_425584	209	39	by	by	IN
10_1101-2021_01_06_425584	209	40	an	an	DT
10_1101-2021_01_06_425584	209	41	increase	increase	NN
10_1101-2021_01_06_425584	209	42	in	in	IN
10_1101-2021_01_06_425584	209	43	protein	protein	NN
10_1101-2021_01_06_425584	209	44	synthesis	synthesis	NN
10_1101-2021_01_06_425584	209	45	(	(	-LRB-
10_1101-2021_01_06_425584	209	46	53	53	CD
10_1101-2021_01_06_425584	209	47	)	)	-RRB-
10_1101-2021_01_06_425584	209	48	.	.	.
10_1101-2021_01_06_425584	210	1	This	this	DT
10_1101-2021_01_06_425584	210	2	MS	MS	NNP
10_1101-2021_01_06_425584	210	3	-	-	HYPH
10_1101-2021_01_06_425584	210	4	based	base	VBN
10_1101-2021_01_06_425584	210	5	methodological	methodological	JJ
10_1101-2021_01_06_425584	210	6	pipeline	pipeline	NN
10_1101-2021_01_06_425584	210	7	400	400	CD
10_1101-2021_01_06_425584	210	8	that	that	WDT
10_1101-2021_01_06_425584	210	9	included	include	VBD
10_1101-2021_01_06_425584	210	10	appropriate	appropriate	JJ
10_1101-2021_01_06_425584	210	11	controls	control	NNS
10_1101-2021_01_06_425584	210	12	during	during	IN
10_1101-2021_01_06_425584	210	13	data	datum	NNS
10_1101-2021_01_06_425584	210	14	acquisition	acquisition	NN
10_1101-2021_01_06_425584	210	15	(	(	-LRB-
10_1101-2021_01_06_425584	210	16	QC	QC	NNP
10_1101-2021_01_06_425584	210	17	)	)	-RRB-
10_1101-2021_01_06_425584	210	18	and	and	CC
10_1101-2021_01_06_425584	210	19	processing	processing	NN
10_1101-2021_01_06_425584	210	20	(	(	-LRB-
10_1101-2021_01_06_425584	210	21	e.g.	e.g.	RB
10_1101-2021_01_06_425584	210	22	,	,	,
10_1101-2021_01_06_425584	210	23	401	401	CD
10_1101-2021_01_06_425584	210	24	normalization	normalization	NN
10_1101-2021_01_06_425584	210	25	,	,	,
10_1101-2021_01_06_425584	210	26	filtering	filtering	NN
10_1101-2021_01_06_425584	210	27	,	,	,
10_1101-2021_01_06_425584	210	28	annotation	annotation	NN
10_1101-2021_01_06_425584	210	29	,	,	,
10_1101-2021_01_06_425584	210	30	dereplication	dereplication	NN
10_1101-2021_01_06_425584	210	31	,	,	,
10_1101-2021_01_06_425584	210	32	etc	etc	FW
10_1101-2021_01_06_425584	210	33	.	.	.
10_1101-2021_01_06_425584	211	1	)	)	-RRB-
10_1101-2021_01_06_425584	211	2	,	,	,
10_1101-2021_01_06_425584	211	3	allowed	allow	VBD
10_1101-2021_01_06_425584	211	4	the	the	DT
10_1101-2021_01_06_425584	211	5	identification	identification	NN
10_1101-2021_01_06_425584	211	6	of	of	IN
10_1101-2021_01_06_425584	211	7	global	global	JJ
10_1101-2021_01_06_425584	211	8	402	402	CD
10_1101-2021_01_06_425584	211	9	changes	change	NNS
10_1101-2021_01_06_425584	211	10	in	in	IN
10_1101-2021_01_06_425584	211	11	the	the	DT
10_1101-2021_01_06_425584	211	12	metabolome	metabolome	NN
10_1101-2021_01_06_425584	211	13	of	of	IN
10_1101-2021_01_06_425584	211	14	CAEC	caec	NN
10_1101-2021_01_06_425584	211	15	under	under	IN
10_1101-2021_01_06_425584	211	16	HG	HG	NNP
10_1101-2021_01_06_425584	211	17	+	+	CC
10_1101-2021_01_06_425584	211	18	HI	hi	UH
10_1101-2021_01_06_425584	211	19	.	.	.
10_1101-2021_01_06_425584	212	1	Specifically	specifically	RB
10_1101-2021_01_06_425584	212	2	,	,	,
10_1101-2021_01_06_425584	212	3	increased	increase	VBN
10_1101-2021_01_06_425584	212	4	abundance	abundance	NN
10_1101-2021_01_06_425584	212	5	of	of	IN
10_1101-2021_01_06_425584	212	6	valine	valine	NN
10_1101-2021_01_06_425584	212	7	,	,	,
10_1101-2021_01_06_425584	212	8	403	403	CD
10_1101-2021_01_06_425584	212	9	leucine	leucine	NN
10_1101-2021_01_06_425584	212	10	,	,	,
10_1101-2021_01_06_425584	212	11	tyrosine	tyrosine	NN
10_1101-2021_01_06_425584	212	12	,	,	,
10_1101-2021_01_06_425584	212	13	serine	serine	NNP
10_1101-2021_01_06_425584	212	14	,	,	,
10_1101-2021_01_06_425584	212	15	leucine	leucine	NNP
10_1101-2021_01_06_425584	212	16	,	,	,
10_1101-2021_01_06_425584	212	17	proline	proline	NNP
10_1101-2021_01_06_425584	212	18	,	,	,
10_1101-2021_01_06_425584	212	19	methionine	methionine	NN
10_1101-2021_01_06_425584	212	20	,	,	,
10_1101-2021_01_06_425584	212	21	and	and	CC
10_1101-2021_01_06_425584	212	22	glutamic	glutamic	NN
10_1101-2021_01_06_425584	212	23	acid	acid	NN
10_1101-2021_01_06_425584	212	24	in	in	IN
10_1101-2021_01_06_425584	212	25	cells	cell	NNS
10_1101-2021_01_06_425584	212	26	under	under	IN
10_1101-2021_01_06_425584	212	27	HG	HG	NNP
10_1101-2021_01_06_425584	212	28	404	404	CD
10_1101-2021_01_06_425584	212	29	conditions	condition	NNS
10_1101-2021_01_06_425584	212	30	was	be	VBD
10_1101-2021_01_06_425584	212	31	observed	observe	VBN
10_1101-2021_01_06_425584	212	32	;	;	:
10_1101-2021_01_06_425584	212	33	and	and	CC
10_1101-2021_01_06_425584	212	34	this	this	DT
10_1101-2021_01_06_425584	212	35	is	be	VBZ
10_1101-2021_01_06_425584	212	36	consistent	consistent	JJ
10_1101-2021_01_06_425584	212	37	with	with	IN
10_1101-2021_01_06_425584	212	38	reports	report	NNS
10_1101-2021_01_06_425584	212	39	on	on	IN
10_1101-2021_01_06_425584	212	40	human	human	JJ
10_1101-2021_01_06_425584	212	41	aortic	aortic	JJ
10_1101-2021_01_06_425584	212	42	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	212	43	cells	cell	NNS
10_1101-2021_01_06_425584	212	44	405	405	CD
10_1101-2021_01_06_425584	212	45	(	(	-LRB-
10_1101-2021_01_06_425584	212	46	54	54	CD
10_1101-2021_01_06_425584	212	47	)	)	-RRB-
10_1101-2021_01_06_425584	212	48	.	.	.
10_1101-2021_01_06_425584	213	1	Notably	notably	RB
10_1101-2021_01_06_425584	213	2	,	,	,
10_1101-2021_01_06_425584	213	3	several	several	JJ
10_1101-2021_01_06_425584	213	4	clinical	clinical	JJ
10_1101-2021_01_06_425584	213	5	studies	study	NNS
10_1101-2021_01_06_425584	213	6	have	have	VBP
10_1101-2021_01_06_425584	213	7	established	establish	VBN
10_1101-2021_01_06_425584	213	8	a	a	DT
10_1101-2021_01_06_425584	213	9	direct	direct	JJ
10_1101-2021_01_06_425584	213	10	relationship	relationship	NN
10_1101-2021_01_06_425584	213	11	between	between	IN
10_1101-2021_01_06_425584	213	12	406	406	CD
10_1101-2021_01_06_425584	213	13	prevalence	prevalence	NN
10_1101-2021_01_06_425584	213	14	/	/	SYM
10_1101-2021_01_06_425584	213	15	incidence	incidence	NN
10_1101-2021_01_06_425584	213	16	of	of	IN
10_1101-2021_01_06_425584	213	17	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	213	18	and	and	CC
10_1101-2021_01_06_425584	213	19	increased	increase	VBN
10_1101-2021_01_06_425584	213	20	levels	level	NNS
10_1101-2021_01_06_425584	213	21	of	of	IN
10_1101-2021_01_06_425584	213	22	valine	valine	NN
10_1101-2021_01_06_425584	213	23	,	,	,
10_1101-2021_01_06_425584	213	24	leucine	leucine	NN
10_1101-2021_01_06_425584	213	25	and	and	CC
10_1101-2021_01_06_425584	213	26	tyrosine	tyrosine	NN
10_1101-2021_01_06_425584	213	27	in	in	IN
10_1101-2021_01_06_425584	213	28	serum	serum	NN
10_1101-2021_01_06_425584	213	29	and	and	CC
10_1101-2021_01_06_425584	213	30	407	407	CD
10_1101-2021_01_06_425584	213	31	plasma	plasma	NN
10_1101-2021_01_06_425584	213	32	(	(	-LRB-
10_1101-2021_01_06_425584	213	33	55	55	CD
10_1101-2021_01_06_425584	213	34	-	-	SYM
10_1101-2021_01_06_425584	213	35	59	59	CD
10_1101-2021_01_06_425584	213	36	)	)	-RRB-
10_1101-2021_01_06_425584	213	37	.	.	.
10_1101-2021_01_06_425584	214	1	Our	-PRON-	PRP$
10_1101-2021_01_06_425584	214	2	results	result	NNS
10_1101-2021_01_06_425584	214	3	support	support	VBP
10_1101-2021_01_06_425584	214	4	the	the	DT
10_1101-2021_01_06_425584	214	5	role	role	NN
10_1101-2021_01_06_425584	214	6	of	of	IN
10_1101-2021_01_06_425584	214	7	CAEC	caec	NN
10_1101-2021_01_06_425584	214	8	in	in	IN
10_1101-2021_01_06_425584	214	9	contributing	contribute	VBG
10_1101-2021_01_06_425584	214	10	to	to	IN
10_1101-2021_01_06_425584	214	11	the	the	DT
10_1101-2021_01_06_425584	214	12	elevated	elevated	JJ
10_1101-2021_01_06_425584	214	13	pool	pool	NN
10_1101-2021_01_06_425584	214	14	of	of	IN
10_1101-2021_01_06_425584	214	15	amino	amino	JJ
10_1101-2021_01_06_425584	214	16	408	408	CD
10_1101-2021_01_06_425584	214	17	acids	acid	NNS
10_1101-2021_01_06_425584	214	18	seen	see	VBN
10_1101-2021_01_06_425584	214	19	in	in	IN
10_1101-2021_01_06_425584	214	20	circulation	circulation	NN
10_1101-2021_01_06_425584	214	21	under	under	IN
10_1101-2021_01_06_425584	214	22	a	a	DT
10_1101-2021_01_06_425584	214	23	HG	HG	NNP
10_1101-2021_01_06_425584	214	24	environment	environment	NN
10_1101-2021_01_06_425584	214	25	.	.	.
10_1101-2021_01_06_425584	215	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	215	2	speculate	speculate	VBP
10_1101-2021_01_06_425584	215	3	that	that	IN
10_1101-2021_01_06_425584	215	4	increased	increase	VBN
10_1101-2021_01_06_425584	215	5	levels	level	NNS
10_1101-2021_01_06_425584	215	6	of	of	IN
10_1101-2021_01_06_425584	215	7	these	these	DT
10_1101-2021_01_06_425584	215	8	409	409	CD
10_1101-2021_01_06_425584	215	9	amino	amino	JJ
10_1101-2021_01_06_425584	215	10	acids	acid	NNS
10_1101-2021_01_06_425584	215	11	could	could	MD
10_1101-2021_01_06_425584	215	12	result	result	VB
10_1101-2021_01_06_425584	215	13	from	from	IN
10_1101-2021_01_06_425584	215	14	either	either	DT
10_1101-2021_01_06_425584	215	15	increased	increase	VBN
10_1101-2021_01_06_425584	215	16	production	production	NN
10_1101-2021_01_06_425584	215	17	or	or	CC
10_1101-2021_01_06_425584	215	18	reduced	reduced	JJ
10_1101-2021_01_06_425584	215	19	degradation	degradation	NN
10_1101-2021_01_06_425584	215	20	as	as	IN
10_1101-2021_01_06_425584	215	21	suggested	suggest	VBD
10_1101-2021_01_06_425584	215	22	410	410	CD
10_1101-2021_01_06_425584	215	23	in	in	IN
10_1101-2021_01_06_425584	215	24	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	215	25	cells	cell	NNS
10_1101-2021_01_06_425584	215	26	(	(	-LRB-
10_1101-2021_01_06_425584	215	27	immortalized	immortalize	VBN
10_1101-2021_01_06_425584	215	28	cell	cell	NN
10_1101-2021_01_06_425584	215	29	line	line	NN
10_1101-2021_01_06_425584	215	30	,	,	,
10_1101-2021_01_06_425584	215	31	EA.hy	EA.hy	NNP
10_1101-2021_01_06_425584	215	32	926	926	CD
10_1101-2021_01_06_425584	215	33	)	)	-RRB-
10_1101-2021_01_06_425584	215	34	that	that	DT
10_1101-2021_01_06_425584	215	35	transition	transition	NN
10_1101-2021_01_06_425584	215	36	from	from	IN
10_1101-2021_01_06_425584	215	37	a	a	DT
10_1101-2021_01_06_425584	215	38	glycolytic	glycolytic	JJ
10_1101-2021_01_06_425584	215	39	metabolism	metabolism	NN
10_1101-2021_01_06_425584	215	40	411	411	CD
10_1101-2021_01_06_425584	215	41	towards	towards	IN
10_1101-2021_01_06_425584	215	42	lipid	lipid	NN
10_1101-2021_01_06_425584	215	43	and	and	CC
10_1101-2021_01_06_425584	215	44	amino	amino	JJ
10_1101-2021_01_06_425584	215	45	acid	acid	NN
10_1101-2021_01_06_425584	215	46	oxidation	oxidation	NN
10_1101-2021_01_06_425584	215	47	when	when	WRB
10_1101-2021_01_06_425584	215	48	challenged	challenge	VBN
10_1101-2021_01_06_425584	215	49	by	by	IN
10_1101-2021_01_06_425584	215	50	HG	HG	NNP
10_1101-2021_01_06_425584	215	51	(	(	-LRB-
10_1101-2021_01_06_425584	215	52	60	60	CD
10_1101-2021_01_06_425584	215	53	)	)	-RRB-
10_1101-2021_01_06_425584	215	54	.	.	.
10_1101-2021_01_06_425584	216	1	Furthermore	furthermore	RB
10_1101-2021_01_06_425584	216	2	,	,	,
10_1101-2021_01_06_425584	216	3	evidence	evidence	NN
10_1101-2021_01_06_425584	216	4	of	of	IN
10_1101-2021_01_06_425584	216	5	412	412	CD
10_1101-2021_01_06_425584	216	6	increased	increase	VBN
10_1101-2021_01_06_425584	216	7	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	216	8	catabolism	catabolism	NN
10_1101-2021_01_06_425584	216	9	was	be	VBD
10_1101-2021_01_06_425584	216	10	identified	identify	VBN
10_1101-2021_01_06_425584	216	11	through	through	IN
10_1101-2021_01_06_425584	216	12	the	the	DT
10_1101-2021_01_06_425584	216	13	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	216	14	pathway	pathway	NN
10_1101-2021_01_06_425584	216	15	.	.	.
10_1101-2021_01_06_425584	217	1	In	in	IN
10_1101-2021_01_06_425584	217	2	this	this	DT
10_1101-2021_01_06_425584	217	3	regard	regard	NN
10_1101-2021_01_06_425584	217	4	,	,	,
10_1101-2021_01_06_425584	217	5	a	a	DT
10_1101-2021_01_06_425584	217	6	413	413	CD
10_1101-2021_01_06_425584	217	7	non	non	JJ
10_1101-2021_01_06_425584	217	8	-	-	JJ
10_1101-2021_01_06_425584	217	9	significant	significant	JJ
10_1101-2021_01_06_425584	217	10	decrease	decrease	NN
10_1101-2021_01_06_425584	217	11	of	of	IN
10_1101-2021_01_06_425584	217	12	~	~	NFP
10_1101-2021_01_06_425584	217	13	40	40	CD
10_1101-2021_01_06_425584	217	14	%	%	NN
10_1101-2021_01_06_425584	217	15	in	in	IN
10_1101-2021_01_06_425584	217	16	the	the	DT
10_1101-2021_01_06_425584	217	17	abundance	abundance	NN
10_1101-2021_01_06_425584	217	18	of	of	IN
10_1101-2021_01_06_425584	217	19	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	217	20	was	be	VBD
10_1101-2021_01_06_425584	217	21	detected	detect	VBN
10_1101-2021_01_06_425584	217	22	.	.	.
10_1101-2021_01_06_425584	218	1	However	however	RB
10_1101-2021_01_06_425584	218	2	,	,	,
10_1101-2021_01_06_425584	218	3	a	a	DT
10_1101-2021_01_06_425584	218	4	414	414	CD
10_1101-2021_01_06_425584	218	5	significant	significant	JJ
10_1101-2021_01_06_425584	218	6	increase	increase	NN
10_1101-2021_01_06_425584	218	7	of	of	IN
10_1101-2021_01_06_425584	218	8	~	~	NFP
10_1101-2021_01_06_425584	218	9	450	450	CD
10_1101-2021_01_06_425584	218	10	%	%	NN
10_1101-2021_01_06_425584	218	11	in	in	IN
10_1101-2021_01_06_425584	218	12	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	218	13	(	(	-LRB-
10_1101-2021_01_06_425584	218	14	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	218	15	’s	’s	POS
10_1101-2021_01_06_425584	218	16	main	main	JJ
10_1101-2021_01_06_425584	218	17	metabolite	metabolite	NN
10_1101-2021_01_06_425584	218	18	)	)	-RRB-
10_1101-2021_01_06_425584	218	19	(	(	-LRB-
10_1101-2021_01_06_425584	218	20	61	61	CD
10_1101-2021_01_06_425584	218	21	)	)	-RRB-
10_1101-2021_01_06_425584	218	22	between	between	IN
10_1101-2021_01_06_425584	218	23	the	the	DT
10_1101-2021_01_06_425584	218	24	HG	HG	NNP
10_1101-2021_01_06_425584	218	25	415	415	CD
10_1101-2021_01_06_425584	218	26	+	+	CC
10_1101-2021_01_06_425584	218	27	HI	HI	NNP
10_1101-2021_01_06_425584	218	28	group	group	NN
10_1101-2021_01_06_425584	218	29	and	and	CC
10_1101-2021_01_06_425584	218	30	NG	NG	NNP
10_1101-2021_01_06_425584	218	31	group	group	NN
10_1101-2021_01_06_425584	218	32	was	be	VBD
10_1101-2021_01_06_425584	218	33	also	also	RB
10_1101-2021_01_06_425584	218	34	observed	observe	VBN
10_1101-2021_01_06_425584	218	35	,	,	,
10_1101-2021_01_06_425584	218	36	which	which	WDT
10_1101-2021_01_06_425584	218	37	is	be	VBZ
10_1101-2021_01_06_425584	218	38	a	a	DT
10_1101-2021_01_06_425584	218	39	key	key	JJ
10_1101-2021_01_06_425584	218	40	finding	finding	NN
10_1101-2021_01_06_425584	218	41	as	as	IN
10_1101-2021_01_06_425584	218	42	elevated	elevated	JJ
10_1101-2021_01_06_425584	218	43	plasma	plasma	NN
10_1101-2021_01_06_425584	218	44	levels	level	NNS
10_1101-2021_01_06_425584	218	45	of	of	IN
10_1101-2021_01_06_425584	218	46	416	416	CD
10_1101-2021_01_06_425584	218	47	kynurenine	kynurenine	NNS
10_1101-2021_01_06_425584	218	48	are	be	VBP
10_1101-2021_01_06_425584	218	49	known	know	VBN
10_1101-2021_01_06_425584	218	50	to	to	TO
10_1101-2021_01_06_425584	218	51	increase	increase	VB
10_1101-2021_01_06_425584	218	52	CVD	CVD	NNP
10_1101-2021_01_06_425584	218	53	risk	risk	NN
10_1101-2021_01_06_425584	218	54	(	(	-LRB-
10_1101-2021_01_06_425584	218	55	62	62	CD
10_1101-2021_01_06_425584	218	56	,	,	,
10_1101-2021_01_06_425584	218	57	63	63	CD
10_1101-2021_01_06_425584	218	58	)	)	-RRB-
10_1101-2021_01_06_425584	218	59	.	.	.
10_1101-2021_01_06_425584	219	1	This	this	DT
10_1101-2021_01_06_425584	219	2	novel	novel	JJ
10_1101-2021_01_06_425584	219	3	finding	finding	NN
10_1101-2021_01_06_425584	219	4	contributes	contribute	NNS
10_1101-2021_01_06_425584	219	5	to	to	IN
10_1101-2021_01_06_425584	219	6	expanding	expand	VBG
10_1101-2021_01_06_425584	219	7	417	417	CD
10_1101-2021_01_06_425584	219	8	the	the	DT
10_1101-2021_01_06_425584	219	9	understanding	understanding	NN
10_1101-2021_01_06_425584	219	10	of	of	IN
10_1101-2021_01_06_425584	219	11	amino	amino	JJ
10_1101-2021_01_06_425584	219	12	acid	acid	NN
10_1101-2021_01_06_425584	219	13	metabolism	metabolism	NN
10_1101-2021_01_06_425584	219	14	in	in	IN
10_1101-2021_01_06_425584	219	15	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	219	16	cells	cell	NNS
10_1101-2021_01_06_425584	219	17	under	under	IN
10_1101-2021_01_06_425584	219	18	simulated	simulated	JJ
10_1101-2021_01_06_425584	219	19	diabetes	diabete	NNS
10_1101-2021_01_06_425584	219	20	.	.	.
10_1101-2021_01_06_425584	220	1	Acetyl	Acetyl	NNP
10_1101-2021_01_06_425584	220	2	418	418	CD
10_1101-2021_01_06_425584	220	3	serotonin	serotonin	NN
10_1101-2021_01_06_425584	220	4	and	and	CC
10_1101-2021_01_06_425584	220	5	melatonin	melatonin	NN
10_1101-2021_01_06_425584	220	6	which	which	WDT
10_1101-2021_01_06_425584	220	7	are	be	VBP
10_1101-2021_01_06_425584	220	8	components	component	NNS
10_1101-2021_01_06_425584	220	9	of	of	IN
10_1101-2021_01_06_425584	220	10	the	the	DT
10_1101-2021_01_06_425584	220	11	serotonin	serotonin	JJ
10_1101-2021_01_06_425584	220	12	pathway	pathway	NN
10_1101-2021_01_06_425584	220	13	that	that	WDT
10_1101-2021_01_06_425584	220	14	degrades	degrade	VBZ
10_1101-2021_01_06_425584	220	15	419	419	CD
10_1101-2021_01_06_425584	220	16	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	220	17	(	(	-LRB-
10_1101-2021_01_06_425584	220	18	64	64	CD
10_1101-2021_01_06_425584	220	19	)	)	-RRB-
10_1101-2021_01_06_425584	220	20	were	be	VBD
10_1101-2021_01_06_425584	220	21	also	also	RB
10_1101-2021_01_06_425584	220	22	detected	detect	VBN
10_1101-2021_01_06_425584	220	23	with	with	IN
10_1101-2021_01_06_425584	220	24	only	only	JJ
10_1101-2021_01_06_425584	220	25	minor	minor	JJ
10_1101-2021_01_06_425584	220	26	abundancy	abundancy	NN
10_1101-2021_01_06_425584	220	27	increases	increase	NNS
10_1101-2021_01_06_425584	220	28	(	(	-LRB-
10_1101-2021_01_06_425584	220	29	20	20	CD
10_1101-2021_01_06_425584	220	30	-	-	SYM
10_1101-2021_01_06_425584	220	31	30	30	CD
10_1101-2021_01_06_425584	220	32	%	%	NN
10_1101-2021_01_06_425584	220	33	)	)	-RRB-
10_1101-2021_01_06_425584	220	34	in	in	IN
10_1101-2021_01_06_425584	220	35	the	the	DT
10_1101-2021_01_06_425584	220	36	HG	HG	NNP
10_1101-2021_01_06_425584	220	37	+	+	CC
10_1101-2021_01_06_425584	220	38	420	420	CD
10_1101-2021_01_06_425584	220	39	HI	HI	NNP
10_1101-2021_01_06_425584	220	40	group	group	NN
10_1101-2021_01_06_425584	220	41	compared	compare	VBN
10_1101-2021_01_06_425584	220	42	to	to	IN
10_1101-2021_01_06_425584	220	43	control	control	NN
10_1101-2021_01_06_425584	220	44	.	.	.
10_1101-2021_01_06_425584	221	1	Differences	difference	NNS
10_1101-2021_01_06_425584	221	2	in	in	IN
10_1101-2021_01_06_425584	221	3	glutathione	glutathione	NN
10_1101-2021_01_06_425584	221	4	(	(	-LRB-
10_1101-2021_01_06_425584	221	5	cysteine	cysteine	JJ
10_1101-2021_01_06_425584	221	6	-	-	HYPH
10_1101-2021_01_06_425584	221	7	glutamic	glutamic	JJ
10_1101-2021_01_06_425584	221	8	acid	acid	NN
10_1101-2021_01_06_425584	221	9	-	-	HYPH
10_1101-2021_01_06_425584	221	10	glycine	glycine	NN
10_1101-2021_01_06_425584	221	11	,	,	,
10_1101-2021_01_06_425584	221	12	421	421	CD
10_1101-2021_01_06_425584	221	13	tripeptide	tripeptide	NN
10_1101-2021_01_06_425584	221	14	)	)	-RRB-
10_1101-2021_01_06_425584	221	15	metabolism	metabolism	NN
10_1101-2021_01_06_425584	221	16	in	in	IN
10_1101-2021_01_06_425584	221	17	CAEC	caec	NN
10_1101-2021_01_06_425584	221	18	were	be	VBD
10_1101-2021_01_06_425584	221	19	also	also	RB
10_1101-2021_01_06_425584	221	20	found	find	VBN
10_1101-2021_01_06_425584	221	21	,	,	,
10_1101-2021_01_06_425584	221	22	suggesting	suggest	VBG
10_1101-2021_01_06_425584	221	23	an	an	DT
10_1101-2021_01_06_425584	221	24	increased	increase	VBN
10_1101-2021_01_06_425584	221	25	response	response	NN
10_1101-2021_01_06_425584	221	26	to	to	IN
10_1101-2021_01_06_425584	221	27	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	221	28	422	422	CD
10_1101-2021_01_06_425584	221	29	stress	stress	NN
10_1101-2021_01_06_425584	221	30	(	(	-LRB-
10_1101-2021_01_06_425584	221	31	65	65	CD
10_1101-2021_01_06_425584	221	32	)	)	-RRB-
10_1101-2021_01_06_425584	221	33	.	.	.
10_1101-2021_01_06_425584	222	1	In	in	IN
10_1101-2021_01_06_425584	222	2	line	line	NN
10_1101-2021_01_06_425584	222	3	with	with	IN
10_1101-2021_01_06_425584	222	4	this	this	DT
10_1101-2021_01_06_425584	222	5	observation	observation	NN
10_1101-2021_01_06_425584	222	6	,	,	,
10_1101-2021_01_06_425584	222	7	previous	previous	JJ
10_1101-2021_01_06_425584	222	8	research	research	NN
10_1101-2021_01_06_425584	222	9	reported	report	VBD
10_1101-2021_01_06_425584	222	10	a	a	DT
10_1101-2021_01_06_425584	222	11	glutathione	glutathione	NN
10_1101-2021_01_06_425584	222	12	-	-	HYPH
10_1101-2021_01_06_425584	222	13	dependent	dependent	JJ
10_1101-2021_01_06_425584	222	14	423	423	CD
10_1101-2021_01_06_425584	222	15	.CC	.CC	,
10_1101-2021_01_06_425584	222	16	-	-	HYPH
10_1101-2021_01_06_425584	222	17	BY	by	IN
10_1101-2021_01_06_425584	222	18	-	-	HYPH
10_1101-2021_01_06_425584	222	19	NC	NC	NNP
10_1101-2021_01_06_425584	222	20	-	-	HYPH
10_1101-2021_01_06_425584	222	21	ND	ND	NNP
10_1101-2021_01_06_425584	222	22	4.0	4.0	CD
10_1101-2021_01_06_425584	222	23	International	International	NNP
10_1101-2021_01_06_425584	222	24	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	222	25	under	under	IN
10_1101-2021_01_06_425584	222	26	a	a	DT
10_1101-2021_01_06_425584	222	27	(	(	-LRB-
10_1101-2021_01_06_425584	222	28	which	which	WDT
10_1101-2021_01_06_425584	222	29	was	be	VBD
10_1101-2021_01_06_425584	222	30	not	not	RB
10_1101-2021_01_06_425584	222	31	certified	certify	VBN
10_1101-2021_01_06_425584	222	32	by	by	IN
10_1101-2021_01_06_425584	222	33	peer	peer	NN
10_1101-2021_01_06_425584	222	34	review	review	NN
10_1101-2021_01_06_425584	222	35	)	)	-RRB-
10_1101-2021_01_06_425584	222	36	is	be	VBZ
10_1101-2021_01_06_425584	222	37	the	the	DT
10_1101-2021_01_06_425584	222	38	author	author	NN
10_1101-2021_01_06_425584	222	39	/	/	SYM
10_1101-2021_01_06_425584	222	40	funder	funder	NN
10_1101-2021_01_06_425584	222	41	,	,	,
10_1101-2021_01_06_425584	222	42	who	who	WP
10_1101-2021_01_06_425584	222	43	has	have	VBZ
10_1101-2021_01_06_425584	222	44	granted	grant	VBN
10_1101-2021_01_06_425584	222	45	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	222	46	a	a	DT
10_1101-2021_01_06_425584	222	47	license	license	NN
10_1101-2021_01_06_425584	222	48	to	to	TO
10_1101-2021_01_06_425584	222	49	display	display	VB
10_1101-2021_01_06_425584	222	50	the	the	DT
10_1101-2021_01_06_425584	222	51	preprint	preprint	NN
10_1101-2021_01_06_425584	222	52	in	in	IN
10_1101-2021_01_06_425584	222	53	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	222	54	.	.	.
10_1101-2021_01_06_425584	223	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	223	2	is	be	VBZ
10_1101-2021_01_06_425584	223	3	made	make	VBN
10_1101-2021_01_06_425584	223	4	The	the	DT
10_1101-2021_01_06_425584	223	5	copyright	copyright	NN
10_1101-2021_01_06_425584	223	6	holder	holder	NN
10_1101-2021_01_06_425584	223	7	for	for	IN
10_1101-2021_01_06_425584	223	8	this	this	DT
10_1101-2021_01_06_425584	223	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	223	10	version	version	NN
10_1101-2021_01_06_425584	223	11	posted	post	VBD
10_1101-2021_01_06_425584	223	12	January	January	NNP
10_1101-2021_01_06_425584	223	13	8	8	CD
10_1101-2021_01_06_425584	223	14	,	,	,
10_1101-2021_01_06_425584	223	15	2021	2021	CD
10_1101-2021_01_06_425584	223	16	.	.	.
10_1101-2021_01_06_425584	223	17	;	;	:
10_1101-2021_01_06_425584	223	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	223	19	:	:	:
10_1101-2021_01_06_425584	223	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	223	21	preprint	preprint	NN
10_1101-2021_01_06_425584	223	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	223	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	223	24	14	14	CD
10_1101-2021_01_06_425584	223	25	reaction	reaction	NN
10_1101-2021_01_06_425584	223	26	to	to	TO
10_1101-2021_01_06_425584	223	27	ambient	ambient	JJ
10_1101-2021_01_06_425584	223	28	HG	HG	NNP
10_1101-2021_01_06_425584	223	29	in	in	IN
10_1101-2021_01_06_425584	223	30	artery	artery	NN
10_1101-2021_01_06_425584	223	31	-	-	HYPH
10_1101-2021_01_06_425584	223	32	derived	derive	VBN
10_1101-2021_01_06_425584	223	33	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	223	34	cells	cell	NNS
10_1101-2021_01_06_425584	223	35	(	(	-LRB-
10_1101-2021_01_06_425584	223	36	66	66	CD
10_1101-2021_01_06_425584	223	37	,	,	,
10_1101-2021_01_06_425584	223	38	67	67	CD
10_1101-2021_01_06_425584	223	39	)	)	-RRB-
10_1101-2021_01_06_425584	223	40	but	but	CC
10_1101-2021_01_06_425584	223	41	the	the	DT
10_1101-2021_01_06_425584	223	42	same	same	JJ
10_1101-2021_01_06_425584	223	43	could	could	MD
10_1101-2021_01_06_425584	223	44	not	not	RB
10_1101-2021_01_06_425584	223	45	be	be	VB
10_1101-2021_01_06_425584	223	46	424	424	CD
10_1101-2021_01_06_425584	223	47	observed	observe	VBN
10_1101-2021_01_06_425584	223	48	in	in	IN
10_1101-2021_01_06_425584	223	49	vein	vein	NN
10_1101-2021_01_06_425584	223	50	-	-	HYPH
10_1101-2021_01_06_425584	223	51	derived	derive	VBN
10_1101-2021_01_06_425584	223	52	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	223	53	cells	cell	NNS
10_1101-2021_01_06_425584	223	54	(	(	-LRB-
10_1101-2021_01_06_425584	223	55	68	68	CD
10_1101-2021_01_06_425584	223	56	,	,	,
10_1101-2021_01_06_425584	223	57	69	69	CD
10_1101-2021_01_06_425584	223	58	)	)	-RRB-
10_1101-2021_01_06_425584	223	59	.	.	.
10_1101-2021_01_06_425584	224	1	This	this	DT
10_1101-2021_01_06_425584	224	2	emphasizes	emphasize	VBZ
10_1101-2021_01_06_425584	224	3	the	the	DT
10_1101-2021_01_06_425584	224	4	different	different	JJ
10_1101-2021_01_06_425584	224	5	responses	response	NNS
10_1101-2021_01_06_425584	224	6	to	to	IN
10_1101-2021_01_06_425584	224	7	425	425	CD
10_1101-2021_01_06_425584	224	8	HG	HG	NNP
10_1101-2021_01_06_425584	224	9	among	among	IN
10_1101-2021_01_06_425584	224	10	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	224	11	phenotypes	phenotype	NNS
10_1101-2021_01_06_425584	224	12	.	.	.
10_1101-2021_01_06_425584	225	1	Here	here	RB
10_1101-2021_01_06_425584	225	2	,	,	,
10_1101-2021_01_06_425584	225	3	novel	novel	JJ
10_1101-2021_01_06_425584	225	4	evidence	evidence	NN
10_1101-2021_01_06_425584	225	5	is	be	VBZ
10_1101-2021_01_06_425584	225	6	provided	provide	VBN
10_1101-2021_01_06_425584	225	7	of	of	IN
10_1101-2021_01_06_425584	225	8	the	the	DT
10_1101-2021_01_06_425584	225	9	up	up	JJ
10_1101-2021_01_06_425584	225	10	-	-	HYPH
10_1101-2021_01_06_425584	225	11	regulation	regulation	NN
10_1101-2021_01_06_425584	225	12	of	of	IN
10_1101-2021_01_06_425584	225	13	426	426	CD
10_1101-2021_01_06_425584	225	14	glutathione	glutathione	NN
10_1101-2021_01_06_425584	225	15	-	-	HYPH
10_1101-2021_01_06_425584	225	16	based	base	VBN
10_1101-2021_01_06_425584	225	17	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	225	18	.	.	.
10_1101-2021_01_06_425584	226	1	The	the	DT
10_1101-2021_01_06_425584	226	2	composite	composite	JJ
10_1101-2021_01_06_425584	226	3	protein	protein	NN
10_1101-2021_01_06_425584	226	4	network	network	NN
10_1101-2021_01_06_425584	226	5	suggested	suggest	VBD
10_1101-2021_01_06_425584	226	6	an	an	DT
10_1101-2021_01_06_425584	226	7	increase	increase	NN
10_1101-2021_01_06_425584	226	8	in	in	IN
10_1101-2021_01_06_425584	226	9	427	427	CD
10_1101-2021_01_06_425584	226	10	glutathione	glutathione	NN
10_1101-2021_01_06_425584	226	11	metabolism	metabolism	NN
10_1101-2021_01_06_425584	226	12	supported	support	VBN
10_1101-2021_01_06_425584	226	13	by	by	IN
10_1101-2021_01_06_425584	226	14	elevated	elevated	JJ
10_1101-2021_01_06_425584	226	15	levels	level	NNS
10_1101-2021_01_06_425584	226	16	of	of	IN
10_1101-2021_01_06_425584	226	17	oxidized	oxidized	JJ
10_1101-2021_01_06_425584	226	18	glutathione	glutathione	NN
10_1101-2021_01_06_425584	226	19	and	and	CC
10_1101-2021_01_06_425584	226	20	,	,	,
10_1101-2021_01_06_425584	226	21	one	one	CD
10_1101-2021_01_06_425584	226	22	of	of	IN
10_1101-2021_01_06_425584	226	23	its	-PRON-	PRP$
10_1101-2021_01_06_425584	226	24	428	428	CD
10_1101-2021_01_06_425584	226	25	synthetic	synthetic	JJ
10_1101-2021_01_06_425584	226	26	precursors	precursor	NNS
10_1101-2021_01_06_425584	226	27	,	,	,
10_1101-2021_01_06_425584	226	28	glutamic	glutamic	JJ
10_1101-2021_01_06_425584	226	29	acid	acid	NN
10_1101-2021_01_06_425584	226	30	.	.	.
10_1101-2021_01_06_425584	227	1	At	at	IN
10_1101-2021_01_06_425584	227	2	the	the	DT
10_1101-2021_01_06_425584	227	3	protein	protein	NN
10_1101-2021_01_06_425584	227	4	level	level	NN
10_1101-2021_01_06_425584	227	5	,	,	,
10_1101-2021_01_06_425584	227	6	peroxiredoxin	peroxiredoxin	NN
10_1101-2021_01_06_425584	227	7	(	(	-LRB-
10_1101-2021_01_06_425584	227	8	PRDX2	PRDX2	NNS
10_1101-2021_01_06_425584	227	9	and	and	CC
10_1101-2021_01_06_425584	227	10	PRDX6	prdx6	NN
10_1101-2021_01_06_425584	227	11	)	)	-RRB-
10_1101-2021_01_06_425584	227	12	and	and	CC
10_1101-2021_01_06_425584	227	13	429	429	CD
10_1101-2021_01_06_425584	227	14	thioredoxin	thioredoxin	NN
10_1101-2021_01_06_425584	227	15	(	(	-LRB-
10_1101-2021_01_06_425584	227	16	TXN2	txn2	UH
10_1101-2021_01_06_425584	227	17	,	,	,
10_1101-2021_01_06_425584	227	18	mitochondrial	mitochondrial	NN
10_1101-2021_01_06_425584	227	19	)	)	-RRB-
10_1101-2021_01_06_425584	227	20	showed	show	VBD
10_1101-2021_01_06_425584	227	21	increased	increase	VBN
10_1101-2021_01_06_425584	227	22	abundances	abundance	NNS
10_1101-2021_01_06_425584	227	23	in	in	IN
10_1101-2021_01_06_425584	227	24	the	the	DT
10_1101-2021_01_06_425584	227	25	experimental	experimental	JJ
10_1101-2021_01_06_425584	227	26	group	group	NN
10_1101-2021_01_06_425584	227	27	,	,	,
10_1101-2021_01_06_425584	227	28	430	430	CD
10_1101-2021_01_06_425584	227	29	which	which	WDT
10_1101-2021_01_06_425584	227	30	are	be	VBP
10_1101-2021_01_06_425584	227	31	part	part	NN
10_1101-2021_01_06_425584	227	32	of	of	IN
10_1101-2021_01_06_425584	227	33	the	the	DT
10_1101-2021_01_06_425584	227	34	cells	cell	NNS
10_1101-2021_01_06_425584	227	35	natural	natural	JJ
10_1101-2021_01_06_425584	227	36	enzymatic	enzymatic	JJ
10_1101-2021_01_06_425584	227	37	defense	defense	NN
10_1101-2021_01_06_425584	227	38	against	against	IN
10_1101-2021_01_06_425584	227	39	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	227	40	stress	stress	NN
10_1101-2021_01_06_425584	227	41	(	(	-LRB-
10_1101-2021_01_06_425584	227	42	70	70	CD
10_1101-2021_01_06_425584	227	43	)	)	-RRB-
10_1101-2021_01_06_425584	227	44	.	.	.
10_1101-2021_01_06_425584	228	1	The	the	DT
10_1101-2021_01_06_425584	228	2	431	431	CD
10_1101-2021_01_06_425584	228	3	substructure	substructure	NN
10_1101-2021_01_06_425584	228	4	analysis	analysis	NN
10_1101-2021_01_06_425584	228	5	of	of	IN
10_1101-2021_01_06_425584	228	6	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	228	7	data	datum	NNS
10_1101-2021_01_06_425584	228	8	facilitated	facilitate	VBN
10_1101-2021_01_06_425584	228	9	identifying	identify	VBG
10_1101-2021_01_06_425584	228	10	glutamic	glutamic	NNP
10_1101-2021_01_06_425584	228	11	acid-	acid-	NNP
10_1101-2021_01_06_425584	228	12	and	and	CC
10_1101-2021_01_06_425584	228	13	432	432	CD
10_1101-2021_01_06_425584	228	14	phenylalanine	phenylalanine	NN
10_1101-2021_01_06_425584	228	15	-	-	HYPH
10_1101-2021_01_06_425584	228	16	based	base	VBN
10_1101-2021_01_06_425584	228	17	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	228	18	,	,	,
10_1101-2021_01_06_425584	228	19	presumably	presumably	RB
10_1101-2021_01_06_425584	228	20	di-	di-	NNP
10_1101-2021_01_06_425584	228	21	or	or	CC
10_1101-2021_01_06_425584	228	22	tri	tri	NNS
10_1101-2021_01_06_425584	228	23	-	-	NNS
10_1101-2021_01_06_425584	228	24	peptides	peptide	NNS
10_1101-2021_01_06_425584	228	25	,	,	,
10_1101-2021_01_06_425584	228	26	including	include	VBG
10_1101-2021_01_06_425584	228	27	the	the	DT
10_1101-2021_01_06_425584	228	28	annotated	annotate	VBN
10_1101-2021_01_06_425584	228	29	433	433	CD
10_1101-2021_01_06_425584	228	30	metabolite	metabolite	NNP
10_1101-2021_01_06_425584	228	31	glutamyl	glutamyl	NNP
10_1101-2021_01_06_425584	228	32	-	-	HYPH
10_1101-2021_01_06_425584	228	33	phenylalanine	phenylalanine	NNP
10_1101-2021_01_06_425584	228	34	.	.	.
10_1101-2021_01_06_425584	229	1	Furthermore	furthermore	RB
10_1101-2021_01_06_425584	229	2	,	,	,
10_1101-2021_01_06_425584	229	3	the	the	DT
10_1101-2021_01_06_425584	229	4	CAEC	caec	NN
10_1101-2021_01_06_425584	229	5	peptidome	peptidome	VBP
10_1101-2021_01_06_425584	229	6	analysis	analysis	NN
10_1101-2021_01_06_425584	229	7	suggested	suggest	VBD
10_1101-2021_01_06_425584	229	8	an	an	DT
10_1101-2021_01_06_425584	229	9	434	434	CD
10_1101-2021_01_06_425584	229	10	increase	increase	NN
10_1101-2021_01_06_425584	229	11	in	in	IN
10_1101-2021_01_06_425584	229	12	proline	proline	NN
10_1101-2021_01_06_425584	229	13	-	-	HYPH
10_1101-2021_01_06_425584	229	14	containing	contain	VBG
10_1101-2021_01_06_425584	229	15	peptides	peptide	NNS
10_1101-2021_01_06_425584	229	16	.	.	.
10_1101-2021_01_06_425584	230	1	This	this	DT
10_1101-2021_01_06_425584	230	2	type	type	NN
10_1101-2021_01_06_425584	230	3	of	of	IN
10_1101-2021_01_06_425584	230	4	peptide	peptide	NN
10_1101-2021_01_06_425584	230	5	is	be	VBZ
10_1101-2021_01_06_425584	230	6	of	of	IN
10_1101-2021_01_06_425584	230	7	particular	particular	JJ
10_1101-2021_01_06_425584	230	8	interest	interest	NN
10_1101-2021_01_06_425584	230	9	because	because	IN
10_1101-2021_01_06_425584	230	10	of	of	IN
10_1101-2021_01_06_425584	230	11	435	435	CD
10_1101-2021_01_06_425584	230	12	their	-PRON-	PRP$
10_1101-2021_01_06_425584	230	13	resistance	resistance	NN
10_1101-2021_01_06_425584	230	14	to	to	IN
10_1101-2021_01_06_425584	230	15	non	non	JJ
10_1101-2021_01_06_425584	230	16	-	-	JJ
10_1101-2021_01_06_425584	230	17	specific	specific	JJ
10_1101-2021_01_06_425584	230	18	proteolytic	proteolytic	JJ
10_1101-2021_01_06_425584	230	19	degradation	degradation	NN
10_1101-2021_01_06_425584	230	20	,	,	,
10_1101-2021_01_06_425584	230	21	body	body	NN
10_1101-2021_01_06_425584	230	22	distribution	distribution	NN
10_1101-2021_01_06_425584	230	23	and	and	CC
10_1101-2021_01_06_425584	230	24	remarkable	remarkable	JJ
10_1101-2021_01_06_425584	230	25	436	436	CD
10_1101-2021_01_06_425584	230	26	biological	biological	JJ
10_1101-2021_01_06_425584	230	27	effects	effect	NNS
10_1101-2021_01_06_425584	230	28	(	(	-LRB-
10_1101-2021_01_06_425584	230	29	71	71	CD
10_1101-2021_01_06_425584	230	30	-	-	SYM
10_1101-2021_01_06_425584	230	31	74	74	CD
10_1101-2021_01_06_425584	230	32	)	)	-RRB-
10_1101-2021_01_06_425584	230	33	.	.	.
10_1101-2021_01_06_425584	231	1	Yet	yet	RB
10_1101-2021_01_06_425584	231	2	,	,	,
10_1101-2021_01_06_425584	231	3	the	the	DT
10_1101-2021_01_06_425584	231	4	precise	precise	JJ
10_1101-2021_01_06_425584	231	5	function	function	NN
10_1101-2021_01_06_425584	231	6	of	of	IN
10_1101-2021_01_06_425584	231	7	such	such	JJ
10_1101-2021_01_06_425584	231	8	phenylalanine-	phenylalanine-	NN
10_1101-2021_01_06_425584	231	9	,	,	,
10_1101-2021_01_06_425584	231	10	glutamine-	glutamine-	NNP
10_1101-2021_01_06_425584	231	11	,	,	,
10_1101-2021_01_06_425584	231	12	and	and	CC
10_1101-2021_01_06_425584	231	13	437	437	CD
10_1101-2021_01_06_425584	231	14	proline	proline	NN
10_1101-2021_01_06_425584	231	15	-	-	HYPH
10_1101-2021_01_06_425584	231	16	based	base	VBN
10_1101-2021_01_06_425584	231	17	peptides	peptide	NNS
10_1101-2021_01_06_425584	231	18	remains	remain	VBZ
10_1101-2021_01_06_425584	231	19	to	to	TO
10_1101-2021_01_06_425584	231	20	be	be	VB
10_1101-2021_01_06_425584	231	21	characterized	characterize	VBN
10_1101-2021_01_06_425584	231	22	in	in	IN
10_1101-2021_01_06_425584	231	23	CAEC	caec	NN
10_1101-2021_01_06_425584	231	24	.	.	.
10_1101-2021_01_06_425584	232	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	232	2	can	can	MD
10_1101-2021_01_06_425584	232	3	only	only	RB
10_1101-2021_01_06_425584	232	4	speculate	speculate	VB
10_1101-2021_01_06_425584	232	5	that	that	IN
10_1101-2021_01_06_425584	232	6	they	-PRON-	PRP
10_1101-2021_01_06_425584	232	7	438	438	CD
10_1101-2021_01_06_425584	232	8	are	be	VBP
10_1101-2021_01_06_425584	232	9	the	the	DT
10_1101-2021_01_06_425584	232	10	result	result	NN
10_1101-2021_01_06_425584	232	11	of	of	IN
10_1101-2021_01_06_425584	232	12	a	a	DT
10_1101-2021_01_06_425584	232	13	compensatory	compensatory	JJ
10_1101-2021_01_06_425584	232	14	mechanism	mechanism	NN
10_1101-2021_01_06_425584	232	15	to	to	TO
10_1101-2021_01_06_425584	232	16	reduce	reduce	VB
10_1101-2021_01_06_425584	232	17	glucose	glucose	NN
10_1101-2021_01_06_425584	232	18	cellular	cellular	JJ
10_1101-2021_01_06_425584	232	19	damage	damage	NN
10_1101-2021_01_06_425584	232	20	.	.	.
10_1101-2021_01_06_425584	233	1	Also	also	RB
10_1101-2021_01_06_425584	233	2	,	,	,
10_1101-2021_01_06_425584	233	3	increased	increase	VBD
10_1101-2021_01_06_425584	233	4	439	439	CD
10_1101-2021_01_06_425584	233	5	protein	protein	NN
10_1101-2021_01_06_425584	233	6	abundance	abundance	NN
10_1101-2021_01_06_425584	233	7	of	of	IN
10_1101-2021_01_06_425584	233	8	core	core	JJ
10_1101-2021_01_06_425584	233	9	and	and	CC
10_1101-2021_01_06_425584	233	10	regulatory	regulatory	JJ
10_1101-2021_01_06_425584	233	11	subunits	subunit	NNS
10_1101-2021_01_06_425584	233	12	from	from	IN
10_1101-2021_01_06_425584	233	13	the	the	DT
10_1101-2021_01_06_425584	233	14	proteasome	proteasome	JJ
10_1101-2021_01_06_425584	233	15	complex	complex	NN
10_1101-2021_01_06_425584	233	16	(	(	-LRB-
10_1101-2021_01_06_425584	233	17	PSMA4	psma4	NN
10_1101-2021_01_06_425584	233	18	and	and	CC
10_1101-2021_01_06_425584	233	19	440	440	CD
10_1101-2021_01_06_425584	233	20	PSMD3	PSMD3	NNP
10_1101-2021_01_06_425584	233	21	)	)	-RRB-
10_1101-2021_01_06_425584	233	22	was	be	VBD
10_1101-2021_01_06_425584	233	23	found	find	VBN
10_1101-2021_01_06_425584	233	24	in	in	IN
10_1101-2021_01_06_425584	233	25	cells	cell	NNS
10_1101-2021_01_06_425584	233	26	under	under	IN
10_1101-2021_01_06_425584	233	27	simulated	simulated	JJ
10_1101-2021_01_06_425584	233	28	diabetes	diabete	NNS
10_1101-2021_01_06_425584	233	29	.	.	.
10_1101-2021_01_06_425584	234	1	This	this	DT
10_1101-2021_01_06_425584	234	2	suggests	suggest	VBZ
10_1101-2021_01_06_425584	234	3	an	an	DT
10_1101-2021_01_06_425584	234	4	increased	increased	JJ
10_1101-2021_01_06_425584	234	5	protein	protein	NN
10_1101-2021_01_06_425584	234	6	441	441	CD
10_1101-2021_01_06_425584	234	7	degradation	degradation	NN
10_1101-2021_01_06_425584	234	8	and	and	CC
10_1101-2021_01_06_425584	234	9	subsequent	subsequent	JJ
10_1101-2021_01_06_425584	234	10	peptide	peptide	NN
10_1101-2021_01_06_425584	234	11	formation	formation	NN
10_1101-2021_01_06_425584	234	12	in	in	IN
10_1101-2021_01_06_425584	234	13	response	response	NN
10_1101-2021_01_06_425584	234	14	to	to	IN
10_1101-2021_01_06_425584	234	15	HG	HG	NNP
10_1101-2021_01_06_425584	234	16	.	.	.
10_1101-2021_01_06_425584	235	1	Metabolomic	metabolomic	JJ
10_1101-2021_01_06_425584	235	2	profiling	profiling	NN
10_1101-2021_01_06_425584	235	3	also	also	RB
10_1101-2021_01_06_425584	235	4	442	442	CD
10_1101-2021_01_06_425584	235	5	revealed	reveal	VBD
10_1101-2021_01_06_425584	235	6	changes	change	NNS
10_1101-2021_01_06_425584	235	7	in	in	IN
10_1101-2021_01_06_425584	235	8	the	the	DT
10_1101-2021_01_06_425584	235	9	lipidome	lipidome	NN
10_1101-2021_01_06_425584	235	10	of	of	IN
10_1101-2021_01_06_425584	235	11	CAEC	caec	NN
10_1101-2021_01_06_425584	235	12	challenged	challenge	VBN
10_1101-2021_01_06_425584	235	13	with	with	IN
10_1101-2021_01_06_425584	235	14	HG	HG	NNP
10_1101-2021_01_06_425584	235	15	+	+	CC
10_1101-2021_01_06_425584	235	16	HI	hi	UH
10_1101-2021_01_06_425584	235	17	,	,	,
10_1101-2021_01_06_425584	235	18	wherein	wherein	WRB
10_1101-2021_01_06_425584	235	19	a	a	DT
10_1101-2021_01_06_425584	235	20	reduction	reduction	NN
10_1101-2021_01_06_425584	235	21	in	in	IN
10_1101-2021_01_06_425584	235	22	443	443	CD
10_1101-2021_01_06_425584	235	23	phosphatidylcholine	phosphatidylcholine	NN
10_1101-2021_01_06_425584	235	24	(	(	-LRB-
10_1101-2021_01_06_425584	235	25	PC	PC	NNP
10_1101-2021_01_06_425584	235	26	)	)	-RRB-
10_1101-2021_01_06_425584	235	27	lipids	lipid	NNS
10_1101-2021_01_06_425584	235	28	and	and	CC
10_1101-2021_01_06_425584	235	29	subsequent	subsequent	JJ
10_1101-2021_01_06_425584	235	30	increase	increase	NN
10_1101-2021_01_06_425584	235	31	in	in	IN
10_1101-2021_01_06_425584	235	32	phosphocholine	phosphocholine	NN
10_1101-2021_01_06_425584	235	33	were	be	VBD
10_1101-2021_01_06_425584	235	34	noted	note	VBN
10_1101-2021_01_06_425584	235	35	.	.	.
10_1101-2021_01_06_425584	236	1	444	444	CD
10_1101-2021_01_06_425584	236	2	Changes	change	NNS
10_1101-2021_01_06_425584	236	3	in	in	IN
10_1101-2021_01_06_425584	236	4	the	the	DT
10_1101-2021_01_06_425584	236	5	phospholipidomic	phospholipidomic	JJ
10_1101-2021_01_06_425584	236	6	profile	profile	NN
10_1101-2021_01_06_425584	236	7	of	of	IN
10_1101-2021_01_06_425584	236	8	bovine	bovine	JJ
10_1101-2021_01_06_425584	236	9	aortic	aortic	JJ
10_1101-2021_01_06_425584	236	10	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	236	11	cells	cell	NNS
10_1101-2021_01_06_425584	236	12	treated	treat	VBN
10_1101-2021_01_06_425584	236	13	with	with	IN
10_1101-2021_01_06_425584	236	14	HG	HG	NNP
10_1101-2021_01_06_425584	236	15	for	for	IN
10_1101-2021_01_06_425584	236	16	24	24	CD
10_1101-2021_01_06_425584	236	17	445	445	CD
10_1101-2021_01_06_425584	236	18	h	h	NN
10_1101-2021_01_06_425584	236	19	has	have	VBZ
10_1101-2021_01_06_425584	236	20	also	also	RB
10_1101-2021_01_06_425584	236	21	been	be	VBN
10_1101-2021_01_06_425584	236	22	reported	report	VBN
10_1101-2021_01_06_425584	236	23	in	in	IN
10_1101-2021_01_06_425584	236	24	a	a	DT
10_1101-2021_01_06_425584	236	25	lipidome	lipidome	JJ
10_1101-2021_01_06_425584	236	26	study	study	NN
10_1101-2021_01_06_425584	236	27	(	(	-LRB-
10_1101-2021_01_06_425584	236	28	75	75	CD
10_1101-2021_01_06_425584	236	29	)	)	-RRB-
10_1101-2021_01_06_425584	236	30	.	.	.
10_1101-2021_01_06_425584	237	1	Here	here	RB
10_1101-2021_01_06_425584	237	2	,	,	,
10_1101-2021_01_06_425584	237	3	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	237	4	and	and	CC
10_1101-2021_01_06_425584	237	5	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	237	6	data	datum	NNS
10_1101-2021_01_06_425584	237	7	were	be	VBD
10_1101-2021_01_06_425584	237	8	446	446	CD
10_1101-2021_01_06_425584	237	9	manually	manually	RB
10_1101-2021_01_06_425584	237	10	integrated	integrate	VBN
10_1101-2021_01_06_425584	237	11	and	and	CC
10_1101-2021_01_06_425584	237	12	this	this	DT
10_1101-2021_01_06_425584	237	13	allowed	allow	VBD
10_1101-2021_01_06_425584	237	14	to	to	TO
10_1101-2021_01_06_425584	237	15	determine	determine	VB
10_1101-2021_01_06_425584	237	16	critical	critical	JJ
10_1101-2021_01_06_425584	237	17	roles	role	NNS
10_1101-2021_01_06_425584	237	18	for	for	IN
10_1101-2021_01_06_425584	237	19	PAFAH1B2	PAFAH1B2	NNP
10_1101-2021_01_06_425584	237	20	and	and	CC
10_1101-2021_01_06_425584	237	21	LYPLA1	LYPLA1	``
10_1101-2021_01_06_425584	237	22	in	in	IN
10_1101-2021_01_06_425584	237	23	447	447	CD
10_1101-2021_01_06_425584	237	24	mediating	mediate	VBG
10_1101-2021_01_06_425584	237	25	the	the	DT
10_1101-2021_01_06_425584	237	26	degradation	degradation	NN
10_1101-2021_01_06_425584	237	27	of	of	IN
10_1101-2021_01_06_425584	237	28	PC	pc	NN
10_1101-2021_01_06_425584	237	29	lipids	lipid	NNS
10_1101-2021_01_06_425584	237	30	(	(	-LRB-
10_1101-2021_01_06_425584	237	31	Figure	figure	NN
10_1101-2021_01_06_425584	237	32	8)	8)	CD
10_1101-2021_01_06_425584	237	33	.	.	.
10_1101-2021_01_06_425584	238	1	PAFAH1B2	PAFAH1B2	NNP
10_1101-2021_01_06_425584	238	2	was	be	VBD
10_1101-2021_01_06_425584	238	3	found	find	VBN
10_1101-2021_01_06_425584	238	4	to	to	TO
10_1101-2021_01_06_425584	238	5	be	be	VB
10_1101-2021_01_06_425584	238	6	up	up	RB
10_1101-2021_01_06_425584	238	7	-	-	HYPH
10_1101-2021_01_06_425584	238	8	regulated	regulated	JJ
10_1101-2021_01_06_425584	238	9	in	in	IN
10_1101-2021_01_06_425584	238	10	448	448	CD
10_1101-2021_01_06_425584	238	11	this	this	DT
10_1101-2021_01_06_425584	238	12	study	study	NN
10_1101-2021_01_06_425584	238	13	and	and	CC
10_1101-2021_01_06_425584	238	14	it	-PRON-	PRP
10_1101-2021_01_06_425584	238	15	is	be	VBZ
10_1101-2021_01_06_425584	238	16	known	know	VBN
10_1101-2021_01_06_425584	238	17	to	to	TO
10_1101-2021_01_06_425584	238	18	be	be	VB
10_1101-2021_01_06_425584	238	19	associated	associate	VBN
10_1101-2021_01_06_425584	238	20	with	with	IN
10_1101-2021_01_06_425584	238	21	inflammation	inflammation	NN
10_1101-2021_01_06_425584	238	22	and	and	CC
10_1101-2021_01_06_425584	238	23	higher	high	JJR
10_1101-2021_01_06_425584	238	24	levels	level	NNS
10_1101-2021_01_06_425584	238	25	of	of	IN
10_1101-2021_01_06_425584	238	26	lysoPC	lysoPC	NNP
10_1101-2021_01_06_425584	238	27	(	(	-LRB-
10_1101-2021_01_06_425584	238	28	76	76	CD
10_1101-2021_01_06_425584	238	29	)	)	-RRB-
10_1101-2021_01_06_425584	238	30	.	.	.
10_1101-2021_01_06_425584	239	1	As	as	IN
10_1101-2021_01_06_425584	239	2	449	449	CD
10_1101-2021_01_06_425584	239	3	a	a	DT
10_1101-2021_01_06_425584	239	4	result	result	NN
10_1101-2021_01_06_425584	239	5	,	,	,
10_1101-2021_01_06_425584	239	6	PAFAH1B2	PAFAH1B2	NNP
10_1101-2021_01_06_425584	239	7	could	could	MD
10_1101-2021_01_06_425584	239	8	increase	increase	VB
10_1101-2021_01_06_425584	239	9	the	the	DT
10_1101-2021_01_06_425584	239	10	pool	pool	NN
10_1101-2021_01_06_425584	239	11	of	of	IN
10_1101-2021_01_06_425584	239	12	lysoPC	lysoPC	NNP
10_1101-2021_01_06_425584	239	13	lipids	lipid	NNS
10_1101-2021_01_06_425584	239	14	,	,	,
10_1101-2021_01_06_425584	239	15	further	further	RB
10_1101-2021_01_06_425584	239	16	exacerbating	exacerbate	VBG
10_1101-2021_01_06_425584	239	17	inflammation	inflammation	NN
10_1101-2021_01_06_425584	239	18	450	450	CD
10_1101-2021_01_06_425584	239	19	in	in	IN
10_1101-2021_01_06_425584	239	20	the	the	DT
10_1101-2021_01_06_425584	239	21	cardiovascular	cardiovascular	JJ
10_1101-2021_01_06_425584	239	22	system	system	NN
10_1101-2021_01_06_425584	239	23	(	(	-LRB-
10_1101-2021_01_06_425584	239	24	77	77	CD
10_1101-2021_01_06_425584	239	25	)	)	-RRB-
10_1101-2021_01_06_425584	239	26	.	.	.
10_1101-2021_01_06_425584	240	1	On	on	IN
10_1101-2021_01_06_425584	240	2	the	the	DT
10_1101-2021_01_06_425584	240	3	other	other	JJ
10_1101-2021_01_06_425584	240	4	hand	hand	NN
10_1101-2021_01_06_425584	240	5	,	,	,
10_1101-2021_01_06_425584	240	6	LYPLA1	LYPLA1	NNP
10_1101-2021_01_06_425584	240	7	has	have	VBZ
10_1101-2021_01_06_425584	240	8	a	a	DT
10_1101-2021_01_06_425584	240	9	lysophospholipase	lysophospholipase	NN
10_1101-2021_01_06_425584	240	10	activity	activity	NN
10_1101-2021_01_06_425584	240	11	451	451	CD
10_1101-2021_01_06_425584	240	12	that	that	WDT
10_1101-2021_01_06_425584	240	13	can	can	MD
10_1101-2021_01_06_425584	240	14	hydrolyze	hydrolyze	VB
10_1101-2021_01_06_425584	240	15	a	a	DT
10_1101-2021_01_06_425584	240	16	range	range	NN
10_1101-2021_01_06_425584	240	17	of	of	IN
10_1101-2021_01_06_425584	240	18	lysophospholipids	lysophospholipid	NNS
10_1101-2021_01_06_425584	240	19	,	,	,
10_1101-2021_01_06_425584	240	20	including	include	VBG
10_1101-2021_01_06_425584	240	21	LysoPC	LysoPC	NNP
10_1101-2021_01_06_425584	240	22	,	,	,
10_1101-2021_01_06_425584	240	23	thereby	thereby	RB
10_1101-2021_01_06_425584	240	24	generating	generate	VBG
10_1101-2021_01_06_425584	240	25	a	a	DT
10_1101-2021_01_06_425584	240	26	fatty	fatty	NN
10_1101-2021_01_06_425584	240	27	452	452	CD
10_1101-2021_01_06_425584	240	28	acid	acid	NN
10_1101-2021_01_06_425584	240	29	and	and	CC
10_1101-2021_01_06_425584	240	30	glycerophosphocholine	glycerophosphocholine	NN
10_1101-2021_01_06_425584	240	31	as	as	IN
10_1101-2021_01_06_425584	240	32	products	product	NNS
10_1101-2021_01_06_425584	240	33	(	(	-LRB-
10_1101-2021_01_06_425584	240	34	78	78	CD
10_1101-2021_01_06_425584	240	35	)	)	-RRB-
10_1101-2021_01_06_425584	240	36	.	.	.
10_1101-2021_01_06_425584	241	1	Increased	increased	JJ
10_1101-2021_01_06_425584	241	2	levels	level	NNS
10_1101-2021_01_06_425584	241	3	of	of	IN
10_1101-2021_01_06_425584	241	4	phosphocholine	phosphocholine	NN
10_1101-2021_01_06_425584	241	5	(	(	-LRB-
10_1101-2021_01_06_425584	241	6	~	~	NFP
10_1101-2021_01_06_425584	241	7	460	460	CD
10_1101-2021_01_06_425584	241	8	%	%	NN
10_1101-2021_01_06_425584	241	9	)	)	-RRB-
10_1101-2021_01_06_425584	241	10	453	453	CD
10_1101-2021_01_06_425584	241	11	were	be	VBD
10_1101-2021_01_06_425584	241	12	detected	detect	VBN
10_1101-2021_01_06_425584	241	13	in	in	IN
10_1101-2021_01_06_425584	241	14	HG	HG	NNP
10_1101-2021_01_06_425584	241	15	treated	treat	VBN
10_1101-2021_01_06_425584	241	16	cells	cell	NNS
10_1101-2021_01_06_425584	241	17	compared	compare	VBN
10_1101-2021_01_06_425584	241	18	to	to	IN
10_1101-2021_01_06_425584	241	19	control	control	NN
10_1101-2021_01_06_425584	241	20	,	,	,
10_1101-2021_01_06_425584	241	21	that	that	DT
10_1101-2021_01_06_425584	241	22	could	could	MD
10_1101-2021_01_06_425584	241	23	be	be	VB
10_1101-2021_01_06_425584	241	24	associated	associate	VBN
10_1101-2021_01_06_425584	241	25	with	with	IN
10_1101-2021_01_06_425584	241	26	the	the	DT
10_1101-2021_01_06_425584	241	27	454	454	CD
10_1101-2021_01_06_425584	241	28	degradation	degradation	NN
10_1101-2021_01_06_425584	241	29	of	of	IN
10_1101-2021_01_06_425584	241	30	LysoPC	LysoPC	NNP
10_1101-2021_01_06_425584	241	31	lipids	lipid	VBZ
10_1101-2021_01_06_425584	241	32	.	.	.
10_1101-2021_01_06_425584	242	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	242	2	should	should	MD
10_1101-2021_01_06_425584	242	3	be	be	VB
10_1101-2021_01_06_425584	242	4	noted	note	VBN
10_1101-2021_01_06_425584	242	5	that	that	IN
10_1101-2021_01_06_425584	242	6	the	the	DT
10_1101-2021_01_06_425584	242	7	use	use	NN
10_1101-2021_01_06_425584	242	8	of	of	IN
10_1101-2021_01_06_425584	242	9	pathways	pathway	NNS
10_1101-2021_01_06_425584	242	10	databases	database	NNS
10_1101-2021_01_06_425584	242	11	such	such	JJ
10_1101-2021_01_06_425584	242	12	as	as	IN
10_1101-2021_01_06_425584	242	13	455	455	CD
10_1101-2021_01_06_425584	242	14	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	242	15	and	and	CC
10_1101-2021_01_06_425584	242	16	REACTOME	reactome	NN
10_1101-2021_01_06_425584	242	17	possess	possess	VBP
10_1101-2021_01_06_425584	242	18	some	some	DT
10_1101-2021_01_06_425584	242	19	limitations	limitation	NNS
10_1101-2021_01_06_425584	242	20	when	when	WRB
10_1101-2021_01_06_425584	242	21	dealing	deal	VBG
10_1101-2021_01_06_425584	242	22	with	with	IN
10_1101-2021_01_06_425584	242	23	lipid	lipid	NN
10_1101-2021_01_06_425584	242	24	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	242	25	because	because	IN
10_1101-2021_01_06_425584	242	26	456	456	CD
10_1101-2021_01_06_425584	242	27	its	-PRON-	PRP$
10_1101-2021_01_06_425584	242	28	chemical	chemical	NN
10_1101-2021_01_06_425584	242	29	diversity	diversity	NN
10_1101-2021_01_06_425584	242	30	is	be	VBZ
10_1101-2021_01_06_425584	242	31	not	not	RB
10_1101-2021_01_06_425584	242	32	well	well	RB
10_1101-2021_01_06_425584	242	33	annotated	annotate	VBN
10_1101-2021_01_06_425584	242	34	/	/	SYM
10_1101-2021_01_06_425584	242	35	defined	define	VBN
10_1101-2021_01_06_425584	242	36	within	within	IN
10_1101-2021_01_06_425584	242	37	the	the	DT
10_1101-2021_01_06_425584	242	38	databases	database	NNS
10_1101-2021_01_06_425584	242	39	.	.	.
10_1101-2021_01_06_425584	243	1	For	for	IN
10_1101-2021_01_06_425584	243	2	example	example	NN
10_1101-2021_01_06_425584	243	3	,	,	,
10_1101-2021_01_06_425584	243	4	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	243	5	457	457	CD
10_1101-2021_01_06_425584	243	6	.CC	.CC	:
10_1101-2021_01_06_425584	243	7	-	-	HYPH
10_1101-2021_01_06_425584	243	8	BY	by	IN
10_1101-2021_01_06_425584	243	9	-	-	HYPH
10_1101-2021_01_06_425584	243	10	NC	NC	NNP
10_1101-2021_01_06_425584	243	11	-	-	HYPH
10_1101-2021_01_06_425584	243	12	ND	ND	NNP
10_1101-2021_01_06_425584	243	13	4.0	4.0	CD
10_1101-2021_01_06_425584	243	14	International	International	NNP
10_1101-2021_01_06_425584	243	15	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	243	16	under	under	IN
10_1101-2021_01_06_425584	243	17	a	a	DT
10_1101-2021_01_06_425584	243	18	(	(	-LRB-
10_1101-2021_01_06_425584	243	19	which	which	WDT
10_1101-2021_01_06_425584	243	20	was	be	VBD
10_1101-2021_01_06_425584	243	21	not	not	RB
10_1101-2021_01_06_425584	243	22	certified	certify	VBN
10_1101-2021_01_06_425584	243	23	by	by	IN
10_1101-2021_01_06_425584	243	24	peer	peer	NN
10_1101-2021_01_06_425584	243	25	review	review	NN
10_1101-2021_01_06_425584	243	26	)	)	-RRB-
10_1101-2021_01_06_425584	243	27	is	be	VBZ
10_1101-2021_01_06_425584	243	28	the	the	DT
10_1101-2021_01_06_425584	243	29	author	author	NN
10_1101-2021_01_06_425584	243	30	/	/	SYM
10_1101-2021_01_06_425584	243	31	funder	funder	NN
10_1101-2021_01_06_425584	243	32	,	,	,
10_1101-2021_01_06_425584	243	33	who	who	WP
10_1101-2021_01_06_425584	243	34	has	have	VBZ
10_1101-2021_01_06_425584	243	35	granted	grant	VBN
10_1101-2021_01_06_425584	243	36	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	243	37	a	a	DT
10_1101-2021_01_06_425584	243	38	license	license	NN
10_1101-2021_01_06_425584	243	39	to	to	TO
10_1101-2021_01_06_425584	243	40	display	display	VB
10_1101-2021_01_06_425584	243	41	the	the	DT
10_1101-2021_01_06_425584	243	42	preprint	preprint	NN
10_1101-2021_01_06_425584	243	43	in	in	IN
10_1101-2021_01_06_425584	243	44	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	243	45	.	.	.
10_1101-2021_01_06_425584	244	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	244	2	is	be	VBZ
10_1101-2021_01_06_425584	244	3	made	make	VBN
10_1101-2021_01_06_425584	244	4	The	the	DT
10_1101-2021_01_06_425584	244	5	copyright	copyright	NN
10_1101-2021_01_06_425584	244	6	holder	holder	NN
10_1101-2021_01_06_425584	244	7	for	for	IN
10_1101-2021_01_06_425584	244	8	this	this	DT
10_1101-2021_01_06_425584	244	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	244	10	version	version	NN
10_1101-2021_01_06_425584	244	11	posted	post	VBD
10_1101-2021_01_06_425584	244	12	January	January	NNP
10_1101-2021_01_06_425584	244	13	8	8	CD
10_1101-2021_01_06_425584	244	14	,	,	,
10_1101-2021_01_06_425584	244	15	2021	2021	CD
10_1101-2021_01_06_425584	244	16	.	.	.
10_1101-2021_01_06_425584	244	17	;	;	:
10_1101-2021_01_06_425584	244	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	244	19	:	:	:
10_1101-2021_01_06_425584	244	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	244	21	preprint	preprint	NN
10_1101-2021_01_06_425584	244	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	244	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	244	24	15	15	CD
10_1101-2021_01_06_425584	244	25	provides	provide	VBZ
10_1101-2021_01_06_425584	244	26	a	a	DT
10_1101-2021_01_06_425584	244	27	chemical	chemical	JJ
10_1101-2021_01_06_425584	244	28	class	class	NN
10_1101-2021_01_06_425584	244	29	identifier	identifier	NN
10_1101-2021_01_06_425584	244	30	instead	instead	RB
10_1101-2021_01_06_425584	244	31	of	of	IN
10_1101-2021_01_06_425584	244	32	individual	individual	JJ
10_1101-2021_01_06_425584	244	33	identity	identity	NN
10_1101-2021_01_06_425584	244	34	to	to	IN
10_1101-2021_01_06_425584	244	35	lipids	lipid	NNS
10_1101-2021_01_06_425584	244	36	,	,	,
10_1101-2021_01_06_425584	244	37	constricting	constrict	VBG
10_1101-2021_01_06_425584	244	38	their	-PRON-	PRP$
10_1101-2021_01_06_425584	244	39	458	458	CD
10_1101-2021_01_06_425584	244	40	biological	biological	JJ
10_1101-2021_01_06_425584	244	41	importance	importance	NN
10_1101-2021_01_06_425584	244	42	(	(	-LRB-
10_1101-2021_01_06_425584	244	43	79	79	CD
10_1101-2021_01_06_425584	244	44	)	)	-RRB-
10_1101-2021_01_06_425584	244	45	.	.	.
10_1101-2021_01_06_425584	245	1	Thus	thus	RB
10_1101-2021_01_06_425584	245	2	,	,	,
10_1101-2021_01_06_425584	245	3	based	base	VBN
10_1101-2021_01_06_425584	245	4	on	on	IN
10_1101-2021_01_06_425584	245	5	our	-PRON-	PRP$
10_1101-2021_01_06_425584	245	6	manual	manual	JJ
10_1101-2021_01_06_425584	245	7	inspection	inspection	NN
10_1101-2021_01_06_425584	245	8	of	of	IN
10_1101-2021_01_06_425584	245	9	the	the	DT
10_1101-2021_01_06_425584	245	10	metabolomics-459	metabolomics-459	NNP
10_1101-2021_01_06_425584	245	11	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	245	12	data	datum	NNS
10_1101-2021_01_06_425584	245	13	and	and	CC
10_1101-2021_01_06_425584	245	14	in	in	IN
10_1101-2021_01_06_425584	245	15	line	line	NN
10_1101-2021_01_06_425584	245	16	with	with	IN
10_1101-2021_01_06_425584	245	17	the	the	DT
10_1101-2021_01_06_425584	245	18	evidence	evidence	NN
10_1101-2021_01_06_425584	245	19	,	,	,
10_1101-2021_01_06_425584	245	20	we	-PRON-	PRP
10_1101-2021_01_06_425584	245	21	suggest	suggest	VBP
10_1101-2021_01_06_425584	245	22	that	that	IN
10_1101-2021_01_06_425584	245	23	simulated	simulate	VBN
10_1101-2021_01_06_425584	245	24	diabetes	diabetes	NN
10_1101-2021_01_06_425584	245	25	evokes	evoke	VBZ
10_1101-2021_01_06_425584	245	26	460	460	CD
10_1101-2021_01_06_425584	245	27	inflammation	inflammation	NN
10_1101-2021_01_06_425584	245	28	on	on	IN
10_1101-2021_01_06_425584	245	29	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	245	30	and	and	CC
10_1101-2021_01_06_425584	245	31	that	that	IN
10_1101-2021_01_06_425584	245	32	PAFAH1B2	PAFAH1B2	NNP
10_1101-2021_01_06_425584	245	33	and	and	CC
10_1101-2021_01_06_425584	245	34	LYPLA1	LYPLA1	NNP
10_1101-2021_01_06_425584	245	35	play	play	VBP
10_1101-2021_01_06_425584	245	36	a	a	DT
10_1101-2021_01_06_425584	245	37	role	role	NN
10_1101-2021_01_06_425584	245	38	in	in	IN
10_1101-2021_01_06_425584	245	39	modulating	modulate	VBG
10_1101-2021_01_06_425584	245	40	such	such	JJ
10_1101-2021_01_06_425584	245	41	461	461	CD
10_1101-2021_01_06_425584	245	42	process	process	NN
10_1101-2021_01_06_425584	245	43	.	.	.
10_1101-2021_01_06_425584	246	1	462	462	CD
10_1101-2021_01_06_425584	246	2	Previously	previously	RB
10_1101-2021_01_06_425584	246	3	,	,	,
10_1101-2021_01_06_425584	246	4	we	-PRON-	PRP
10_1101-2021_01_06_425584	246	5	reported	report	VBD
10_1101-2021_01_06_425584	246	6	the	the	DT
10_1101-2021_01_06_425584	246	7	multinucleation	multinucleation	NN
10_1101-2021_01_06_425584	246	8	of	of	IN
10_1101-2021_01_06_425584	246	9	CAEC	caec	NN
10_1101-2021_01_06_425584	246	10	cultured	culture	VBN
10_1101-2021_01_06_425584	246	11	under	under	IN
10_1101-2021_01_06_425584	246	12	simulated	simulate	VBN
10_1101-2021_01_06_425584	246	13	diabetes	diabete	NNS
10_1101-2021_01_06_425584	246	14	(	(	-LRB-
10_1101-2021_01_06_425584	246	15	15	15	CD
10_1101-2021_01_06_425584	246	16	)	)	-RRB-
10_1101-2021_01_06_425584	246	17	.	.	.
10_1101-2021_01_06_425584	247	1	This	this	DT
10_1101-2021_01_06_425584	247	2	463	463	CD
10_1101-2021_01_06_425584	247	3	type	type	NN
10_1101-2021_01_06_425584	247	4	of	of	IN
10_1101-2021_01_06_425584	247	5	cell	cell	NN
10_1101-2021_01_06_425584	247	6	possesses	possess	VBZ
10_1101-2021_01_06_425584	247	7	≥2	≥2	NNP
10_1101-2021_01_06_425584	247	8	nuclei	nucleus	NNS
10_1101-2021_01_06_425584	247	9	.	.	.
10_1101-2021_01_06_425584	248	1	Here	here	RB
10_1101-2021_01_06_425584	248	2	,	,	,
10_1101-2021_01_06_425584	248	3	we	-PRON-	PRP
10_1101-2021_01_06_425584	248	4	replicated	replicate	VBD
10_1101-2021_01_06_425584	248	5	our	-PRON-	PRP$
10_1101-2021_01_06_425584	248	6	previous	previous	JJ
10_1101-2021_01_06_425584	248	7	findings	finding	NNS
10_1101-2021_01_06_425584	248	8	of	of	IN
10_1101-2021_01_06_425584	248	9	increased	increase	VBN
10_1101-2021_01_06_425584	248	10	464	464	CD
10_1101-2021_01_06_425584	248	11	binucleation	binucleation	NN
10_1101-2021_01_06_425584	248	12	in	in	IN
10_1101-2021_01_06_425584	248	13	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	248	14	.	.	.
10_1101-2021_01_06_425584	249	1	The	the	DT
10_1101-2021_01_06_425584	249	2	same	same	JJ
10_1101-2021_01_06_425584	249	3	outcome	outcome	NN
10_1101-2021_01_06_425584	249	4	was	be	VBD
10_1101-2021_01_06_425584	249	5	obtained	obtain	VBN
10_1101-2021_01_06_425584	249	6	when	when	WRB
10_1101-2021_01_06_425584	249	7	using	use	VBG
10_1101-2021_01_06_425584	249	8	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	249	9	as	as	IN
10_1101-2021_01_06_425584	249	10	a	a	DT
10_1101-2021_01_06_425584	249	11	human	human	NN
10_1101-2021_01_06_425584	249	12	in	in	FW
10_1101-2021_01_06_425584	249	13	vitro	vitro	FW
10_1101-2021_01_06_425584	249	14	465	465	CD
10_1101-2021_01_06_425584	249	15	model	model	NN
10_1101-2021_01_06_425584	249	16	(	(	-LRB-
10_1101-2021_01_06_425584	249	17	Figure	figure	NN
10_1101-2021_01_06_425584	249	18	7A	7a	NN
10_1101-2021_01_06_425584	249	19	and	and	CC
10_1101-2021_01_06_425584	249	20	7B	7b	NN
10_1101-2021_01_06_425584	249	21	)	)	-RRB-
10_1101-2021_01_06_425584	249	22	,	,	,
10_1101-2021_01_06_425584	249	23	validating	validate	VBG
10_1101-2021_01_06_425584	249	24	the	the	DT
10_1101-2021_01_06_425584	249	25	binucleation	binucleation	NN
10_1101-2021_01_06_425584	249	26	process	process	NN
10_1101-2021_01_06_425584	249	27	in	in	IN
10_1101-2021_01_06_425584	249	28	other	other	JJ
10_1101-2021_01_06_425584	249	29	CAEC	caec	NN
10_1101-2021_01_06_425584	249	30	.	.	.
10_1101-2021_01_06_425584	250	1	After	after	IN
10_1101-2021_01_06_425584	250	2	refinement	refinement	JJ
10_1101-2021_01_06_425584	250	3	466	466	CD
10_1101-2021_01_06_425584	250	4	of	of	IN
10_1101-2021_01_06_425584	250	5	LC	LC	NNP
10_1101-2021_01_06_425584	250	6	-	-	HYPH
10_1101-2021_01_06_425584	250	7	MS2	MS2	NNP
10_1101-2021_01_06_425584	250	8	data	datum	NNS
10_1101-2021_01_06_425584	250	9	and	and	CC
10_1101-2021_01_06_425584	250	10	bioinformatics	bioinformatic	NNS
10_1101-2021_01_06_425584	250	11	re	re	NN
10_1101-2021_01_06_425584	250	12	-	-	NN
10_1101-2021_01_06_425584	250	13	processing	processing	NN
10_1101-2021_01_06_425584	250	14	of	of	IN
10_1101-2021_01_06_425584	250	15	published	publish	VBN
10_1101-2021_01_06_425584	250	16	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	250	17	-	-	HYPH
10_1101-2021_01_06_425584	250	18	based	base	VBN
10_1101-2021_01_06_425584	250	19	datasets	dataset	NNS
10_1101-2021_01_06_425584	250	20	of	of	IN
10_1101-2021_01_06_425584	250	21	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	250	22	467	467	CD
10_1101-2021_01_06_425584	250	23	under	under	IN
10_1101-2021_01_06_425584	250	24	simulated	simulate	VBN
10_1101-2021_01_06_425584	250	25	diabetes	diabete	NNS
10_1101-2021_01_06_425584	250	26	(	(	-LRB-
10_1101-2021_01_06_425584	250	27	15	15	CD
10_1101-2021_01_06_425584	250	28	)	)	-RRB-
10_1101-2021_01_06_425584	250	29	,	,	,
10_1101-2021_01_06_425584	250	30	molecular	molecular	JJ
10_1101-2021_01_06_425584	250	31	signatures	signature	NNS
10_1101-2021_01_06_425584	250	32	and	and	CC
10_1101-2021_01_06_425584	250	33	pathways	pathway	NNS
10_1101-2021_01_06_425584	250	34	that	that	WDT
10_1101-2021_01_06_425584	250	35	could	could	MD
10_1101-2021_01_06_425584	250	36	be	be	VB
10_1101-2021_01_06_425584	250	37	linked	link	VBN
10_1101-2021_01_06_425584	250	38	to	to	IN
10_1101-2021_01_06_425584	250	39	the	the	DT
10_1101-2021_01_06_425584	250	40	468	468	CD
10_1101-2021_01_06_425584	250	41	binucleation	binucleation	NN
10_1101-2021_01_06_425584	250	42	process	process	NN
10_1101-2021_01_06_425584	250	43	were	be	VBD
10_1101-2021_01_06_425584	250	44	found	find	VBN
10_1101-2021_01_06_425584	250	45	(	(	-LRB-
10_1101-2021_01_06_425584	250	46	Figure	figure	NN
10_1101-2021_01_06_425584	250	47	8)	8)	CD
10_1101-2021_01_06_425584	250	48	.	.	.
10_1101-2021_01_06_425584	251	1	For	for	IN
10_1101-2021_01_06_425584	251	2	instance	instance	NN
10_1101-2021_01_06_425584	251	3	,	,	,
10_1101-2021_01_06_425584	251	4	we	-PRON-	PRP
10_1101-2021_01_06_425584	251	5	noted	note	VBD
10_1101-2021_01_06_425584	251	6	an	an	DT
10_1101-2021_01_06_425584	251	7	increased	increase	VBN
10_1101-2021_01_06_425584	251	8	abundance	abundance	NN
10_1101-2021_01_06_425584	251	9	of	of	IN
10_1101-2021_01_06_425584	251	10	469	469	CD
10_1101-2021_01_06_425584	251	11	proteins	protein	NNS
10_1101-2021_01_06_425584	251	12	,	,	,
10_1101-2021_01_06_425584	251	13	under	under	IN
10_1101-2021_01_06_425584	251	14	simulated	simulated	JJ
10_1101-2021_01_06_425584	251	15	diabetes	diabete	NNS
10_1101-2021_01_06_425584	251	16	,	,	,
10_1101-2021_01_06_425584	251	17	with	with	IN
10_1101-2021_01_06_425584	251	18	reported	report	VBN
10_1101-2021_01_06_425584	251	19	nuclei	nuclei	NN
10_1101-2021_01_06_425584	251	20	localization	localization	NN
10_1101-2021_01_06_425584	251	21	and	and	CC
10_1101-2021_01_06_425584	251	22	linked	link	VBN
10_1101-2021_01_06_425584	251	23	to	to	IN
10_1101-2021_01_06_425584	251	24	DNA	dna	NN
10_1101-2021_01_06_425584	251	25	470	470	CD
10_1101-2021_01_06_425584	251	26	metabolism	metabolism	NN
10_1101-2021_01_06_425584	251	27	,	,	,
10_1101-2021_01_06_425584	251	28	including	include	VBG
10_1101-2021_01_06_425584	251	29	ribosomal	ribosomal	JJ
10_1101-2021_01_06_425584	251	30	proteins	protein	NNS
10_1101-2021_01_06_425584	251	31	RPS7	RPS7	NNP
10_1101-2021_01_06_425584	251	32	,	,	,
10_1101-2021_01_06_425584	251	33	RPS13	RPS13	NNP
10_1101-2021_01_06_425584	251	34	,	,	,
10_1101-2021_01_06_425584	251	35	and	and	CC
10_1101-2021_01_06_425584	251	36	RPL9	RPL9	NNP
10_1101-2021_01_06_425584	251	37	(	(	-LRB-
10_1101-2021_01_06_425584	251	38	80	80	CD
10_1101-2021_01_06_425584	251	39	)	)	-RRB-
10_1101-2021_01_06_425584	251	40	.	.	.
10_1101-2021_01_06_425584	252	1	Further	further	RB
10_1101-2021_01_06_425584	252	2	,	,	,
10_1101-2021_01_06_425584	252	3	we	-PRON-	PRP
10_1101-2021_01_06_425584	252	4	observed	observe	VBD
10_1101-2021_01_06_425584	252	5	471	471	CD
10_1101-2021_01_06_425584	252	6	an	an	DT
10_1101-2021_01_06_425584	252	7	increased	increase	VBN
10_1101-2021_01_06_425584	252	8	abundance	abundance	NN
10_1101-2021_01_06_425584	252	9	of	of	IN
10_1101-2021_01_06_425584	252	10	proteasome	proteasome	JJ
10_1101-2021_01_06_425584	252	11	proteins	protein	NNS
10_1101-2021_01_06_425584	252	12	,	,	,
10_1101-2021_01_06_425584	252	13	PSMA4	PSMA4	''
10_1101-2021_01_06_425584	252	14	and	and	CC
10_1101-2021_01_06_425584	252	15	PSMD3	PSMD3	NNP
10_1101-2021_01_06_425584	252	16	,	,	,
10_1101-2021_01_06_425584	252	17	which	which	WDT
10_1101-2021_01_06_425584	252	18	are	be	VBP
10_1101-2021_01_06_425584	252	19	linked	link	VBN
10_1101-2021_01_06_425584	252	20	to	to	IN
10_1101-2021_01_06_425584	252	21	protein	protein	NN
10_1101-2021_01_06_425584	252	22	472	472	CD
10_1101-2021_01_06_425584	252	23	metabolism	metabolism	NN
10_1101-2021_01_06_425584	252	24	(	(	-LRB-
10_1101-2021_01_06_425584	252	25	81	81	CD
10_1101-2021_01_06_425584	252	26	)	)	-RRB-
10_1101-2021_01_06_425584	252	27	.	.	.
10_1101-2021_01_06_425584	253	1	Hence	hence	RB
10_1101-2021_01_06_425584	253	2	,	,	,
10_1101-2021_01_06_425584	253	3	we	-PRON-	PRP
10_1101-2021_01_06_425584	253	4	infer	infer	VBP
10_1101-2021_01_06_425584	253	5	that	that	IN
10_1101-2021_01_06_425584	253	6	the	the	DT
10_1101-2021_01_06_425584	253	7	CAEC	caec	NN
10_1101-2021_01_06_425584	253	8	binucleation	binucleation	NN
10_1101-2021_01_06_425584	253	9	occurs	occur	VBZ
10_1101-2021_01_06_425584	253	10	as	as	IN
10_1101-2021_01_06_425584	253	11	a	a	DT
10_1101-2021_01_06_425584	253	12	compensatory	compensatory	JJ
10_1101-2021_01_06_425584	253	13	473	473	CD
10_1101-2021_01_06_425584	253	14	mechanism	mechanism	NN
10_1101-2021_01_06_425584	253	15	to	to	TO
10_1101-2021_01_06_425584	253	16	increase	increase	VB
10_1101-2021_01_06_425584	253	17	the	the	DT
10_1101-2021_01_06_425584	253	18	cell	cell	NN
10_1101-2021_01_06_425584	253	19	capacity	capacity	NN
10_1101-2021_01_06_425584	253	20	to	to	TO
10_1101-2021_01_06_425584	253	21	metabolize	metabolize	VB
10_1101-2021_01_06_425584	253	22	the	the	DT
10_1101-2021_01_06_425584	253	23	excess	excess	NN
10_1101-2021_01_06_425584	253	24	of	of	IN
10_1101-2021_01_06_425584	253	25	ambient	ambient	JJ
10_1101-2021_01_06_425584	253	26	glucose	glucose	NN
10_1101-2021_01_06_425584	253	27	by	by	IN
10_1101-2021_01_06_425584	253	28	474	474	CD
10_1101-2021_01_06_425584	253	29	increasing	increase	VBG
10_1101-2021_01_06_425584	253	30	the	the	DT
10_1101-2021_01_06_425584	253	31	cell	cell	NN
10_1101-2021_01_06_425584	253	32	metabolic	metabolic	JJ
10_1101-2021_01_06_425584	253	33	machinery	machinery	NN
10_1101-2021_01_06_425584	253	34	(	(	-LRB-
10_1101-2021_01_06_425584	253	35	transcription	transcription	NN
10_1101-2021_01_06_425584	253	36	/	/	SYM
10_1101-2021_01_06_425584	253	37	translation	translation	NN
10_1101-2021_01_06_425584	253	38	processes	process	NNS
10_1101-2021_01_06_425584	253	39	)	)	-RRB-
10_1101-2021_01_06_425584	253	40	.	.	.
10_1101-2021_01_06_425584	254	1	Although	although	IN
10_1101-2021_01_06_425584	254	2	an	an	DT
10_1101-2021_01_06_425584	254	3	475	475	CD
10_1101-2021_01_06_425584	254	4	increase	increase	NN
10_1101-2021_01_06_425584	254	5	in	in	IN
10_1101-2021_01_06_425584	254	6	cell	cell	NN
10_1101-2021_01_06_425584	254	7	proliferation	proliferation	NN
10_1101-2021_01_06_425584	254	8	could	could	MD
10_1101-2021_01_06_425584	254	9	boost	boost	VB
10_1101-2021_01_06_425584	254	10	a	a	DT
10_1101-2021_01_06_425584	254	11	coordinated	coordinated	JJ
10_1101-2021_01_06_425584	254	12	increase	increase	NN
10_1101-2021_01_06_425584	254	13	of	of	IN
10_1101-2021_01_06_425584	254	14	ribosomal	ribosomal	NN
10_1101-2021_01_06_425584	254	15	and	and	CC
10_1101-2021_01_06_425584	254	16	proteasome	proteasome	JJ
10_1101-2021_01_06_425584	254	17	476	476	CD
10_1101-2021_01_06_425584	254	18	proteins	protein	NNS
10_1101-2021_01_06_425584	254	19	,	,	,
10_1101-2021_01_06_425584	254	20	we	-PRON-	PRP
10_1101-2021_01_06_425584	254	21	do	do	VBP
10_1101-2021_01_06_425584	254	22	not	not	RB
10_1101-2021_01_06_425584	254	23	believe	believe	VB
10_1101-2021_01_06_425584	254	24	this	this	DT
10_1101-2021_01_06_425584	254	25	is	be	VBZ
10_1101-2021_01_06_425584	254	26	the	the	DT
10_1101-2021_01_06_425584	254	27	case	case	NN
10_1101-2021_01_06_425584	254	28	here	here	RB
10_1101-2021_01_06_425584	254	29	,	,	,
10_1101-2021_01_06_425584	254	30	as	as	IN
10_1101-2021_01_06_425584	254	31	mentioned	mention	VBN
10_1101-2021_01_06_425584	254	32	before	before	RB
10_1101-2021_01_06_425584	254	33	.	.	.
10_1101-2021_01_06_425584	255	1	After	after	IN
10_1101-2021_01_06_425584	255	2	4	4	CD
10_1101-2021_01_06_425584	255	3	-	-	SYM
10_1101-2021_01_06_425584	255	4	5	5	CD
10_1101-2021_01_06_425584	255	5	days	day	NNS
10_1101-2021_01_06_425584	255	6	of	of	IN
10_1101-2021_01_06_425584	255	7	simulated	simulate	VBN
10_1101-2021_01_06_425584	255	8	477	477	CD
10_1101-2021_01_06_425584	255	9	diabetes	diabete	NNS
10_1101-2021_01_06_425584	255	10	,	,	,
10_1101-2021_01_06_425584	255	11	cells	cell	NNS
10_1101-2021_01_06_425584	255	12	occupied	occupy	VBD
10_1101-2021_01_06_425584	255	13	100	100	CD
10_1101-2021_01_06_425584	255	14	%	%	NN
10_1101-2021_01_06_425584	255	15	of	of	IN
10_1101-2021_01_06_425584	255	16	the	the	DT
10_1101-2021_01_06_425584	255	17	well	well	NN
10_1101-2021_01_06_425584	255	18	's	's	POS
10_1101-2021_01_06_425584	255	19	plate	plate	NN
10_1101-2021_01_06_425584	255	20	surface	surface	NN
10_1101-2021_01_06_425584	255	21	,	,	,
10_1101-2021_01_06_425584	255	22	thereby	thereby	RB
10_1101-2021_01_06_425584	255	23	impeding	impede	VBG
10_1101-2021_01_06_425584	255	24	to	to	TO
10_1101-2021_01_06_425584	255	25	harbor	harbor	VB
10_1101-2021_01_06_425584	255	26	more	more	JJR
10_1101-2021_01_06_425584	255	27	cells	cell	NNS
10_1101-2021_01_06_425584	255	28	478	478	CD
10_1101-2021_01_06_425584	255	29	because	because	IN
10_1101-2021_01_06_425584	255	30	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	255	31	cells	cell	NNS
10_1101-2021_01_06_425584	255	32	grow	grow	VBP
10_1101-2021_01_06_425584	255	33	as	as	IN
10_1101-2021_01_06_425584	255	34	a	a	DT
10_1101-2021_01_06_425584	255	35	monolayer	monolayer	NN
10_1101-2021_01_06_425584	255	36	.	.	.
10_1101-2021_01_06_425584	256	1	This	this	DT
10_1101-2021_01_06_425584	256	2	is	be	VBZ
10_1101-2021_01_06_425584	256	3	consistent	consistent	JJ
10_1101-2021_01_06_425584	256	4	with	with	IN
10_1101-2021_01_06_425584	256	5	findings	finding	NNS
10_1101-2021_01_06_425584	256	6	stating	state	VBG
10_1101-2021_01_06_425584	256	7	that	that	IN
10_1101-2021_01_06_425584	256	8	when	when	WRB
10_1101-2021_01_06_425584	256	9	479	479	CD
10_1101-2021_01_06_425584	256	10	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	256	11	cells	cell	NNS
10_1101-2021_01_06_425584	256	12	become	become	VBP
10_1101-2021_01_06_425584	256	13	highly	highly	RB
10_1101-2021_01_06_425584	256	14	confluent	confluent	JJ
10_1101-2021_01_06_425584	256	15	,	,	,
10_1101-2021_01_06_425584	256	16	they	-PRON-	PRP
10_1101-2021_01_06_425584	256	17	stop	stop	VBP
10_1101-2021_01_06_425584	256	18	growing	grow	VBG
10_1101-2021_01_06_425584	256	19	due	due	JJ
10_1101-2021_01_06_425584	256	20	to	to	IN
10_1101-2021_01_06_425584	256	21	cell	cell	NN
10_1101-2021_01_06_425584	256	22	-	-	HYPH
10_1101-2021_01_06_425584	256	23	cell	cell	NN
10_1101-2021_01_06_425584	256	24	contact	contact	NN
10_1101-2021_01_06_425584	256	25	,	,	,
10_1101-2021_01_06_425584	256	26	even	even	RB
10_1101-2021_01_06_425584	256	27	in	in	IN
10_1101-2021_01_06_425584	256	28	the	the	DT
10_1101-2021_01_06_425584	256	29	480	480	CD
10_1101-2021_01_06_425584	256	30	presence	presence	NN
10_1101-2021_01_06_425584	256	31	of	of	IN
10_1101-2021_01_06_425584	256	32	growth	growth	NN
10_1101-2021_01_06_425584	256	33	factors	factor	NNS
10_1101-2021_01_06_425584	256	34	(	(	-LRB-
10_1101-2021_01_06_425584	256	35	82	82	CD
10_1101-2021_01_06_425584	256	36	)	)	-RRB-
10_1101-2021_01_06_425584	256	37	.	.	.
10_1101-2021_01_06_425584	257	1	In	in	IN
10_1101-2021_01_06_425584	257	2	support	support	NN
10_1101-2021_01_06_425584	257	3	of	of	IN
10_1101-2021_01_06_425584	257	4	this	this	DT
10_1101-2021_01_06_425584	257	5	,	,	,
10_1101-2021_01_06_425584	257	6	up	up	NN
10_1101-2021_01_06_425584	257	7	-	-	HYPH
10_1101-2021_01_06_425584	257	8	stream	stream	NN
10_1101-2021_01_06_425584	257	9	(	(	-LRB-
10_1101-2021_01_06_425584	257	10	CTGF	CTGF	NNP
10_1101-2021_01_06_425584	257	11	and	and	CC
10_1101-2021_01_06_425584	257	12	CD62	CD62	NNP
10_1101-2021_01_06_425584	257	13	)	)	-RRB-
10_1101-2021_01_06_425584	257	14	(	(	-LRB-
10_1101-2021_01_06_425584	257	15	83	83	CD
10_1101-2021_01_06_425584	257	16	,	,	,
10_1101-2021_01_06_425584	257	17	84	84	CD
10_1101-2021_01_06_425584	257	18	)	)	-RRB-
10_1101-2021_01_06_425584	257	19	(	(	-LRB-
10_1101-2021_01_06_425584	257	20	Table	table	NN
10_1101-2021_01_06_425584	257	21	481	481	CD
10_1101-2021_01_06_425584	257	22	S5	s5	NN
10_1101-2021_01_06_425584	257	23	)	)	-RRB-
10_1101-2021_01_06_425584	257	24	and	and	CC
10_1101-2021_01_06_425584	257	25	down	down	IN
10_1101-2021_01_06_425584	257	26	-	-	HYPH
10_1101-2021_01_06_425584	257	27	stream	stream	NN
10_1101-2021_01_06_425584	257	28	proteins	protein	NNS
10_1101-2021_01_06_425584	257	29	(	(	-LRB-
10_1101-2021_01_06_425584	257	30	FABP4	fabp4	$
10_1101-2021_01_06_425584	257	31	)	)	-RRB-
10_1101-2021_01_06_425584	257	32	(	(	-LRB-
10_1101-2021_01_06_425584	257	33	85	85	CD
10_1101-2021_01_06_425584	257	34	)	)	-RRB-
10_1101-2021_01_06_425584	257	35	(	(	-LRB-
10_1101-2021_01_06_425584	257	36	Table	table	NN
10_1101-2021_01_06_425584	257	37	S5	s5	NN
10_1101-2021_01_06_425584	257	38	)	)	-RRB-
10_1101-2021_01_06_425584	257	39	involved	involve	VBN
10_1101-2021_01_06_425584	257	40	in	in	IN
10_1101-2021_01_06_425584	257	41	angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	257	42	and	and	CC
10_1101-2021_01_06_425584	257	43	proliferation	proliferation	NN
10_1101-2021_01_06_425584	257	44	482	482	CD
10_1101-2021_01_06_425584	257	45	were	be	VBD
10_1101-2021_01_06_425584	257	46	down	down	RB
10_1101-2021_01_06_425584	257	47	-	-	HYPH
10_1101-2021_01_06_425584	257	48	regulated	regulate	VBN
10_1101-2021_01_06_425584	257	49	by	by	IN
10_1101-2021_01_06_425584	257	50	simulated	simulated	JJ
10_1101-2021_01_06_425584	257	51	diabetes	diabete	NNS
10_1101-2021_01_06_425584	257	52	.	.	.
10_1101-2021_01_06_425584	258	1	Importantly	importantly	RB
10_1101-2021_01_06_425584	258	2	,	,	,
10_1101-2021_01_06_425584	258	3	there	there	EX
10_1101-2021_01_06_425584	258	4	is	be	VBZ
10_1101-2021_01_06_425584	258	5	evidence	evidence	NN
10_1101-2021_01_06_425584	258	6	(	(	-LRB-
10_1101-2021_01_06_425584	258	7	not	not	RB
10_1101-2021_01_06_425584	258	8	in	in	IN
10_1101-2021_01_06_425584	258	9	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	258	10	483	483	CD
10_1101-2021_01_06_425584	258	11	cells	cell	NNS
10_1101-2021_01_06_425584	258	12	)	)	-RRB-
10_1101-2021_01_06_425584	258	13	of	of	IN
10_1101-2021_01_06_425584	258	14	cellular	cellular	JJ
10_1101-2021_01_06_425584	258	15	processes	process	NNS
10_1101-2021_01_06_425584	258	16	contributing	contribute	VBG
10_1101-2021_01_06_425584	258	17	to	to	IN
10_1101-2021_01_06_425584	258	18	the	the	DT
10_1101-2021_01_06_425584	258	19	stimulation	stimulation	NN
10_1101-2021_01_06_425584	258	20	of	of	IN
10_1101-2021_01_06_425584	258	21	cellular	cellular	JJ
10_1101-2021_01_06_425584	258	22	binucleation	binucleation	NN
10_1101-2021_01_06_425584	258	23	without	without	IN
10_1101-2021_01_06_425584	258	24	increases	increase	NNS
10_1101-2021_01_06_425584	258	25	484	484	CD
10_1101-2021_01_06_425584	258	26	in	in	IN
10_1101-2021_01_06_425584	258	27	cell	cell	NN
10_1101-2021_01_06_425584	258	28	proliferation	proliferation	NN
10_1101-2021_01_06_425584	258	29	,	,	,
10_1101-2021_01_06_425584	258	30	including	include	VBG
10_1101-2021_01_06_425584	258	31	cellular	cellular	JJ
10_1101-2021_01_06_425584	258	32	enhancement	enhancement	NN
10_1101-2021_01_06_425584	258	33	of	of	IN
10_1101-2021_01_06_425584	258	34	antimicrobial	antimicrobial	JJ
10_1101-2021_01_06_425584	258	35	defenses	defense	NNS
10_1101-2021_01_06_425584	258	36	(	(	-LRB-
10_1101-2021_01_06_425584	258	37	86	86	CD
10_1101-2021_01_06_425584	258	38	)	)	-RRB-
10_1101-2021_01_06_425584	258	39	,	,	,
10_1101-2021_01_06_425584	258	40	senescence	senescence	NN
10_1101-2021_01_06_425584	258	41	485	485	CD
10_1101-2021_01_06_425584	258	42	(	(	-LRB-
10_1101-2021_01_06_425584	258	43	87	87	CD
10_1101-2021_01_06_425584	258	44	)	)	-RRB-
10_1101-2021_01_06_425584	258	45	,	,	,
10_1101-2021_01_06_425584	258	46	and	and	CC
10_1101-2021_01_06_425584	258	47	malignancy	malignancy	NNP
10_1101-2021_01_06_425584	258	48	(	(	-LRB-
10_1101-2021_01_06_425584	258	49	88	88	CD
10_1101-2021_01_06_425584	258	50	)	)	-RRB-
10_1101-2021_01_06_425584	258	51	.	.	.
10_1101-2021_01_06_425584	259	1	Various	various	JJ
10_1101-2021_01_06_425584	259	2	mechanisms	mechanism	NNS
10_1101-2021_01_06_425584	259	3	have	have	VBP
10_1101-2021_01_06_425584	259	4	been	be	VBN
10_1101-2021_01_06_425584	259	5	linked	link	VBN
10_1101-2021_01_06_425584	259	6	to	to	IN
10_1101-2021_01_06_425584	259	7	the	the	DT
10_1101-2021_01_06_425584	259	8	binucleation	binucleation	NN
10_1101-2021_01_06_425584	259	9	process	process	NN
10_1101-2021_01_06_425584	259	10	,	,	,
10_1101-2021_01_06_425584	259	11	486	486	CD
10_1101-2021_01_06_425584	259	12	such	such	JJ
10_1101-2021_01_06_425584	259	13	as	as	IN
10_1101-2021_01_06_425584	259	14	cytokinesis	cytokinesis	NN
10_1101-2021_01_06_425584	259	15	failure	failure	NN
10_1101-2021_01_06_425584	259	16	,	,	,
10_1101-2021_01_06_425584	259	17	cellular	cellular	JJ
10_1101-2021_01_06_425584	259	18	fusion	fusion	NN
10_1101-2021_01_06_425584	259	19	,	,	,
10_1101-2021_01_06_425584	259	20	mitotic	mitotic	JJ
10_1101-2021_01_06_425584	259	21	slippage	slippage	NN
10_1101-2021_01_06_425584	259	22	,	,	,
10_1101-2021_01_06_425584	259	23	and	and	CC
10_1101-2021_01_06_425584	259	24	endoreduplication	endoreduplication	NN
10_1101-2021_01_06_425584	259	25	(	(	-LRB-
10_1101-2021_01_06_425584	259	26	89	89	CD
10_1101-2021_01_06_425584	259	27	)	)	-RRB-
10_1101-2021_01_06_425584	259	28	.	.	.
10_1101-2021_01_06_425584	260	1	The	the	DT
10_1101-2021_01_06_425584	260	2	487	487	CD
10_1101-2021_01_06_425584	260	3	elucidation	elucidation	NN
10_1101-2021_01_06_425584	260	4	of	of	IN
10_1101-2021_01_06_425584	260	5	the	the	DT
10_1101-2021_01_06_425584	260	6	exact	exact	JJ
10_1101-2021_01_06_425584	260	7	molecular	molecular	JJ
10_1101-2021_01_06_425584	260	8	mechanisms	mechanism	NNS
10_1101-2021_01_06_425584	260	9	leading	lead	VBG
10_1101-2021_01_06_425584	260	10	to	to	IN
10_1101-2021_01_06_425584	260	11	the	the	DT
10_1101-2021_01_06_425584	260	12	binucleation	binucleation	NN
10_1101-2021_01_06_425584	260	13	process	process	NN
10_1101-2021_01_06_425584	260	14	of	of	IN
10_1101-2021_01_06_425584	260	15	CAEC	CAEC	NNP
10_1101-2021_01_06_425584	260	16	is	be	VBZ
10_1101-2021_01_06_425584	260	17	488	488	CD
10_1101-2021_01_06_425584	260	18	beyond	beyond	IN
10_1101-2021_01_06_425584	260	19	the	the	DT
10_1101-2021_01_06_425584	260	20	scope	scope	NN
10_1101-2021_01_06_425584	260	21	of	of	IN
10_1101-2021_01_06_425584	260	22	our	-PRON-	PRP$
10_1101-2021_01_06_425584	260	23	study	study	NN
10_1101-2021_01_06_425584	260	24	.	.	.
10_1101-2021_01_06_425584	261	1	489	489	CD
10_1101-2021_01_06_425584	261	2	In	in	IN
10_1101-2021_01_06_425584	261	3	conclusion	conclusion	NN
10_1101-2021_01_06_425584	261	4	,	,	,
10_1101-2021_01_06_425584	261	5	this	this	DT
10_1101-2021_01_06_425584	261	6	study	study	NN
10_1101-2021_01_06_425584	261	7	applied	apply	VBD
10_1101-2021_01_06_425584	261	8	an	an	DT
10_1101-2021_01_06_425584	261	9	integrated	integrated	JJ
10_1101-2021_01_06_425584	261	10	multi	multi	JJ
10_1101-2021_01_06_425584	261	11	-	-	NNS
10_1101-2021_01_06_425584	261	12	omics	omic	NNS
10_1101-2021_01_06_425584	261	13	and	and	CC
10_1101-2021_01_06_425584	261	14	bioinformatics	bioinformatic	NNS
10_1101-2021_01_06_425584	261	15	/	/	SYM
10_1101-2021_01_06_425584	261	16	chemoinformatics	chemoinformatic	NNS
10_1101-2021_01_06_425584	261	17	490	490	CD
10_1101-2021_01_06_425584	261	18	approach	approach	NN
10_1101-2021_01_06_425584	261	19	to	to	TO
10_1101-2021_01_06_425584	261	20	characterize	characterize	VB
10_1101-2021_01_06_425584	261	21	the	the	DT
10_1101-2021_01_06_425584	261	22	molecular	molecular	JJ
10_1101-2021_01_06_425584	261	23	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	261	24	that	that	WDT
10_1101-2021_01_06_425584	261	25	simulated	simulate	VBD
10_1101-2021_01_06_425584	261	26	diabetes	diabetes	NN
10_1101-2021_01_06_425584	261	27	exerts	exert	NNS
10_1101-2021_01_06_425584	261	28	on	on	IN
10_1101-2021_01_06_425584	261	29	CAEC	caec	NN
10_1101-2021_01_06_425584	261	30	.	.	.
10_1101-2021_01_06_425584	262	1	491	491	CD
10_1101-2021_01_06_425584	262	2	.CC	.CC	:
10_1101-2021_01_06_425584	262	3	-	-	HYPH
10_1101-2021_01_06_425584	262	4	BY	by	IN
10_1101-2021_01_06_425584	262	5	-	-	HYPH
10_1101-2021_01_06_425584	262	6	NC	NC	NNP
10_1101-2021_01_06_425584	262	7	-	-	HYPH
10_1101-2021_01_06_425584	262	8	ND	ND	NNP
10_1101-2021_01_06_425584	262	9	4.0	4.0	CD
10_1101-2021_01_06_425584	262	10	International	International	NNP
10_1101-2021_01_06_425584	262	11	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	262	12	under	under	IN
10_1101-2021_01_06_425584	262	13	a	a	DT
10_1101-2021_01_06_425584	262	14	(	(	-LRB-
10_1101-2021_01_06_425584	262	15	which	which	WDT
10_1101-2021_01_06_425584	262	16	was	be	VBD
10_1101-2021_01_06_425584	262	17	not	not	RB
10_1101-2021_01_06_425584	262	18	certified	certify	VBN
10_1101-2021_01_06_425584	262	19	by	by	IN
10_1101-2021_01_06_425584	262	20	peer	peer	NN
10_1101-2021_01_06_425584	262	21	review	review	NN
10_1101-2021_01_06_425584	262	22	)	)	-RRB-
10_1101-2021_01_06_425584	262	23	is	be	VBZ
10_1101-2021_01_06_425584	262	24	the	the	DT
10_1101-2021_01_06_425584	262	25	author	author	NN
10_1101-2021_01_06_425584	262	26	/	/	SYM
10_1101-2021_01_06_425584	262	27	funder	funder	NN
10_1101-2021_01_06_425584	262	28	,	,	,
10_1101-2021_01_06_425584	262	29	who	who	WP
10_1101-2021_01_06_425584	262	30	has	have	VBZ
10_1101-2021_01_06_425584	262	31	granted	grant	VBN
10_1101-2021_01_06_425584	262	32	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	262	33	a	a	DT
10_1101-2021_01_06_425584	262	34	license	license	NN
10_1101-2021_01_06_425584	262	35	to	to	TO
10_1101-2021_01_06_425584	262	36	display	display	VB
10_1101-2021_01_06_425584	262	37	the	the	DT
10_1101-2021_01_06_425584	262	38	preprint	preprint	NN
10_1101-2021_01_06_425584	262	39	in	in	IN
10_1101-2021_01_06_425584	262	40	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	262	41	.	.	.
10_1101-2021_01_06_425584	263	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	263	2	is	be	VBZ
10_1101-2021_01_06_425584	263	3	made	make	VBN
10_1101-2021_01_06_425584	263	4	The	the	DT
10_1101-2021_01_06_425584	263	5	copyright	copyright	NN
10_1101-2021_01_06_425584	263	6	holder	holder	NN
10_1101-2021_01_06_425584	263	7	for	for	IN
10_1101-2021_01_06_425584	263	8	this	this	DT
10_1101-2021_01_06_425584	263	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	263	10	version	version	NN
10_1101-2021_01_06_425584	263	11	posted	post	VBD
10_1101-2021_01_06_425584	263	12	January	January	NNP
10_1101-2021_01_06_425584	263	13	8	8	CD
10_1101-2021_01_06_425584	263	14	,	,	,
10_1101-2021_01_06_425584	263	15	2021	2021	CD
10_1101-2021_01_06_425584	263	16	.	.	.
10_1101-2021_01_06_425584	263	17	;	;	:
10_1101-2021_01_06_425584	263	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	263	19	:	:	:
10_1101-2021_01_06_425584	263	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	263	21	preprint	preprint	NN
10_1101-2021_01_06_425584	263	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	263	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2021_01_06_425584	263	24	16	16	CD
10_1101-2021_01_06_425584	263	25	We	-PRON-	PRP
10_1101-2021_01_06_425584	263	26	confirmed	confirm	VBD
10_1101-2021_01_06_425584	263	27	several	several	JJ
10_1101-2021_01_06_425584	263	28	independent	independent	JJ
10_1101-2021_01_06_425584	263	29	studies	study	NNS
10_1101-2021_01_06_425584	263	30	that	that	WDT
10_1101-2021_01_06_425584	263	31	reported	report	VBD
10_1101-2021_01_06_425584	263	32	alterations	alteration	NNS
10_1101-2021_01_06_425584	263	33	at	at	IN
10_1101-2021_01_06_425584	263	34	protein	protein	NN
10_1101-2021_01_06_425584	263	35	and	and	CC
10_1101-2021_01_06_425584	263	36	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	263	37	492	492	CD
10_1101-2021_01_06_425584	263	38	levels	level	NNS
10_1101-2021_01_06_425584	263	39	in	in	IN
10_1101-2021_01_06_425584	263	40	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	263	41	cells	cell	NNS
10_1101-2021_01_06_425584	263	42	of	of	IN
10_1101-2021_01_06_425584	263	43	different	different	JJ
10_1101-2021_01_06_425584	263	44	sources	source	NNS
10_1101-2021_01_06_425584	263	45	than	than	IN
10_1101-2021_01_06_425584	263	46	coronary	coronary	JJ
10_1101-2021_01_06_425584	263	47	vessels	vessel	NNS
10_1101-2021_01_06_425584	263	48	.	.	.
10_1101-2021_01_06_425584	264	1	Metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	264	2	,	,	,
10_1101-2021_01_06_425584	264	3	identified	identify	VBD
10_1101-2021_01_06_425584	264	4	493	493	CD
10_1101-2021_01_06_425584	264	5	alterations	alteration	NNS
10_1101-2021_01_06_425584	264	6	in	in	IN
10_1101-2021_01_06_425584	264	7	amino	amino	JJ
10_1101-2021_01_06_425584	264	8	acid	acid	NN
10_1101-2021_01_06_425584	264	9	,	,	,
10_1101-2021_01_06_425584	264	10	peptide	peptide	NN
10_1101-2021_01_06_425584	264	11	,	,	,
10_1101-2021_01_06_425584	264	12	and	and	CC
10_1101-2021_01_06_425584	264	13	phospholipid	phospholipid	NN
10_1101-2021_01_06_425584	264	14	metabolism	metabolism	NN
10_1101-2021_01_06_425584	264	15	.	.	.
10_1101-2021_01_06_425584	265	1	Notably	notably	RB
10_1101-2021_01_06_425584	265	2	,	,	,
10_1101-2021_01_06_425584	265	3	the	the	DT
10_1101-2021_01_06_425584	265	4	chemoinformatic	chemoinformatic	JJ
10_1101-2021_01_06_425584	265	5	494	494	CD
10_1101-2021_01_06_425584	265	6	analysis	analysis	NN
10_1101-2021_01_06_425584	265	7	identified	identify	VBD
10_1101-2021_01_06_425584	265	8	unreported	unreported	JJ
10_1101-2021_01_06_425584	265	9	alterations	alteration	NNS
10_1101-2021_01_06_425584	265	10	of	of	IN
10_1101-2021_01_06_425584	265	11	phenylalanine-	phenylalanine-	NN
10_1101-2021_01_06_425584	265	12	,	,	,
10_1101-2021_01_06_425584	265	13	glutathione-	glutathione-	NNP
10_1101-2021_01_06_425584	265	14	,	,	,
10_1101-2021_01_06_425584	265	15	and	and	CC
10_1101-2021_01_06_425584	265	16	proline	proline	NN
10_1101-2021_01_06_425584	265	17	-	-	HYPH
10_1101-2021_01_06_425584	265	18	based	base	VBN
10_1101-2021_01_06_425584	265	19	495	495	CD
10_1101-2021_01_06_425584	265	20	peptides	peptide	NNS
10_1101-2021_01_06_425584	265	21	on	on	IN
10_1101-2021_01_06_425584	265	22	coronary	coronary	JJ
10_1101-2021_01_06_425584	265	23	endothelium	endothelium	NN
10_1101-2021_01_06_425584	265	24	under	under	IN
10_1101-2021_01_06_425584	265	25	simulated	simulate	VBN
10_1101-2021_01_06_425584	265	26	diabetes	diabete	NNS
10_1101-2021_01_06_425584	265	27	.	.	.
10_1101-2021_01_06_425584	266	1	Proteomics	proteomic	NNS
10_1101-2021_01_06_425584	266	2	provided	provide	VBD
10_1101-2021_01_06_425584	266	3	evidence	evidence	NN
10_1101-2021_01_06_425584	266	4	of	of	IN
10_1101-2021_01_06_425584	266	5	496	496	CD
10_1101-2021_01_06_425584	266	6	reduced	reduce	VBN
10_1101-2021_01_06_425584	266	7	mitochondrial	mitochondrial	NN
10_1101-2021_01_06_425584	266	8	mass	mass	NN
10_1101-2021_01_06_425584	266	9	and	and	CC
10_1101-2021_01_06_425584	266	10	angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	266	11	.	.	.
10_1101-2021_01_06_425584	267	1	The	the	DT
10_1101-2021_01_06_425584	267	2	integration	integration	NN
10_1101-2021_01_06_425584	267	3	of	of	IN
10_1101-2021_01_06_425584	267	4	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	267	5	and	and	CC
10_1101-2021_01_06_425584	267	6	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	267	7	497	497	CD
10_1101-2021_01_06_425584	267	8	identified	identify	VBN
10_1101-2021_01_06_425584	267	9	increased	increase	VBN
10_1101-2021_01_06_425584	267	10	glutamic	glutamic	JJ
10_1101-2021_01_06_425584	267	11	acid	acid	NN
10_1101-2021_01_06_425584	267	12	metabolism	metabolism	NN
10_1101-2021_01_06_425584	267	13	and	and	CC
10_1101-2021_01_06_425584	267	14	suggested	suggest	VBD
10_1101-2021_01_06_425584	267	15	that	that	IN
10_1101-2021_01_06_425584	267	16	the	the	DT
10_1101-2021_01_06_425584	267	17	antioxidant	antioxidant	JJ
10_1101-2021_01_06_425584	267	18	enzymes	enzyme	NNS
10_1101-2021_01_06_425584	267	19	are	be	VBP
10_1101-2021_01_06_425584	267	20	498	498	CD
10_1101-2021_01_06_425584	267	21	involved	involved	JJ
10_1101-2021_01_06_425584	267	22	in	in	IN
10_1101-2021_01_06_425584	267	23	protecting	protect	VBG
10_1101-2021_01_06_425584	267	24	the	the	DT
10_1101-2021_01_06_425584	267	25	cells	cell	NNS
10_1101-2021_01_06_425584	267	26	from	from	IN
10_1101-2021_01_06_425584	267	27	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	267	28	stress	stress	NN
10_1101-2021_01_06_425584	267	29	.	.	.
10_1101-2021_01_06_425584	268	1	Fluorescence	fluorescence	NN
10_1101-2021_01_06_425584	268	2	microscopy	microscopy	NN
10_1101-2021_01_06_425584	268	3	reported	report	VBD
10_1101-2021_01_06_425584	268	4	the	the	DT
10_1101-2021_01_06_425584	268	5	499	499	CD
10_1101-2021_01_06_425584	268	6	appearance	appearance	NN
10_1101-2021_01_06_425584	268	7	of	of	IN
10_1101-2021_01_06_425584	268	8	non	non	JJ
10_1101-2021_01_06_425584	268	9	-	-	JJ
10_1101-2021_01_06_425584	268	10	proliferative	proliferative	JJ
10_1101-2021_01_06_425584	268	11	binucleated	binucleated	JJ
10_1101-2021_01_06_425584	268	12	CAEC	caec	NN
10_1101-2021_01_06_425584	268	13	cells	cell	NNS
10_1101-2021_01_06_425584	268	14	as	as	IN
10_1101-2021_01_06_425584	268	15	a	a	DT
10_1101-2021_01_06_425584	268	16	mean	mean	NN
10_1101-2021_01_06_425584	268	17	to	to	TO
10_1101-2021_01_06_425584	268	18	metabolize	metabolize	VB
10_1101-2021_01_06_425584	268	19	the	the	DT
10_1101-2021_01_06_425584	268	20	excess	excess	NN
10_1101-2021_01_06_425584	268	21	of	of	IN
10_1101-2021_01_06_425584	268	22	500	500	CD
10_1101-2021_01_06_425584	268	23	ambient	ambient	JJ
10_1101-2021_01_06_425584	268	24	glucose	glucose	NN
10_1101-2021_01_06_425584	268	25	.	.	.
10_1101-2021_01_06_425584	269	1	Overall	overall	RB
10_1101-2021_01_06_425584	269	2	,	,	,
10_1101-2021_01_06_425584	269	3	our	-PRON-	PRP$
10_1101-2021_01_06_425584	269	4	study	study	NN
10_1101-2021_01_06_425584	269	5	improved	improve	VBD
10_1101-2021_01_06_425584	269	6	the	the	DT
10_1101-2021_01_06_425584	269	7	understanding	understanding	NN
10_1101-2021_01_06_425584	269	8	of	of	IN
10_1101-2021_01_06_425584	269	9	the	the	DT
10_1101-2021_01_06_425584	269	10	molecular	molecular	JJ
10_1101-2021_01_06_425584	269	11	disturbances	disturbance	NNS
10_1101-2021_01_06_425584	269	12	501	501	CD
10_1101-2021_01_06_425584	269	13	caused	cause	VBN
10_1101-2021_01_06_425584	269	14	by	by	IN
10_1101-2021_01_06_425584	269	15	simulated	simulated	JJ
10_1101-2021_01_06_425584	269	16	diabetes	diabete	NNS
10_1101-2021_01_06_425584	269	17	that	that	WDT
10_1101-2021_01_06_425584	269	18	could	could	MD
10_1101-2021_01_06_425584	269	19	mediate	mediate	VB
10_1101-2021_01_06_425584	269	20	CAEC	caec	NN
10_1101-2021_01_06_425584	269	21	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	269	22	and	and	CC
10_1101-2021_01_06_425584	269	23	may	may	MD
10_1101-2021_01_06_425584	269	24	be	be	VB
10_1101-2021_01_06_425584	269	25	relevant	relevant	JJ
10_1101-2021_01_06_425584	269	26	in	in	IN
10_1101-2021_01_06_425584	269	27	the	the	DT
10_1101-2021_01_06_425584	269	28	502	502	CD
10_1101-2021_01_06_425584	269	29	context	context	NN
10_1101-2021_01_06_425584	269	30	of	of	IN
10_1101-2021_01_06_425584	269	31	CVD	CVD	NNP
10_1101-2021_01_06_425584	269	32	in	in	IN
10_1101-2021_01_06_425584	269	33	subjects	subject	NNS
10_1101-2021_01_06_425584	269	34	with	with	IN
10_1101-2021_01_06_425584	269	35	T2DM	T2DM	NNP
10_1101-2021_01_06_425584	269	36	.	.	.
10_1101-2021_01_06_425584	270	1	503	503	CD
10_1101-2021_01_06_425584	270	2	504	504	CD
10_1101-2021_01_06_425584	270	3	505	505	CD
10_1101-2021_01_06_425584	270	4	.CC	.CC	NFP
10_1101-2021_01_06_425584	270	5	-	-	HYPH
10_1101-2021_01_06_425584	270	6	BY	by	IN
10_1101-2021_01_06_425584	270	7	-	-	HYPH
10_1101-2021_01_06_425584	270	8	NC	NC	NNP
10_1101-2021_01_06_425584	270	9	-	-	HYPH
10_1101-2021_01_06_425584	270	10	ND	ND	NNP
10_1101-2021_01_06_425584	270	11	4.0	4.0	CD
10_1101-2021_01_06_425584	270	12	International	International	NNP
10_1101-2021_01_06_425584	270	13	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	270	14	under	under	IN
10_1101-2021_01_06_425584	270	15	a	a	DT
10_1101-2021_01_06_425584	270	16	(	(	-LRB-
10_1101-2021_01_06_425584	270	17	which	which	WDT
10_1101-2021_01_06_425584	270	18	was	be	VBD
10_1101-2021_01_06_425584	270	19	not	not	RB
10_1101-2021_01_06_425584	270	20	certified	certify	VBN
10_1101-2021_01_06_425584	270	21	by	by	IN
10_1101-2021_01_06_425584	270	22	peer	peer	NN
10_1101-2021_01_06_425584	270	23	review	review	NN
10_1101-2021_01_06_425584	270	24	)	)	-RRB-
10_1101-2021_01_06_425584	270	25	is	be	VBZ
10_1101-2021_01_06_425584	270	26	the	the	DT
10_1101-2021_01_06_425584	270	27	author	author	NN
10_1101-2021_01_06_425584	270	28	/	/	SYM
10_1101-2021_01_06_425584	270	29	funder	funder	NN
10_1101-2021_01_06_425584	270	30	,	,	,
10_1101-2021_01_06_425584	270	31	who	who	WP
10_1101-2021_01_06_425584	270	32	has	have	VBZ
10_1101-2021_01_06_425584	270	33	granted	grant	VBN
10_1101-2021_01_06_425584	270	34	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	270	35	a	a	DT
10_1101-2021_01_06_425584	270	36	license	license	NN
10_1101-2021_01_06_425584	270	37	to	to	TO
10_1101-2021_01_06_425584	270	38	display	display	VB
10_1101-2021_01_06_425584	270	39	the	the	DT
10_1101-2021_01_06_425584	270	40	preprint	preprint	NN
10_1101-2021_01_06_425584	270	41	in	in	IN
10_1101-2021_01_06_425584	270	42	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	270	43	.	.	.
10_1101-2021_01_06_425584	271	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	271	2	is	be	VBZ
10_1101-2021_01_06_425584	271	3	made	make	VBN
10_1101-2021_01_06_425584	271	4	The	the	DT
10_1101-2021_01_06_425584	271	5	copyright	copyright	NN
10_1101-2021_01_06_425584	271	6	holder	holder	NN
10_1101-2021_01_06_425584	271	7	for	for	IN
10_1101-2021_01_06_425584	271	8	this	this	DT
10_1101-2021_01_06_425584	271	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	271	10	version	version	NN
10_1101-2021_01_06_425584	271	11	posted	post	VBD
10_1101-2021_01_06_425584	271	12	January	January	NNP
10_1101-2021_01_06_425584	271	13	8	8	CD
10_1101-2021_01_06_425584	271	14	,	,	,
10_1101-2021_01_06_425584	271	15	2021	2021	CD
10_1101-2021_01_06_425584	271	16	.	.	.
10_1101-2021_01_06_425584	271	17	;	;	:
10_1101-2021_01_06_425584	271	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	271	19	:	:	:
10_1101-2021_01_06_425584	271	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	271	21	preprint	preprint	NN
10_1101-2021_01_06_425584	271	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	271	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	271	24	17	17	CD
10_1101-2021_01_06_425584	271	25	5	5	CD
10_1101-2021_01_06_425584	271	26	.	.	.
10_1101-2021_01_06_425584	272	1	Acknowledgements	acknowledgement	NNS
10_1101-2021_01_06_425584	272	2	506	506	CD
10_1101-2021_01_06_425584	272	3	This	this	DT
10_1101-2021_01_06_425584	272	4	work	work	NN
10_1101-2021_01_06_425584	272	5	was	be	VBD
10_1101-2021_01_06_425584	272	6	derived	derive	VBN
10_1101-2021_01_06_425584	272	7	in	in	IN
10_1101-2021_01_06_425584	272	8	part	part	NN
10_1101-2021_01_06_425584	272	9	from	from	IN
10_1101-2021_01_06_425584	272	10	the	the	DT
10_1101-2021_01_06_425584	272	11	Thesis	Thesis	NNP
10_1101-2021_01_06_425584	272	12	Project	Project	NNP
10_1101-2021_01_06_425584	272	13	of	of	IN
10_1101-2021_01_06_425584	272	14	H.C.D.H.	H.C.D.H.	NNP
10_1101-2021_01_06_425584	273	1	at	at	IN
10_1101-2021_01_06_425584	273	2	the	the	DT
10_1101-2021_01_06_425584	273	3	Posgrado	Posgrado	NNP
10_1101-2021_01_06_425584	273	4	en	en	NNP
10_1101-2021_01_06_425584	273	5	507	507	CD
10_1101-2021_01_06_425584	273	6	Ciencias	Ciencias	NNP
10_1101-2021_01_06_425584	273	7	de	de	NNP
10_1101-2021_01_06_425584	273	8	la	la	NNP
10_1101-2021_01_06_425584	273	9	Vida	Vida	NNP
10_1101-2021_01_06_425584	273	10	,	,	,
10_1101-2021_01_06_425584	273	11	CICESE	CICESE	NNP
10_1101-2021_01_06_425584	273	12	.	.	.
10_1101-2021_01_06_425584	274	1	We	-PRON-	PRP
10_1101-2021_01_06_425584	274	2	thank	thank	VBP
10_1101-2021_01_06_425584	274	3	Alan	Alan	NNP
10_1101-2021_01_06_425584	274	4	G.	G.	NNP
10_1101-2021_01_06_425584	274	5	Hernández	Hernández	NNP
10_1101-2021_01_06_425584	274	6	-	-	HYPH
10_1101-2021_01_06_425584	274	7	Melgar	Melgar	NNP
10_1101-2021_01_06_425584	274	8	for	for	IN
10_1101-2021_01_06_425584	274	9	his	-PRON-	PRP$
10_1101-2021_01_06_425584	274	10	invaluable	invaluable	JJ
10_1101-2021_01_06_425584	274	11	508	508	CD
10_1101-2021_01_06_425584	274	12	technical	technical	JJ
10_1101-2021_01_06_425584	274	13	assistance	assistance	NN
10_1101-2021_01_06_425584	274	14	with	with	IN
10_1101-2021_01_06_425584	274	15	the	the	DT
10_1101-2021_01_06_425584	274	16	NormalyzerDE	NormalyzerDE	NNP
10_1101-2021_01_06_425584	274	17	software	software	NN
10_1101-2021_01_06_425584	274	18	.	.	.
10_1101-2021_01_06_425584	275	1	509	509	CD
10_1101-2021_01_06_425584	275	2	510	510	CD
10_1101-2021_01_06_425584	275	3	511	511	CD
10_1101-2021_01_06_425584	275	4	512	512	CD
10_1101-2021_01_06_425584	275	5	513	513	CD
10_1101-2021_01_06_425584	275	6	514	514	CD
10_1101-2021_01_06_425584	275	7	515	515	CD
10_1101-2021_01_06_425584	275	8	.CC	.CC	:
10_1101-2021_01_06_425584	275	9	-	-	:
10_1101-2021_01_06_425584	275	10	BY	by	IN
10_1101-2021_01_06_425584	275	11	-	-	HYPH
10_1101-2021_01_06_425584	275	12	NC	NC	NNP
10_1101-2021_01_06_425584	275	13	-	-	HYPH
10_1101-2021_01_06_425584	275	14	ND	ND	NNP
10_1101-2021_01_06_425584	275	15	4.0	4.0	CD
10_1101-2021_01_06_425584	275	16	International	International	NNP
10_1101-2021_01_06_425584	275	17	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	275	18	under	under	IN
10_1101-2021_01_06_425584	275	19	a	a	DT
10_1101-2021_01_06_425584	275	20	(	(	-LRB-
10_1101-2021_01_06_425584	275	21	which	which	WDT
10_1101-2021_01_06_425584	275	22	was	be	VBD
10_1101-2021_01_06_425584	275	23	not	not	RB
10_1101-2021_01_06_425584	275	24	certified	certify	VBN
10_1101-2021_01_06_425584	275	25	by	by	IN
10_1101-2021_01_06_425584	275	26	peer	peer	NN
10_1101-2021_01_06_425584	275	27	review	review	NN
10_1101-2021_01_06_425584	275	28	)	)	-RRB-
10_1101-2021_01_06_425584	275	29	is	be	VBZ
10_1101-2021_01_06_425584	275	30	the	the	DT
10_1101-2021_01_06_425584	275	31	author	author	NN
10_1101-2021_01_06_425584	275	32	/	/	SYM
10_1101-2021_01_06_425584	275	33	funder	funder	NN
10_1101-2021_01_06_425584	275	34	,	,	,
10_1101-2021_01_06_425584	275	35	who	who	WP
10_1101-2021_01_06_425584	275	36	has	have	VBZ
10_1101-2021_01_06_425584	275	37	granted	grant	VBN
10_1101-2021_01_06_425584	275	38	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	275	39	a	a	DT
10_1101-2021_01_06_425584	275	40	license	license	NN
10_1101-2021_01_06_425584	275	41	to	to	TO
10_1101-2021_01_06_425584	275	42	display	display	VB
10_1101-2021_01_06_425584	275	43	the	the	DT
10_1101-2021_01_06_425584	275	44	preprint	preprint	NN
10_1101-2021_01_06_425584	275	45	in	in	IN
10_1101-2021_01_06_425584	275	46	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	275	47	.	.	.
10_1101-2021_01_06_425584	276	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	276	2	is	be	VBZ
10_1101-2021_01_06_425584	276	3	made	make	VBN
10_1101-2021_01_06_425584	276	4	The	the	DT
10_1101-2021_01_06_425584	276	5	copyright	copyright	NN
10_1101-2021_01_06_425584	276	6	holder	holder	NN
10_1101-2021_01_06_425584	276	7	for	for	IN
10_1101-2021_01_06_425584	276	8	this	this	DT
10_1101-2021_01_06_425584	276	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	276	10	version	version	NN
10_1101-2021_01_06_425584	276	11	posted	post	VBD
10_1101-2021_01_06_425584	276	12	January	January	NNP
10_1101-2021_01_06_425584	276	13	8	8	CD
10_1101-2021_01_06_425584	276	14	,	,	,
10_1101-2021_01_06_425584	276	15	2021	2021	CD
10_1101-2021_01_06_425584	276	16	.	.	.
10_1101-2021_01_06_425584	276	17	;	;	:
10_1101-2021_01_06_425584	276	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	276	19	:	:	:
10_1101-2021_01_06_425584	276	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	276	21	preprint	preprint	NN
10_1101-2021_01_06_425584	276	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	276	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	276	24	18	18	CD
10_1101-2021_01_06_425584	276	25	6	6	CD
10_1101-2021_01_06_425584	276	26	.	.	.
10_1101-2021_01_06_425584	277	1	Funding	fund	VBG
10_1101-2021_01_06_425584	277	2	516	516	CD
10_1101-2021_01_06_425584	277	3	Part	part	NN
10_1101-2021_01_06_425584	277	4	of	of	IN
10_1101-2021_01_06_425584	277	5	this	this	DT
10_1101-2021_01_06_425584	277	6	work	work	NN
10_1101-2021_01_06_425584	277	7	was	be	VBD
10_1101-2021_01_06_425584	277	8	supported	support	VBN
10_1101-2021_01_06_425584	277	9	by	by	IN
10_1101-2021_01_06_425584	277	10	CICESE	CICESE	NNP
10_1101-2021_01_06_425584	277	11	(	(	-LRB-
10_1101-2021_01_06_425584	277	12	Grant	Grant	NNP
10_1101-2021_01_06_425584	277	13	No	No	NNP
10_1101-2021_01_06_425584	277	14	.	.	.
10_1101-2021_01_06_425584	278	1	685109	685109	CD
10_1101-2021_01_06_425584	278	2	to	to	IN
10_1101-2021_01_06_425584	278	3	AMU	AMU	NNP
10_1101-2021_01_06_425584	278	4	and	and	CC
10_1101-2021_01_06_425584	278	5	Internal	Internal	NNP
10_1101-2021_01_06_425584	278	6	517	517	CD
10_1101-2021_01_06_425584	278	7	Project	Project	NNP
10_1101-2021_01_06_425584	278	8	No	no	UH
10_1101-2021_01_06_425584	278	9	.	.	.
10_1101-2021_01_06_425584	279	1	685	685	CD
10_1101-2021_01_06_425584	279	2	-	-	SYM
10_1101-2021_01_06_425584	279	3	110	110	CD
10_1101-2021_01_06_425584	279	4	from	from	IN
10_1101-2021_01_06_425584	279	5	CAD	CAD	NNP
10_1101-2021_01_06_425584	279	6	)	)	-RRB-
10_1101-2021_01_06_425584	279	7	,	,	,
10_1101-2021_01_06_425584	279	8	NIH	NIH	NNP
10_1101-2021_01_06_425584	279	9	R01	R01	NNP
10_1101-2021_01_06_425584	279	10	DK98717	dk98717	NN
10_1101-2021_01_06_425584	279	11	(	(	-LRB-
10_1101-2021_01_06_425584	279	12	to	to	IN
10_1101-2021_01_06_425584	279	13	FV	FV	NNP
10_1101-2021_01_06_425584	279	14	)	)	-RRB-
10_1101-2021_01_06_425584	279	15	,	,	,
10_1101-2021_01_06_425584	279	16	and	and	CC
10_1101-2021_01_06_425584	279	17	VA	VA	NNP
10_1101-2021_01_06_425584	279	18	Merit	Merit	NNP
10_1101-2021_01_06_425584	279	19	-	-	HYPH
10_1101-2021_01_06_425584	279	20	I01	I01	NNP
10_1101-2021_01_06_425584	279	21	BX3230	bx3230	NN
10_1101-2021_01_06_425584	279	22	(	(	-LRB-
10_1101-2021_01_06_425584	279	23	to	to	IN
10_1101-2021_01_06_425584	279	24	518	518	CD
10_1101-2021_01_06_425584	279	25	FV	FV	NNP
10_1101-2021_01_06_425584	279	26	)	)	-RRB-
10_1101-2021_01_06_425584	279	27	.	.	.
10_1101-2021_01_06_425584	280	1	519	519	CD
10_1101-2021_01_06_425584	280	2	520	520	CD
10_1101-2021_01_06_425584	280	3	521	521	CD
10_1101-2021_01_06_425584	280	4	.CC	.CC	:
10_1101-2021_01_06_425584	280	5	-	-	HYPH
10_1101-2021_01_06_425584	280	6	BY	by	IN
10_1101-2021_01_06_425584	280	7	-	-	HYPH
10_1101-2021_01_06_425584	280	8	NC	NC	NNP
10_1101-2021_01_06_425584	280	9	-	-	HYPH
10_1101-2021_01_06_425584	280	10	ND	ND	NNP
10_1101-2021_01_06_425584	280	11	4.0	4.0	CD
10_1101-2021_01_06_425584	280	12	International	International	NNP
10_1101-2021_01_06_425584	280	13	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	280	14	under	under	IN
10_1101-2021_01_06_425584	280	15	a	a	DT
10_1101-2021_01_06_425584	280	16	(	(	-LRB-
10_1101-2021_01_06_425584	280	17	which	which	WDT
10_1101-2021_01_06_425584	280	18	was	be	VBD
10_1101-2021_01_06_425584	280	19	not	not	RB
10_1101-2021_01_06_425584	280	20	certified	certify	VBN
10_1101-2021_01_06_425584	280	21	by	by	IN
10_1101-2021_01_06_425584	280	22	peer	peer	NN
10_1101-2021_01_06_425584	280	23	review	review	NN
10_1101-2021_01_06_425584	280	24	)	)	-RRB-
10_1101-2021_01_06_425584	280	25	is	be	VBZ
10_1101-2021_01_06_425584	280	26	the	the	DT
10_1101-2021_01_06_425584	280	27	author	author	NN
10_1101-2021_01_06_425584	280	28	/	/	SYM
10_1101-2021_01_06_425584	280	29	funder	funder	NN
10_1101-2021_01_06_425584	280	30	,	,	,
10_1101-2021_01_06_425584	280	31	who	who	WP
10_1101-2021_01_06_425584	280	32	has	have	VBZ
10_1101-2021_01_06_425584	280	33	granted	grant	VBN
10_1101-2021_01_06_425584	280	34	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	280	35	a	a	DT
10_1101-2021_01_06_425584	280	36	license	license	NN
10_1101-2021_01_06_425584	280	37	to	to	TO
10_1101-2021_01_06_425584	280	38	display	display	VB
10_1101-2021_01_06_425584	280	39	the	the	DT
10_1101-2021_01_06_425584	280	40	preprint	preprint	NN
10_1101-2021_01_06_425584	280	41	in	in	IN
10_1101-2021_01_06_425584	280	42	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	280	43	.	.	.
10_1101-2021_01_06_425584	281	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	281	2	is	be	VBZ
10_1101-2021_01_06_425584	281	3	made	make	VBN
10_1101-2021_01_06_425584	281	4	The	the	DT
10_1101-2021_01_06_425584	281	5	copyright	copyright	NN
10_1101-2021_01_06_425584	281	6	holder	holder	NN
10_1101-2021_01_06_425584	281	7	for	for	IN
10_1101-2021_01_06_425584	281	8	this	this	DT
10_1101-2021_01_06_425584	281	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	281	10	version	version	NN
10_1101-2021_01_06_425584	281	11	posted	post	VBD
10_1101-2021_01_06_425584	281	12	January	January	NNP
10_1101-2021_01_06_425584	281	13	8	8	CD
10_1101-2021_01_06_425584	281	14	,	,	,
10_1101-2021_01_06_425584	281	15	2021	2021	CD
10_1101-2021_01_06_425584	281	16	.	.	.
10_1101-2021_01_06_425584	281	17	;	;	:
10_1101-2021_01_06_425584	281	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	281	19	:	:	:
10_1101-2021_01_06_425584	281	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	281	21	preprint	preprint	NN
10_1101-2021_01_06_425584	281	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	281	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	281	24	19	19	CD
10_1101-2021_01_06_425584	281	25	7	7	CD
10_1101-2021_01_06_425584	281	26	.	.	.
10_1101-2021_01_06_425584	282	1	Conflict	conflict	NN
10_1101-2021_01_06_425584	282	2	of	of	IN
10_1101-2021_01_06_425584	282	3	interest	interest	NN
10_1101-2021_01_06_425584	282	4	522	522	CD
10_1101-2021_01_06_425584	282	5	Dr.	Dr.	NNP
10_1101-2021_01_06_425584	282	6	Villarreal	Villarreal	NNP
10_1101-2021_01_06_425584	282	7	is	be	VBZ
10_1101-2021_01_06_425584	282	8	a	a	DT
10_1101-2021_01_06_425584	282	9	co	co	NN
10_1101-2021_01_06_425584	282	10	-	-	NN
10_1101-2021_01_06_425584	282	11	founder	founder	NN
10_1101-2021_01_06_425584	282	12	and	and	CC
10_1101-2021_01_06_425584	282	13	stockholder	stockholder	NN
10_1101-2021_01_06_425584	282	14	of	of	IN
10_1101-2021_01_06_425584	282	15	Cardero	Cardero	NNP
10_1101-2021_01_06_425584	282	16	Therapeutics	Therapeutics	NNP
10_1101-2021_01_06_425584	282	17	,	,	,
10_1101-2021_01_06_425584	282	18	Inc.	Inc.	NNP
10_1101-2021_01_06_425584	282	19	523	523	CD
10_1101-2021_01_06_425584	282	20	524	524	CD
10_1101-2021_01_06_425584	282	21	525	525	CD
10_1101-2021_01_06_425584	282	22	.CC	.CC	:
10_1101-2021_01_06_425584	282	23	-	-	HYPH
10_1101-2021_01_06_425584	282	24	BY	by	IN
10_1101-2021_01_06_425584	282	25	-	-	HYPH
10_1101-2021_01_06_425584	282	26	NC	NC	NNP
10_1101-2021_01_06_425584	282	27	-	-	HYPH
10_1101-2021_01_06_425584	282	28	ND	ND	NNP
10_1101-2021_01_06_425584	282	29	4.0	4.0	CD
10_1101-2021_01_06_425584	282	30	International	International	NNP
10_1101-2021_01_06_425584	282	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	282	32	under	under	IN
10_1101-2021_01_06_425584	282	33	a	a	DT
10_1101-2021_01_06_425584	282	34	(	(	-LRB-
10_1101-2021_01_06_425584	282	35	which	which	WDT
10_1101-2021_01_06_425584	282	36	was	be	VBD
10_1101-2021_01_06_425584	282	37	not	not	RB
10_1101-2021_01_06_425584	282	38	certified	certify	VBN
10_1101-2021_01_06_425584	282	39	by	by	IN
10_1101-2021_01_06_425584	282	40	peer	peer	NN
10_1101-2021_01_06_425584	282	41	review	review	NN
10_1101-2021_01_06_425584	282	42	)	)	-RRB-
10_1101-2021_01_06_425584	282	43	is	be	VBZ
10_1101-2021_01_06_425584	282	44	the	the	DT
10_1101-2021_01_06_425584	282	45	author	author	NN
10_1101-2021_01_06_425584	282	46	/	/	SYM
10_1101-2021_01_06_425584	282	47	funder	funder	NN
10_1101-2021_01_06_425584	282	48	,	,	,
10_1101-2021_01_06_425584	282	49	who	who	WP
10_1101-2021_01_06_425584	282	50	has	have	VBZ
10_1101-2021_01_06_425584	282	51	granted	grant	VBN
10_1101-2021_01_06_425584	282	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	282	53	a	a	DT
10_1101-2021_01_06_425584	282	54	license	license	NN
10_1101-2021_01_06_425584	282	55	to	to	TO
10_1101-2021_01_06_425584	282	56	display	display	VB
10_1101-2021_01_06_425584	282	57	the	the	DT
10_1101-2021_01_06_425584	282	58	preprint	preprint	NN
10_1101-2021_01_06_425584	282	59	in	in	IN
10_1101-2021_01_06_425584	282	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	282	61	.	.	.
10_1101-2021_01_06_425584	283	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	283	2	is	be	VBZ
10_1101-2021_01_06_425584	283	3	made	make	VBN
10_1101-2021_01_06_425584	283	4	The	the	DT
10_1101-2021_01_06_425584	283	5	copyright	copyright	NN
10_1101-2021_01_06_425584	283	6	holder	holder	NN
10_1101-2021_01_06_425584	283	7	for	for	IN
10_1101-2021_01_06_425584	283	8	this	this	DT
10_1101-2021_01_06_425584	283	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	283	10	version	version	NN
10_1101-2021_01_06_425584	283	11	posted	post	VBD
10_1101-2021_01_06_425584	283	12	January	January	NNP
10_1101-2021_01_06_425584	283	13	8	8	CD
10_1101-2021_01_06_425584	283	14	,	,	,
10_1101-2021_01_06_425584	283	15	2021	2021	CD
10_1101-2021_01_06_425584	283	16	.	.	.
10_1101-2021_01_06_425584	283	17	;	;	:
10_1101-2021_01_06_425584	283	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	283	19	:	:	:
10_1101-2021_01_06_425584	283	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	283	21	preprint	preprint	NN
10_1101-2021_01_06_425584	283	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	283	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	283	24	20	20	CD
10_1101-2021_01_06_425584	283	25	8	8	CD
10_1101-2021_01_06_425584	283	26	.	.	.
10_1101-2021_01_06_425584	284	1	Author	author	NN
10_1101-2021_01_06_425584	284	2	contributions	contribution	NNS
10_1101-2021_01_06_425584	284	3	526	526	CD
10_1101-2021_01_06_425584	284	4	A.M.U.	A.M.U.	NNP
10_1101-2021_01_06_425584	285	1	contributed	contribute	VBD
10_1101-2021_01_06_425584	285	2	to	to	IN
10_1101-2021_01_06_425584	285	3	the	the	DT
10_1101-2021_01_06_425584	285	4	study	study	NN
10_1101-2021_01_06_425584	285	5	conception	conception	NN
10_1101-2021_01_06_425584	285	6	and	and	CC
10_1101-2021_01_06_425584	285	7	design	design	NN
10_1101-2021_01_06_425584	285	8	,	,	,
10_1101-2021_01_06_425584	285	9	data	datum	NNS
10_1101-2021_01_06_425584	285	10	acquisition	acquisition	NN
10_1101-2021_01_06_425584	285	11	,	,	,
10_1101-2021_01_06_425584	285	12	formal	formal	JJ
10_1101-2021_01_06_425584	285	13	analysis	analysis	NN
10_1101-2021_01_06_425584	285	14	,	,	,
10_1101-2021_01_06_425584	285	15	527	527	CD
10_1101-2021_01_06_425584	285	16	methodology	methodology	NN
10_1101-2021_01_06_425584	285	17	,	,	,
10_1101-2021_01_06_425584	285	18	project	project	NN
10_1101-2021_01_06_425584	285	19	administration	administration	NN
10_1101-2021_01_06_425584	285	20	,	,	,
10_1101-2021_01_06_425584	285	21	and	and	CC
10_1101-2021_01_06_425584	285	22	funding	funding	NN
10_1101-2021_01_06_425584	285	23	acquisition	acquisition	NN
10_1101-2021_01_06_425584	285	24	.	.	.
10_1101-2021_01_06_425584	286	1	H.C.D.H.	H.C.D.H.	NNP
10_1101-2021_01_06_425584	286	2	,	,	,
10_1101-2021_01_06_425584	286	3	L.D.M	L.D.M	NNP
10_1101-2021_01_06_425584	286	4	,	,	,
10_1101-2021_01_06_425584	286	5	and	and	CC
10_1101-2021_01_06_425584	286	6	R.A.C.C.	R.A.C.C.	NNP
10_1101-2021_01_06_425584	287	1	528	528	CD
10_1101-2021_01_06_425584	287	2	contributed	contribute	VBN
10_1101-2021_01_06_425584	287	3	to	to	IN
10_1101-2021_01_06_425584	287	4	the	the	DT
10_1101-2021_01_06_425584	287	5	data	datum	NNS
10_1101-2021_01_06_425584	287	6	acquisition	acquisition	NN
10_1101-2021_01_06_425584	287	7	,	,	,
10_1101-2021_01_06_425584	287	8	formal	formal	JJ
10_1101-2021_01_06_425584	287	9	analysis	analysis	NN
10_1101-2021_01_06_425584	287	10	and	and	CC
10_1101-2021_01_06_425584	287	11	interpretation	interpretation	NN
10_1101-2021_01_06_425584	287	12	of	of	IN
10_1101-2021_01_06_425584	287	13	some	some	DT
10_1101-2021_01_06_425584	287	14	experiments	experiment	NNS
10_1101-2021_01_06_425584	287	15	.	.	.
10_1101-2021_01_06_425584	288	1	529	529	CD
10_1101-2021_01_06_425584	288	2	C.A.D.	C.A.D.	NNP
10_1101-2021_01_06_425584	288	3	,	,	,
10_1101-2021_01_06_425584	288	4	and	and	CC
10_1101-2021_01_06_425584	288	5	F.V.	F.V.	NNP
10_1101-2021_01_06_425584	289	1	contributed	contribute	VBD
10_1101-2021_01_06_425584	289	2	to	to	IN
10_1101-2021_01_06_425584	289	3	funding	funding	NN
10_1101-2021_01_06_425584	289	4	acquisition	acquisition	NN
10_1101-2021_01_06_425584	289	5	and	and	CC
10_1101-2021_01_06_425584	289	6	resources	resource	NNS
10_1101-2021_01_06_425584	289	7	.	.	.
10_1101-2021_01_06_425584	290	1	O.M.P	O.M.P	NNP
10_1101-2021_01_06_425584	290	2	contributed	contribute	VBD
10_1101-2021_01_06_425584	290	3	to	to	IN
10_1101-2021_01_06_425584	290	4	data	datum	NNS
10_1101-2021_01_06_425584	290	5	530	530	CD
10_1101-2021_01_06_425584	290	6	interpretation	interpretation	NN
10_1101-2021_01_06_425584	290	7	and	and	CC
10_1101-2021_01_06_425584	290	8	critical	critical	JJ
10_1101-2021_01_06_425584	290	9	revision	revision	NN
10_1101-2021_01_06_425584	290	10	of	of	IN
10_1101-2021_01_06_425584	290	11	manuscript	manuscript	NN
10_1101-2021_01_06_425584	290	12	.	.	.
10_1101-2021_01_06_425584	291	1	All	all	DT
10_1101-2021_01_06_425584	291	2	authors	author	NNS
10_1101-2021_01_06_425584	291	3	contributed	contribute	VBD
10_1101-2021_01_06_425584	291	4	to	to	IN
10_1101-2021_01_06_425584	291	5	the	the	DT
10_1101-2021_01_06_425584	291	6	drafting	drafting	NN
10_1101-2021_01_06_425584	291	7	,	,	,
10_1101-2021_01_06_425584	291	8	revising	revise	VBG
10_1101-2021_01_06_425584	291	9	,	,	,
10_1101-2021_01_06_425584	291	10	531	531	CD
10_1101-2021_01_06_425584	291	11	and	and	CC
10_1101-2021_01_06_425584	291	12	approval	approval	NN
10_1101-2021_01_06_425584	291	13	of	of	IN
10_1101-2021_01_06_425584	291	14	the	the	DT
10_1101-2021_01_06_425584	291	15	final	final	JJ
10_1101-2021_01_06_425584	291	16	version	version	NN
10_1101-2021_01_06_425584	291	17	of	of	IN
10_1101-2021_01_06_425584	291	18	the	the	DT
10_1101-2021_01_06_425584	291	19	manuscript	manuscript	NN
10_1101-2021_01_06_425584	291	20	.	.	.
10_1101-2021_01_06_425584	292	1	532	532	CD
10_1101-2021_01_06_425584	292	2	533	533	CD
10_1101-2021_01_06_425584	292	3	.CC	.CC	:
10_1101-2021_01_06_425584	292	4	-	-	HYPH
10_1101-2021_01_06_425584	292	5	BY	by	IN
10_1101-2021_01_06_425584	292	6	-	-	HYPH
10_1101-2021_01_06_425584	292	7	NC	NC	NNP
10_1101-2021_01_06_425584	292	8	-	-	HYPH
10_1101-2021_01_06_425584	292	9	ND	ND	NNP
10_1101-2021_01_06_425584	292	10	4.0	4.0	CD
10_1101-2021_01_06_425584	292	11	International	International	NNP
10_1101-2021_01_06_425584	292	12	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	292	13	under	under	IN
10_1101-2021_01_06_425584	292	14	a	a	DT
10_1101-2021_01_06_425584	292	15	(	(	-LRB-
10_1101-2021_01_06_425584	292	16	which	which	WDT
10_1101-2021_01_06_425584	292	17	was	be	VBD
10_1101-2021_01_06_425584	292	18	not	not	RB
10_1101-2021_01_06_425584	292	19	certified	certify	VBN
10_1101-2021_01_06_425584	292	20	by	by	IN
10_1101-2021_01_06_425584	292	21	peer	peer	NN
10_1101-2021_01_06_425584	292	22	review	review	NN
10_1101-2021_01_06_425584	292	23	)	)	-RRB-
10_1101-2021_01_06_425584	292	24	is	be	VBZ
10_1101-2021_01_06_425584	292	25	the	the	DT
10_1101-2021_01_06_425584	292	26	author	author	NN
10_1101-2021_01_06_425584	292	27	/	/	SYM
10_1101-2021_01_06_425584	292	28	funder	funder	NN
10_1101-2021_01_06_425584	292	29	,	,	,
10_1101-2021_01_06_425584	292	30	who	who	WP
10_1101-2021_01_06_425584	292	31	has	have	VBZ
10_1101-2021_01_06_425584	292	32	granted	grant	VBN
10_1101-2021_01_06_425584	292	33	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	292	34	a	a	DT
10_1101-2021_01_06_425584	292	35	license	license	NN
10_1101-2021_01_06_425584	292	36	to	to	TO
10_1101-2021_01_06_425584	292	37	display	display	VB
10_1101-2021_01_06_425584	292	38	the	the	DT
10_1101-2021_01_06_425584	292	39	preprint	preprint	NN
10_1101-2021_01_06_425584	292	40	in	in	IN
10_1101-2021_01_06_425584	292	41	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	292	42	.	.	.
10_1101-2021_01_06_425584	293	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	293	2	is	be	VBZ
10_1101-2021_01_06_425584	293	3	made	make	VBN
10_1101-2021_01_06_425584	293	4	The	the	DT
10_1101-2021_01_06_425584	293	5	copyright	copyright	NN
10_1101-2021_01_06_425584	293	6	holder	holder	NN
10_1101-2021_01_06_425584	293	7	for	for	IN
10_1101-2021_01_06_425584	293	8	this	this	DT
10_1101-2021_01_06_425584	293	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	293	10	version	version	NN
10_1101-2021_01_06_425584	293	11	posted	post	VBD
10_1101-2021_01_06_425584	293	12	January	January	NNP
10_1101-2021_01_06_425584	293	13	8	8	CD
10_1101-2021_01_06_425584	293	14	,	,	,
10_1101-2021_01_06_425584	293	15	2021	2021	CD
10_1101-2021_01_06_425584	293	16	.	.	.
10_1101-2021_01_06_425584	293	17	;	;	:
10_1101-2021_01_06_425584	293	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	293	19	:	:	:
10_1101-2021_01_06_425584	293	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	293	21	preprint	preprint	NN
10_1101-2021_01_06_425584	293	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	293	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2021_01_06_425584	293	24	21	21	CD
10_1101-2021_01_06_425584	293	25	References	reference	NNS
10_1101-2021_01_06_425584	293	26	534	534	CD
10_1101-2021_01_06_425584	293	27	535	535	CD
10_1101-2021_01_06_425584	293	28	1	1	CD
10_1101-2021_01_06_425584	293	29	.	.	.
10_1101-2021_01_06_425584	294	1	Halcox	Halcox	NNP
10_1101-2021_01_06_425584	294	2	,	,	,
10_1101-2021_01_06_425584	294	3	J.	J.	NNP
10_1101-2021_01_06_425584	294	4	P.	P.	NNP
10_1101-2021_01_06_425584	294	5	;	;	:
10_1101-2021_01_06_425584	294	6	Schenke	Schenke	NNP
10_1101-2021_01_06_425584	294	7	,	,	,
10_1101-2021_01_06_425584	294	8	W.	W.	NNP
10_1101-2021_01_06_425584	294	9	H.	H.	NNP
10_1101-2021_01_06_425584	294	10	;	;	:
10_1101-2021_01_06_425584	294	11	Zalos	Zalos	NNP
10_1101-2021_01_06_425584	294	12	,	,	,
10_1101-2021_01_06_425584	294	13	G.	G.	NNP
10_1101-2021_01_06_425584	294	14	;	;	:
10_1101-2021_01_06_425584	294	15	Mincemoyer	Mincemoyer	NNP
10_1101-2021_01_06_425584	294	16	,	,	,
10_1101-2021_01_06_425584	294	17	R.	R.	NNP
10_1101-2021_01_06_425584	294	18	;	;	:
10_1101-2021_01_06_425584	294	19	Prasad	Prasad	NNP
10_1101-2021_01_06_425584	294	20	,	,	,
10_1101-2021_01_06_425584	294	21	A.	a.	NN
10_1101-2021_01_06_425584	294	22	;	;	:
10_1101-2021_01_06_425584	294	23	Waclawiw	Waclawiw	NNP
10_1101-2021_01_06_425584	294	24	,	,	,
10_1101-2021_01_06_425584	294	25	M.	M.	NNP
10_1101-2021_01_06_425584	294	26	A.	A.	NNP
10_1101-2021_01_06_425584	294	27	;	;	:
10_1101-2021_01_06_425584	294	28	536	536	CD
10_1101-2021_01_06_425584	294	29	Nour	Nour	NNP
10_1101-2021_01_06_425584	294	30	,	,	,
10_1101-2021_01_06_425584	294	31	K.	K.	NNP
10_1101-2021_01_06_425584	294	32	R.	R.	NNP
10_1101-2021_01_06_425584	294	33	;	;	:
10_1101-2021_01_06_425584	294	34	Quyyumi	Quyyumi	NNP
10_1101-2021_01_06_425584	294	35	,	,	,
10_1101-2021_01_06_425584	294	36	A.	a.	NN
10_1101-2021_01_06_425584	295	1	A.	a.	LS
10_1101-2021_01_06_425584	295	2	,	,	,
10_1101-2021_01_06_425584	295	3	Prognostic	prognostic	JJ
10_1101-2021_01_06_425584	295	4	value	value	NN
10_1101-2021_01_06_425584	295	5	of	of	IN
10_1101-2021_01_06_425584	295	6	coronary	coronary	JJ
10_1101-2021_01_06_425584	295	7	vascular	vascular	JJ
10_1101-2021_01_06_425584	295	8	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	295	9	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	295	10	.	.	.
10_1101-2021_01_06_425584	296	1	537	537	CD
10_1101-2021_01_06_425584	296	2	Circulation	Circulation	NNP
10_1101-2021_01_06_425584	296	3	2002	2002	CD
10_1101-2021_01_06_425584	296	4	,	,	,
10_1101-2021_01_06_425584	296	5	106	106	CD
10_1101-2021_01_06_425584	296	6	,	,	,
10_1101-2021_01_06_425584	296	7	(	(	-LRB-
10_1101-2021_01_06_425584	296	8	6	6	CD
10_1101-2021_01_06_425584	296	9	)	)	-RRB-
10_1101-2021_01_06_425584	296	10	,	,	,
10_1101-2021_01_06_425584	296	11	653	653	CD
10_1101-2021_01_06_425584	296	12	-	-	SYM
10_1101-2021_01_06_425584	296	13	8	8	CD
10_1101-2021_01_06_425584	296	14	.	.	.
10_1101-2021_01_06_425584	297	1	538	538	CD
10_1101-2021_01_06_425584	297	2	2	2	CD
10_1101-2021_01_06_425584	297	3	.	.	.
10_1101-2021_01_06_425584	298	1	Lind	Lind	NNP
10_1101-2021_01_06_425584	298	2	,	,	,
10_1101-2021_01_06_425584	298	3	M.	M.	NNP
10_1101-2021_01_06_425584	298	4	;	;	:
10_1101-2021_01_06_425584	298	5	Wedel	Wedel	NNP
10_1101-2021_01_06_425584	298	6	,	,	,
10_1101-2021_01_06_425584	298	7	H.	H.	NNP
10_1101-2021_01_06_425584	298	8	;	;	:
10_1101-2021_01_06_425584	298	9	Rosengren	Rosengren	NNP
10_1101-2021_01_06_425584	298	10	,	,	,
10_1101-2021_01_06_425584	298	11	A.	a.	NN
10_1101-2021_01_06_425584	298	12	,	,	,
10_1101-2021_01_06_425584	298	13	Excess	Excess	NNP
10_1101-2021_01_06_425584	298	14	Mortality	mortality	NN
10_1101-2021_01_06_425584	298	15	among	among	IN
10_1101-2021_01_06_425584	298	16	Persons	Persons	NNPS
10_1101-2021_01_06_425584	298	17	with	with	IN
10_1101-2021_01_06_425584	298	18	Type	Type	NNP
10_1101-2021_01_06_425584	298	19	2	2	CD
10_1101-2021_01_06_425584	298	20	539	539	CD
10_1101-2021_01_06_425584	298	21	Diabetes	diabete	NNS
10_1101-2021_01_06_425584	298	22	.	.	.
10_1101-2021_01_06_425584	299	1	N	N	NNP
10_1101-2021_01_06_425584	299	2	Engl	Engl	NNP
10_1101-2021_01_06_425584	299	3	J	J	NNP
10_1101-2021_01_06_425584	299	4	Med	Med	NNP
10_1101-2021_01_06_425584	299	5	2016	2016	CD
10_1101-2021_01_06_425584	299	6	,	,	,
10_1101-2021_01_06_425584	299	7	374	374	CD
10_1101-2021_01_06_425584	299	8	,	,	,
10_1101-2021_01_06_425584	299	9	(	(	-LRB-
10_1101-2021_01_06_425584	299	10	8)	8)	CD
10_1101-2021_01_06_425584	299	11	,	,	,
10_1101-2021_01_06_425584	299	12	788	788	CD
10_1101-2021_01_06_425584	299	13	-	-	SYM
10_1101-2021_01_06_425584	299	14	9	9	CD
10_1101-2021_01_06_425584	299	15	.	.	.
10_1101-2021_01_06_425584	300	1	540	540	CD
10_1101-2021_01_06_425584	300	2	3	3	CD
10_1101-2021_01_06_425584	300	3	.	.	.
10_1101-2021_01_06_425584	301	1	Gutierrez	Gutierrez	NNP
10_1101-2021_01_06_425584	301	2	,	,	,
10_1101-2021_01_06_425584	301	3	E.	E.	NNP
10_1101-2021_01_06_425584	301	4	;	;	:
10_1101-2021_01_06_425584	301	5	Flammer	Flammer	NNP
10_1101-2021_01_06_425584	301	6	,	,	,
10_1101-2021_01_06_425584	301	7	A.	A.	NNP
10_1101-2021_01_06_425584	301	8	J.	J.	NNP
10_1101-2021_01_06_425584	301	9	;	;	:
10_1101-2021_01_06_425584	301	10	Lerman	Lerman	NNP
10_1101-2021_01_06_425584	301	11	,	,	,
10_1101-2021_01_06_425584	301	12	L.	L.	NNP
10_1101-2021_01_06_425584	301	13	O.	O.	NNP
10_1101-2021_01_06_425584	301	14	;	;	:
10_1101-2021_01_06_425584	301	15	Elizaga	Elizaga	NNP
10_1101-2021_01_06_425584	301	16	,	,	,
10_1101-2021_01_06_425584	301	17	J.	J.	NNP
10_1101-2021_01_06_425584	301	18	;	;	:
10_1101-2021_01_06_425584	301	19	Lerman	Lerman	NNP
10_1101-2021_01_06_425584	301	20	,	,	,
10_1101-2021_01_06_425584	301	21	A.	a.	NN
10_1101-2021_01_06_425584	301	22	;	;	:
10_1101-2021_01_06_425584	301	23	Fernandez	Fernandez	NNP
10_1101-2021_01_06_425584	301	24	-	-	HYPH
10_1101-2021_01_06_425584	301	25	Aviles	Aviles	NNP
10_1101-2021_01_06_425584	301	26	,	,	,
10_1101-2021_01_06_425584	301	27	541	541	CD
10_1101-2021_01_06_425584	301	28	F.	F.	NNP
10_1101-2021_01_06_425584	301	29	,	,	,
10_1101-2021_01_06_425584	301	30	Endothelial	endothelial	JJ
10_1101-2021_01_06_425584	301	31	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	301	32	over	over	IN
10_1101-2021_01_06_425584	301	33	the	the	DT
10_1101-2021_01_06_425584	301	34	course	course	NN
10_1101-2021_01_06_425584	301	35	of	of	IN
10_1101-2021_01_06_425584	301	36	coronary	coronary	JJ
10_1101-2021_01_06_425584	301	37	artery	artery	NN
10_1101-2021_01_06_425584	301	38	disease	disease	NN
10_1101-2021_01_06_425584	301	39	.	.	.
10_1101-2021_01_06_425584	302	1	Eur	Eur	NNP
10_1101-2021_01_06_425584	302	2	Heart	Heart	NNP
10_1101-2021_01_06_425584	302	3	J	J	NNP
10_1101-2021_01_06_425584	302	4	2013	2013	CD
10_1101-2021_01_06_425584	302	5	,	,	,
10_1101-2021_01_06_425584	302	6	34	34	CD
10_1101-2021_01_06_425584	302	7	,	,	,
10_1101-2021_01_06_425584	302	8	542	542	CD
10_1101-2021_01_06_425584	302	9	(	(	-LRB-
10_1101-2021_01_06_425584	302	10	41	41	CD
10_1101-2021_01_06_425584	302	11	)	)	-RRB-
10_1101-2021_01_06_425584	302	12	,	,	,
10_1101-2021_01_06_425584	302	13	3175	3175	CD
10_1101-2021_01_06_425584	302	14	-	-	SYM
10_1101-2021_01_06_425584	302	15	81	81	CD
10_1101-2021_01_06_425584	302	16	.	.	.
10_1101-2021_01_06_425584	303	1	543	543	CD
10_1101-2021_01_06_425584	303	2	4	4	CD
10_1101-2021_01_06_425584	303	3	.	.	.
10_1101-2021_01_06_425584	304	1	Lorenzi	Lorenzi	NNP
10_1101-2021_01_06_425584	304	2	,	,	,
10_1101-2021_01_06_425584	304	3	M.	M.	NNP
10_1101-2021_01_06_425584	304	4	;	;	:
10_1101-2021_01_06_425584	304	5	Cagliero	Cagliero	NNP
10_1101-2021_01_06_425584	304	6	,	,	,
10_1101-2021_01_06_425584	304	7	E.	E.	NNP
10_1101-2021_01_06_425584	304	8	;	;	:
10_1101-2021_01_06_425584	304	9	Toledo	Toledo	NNP
10_1101-2021_01_06_425584	304	10	,	,	,
10_1101-2021_01_06_425584	304	11	S.	S.	NNP
10_1101-2021_01_06_425584	304	12	,	,	,
10_1101-2021_01_06_425584	304	13	Glucose	Glucose	NNP
10_1101-2021_01_06_425584	304	14	toxicity	toxicity	NN
10_1101-2021_01_06_425584	304	15	for	for	IN
10_1101-2021_01_06_425584	304	16	human	human	JJ
10_1101-2021_01_06_425584	304	17	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	304	18	cells	cell	NNS
10_1101-2021_01_06_425584	304	19	in	in	IN
10_1101-2021_01_06_425584	304	20	544	544	CD
10_1101-2021_01_06_425584	304	21	culture	culture	NN
10_1101-2021_01_06_425584	304	22	.	.	.
10_1101-2021_01_06_425584	305	1	Delayed	delay	VBN
10_1101-2021_01_06_425584	305	2	replication	replication	NN
10_1101-2021_01_06_425584	305	3	,	,	,
10_1101-2021_01_06_425584	305	4	disturbed	disturbed	JJ
10_1101-2021_01_06_425584	305	5	cell	cell	NN
10_1101-2021_01_06_425584	305	6	cycle	cycle	NN
10_1101-2021_01_06_425584	305	7	,	,	,
10_1101-2021_01_06_425584	305	8	and	and	CC
10_1101-2021_01_06_425584	305	9	accelerated	accelerate	VBD
10_1101-2021_01_06_425584	305	10	death	death	NN
10_1101-2021_01_06_425584	305	11	.	.	.
10_1101-2021_01_06_425584	306	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	306	2	1985	1985	CD
10_1101-2021_01_06_425584	306	3	,	,	,
10_1101-2021_01_06_425584	306	4	34	34	CD
10_1101-2021_01_06_425584	306	5	,	,	,
10_1101-2021_01_06_425584	306	6	(	(	-LRB-
10_1101-2021_01_06_425584	306	7	7	7	CD
10_1101-2021_01_06_425584	306	8	)	)	-RRB-
10_1101-2021_01_06_425584	306	9	,	,	,
10_1101-2021_01_06_425584	306	10	545	545	CD
10_1101-2021_01_06_425584	306	11	621	621	CD
10_1101-2021_01_06_425584	306	12	-	-	SYM
10_1101-2021_01_06_425584	306	13	7	7	CD
10_1101-2021_01_06_425584	306	14	.	.	.
10_1101-2021_01_06_425584	307	1	546	546	CD
10_1101-2021_01_06_425584	307	2	5	5	CD
10_1101-2021_01_06_425584	307	3	.	.	.
10_1101-2021_01_06_425584	308	1	Kageyama	Kageyama	NNP
10_1101-2021_01_06_425584	308	2	,	,	,
10_1101-2021_01_06_425584	308	3	S.	S.	NNP
10_1101-2021_01_06_425584	308	4	;	;	:
10_1101-2021_01_06_425584	308	5	Yokoo	Yokoo	NNP
10_1101-2021_01_06_425584	308	6	,	,	,
10_1101-2021_01_06_425584	308	7	H.	H.	NNP
10_1101-2021_01_06_425584	308	8	;	;	:
10_1101-2021_01_06_425584	308	9	Tomita	Tomita	NNP
10_1101-2021_01_06_425584	308	10	,	,	,
10_1101-2021_01_06_425584	308	11	K.	K.	NNP
10_1101-2021_01_06_425584	308	12	;	;	:
10_1101-2021_01_06_425584	308	13	Kageyama	Kageyama	NNP
10_1101-2021_01_06_425584	308	14	-	-	HYPH
10_1101-2021_01_06_425584	308	15	Yahara	Yahara	NNP
10_1101-2021_01_06_425584	308	16	,	,	,
10_1101-2021_01_06_425584	308	17	N.	N.	NNP
10_1101-2021_01_06_425584	308	18	;	;	:
10_1101-2021_01_06_425584	308	19	Uchimido	Uchimido	NNP
10_1101-2021_01_06_425584	308	20	,	,	,
10_1101-2021_01_06_425584	308	21	R.	R.	NNP
10_1101-2021_01_06_425584	308	22	;	;	:
10_1101-2021_01_06_425584	308	23	Matsuda	Matsuda	NNP
10_1101-2021_01_06_425584	308	24	,	,	,
10_1101-2021_01_06_425584	308	25	547	547	CD
10_1101-2021_01_06_425584	308	26	N.	n.	NN
10_1101-2021_01_06_425584	308	27	;	;	:
10_1101-2021_01_06_425584	308	28	Yamamoto	Yamamoto	NNP
10_1101-2021_01_06_425584	308	29	,	,	,
10_1101-2021_01_06_425584	308	30	S.	S.	NNP
10_1101-2021_01_06_425584	308	31	;	;	:
10_1101-2021_01_06_425584	308	32	Hattori	Hattori	NNP
10_1101-2021_01_06_425584	308	33	,	,	,
10_1101-2021_01_06_425584	308	34	Y.	Y.	NNP
10_1101-2021_01_06_425584	308	35	,	,	,
10_1101-2021_01_06_425584	308	36	High	high	JJ
10_1101-2021_01_06_425584	308	37	glucose	glucose	NN
10_1101-2021_01_06_425584	308	38	-	-	HYPH
10_1101-2021_01_06_425584	308	39	induced	induce	VBN
10_1101-2021_01_06_425584	308	40	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	308	41	in	in	IN
10_1101-2021_01_06_425584	308	42	human	human	JJ
10_1101-2021_01_06_425584	308	43	coronary	coronary	JJ
10_1101-2021_01_06_425584	308	44	artery	artery	NN
10_1101-2021_01_06_425584	308	45	548	548	CD
10_1101-2021_01_06_425584	308	46	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	308	47	cells	cell	NNS
10_1101-2021_01_06_425584	308	48	involves	involve	VBZ
10_1101-2021_01_06_425584	308	49	up	up	IN
10_1101-2021_01_06_425584	308	50	-	-	HYPH
10_1101-2021_01_06_425584	308	51	regulation	regulation	NN
10_1101-2021_01_06_425584	308	52	of	of	IN
10_1101-2021_01_06_425584	308	53	death	death	NN
10_1101-2021_01_06_425584	308	54	receptors	receptor	NNS
10_1101-2021_01_06_425584	308	55	.	.	.
10_1101-2021_01_06_425584	309	1	Cardiovasc	Cardiovasc	NNP
10_1101-2021_01_06_425584	309	2	Diabetol	Diabetol	NNP
10_1101-2021_01_06_425584	309	3	2011	2011	CD
10_1101-2021_01_06_425584	309	4	,	,	,
10_1101-2021_01_06_425584	309	5	10	10	CD
10_1101-2021_01_06_425584	309	6	,	,	,
10_1101-2021_01_06_425584	309	7	73	73	CD
10_1101-2021_01_06_425584	309	8	.	.	.
10_1101-2021_01_06_425584	310	1	549	549	CD
10_1101-2021_01_06_425584	310	2	6	6	CD
10_1101-2021_01_06_425584	310	3	.	.	.
10_1101-2021_01_06_425584	311	1	Dubois	Dubois	NNP
10_1101-2021_01_06_425584	311	2	,	,	,
10_1101-2021_01_06_425584	311	3	S.	S.	NNP
10_1101-2021_01_06_425584	311	4	;	;	:
10_1101-2021_01_06_425584	311	5	Madec	Madec	NNP
10_1101-2021_01_06_425584	311	6	,	,	,
10_1101-2021_01_06_425584	311	7	A.	a.	NN
10_1101-2021_01_06_425584	311	8	M.	M.	NNP
10_1101-2021_01_06_425584	311	9	;	;	:
10_1101-2021_01_06_425584	311	10	Mesnier	Mesnier	NNP
10_1101-2021_01_06_425584	311	11	,	,	,
10_1101-2021_01_06_425584	311	12	A.	a.	NN
10_1101-2021_01_06_425584	311	13	;	;	:
10_1101-2021_01_06_425584	311	14	Armanet	Armanet	NNP
10_1101-2021_01_06_425584	311	15	,	,	,
10_1101-2021_01_06_425584	311	16	M.	M.	NNP
10_1101-2021_01_06_425584	311	17	;	;	:
10_1101-2021_01_06_425584	311	18	Chikh	Chikh	NNP
10_1101-2021_01_06_425584	311	19	,	,	,
10_1101-2021_01_06_425584	311	20	K.	K.	NNP
10_1101-2021_01_06_425584	311	21	;	;	:
10_1101-2021_01_06_425584	311	22	Berney	Berney	NNP
10_1101-2021_01_06_425584	311	23	,	,	,
10_1101-2021_01_06_425584	311	24	T.	T.	NNP
10_1101-2021_01_06_425584	311	25	;	;	:
10_1101-2021_01_06_425584	311	26	Thivolet	Thivolet	NNP
10_1101-2021_01_06_425584	311	27	,	,	,
10_1101-2021_01_06_425584	311	28	C.	C.	NNP
10_1101-2021_01_06_425584	311	29	,	,	,
10_1101-2021_01_06_425584	311	30	550	550	CD
10_1101-2021_01_06_425584	311	31	Glucose	Glucose	NNP
10_1101-2021_01_06_425584	311	32	inhibits	inhibit	VBZ
10_1101-2021_01_06_425584	311	33	angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	311	34	of	of	IN
10_1101-2021_01_06_425584	311	35	isolated	isolated	JJ
10_1101-2021_01_06_425584	311	36	human	human	JJ
10_1101-2021_01_06_425584	311	37	pancreatic	pancreatic	JJ
10_1101-2021_01_06_425584	311	38	islets	islet	NNS
10_1101-2021_01_06_425584	311	39	.	.	.
10_1101-2021_01_06_425584	312	1	J	J	NNP
10_1101-2021_01_06_425584	312	2	Mol	Mol	NNP
10_1101-2021_01_06_425584	312	3	Endocrinol	Endocrinol	NNP
10_1101-2021_01_06_425584	312	4	2010	2010	CD
10_1101-2021_01_06_425584	312	5	,	,	,
10_1101-2021_01_06_425584	312	6	45	45	CD
10_1101-2021_01_06_425584	312	7	,	,	,
10_1101-2021_01_06_425584	312	8	551	551	CD
10_1101-2021_01_06_425584	312	9	(	(	-LRB-
10_1101-2021_01_06_425584	312	10	2	2	CD
10_1101-2021_01_06_425584	312	11	)	)	-RRB-
10_1101-2021_01_06_425584	312	12	,	,	,
10_1101-2021_01_06_425584	312	13	99	99	CD
10_1101-2021_01_06_425584	312	14	-	-	SYM
10_1101-2021_01_06_425584	312	15	105	105	CD
10_1101-2021_01_06_425584	312	16	.	.	.
10_1101-2021_01_06_425584	313	1	552	552	CD
10_1101-2021_01_06_425584	313	2	7	7	CD
10_1101-2021_01_06_425584	313	3	.	.	.
10_1101-2021_01_06_425584	314	1	Lorenzi	Lorenzi	NNP
10_1101-2021_01_06_425584	314	2	,	,	,
10_1101-2021_01_06_425584	314	3	M.	M.	NNP
10_1101-2021_01_06_425584	314	4	;	;	:
10_1101-2021_01_06_425584	314	5	Montisano	Montisano	NNP
10_1101-2021_01_06_425584	314	6	,	,	,
10_1101-2021_01_06_425584	314	7	D.	D.	NNP
10_1101-2021_01_06_425584	314	8	F.	F.	NNP
10_1101-2021_01_06_425584	314	9	;	;	:
10_1101-2021_01_06_425584	314	10	Toledo	Toledo	NNP
10_1101-2021_01_06_425584	314	11	,	,	,
10_1101-2021_01_06_425584	314	12	S.	S.	NNP
10_1101-2021_01_06_425584	314	13	;	;	:
10_1101-2021_01_06_425584	314	14	Barrieux	Barrieux	NNP
10_1101-2021_01_06_425584	314	15	,	,	,
10_1101-2021_01_06_425584	314	16	A.	a.	NN
10_1101-2021_01_06_425584	314	17	,	,	,
10_1101-2021_01_06_425584	314	18	High	high	JJ
10_1101-2021_01_06_425584	314	19	glucose	glucose	NN
10_1101-2021_01_06_425584	314	20	induces	induce	NNS
10_1101-2021_01_06_425584	314	21	DNA	dna	NN
10_1101-2021_01_06_425584	314	22	553	553	CD
10_1101-2021_01_06_425584	314	23	damage	damage	NN
10_1101-2021_01_06_425584	314	24	in	in	IN
10_1101-2021_01_06_425584	314	25	cultured	cultured	JJ
10_1101-2021_01_06_425584	314	26	human	human	JJ
10_1101-2021_01_06_425584	314	27	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	314	28	cells	cell	NNS
10_1101-2021_01_06_425584	314	29	.	.	.
10_1101-2021_01_06_425584	315	1	J	J	NNP
10_1101-2021_01_06_425584	315	2	Clin	Clin	NNP
10_1101-2021_01_06_425584	315	3	Invest	Invest	NNP
10_1101-2021_01_06_425584	315	4	1986	1986	CD
10_1101-2021_01_06_425584	315	5	,	,	,
10_1101-2021_01_06_425584	315	6	77	77	CD
10_1101-2021_01_06_425584	315	7	,	,	,
10_1101-2021_01_06_425584	315	8	(	(	-LRB-
10_1101-2021_01_06_425584	315	9	1	1	CD
10_1101-2021_01_06_425584	315	10	)	)	-RRB-
10_1101-2021_01_06_425584	315	11	,	,	,
10_1101-2021_01_06_425584	315	12	322	322	CD
10_1101-2021_01_06_425584	315	13	-	-	SYM
10_1101-2021_01_06_425584	315	14	5	5	CD
10_1101-2021_01_06_425584	315	15	.	.	.
10_1101-2021_01_06_425584	316	1	554	554	CD
10_1101-2021_01_06_425584	316	2	8	8	CD
10_1101-2021_01_06_425584	316	3	.	.	.
10_1101-2021_01_06_425584	317	1	Patel	Patel	NNP
10_1101-2021_01_06_425584	317	2	,	,	,
10_1101-2021_01_06_425584	317	3	H.	H.	NNP
10_1101-2021_01_06_425584	317	4	;	;	:
10_1101-2021_01_06_425584	317	5	Chen	Chen	NNP
10_1101-2021_01_06_425584	317	6	,	,	,
10_1101-2021_01_06_425584	317	7	J.	J.	NNP
10_1101-2021_01_06_425584	317	8	;	;	:
10_1101-2021_01_06_425584	317	9	Das	Das	NNP
10_1101-2021_01_06_425584	317	10	,	,	,
10_1101-2021_01_06_425584	317	11	K.	K.	NNP
10_1101-2021_01_06_425584	317	12	C.	C.	NNP
10_1101-2021_01_06_425584	317	13	;	;	:
10_1101-2021_01_06_425584	317	14	Kavdia	Kavdia	NNP
10_1101-2021_01_06_425584	317	15	,	,	,
10_1101-2021_01_06_425584	317	16	M.	M.	NNP
10_1101-2021_01_06_425584	317	17	,	,	,
10_1101-2021_01_06_425584	317	18	Hyperglycemia	Hyperglycemia	NNP
10_1101-2021_01_06_425584	317	19	induces	induce	VBZ
10_1101-2021_01_06_425584	317	20	differential	differential	VBP
10_1101-2021_01_06_425584	317	21	change	change	NN
10_1101-2021_01_06_425584	317	22	in	in	IN
10_1101-2021_01_06_425584	317	23	555	555	CD
10_1101-2021_01_06_425584	317	24	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	317	25	stress	stress	NN
10_1101-2021_01_06_425584	317	26	at	at	IN
10_1101-2021_01_06_425584	317	27	gene	gene	NN
10_1101-2021_01_06_425584	317	28	expression	expression	NN
10_1101-2021_01_06_425584	317	29	and	and	CC
10_1101-2021_01_06_425584	317	30	functional	functional	JJ
10_1101-2021_01_06_425584	317	31	levels	level	NNS
10_1101-2021_01_06_425584	317	32	in	in	IN
10_1101-2021_01_06_425584	317	33	HUVEC	HUVEC	NNP
10_1101-2021_01_06_425584	317	34	and	and	CC
10_1101-2021_01_06_425584	317	35	HMVEC	HMVEC	NNP
10_1101-2021_01_06_425584	317	36	.	.	.
10_1101-2021_01_06_425584	318	1	Cardiovasc	Cardiovasc	NNP
10_1101-2021_01_06_425584	318	2	556	556	CD
10_1101-2021_01_06_425584	318	3	Diabetol	Diabetol	NNP
10_1101-2021_01_06_425584	318	4	2013	2013	CD
10_1101-2021_01_06_425584	318	5	,	,	,
10_1101-2021_01_06_425584	318	6	12	12	CD
10_1101-2021_01_06_425584	318	7	,	,	,
10_1101-2021_01_06_425584	318	8	142	142	CD
10_1101-2021_01_06_425584	318	9	.	.	.
10_1101-2021_01_06_425584	319	1	557	557	CD
10_1101-2021_01_06_425584	319	2	9	9	CD
10_1101-2021_01_06_425584	319	3	.	.	.
10_1101-2021_01_06_425584	320	1	Pala	Pala	NNP
10_1101-2021_01_06_425584	320	2	,	,	,
10_1101-2021_01_06_425584	320	3	L.	L.	NNP
10_1101-2021_01_06_425584	320	4	;	;	:
10_1101-2021_01_06_425584	320	5	Pezzatini	Pezzatini	NNP
10_1101-2021_01_06_425584	320	6	,	,	,
10_1101-2021_01_06_425584	320	7	A.	a.	NN
10_1101-2021_01_06_425584	320	8	;	;	:
10_1101-2021_01_06_425584	320	9	Dicembrini	Dicembrini	NNP
10_1101-2021_01_06_425584	320	10	,	,	,
10_1101-2021_01_06_425584	320	11	I.	i.	NN
10_1101-2021_01_06_425584	320	12	;	;	:
10_1101-2021_01_06_425584	320	13	Ciani	Ciani	NNP
10_1101-2021_01_06_425584	320	14	,	,	,
10_1101-2021_01_06_425584	320	15	S.	S.	NNP
10_1101-2021_01_06_425584	320	16	;	;	:
10_1101-2021_01_06_425584	320	17	Gelmini	Gelmini	NNP
10_1101-2021_01_06_425584	320	18	,	,	,
10_1101-2021_01_06_425584	320	19	S.	S.	NNP
10_1101-2021_01_06_425584	320	20	;	;	:
10_1101-2021_01_06_425584	320	21	Vannelli	Vannelli	NNP
10_1101-2021_01_06_425584	320	22	,	,	,
10_1101-2021_01_06_425584	320	23	B.	B.	NNP
10_1101-2021_01_06_425584	320	24	G.	G.	NNP
10_1101-2021_01_06_425584	320	25	;	;	:
10_1101-2021_01_06_425584	320	26	Cresci	Cresci	NNP
10_1101-2021_01_06_425584	320	27	,	,	,
10_1101-2021_01_06_425584	320	28	B.	B.	NNP
10_1101-2021_01_06_425584	320	29	;	;	:
10_1101-2021_01_06_425584	320	30	558	558	CD
10_1101-2021_01_06_425584	320	31	Mannucci	Mannucci	NNP
10_1101-2021_01_06_425584	320	32	,	,	,
10_1101-2021_01_06_425584	320	33	E.	E.	NNP
10_1101-2021_01_06_425584	320	34	;	;	:
10_1101-2021_01_06_425584	320	35	Rotella	Rotella	NNP
10_1101-2021_01_06_425584	320	36	,	,	,
10_1101-2021_01_06_425584	320	37	C.	C.	NNP
10_1101-2021_01_06_425584	320	38	M.	M.	NNP
10_1101-2021_01_06_425584	320	39	,	,	,
10_1101-2021_01_06_425584	320	40	Different	different	JJ
10_1101-2021_01_06_425584	320	41	modulation	modulation	NN
10_1101-2021_01_06_425584	320	42	of	of	IN
10_1101-2021_01_06_425584	320	43	dipeptidyl	dipeptidyl	JJ
10_1101-2021_01_06_425584	320	44	peptidase-4	peptidase-4	NNP
10_1101-2021_01_06_425584	320	45	activity	activity	NN
10_1101-2021_01_06_425584	320	46	between	between	IN
10_1101-2021_01_06_425584	320	47	559	559	CD
10_1101-2021_01_06_425584	320	48	microvascular	microvascular	JJ
10_1101-2021_01_06_425584	320	49	and	and	CC
10_1101-2021_01_06_425584	320	50	macrovascular	macrovascular	JJ
10_1101-2021_01_06_425584	320	51	human	human	JJ
10_1101-2021_01_06_425584	320	52	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	320	53	cells	cell	NNS
10_1101-2021_01_06_425584	320	54	.	.	.
10_1101-2021_01_06_425584	321	1	Acta	Acta	NNP
10_1101-2021_01_06_425584	321	2	Diabetol	Diabetol	NNP
10_1101-2021_01_06_425584	321	3	2012	2012	CD
10_1101-2021_01_06_425584	321	4	,	,	,
10_1101-2021_01_06_425584	321	5	49	49	CD
10_1101-2021_01_06_425584	321	6	Suppl	suppl	NN
10_1101-2021_01_06_425584	321	7	1	1	CD
10_1101-2021_01_06_425584	321	8	,	,	,
10_1101-2021_01_06_425584	321	9	560	560	CD
10_1101-2021_01_06_425584	321	10	S59	S59	NNP
10_1101-2021_01_06_425584	321	11	-	-	HYPH
10_1101-2021_01_06_425584	321	12	63	63	CD
10_1101-2021_01_06_425584	321	13	.	.	.
10_1101-2021_01_06_425584	322	1	561	561	CD
10_1101-2021_01_06_425584	322	2	10	10	CD
10_1101-2021_01_06_425584	322	3	.	.	.
10_1101-2021_01_06_425584	323	1	Esposito	Esposito	NNP
10_1101-2021_01_06_425584	323	2	,	,	,
10_1101-2021_01_06_425584	323	3	C.	C.	NNP
10_1101-2021_01_06_425584	323	4	;	;	:
10_1101-2021_01_06_425584	323	5	Fasoli	Fasoli	NNP
10_1101-2021_01_06_425584	323	6	,	,	,
10_1101-2021_01_06_425584	323	7	G.	G.	NNP
10_1101-2021_01_06_425584	323	8	;	;	:
10_1101-2021_01_06_425584	323	9	Plati	Plati	NNP
10_1101-2021_01_06_425584	323	10	,	,	,
10_1101-2021_01_06_425584	323	11	A.	A.	NNP
10_1101-2021_01_06_425584	323	12	R.	R.	NNP
10_1101-2021_01_06_425584	323	13	;	;	:
10_1101-2021_01_06_425584	323	14	Bellotti	Bellotti	NNP
10_1101-2021_01_06_425584	323	15	,	,	,
10_1101-2021_01_06_425584	323	16	N.	N.	NNP
10_1101-2021_01_06_425584	323	17	;	;	:
10_1101-2021_01_06_425584	323	18	Conte	Conte	NNP
10_1101-2021_01_06_425584	323	19	,	,	,
10_1101-2021_01_06_425584	323	20	M.	M.	NNP
10_1101-2021_01_06_425584	323	21	M.	M.	NNP
10_1101-2021_01_06_425584	323	22	;	;	:
10_1101-2021_01_06_425584	323	23	Cornacchia	Cornacchia	NNP
10_1101-2021_01_06_425584	323	24	,	,	,
10_1101-2021_01_06_425584	323	25	F.	F.	NNP
10_1101-2021_01_06_425584	323	26	;	;	:
10_1101-2021_01_06_425584	323	27	Foschi	Foschi	NNP
10_1101-2021_01_06_425584	323	28	,	,	,
10_1101-2021_01_06_425584	323	29	A.	a.	NN
10_1101-2021_01_06_425584	323	30	;	;	:
10_1101-2021_01_06_425584	323	31	562	562	CD
10_1101-2021_01_06_425584	323	32	Mazzullo	Mazzullo	NNP
10_1101-2021_01_06_425584	323	33	,	,	,
10_1101-2021_01_06_425584	323	34	T.	T.	NNP
10_1101-2021_01_06_425584	323	35	;	;	:
10_1101-2021_01_06_425584	323	36	Semeraro	Semeraro	NNP
10_1101-2021_01_06_425584	323	37	,	,	,
10_1101-2021_01_06_425584	323	38	L.	L.	NNP
10_1101-2021_01_06_425584	323	39	;	;	:
10_1101-2021_01_06_425584	323	40	Dal	Dal	NNP
10_1101-2021_01_06_425584	323	41	Canton	Canton	NNP
10_1101-2021_01_06_425584	323	42	,	,	,
10_1101-2021_01_06_425584	323	43	A.	a.	NN
10_1101-2021_01_06_425584	323	44	,	,	,
10_1101-2021_01_06_425584	323	45	Long	long	JJ
10_1101-2021_01_06_425584	323	46	-	-	HYPH
10_1101-2021_01_06_425584	323	47	term	term	NN
10_1101-2021_01_06_425584	323	48	exposure	exposure	NN
10_1101-2021_01_06_425584	323	49	to	to	IN
10_1101-2021_01_06_425584	323	50	high	high	JJ
10_1101-2021_01_06_425584	323	51	glucose	glucose	VB
10_1101-2021_01_06_425584	323	52	up	up	RP
10_1101-2021_01_06_425584	323	53	-	-	HYPH
10_1101-2021_01_06_425584	323	54	regulates	regulate	VBZ
10_1101-2021_01_06_425584	323	55	563	563	CD
10_1101-2021_01_06_425584	323	56	VCAM	VCAM	NNS
10_1101-2021_01_06_425584	323	57	-	-	HYPH
10_1101-2021_01_06_425584	323	58	induced	induce	VBN
10_1101-2021_01_06_425584	323	59	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	323	60	cell	cell	NN
10_1101-2021_01_06_425584	323	61	adhesiveness	adhesiveness	NN
10_1101-2021_01_06_425584	323	62	to	to	IN
10_1101-2021_01_06_425584	323	63	PBMC	PBMC	NNP
10_1101-2021_01_06_425584	323	64	.	.	.
10_1101-2021_01_06_425584	324	1	Kidney	Kidney	NNP
10_1101-2021_01_06_425584	324	2	Int	Int	NNP
10_1101-2021_01_06_425584	324	3	2001	2001	CD
10_1101-2021_01_06_425584	324	4	,	,	,
10_1101-2021_01_06_425584	324	5	59	59	CD
10_1101-2021_01_06_425584	324	6	,	,	,
10_1101-2021_01_06_425584	324	7	(	(	-LRB-
10_1101-2021_01_06_425584	324	8	5	5	CD
10_1101-2021_01_06_425584	324	9	)	)	-RRB-
10_1101-2021_01_06_425584	324	10	,	,	,
10_1101-2021_01_06_425584	324	11	1842	1842	CD
10_1101-2021_01_06_425584	324	12	-	-	SYM
10_1101-2021_01_06_425584	324	13	9	9	CD
10_1101-2021_01_06_425584	324	14	.	.	.
10_1101-2021_01_06_425584	325	1	564	564	CD
10_1101-2021_01_06_425584	325	2	11	11	CD
10_1101-2021_01_06_425584	325	3	.	.	.
10_1101-2021_01_06_425584	326	1	Baumgartner	Baumgartner	NNP
10_1101-2021_01_06_425584	326	2	-	-	HYPH
10_1101-2021_01_06_425584	326	3	Parzer	Parzer	NNP
10_1101-2021_01_06_425584	326	4	,	,	,
10_1101-2021_01_06_425584	326	5	S.	S.	NNP
10_1101-2021_01_06_425584	326	6	M.	M.	NNP
10_1101-2021_01_06_425584	326	7	;	;	:
10_1101-2021_01_06_425584	326	8	Wagner	Wagner	NNP
10_1101-2021_01_06_425584	326	9	,	,	,
10_1101-2021_01_06_425584	326	10	L.	L.	NNP
10_1101-2021_01_06_425584	326	11	;	;	:
10_1101-2021_01_06_425584	326	12	Pettermann	Pettermann	NNP
10_1101-2021_01_06_425584	326	13	,	,	,
10_1101-2021_01_06_425584	326	14	M.	M.	NNP
10_1101-2021_01_06_425584	326	15	;	;	:
10_1101-2021_01_06_425584	326	16	Grillari	Grillari	NNP
10_1101-2021_01_06_425584	326	17	,	,	,
10_1101-2021_01_06_425584	326	18	J.	J.	NNP
10_1101-2021_01_06_425584	326	19	;	;	:
10_1101-2021_01_06_425584	326	20	Gessl	Gessl	NNP
10_1101-2021_01_06_425584	326	21	,	,	,
10_1101-2021_01_06_425584	326	22	A.	a.	NN
10_1101-2021_01_06_425584	326	23	;	;	:
10_1101-2021_01_06_425584	326	24	565	565	CD
10_1101-2021_01_06_425584	326	25	Waldhausl	Waldhausl	NNP
10_1101-2021_01_06_425584	326	26	,	,	,
10_1101-2021_01_06_425584	326	27	W.	W.	NNP
10_1101-2021_01_06_425584	326	28	,	,	,
10_1101-2021_01_06_425584	326	29	High	High	NNP
10_1101-2021_01_06_425584	326	30	-	-	HYPH
10_1101-2021_01_06_425584	326	31	glucose	glucose	NNP
10_1101-2021_01_06_425584	326	32	--	--	:
10_1101-2021_01_06_425584	326	33	triggered	trigger	VBD
10_1101-2021_01_06_425584	326	34	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	326	35	in	in	IN
10_1101-2021_01_06_425584	326	36	cultured	cultured	JJ
10_1101-2021_01_06_425584	326	37	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	326	38	cells	cell	NNS
10_1101-2021_01_06_425584	326	39	.	.	.
10_1101-2021_01_06_425584	327	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	327	2	1995	1995	CD
10_1101-2021_01_06_425584	327	3	,	,	,
10_1101-2021_01_06_425584	327	4	566	566	CD
10_1101-2021_01_06_425584	327	5	44	44	CD
10_1101-2021_01_06_425584	327	6	,	,	,
10_1101-2021_01_06_425584	327	7	(	(	-LRB-
10_1101-2021_01_06_425584	327	8	11	11	CD
10_1101-2021_01_06_425584	327	9	)	)	-RRB-
10_1101-2021_01_06_425584	327	10	,	,	,
10_1101-2021_01_06_425584	327	11	1323	1323	CD
10_1101-2021_01_06_425584	327	12	-	-	SYM
10_1101-2021_01_06_425584	327	13	7	7	CD
10_1101-2021_01_06_425584	327	14	.	.	.
10_1101-2021_01_06_425584	328	1	567	567	CD
10_1101-2021_01_06_425584	328	2	12	12	CD
10_1101-2021_01_06_425584	328	3	.	.	.
10_1101-2021_01_06_425584	329	1	Ramirez	Ramirez	NNP
10_1101-2021_01_06_425584	329	2	-	-	HYPH
10_1101-2021_01_06_425584	329	3	Sanchez	Sanchez	NNP
10_1101-2021_01_06_425584	329	4	,	,	,
10_1101-2021_01_06_425584	329	5	I.	I.	NNP
10_1101-2021_01_06_425584	329	6	;	;	:
10_1101-2021_01_06_425584	329	7	Rodriguez	Rodriguez	NNP
10_1101-2021_01_06_425584	329	8	,	,	,
10_1101-2021_01_06_425584	329	9	A.	a.	NN
10_1101-2021_01_06_425584	329	10	;	;	:
10_1101-2021_01_06_425584	329	11	Moreno	Moreno	NNP
10_1101-2021_01_06_425584	329	12	-	-	HYPH
10_1101-2021_01_06_425584	329	13	Ulloa	Ulloa	NNP
10_1101-2021_01_06_425584	329	14	,	,	,
10_1101-2021_01_06_425584	329	15	A.	a.	NN
10_1101-2021_01_06_425584	329	16	;	;	:
10_1101-2021_01_06_425584	329	17	Ceballos	Ceballos	NNP
10_1101-2021_01_06_425584	329	18	,	,	,
10_1101-2021_01_06_425584	329	19	G.	G.	NNP
10_1101-2021_01_06_425584	329	20	;	;	:
10_1101-2021_01_06_425584	329	21	Villarreal	Villarreal	NNP
10_1101-2021_01_06_425584	329	22	,	,	,
10_1101-2021_01_06_425584	329	23	F.	F.	NNP
10_1101-2021_01_06_425584	329	24	,	,	,
10_1101-2021_01_06_425584	329	25	(	(	-LRB-
10_1101-2021_01_06_425584	329	26	-)-568	-)-568	NNP
10_1101-2021_01_06_425584	329	27	Epicatechin	epicatechin	NN
10_1101-2021_01_06_425584	329	28	-	-	HYPH
10_1101-2021_01_06_425584	329	29	induced	induce	VBN
10_1101-2021_01_06_425584	329	30	recovery	recovery	NN
10_1101-2021_01_06_425584	329	31	of	of	IN
10_1101-2021_01_06_425584	329	32	mitochondria	mitochondria	NNP
10_1101-2021_01_06_425584	329	33	from	from	IN
10_1101-2021_01_06_425584	329	34	simulated	simulated	JJ
10_1101-2021_01_06_425584	329	35	diabetes	diabete	NNS
10_1101-2021_01_06_425584	329	36	:	:	:
10_1101-2021_01_06_425584	329	37	Potential	potential	JJ
10_1101-2021_01_06_425584	329	38	role	role	NN
10_1101-2021_01_06_425584	329	39	of	of	IN
10_1101-2021_01_06_425584	329	40	569	569	CD
10_1101-2021_01_06_425584	329	41	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	329	42	nitric	nitric	NN
10_1101-2021_01_06_425584	329	43	oxide	oxide	NN
10_1101-2021_01_06_425584	329	44	synthase	synthase	NN
10_1101-2021_01_06_425584	329	45	.	.	.
10_1101-2021_01_06_425584	330	1	Diab	Diab	NNP
10_1101-2021_01_06_425584	330	2	Vasc	Vasc	NNP
10_1101-2021_01_06_425584	330	3	Dis	Dis	NNP
10_1101-2021_01_06_425584	330	4	Res	Res	NNP
10_1101-2021_01_06_425584	330	5	2016	2016	CD
10_1101-2021_01_06_425584	330	6	,	,	,
10_1101-2021_01_06_425584	330	7	13	13	CD
10_1101-2021_01_06_425584	330	8	,	,	,
10_1101-2021_01_06_425584	330	9	(	(	-LRB-
10_1101-2021_01_06_425584	330	10	3	3	CD
10_1101-2021_01_06_425584	330	11	)	)	-RRB-
10_1101-2021_01_06_425584	330	12	,	,	,
10_1101-2021_01_06_425584	330	13	201	201	CD
10_1101-2021_01_06_425584	330	14	-	-	SYM
10_1101-2021_01_06_425584	330	15	10	10	CD
10_1101-2021_01_06_425584	330	16	.	.	.
10_1101-2021_01_06_425584	331	1	570	570	CD
10_1101-2021_01_06_425584	331	2	13	13	CD
10_1101-2021_01_06_425584	331	3	.	.	.
10_1101-2021_01_06_425584	332	1	Liu	Liu	NNP
10_1101-2021_01_06_425584	332	2	,	,	,
10_1101-2021_01_06_425584	332	3	T.	t.	NN
10_1101-2021_01_06_425584	332	4	;	;	:
10_1101-2021_01_06_425584	332	5	Gong	Gong	NNP
10_1101-2021_01_06_425584	332	6	,	,	,
10_1101-2021_01_06_425584	332	7	J.	J.	NNP
10_1101-2021_01_06_425584	332	8	;	;	:
10_1101-2021_01_06_425584	332	9	Chen	Chen	NNP
10_1101-2021_01_06_425584	332	10	,	,	,
10_1101-2021_01_06_425584	332	11	Y.	Y.	NNP
10_1101-2021_01_06_425584	332	12	;	;	:
10_1101-2021_01_06_425584	332	13	Jiang	Jiang	NNP
10_1101-2021_01_06_425584	332	14	,	,	,
10_1101-2021_01_06_425584	332	15	S.	S.	NNP
10_1101-2021_01_06_425584	332	16	,	,	,
10_1101-2021_01_06_425584	332	17	Periodic	Periodic	NNP
10_1101-2021_01_06_425584	332	18	vs	vs	IN
10_1101-2021_01_06_425584	332	19	constant	constant	JJ
10_1101-2021_01_06_425584	332	20	high	high	JJ
10_1101-2021_01_06_425584	332	21	glucose	glucose	NN
10_1101-2021_01_06_425584	332	22	in	in	IN
10_1101-2021_01_06_425584	332	23	inducing	induce	VBG
10_1101-2021_01_06_425584	332	24	pro-571	pro-571	VB
10_1101-2021_01_06_425584	332	25	inflammatory	inflammatory	JJ
10_1101-2021_01_06_425584	332	26	cytokine	cytokine	JJ
10_1101-2021_01_06_425584	332	27	expression	expression	NN
10_1101-2021_01_06_425584	332	28	in	in	IN
10_1101-2021_01_06_425584	332	29	human	human	JJ
10_1101-2021_01_06_425584	332	30	coronary	coronary	JJ
10_1101-2021_01_06_425584	332	31	artery	artery	NN
10_1101-2021_01_06_425584	332	32	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	332	33	cells	cell	NNS
10_1101-2021_01_06_425584	332	34	.	.	.
10_1101-2021_01_06_425584	333	1	Inflamm	Inflamm	NNP
10_1101-2021_01_06_425584	333	2	Res	Res	NNP
10_1101-2021_01_06_425584	333	3	2013	2013	CD
10_1101-2021_01_06_425584	333	4	,	,	,
10_1101-2021_01_06_425584	333	5	572	572	CD
10_1101-2021_01_06_425584	333	6	62	62	CD
10_1101-2021_01_06_425584	333	7	,	,	,
10_1101-2021_01_06_425584	333	8	(	(	-LRB-
10_1101-2021_01_06_425584	333	9	7	7	CD
10_1101-2021_01_06_425584	333	10	)	)	-RRB-
10_1101-2021_01_06_425584	333	11	,	,	,
10_1101-2021_01_06_425584	333	12	697	697	CD
10_1101-2021_01_06_425584	333	13	-	-	SYM
10_1101-2021_01_06_425584	333	14	701	701	CD
10_1101-2021_01_06_425584	333	15	.	.	.
10_1101-2021_01_06_425584	334	1	573	573	CD
10_1101-2021_01_06_425584	334	2	14	14	CD
10_1101-2021_01_06_425584	334	3	.	.	.
10_1101-2021_01_06_425584	335	1	Liu	Liu	NNP
10_1101-2021_01_06_425584	335	2	,	,	,
10_1101-2021_01_06_425584	335	3	T.	T.	NNP
10_1101-2021_01_06_425584	335	4	S.	S.	NNP
10_1101-2021_01_06_425584	335	5	;	;	:
10_1101-2021_01_06_425584	335	6	Pei	Pei	NNP
10_1101-2021_01_06_425584	335	7	,	,	,
10_1101-2021_01_06_425584	335	8	Y.	Y.	NNP
10_1101-2021_01_06_425584	335	9	H.	H.	NNP
10_1101-2021_01_06_425584	335	10	;	;	:
10_1101-2021_01_06_425584	335	11	Peng	Peng	NNP
10_1101-2021_01_06_425584	335	12	,	,	,
10_1101-2021_01_06_425584	335	13	Y.	Y.	NNP
10_1101-2021_01_06_425584	335	14	P.	P.	NNP
10_1101-2021_01_06_425584	335	15	;	;	:
10_1101-2021_01_06_425584	335	16	Chen	Chen	NNP
10_1101-2021_01_06_425584	335	17	,	,	,
10_1101-2021_01_06_425584	335	18	J.	J.	NNP
10_1101-2021_01_06_425584	335	19	;	;	:
10_1101-2021_01_06_425584	335	20	Jiang	Jiang	NNP
10_1101-2021_01_06_425584	335	21	,	,	,
10_1101-2021_01_06_425584	335	22	S.	S.	NNP
10_1101-2021_01_06_425584	335	23	S.	S.	NNP
10_1101-2021_01_06_425584	335	24	;	;	:
10_1101-2021_01_06_425584	335	25	Gong	Gong	NNP
10_1101-2021_01_06_425584	335	26	,	,	,
10_1101-2021_01_06_425584	335	27	J.	J.	NNP
10_1101-2021_01_06_425584	336	1	B.	B.	NNP
10_1101-2021_01_06_425584	336	2	,	,	,
10_1101-2021_01_06_425584	336	3	Oscillating	oscillate	VBG
10_1101-2021_01_06_425584	336	4	high	high	JJ
10_1101-2021_01_06_425584	336	5	574	574	CD
10_1101-2021_01_06_425584	336	6	glucose	glucose	NN
10_1101-2021_01_06_425584	336	7	enhances	enhance	VBZ
10_1101-2021_01_06_425584	336	8	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	336	9	stress	stress	NN
10_1101-2021_01_06_425584	336	10	and	and	CC
10_1101-2021_01_06_425584	336	11	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	336	12	in	in	IN
10_1101-2021_01_06_425584	336	13	human	human	JJ
10_1101-2021_01_06_425584	336	14	coronary	coronary	JJ
10_1101-2021_01_06_425584	336	15	artery	artery	NN
10_1101-2021_01_06_425584	336	16	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	336	17	cells	cell	NNS
10_1101-2021_01_06_425584	336	18	.	.	.
10_1101-2021_01_06_425584	337	1	J	J	NNP
10_1101-2021_01_06_425584	337	2	575	575	CD
10_1101-2021_01_06_425584	337	3	Endocrinol	Endocrinol	NNP
10_1101-2021_01_06_425584	337	4	Invest	Invest	NNP
10_1101-2021_01_06_425584	337	5	2014	2014	CD
10_1101-2021_01_06_425584	337	6	,	,	,
10_1101-2021_01_06_425584	337	7	37	37	CD
10_1101-2021_01_06_425584	337	8	,	,	,
10_1101-2021_01_06_425584	337	9	(	(	-LRB-
10_1101-2021_01_06_425584	337	10	7	7	CD
10_1101-2021_01_06_425584	337	11	)	)	-RRB-
10_1101-2021_01_06_425584	337	12	,	,	,
10_1101-2021_01_06_425584	337	13	645	645	CD
10_1101-2021_01_06_425584	337	14	-	-	SYM
10_1101-2021_01_06_425584	337	15	51	51	CD
10_1101-2021_01_06_425584	337	16	.	.	.
10_1101-2021_01_06_425584	338	1	576	576	CD
10_1101-2021_01_06_425584	338	2	15	15	CD
10_1101-2021_01_06_425584	338	3	.	.	.
10_1101-2021_01_06_425584	339	1	Hilda	Hilda	NNP
10_1101-2021_01_06_425584	339	2	Carolina	Carolina	NNP
10_1101-2021_01_06_425584	339	3	Delgado	Delgado	NNP
10_1101-2021_01_06_425584	339	4	De	De	NNP
10_1101-2021_01_06_425584	339	5	la	la	NNP
10_1101-2021_01_06_425584	339	6	Herrán	Herrán	NNP
10_1101-2021_01_06_425584	339	7	,	,	,
10_1101-2021_01_06_425584	339	8	L.	L.	NNP
10_1101-2021_01_06_425584	339	9	D.-M.	D.-M.	NNP
10_1101-2021_01_06_425584	339	10	,	,	,
10_1101-2021_01_06_425584	339	11	Carolina	Carolina	NNP
10_1101-2021_01_06_425584	339	12	Álvarez	Álvarez	NNP
10_1101-2021_01_06_425584	339	13	-	-	HYPH
10_1101-2021_01_06_425584	339	14	Delgado	Delgado	NNP
10_1101-2021_01_06_425584	339	15	,	,	,
10_1101-2021_01_06_425584	339	16	Francisco	Francisco	NNP
10_1101-2021_01_06_425584	339	17	577	577	CD
10_1101-2021_01_06_425584	339	18	Villarreal	villarreal	NN
10_1101-2021_01_06_425584	339	19	,	,	,
10_1101-2021_01_06_425584	339	20	Aldo	Aldo	NNP
10_1101-2021_01_06_425584	339	21	Moreno	Moreno	NNP
10_1101-2021_01_06_425584	339	22	-	-	HYPH
10_1101-2021_01_06_425584	339	23	Ulloa	Ulloa	NNP
10_1101-2021_01_06_425584	339	24	,	,	,
10_1101-2021_01_06_425584	339	25	Formation	formation	NN
10_1101-2021_01_06_425584	339	26	of	of	IN
10_1101-2021_01_06_425584	339	27	multinucleated	multinucleate	VBN
10_1101-2021_01_06_425584	339	28	variant	variant	JJ
10_1101-2021_01_06_425584	339	29	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	339	30	cells	cell	NNS
10_1101-2021_01_06_425584	339	31	with	with	IN
10_1101-2021_01_06_425584	339	32	altered	altered	JJ
10_1101-2021_01_06_425584	339	33	578	578	CD
10_1101-2021_01_06_425584	339	34	mitochondrial	mitochondrial	NN
10_1101-2021_01_06_425584	339	35	function	function	NN
10_1101-2021_01_06_425584	339	36	in	in	IN
10_1101-2021_01_06_425584	339	37	cultured	cultured	JJ
10_1101-2021_01_06_425584	339	38	coronary	coronary	JJ
10_1101-2021_01_06_425584	339	39	endothelium	endothelium	NN
10_1101-2021_01_06_425584	339	40	under	under	IN
10_1101-2021_01_06_425584	339	41	simulated	simulate	VBN
10_1101-2021_01_06_425584	339	42	diabetes	diabete	NNS
10_1101-2021_01_06_425584	339	43	.	.	.
10_1101-2021_01_06_425584	340	1	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	340	2	579	579	CD
10_1101-2021_01_06_425584	340	3	2019	2019	CD
10_1101-2021_01_06_425584	340	4	.	.	.
10_1101-2021_01_06_425584	341	1	580	580	CD
10_1101-2021_01_06_425584	341	2	.CC	.CC	NFP
10_1101-2021_01_06_425584	341	3	-	-	HYPH
10_1101-2021_01_06_425584	341	4	BY	by	IN
10_1101-2021_01_06_425584	341	5	-	-	HYPH
10_1101-2021_01_06_425584	341	6	NC	NC	NNP
10_1101-2021_01_06_425584	341	7	-	-	HYPH
10_1101-2021_01_06_425584	341	8	ND	ND	NNP
10_1101-2021_01_06_425584	341	9	4.0	4.0	CD
10_1101-2021_01_06_425584	341	10	International	International	NNP
10_1101-2021_01_06_425584	341	11	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	341	12	under	under	IN
10_1101-2021_01_06_425584	341	13	a	a	DT
10_1101-2021_01_06_425584	341	14	(	(	-LRB-
10_1101-2021_01_06_425584	341	15	which	which	WDT
10_1101-2021_01_06_425584	341	16	was	be	VBD
10_1101-2021_01_06_425584	341	17	not	not	RB
10_1101-2021_01_06_425584	341	18	certified	certify	VBN
10_1101-2021_01_06_425584	341	19	by	by	IN
10_1101-2021_01_06_425584	341	20	peer	peer	NN
10_1101-2021_01_06_425584	341	21	review	review	NN
10_1101-2021_01_06_425584	341	22	)	)	-RRB-
10_1101-2021_01_06_425584	341	23	is	be	VBZ
10_1101-2021_01_06_425584	341	24	the	the	DT
10_1101-2021_01_06_425584	341	25	author	author	NN
10_1101-2021_01_06_425584	341	26	/	/	SYM
10_1101-2021_01_06_425584	341	27	funder	funder	NN
10_1101-2021_01_06_425584	341	28	,	,	,
10_1101-2021_01_06_425584	341	29	who	who	WP
10_1101-2021_01_06_425584	341	30	has	have	VBZ
10_1101-2021_01_06_425584	341	31	granted	grant	VBN
10_1101-2021_01_06_425584	341	32	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	341	33	a	a	DT
10_1101-2021_01_06_425584	341	34	license	license	NN
10_1101-2021_01_06_425584	341	35	to	to	TO
10_1101-2021_01_06_425584	341	36	display	display	VB
10_1101-2021_01_06_425584	341	37	the	the	DT
10_1101-2021_01_06_425584	341	38	preprint	preprint	NN
10_1101-2021_01_06_425584	341	39	in	in	IN
10_1101-2021_01_06_425584	341	40	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	341	41	.	.	.
10_1101-2021_01_06_425584	342	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	342	2	is	be	VBZ
10_1101-2021_01_06_425584	342	3	made	make	VBN
10_1101-2021_01_06_425584	342	4	The	the	DT
10_1101-2021_01_06_425584	342	5	copyright	copyright	NN
10_1101-2021_01_06_425584	342	6	holder	holder	NN
10_1101-2021_01_06_425584	342	7	for	for	IN
10_1101-2021_01_06_425584	342	8	this	this	DT
10_1101-2021_01_06_425584	342	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	342	10	version	version	NN
10_1101-2021_01_06_425584	342	11	posted	post	VBD
10_1101-2021_01_06_425584	342	12	January	January	NNP
10_1101-2021_01_06_425584	342	13	8	8	CD
10_1101-2021_01_06_425584	342	14	,	,	,
10_1101-2021_01_06_425584	342	15	2021	2021	CD
10_1101-2021_01_06_425584	342	16	.	.	.
10_1101-2021_01_06_425584	342	17	;	;	:
10_1101-2021_01_06_425584	342	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	342	19	:	:	:
10_1101-2021_01_06_425584	342	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	342	21	preprint	preprint	NN
10_1101-2021_01_06_425584	342	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	342	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	342	24	22	22	CD
10_1101-2021_01_06_425584	342	25	16	16	CD
10_1101-2021_01_06_425584	342	26	.	.	.
10_1101-2021_01_06_425584	343	1	Li	Li	NNP
10_1101-2021_01_06_425584	343	2	,	,	,
10_1101-2021_01_06_425584	343	3	X.	X.	NNP
10_1101-2021_01_06_425584	343	4	X.	X.	NNP
10_1101-2021_01_06_425584	343	5	;	;	:
10_1101-2021_01_06_425584	343	6	Liu	Liu	NNP
10_1101-2021_01_06_425584	343	7	,	,	,
10_1101-2021_01_06_425584	343	8	Y.	Y.	NNP
10_1101-2021_01_06_425584	343	9	M.	M.	NNP
10_1101-2021_01_06_425584	343	10	;	;	:
10_1101-2021_01_06_425584	343	11	Li	Li	NNP
10_1101-2021_01_06_425584	343	12	,	,	,
10_1101-2021_01_06_425584	343	13	Y.	Y.	NNP
10_1101-2021_01_06_425584	343	14	J.	J.	NNP
10_1101-2021_01_06_425584	343	15	;	;	:
10_1101-2021_01_06_425584	343	16	Xie	Xie	NNP
10_1101-2021_01_06_425584	343	17	,	,	,
10_1101-2021_01_06_425584	343	18	N.	N.	NNP
10_1101-2021_01_06_425584	343	19	;	;	:
10_1101-2021_01_06_425584	343	20	Yan	Yan	NNP
10_1101-2021_01_06_425584	343	21	,	,	,
10_1101-2021_01_06_425584	343	22	Y.	Y.	NNP
10_1101-2021_01_06_425584	343	23	F.	F.	NNP
10_1101-2021_01_06_425584	343	24	;	;	:
10_1101-2021_01_06_425584	343	25	Chi	Chi	NNP
10_1101-2021_01_06_425584	343	26	,	,	,
10_1101-2021_01_06_425584	343	27	Y.	Y.	NNP
10_1101-2021_01_06_425584	343	28	L.	L.	NNP
10_1101-2021_01_06_425584	343	29	;	;	:
10_1101-2021_01_06_425584	343	30	Zhou	Zhou	NNP
10_1101-2021_01_06_425584	343	31	,	,	,
10_1101-2021_01_06_425584	343	32	L.	L.	NNP
10_1101-2021_01_06_425584	343	33	;	;	:
10_1101-2021_01_06_425584	343	34	Xie	Xie	NNP
10_1101-2021_01_06_425584	343	35	,	,	,
10_1101-2021_01_06_425584	343	36	S.	S.	NNP
10_1101-2021_01_06_425584	343	37	Y.	Y.	NNP
10_1101-2021_01_06_425584	343	38	;	;	:
10_1101-2021_01_06_425584	343	39	Wang	Wang	NNP
10_1101-2021_01_06_425584	343	40	,	,	,
10_1101-2021_01_06_425584	343	41	P.	P.	NNP
10_1101-2021_01_06_425584	343	42	581	581	CD
10_1101-2021_01_06_425584	343	43	Y.	Y.	NNP
10_1101-2021_01_06_425584	343	44	,	,	,
10_1101-2021_01_06_425584	343	45	High	High	NNP
10_1101-2021_01_06_425584	343	46	glucose	glucose	NN
10_1101-2021_01_06_425584	343	47	concentration	concentration	NN
10_1101-2021_01_06_425584	343	48	induces	induce	NNS
10_1101-2021_01_06_425584	343	49	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	343	50	cell	cell	NN
10_1101-2021_01_06_425584	343	51	proliferation	proliferation	NN
10_1101-2021_01_06_425584	343	52	by	by	IN
10_1101-2021_01_06_425584	343	53	regulating	regulate	VBG
10_1101-2021_01_06_425584	343	54	cyclin	cyclin	NNP
10_1101-2021_01_06_425584	343	55	-	-	HYPH
10_1101-2021_01_06_425584	343	56	D2	D2	NNP
10_1101-2021_01_06_425584	343	57	-	-	HYPH
10_1101-2021_01_06_425584	343	58	582	582	NNP
10_1101-2021_01_06_425584	343	59	related	related	JJ
10_1101-2021_01_06_425584	343	60	miR-98	mir-98	NN
10_1101-2021_01_06_425584	343	61	.	.	.
10_1101-2021_01_06_425584	344	1	J	J	NNP
10_1101-2021_01_06_425584	344	2	Cell	Cell	NNP
10_1101-2021_01_06_425584	344	3	Mol	Mol	NNP
10_1101-2021_01_06_425584	344	4	Med	Med	NNP
10_1101-2021_01_06_425584	344	5	2016	2016	CD
10_1101-2021_01_06_425584	344	6	,	,	,
10_1101-2021_01_06_425584	344	7	20	20	CD
10_1101-2021_01_06_425584	344	8	,	,	,
10_1101-2021_01_06_425584	344	9	(	(	-LRB-
10_1101-2021_01_06_425584	344	10	6	6	CD
10_1101-2021_01_06_425584	344	11	)	)	-RRB-
10_1101-2021_01_06_425584	344	12	,	,	,
10_1101-2021_01_06_425584	344	13	1159	1159	CD
10_1101-2021_01_06_425584	344	14	-	-	SYM
10_1101-2021_01_06_425584	344	15	69	69	CD
10_1101-2021_01_06_425584	344	16	.	.	.
10_1101-2021_01_06_425584	345	1	583	583	CD
10_1101-2021_01_06_425584	345	2	17	17	CD
10_1101-2021_01_06_425584	345	3	.	.	.
10_1101-2021_01_06_425584	346	1	Madonna	Madonna	NNP
10_1101-2021_01_06_425584	346	2	,	,	,
10_1101-2021_01_06_425584	346	3	R.	R.	NNP
10_1101-2021_01_06_425584	346	4	;	;	:
10_1101-2021_01_06_425584	346	5	De	De	NNP
10_1101-2021_01_06_425584	346	6	Caterina	Caterina	NNP
10_1101-2021_01_06_425584	346	7	,	,	,
10_1101-2021_01_06_425584	346	8	R.	R.	NNP
10_1101-2021_01_06_425584	346	9	,	,	,
10_1101-2021_01_06_425584	346	10	Prolonged	prolonged	JJ
10_1101-2021_01_06_425584	346	11	exposure	exposure	NN
10_1101-2021_01_06_425584	346	12	to	to	IN
10_1101-2021_01_06_425584	346	13	high	high	JJ
10_1101-2021_01_06_425584	346	14	insulin	insulin	NN
10_1101-2021_01_06_425584	346	15	impairs	impairs	VB
10_1101-2021_01_06_425584	346	16	the	the	DT
10_1101-2021_01_06_425584	346	17	584	584	CD
10_1101-2021_01_06_425584	346	18	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	346	19	PI3-kinase	pi3-kinase	NN
10_1101-2021_01_06_425584	346	20	/	/	SYM
10_1101-2021_01_06_425584	346	21	Akt	Akt	NNP
10_1101-2021_01_06_425584	346	22	/	/	SYM
10_1101-2021_01_06_425584	346	23	nitric	nitric	JJ
10_1101-2021_01_06_425584	346	24	oxide	oxide	NN
10_1101-2021_01_06_425584	346	25	signalling	signalling	NN
10_1101-2021_01_06_425584	346	26	.	.	.
10_1101-2021_01_06_425584	347	1	Thromb	Thromb	NNP
10_1101-2021_01_06_425584	347	2	Haemost	Haemost	NNP
10_1101-2021_01_06_425584	347	3	2009	2009	CD
10_1101-2021_01_06_425584	347	4	,	,	,
10_1101-2021_01_06_425584	347	5	101	101	CD
10_1101-2021_01_06_425584	347	6	,	,	,
10_1101-2021_01_06_425584	347	7	(	(	-LRB-
10_1101-2021_01_06_425584	347	8	2	2	CD
10_1101-2021_01_06_425584	347	9	)	)	-RRB-
10_1101-2021_01_06_425584	347	10	,	,	,
10_1101-2021_01_06_425584	347	11	345	345	CD
10_1101-2021_01_06_425584	347	12	-	-	SYM
10_1101-2021_01_06_425584	347	13	50	50	CD
10_1101-2021_01_06_425584	347	14	.	.	.
10_1101-2021_01_06_425584	348	1	585	585	CD
10_1101-2021_01_06_425584	348	2	18	18	CD
10_1101-2021_01_06_425584	348	3	.	.	.
10_1101-2021_01_06_425584	349	1	Zaccardi	Zaccardi	NNP
10_1101-2021_01_06_425584	349	2	,	,	,
10_1101-2021_01_06_425584	349	3	F.	F.	NNP
10_1101-2021_01_06_425584	349	4	;	;	:
10_1101-2021_01_06_425584	349	5	Webb	Webb	NNP
10_1101-2021_01_06_425584	349	6	,	,	,
10_1101-2021_01_06_425584	349	7	D.	D.	NNP
10_1101-2021_01_06_425584	349	8	R.	R.	NNP
10_1101-2021_01_06_425584	349	9	;	;	:
10_1101-2021_01_06_425584	349	10	Yates	Yates	NNP
10_1101-2021_01_06_425584	349	11	,	,	,
10_1101-2021_01_06_425584	349	12	T.	t.	NN
10_1101-2021_01_06_425584	349	13	;	;	:
10_1101-2021_01_06_425584	349	14	Davies	Davies	NNP
10_1101-2021_01_06_425584	349	15	,	,	,
10_1101-2021_01_06_425584	349	16	M.	M.	NNP
10_1101-2021_01_06_425584	349	17	J.	J.	NNP
10_1101-2021_01_06_425584	349	18	,	,	,
10_1101-2021_01_06_425584	349	19	Pathophysiology	Pathophysiology	NNP
10_1101-2021_01_06_425584	349	20	of	of	IN
10_1101-2021_01_06_425584	349	21	type	type	NN
10_1101-2021_01_06_425584	349	22	1	1	CD
10_1101-2021_01_06_425584	349	23	and	and	CC
10_1101-2021_01_06_425584	349	24	type	type	NN
10_1101-2021_01_06_425584	349	25	2	2	CD
10_1101-2021_01_06_425584	349	26	586	586	CD
10_1101-2021_01_06_425584	349	27	diabetes	diabetes	NN
10_1101-2021_01_06_425584	349	28	mellitus	mellitus	NN
10_1101-2021_01_06_425584	349	29	:	:	:
10_1101-2021_01_06_425584	349	30	a	a	DT
10_1101-2021_01_06_425584	349	31	90-year	90-year	CD
10_1101-2021_01_06_425584	349	32	perspective	perspective	NN
10_1101-2021_01_06_425584	349	33	.	.	.
10_1101-2021_01_06_425584	350	1	Postgrad	Postgrad	NNP
10_1101-2021_01_06_425584	350	2	Med	Med	NNP
10_1101-2021_01_06_425584	350	3	J	J	NNP
10_1101-2021_01_06_425584	350	4	2016	2016	CD
10_1101-2021_01_06_425584	350	5	,	,	,
10_1101-2021_01_06_425584	350	6	92	92	CD
10_1101-2021_01_06_425584	350	7	,	,	,
10_1101-2021_01_06_425584	350	8	(	(	-LRB-
10_1101-2021_01_06_425584	350	9	1084	1084	CD
10_1101-2021_01_06_425584	350	10	)	)	-RRB-
10_1101-2021_01_06_425584	350	11	,	,	,
10_1101-2021_01_06_425584	350	12	63	63	CD
10_1101-2021_01_06_425584	350	13	-	-	SYM
10_1101-2021_01_06_425584	350	14	9	9	CD
10_1101-2021_01_06_425584	350	15	.	.	.
10_1101-2021_01_06_425584	351	1	587	587	CD
10_1101-2021_01_06_425584	351	2	19	19	CD
10_1101-2021_01_06_425584	351	3	.	.	.
10_1101-2021_01_06_425584	352	1	Moreno	Moreno	NNP
10_1101-2021_01_06_425584	352	2	-	-	HYPH
10_1101-2021_01_06_425584	352	3	Ulloa	Ulloa	NNP
10_1101-2021_01_06_425584	352	4	,	,	,
10_1101-2021_01_06_425584	352	5	A.	a.	NN
10_1101-2021_01_06_425584	352	6	;	;	:
10_1101-2021_01_06_425584	352	7	Miranda	Miranda	NNP
10_1101-2021_01_06_425584	352	8	-	-	HYPH
10_1101-2021_01_06_425584	352	9	Cervantes	Cervantes	NNP
10_1101-2021_01_06_425584	352	10	,	,	,
10_1101-2021_01_06_425584	352	11	A.	a.	NN
10_1101-2021_01_06_425584	352	12	;	;	:
10_1101-2021_01_06_425584	352	13	Licea	Licea	NNP
10_1101-2021_01_06_425584	352	14	-	-	HYPH
10_1101-2021_01_06_425584	352	15	Navarro	Navarro	NNP
10_1101-2021_01_06_425584	352	16	,	,	,
10_1101-2021_01_06_425584	352	17	A.	a.	NN
10_1101-2021_01_06_425584	352	18	;	;	:
10_1101-2021_01_06_425584	352	19	Mansour	Mansour	NNP
10_1101-2021_01_06_425584	352	20	,	,	,
10_1101-2021_01_06_425584	352	21	C.	C.	NNP
10_1101-2021_01_06_425584	352	22	;	;	:
10_1101-2021_01_06_425584	352	23	Beltran-588	Beltran-588	NNP
10_1101-2021_01_06_425584	352	24	Partida	Partida	NNP
10_1101-2021_01_06_425584	352	25	,	,	,
10_1101-2021_01_06_425584	352	26	E.	E.	NNP
10_1101-2021_01_06_425584	352	27	;	;	:
10_1101-2021_01_06_425584	352	28	Donis	Donis	NNP
10_1101-2021_01_06_425584	352	29	-	-	HYPH
10_1101-2021_01_06_425584	352	30	Maturano	Maturano	NNP
10_1101-2021_01_06_425584	352	31	,	,	,
10_1101-2021_01_06_425584	352	32	L.	L.	NNP
10_1101-2021_01_06_425584	352	33	;	;	:
10_1101-2021_01_06_425584	352	34	Delgado	Delgado	NNP
10_1101-2021_01_06_425584	352	35	De	De	NNP
10_1101-2021_01_06_425584	352	36	la	la	NNP
10_1101-2021_01_06_425584	352	37	Herran	Herran	NNP
10_1101-2021_01_06_425584	352	38	,	,	,
10_1101-2021_01_06_425584	352	39	H.	H.	NNP
10_1101-2021_01_06_425584	352	40	C.	C.	NNP
10_1101-2021_01_06_425584	352	41	;	;	:
10_1101-2021_01_06_425584	352	42	Villarreal	Villarreal	NNP
10_1101-2021_01_06_425584	352	43	,	,	,
10_1101-2021_01_06_425584	352	44	F.	F.	NNP
10_1101-2021_01_06_425584	352	45	;	;	:
10_1101-2021_01_06_425584	352	46	Alvarez	Alvarez	NNP
10_1101-2021_01_06_425584	352	47	-	-	HYPH
10_1101-2021_01_06_425584	352	48	Delgado	Delgado	NNP
10_1101-2021_01_06_425584	352	49	,	,	,
10_1101-2021_01_06_425584	352	50	C.	C.	NNP
10_1101-2021_01_06_425584	352	51	,	,	,
10_1101-2021_01_06_425584	352	52	589	589	CD
10_1101-2021_01_06_425584	352	53	(	(	-LRB-
10_1101-2021_01_06_425584	352	54	-)-Epicatechin	-)-Epicatechin	:
10_1101-2021_01_06_425584	352	55	stimulates	stimulate	VBZ
10_1101-2021_01_06_425584	352	56	mitochondrial	mitochondrial	NN
10_1101-2021_01_06_425584	352	57	biogenesis	biogenesis	NN
10_1101-2021_01_06_425584	352	58	and	and	CC
10_1101-2021_01_06_425584	352	59	cell	cell	NN
10_1101-2021_01_06_425584	352	60	growth	growth	NN
10_1101-2021_01_06_425584	352	61	in	in	IN
10_1101-2021_01_06_425584	352	62	C2C12	C2C12	NNP
10_1101-2021_01_06_425584	352	63	myotubes	myotube	NNS
10_1101-2021_01_06_425584	352	64	via	via	IN
10_1101-2021_01_06_425584	352	65	the	the	DT
10_1101-2021_01_06_425584	352	66	590	590	CD
10_1101-2021_01_06_425584	352	67	G	g	NN
10_1101-2021_01_06_425584	352	68	-	-	HYPH
10_1101-2021_01_06_425584	352	69	protein	protein	NN
10_1101-2021_01_06_425584	352	70	coupled	couple	VBN
10_1101-2021_01_06_425584	352	71	estrogen	estrogen	NNP
10_1101-2021_01_06_425584	352	72	receptor	receptor	NN
10_1101-2021_01_06_425584	352	73	.	.	.
10_1101-2021_01_06_425584	353	1	Eur	Eur	NNP
10_1101-2021_01_06_425584	353	2	J	J	NNP
10_1101-2021_01_06_425584	353	3	Pharmacol	Pharmacol	NNP
10_1101-2021_01_06_425584	353	4	2018	2018	CD
10_1101-2021_01_06_425584	353	5	,	,	,
10_1101-2021_01_06_425584	353	6	822	822	CD
10_1101-2021_01_06_425584	353	7	,	,	,
10_1101-2021_01_06_425584	353	8	95	95	CD
10_1101-2021_01_06_425584	353	9	-	-	SYM
10_1101-2021_01_06_425584	353	10	107	107	CD
10_1101-2021_01_06_425584	353	11	.	.	.
10_1101-2021_01_06_425584	354	1	591	591	CD
10_1101-2021_01_06_425584	354	2	20	20	CD
10_1101-2021_01_06_425584	354	3	.	.	.
10_1101-2021_01_06_425584	355	1	Kirkwood	Kirkwood	NNP
10_1101-2021_01_06_425584	355	2	,	,	,
10_1101-2021_01_06_425584	355	3	J.	J.	NNP
10_1101-2021_01_06_425584	355	4	S.	S.	NNP
10_1101-2021_01_06_425584	355	5	;	;	:
10_1101-2021_01_06_425584	355	6	Maier	Maier	NNP
10_1101-2021_01_06_425584	355	7	,	,	,
10_1101-2021_01_06_425584	355	8	C.	C.	NNP
10_1101-2021_01_06_425584	355	9	;	;	:
10_1101-2021_01_06_425584	355	10	Stevens	Stevens	NNP
10_1101-2021_01_06_425584	355	11	,	,	,
10_1101-2021_01_06_425584	355	12	J.	J.	NNP
10_1101-2021_01_06_425584	355	13	F.	F.	NNP
10_1101-2021_01_06_425584	355	14	,	,	,
10_1101-2021_01_06_425584	355	15	Simultaneous	Simultaneous	NNP
10_1101-2021_01_06_425584	355	16	,	,	,
10_1101-2021_01_06_425584	355	17	untargeted	untargeted	JJ
10_1101-2021_01_06_425584	355	18	metabolic	metabolic	JJ
10_1101-2021_01_06_425584	355	19	profiling	profile	VBG
10_1101-2021_01_06_425584	355	20	592	592	CD
10_1101-2021_01_06_425584	355	21	of	of	IN
10_1101-2021_01_06_425584	355	22	polar	polar	JJ
10_1101-2021_01_06_425584	355	23	and	and	CC
10_1101-2021_01_06_425584	355	24	nonpolar	nonpolar	JJ
10_1101-2021_01_06_425584	355	25	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	355	26	by	by	IN
10_1101-2021_01_06_425584	355	27	LC	LC	NNP
10_1101-2021_01_06_425584	355	28	-	-	HYPH
10_1101-2021_01_06_425584	355	29	Q	Q	NNP
10_1101-2021_01_06_425584	355	30	-	-	HYPH
10_1101-2021_01_06_425584	355	31	TOF	TOF	NNP
10_1101-2021_01_06_425584	355	32	mass	mass	NN
10_1101-2021_01_06_425584	355	33	spectrometry	spectrometry	NN
10_1101-2021_01_06_425584	355	34	.	.	.
10_1101-2021_01_06_425584	356	1	Curr	Curr	NNP
10_1101-2021_01_06_425584	356	2	Protoc	Protoc	NNP
10_1101-2021_01_06_425584	356	3	Toxicol	Toxicol	NNP
10_1101-2021_01_06_425584	356	4	2013	2013	CD
10_1101-2021_01_06_425584	356	5	,	,	,
10_1101-2021_01_06_425584	356	6	593	593	CD
10_1101-2021_01_06_425584	356	7	Chapter	chapter	NN
10_1101-2021_01_06_425584	356	8	4	4	CD
10_1101-2021_01_06_425584	356	9	,	,	,
10_1101-2021_01_06_425584	356	10	Unit4	unit4	RB
10_1101-2021_01_06_425584	356	11	39	39	CD
10_1101-2021_01_06_425584	356	12	.	.	.
10_1101-2021_01_06_425584	357	1	594	594	CD
10_1101-2021_01_06_425584	357	2	21	21	CD
10_1101-2021_01_06_425584	357	3	.	.	.
10_1101-2021_01_06_425584	358	1	Moreno	Moreno	NNP
10_1101-2021_01_06_425584	358	2	-	-	HYPH
10_1101-2021_01_06_425584	358	3	Ulloa	Ulloa	NNP
10_1101-2021_01_06_425584	358	4	,	,	,
10_1101-2021_01_06_425584	358	5	A.	a.	NN
10_1101-2021_01_06_425584	358	6	;	;	:
10_1101-2021_01_06_425584	358	7	Sicairos	Sicairos	NNP
10_1101-2021_01_06_425584	358	8	Diaz	Diaz	NNP
10_1101-2021_01_06_425584	358	9	,	,	,
10_1101-2021_01_06_425584	358	10	V.	V.	NNP
10_1101-2021_01_06_425584	358	11	;	;	:
10_1101-2021_01_06_425584	358	12	Tejeda	Tejeda	NNP
10_1101-2021_01_06_425584	358	13	-	-	HYPH
10_1101-2021_01_06_425584	358	14	Mora	Mora	NNP
10_1101-2021_01_06_425584	358	15	,	,	,
10_1101-2021_01_06_425584	358	16	J.	J.	NNP
10_1101-2021_01_06_425584	359	1	A.	a.	LS
10_1101-2021_01_06_425584	359	2	;	;	:
10_1101-2021_01_06_425584	359	3	Macias	Macias	NNP
10_1101-2021_01_06_425584	359	4	Contreras	Contreras	NNP
10_1101-2021_01_06_425584	359	5	,	,	,
10_1101-2021_01_06_425584	359	6	M.	M.	NNP
10_1101-2021_01_06_425584	359	7	I.	I.	NNP
10_1101-2021_01_06_425584	359	8	;	;	:
10_1101-2021_01_06_425584	359	9	Castillo	Castillo	NNP
10_1101-2021_01_06_425584	359	10	,	,	,
10_1101-2021_01_06_425584	359	11	595	595	CD
10_1101-2021_01_06_425584	359	12	F.	F.	NNP
10_1101-2021_01_06_425584	359	13	D.	D.	NNP
10_1101-2021_01_06_425584	359	14	;	;	:
10_1101-2021_01_06_425584	359	15	Guerrero	Guerrero	NNP
10_1101-2021_01_06_425584	359	16	,	,	,
10_1101-2021_01_06_425584	359	17	A.	a.	NN
10_1101-2021_01_06_425584	359	18	;	;	:
10_1101-2021_01_06_425584	359	19	Gonzalez	Gonzalez	NNP
10_1101-2021_01_06_425584	359	20	Sanchez	Sanchez	NNP
10_1101-2021_01_06_425584	359	21	,	,	,
10_1101-2021_01_06_425584	359	22	R.	R.	NNP
10_1101-2021_01_06_425584	359	23	;	;	:
10_1101-2021_01_06_425584	359	24	Mendoza	Mendoza	NNP
10_1101-2021_01_06_425584	359	25	-	-	HYPH
10_1101-2021_01_06_425584	359	26	Porras	Porras	NNP
10_1101-2021_01_06_425584	359	27	,	,	,
10_1101-2021_01_06_425584	359	28	O.	O.	NNP
10_1101-2021_01_06_425584	359	29	;	;	:
10_1101-2021_01_06_425584	359	30	Vazquez	Vazquez	NNP
10_1101-2021_01_06_425584	359	31	Duhalt	Duhalt	NNP
10_1101-2021_01_06_425584	359	32	,	,	,
10_1101-2021_01_06_425584	359	33	R.	R.	NNP
10_1101-2021_01_06_425584	359	34	;	;	:
10_1101-2021_01_06_425584	359	35	Licea-596	Licea-596	NNP
10_1101-2021_01_06_425584	359	36	Navarro	Navarro	NNP
10_1101-2021_01_06_425584	359	37	,	,	,
10_1101-2021_01_06_425584	359	38	A.	A.	NNP
10_1101-2021_01_06_425584	359	39	,	,	,
10_1101-2021_01_06_425584	359	40	Chemical	Chemical	NNP
10_1101-2021_01_06_425584	359	41	Profiling	Profiling	NNP
10_1101-2021_01_06_425584	359	42	Provides	provide	VBZ
10_1101-2021_01_06_425584	359	43	Insights	Insights	NNPS
10_1101-2021_01_06_425584	359	44	into	into	IN
10_1101-2021_01_06_425584	359	45	the	the	DT
10_1101-2021_01_06_425584	359	46	Metabolic	Metabolic	NNP
10_1101-2021_01_06_425584	359	47	Machinery	Machinery	NNP
10_1101-2021_01_06_425584	359	48	of	of	IN
10_1101-2021_01_06_425584	359	49	Hydrocarbon-597	Hydrocarbon-597	NNP
10_1101-2021_01_06_425584	359	50	Degrading	Degrading	NNP
10_1101-2021_01_06_425584	359	51	Deep	Deep	NNP
10_1101-2021_01_06_425584	359	52	-	-	HYPH
10_1101-2021_01_06_425584	359	53	Sea	Sea	NNP
10_1101-2021_01_06_425584	359	54	Microbes	Microbes	NNPS
10_1101-2021_01_06_425584	359	55	.	.	.
10_1101-2021_01_06_425584	360	1	mSystems	mSystems	NNP
10_1101-2021_01_06_425584	360	2	2020	2020	CD
10_1101-2021_01_06_425584	360	3	,	,	,
10_1101-2021_01_06_425584	360	4	5	5	CD
10_1101-2021_01_06_425584	360	5	,	,	,
10_1101-2021_01_06_425584	360	6	(	(	-LRB-
10_1101-2021_01_06_425584	360	7	6	6	CD
10_1101-2021_01_06_425584	360	8	)	)	-RRB-
10_1101-2021_01_06_425584	360	9	.	.	.
10_1101-2021_01_06_425584	361	1	598	598	CD
10_1101-2021_01_06_425584	361	2	22	22	CD
10_1101-2021_01_06_425584	361	3	.	.	.
10_1101-2021_01_06_425584	362	1	Gowda	Gowda	NNP
10_1101-2021_01_06_425584	362	2	,	,	,
10_1101-2021_01_06_425584	362	3	H.	H.	NNP
10_1101-2021_01_06_425584	362	4	;	;	:
10_1101-2021_01_06_425584	362	5	Ivanisevic	Ivanisevic	NNP
10_1101-2021_01_06_425584	362	6	,	,	,
10_1101-2021_01_06_425584	362	7	J.	J.	NNP
10_1101-2021_01_06_425584	362	8	;	;	:
10_1101-2021_01_06_425584	362	9	Johnson	Johnson	NNP
10_1101-2021_01_06_425584	362	10	,	,	,
10_1101-2021_01_06_425584	362	11	C.	C.	NNP
10_1101-2021_01_06_425584	362	12	H.	H.	NNP
10_1101-2021_01_06_425584	362	13	;	;	:
10_1101-2021_01_06_425584	362	14	Kurczy	Kurczy	NNP
10_1101-2021_01_06_425584	362	15	,	,	,
10_1101-2021_01_06_425584	362	16	M.	M.	NNP
10_1101-2021_01_06_425584	362	17	E.	E.	NNP
10_1101-2021_01_06_425584	362	18	;	;	:
10_1101-2021_01_06_425584	362	19	Benton	Benton	NNP
10_1101-2021_01_06_425584	362	20	,	,	,
10_1101-2021_01_06_425584	362	21	H.	H.	NNP
10_1101-2021_01_06_425584	362	22	P.	P.	NNP
10_1101-2021_01_06_425584	362	23	;	;	:
10_1101-2021_01_06_425584	362	24	Rinehart	Rinehart	NNP
10_1101-2021_01_06_425584	362	25	,	,	,
10_1101-2021_01_06_425584	362	26	D.	D.	NNP
10_1101-2021_01_06_425584	362	27	;	;	:
10_1101-2021_01_06_425584	362	28	599	599	CD
10_1101-2021_01_06_425584	362	29	Nguyen	Nguyen	NNP
10_1101-2021_01_06_425584	362	30	,	,	,
10_1101-2021_01_06_425584	362	31	T.	T.	NNP
10_1101-2021_01_06_425584	362	32	;	;	:
10_1101-2021_01_06_425584	362	33	Ray	Ray	NNP
10_1101-2021_01_06_425584	362	34	,	,	,
10_1101-2021_01_06_425584	362	35	J.	J.	NNP
10_1101-2021_01_06_425584	362	36	;	;	:
10_1101-2021_01_06_425584	362	37	Kuehl	Kuehl	NNP
10_1101-2021_01_06_425584	362	38	,	,	,
10_1101-2021_01_06_425584	362	39	J.	J.	NNP
10_1101-2021_01_06_425584	362	40	;	;	:
10_1101-2021_01_06_425584	362	41	Arevalo	Arevalo	NNP
10_1101-2021_01_06_425584	362	42	,	,	,
10_1101-2021_01_06_425584	362	43	B.	B.	NNP
10_1101-2021_01_06_425584	362	44	;	;	:
10_1101-2021_01_06_425584	362	45	Westenskow	Westenskow	NNP
10_1101-2021_01_06_425584	362	46	,	,	,
10_1101-2021_01_06_425584	362	47	P.	P.	NNP
10_1101-2021_01_06_425584	362	48	D.	D.	NNP
10_1101-2021_01_06_425584	362	49	;	;	:
10_1101-2021_01_06_425584	362	50	Wang	Wang	NNP
10_1101-2021_01_06_425584	362	51	,	,	,
10_1101-2021_01_06_425584	362	52	J.	J.	NNP
10_1101-2021_01_06_425584	362	53	;	;	:
10_1101-2021_01_06_425584	362	54	Arkin	Arkin	NNP
10_1101-2021_01_06_425584	362	55	,	,	,
10_1101-2021_01_06_425584	362	56	A.	a.	NN
10_1101-2021_01_06_425584	362	57	P.	P.	NNP
10_1101-2021_01_06_425584	362	58	;	;	:
10_1101-2021_01_06_425584	362	59	600	600	CD
10_1101-2021_01_06_425584	362	60	Deutschbauer	Deutschbauer	NNP
10_1101-2021_01_06_425584	362	61	,	,	,
10_1101-2021_01_06_425584	362	62	A.	a.	NN
10_1101-2021_01_06_425584	362	63	M.	M.	NNP
10_1101-2021_01_06_425584	362	64	;	;	:
10_1101-2021_01_06_425584	362	65	Patti	Patti	NNP
10_1101-2021_01_06_425584	362	66	,	,	,
10_1101-2021_01_06_425584	362	67	G.	G.	NNP
10_1101-2021_01_06_425584	362	68	J.	J.	NNP
10_1101-2021_01_06_425584	362	69	;	;	:
10_1101-2021_01_06_425584	362	70	Siuzdak	Siuzdak	NNP
10_1101-2021_01_06_425584	362	71	,	,	,
10_1101-2021_01_06_425584	362	72	G.	G.	NNP
10_1101-2021_01_06_425584	362	73	,	,	,
10_1101-2021_01_06_425584	362	74	Interactive	Interactive	NNP
10_1101-2021_01_06_425584	362	75	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	362	76	Online	online	RB
10_1101-2021_01_06_425584	362	77	:	:	:
10_1101-2021_01_06_425584	362	78	simplifying	simplify	VBG
10_1101-2021_01_06_425584	362	79	advanced	advanced	JJ
10_1101-2021_01_06_425584	362	80	601	601	CD
10_1101-2021_01_06_425584	362	81	metabolomic	metabolomic	JJ
10_1101-2021_01_06_425584	362	82	data	datum	NNS
10_1101-2021_01_06_425584	362	83	processing	processing	NN
10_1101-2021_01_06_425584	362	84	and	and	CC
10_1101-2021_01_06_425584	362	85	subsequent	subsequent	JJ
10_1101-2021_01_06_425584	362	86	statistical	statistical	JJ
10_1101-2021_01_06_425584	362	87	analyses	analysis	NNS
10_1101-2021_01_06_425584	362	88	.	.	.
10_1101-2021_01_06_425584	363	1	Anal	Anal	NNP
10_1101-2021_01_06_425584	363	2	Chem	Chem	NNP
10_1101-2021_01_06_425584	363	3	2014	2014	CD
10_1101-2021_01_06_425584	363	4	,	,	,
10_1101-2021_01_06_425584	363	5	86	86	CD
10_1101-2021_01_06_425584	363	6	,	,	,
10_1101-2021_01_06_425584	363	7	(	(	-LRB-
10_1101-2021_01_06_425584	363	8	14	14	CD
10_1101-2021_01_06_425584	363	9	)	)	-RRB-
10_1101-2021_01_06_425584	363	10	,	,	,
10_1101-2021_01_06_425584	363	11	602	602	CD
10_1101-2021_01_06_425584	363	12	6931	6931	CD
10_1101-2021_01_06_425584	363	13	-	-	SYM
10_1101-2021_01_06_425584	363	14	9	9	CD
10_1101-2021_01_06_425584	363	15	.	.	.
10_1101-2021_01_06_425584	364	1	603	603	CD
10_1101-2021_01_06_425584	364	2	23	23	CD
10_1101-2021_01_06_425584	364	3	.	.	.
10_1101-2021_01_06_425584	365	1	Pluskal	Pluskal	NNP
10_1101-2021_01_06_425584	365	2	,	,	,
10_1101-2021_01_06_425584	365	3	T.	t.	NN
10_1101-2021_01_06_425584	365	4	;	;	:
10_1101-2021_01_06_425584	365	5	Castillo	Castillo	NNP
10_1101-2021_01_06_425584	365	6	,	,	,
10_1101-2021_01_06_425584	365	7	S.	S.	NNP
10_1101-2021_01_06_425584	365	8	;	;	:
10_1101-2021_01_06_425584	365	9	Villar	Villar	NNP
10_1101-2021_01_06_425584	365	10	-	-	HYPH
10_1101-2021_01_06_425584	365	11	Briones	Briones	NNP
10_1101-2021_01_06_425584	365	12	,	,	,
10_1101-2021_01_06_425584	365	13	A.	a.	NN
10_1101-2021_01_06_425584	365	14	;	;	:
10_1101-2021_01_06_425584	365	15	Oresic	Oresic	NNP
10_1101-2021_01_06_425584	365	16	,	,	,
10_1101-2021_01_06_425584	365	17	M.	M.	NNP
10_1101-2021_01_06_425584	365	18	,	,	,
10_1101-2021_01_06_425584	365	19	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	365	20	2	2	CD
10_1101-2021_01_06_425584	365	21	:	:	:
10_1101-2021_01_06_425584	365	22	modular	modular	JJ
10_1101-2021_01_06_425584	365	23	framework	framework	NN
10_1101-2021_01_06_425584	365	24	for	for	IN
10_1101-2021_01_06_425584	365	25	604	604	CD
10_1101-2021_01_06_425584	365	26	processing	processing	NN
10_1101-2021_01_06_425584	365	27	,	,	,
10_1101-2021_01_06_425584	365	28	visualizing	visualizing	NN
10_1101-2021_01_06_425584	365	29	,	,	,
10_1101-2021_01_06_425584	365	30	and	and	CC
10_1101-2021_01_06_425584	365	31	analyzing	analyze	VBG
10_1101-2021_01_06_425584	365	32	mass	mass	NN
10_1101-2021_01_06_425584	365	33	spectrometry	spectrometry	NN
10_1101-2021_01_06_425584	365	34	-	-	HYPH
10_1101-2021_01_06_425584	365	35	based	base	VBN
10_1101-2021_01_06_425584	365	36	molecular	molecular	JJ
10_1101-2021_01_06_425584	365	37	profile	profile	NN
10_1101-2021_01_06_425584	365	38	data	datum	NNS
10_1101-2021_01_06_425584	365	39	.	.	.
10_1101-2021_01_06_425584	366	1	BMC	BMC	NNP
10_1101-2021_01_06_425584	366	2	605	605	CD
10_1101-2021_01_06_425584	366	3	Bioinformatics	Bioinformatics	NNP
10_1101-2021_01_06_425584	366	4	2010	2010	CD
10_1101-2021_01_06_425584	366	5	,	,	,
10_1101-2021_01_06_425584	366	6	11	11	CD
10_1101-2021_01_06_425584	366	7	,	,	,
10_1101-2021_01_06_425584	366	8	395	395	CD
10_1101-2021_01_06_425584	366	9	.	.	.
10_1101-2021_01_06_425584	367	1	606	606	CD
10_1101-2021_01_06_425584	367	2	24	24	CD
10_1101-2021_01_06_425584	367	3	.	.	.
10_1101-2021_01_06_425584	368	1	Aron	Aron	NNP
10_1101-2021_01_06_425584	368	2	,	,	,
10_1101-2021_01_06_425584	368	3	A.	a.	NN
10_1101-2021_01_06_425584	368	4	T.	t.	XX
10_1101-2021_01_06_425584	368	5	;	;	:
10_1101-2021_01_06_425584	368	6	Gentry	Gentry	NNP
10_1101-2021_01_06_425584	368	7	,	,	,
10_1101-2021_01_06_425584	368	8	E.	E.	NNP
10_1101-2021_01_06_425584	368	9	C.	C.	NNP
10_1101-2021_01_06_425584	368	10	;	;	:
10_1101-2021_01_06_425584	368	11	McPhail	McPhail	NNP
10_1101-2021_01_06_425584	368	12	,	,	,
10_1101-2021_01_06_425584	368	13	K.	K.	NNP
10_1101-2021_01_06_425584	368	14	L.	L.	NNP
10_1101-2021_01_06_425584	368	15	;	;	:
10_1101-2021_01_06_425584	368	16	Nothias	Nothias	NNP
10_1101-2021_01_06_425584	368	17	,	,	,
10_1101-2021_01_06_425584	368	18	L.	L.	NNP
10_1101-2021_01_06_425584	368	19	F.	F.	NNP
10_1101-2021_01_06_425584	368	20	;	;	:
10_1101-2021_01_06_425584	368	21	Nothias	Nothias	NNP
10_1101-2021_01_06_425584	368	22	-	-	HYPH
10_1101-2021_01_06_425584	368	23	Esposito	Esposito	NNP
10_1101-2021_01_06_425584	368	24	,	,	,
10_1101-2021_01_06_425584	368	25	M.	M.	NNP
10_1101-2021_01_06_425584	368	26	;	;	:
10_1101-2021_01_06_425584	368	27	607	607	CD
10_1101-2021_01_06_425584	368	28	Bouslimani	Bouslimani	NNP
10_1101-2021_01_06_425584	368	29	,	,	,
10_1101-2021_01_06_425584	368	30	A.	a.	NN
10_1101-2021_01_06_425584	368	31	;	;	:
10_1101-2021_01_06_425584	368	32	Petras	Petras	NNP
10_1101-2021_01_06_425584	368	33	,	,	,
10_1101-2021_01_06_425584	368	34	D.	D.	NNP
10_1101-2021_01_06_425584	368	35	;	;	:
10_1101-2021_01_06_425584	368	36	Gauglitz	Gauglitz	NNP
10_1101-2021_01_06_425584	368	37	,	,	,
10_1101-2021_01_06_425584	368	38	J.	J.	NNP
10_1101-2021_01_06_425584	368	39	M.	M.	NNP
10_1101-2021_01_06_425584	368	40	;	;	:
10_1101-2021_01_06_425584	368	41	Sikora	Sikora	NNP
10_1101-2021_01_06_425584	368	42	,	,	,
10_1101-2021_01_06_425584	368	43	N.	N.	NNP
10_1101-2021_01_06_425584	368	44	;	;	:
10_1101-2021_01_06_425584	368	45	Vargas	Vargas	NNP
10_1101-2021_01_06_425584	368	46	,	,	,
10_1101-2021_01_06_425584	368	47	F.	F.	NNP
10_1101-2021_01_06_425584	368	48	;	;	:
10_1101-2021_01_06_425584	368	49	van	van	NNP
10_1101-2021_01_06_425584	368	50	der	der	NNP
10_1101-2021_01_06_425584	368	51	Hooft	Hooft	NNP
10_1101-2021_01_06_425584	368	52	,	,	,
10_1101-2021_01_06_425584	368	53	J.	J.	NNP
10_1101-2021_01_06_425584	368	54	J.	J.	NNP
10_1101-2021_01_06_425584	368	55	J.	J.	NNP
10_1101-2021_01_06_425584	368	56	;	;	:
10_1101-2021_01_06_425584	368	57	Ernst	Ernst	NNP
10_1101-2021_01_06_425584	368	58	,	,	,
10_1101-2021_01_06_425584	368	59	608	608	CD
10_1101-2021_01_06_425584	368	60	M.	M.	NNP
10_1101-2021_01_06_425584	368	61	;	;	:
10_1101-2021_01_06_425584	368	62	Kang	Kang	NNP
10_1101-2021_01_06_425584	368	63	,	,	,
10_1101-2021_01_06_425584	368	64	K.	K.	NNP
10_1101-2021_01_06_425584	368	65	B.	B.	NNP
10_1101-2021_01_06_425584	368	66	;	;	:
10_1101-2021_01_06_425584	368	67	Aceves	Aceves	NNP
10_1101-2021_01_06_425584	368	68	,	,	,
10_1101-2021_01_06_425584	368	69	C.	C.	NNP
10_1101-2021_01_06_425584	368	70	M.	M.	NNP
10_1101-2021_01_06_425584	368	71	;	;	:
10_1101-2021_01_06_425584	368	72	Caraballo	Caraballo	NNP
10_1101-2021_01_06_425584	368	73	-	-	HYPH
10_1101-2021_01_06_425584	368	74	Rodriguez	Rodriguez	NNP
10_1101-2021_01_06_425584	368	75	,	,	,
10_1101-2021_01_06_425584	368	76	A.	a.	NN
10_1101-2021_01_06_425584	368	77	M.	M.	NNP
10_1101-2021_01_06_425584	368	78	;	;	:
10_1101-2021_01_06_425584	368	79	Koester	Koester	NNP
10_1101-2021_01_06_425584	368	80	,	,	,
10_1101-2021_01_06_425584	368	81	I.	i.	NN
10_1101-2021_01_06_425584	368	82	;	;	:
10_1101-2021_01_06_425584	368	83	Weldon	Weldon	NNP
10_1101-2021_01_06_425584	368	84	,	,	,
10_1101-2021_01_06_425584	368	85	K.	K.	NNP
10_1101-2021_01_06_425584	368	86	C.	C.	NNP
10_1101-2021_01_06_425584	368	87	;	;	:
10_1101-2021_01_06_425584	368	88	609	609	CD
10_1101-2021_01_06_425584	368	89	Bertrand	Bertrand	NNP
10_1101-2021_01_06_425584	368	90	,	,	,
10_1101-2021_01_06_425584	368	91	S.	S.	NNP
10_1101-2021_01_06_425584	368	92	;	;	:
10_1101-2021_01_06_425584	368	93	Roullier	Roullier	NNP
10_1101-2021_01_06_425584	368	94	,	,	,
10_1101-2021_01_06_425584	368	95	C.	C.	NNP
10_1101-2021_01_06_425584	368	96	;	;	:
10_1101-2021_01_06_425584	368	97	Sun	Sun	NNP
10_1101-2021_01_06_425584	368	98	,	,	,
10_1101-2021_01_06_425584	368	99	K.	K.	NNP
10_1101-2021_01_06_425584	368	100	;	;	:
10_1101-2021_01_06_425584	368	101	Tehan	Tehan	NNP
10_1101-2021_01_06_425584	368	102	,	,	,
10_1101-2021_01_06_425584	368	103	R.	R.	NNP
10_1101-2021_01_06_425584	368	104	M.	M.	NNP
10_1101-2021_01_06_425584	368	105	;	;	:
10_1101-2021_01_06_425584	368	106	Boya	Boya	NNP
10_1101-2021_01_06_425584	368	107	,	,	,
10_1101-2021_01_06_425584	368	108	P.	P.	NNP
10_1101-2021_01_06_425584	368	109	C.	C.	NNP
10_1101-2021_01_06_425584	368	110	;	;	:
10_1101-2021_01_06_425584	368	111	Christian	Christian	NNP
10_1101-2021_01_06_425584	368	112	,	,	,
10_1101-2021_01_06_425584	368	113	M.	M.	NNP
10_1101-2021_01_06_425584	368	114	H.	H.	NNP
10_1101-2021_01_06_425584	368	115	;	;	:
10_1101-2021_01_06_425584	368	116	Gutierrez	Gutierrez	NNP
10_1101-2021_01_06_425584	368	117	,	,	,
10_1101-2021_01_06_425584	368	118	M.	M.	NNP
10_1101-2021_01_06_425584	368	119	;	;	:
10_1101-2021_01_06_425584	368	120	610	610	CD
10_1101-2021_01_06_425584	368	121	Ulloa	Ulloa	NNP
10_1101-2021_01_06_425584	368	122	,	,	,
10_1101-2021_01_06_425584	368	123	A.	a.	NN
10_1101-2021_01_06_425584	368	124	M.	M.	NNP
10_1101-2021_01_06_425584	368	125	;	;	:
10_1101-2021_01_06_425584	368	126	Tejeda	Tejeda	NNP
10_1101-2021_01_06_425584	368	127	Mora	Mora	NNP
10_1101-2021_01_06_425584	368	128	,	,	,
10_1101-2021_01_06_425584	368	129	J.	J.	NNP
10_1101-2021_01_06_425584	369	1	A.	a.	LS
10_1101-2021_01_06_425584	369	2	;	;	:
10_1101-2021_01_06_425584	369	3	Mojica	Mojica	NNP
10_1101-2021_01_06_425584	369	4	-	-	HYPH
10_1101-2021_01_06_425584	369	5	Flores	Flores	NNP
10_1101-2021_01_06_425584	369	6	,	,	,
10_1101-2021_01_06_425584	369	7	R.	R.	NNP
10_1101-2021_01_06_425584	369	8	;	;	:
10_1101-2021_01_06_425584	369	9	Lakey	Lakey	NNP
10_1101-2021_01_06_425584	369	10	-	-	HYPH
10_1101-2021_01_06_425584	369	11	Beitia	Beitia	NNP
10_1101-2021_01_06_425584	369	12	,	,	,
10_1101-2021_01_06_425584	369	13	J.	J.	NNP
10_1101-2021_01_06_425584	369	14	;	;	:
10_1101-2021_01_06_425584	369	15	Vasquez	Vasquez	NNP
10_1101-2021_01_06_425584	369	16	-	-	HYPH
10_1101-2021_01_06_425584	369	17	Chaves	Chaves	NNPS
10_1101-2021_01_06_425584	369	18	,	,	,
10_1101-2021_01_06_425584	369	19	V.	V.	NNP
10_1101-2021_01_06_425584	369	20	;	;	:
10_1101-2021_01_06_425584	369	21	611	611	CD
10_1101-2021_01_06_425584	369	22	Zhang	Zhang	NNP
10_1101-2021_01_06_425584	369	23	,	,	,
10_1101-2021_01_06_425584	369	24	Y.	Y.	NNP
10_1101-2021_01_06_425584	369	25	;	;	:
10_1101-2021_01_06_425584	369	26	Calderon	Calderon	NNP
10_1101-2021_01_06_425584	369	27	,	,	,
10_1101-2021_01_06_425584	369	28	A.	a.	NN
10_1101-2021_01_06_425584	369	29	I.	i.	NN
10_1101-2021_01_06_425584	369	30	;	;	:
10_1101-2021_01_06_425584	369	31	Tayler	Tayler	NNP
10_1101-2021_01_06_425584	369	32	,	,	,
10_1101-2021_01_06_425584	369	33	N.	N.	NNP
10_1101-2021_01_06_425584	369	34	;	;	:
10_1101-2021_01_06_425584	369	35	Keyzers	Keyzers	NNP
10_1101-2021_01_06_425584	369	36	,	,	,
10_1101-2021_01_06_425584	369	37	R.	R.	NNP
10_1101-2021_01_06_425584	369	38	A.	a.	NN
10_1101-2021_01_06_425584	369	39	;	;	:
10_1101-2021_01_06_425584	369	40	Tugizimana	Tugizimana	NNP
10_1101-2021_01_06_425584	369	41	,	,	,
10_1101-2021_01_06_425584	369	42	F.	F.	NNP
10_1101-2021_01_06_425584	369	43	;	;	:
10_1101-2021_01_06_425584	369	44	Ndlovu	Ndlovu	NNP
10_1101-2021_01_06_425584	369	45	,	,	,
10_1101-2021_01_06_425584	369	46	N.	N.	NNP
10_1101-2021_01_06_425584	369	47	;	;	:
10_1101-2021_01_06_425584	369	48	Aksenov	Aksenov	NNP
10_1101-2021_01_06_425584	369	49	,	,	,
10_1101-2021_01_06_425584	369	50	A.	a.	NN
10_1101-2021_01_06_425584	370	1	612	612	CD
10_1101-2021_01_06_425584	370	2	A.	a.	NN
10_1101-2021_01_06_425584	370	3	;	;	:
10_1101-2021_01_06_425584	370	4	Jarmusch	Jarmusch	NNP
10_1101-2021_01_06_425584	370	5	,	,	,
10_1101-2021_01_06_425584	370	6	A.	A.	NNP
10_1101-2021_01_06_425584	370	7	K.	K.	NNP
10_1101-2021_01_06_425584	370	8	;	;	:
10_1101-2021_01_06_425584	370	9	Schmid	Schmid	NNP
10_1101-2021_01_06_425584	370	10	,	,	,
10_1101-2021_01_06_425584	370	11	R.	R.	NNP
10_1101-2021_01_06_425584	370	12	;	;	:
10_1101-2021_01_06_425584	370	13	Truman	Truman	NNP
10_1101-2021_01_06_425584	370	14	,	,	,
10_1101-2021_01_06_425584	370	15	A.	a.	NN
10_1101-2021_01_06_425584	370	16	W.	W.	NNP
10_1101-2021_01_06_425584	370	17	;	;	:
10_1101-2021_01_06_425584	370	18	Bandeira	Bandeira	NNP
10_1101-2021_01_06_425584	370	19	,	,	,
10_1101-2021_01_06_425584	370	20	N.	N.	NNP
10_1101-2021_01_06_425584	370	21	;	;	:
10_1101-2021_01_06_425584	370	22	Wang	Wang	NNP
10_1101-2021_01_06_425584	370	23	,	,	,
10_1101-2021_01_06_425584	370	24	M.	M.	NNP
10_1101-2021_01_06_425584	370	25	;	;	:
10_1101-2021_01_06_425584	370	26	Dorrestein	Dorrestein	NNP
10_1101-2021_01_06_425584	370	27	,	,	,
10_1101-2021_01_06_425584	370	28	P.	P.	NNP
10_1101-2021_01_06_425584	370	29	C.	C.	NNP
10_1101-2021_01_06_425584	370	30	,	,	,
10_1101-2021_01_06_425584	370	31	613	613	CD
10_1101-2021_01_06_425584	370	32	Reproducible	reproducible	NN
10_1101-2021_01_06_425584	370	33	molecular	molecular	JJ
10_1101-2021_01_06_425584	370	34	networking	networking	NN
10_1101-2021_01_06_425584	370	35	of	of	IN
10_1101-2021_01_06_425584	370	36	untargeted	untargeted	JJ
10_1101-2021_01_06_425584	370	37	mass	mass	JJ
10_1101-2021_01_06_425584	370	38	spectrometry	spectrometry	NN
10_1101-2021_01_06_425584	370	39	data	datum	NNS
10_1101-2021_01_06_425584	370	40	using	use	VBG
10_1101-2021_01_06_425584	370	41	GNPS	gnps	NN
10_1101-2021_01_06_425584	370	42	.	.	.
10_1101-2021_01_06_425584	371	1	Nat	Nat	NNP
10_1101-2021_01_06_425584	371	2	614	614	CD
10_1101-2021_01_06_425584	371	3	Protoc	Protoc	NNP
10_1101-2021_01_06_425584	371	4	2020	2020	CD
10_1101-2021_01_06_425584	371	5	.	.	.
10_1101-2021_01_06_425584	372	1	615	615	CD
10_1101-2021_01_06_425584	372	2	25	25	CD
10_1101-2021_01_06_425584	372	3	.	.	.
10_1101-2021_01_06_425584	372	4	da	da	NNP
10_1101-2021_01_06_425584	372	5	Silva	Silva	NNP
10_1101-2021_01_06_425584	372	6	,	,	,
10_1101-2021_01_06_425584	372	7	R.	R.	NNP
10_1101-2021_01_06_425584	372	8	R.	R.	NNP
10_1101-2021_01_06_425584	372	9	;	;	:
10_1101-2021_01_06_425584	372	10	Wang	Wang	NNP
10_1101-2021_01_06_425584	372	11	,	,	,
10_1101-2021_01_06_425584	372	12	M.	M.	NNP
10_1101-2021_01_06_425584	372	13	;	;	:
10_1101-2021_01_06_425584	372	14	Nothias	Nothias	NNP
10_1101-2021_01_06_425584	372	15	,	,	,
10_1101-2021_01_06_425584	372	16	L.	L.	NNP
10_1101-2021_01_06_425584	372	17	F.	F.	NNP
10_1101-2021_01_06_425584	372	18	;	;	:
10_1101-2021_01_06_425584	372	19	van	van	NNP
10_1101-2021_01_06_425584	372	20	der	der	NNP
10_1101-2021_01_06_425584	372	21	Hooft	Hooft	NNP
10_1101-2021_01_06_425584	372	22	,	,	,
10_1101-2021_01_06_425584	372	23	J.	J.	NNP
10_1101-2021_01_06_425584	372	24	J.	J.	NNP
10_1101-2021_01_06_425584	372	25	J.	J.	NNP
10_1101-2021_01_06_425584	372	26	;	;	:
10_1101-2021_01_06_425584	372	27	Caraballo	Caraballo	NNP
10_1101-2021_01_06_425584	372	28	-	-	HYPH
10_1101-2021_01_06_425584	372	29	Rodriguez	Rodriguez	NNP
10_1101-2021_01_06_425584	372	30	,	,	,
10_1101-2021_01_06_425584	372	31	A.	a.	NN
10_1101-2021_01_06_425584	373	1	616	616	CD
10_1101-2021_01_06_425584	373	2	M.	M.	NNP
10_1101-2021_01_06_425584	373	3	;	;	:
10_1101-2021_01_06_425584	373	4	Fox	Fox	NNP
10_1101-2021_01_06_425584	373	5	,	,	,
10_1101-2021_01_06_425584	373	6	E.	E.	NNP
10_1101-2021_01_06_425584	373	7	;	;	:
10_1101-2021_01_06_425584	373	8	Balunas	Balunas	NNP
10_1101-2021_01_06_425584	373	9	,	,	,
10_1101-2021_01_06_425584	373	10	M.	M.	NNP
10_1101-2021_01_06_425584	373	11	J.	J.	NNP
10_1101-2021_01_06_425584	373	12	;	;	:
10_1101-2021_01_06_425584	373	13	Klassen	Klassen	NNP
10_1101-2021_01_06_425584	373	14	,	,	,
10_1101-2021_01_06_425584	373	15	J.	J.	NNP
10_1101-2021_01_06_425584	373	16	L.	L.	NNP
10_1101-2021_01_06_425584	373	17	;	;	:
10_1101-2021_01_06_425584	373	18	Lopes	Lopes	NNP
10_1101-2021_01_06_425584	373	19	,	,	,
10_1101-2021_01_06_425584	373	20	N.	N.	NNP
10_1101-2021_01_06_425584	373	21	P.	P.	NNP
10_1101-2021_01_06_425584	373	22	;	;	:
10_1101-2021_01_06_425584	373	23	Dorrestein	Dorrestein	NNP
10_1101-2021_01_06_425584	373	24	,	,	,
10_1101-2021_01_06_425584	373	25	P.	P.	NNP
10_1101-2021_01_06_425584	373	26	C.	C.	NNP
10_1101-2021_01_06_425584	373	27	,	,	,
10_1101-2021_01_06_425584	373	28	Propagating	propagate	VBG
10_1101-2021_01_06_425584	373	29	617	617	CD
10_1101-2021_01_06_425584	373	30	annotations	annotation	NNS
10_1101-2021_01_06_425584	373	31	of	of	IN
10_1101-2021_01_06_425584	373	32	molecular	molecular	JJ
10_1101-2021_01_06_425584	373	33	networks	network	NNS
10_1101-2021_01_06_425584	373	34	using	use	VBG
10_1101-2021_01_06_425584	373	35	in	in	IN
10_1101-2021_01_06_425584	373	36	silico	silico	NNP
10_1101-2021_01_06_425584	373	37	fragmentation	fragmentation	NN
10_1101-2021_01_06_425584	373	38	.	.	.
10_1101-2021_01_06_425584	374	1	PLoS	PLoS	:
10_1101-2021_01_06_425584	374	2	Comput	Comput	NNP
10_1101-2021_01_06_425584	374	3	Biol	Biol	NNP
10_1101-2021_01_06_425584	374	4	2018	2018	CD
10_1101-2021_01_06_425584	374	5	,	,	,
10_1101-2021_01_06_425584	374	6	14	14	CD
10_1101-2021_01_06_425584	374	7	,	,	,
10_1101-2021_01_06_425584	374	8	618	618	CD
10_1101-2021_01_06_425584	374	9	(	(	-LRB-
10_1101-2021_01_06_425584	374	10	4	4	CD
10_1101-2021_01_06_425584	374	11	)	)	-RRB-
10_1101-2021_01_06_425584	374	12	,	,	,
10_1101-2021_01_06_425584	374	13	e1006089	e1006089	NNP
10_1101-2021_01_06_425584	374	14	.	.	.
10_1101-2021_01_06_425584	375	1	619	619	CD
10_1101-2021_01_06_425584	375	2	26	26	CD
10_1101-2021_01_06_425584	375	3	.	.	.
10_1101-2021_01_06_425584	375	4	van	van	NNP
10_1101-2021_01_06_425584	375	5	der	der	NNP
10_1101-2021_01_06_425584	375	6	Hooft	Hooft	NNP
10_1101-2021_01_06_425584	375	7	,	,	,
10_1101-2021_01_06_425584	375	8	J.	J.	NNP
10_1101-2021_01_06_425584	375	9	J.	J.	NNP
10_1101-2021_01_06_425584	375	10	;	;	:
10_1101-2021_01_06_425584	375	11	Wandy	Wandy	NNP
10_1101-2021_01_06_425584	375	12	,	,	,
10_1101-2021_01_06_425584	375	13	J.	J.	NNP
10_1101-2021_01_06_425584	375	14	;	;	:
10_1101-2021_01_06_425584	375	15	Barrett	Barrett	NNP
10_1101-2021_01_06_425584	375	16	,	,	,
10_1101-2021_01_06_425584	375	17	M.	M.	NNP
10_1101-2021_01_06_425584	375	18	P.	P.	NNP
10_1101-2021_01_06_425584	375	19	;	;	:
10_1101-2021_01_06_425584	375	20	Burgess	Burgess	NNP
10_1101-2021_01_06_425584	375	21	,	,	,
10_1101-2021_01_06_425584	375	22	K.	K.	NNP
10_1101-2021_01_06_425584	375	23	E.	E.	NNP
10_1101-2021_01_06_425584	375	24	;	;	:
10_1101-2021_01_06_425584	375	25	Rogers	Rogers	NNP
10_1101-2021_01_06_425584	375	26	,	,	,
10_1101-2021_01_06_425584	375	27	S.	S.	NNP
10_1101-2021_01_06_425584	375	28	,	,	,
10_1101-2021_01_06_425584	375	29	Topic	Topic	NNP
10_1101-2021_01_06_425584	375	30	620	620	CD
10_1101-2021_01_06_425584	375	31	modeling	model	VBG
10_1101-2021_01_06_425584	375	32	for	for	IN
10_1101-2021_01_06_425584	375	33	untargeted	untargeted	JJ
10_1101-2021_01_06_425584	375	34	substructure	substructure	NN
10_1101-2021_01_06_425584	375	35	exploration	exploration	NN
10_1101-2021_01_06_425584	375	36	in	in	IN
10_1101-2021_01_06_425584	375	37	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	375	38	.	.	.
10_1101-2021_01_06_425584	376	1	Proc	Proc	NNP
10_1101-2021_01_06_425584	376	2	Natl	Natl	NNP
10_1101-2021_01_06_425584	376	3	Acad	Acad	NNP
10_1101-2021_01_06_425584	376	4	Sci	Sci	NNP
10_1101-2021_01_06_425584	376	5	U	U	NNP
10_1101-2021_01_06_425584	376	6	S	S	NNP
10_1101-2021_01_06_425584	376	7	A	A	NNP
10_1101-2021_01_06_425584	376	8	621	621	CD
10_1101-2021_01_06_425584	376	9	2016	2016	CD
10_1101-2021_01_06_425584	376	10	,	,	,
10_1101-2021_01_06_425584	376	11	113	113	CD
10_1101-2021_01_06_425584	376	12	,	,	,
10_1101-2021_01_06_425584	376	13	(	(	-LRB-
10_1101-2021_01_06_425584	376	14	48	48	CD
10_1101-2021_01_06_425584	376	15	)	)	-RRB-
10_1101-2021_01_06_425584	376	16	,	,	,
10_1101-2021_01_06_425584	376	17	13738	13738	CD
10_1101-2021_01_06_425584	376	18	-	-	SYM
10_1101-2021_01_06_425584	376	19	13743	13743	CD
10_1101-2021_01_06_425584	376	20	.	.	.
10_1101-2021_01_06_425584	377	1	622	622	CD
10_1101-2021_01_06_425584	377	2	27	27	CD
10_1101-2021_01_06_425584	377	3	.	.	.
10_1101-2021_01_06_425584	378	1	Djoumbou	Djoumbou	NNP
10_1101-2021_01_06_425584	378	2	Feunang	Feunang	NNP
10_1101-2021_01_06_425584	378	3	,	,	,
10_1101-2021_01_06_425584	378	4	Y.	Y.	NNP
10_1101-2021_01_06_425584	378	5	;	;	:
10_1101-2021_01_06_425584	378	6	Eisner	Eisner	NNP
10_1101-2021_01_06_425584	378	7	,	,	,
10_1101-2021_01_06_425584	378	8	R.	R.	NNP
10_1101-2021_01_06_425584	378	9	;	;	:
10_1101-2021_01_06_425584	378	10	Knox	Knox	NNP
10_1101-2021_01_06_425584	378	11	,	,	,
10_1101-2021_01_06_425584	378	12	C.	C.	NNP
10_1101-2021_01_06_425584	378	13	;	;	:
10_1101-2021_01_06_425584	378	14	Chepelev	Chepelev	NNP
10_1101-2021_01_06_425584	378	15	,	,	,
10_1101-2021_01_06_425584	378	16	L.	L.	NNP
10_1101-2021_01_06_425584	378	17	;	;	:
10_1101-2021_01_06_425584	378	18	Hastings	Hastings	NNP
10_1101-2021_01_06_425584	378	19	,	,	,
10_1101-2021_01_06_425584	378	20	J.	J.	NNP
10_1101-2021_01_06_425584	378	21	;	;	:
10_1101-2021_01_06_425584	378	22	Owen	Owen	NNP
10_1101-2021_01_06_425584	378	23	,	,	,
10_1101-2021_01_06_425584	378	24	G.	G.	NNP
10_1101-2021_01_06_425584	378	25	;	;	:
10_1101-2021_01_06_425584	378	26	623	623	CD
10_1101-2021_01_06_425584	378	27	Fahy	Fahy	NNP
10_1101-2021_01_06_425584	378	28	,	,	,
10_1101-2021_01_06_425584	378	29	E.	E.	NNP
10_1101-2021_01_06_425584	378	30	;	;	:
10_1101-2021_01_06_425584	378	31	Steinbeck	Steinbeck	NNP
10_1101-2021_01_06_425584	378	32	,	,	,
10_1101-2021_01_06_425584	378	33	C.	C.	NNP
10_1101-2021_01_06_425584	378	34	;	;	:
10_1101-2021_01_06_425584	378	35	Subramanian	Subramanian	NNP
10_1101-2021_01_06_425584	378	36	,	,	,
10_1101-2021_01_06_425584	378	37	S.	S.	NNP
10_1101-2021_01_06_425584	378	38	;	;	:
10_1101-2021_01_06_425584	378	39	Bolton	Bolton	NNP
10_1101-2021_01_06_425584	378	40	,	,	,
10_1101-2021_01_06_425584	378	41	E.	E.	NNP
10_1101-2021_01_06_425584	378	42	;	;	:
10_1101-2021_01_06_425584	378	43	Greiner	Greiner	NNP
10_1101-2021_01_06_425584	378	44	,	,	,
10_1101-2021_01_06_425584	378	45	R.	R.	NNP
10_1101-2021_01_06_425584	378	46	;	;	:
10_1101-2021_01_06_425584	378	47	Wishart	Wishart	NNP
10_1101-2021_01_06_425584	378	48	,	,	,
10_1101-2021_01_06_425584	378	49	D.	D.	NNP
10_1101-2021_01_06_425584	378	50	S.	S.	NNP
10_1101-2021_01_06_425584	378	51	,	,	,
10_1101-2021_01_06_425584	378	52	ClassyFire	ClassyFire	NNP
10_1101-2021_01_06_425584	378	53	:	:	:
10_1101-2021_01_06_425584	378	54	624	624	CD
10_1101-2021_01_06_425584	378	55	automated	automate	VBD
10_1101-2021_01_06_425584	378	56	chemical	chemical	NN
10_1101-2021_01_06_425584	378	57	classification	classification	NN
10_1101-2021_01_06_425584	378	58	with	with	IN
10_1101-2021_01_06_425584	378	59	a	a	DT
10_1101-2021_01_06_425584	378	60	comprehensive	comprehensive	JJ
10_1101-2021_01_06_425584	378	61	,	,	,
10_1101-2021_01_06_425584	378	62	computable	computable	JJ
10_1101-2021_01_06_425584	378	63	taxonomy	taxonomy	NN
10_1101-2021_01_06_425584	378	64	.	.	.
10_1101-2021_01_06_425584	379	1	J	J	NNP
10_1101-2021_01_06_425584	379	2	Cheminform	Cheminform	NNP
10_1101-2021_01_06_425584	379	3	625	625	CD
10_1101-2021_01_06_425584	379	4	2016	2016	CD
10_1101-2021_01_06_425584	379	5	,	,	,
10_1101-2021_01_06_425584	379	6	8	8	CD
10_1101-2021_01_06_425584	379	7	,	,	,
10_1101-2021_01_06_425584	379	8	61	61	CD
10_1101-2021_01_06_425584	379	9	.	.	.
10_1101-2021_01_06_425584	380	1	626	626	CD
10_1101-2021_01_06_425584	380	2	28	28	CD
10_1101-2021_01_06_425584	380	3	.	.	.
10_1101-2021_01_06_425584	381	1	Schymanski	Schymanski	NNP
10_1101-2021_01_06_425584	381	2	,	,	,
10_1101-2021_01_06_425584	381	3	E.	E.	NNP
10_1101-2021_01_06_425584	381	4	L.	L.	NNP
10_1101-2021_01_06_425584	381	5	;	;	:
10_1101-2021_01_06_425584	381	6	Jeon	Jeon	NNP
10_1101-2021_01_06_425584	381	7	,	,	,
10_1101-2021_01_06_425584	381	8	J.	J.	NNP
10_1101-2021_01_06_425584	381	9	;	;	:
10_1101-2021_01_06_425584	381	10	Gulde	Gulde	NNP
10_1101-2021_01_06_425584	381	11	,	,	,
10_1101-2021_01_06_425584	381	12	R.	R.	NNP
10_1101-2021_01_06_425584	381	13	;	;	:
10_1101-2021_01_06_425584	381	14	Fenner	Fenner	NNP
10_1101-2021_01_06_425584	381	15	,	,	,
10_1101-2021_01_06_425584	381	16	K.	K.	NNP
10_1101-2021_01_06_425584	381	17	;	;	:
10_1101-2021_01_06_425584	381	18	Ruff	Ruff	NNP
10_1101-2021_01_06_425584	381	19	,	,	,
10_1101-2021_01_06_425584	381	20	M.	M.	NNP
10_1101-2021_01_06_425584	381	21	;	;	:
10_1101-2021_01_06_425584	381	22	Singer	Singer	NNP
10_1101-2021_01_06_425584	381	23	,	,	,
10_1101-2021_01_06_425584	381	24	H.	H.	NNP
10_1101-2021_01_06_425584	381	25	P.	P.	NNP
10_1101-2021_01_06_425584	381	26	;	;	:
10_1101-2021_01_06_425584	381	27	Hollender	Hollender	NNP
10_1101-2021_01_06_425584	381	28	,	,	,
10_1101-2021_01_06_425584	381	29	J.	J.	NNP
10_1101-2021_01_06_425584	381	30	,	,	,
10_1101-2021_01_06_425584	381	31	627	627	CD
10_1101-2021_01_06_425584	381	32	Identifying	identify	VBG
10_1101-2021_01_06_425584	381	33	small	small	JJ
10_1101-2021_01_06_425584	381	34	molecules	molecule	NNS
10_1101-2021_01_06_425584	381	35	via	via	IN
10_1101-2021_01_06_425584	381	36	high	high	JJ
10_1101-2021_01_06_425584	381	37	resolution	resolution	NN
10_1101-2021_01_06_425584	381	38	mass	mass	NN
10_1101-2021_01_06_425584	381	39	spectrometry	spectrometry	NN
10_1101-2021_01_06_425584	381	40	:	:	:
10_1101-2021_01_06_425584	381	41	communicating	communicate	VBG
10_1101-2021_01_06_425584	381	42	confidence	confidence	NN
10_1101-2021_01_06_425584	381	43	.	.	.
10_1101-2021_01_06_425584	382	1	628	628	CD
10_1101-2021_01_06_425584	382	2	Environ	Environ	NNP
10_1101-2021_01_06_425584	382	3	Sci	Sci	NNP
10_1101-2021_01_06_425584	382	4	Technol	Technol	NNP
10_1101-2021_01_06_425584	382	5	2014	2014	CD
10_1101-2021_01_06_425584	382	6	,	,	,
10_1101-2021_01_06_425584	382	7	48	48	CD
10_1101-2021_01_06_425584	382	8	,	,	,
10_1101-2021_01_06_425584	382	9	(	(	-LRB-
10_1101-2021_01_06_425584	382	10	4	4	CD
10_1101-2021_01_06_425584	382	11	)	)	-RRB-
10_1101-2021_01_06_425584	382	12	,	,	,
10_1101-2021_01_06_425584	382	13	2097	2097	CD
10_1101-2021_01_06_425584	382	14	-	-	SYM
10_1101-2021_01_06_425584	382	15	8	8	CD
10_1101-2021_01_06_425584	382	16	.	.	.
10_1101-2021_01_06_425584	383	1	629	629	CD
10_1101-2021_01_06_425584	383	2	.CC	.CC	:
10_1101-2021_01_06_425584	383	3	-	-	HYPH
10_1101-2021_01_06_425584	383	4	BY	by	IN
10_1101-2021_01_06_425584	383	5	-	-	HYPH
10_1101-2021_01_06_425584	383	6	NC	NC	NNP
10_1101-2021_01_06_425584	383	7	-	-	HYPH
10_1101-2021_01_06_425584	383	8	ND	ND	NNP
10_1101-2021_01_06_425584	383	9	4.0	4.0	CD
10_1101-2021_01_06_425584	383	10	International	International	NNP
10_1101-2021_01_06_425584	383	11	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	383	12	under	under	IN
10_1101-2021_01_06_425584	383	13	a	a	DT
10_1101-2021_01_06_425584	383	14	(	(	-LRB-
10_1101-2021_01_06_425584	383	15	which	which	WDT
10_1101-2021_01_06_425584	383	16	was	be	VBD
10_1101-2021_01_06_425584	383	17	not	not	RB
10_1101-2021_01_06_425584	383	18	certified	certify	VBN
10_1101-2021_01_06_425584	383	19	by	by	IN
10_1101-2021_01_06_425584	383	20	peer	peer	NN
10_1101-2021_01_06_425584	383	21	review	review	NN
10_1101-2021_01_06_425584	383	22	)	)	-RRB-
10_1101-2021_01_06_425584	383	23	is	be	VBZ
10_1101-2021_01_06_425584	383	24	the	the	DT
10_1101-2021_01_06_425584	383	25	author	author	NN
10_1101-2021_01_06_425584	383	26	/	/	SYM
10_1101-2021_01_06_425584	383	27	funder	funder	NN
10_1101-2021_01_06_425584	383	28	,	,	,
10_1101-2021_01_06_425584	383	29	who	who	WP
10_1101-2021_01_06_425584	383	30	has	have	VBZ
10_1101-2021_01_06_425584	383	31	granted	grant	VBN
10_1101-2021_01_06_425584	383	32	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	383	33	a	a	DT
10_1101-2021_01_06_425584	383	34	license	license	NN
10_1101-2021_01_06_425584	383	35	to	to	TO
10_1101-2021_01_06_425584	383	36	display	display	VB
10_1101-2021_01_06_425584	383	37	the	the	DT
10_1101-2021_01_06_425584	383	38	preprint	preprint	NN
10_1101-2021_01_06_425584	383	39	in	in	IN
10_1101-2021_01_06_425584	383	40	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	383	41	.	.	.
10_1101-2021_01_06_425584	384	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	384	2	is	be	VBZ
10_1101-2021_01_06_425584	384	3	made	make	VBN
10_1101-2021_01_06_425584	384	4	The	the	DT
10_1101-2021_01_06_425584	384	5	copyright	copyright	NN
10_1101-2021_01_06_425584	384	6	holder	holder	NN
10_1101-2021_01_06_425584	384	7	for	for	IN
10_1101-2021_01_06_425584	384	8	this	this	DT
10_1101-2021_01_06_425584	384	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	384	10	version	version	NN
10_1101-2021_01_06_425584	384	11	posted	post	VBD
10_1101-2021_01_06_425584	384	12	January	January	NNP
10_1101-2021_01_06_425584	384	13	8	8	CD
10_1101-2021_01_06_425584	384	14	,	,	,
10_1101-2021_01_06_425584	384	15	2021	2021	CD
10_1101-2021_01_06_425584	384	16	.	.	.
10_1101-2021_01_06_425584	384	17	;	;	:
10_1101-2021_01_06_425584	384	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	384	19	:	:	:
10_1101-2021_01_06_425584	384	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	384	21	preprint	preprint	NN
10_1101-2021_01_06_425584	384	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	384	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	384	24	23	23	CD
10_1101-2021_01_06_425584	384	25	29	29	CD
10_1101-2021_01_06_425584	384	26	.	.	.
10_1101-2021_01_06_425584	385	1	Ernst	Ernst	NNP
10_1101-2021_01_06_425584	385	2	,	,	,
10_1101-2021_01_06_425584	385	3	M.	M.	NNP
10_1101-2021_01_06_425584	385	4	;	;	:
10_1101-2021_01_06_425584	385	5	Kang	Kang	NNP
10_1101-2021_01_06_425584	385	6	,	,	,
10_1101-2021_01_06_425584	385	7	K.	K.	NNP
10_1101-2021_01_06_425584	385	8	B.	B.	NNP
10_1101-2021_01_06_425584	385	9	;	;	:
10_1101-2021_01_06_425584	385	10	Caraballo	Caraballo	NNP
10_1101-2021_01_06_425584	385	11	-	-	HYPH
10_1101-2021_01_06_425584	385	12	Rodriguez	Rodriguez	NNP
10_1101-2021_01_06_425584	385	13	,	,	,
10_1101-2021_01_06_425584	385	14	A.	a.	NN
10_1101-2021_01_06_425584	385	15	M.	M.	NNP
10_1101-2021_01_06_425584	385	16	;	;	:
10_1101-2021_01_06_425584	385	17	Nothias	Nothias	NNP
10_1101-2021_01_06_425584	385	18	,	,	,
10_1101-2021_01_06_425584	385	19	L.	L.	NNP
10_1101-2021_01_06_425584	385	20	F.	F.	NNP
10_1101-2021_01_06_425584	385	21	;	;	:
10_1101-2021_01_06_425584	385	22	Wandy	Wandy	NNP
10_1101-2021_01_06_425584	385	23	,	,	,
10_1101-2021_01_06_425584	385	24	J.	J.	NNP
10_1101-2021_01_06_425584	385	25	;	;	:
10_1101-2021_01_06_425584	385	26	Chen	Chen	NNP
10_1101-2021_01_06_425584	385	27	,	,	,
10_1101-2021_01_06_425584	385	28	C.	C.	NNP
10_1101-2021_01_06_425584	385	29	;	;	:
10_1101-2021_01_06_425584	385	30	630	630	CD
10_1101-2021_01_06_425584	385	31	Wang	Wang	NNP
10_1101-2021_01_06_425584	385	32	,	,	,
10_1101-2021_01_06_425584	385	33	M.	M.	NNP
10_1101-2021_01_06_425584	385	34	;	;	:
10_1101-2021_01_06_425584	385	35	Rogers	Rogers	NNP
10_1101-2021_01_06_425584	385	36	,	,	,
10_1101-2021_01_06_425584	385	37	S.	S.	NNP
10_1101-2021_01_06_425584	385	38	;	;	:
10_1101-2021_01_06_425584	385	39	Medema	Medema	NNP
10_1101-2021_01_06_425584	385	40	,	,	,
10_1101-2021_01_06_425584	385	41	M.	M.	NNP
10_1101-2021_01_06_425584	385	42	H.	H.	NNP
10_1101-2021_01_06_425584	385	43	;	;	:
10_1101-2021_01_06_425584	385	44	Dorrestein	Dorrestein	NNP
10_1101-2021_01_06_425584	385	45	,	,	,
10_1101-2021_01_06_425584	385	46	P.	P.	NNP
10_1101-2021_01_06_425584	385	47	C.	C.	NNP
10_1101-2021_01_06_425584	385	48	;	;	:
10_1101-2021_01_06_425584	385	49	van	van	NNP
10_1101-2021_01_06_425584	385	50	der	der	NNP
10_1101-2021_01_06_425584	385	51	Hooft	Hooft	NNP
10_1101-2021_01_06_425584	385	52	,	,	,
10_1101-2021_01_06_425584	385	53	J.	J.	NNP
10_1101-2021_01_06_425584	385	54	J.	J.	NNP
10_1101-2021_01_06_425584	385	55	J.	J.	NNP
10_1101-2021_01_06_425584	385	56	,	,	,
10_1101-2021_01_06_425584	385	57	631	631	CD
10_1101-2021_01_06_425584	385	58	MolNetEnhancer	molnetenhancer	NN
10_1101-2021_01_06_425584	385	59	:	:	:
10_1101-2021_01_06_425584	385	60	Enhanced	Enhanced	NNP
10_1101-2021_01_06_425584	385	61	Molecular	Molecular	NNP
10_1101-2021_01_06_425584	385	62	Networks	Networks	NNP
10_1101-2021_01_06_425584	385	63	by	by	IN
10_1101-2021_01_06_425584	385	64	Integrating	integrate	VBG
10_1101-2021_01_06_425584	385	65	Metabolome	Metabolome	NNP
10_1101-2021_01_06_425584	385	66	Mining	Mining	NNP
10_1101-2021_01_06_425584	385	67	and	and	CC
10_1101-2021_01_06_425584	385	68	632	632	CD
10_1101-2021_01_06_425584	385	69	Annotation	annotation	NN
10_1101-2021_01_06_425584	385	70	Tools	tool	NNS
10_1101-2021_01_06_425584	385	71	.	.	.
10_1101-2021_01_06_425584	386	1	Metabolites	metabolite	NNS
10_1101-2021_01_06_425584	386	2	2019	2019	CD
10_1101-2021_01_06_425584	386	3	,	,	,
10_1101-2021_01_06_425584	386	4	9	9	CD
10_1101-2021_01_06_425584	386	5	,	,	,
10_1101-2021_01_06_425584	386	6	(	(	-LRB-
10_1101-2021_01_06_425584	386	7	7	7	CD
10_1101-2021_01_06_425584	386	8	)	)	-RRB-
10_1101-2021_01_06_425584	386	9	.	.	.
10_1101-2021_01_06_425584	387	1	633	633	CD
10_1101-2021_01_06_425584	387	2	30	30	CD
10_1101-2021_01_06_425584	387	3	.	.	.
10_1101-2021_01_06_425584	388	1	Shannon	Shannon	NNP
10_1101-2021_01_06_425584	388	2	,	,	,
10_1101-2021_01_06_425584	388	3	P.	P.	NNP
10_1101-2021_01_06_425584	388	4	;	;	:
10_1101-2021_01_06_425584	388	5	Markiel	Markiel	NNP
10_1101-2021_01_06_425584	388	6	,	,	,
10_1101-2021_01_06_425584	388	7	A.	a.	NN
10_1101-2021_01_06_425584	388	8	;	;	:
10_1101-2021_01_06_425584	388	9	Ozier	Ozier	NNP
10_1101-2021_01_06_425584	388	10	,	,	,
10_1101-2021_01_06_425584	388	11	O.	O.	NNP
10_1101-2021_01_06_425584	388	12	;	;	:
10_1101-2021_01_06_425584	388	13	Baliga	Baliga	NNP
10_1101-2021_01_06_425584	388	14	,	,	,
10_1101-2021_01_06_425584	388	15	N.	N.	NNP
10_1101-2021_01_06_425584	388	16	S.	S.	NNP
10_1101-2021_01_06_425584	388	17	;	;	:
10_1101-2021_01_06_425584	388	18	Wang	Wang	NNP
10_1101-2021_01_06_425584	388	19	,	,	,
10_1101-2021_01_06_425584	388	20	J.	J.	NNP
10_1101-2021_01_06_425584	388	21	T.	T.	NNP
10_1101-2021_01_06_425584	388	22	;	;	:
10_1101-2021_01_06_425584	388	23	Ramage	Ramage	NNP
10_1101-2021_01_06_425584	388	24	,	,	,
10_1101-2021_01_06_425584	388	25	D.	D.	NNP
10_1101-2021_01_06_425584	388	26	;	;	:
10_1101-2021_01_06_425584	388	27	Amin	Amin	NNP
10_1101-2021_01_06_425584	388	28	,	,	,
10_1101-2021_01_06_425584	388	29	N.	N.	NNP
10_1101-2021_01_06_425584	388	30	;	;	:
10_1101-2021_01_06_425584	388	31	634	634	CD
10_1101-2021_01_06_425584	388	32	Schwikowski	Schwikowski	NNP
10_1101-2021_01_06_425584	388	33	,	,	,
10_1101-2021_01_06_425584	388	34	B.	B.	NNP
10_1101-2021_01_06_425584	388	35	;	;	:
10_1101-2021_01_06_425584	388	36	Ideker	Ideker	NNP
10_1101-2021_01_06_425584	388	37	,	,	,
10_1101-2021_01_06_425584	388	38	T.	T.	NNP
10_1101-2021_01_06_425584	388	39	,	,	,
10_1101-2021_01_06_425584	388	40	Cytoscape	Cytoscape	NNP
10_1101-2021_01_06_425584	388	41	:	:	:
10_1101-2021_01_06_425584	388	42	a	a	DT
10_1101-2021_01_06_425584	388	43	software	software	NN
10_1101-2021_01_06_425584	388	44	environment	environment	NN
10_1101-2021_01_06_425584	388	45	for	for	IN
10_1101-2021_01_06_425584	388	46	integrated	integrate	VBN
10_1101-2021_01_06_425584	388	47	models	model	NNS
10_1101-2021_01_06_425584	388	48	of	of	IN
10_1101-2021_01_06_425584	388	49	635	635	CD
10_1101-2021_01_06_425584	388	50	biomolecular	biomolecular	JJ
10_1101-2021_01_06_425584	388	51	interaction	interaction	NN
10_1101-2021_01_06_425584	388	52	networks	network	NNS
10_1101-2021_01_06_425584	388	53	.	.	.
10_1101-2021_01_06_425584	389	1	Genome	Genome	NNP
10_1101-2021_01_06_425584	389	2	Res	Res	NNP
10_1101-2021_01_06_425584	389	3	2003	2003	CD
10_1101-2021_01_06_425584	389	4	,	,	,
10_1101-2021_01_06_425584	389	5	13	13	CD
10_1101-2021_01_06_425584	389	6	,	,	,
10_1101-2021_01_06_425584	389	7	(	(	-LRB-
10_1101-2021_01_06_425584	389	8	11	11	CD
10_1101-2021_01_06_425584	389	9	)	)	-RRB-
10_1101-2021_01_06_425584	389	10	,	,	,
10_1101-2021_01_06_425584	389	11	2498	2498	CD
10_1101-2021_01_06_425584	389	12	-	-	SYM
10_1101-2021_01_06_425584	389	13	504	504	CD
10_1101-2021_01_06_425584	389	14	.	.	.
10_1101-2021_01_06_425584	390	1	636	636	CD
10_1101-2021_01_06_425584	390	2	31	31	CD
10_1101-2021_01_06_425584	390	3	.	.	.
10_1101-2021_01_06_425584	391	1	Perez	Perez	NNP
10_1101-2021_01_06_425584	391	2	-	-	HYPH
10_1101-2021_01_06_425584	391	3	Riverol	Riverol	NNP
10_1101-2021_01_06_425584	391	4	,	,	,
10_1101-2021_01_06_425584	391	5	Y.	Y.	NNP
10_1101-2021_01_06_425584	391	6	;	;	:
10_1101-2021_01_06_425584	391	7	Csordas	Csordas	NNP
10_1101-2021_01_06_425584	391	8	,	,	,
10_1101-2021_01_06_425584	391	9	A.	a.	NN
10_1101-2021_01_06_425584	391	10	;	;	:
10_1101-2021_01_06_425584	391	11	Bai	Bai	NNP
10_1101-2021_01_06_425584	391	12	,	,	,
10_1101-2021_01_06_425584	391	13	J.	J.	NNP
10_1101-2021_01_06_425584	391	14	;	;	:
10_1101-2021_01_06_425584	391	15	Bernal	Bernal	NNP
10_1101-2021_01_06_425584	391	16	-	-	HYPH
10_1101-2021_01_06_425584	391	17	Llinares	Llinares	NNP
10_1101-2021_01_06_425584	391	18	,	,	,
10_1101-2021_01_06_425584	391	19	M.	M.	NNP
10_1101-2021_01_06_425584	391	20	;	;	:
10_1101-2021_01_06_425584	391	21	Hewapathirana	Hewapathirana	NNP
10_1101-2021_01_06_425584	391	22	,	,	,
10_1101-2021_01_06_425584	391	23	S.	S.	NNP
10_1101-2021_01_06_425584	391	24	;	;	:
10_1101-2021_01_06_425584	391	25	Kundu	Kundu	NNP
10_1101-2021_01_06_425584	391	26	,	,	,
10_1101-2021_01_06_425584	391	27	637	637	CD
10_1101-2021_01_06_425584	391	28	D.	D.	NNP
10_1101-2021_01_06_425584	391	29	J.	J.	NNP
10_1101-2021_01_06_425584	391	30	;	;	:
10_1101-2021_01_06_425584	391	31	Inuganti	Inuganti	NNP
10_1101-2021_01_06_425584	391	32	,	,	,
10_1101-2021_01_06_425584	391	33	A.	a.	NN
10_1101-2021_01_06_425584	391	34	;	;	:
10_1101-2021_01_06_425584	391	35	Griss	Griss	NNP
10_1101-2021_01_06_425584	391	36	,	,	,
10_1101-2021_01_06_425584	391	37	J.	J.	NNP
10_1101-2021_01_06_425584	391	38	;	;	:
10_1101-2021_01_06_425584	391	39	Mayer	Mayer	NNP
10_1101-2021_01_06_425584	391	40	,	,	,
10_1101-2021_01_06_425584	391	41	G.	G.	NNP
10_1101-2021_01_06_425584	391	42	;	;	:
10_1101-2021_01_06_425584	391	43	Eisenacher	Eisenacher	NNP
10_1101-2021_01_06_425584	391	44	,	,	,
10_1101-2021_01_06_425584	391	45	M.	M.	NNP
10_1101-2021_01_06_425584	391	46	;	;	:
10_1101-2021_01_06_425584	391	47	Perez	Perez	NNP
10_1101-2021_01_06_425584	391	48	,	,	,
10_1101-2021_01_06_425584	391	49	E.	E.	NNP
10_1101-2021_01_06_425584	391	50	;	;	:
10_1101-2021_01_06_425584	391	51	Uszkoreit	Uszkoreit	NNP
10_1101-2021_01_06_425584	391	52	,	,	,
10_1101-2021_01_06_425584	391	53	J.	J.	NNP
10_1101-2021_01_06_425584	391	54	;	;	:
10_1101-2021_01_06_425584	391	55	Pfeuffer	Pfeuffer	NNP
10_1101-2021_01_06_425584	391	56	,	,	,
10_1101-2021_01_06_425584	391	57	J.	J.	NNP
10_1101-2021_01_06_425584	391	58	;	;	:
10_1101-2021_01_06_425584	391	59	638	638	CD
10_1101-2021_01_06_425584	391	60	Sachsenberg	Sachsenberg	NNP
10_1101-2021_01_06_425584	391	61	,	,	,
10_1101-2021_01_06_425584	391	62	T.	T.	NNP
10_1101-2021_01_06_425584	391	63	;	;	:
10_1101-2021_01_06_425584	391	64	Yilmaz	Yilmaz	NNP
10_1101-2021_01_06_425584	391	65	,	,	,
10_1101-2021_01_06_425584	391	66	S.	S.	NNP
10_1101-2021_01_06_425584	391	67	;	;	:
10_1101-2021_01_06_425584	391	68	Tiwary	Tiwary	NNP
10_1101-2021_01_06_425584	391	69	,	,	,
10_1101-2021_01_06_425584	391	70	S.	S.	NNP
10_1101-2021_01_06_425584	391	71	;	;	:
10_1101-2021_01_06_425584	391	72	Cox	Cox	NNP
10_1101-2021_01_06_425584	391	73	,	,	,
10_1101-2021_01_06_425584	391	74	J.	J.	NNP
10_1101-2021_01_06_425584	391	75	;	;	:
10_1101-2021_01_06_425584	391	76	Audain	Audain	NNP
10_1101-2021_01_06_425584	391	77	,	,	,
10_1101-2021_01_06_425584	391	78	E.	E.	NNP
10_1101-2021_01_06_425584	391	79	;	;	:
10_1101-2021_01_06_425584	391	80	Walzer	Walzer	NNP
10_1101-2021_01_06_425584	391	81	,	,	,
10_1101-2021_01_06_425584	391	82	M.	M.	NNP
10_1101-2021_01_06_425584	391	83	;	;	:
10_1101-2021_01_06_425584	391	84	Jarnuczak	Jarnuczak	NNP
10_1101-2021_01_06_425584	391	85	,	,	,
10_1101-2021_01_06_425584	391	86	A.	A.	NNP
10_1101-2021_01_06_425584	391	87	F.	F.	NNP
10_1101-2021_01_06_425584	391	88	;	;	:
10_1101-2021_01_06_425584	391	89	639	639	CD
10_1101-2021_01_06_425584	391	90	Ternent	ternent	NN
10_1101-2021_01_06_425584	391	91	,	,	,
10_1101-2021_01_06_425584	391	92	T.	t.	NN
10_1101-2021_01_06_425584	391	93	;	;	:
10_1101-2021_01_06_425584	391	94	Brazma	Brazma	NNP
10_1101-2021_01_06_425584	391	95	,	,	,
10_1101-2021_01_06_425584	391	96	A.	a.	NN
10_1101-2021_01_06_425584	391	97	;	;	:
10_1101-2021_01_06_425584	391	98	Vizcaino	Vizcaino	NNP
10_1101-2021_01_06_425584	391	99	,	,	,
10_1101-2021_01_06_425584	391	100	J.	J.	NNP
10_1101-2021_01_06_425584	392	1	A.	A.	NNP
10_1101-2021_01_06_425584	392	2	,	,	,
10_1101-2021_01_06_425584	392	3	The	the	DT
10_1101-2021_01_06_425584	392	4	PRIDE	PRIDE	NNP
10_1101-2021_01_06_425584	392	5	database	database	NN
10_1101-2021_01_06_425584	392	6	and	and	CC
10_1101-2021_01_06_425584	392	7	related	related	JJ
10_1101-2021_01_06_425584	392	8	tools	tool	NNS
10_1101-2021_01_06_425584	392	9	and	and	CC
10_1101-2021_01_06_425584	392	10	resources	resource	NNS
10_1101-2021_01_06_425584	392	11	640	640	CD
10_1101-2021_01_06_425584	392	12	in	in	IN
10_1101-2021_01_06_425584	392	13	2019	2019	CD
10_1101-2021_01_06_425584	392	14	:	:	:
10_1101-2021_01_06_425584	392	15	improving	improve	VBG
10_1101-2021_01_06_425584	392	16	support	support	NN
10_1101-2021_01_06_425584	392	17	for	for	IN
10_1101-2021_01_06_425584	392	18	quantification	quantification	NN
10_1101-2021_01_06_425584	392	19	data	datum	NNS
10_1101-2021_01_06_425584	392	20	.	.	.
10_1101-2021_01_06_425584	393	1	Nucleic	Nucleic	NNP
10_1101-2021_01_06_425584	393	2	Acids	Acids	NNPS
10_1101-2021_01_06_425584	393	3	Res	Res	NNP
10_1101-2021_01_06_425584	393	4	2019	2019	CD
10_1101-2021_01_06_425584	393	5	,	,	,
10_1101-2021_01_06_425584	393	6	47	47	CD
10_1101-2021_01_06_425584	393	7	,	,	,
10_1101-2021_01_06_425584	393	8	(	(	-LRB-
10_1101-2021_01_06_425584	393	9	D1	d1	NN
10_1101-2021_01_06_425584	393	10	)	)	-RRB-
10_1101-2021_01_06_425584	393	11	,	,	,
10_1101-2021_01_06_425584	393	12	D442	D442	NNPS
10_1101-2021_01_06_425584	393	13	-	-	HYPH
10_1101-2021_01_06_425584	393	14	641	641	CD
10_1101-2021_01_06_425584	393	15	D450	D450	NNP
10_1101-2021_01_06_425584	393	16	.	.	.
10_1101-2021_01_06_425584	394	1	642	642	CD
10_1101-2021_01_06_425584	394	2	32	32	CD
10_1101-2021_01_06_425584	394	3	.	.	.
10_1101-2021_01_06_425584	395	1	Willforss	Willforss	NNP
10_1101-2021_01_06_425584	395	2	,	,	,
10_1101-2021_01_06_425584	395	3	J.	J.	NNP
10_1101-2021_01_06_425584	395	4	;	;	:
10_1101-2021_01_06_425584	395	5	Chawade	Chawade	NNP
10_1101-2021_01_06_425584	395	6	,	,	,
10_1101-2021_01_06_425584	395	7	A.	a.	NN
10_1101-2021_01_06_425584	395	8	;	;	:
10_1101-2021_01_06_425584	395	9	Levander	Levander	NNP
10_1101-2021_01_06_425584	395	10	,	,	,
10_1101-2021_01_06_425584	395	11	F.	F.	NNP
10_1101-2021_01_06_425584	395	12	,	,	,
10_1101-2021_01_06_425584	395	13	NormalyzerDE	NormalyzerDE	NNP
10_1101-2021_01_06_425584	395	14	:	:	:
10_1101-2021_01_06_425584	395	15	Online	Online	NNP
10_1101-2021_01_06_425584	395	16	Tool	Tool	NNP
10_1101-2021_01_06_425584	395	17	for	for	IN
10_1101-2021_01_06_425584	395	18	Improved	Improved	NNP
10_1101-2021_01_06_425584	395	19	643	643	CD
10_1101-2021_01_06_425584	395	20	Normalization	Normalization	NNP
10_1101-2021_01_06_425584	395	21	of	of	IN
10_1101-2021_01_06_425584	395	22	Omics	Omics	NNP
10_1101-2021_01_06_425584	395	23	Expression	Expression	NNP
10_1101-2021_01_06_425584	395	24	Data	Data	NNP
10_1101-2021_01_06_425584	395	25	and	and	CC
10_1101-2021_01_06_425584	395	26	High	High	NNP
10_1101-2021_01_06_425584	395	27	-	-	HYPH
10_1101-2021_01_06_425584	395	28	Sensitivity	Sensitivity	NNP
10_1101-2021_01_06_425584	395	29	Differential	Differential	NNP
10_1101-2021_01_06_425584	395	30	Expression	Expression	NNP
10_1101-2021_01_06_425584	395	31	Analysis	Analysis	NNP
10_1101-2021_01_06_425584	395	32	.	.	.
10_1101-2021_01_06_425584	396	1	J	J	NNP
10_1101-2021_01_06_425584	396	2	644	644	CD
10_1101-2021_01_06_425584	396	3	Proteome	Proteome	NNP
10_1101-2021_01_06_425584	396	4	Res	Res	NNP
10_1101-2021_01_06_425584	396	5	2019	2019	CD
10_1101-2021_01_06_425584	396	6	,	,	,
10_1101-2021_01_06_425584	396	7	18	18	CD
10_1101-2021_01_06_425584	396	8	,	,	,
10_1101-2021_01_06_425584	396	9	(	(	-LRB-
10_1101-2021_01_06_425584	396	10	2	2	CD
10_1101-2021_01_06_425584	396	11	)	)	-RRB-
10_1101-2021_01_06_425584	396	12	,	,	,
10_1101-2021_01_06_425584	396	13	732	732	CD
10_1101-2021_01_06_425584	396	14	-	-	SYM
10_1101-2021_01_06_425584	396	15	740	740	CD
10_1101-2021_01_06_425584	396	16	.	.	.
10_1101-2021_01_06_425584	397	1	645	645	CD
10_1101-2021_01_06_425584	397	2	33	33	CD
10_1101-2021_01_06_425584	397	3	.	.	.
10_1101-2021_01_06_425584	398	1	Zhou	Zhou	NNP
10_1101-2021_01_06_425584	398	2	,	,	,
10_1101-2021_01_06_425584	398	3	G.	G.	NNP
10_1101-2021_01_06_425584	398	4	;	;	:
10_1101-2021_01_06_425584	398	5	Xia	Xia	NNP
10_1101-2021_01_06_425584	398	6	,	,	,
10_1101-2021_01_06_425584	398	7	J.	J.	NNP
10_1101-2021_01_06_425584	398	8	,	,	,
10_1101-2021_01_06_425584	398	9	Using	use	VBG
10_1101-2021_01_06_425584	398	10	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	398	11	for	for	IN
10_1101-2021_01_06_425584	398	12	Network	Network	NNP
10_1101-2021_01_06_425584	398	13	Integration	Integration	NNP
10_1101-2021_01_06_425584	398	14	and	and	CC
10_1101-2021_01_06_425584	398	15	3D	3d	JJ
10_1101-2021_01_06_425584	398	16	Visualization	visualization	NN
10_1101-2021_01_06_425584	398	17	.	.	.
10_1101-2021_01_06_425584	399	1	Curr	Curr	NNP
10_1101-2021_01_06_425584	399	2	646	646	CD
10_1101-2021_01_06_425584	399	3	Protoc	Protoc	NNP
10_1101-2021_01_06_425584	399	4	Bioinformatics	Bioinformatics	NNPS
10_1101-2021_01_06_425584	399	5	2019	2019	CD
10_1101-2021_01_06_425584	399	6	,	,	,
10_1101-2021_01_06_425584	399	7	65	65	CD
10_1101-2021_01_06_425584	399	8	,	,	,
10_1101-2021_01_06_425584	399	9	(	(	-LRB-
10_1101-2021_01_06_425584	399	10	1	1	CD
10_1101-2021_01_06_425584	399	11	)	)	-RRB-
10_1101-2021_01_06_425584	399	12	,	,	,
10_1101-2021_01_06_425584	399	13	e69	e69	CD
10_1101-2021_01_06_425584	399	14	.	.	.
10_1101-2021_01_06_425584	400	1	647	647	CD
10_1101-2021_01_06_425584	400	2	34	34	CD
10_1101-2021_01_06_425584	400	3	.	.	.
10_1101-2021_01_06_425584	401	1	Zhou	Zhou	NNP
10_1101-2021_01_06_425584	401	2	,	,	,
10_1101-2021_01_06_425584	401	3	G.	G.	NNP
10_1101-2021_01_06_425584	401	4	;	;	:
10_1101-2021_01_06_425584	401	5	Xia	Xia	NNP
10_1101-2021_01_06_425584	401	6	,	,	,
10_1101-2021_01_06_425584	401	7	J.	J.	NNP
10_1101-2021_01_06_425584	401	8	,	,	,
10_1101-2021_01_06_425584	401	9	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	401	10	:	:	:
10_1101-2021_01_06_425584	401	11	a	a	DT
10_1101-2021_01_06_425584	401	12	web	web	NN
10_1101-2021_01_06_425584	401	13	-	-	HYPH
10_1101-2021_01_06_425584	401	14	based	base	VBN
10_1101-2021_01_06_425584	401	15	tool	tool	NN
10_1101-2021_01_06_425584	401	16	for	for	IN
10_1101-2021_01_06_425584	401	17	creation	creation	NN
10_1101-2021_01_06_425584	401	18	and	and	CC
10_1101-2021_01_06_425584	401	19	visual	visual	JJ
10_1101-2021_01_06_425584	401	20	analysis	analysis	NN
10_1101-2021_01_06_425584	401	21	of	of	IN
10_1101-2021_01_06_425584	401	22	648	648	CD
10_1101-2021_01_06_425584	401	23	biological	biological	JJ
10_1101-2021_01_06_425584	401	24	networks	network	NNS
10_1101-2021_01_06_425584	401	25	in	in	IN
10_1101-2021_01_06_425584	401	26	3D	3D	NNP
10_1101-2021_01_06_425584	401	27	space	space	NN
10_1101-2021_01_06_425584	401	28	.	.	.
10_1101-2021_01_06_425584	402	1	Nucleic	Nucleic	NNP
10_1101-2021_01_06_425584	402	2	Acids	Acids	NNPS
10_1101-2021_01_06_425584	402	3	Res	Res	NNP
10_1101-2021_01_06_425584	402	4	2018	2018	CD
10_1101-2021_01_06_425584	402	5	,	,	,
10_1101-2021_01_06_425584	402	6	46	46	CD
10_1101-2021_01_06_425584	402	7	,	,	,
10_1101-2021_01_06_425584	402	8	(	(	-LRB-
10_1101-2021_01_06_425584	402	9	W1	W1	NNP
10_1101-2021_01_06_425584	402	10	)	)	-RRB-
10_1101-2021_01_06_425584	402	11	,	,	,
10_1101-2021_01_06_425584	402	12	W514-W522	W514-W522	NNP
10_1101-2021_01_06_425584	402	13	.	.	.
10_1101-2021_01_06_425584	403	1	649	649	CD
10_1101-2021_01_06_425584	403	2	35	35	CD
10_1101-2021_01_06_425584	403	3	.	.	.
10_1101-2021_01_06_425584	404	1	Szklarczyk	Szklarczyk	NNP
10_1101-2021_01_06_425584	404	2	,	,	,
10_1101-2021_01_06_425584	404	3	D.	D.	NNP
10_1101-2021_01_06_425584	404	4	;	;	:
10_1101-2021_01_06_425584	404	5	Franceschini	Franceschini	NNP
10_1101-2021_01_06_425584	404	6	,	,	,
10_1101-2021_01_06_425584	404	7	A.	a.	NN
10_1101-2021_01_06_425584	404	8	;	;	:
10_1101-2021_01_06_425584	404	9	Wyder	Wyder	NNP
10_1101-2021_01_06_425584	404	10	,	,	,
10_1101-2021_01_06_425584	404	11	S.	S.	NNP
10_1101-2021_01_06_425584	404	12	;	;	:
10_1101-2021_01_06_425584	404	13	Forslund	Forslund	NNP
10_1101-2021_01_06_425584	404	14	,	,	,
10_1101-2021_01_06_425584	404	15	K.	K.	NNP
10_1101-2021_01_06_425584	404	16	;	;	:
10_1101-2021_01_06_425584	404	17	Heller	Heller	NNP
10_1101-2021_01_06_425584	404	18	,	,	,
10_1101-2021_01_06_425584	404	19	D.	D.	NNP
10_1101-2021_01_06_425584	404	20	;	;	:
10_1101-2021_01_06_425584	404	21	Huerta	Huerta	NNP
10_1101-2021_01_06_425584	404	22	-	-	HYPH
10_1101-2021_01_06_425584	404	23	Cepas	Cepas	NNP
10_1101-2021_01_06_425584	404	24	,	,	,
10_1101-2021_01_06_425584	404	25	J.	J.	NNP
10_1101-2021_01_06_425584	404	26	;	;	:
10_1101-2021_01_06_425584	404	27	650	650	CD
10_1101-2021_01_06_425584	404	28	Simonovic	Simonovic	NNP
10_1101-2021_01_06_425584	404	29	,	,	,
10_1101-2021_01_06_425584	404	30	M.	M.	NNP
10_1101-2021_01_06_425584	404	31	;	;	:
10_1101-2021_01_06_425584	404	32	Roth	Roth	NNP
10_1101-2021_01_06_425584	404	33	,	,	,
10_1101-2021_01_06_425584	404	34	A.	a.	NN
10_1101-2021_01_06_425584	404	35	;	;	:
10_1101-2021_01_06_425584	404	36	Santos	Santos	NNP
10_1101-2021_01_06_425584	404	37	,	,	,
10_1101-2021_01_06_425584	404	38	A.	a.	NN
10_1101-2021_01_06_425584	404	39	;	;	:
10_1101-2021_01_06_425584	404	40	Tsafou	Tsafou	NNP
10_1101-2021_01_06_425584	404	41	,	,	,
10_1101-2021_01_06_425584	404	42	K.	K.	NNP
10_1101-2021_01_06_425584	404	43	P.	P.	NNP
10_1101-2021_01_06_425584	404	44	;	;	:
10_1101-2021_01_06_425584	404	45	Kuhn	Kuhn	NNP
10_1101-2021_01_06_425584	404	46	,	,	,
10_1101-2021_01_06_425584	404	47	M.	M.	NNP
10_1101-2021_01_06_425584	404	48	;	;	:
10_1101-2021_01_06_425584	404	49	Bork	Bork	NNP
10_1101-2021_01_06_425584	404	50	,	,	,
10_1101-2021_01_06_425584	404	51	P.	P.	NNP
10_1101-2021_01_06_425584	404	52	;	;	:
10_1101-2021_01_06_425584	404	53	Jensen	Jensen	NNP
10_1101-2021_01_06_425584	404	54	,	,	,
10_1101-2021_01_06_425584	404	55	L.	L.	NNP
10_1101-2021_01_06_425584	404	56	J.	J.	NNP
10_1101-2021_01_06_425584	404	57	;	;	:
10_1101-2021_01_06_425584	404	58	von	von	NNP
10_1101-2021_01_06_425584	404	59	651	651	CD
10_1101-2021_01_06_425584	404	60	Mering	Mering	NNP
10_1101-2021_01_06_425584	404	61	,	,	,
10_1101-2021_01_06_425584	404	62	C.	C.	NNP
10_1101-2021_01_06_425584	404	63	,	,	,
10_1101-2021_01_06_425584	404	64	STRING	STRING	NNP
10_1101-2021_01_06_425584	404	65	v10	v10	NN
10_1101-2021_01_06_425584	404	66	:	:	:
10_1101-2021_01_06_425584	404	67	protein	protein	NN
10_1101-2021_01_06_425584	404	68	-	-	HYPH
10_1101-2021_01_06_425584	404	69	protein	protein	NN
10_1101-2021_01_06_425584	404	70	interaction	interaction	NN
10_1101-2021_01_06_425584	404	71	networks	network	NNS
10_1101-2021_01_06_425584	404	72	,	,	,
10_1101-2021_01_06_425584	404	73	integrated	integrate	VBN
10_1101-2021_01_06_425584	404	74	over	over	IN
10_1101-2021_01_06_425584	404	75	the	the	DT
10_1101-2021_01_06_425584	404	76	tree	tree	NN
10_1101-2021_01_06_425584	404	77	of	of	IN
10_1101-2021_01_06_425584	404	78	life	life	NN
10_1101-2021_01_06_425584	404	79	.	.	.
10_1101-2021_01_06_425584	405	1	652	652	CD
10_1101-2021_01_06_425584	405	2	Nucleic	Nucleic	NNP
10_1101-2021_01_06_425584	405	3	Acids	Acids	NNPS
10_1101-2021_01_06_425584	405	4	Res	Res	NNP
10_1101-2021_01_06_425584	405	5	2015	2015	CD
10_1101-2021_01_06_425584	405	6	,	,	,
10_1101-2021_01_06_425584	405	7	43	43	CD
10_1101-2021_01_06_425584	405	8	,	,	,
10_1101-2021_01_06_425584	405	9	(	(	-LRB-
10_1101-2021_01_06_425584	405	10	Database	Database	NNP
10_1101-2021_01_06_425584	405	11	issue	issue	NN
10_1101-2021_01_06_425584	405	12	)	)	-RRB-
10_1101-2021_01_06_425584	405	13	,	,	,
10_1101-2021_01_06_425584	405	14	D447	D447	NNP
10_1101-2021_01_06_425584	405	15	-	-	HYPH
10_1101-2021_01_06_425584	405	16	52	52	CD
10_1101-2021_01_06_425584	405	17	.	.	.
10_1101-2021_01_06_425584	406	1	653	653	CD
10_1101-2021_01_06_425584	406	2	36	36	CD
10_1101-2021_01_06_425584	406	3	.	.	.
10_1101-2021_01_06_425584	407	1	Muntel	Muntel	NNP
10_1101-2021_01_06_425584	407	2	,	,	,
10_1101-2021_01_06_425584	407	3	J.	J.	NNP
10_1101-2021_01_06_425584	407	4	;	;	:
10_1101-2021_01_06_425584	407	5	Kirkpatrick	Kirkpatrick	NNP
10_1101-2021_01_06_425584	407	6	,	,	,
10_1101-2021_01_06_425584	407	7	J.	J.	NNP
10_1101-2021_01_06_425584	407	8	;	;	:
10_1101-2021_01_06_425584	407	9	Bruderer	Bruderer	NNP
10_1101-2021_01_06_425584	407	10	,	,	,
10_1101-2021_01_06_425584	407	11	R.	R.	NNP
10_1101-2021_01_06_425584	407	12	;	;	:
10_1101-2021_01_06_425584	407	13	Huang	Huang	NNP
10_1101-2021_01_06_425584	407	14	,	,	,
10_1101-2021_01_06_425584	407	15	T.	T.	NNP
10_1101-2021_01_06_425584	407	16	;	;	:
10_1101-2021_01_06_425584	407	17	Vitek	Vitek	NNP
10_1101-2021_01_06_425584	407	18	,	,	,
10_1101-2021_01_06_425584	407	19	O.	O.	NNP
10_1101-2021_01_06_425584	407	20	;	;	:
10_1101-2021_01_06_425584	407	21	Ori	Ori	NNP
10_1101-2021_01_06_425584	407	22	,	,	,
10_1101-2021_01_06_425584	407	23	A.	A.	NNP
10_1101-2021_01_06_425584	407	24	;	;	:
10_1101-2021_01_06_425584	407	25	Reiter	Reiter	NNP
10_1101-2021_01_06_425584	407	26	,	,	,
10_1101-2021_01_06_425584	407	27	L.	L.	NNP
10_1101-2021_01_06_425584	407	28	,	,	,
10_1101-2021_01_06_425584	407	29	654	654	CD
10_1101-2021_01_06_425584	407	30	Comparison	Comparison	NNP
10_1101-2021_01_06_425584	407	31	of	of	IN
10_1101-2021_01_06_425584	407	32	Protein	Protein	NNP
10_1101-2021_01_06_425584	407	33	Quantification	Quantification	NNP
10_1101-2021_01_06_425584	407	34	in	in	IN
10_1101-2021_01_06_425584	407	35	a	a	DT
10_1101-2021_01_06_425584	407	36	Complex	Complex	NNP
10_1101-2021_01_06_425584	407	37	Background	Background	NNP
10_1101-2021_01_06_425584	407	38	by	by	IN
10_1101-2021_01_06_425584	407	39	DIA	DIA	NNP
10_1101-2021_01_06_425584	407	40	and	and	CC
10_1101-2021_01_06_425584	407	41	TMT	TMT	NNP
10_1101-2021_01_06_425584	407	42	Workflows	Workflows	NNPS
10_1101-2021_01_06_425584	407	43	655	655	CD
10_1101-2021_01_06_425584	407	44	with	with	IN
10_1101-2021_01_06_425584	407	45	Fixed	fix	VBN
10_1101-2021_01_06_425584	407	46	Instrument	Instrument	NNP
10_1101-2021_01_06_425584	407	47	Time	Time	NNP
10_1101-2021_01_06_425584	407	48	.	.	.
10_1101-2021_01_06_425584	408	1	J	J	NNP
10_1101-2021_01_06_425584	408	2	Proteome	Proteome	NNP
10_1101-2021_01_06_425584	408	3	Res	Res	NNP
10_1101-2021_01_06_425584	408	4	2019	2019	CD
10_1101-2021_01_06_425584	408	5	,	,	,
10_1101-2021_01_06_425584	408	6	18	18	CD
10_1101-2021_01_06_425584	408	7	,	,	,
10_1101-2021_01_06_425584	408	8	(	(	-LRB-
10_1101-2021_01_06_425584	408	9	3	3	CD
10_1101-2021_01_06_425584	408	10	)	)	-RRB-
10_1101-2021_01_06_425584	408	11	,	,	,
10_1101-2021_01_06_425584	408	12	1340	1340	CD
10_1101-2021_01_06_425584	408	13	-	-	SYM
10_1101-2021_01_06_425584	408	14	1351	1351	CD
10_1101-2021_01_06_425584	408	15	.	.	.
10_1101-2021_01_06_425584	409	1	656	656	CD
10_1101-2021_01_06_425584	409	2	37	37	CD
10_1101-2021_01_06_425584	409	3	.	.	.
10_1101-2021_01_06_425584	410	1	Pascovici	Pascovici	NNP
10_1101-2021_01_06_425584	410	2	,	,	,
10_1101-2021_01_06_425584	410	3	D.	D.	NNP
10_1101-2021_01_06_425584	410	4	;	;	:
10_1101-2021_01_06_425584	410	5	Handler	Handler	NNP
10_1101-2021_01_06_425584	410	6	,	,	,
10_1101-2021_01_06_425584	410	7	D.	D.	NNP
10_1101-2021_01_06_425584	410	8	C.	C.	NNP
10_1101-2021_01_06_425584	410	9	;	;	:
10_1101-2021_01_06_425584	410	10	Wu	Wu	NNP
10_1101-2021_01_06_425584	410	11	,	,	,
10_1101-2021_01_06_425584	410	12	J.	J.	NNP
10_1101-2021_01_06_425584	410	13	X.	X.	NNP
10_1101-2021_01_06_425584	410	14	;	;	:
10_1101-2021_01_06_425584	410	15	Haynes	Haynes	NNP
10_1101-2021_01_06_425584	410	16	,	,	,
10_1101-2021_01_06_425584	410	17	P.	P.	NNP
10_1101-2021_01_06_425584	410	18	A.	A.	NNP
10_1101-2021_01_06_425584	410	19	,	,	,
10_1101-2021_01_06_425584	410	20	Multiple	multiple	JJ
10_1101-2021_01_06_425584	410	21	testing	testing	NN
10_1101-2021_01_06_425584	410	22	corrections	correction	NNS
10_1101-2021_01_06_425584	410	23	in	in	IN
10_1101-2021_01_06_425584	410	24	657	657	CD
10_1101-2021_01_06_425584	410	25	quantitative	quantitative	JJ
10_1101-2021_01_06_425584	410	26	proteomics	proteomic	NNS
10_1101-2021_01_06_425584	410	27	:	:	:
10_1101-2021_01_06_425584	410	28	A	a	DT
10_1101-2021_01_06_425584	410	29	useful	useful	JJ
10_1101-2021_01_06_425584	410	30	but	but	CC
10_1101-2021_01_06_425584	410	31	blunt	blunt	JJ
10_1101-2021_01_06_425584	410	32	tool	tool	NN
10_1101-2021_01_06_425584	410	33	.	.	.
10_1101-2021_01_06_425584	411	1	Proteomics	proteomic	NNS
10_1101-2021_01_06_425584	411	2	2016	2016	CD
10_1101-2021_01_06_425584	411	3	,	,	,
10_1101-2021_01_06_425584	411	4	16	16	CD
10_1101-2021_01_06_425584	411	5	,	,	,
10_1101-2021_01_06_425584	411	6	(	(	-LRB-
10_1101-2021_01_06_425584	411	7	18	18	CD
10_1101-2021_01_06_425584	411	8	)	)	-RRB-
10_1101-2021_01_06_425584	411	9	,	,	,
10_1101-2021_01_06_425584	411	10	2448	2448	CD
10_1101-2021_01_06_425584	411	11	-	-	SYM
10_1101-2021_01_06_425584	411	12	53	53	CD
10_1101-2021_01_06_425584	411	13	.	.	.
10_1101-2021_01_06_425584	412	1	658	658	CD
10_1101-2021_01_06_425584	412	2	38	38	CD
10_1101-2021_01_06_425584	412	3	.	.	.
10_1101-2021_01_06_425584	413	1	Wang	Wang	NNP
10_1101-2021_01_06_425584	413	2	,	,	,
10_1101-2021_01_06_425584	413	3	M.	M.	NNP
10_1101-2021_01_06_425584	413	4	;	;	:
10_1101-2021_01_06_425584	413	5	Carver	Carver	NNP
10_1101-2021_01_06_425584	413	6	,	,	,
10_1101-2021_01_06_425584	413	7	J.	J.	NNP
10_1101-2021_01_06_425584	413	8	J.	J.	NNP
10_1101-2021_01_06_425584	413	9	;	;	:
10_1101-2021_01_06_425584	413	10	Phelan	Phelan	NNP
10_1101-2021_01_06_425584	413	11	,	,	,
10_1101-2021_01_06_425584	413	12	V.	V.	NNP
10_1101-2021_01_06_425584	413	13	V.	V.	NNP
10_1101-2021_01_06_425584	413	14	;	;	:
10_1101-2021_01_06_425584	413	15	Sanchez	Sanchez	NNP
10_1101-2021_01_06_425584	413	16	,	,	,
10_1101-2021_01_06_425584	413	17	L.	L.	NNP
10_1101-2021_01_06_425584	413	18	M.	M.	NNP
10_1101-2021_01_06_425584	413	19	;	;	:
10_1101-2021_01_06_425584	413	20	Garg	Garg	NNP
10_1101-2021_01_06_425584	413	21	,	,	,
10_1101-2021_01_06_425584	413	22	N.	N.	NNP
10_1101-2021_01_06_425584	413	23	;	;	:
10_1101-2021_01_06_425584	413	24	Peng	Peng	NNP
10_1101-2021_01_06_425584	413	25	,	,	,
10_1101-2021_01_06_425584	413	26	Y.	Y.	NNP
10_1101-2021_01_06_425584	413	27	;	;	:
10_1101-2021_01_06_425584	413	28	Nguyen	Nguyen	NNP
10_1101-2021_01_06_425584	413	29	,	,	,
10_1101-2021_01_06_425584	413	30	D.	D.	NNP
10_1101-2021_01_06_425584	413	31	659	659	CD
10_1101-2021_01_06_425584	413	32	D.	D.	NNP
10_1101-2021_01_06_425584	413	33	;	;	:
10_1101-2021_01_06_425584	413	34	Watrous	watrous	JJ
10_1101-2021_01_06_425584	413	35	,	,	,
10_1101-2021_01_06_425584	413	36	J.	J.	NNP
10_1101-2021_01_06_425584	413	37	;	;	:
10_1101-2021_01_06_425584	413	38	Kapono	Kapono	NNP
10_1101-2021_01_06_425584	413	39	,	,	,
10_1101-2021_01_06_425584	413	40	C.	C.	NNP
10_1101-2021_01_06_425584	413	41	A.	A.	NNP
10_1101-2021_01_06_425584	413	42	;	;	:
10_1101-2021_01_06_425584	413	43	Luzzatto	Luzzatto	NNP
10_1101-2021_01_06_425584	413	44	-	-	HYPH
10_1101-2021_01_06_425584	413	45	Knaan	Knaan	NNP
10_1101-2021_01_06_425584	413	46	,	,	,
10_1101-2021_01_06_425584	413	47	T.	T.	NNP
10_1101-2021_01_06_425584	413	48	;	;	:
10_1101-2021_01_06_425584	413	49	Porto	Porto	NNP
10_1101-2021_01_06_425584	413	50	,	,	,
10_1101-2021_01_06_425584	413	51	C.	C.	NNP
10_1101-2021_01_06_425584	413	52	;	;	:
10_1101-2021_01_06_425584	413	53	Bouslimani	Bouslimani	NNP
10_1101-2021_01_06_425584	413	54	,	,	,
10_1101-2021_01_06_425584	413	55	A.	a.	NN
10_1101-2021_01_06_425584	413	56	;	;	:
10_1101-2021_01_06_425584	413	57	Melnik	Melnik	NNP
10_1101-2021_01_06_425584	413	58	,	,	,
10_1101-2021_01_06_425584	413	59	A.	a.	NN
10_1101-2021_01_06_425584	413	60	V.	v.	NN
10_1101-2021_01_06_425584	413	61	;	;	:
10_1101-2021_01_06_425584	413	62	660	660	CD
10_1101-2021_01_06_425584	413	63	Meehan	Meehan	NNP
10_1101-2021_01_06_425584	413	64	,	,	,
10_1101-2021_01_06_425584	413	65	M.	M.	NNP
10_1101-2021_01_06_425584	413	66	J.	J.	NNP
10_1101-2021_01_06_425584	413	67	;	;	:
10_1101-2021_01_06_425584	413	68	Liu	Liu	NNP
10_1101-2021_01_06_425584	413	69	,	,	,
10_1101-2021_01_06_425584	413	70	W.	W.	NNP
10_1101-2021_01_06_425584	413	71	T.	T.	NNP
10_1101-2021_01_06_425584	413	72	;	;	:
10_1101-2021_01_06_425584	413	73	Crusemann	Crusemann	NNP
10_1101-2021_01_06_425584	413	74	,	,	,
10_1101-2021_01_06_425584	413	75	M.	M.	NNP
10_1101-2021_01_06_425584	413	76	;	;	:
10_1101-2021_01_06_425584	413	77	Boudreau	Boudreau	NNP
10_1101-2021_01_06_425584	413	78	,	,	,
10_1101-2021_01_06_425584	413	79	P.	P.	NNP
10_1101-2021_01_06_425584	413	80	D.	D.	NNP
10_1101-2021_01_06_425584	413	81	;	;	:
10_1101-2021_01_06_425584	413	82	Esquenazi	Esquenazi	NNP
10_1101-2021_01_06_425584	413	83	,	,	,
10_1101-2021_01_06_425584	413	84	E.	E.	NNP
10_1101-2021_01_06_425584	413	85	;	;	:
10_1101-2021_01_06_425584	413	86	Sandoval	Sandoval	NNP
10_1101-2021_01_06_425584	413	87	-	-	HYPH
10_1101-2021_01_06_425584	413	88	Calderon	Calderon	NNP
10_1101-2021_01_06_425584	413	89	,	,	,
10_1101-2021_01_06_425584	413	90	661	661	CD
10_1101-2021_01_06_425584	413	91	M.	M.	NNP
10_1101-2021_01_06_425584	413	92	;	;	:
10_1101-2021_01_06_425584	413	93	Kersten	Kersten	NNP
10_1101-2021_01_06_425584	413	94	,	,	,
10_1101-2021_01_06_425584	413	95	R.	R.	NNP
10_1101-2021_01_06_425584	413	96	D.	D.	NNP
10_1101-2021_01_06_425584	413	97	;	;	:
10_1101-2021_01_06_425584	413	98	Pace	Pace	NNP
10_1101-2021_01_06_425584	413	99	,	,	,
10_1101-2021_01_06_425584	413	100	L.	L.	NNP
10_1101-2021_01_06_425584	413	101	A.	a.	NN
10_1101-2021_01_06_425584	413	102	;	;	:
10_1101-2021_01_06_425584	413	103	Quinn	Quinn	NNP
10_1101-2021_01_06_425584	413	104	,	,	,
10_1101-2021_01_06_425584	413	105	R.	R.	NNP
10_1101-2021_01_06_425584	413	106	A.	a.	NN
10_1101-2021_01_06_425584	413	107	;	;	:
10_1101-2021_01_06_425584	413	108	Duncan	Duncan	NNP
10_1101-2021_01_06_425584	413	109	,	,	,
10_1101-2021_01_06_425584	413	110	K.	K.	NNP
10_1101-2021_01_06_425584	413	111	R.	R.	NNP
10_1101-2021_01_06_425584	413	112	;	;	:
10_1101-2021_01_06_425584	413	113	Hsu	Hsu	NNP
10_1101-2021_01_06_425584	413	114	,	,	,
10_1101-2021_01_06_425584	413	115	C.	C.	NNP
10_1101-2021_01_06_425584	413	116	C.	C.	NNP
10_1101-2021_01_06_425584	413	117	;	;	:
10_1101-2021_01_06_425584	413	118	Floros	Floros	NNP
10_1101-2021_01_06_425584	413	119	,	,	,
10_1101-2021_01_06_425584	413	120	D.	D.	NNP
10_1101-2021_01_06_425584	413	121	J.	J.	NNP
10_1101-2021_01_06_425584	413	122	;	;	:
10_1101-2021_01_06_425584	413	123	Gavilan	Gavilan	NNP
10_1101-2021_01_06_425584	413	124	,	,	,
10_1101-2021_01_06_425584	413	125	662	662	CD
10_1101-2021_01_06_425584	413	126	R.	R.	NNP
10_1101-2021_01_06_425584	413	127	G.	G.	NNP
10_1101-2021_01_06_425584	413	128	;	;	:
10_1101-2021_01_06_425584	413	129	Kleigrewe	Kleigrewe	NNP
10_1101-2021_01_06_425584	413	130	,	,	,
10_1101-2021_01_06_425584	413	131	K.	K.	NNP
10_1101-2021_01_06_425584	413	132	;	;	:
10_1101-2021_01_06_425584	413	133	Northen	Northen	NNP
10_1101-2021_01_06_425584	413	134	,	,	,
10_1101-2021_01_06_425584	413	135	T.	T.	NNP
10_1101-2021_01_06_425584	413	136	;	;	:
10_1101-2021_01_06_425584	413	137	Dutton	Dutton	NNP
10_1101-2021_01_06_425584	413	138	,	,	,
10_1101-2021_01_06_425584	413	139	R.	R.	NNP
10_1101-2021_01_06_425584	413	140	J.	J.	NNP
10_1101-2021_01_06_425584	413	141	;	;	:
10_1101-2021_01_06_425584	413	142	Parrot	Parrot	NNP
10_1101-2021_01_06_425584	413	143	,	,	,
10_1101-2021_01_06_425584	413	144	D.	D.	NNP
10_1101-2021_01_06_425584	413	145	;	;	:
10_1101-2021_01_06_425584	413	146	Carlson	Carlson	NNP
10_1101-2021_01_06_425584	413	147	,	,	,
10_1101-2021_01_06_425584	413	148	E.	E.	NNP
10_1101-2021_01_06_425584	413	149	E.	E.	NNP
10_1101-2021_01_06_425584	413	150	;	;	:
10_1101-2021_01_06_425584	413	151	Aigle	Aigle	NNP
10_1101-2021_01_06_425584	413	152	,	,	,
10_1101-2021_01_06_425584	413	153	B.	B.	NNP
10_1101-2021_01_06_425584	413	154	;	;	:
10_1101-2021_01_06_425584	413	155	Michelsen	Michelsen	NNP
10_1101-2021_01_06_425584	413	156	,	,	,
10_1101-2021_01_06_425584	413	157	663	663	CD
10_1101-2021_01_06_425584	413	158	C.	C.	NNP
10_1101-2021_01_06_425584	413	159	F.	F.	NNP
10_1101-2021_01_06_425584	413	160	;	;	:
10_1101-2021_01_06_425584	413	161	Jelsbak	Jelsbak	NNP
10_1101-2021_01_06_425584	413	162	,	,	,
10_1101-2021_01_06_425584	413	163	L.	L.	NNP
10_1101-2021_01_06_425584	413	164	;	;	:
10_1101-2021_01_06_425584	413	165	Sohlenkamp	Sohlenkamp	NNP
10_1101-2021_01_06_425584	413	166	,	,	,
10_1101-2021_01_06_425584	413	167	C.	C.	NNP
10_1101-2021_01_06_425584	413	168	;	;	:
10_1101-2021_01_06_425584	413	169	Pevzner	Pevzner	NNP
10_1101-2021_01_06_425584	413	170	,	,	,
10_1101-2021_01_06_425584	413	171	P.	P.	NNP
10_1101-2021_01_06_425584	413	172	;	;	:
10_1101-2021_01_06_425584	413	173	Edlund	Edlund	NNP
10_1101-2021_01_06_425584	413	174	,	,	,
10_1101-2021_01_06_425584	413	175	A.	a.	NN
10_1101-2021_01_06_425584	413	176	;	;	:
10_1101-2021_01_06_425584	413	177	McLean	McLean	NNP
10_1101-2021_01_06_425584	413	178	,	,	,
10_1101-2021_01_06_425584	413	179	J.	J.	NNP
10_1101-2021_01_06_425584	413	180	;	;	:
10_1101-2021_01_06_425584	413	181	Piel	Piel	NNP
10_1101-2021_01_06_425584	413	182	,	,	,
10_1101-2021_01_06_425584	413	183	J.	J.	NNP
10_1101-2021_01_06_425584	413	184	;	;	:
10_1101-2021_01_06_425584	413	185	Murphy	Murphy	NNP
10_1101-2021_01_06_425584	413	186	,	,	,
10_1101-2021_01_06_425584	413	187	B.	B.	NNP
10_1101-2021_01_06_425584	413	188	T.	T.	NNP
10_1101-2021_01_06_425584	413	189	;	;	:
10_1101-2021_01_06_425584	413	190	664	664	CD
10_1101-2021_01_06_425584	413	191	Gerwick	Gerwick	NNP
10_1101-2021_01_06_425584	413	192	,	,	,
10_1101-2021_01_06_425584	413	193	L.	L.	NNP
10_1101-2021_01_06_425584	413	194	;	;	:
10_1101-2021_01_06_425584	413	195	Liaw	Liaw	NNP
10_1101-2021_01_06_425584	413	196	,	,	,
10_1101-2021_01_06_425584	413	197	C.	C.	NNP
10_1101-2021_01_06_425584	413	198	C.	C.	NNP
10_1101-2021_01_06_425584	413	199	;	;	:
10_1101-2021_01_06_425584	413	200	Yang	Yang	NNP
10_1101-2021_01_06_425584	413	201	,	,	,
10_1101-2021_01_06_425584	413	202	Y.	Y.	NNP
10_1101-2021_01_06_425584	413	203	L.	L.	NNP
10_1101-2021_01_06_425584	413	204	;	;	:
10_1101-2021_01_06_425584	413	205	Humpf	Humpf	NNP
10_1101-2021_01_06_425584	413	206	,	,	,
10_1101-2021_01_06_425584	413	207	H.	H.	NNP
10_1101-2021_01_06_425584	413	208	U.	U.	NNP
10_1101-2021_01_06_425584	413	209	;	;	:
10_1101-2021_01_06_425584	413	210	Maansson	Maansson	NNP
10_1101-2021_01_06_425584	413	211	,	,	,
10_1101-2021_01_06_425584	413	212	M.	M.	NNP
10_1101-2021_01_06_425584	413	213	;	;	:
10_1101-2021_01_06_425584	413	214	Keyzers	Keyzers	NNP
10_1101-2021_01_06_425584	413	215	,	,	,
10_1101-2021_01_06_425584	413	216	R.	R.	NNP
10_1101-2021_01_06_425584	413	217	A.	a.	NN
10_1101-2021_01_06_425584	413	218	;	;	:
10_1101-2021_01_06_425584	413	219	Sims	Sims	NNP
10_1101-2021_01_06_425584	413	220	,	,	,
10_1101-2021_01_06_425584	413	221	A.	a.	NN
10_1101-2021_01_06_425584	413	222	C.	C.	NNP
10_1101-2021_01_06_425584	413	223	;	;	:
10_1101-2021_01_06_425584	413	224	665	665	CD
10_1101-2021_01_06_425584	413	225	Johnson	Johnson	NNP
10_1101-2021_01_06_425584	413	226	,	,	,
10_1101-2021_01_06_425584	413	227	A.	A.	NNP
10_1101-2021_01_06_425584	413	228	R.	R.	NNP
10_1101-2021_01_06_425584	413	229	;	;	:
10_1101-2021_01_06_425584	413	230	Sidebottom	Sidebottom	NNP
10_1101-2021_01_06_425584	413	231	,	,	,
10_1101-2021_01_06_425584	413	232	A.	a.	NN
10_1101-2021_01_06_425584	413	233	M.	M.	NNP
10_1101-2021_01_06_425584	413	234	;	;	:
10_1101-2021_01_06_425584	413	235	Sedio	Sedio	NNP
10_1101-2021_01_06_425584	413	236	,	,	,
10_1101-2021_01_06_425584	413	237	B.	B.	NNP
10_1101-2021_01_06_425584	413	238	E.	E.	NNP
10_1101-2021_01_06_425584	413	239	;	;	:
10_1101-2021_01_06_425584	413	240	Klitgaard	Klitgaard	NNP
10_1101-2021_01_06_425584	413	241	,	,	,
10_1101-2021_01_06_425584	413	242	A.	A.	NNP
10_1101-2021_01_06_425584	413	243	;	;	:
10_1101-2021_01_06_425584	413	244	Larson	Larson	NNP
10_1101-2021_01_06_425584	413	245	,	,	,
10_1101-2021_01_06_425584	413	246	C.	C.	NNP
10_1101-2021_01_06_425584	413	247	B.	B.	NNP
10_1101-2021_01_06_425584	413	248	;	;	:
10_1101-2021_01_06_425584	413	249	P	P	NNP
10_1101-2021_01_06_425584	413	250	,	,	,
10_1101-2021_01_06_425584	413	251	C.	C.	NNP
10_1101-2021_01_06_425584	413	252	A.	A.	NNP
10_1101-2021_01_06_425584	414	1	B.	B.	NNP
10_1101-2021_01_06_425584	414	2	;	;	:
10_1101-2021_01_06_425584	414	3	Torres-666	Torres-666	NNP
10_1101-2021_01_06_425584	414	4	Mendoza	Mendoza	NNP
10_1101-2021_01_06_425584	414	5	,	,	,
10_1101-2021_01_06_425584	414	6	D.	D.	NNP
10_1101-2021_01_06_425584	414	7	;	;	:
10_1101-2021_01_06_425584	414	8	Gonzalez	Gonzalez	NNP
10_1101-2021_01_06_425584	414	9	,	,	,
10_1101-2021_01_06_425584	414	10	D.	D.	NNP
10_1101-2021_01_06_425584	414	11	J.	J.	NNP
10_1101-2021_01_06_425584	414	12	;	;	:
10_1101-2021_01_06_425584	414	13	Silva	Silva	NNP
10_1101-2021_01_06_425584	414	14	,	,	,
10_1101-2021_01_06_425584	414	15	D.	D.	NNP
10_1101-2021_01_06_425584	414	16	B.	B.	NNP
10_1101-2021_01_06_425584	414	17	;	;	:
10_1101-2021_01_06_425584	414	18	Marques	Marques	NNP
10_1101-2021_01_06_425584	414	19	,	,	,
10_1101-2021_01_06_425584	414	20	L.	L.	NNP
10_1101-2021_01_06_425584	414	21	M.	M.	NNP
10_1101-2021_01_06_425584	414	22	;	;	:
10_1101-2021_01_06_425584	414	23	Demarque	Demarque	NNP
10_1101-2021_01_06_425584	414	24	,	,	,
10_1101-2021_01_06_425584	414	25	D.	D.	NNP
10_1101-2021_01_06_425584	414	26	P.	P.	NNP
10_1101-2021_01_06_425584	414	27	;	;	:
10_1101-2021_01_06_425584	414	28	Pociute	Pociute	NNP
10_1101-2021_01_06_425584	414	29	,	,	,
10_1101-2021_01_06_425584	414	30	E.	E.	NNP
10_1101-2021_01_06_425584	414	31	;	;	:
10_1101-2021_01_06_425584	414	32	667	667	CD
10_1101-2021_01_06_425584	414	33	O'Neill	O'Neill	NNP
10_1101-2021_01_06_425584	414	34	,	,	,
10_1101-2021_01_06_425584	414	35	E.	E.	NNP
10_1101-2021_01_06_425584	414	36	C.	C.	NNP
10_1101-2021_01_06_425584	414	37	;	;	:
10_1101-2021_01_06_425584	414	38	Briand	Briand	NNP
10_1101-2021_01_06_425584	414	39	,	,	,
10_1101-2021_01_06_425584	414	40	E.	E.	NNP
10_1101-2021_01_06_425584	414	41	;	;	:
10_1101-2021_01_06_425584	414	42	Helfrich	Helfrich	NNP
10_1101-2021_01_06_425584	414	43	,	,	,
10_1101-2021_01_06_425584	414	44	E.	E.	NNP
10_1101-2021_01_06_425584	414	45	J.	J.	NNP
10_1101-2021_01_06_425584	414	46	N.	N.	NNP
10_1101-2021_01_06_425584	414	47	;	;	:
10_1101-2021_01_06_425584	414	48	Granatosky	Granatosky	NNP
10_1101-2021_01_06_425584	414	49	,	,	,
10_1101-2021_01_06_425584	414	50	E.	E.	NNP
10_1101-2021_01_06_425584	414	51	A.	A.	NNP
10_1101-2021_01_06_425584	414	52	;	;	:
10_1101-2021_01_06_425584	414	53	Glukhov	Glukhov	NNP
10_1101-2021_01_06_425584	414	54	,	,	,
10_1101-2021_01_06_425584	414	55	E.	E.	NNP
10_1101-2021_01_06_425584	414	56	;	;	:
10_1101-2021_01_06_425584	414	57	Ryffel	Ryffel	NNP
10_1101-2021_01_06_425584	414	58	,	,	,
10_1101-2021_01_06_425584	414	59	F.	F.	NNP
10_1101-2021_01_06_425584	414	60	;	;	:
10_1101-2021_01_06_425584	414	61	Houson	Houson	NNP
10_1101-2021_01_06_425584	414	62	,	,	,
10_1101-2021_01_06_425584	414	63	668	668	CD
10_1101-2021_01_06_425584	414	64	H.	h.	NN
10_1101-2021_01_06_425584	414	65	;	;	:
10_1101-2021_01_06_425584	414	66	Mohimani	Mohimani	NNP
10_1101-2021_01_06_425584	414	67	,	,	,
10_1101-2021_01_06_425584	414	68	H.	H.	NNP
10_1101-2021_01_06_425584	414	69	;	;	:
10_1101-2021_01_06_425584	414	70	Kharbush	Kharbush	NNP
10_1101-2021_01_06_425584	414	71	,	,	,
10_1101-2021_01_06_425584	414	72	J.	J.	NNP
10_1101-2021_01_06_425584	414	73	J.	J.	NNP
10_1101-2021_01_06_425584	414	74	;	;	:
10_1101-2021_01_06_425584	414	75	Zeng	Zeng	NNP
10_1101-2021_01_06_425584	414	76	,	,	,
10_1101-2021_01_06_425584	414	77	Y.	Y.	NNP
10_1101-2021_01_06_425584	414	78	;	;	:
10_1101-2021_01_06_425584	414	79	Vorholt	Vorholt	NNP
10_1101-2021_01_06_425584	414	80	,	,	,
10_1101-2021_01_06_425584	414	81	J.	J.	NNP
10_1101-2021_01_06_425584	415	1	A.	a.	LS
10_1101-2021_01_06_425584	415	2	;	;	:
10_1101-2021_01_06_425584	415	3	Kurita	Kurita	NNP
10_1101-2021_01_06_425584	415	4	,	,	,
10_1101-2021_01_06_425584	415	5	K.	K.	NNP
10_1101-2021_01_06_425584	415	6	L.	L.	NNP
10_1101-2021_01_06_425584	415	7	;	;	:
10_1101-2021_01_06_425584	415	8	Charusanti	Charusanti	NNP
10_1101-2021_01_06_425584	415	9	,	,	,
10_1101-2021_01_06_425584	415	10	P.	P.	NNP
10_1101-2021_01_06_425584	415	11	;	;	:
10_1101-2021_01_06_425584	415	12	McPhail	McPhail	NNP
10_1101-2021_01_06_425584	415	13	,	,	,
10_1101-2021_01_06_425584	415	14	669	669	CD
10_1101-2021_01_06_425584	415	15	K.	K.	NNP
10_1101-2021_01_06_425584	415	16	L.	L.	NNP
10_1101-2021_01_06_425584	415	17	;	;	:
10_1101-2021_01_06_425584	415	18	Nielsen	Nielsen	NNP
10_1101-2021_01_06_425584	415	19	,	,	,
10_1101-2021_01_06_425584	415	20	K.	K.	NNP
10_1101-2021_01_06_425584	415	21	F.	F.	NNP
10_1101-2021_01_06_425584	415	22	;	;	:
10_1101-2021_01_06_425584	415	23	Vuong	Vuong	NNP
10_1101-2021_01_06_425584	415	24	,	,	,
10_1101-2021_01_06_425584	415	25	L.	L.	NNP
10_1101-2021_01_06_425584	415	26	;	;	:
10_1101-2021_01_06_425584	415	27	Elfeki	Elfeki	NNP
10_1101-2021_01_06_425584	415	28	,	,	,
10_1101-2021_01_06_425584	415	29	M.	M.	NNP
10_1101-2021_01_06_425584	415	30	;	;	:
10_1101-2021_01_06_425584	415	31	Traxler	Traxler	NNP
10_1101-2021_01_06_425584	415	32	,	,	,
10_1101-2021_01_06_425584	415	33	M.	M.	NNP
10_1101-2021_01_06_425584	415	34	F.	F.	NNP
10_1101-2021_01_06_425584	415	35	;	;	:
10_1101-2021_01_06_425584	415	36	Engene	engene	UH
10_1101-2021_01_06_425584	415	37	,	,	,
10_1101-2021_01_06_425584	415	38	N.	N.	NNP
10_1101-2021_01_06_425584	415	39	;	;	:
10_1101-2021_01_06_425584	415	40	Koyama	Koyama	NNP
10_1101-2021_01_06_425584	415	41	,	,	,
10_1101-2021_01_06_425584	415	42	N.	N.	NNP
10_1101-2021_01_06_425584	415	43	;	;	:
10_1101-2021_01_06_425584	415	44	Vining	Vining	NNP
10_1101-2021_01_06_425584	415	45	,	,	,
10_1101-2021_01_06_425584	415	46	O.	O.	NNP
10_1101-2021_01_06_425584	416	1	B.	B.	NNP
10_1101-2021_01_06_425584	416	2	;	;	:
10_1101-2021_01_06_425584	416	3	670	670	CD
10_1101-2021_01_06_425584	416	4	Baric	Baric	NNP
10_1101-2021_01_06_425584	416	5	,	,	,
10_1101-2021_01_06_425584	416	6	R.	R.	NNP
10_1101-2021_01_06_425584	416	7	;	;	:
10_1101-2021_01_06_425584	416	8	Silva	Silva	NNP
10_1101-2021_01_06_425584	416	9	,	,	,
10_1101-2021_01_06_425584	416	10	R.	R.	NNP
10_1101-2021_01_06_425584	416	11	R.	R.	NNP
10_1101-2021_01_06_425584	416	12	;	;	:
10_1101-2021_01_06_425584	416	13	Mascuch	Mascuch	NNP
10_1101-2021_01_06_425584	416	14	,	,	,
10_1101-2021_01_06_425584	416	15	S.	S.	NNP
10_1101-2021_01_06_425584	416	16	J.	J.	NNP
10_1101-2021_01_06_425584	416	17	;	;	:
10_1101-2021_01_06_425584	416	18	Tomasi	Tomasi	NNP
10_1101-2021_01_06_425584	416	19	,	,	,
10_1101-2021_01_06_425584	416	20	S.	S.	NNP
10_1101-2021_01_06_425584	416	21	;	;	:
10_1101-2021_01_06_425584	416	22	Jenkins	Jenkins	NNP
10_1101-2021_01_06_425584	416	23	,	,	,
10_1101-2021_01_06_425584	416	24	S.	S.	NNP
10_1101-2021_01_06_425584	416	25	;	;	:
10_1101-2021_01_06_425584	416	26	Macherla	Macherla	NNP
10_1101-2021_01_06_425584	416	27	,	,	,
10_1101-2021_01_06_425584	416	28	V.	V.	NNP
10_1101-2021_01_06_425584	416	29	;	;	:
10_1101-2021_01_06_425584	416	30	Hoffman	Hoffman	NNP
10_1101-2021_01_06_425584	416	31	,	,	,
10_1101-2021_01_06_425584	416	32	T.	t.	NN
10_1101-2021_01_06_425584	416	33	;	;	:
10_1101-2021_01_06_425584	416	34	671	671	CD
10_1101-2021_01_06_425584	416	35	Agarwal	Agarwal	NNP
10_1101-2021_01_06_425584	416	36	,	,	,
10_1101-2021_01_06_425584	416	37	V.	V.	NNP
10_1101-2021_01_06_425584	416	38	;	;	:
10_1101-2021_01_06_425584	416	39	Williams	Williams	NNP
10_1101-2021_01_06_425584	416	40	,	,	,
10_1101-2021_01_06_425584	416	41	P.	P.	NNP
10_1101-2021_01_06_425584	416	42	G.	G.	NNP
10_1101-2021_01_06_425584	416	43	;	;	:
10_1101-2021_01_06_425584	416	44	Dai	Dai	NNP
10_1101-2021_01_06_425584	416	45	,	,	,
10_1101-2021_01_06_425584	416	46	J.	J.	NNP
10_1101-2021_01_06_425584	416	47	;	;	:
10_1101-2021_01_06_425584	416	48	Neupane	Neupane	NNP
10_1101-2021_01_06_425584	416	49	,	,	,
10_1101-2021_01_06_425584	416	50	R.	R.	NNP
10_1101-2021_01_06_425584	416	51	;	;	:
10_1101-2021_01_06_425584	416	52	Gurr	Gurr	NNP
10_1101-2021_01_06_425584	416	53	,	,	,
10_1101-2021_01_06_425584	416	54	J.	J.	NNP
10_1101-2021_01_06_425584	416	55	;	;	:
10_1101-2021_01_06_425584	416	56	Rodriguez	Rodriguez	NNP
10_1101-2021_01_06_425584	416	57	,	,	,
10_1101-2021_01_06_425584	416	58	A.	a.	NN
10_1101-2021_01_06_425584	416	59	M.	M.	NNP
10_1101-2021_01_06_425584	416	60	C.	C.	NNP
10_1101-2021_01_06_425584	416	61	;	;	:
10_1101-2021_01_06_425584	416	62	Lamsa	Lamsa	NNP
10_1101-2021_01_06_425584	416	63	,	,	,
10_1101-2021_01_06_425584	416	64	A.	a.	NN
10_1101-2021_01_06_425584	416	65	;	;	:
10_1101-2021_01_06_425584	416	66	672	672	CD
10_1101-2021_01_06_425584	416	67	Zhang	Zhang	NNP
10_1101-2021_01_06_425584	416	68	,	,	,
10_1101-2021_01_06_425584	416	69	C.	C.	NNP
10_1101-2021_01_06_425584	416	70	;	;	:
10_1101-2021_01_06_425584	416	71	Dorrestein	Dorrestein	NNP
10_1101-2021_01_06_425584	416	72	,	,	,
10_1101-2021_01_06_425584	416	73	K.	K.	NNP
10_1101-2021_01_06_425584	416	74	;	;	:
10_1101-2021_01_06_425584	416	75	Duggan	Duggan	NNP
10_1101-2021_01_06_425584	416	76	,	,	,
10_1101-2021_01_06_425584	416	77	B.	B.	NNP
10_1101-2021_01_06_425584	416	78	M.	M.	NNP
10_1101-2021_01_06_425584	416	79	;	;	:
10_1101-2021_01_06_425584	416	80	Almaliti	Almaliti	NNP
10_1101-2021_01_06_425584	416	81	,	,	,
10_1101-2021_01_06_425584	416	82	J.	J.	NNP
10_1101-2021_01_06_425584	416	83	;	;	:
10_1101-2021_01_06_425584	416	84	Allard	Allard	NNP
10_1101-2021_01_06_425584	416	85	,	,	,
10_1101-2021_01_06_425584	416	86	P.	P.	NNP
10_1101-2021_01_06_425584	416	87	M.	M.	NNP
10_1101-2021_01_06_425584	416	88	;	;	:
10_1101-2021_01_06_425584	416	89	Phapale	Phapale	NNP
10_1101-2021_01_06_425584	416	90	,	,	,
10_1101-2021_01_06_425584	416	91	P.	P.	NNP
10_1101-2021_01_06_425584	416	92	;	;	:
10_1101-2021_01_06_425584	416	93	Nothias	Nothias	NNP
10_1101-2021_01_06_425584	416	94	,	,	,
10_1101-2021_01_06_425584	416	95	L.	L.	NNP
10_1101-2021_01_06_425584	416	96	F.	F.	NNP
10_1101-2021_01_06_425584	416	97	;	;	:
10_1101-2021_01_06_425584	416	98	673	673	NNP
10_1101-2021_01_06_425584	416	99	Alexandrov	Alexandrov	NNP
10_1101-2021_01_06_425584	416	100	,	,	,
10_1101-2021_01_06_425584	416	101	T.	T.	NNP
10_1101-2021_01_06_425584	416	102	;	;	:
10_1101-2021_01_06_425584	416	103	Litaudon	Litaudon	NNP
10_1101-2021_01_06_425584	416	104	,	,	,
10_1101-2021_01_06_425584	416	105	M.	M.	NNP
10_1101-2021_01_06_425584	416	106	;	;	:
10_1101-2021_01_06_425584	416	107	Wolfender	Wolfender	NNP
10_1101-2021_01_06_425584	416	108	,	,	,
10_1101-2021_01_06_425584	416	109	J.	J.	NNP
10_1101-2021_01_06_425584	416	110	L.	L.	NNP
10_1101-2021_01_06_425584	416	111	;	;	:
10_1101-2021_01_06_425584	416	112	Kyle	Kyle	NNP
10_1101-2021_01_06_425584	416	113	,	,	,
10_1101-2021_01_06_425584	416	114	J.	J.	NNP
10_1101-2021_01_06_425584	416	115	E.	E.	NNP
10_1101-2021_01_06_425584	416	116	;	;	:
10_1101-2021_01_06_425584	416	117	Metz	Metz	NNP
10_1101-2021_01_06_425584	416	118	,	,	,
10_1101-2021_01_06_425584	416	119	T.	T.	NNP
10_1101-2021_01_06_425584	416	120	O.	O.	NNP
10_1101-2021_01_06_425584	416	121	;	;	:
10_1101-2021_01_06_425584	416	122	Peryea	Peryea	NNP
10_1101-2021_01_06_425584	416	123	,	,	,
10_1101-2021_01_06_425584	416	124	T.	T.	NNP
10_1101-2021_01_06_425584	416	125	;	;	:
10_1101-2021_01_06_425584	416	126	Nguyen	Nguyen	NNP
10_1101-2021_01_06_425584	416	127	,	,	,
10_1101-2021_01_06_425584	416	128	D.	D.	NNP
10_1101-2021_01_06_425584	416	129	674	674	CD
10_1101-2021_01_06_425584	416	130	T.	T.	NNP
10_1101-2021_01_06_425584	416	131	;	;	:
10_1101-2021_01_06_425584	416	132	VanLeer	VanLeer	NNP
10_1101-2021_01_06_425584	416	133	,	,	,
10_1101-2021_01_06_425584	416	134	D.	D.	NNP
10_1101-2021_01_06_425584	416	135	;	;	:
10_1101-2021_01_06_425584	416	136	Shinn	Shinn	NNP
10_1101-2021_01_06_425584	416	137	,	,	,
10_1101-2021_01_06_425584	416	138	P.	P.	NNP
10_1101-2021_01_06_425584	416	139	;	;	:
10_1101-2021_01_06_425584	416	140	Jadhav	Jadhav	NNP
10_1101-2021_01_06_425584	416	141	,	,	,
10_1101-2021_01_06_425584	416	142	A.	A.	NNP
10_1101-2021_01_06_425584	416	143	;	;	:
10_1101-2021_01_06_425584	416	144	Muller	Muller	NNP
10_1101-2021_01_06_425584	416	145	,	,	,
10_1101-2021_01_06_425584	416	146	R.	R.	NNP
10_1101-2021_01_06_425584	416	147	;	;	:
10_1101-2021_01_06_425584	416	148	Waters	Waters	NNP
10_1101-2021_01_06_425584	416	149	,	,	,
10_1101-2021_01_06_425584	416	150	K.	K.	NNP
10_1101-2021_01_06_425584	416	151	M.	M.	NNP
10_1101-2021_01_06_425584	416	152	;	;	:
10_1101-2021_01_06_425584	416	153	Shi	Shi	NNP
10_1101-2021_01_06_425584	416	154	,	,	,
10_1101-2021_01_06_425584	416	155	W.	W.	NNP
10_1101-2021_01_06_425584	416	156	;	;	:
10_1101-2021_01_06_425584	416	157	Liu	Liu	NNP
10_1101-2021_01_06_425584	416	158	,	,	,
10_1101-2021_01_06_425584	416	159	X.	X.	NNP
10_1101-2021_01_06_425584	416	160	;	;	:
10_1101-2021_01_06_425584	416	161	Zhang	Zhang	NNP
10_1101-2021_01_06_425584	416	162	,	,	,
10_1101-2021_01_06_425584	416	163	L.	L.	NNP
10_1101-2021_01_06_425584	416	164	;	;	:
10_1101-2021_01_06_425584	416	165	675	675	CD
10_1101-2021_01_06_425584	416	166	Knight	Knight	NNP
10_1101-2021_01_06_425584	416	167	,	,	,
10_1101-2021_01_06_425584	416	168	R.	R.	NNP
10_1101-2021_01_06_425584	416	169	;	;	:
10_1101-2021_01_06_425584	416	170	Jensen	Jensen	NNP
10_1101-2021_01_06_425584	416	171	,	,	,
10_1101-2021_01_06_425584	416	172	P.	P.	NNP
10_1101-2021_01_06_425584	416	173	R.	R.	NNP
10_1101-2021_01_06_425584	416	174	;	;	:
10_1101-2021_01_06_425584	416	175	Palsson	Palsson	NNP
10_1101-2021_01_06_425584	416	176	,	,	,
10_1101-2021_01_06_425584	416	177	B.	B.	NNP
10_1101-2021_01_06_425584	416	178	O.	O.	NNP
10_1101-2021_01_06_425584	416	179	;	;	:
10_1101-2021_01_06_425584	416	180	Pogliano	Pogliano	NNP
10_1101-2021_01_06_425584	416	181	,	,	,
10_1101-2021_01_06_425584	416	182	K.	K.	NNP
10_1101-2021_01_06_425584	416	183	;	;	:
10_1101-2021_01_06_425584	416	184	Linington	Linington	NNP
10_1101-2021_01_06_425584	416	185	,	,	,
10_1101-2021_01_06_425584	416	186	R.	R.	NNP
10_1101-2021_01_06_425584	416	187	G.	G.	NNP
10_1101-2021_01_06_425584	416	188	;	;	:
10_1101-2021_01_06_425584	416	189	Gutierrez	Gutierrez	NNP
10_1101-2021_01_06_425584	416	190	,	,	,
10_1101-2021_01_06_425584	416	191	M.	M.	NNP
10_1101-2021_01_06_425584	416	192	;	;	:
10_1101-2021_01_06_425584	416	193	Lopes	Lopes	NNP
10_1101-2021_01_06_425584	416	194	,	,	,
10_1101-2021_01_06_425584	416	195	N.	N.	NNP
10_1101-2021_01_06_425584	416	196	676	676	CD
10_1101-2021_01_06_425584	416	197	P.	P.	NNP
10_1101-2021_01_06_425584	416	198	;	;	:
10_1101-2021_01_06_425584	416	199	Gerwick	Gerwick	NNP
10_1101-2021_01_06_425584	416	200	,	,	,
10_1101-2021_01_06_425584	416	201	W.	W.	NNP
10_1101-2021_01_06_425584	416	202	H.	H.	NNP
10_1101-2021_01_06_425584	416	203	;	;	:
10_1101-2021_01_06_425584	416	204	Moore	Moore	NNP
10_1101-2021_01_06_425584	416	205	,	,	,
10_1101-2021_01_06_425584	416	206	B.	B.	NNP
10_1101-2021_01_06_425584	416	207	S.	S.	NNP
10_1101-2021_01_06_425584	416	208	;	;	:
10_1101-2021_01_06_425584	416	209	Dorrestein	Dorrestein	NNP
10_1101-2021_01_06_425584	416	210	,	,	,
10_1101-2021_01_06_425584	416	211	P.	P.	NNP
10_1101-2021_01_06_425584	416	212	C.	C.	NNP
10_1101-2021_01_06_425584	416	213	;	;	:
10_1101-2021_01_06_425584	416	214	Bandeira	Bandeira	NNP
10_1101-2021_01_06_425584	416	215	,	,	,
10_1101-2021_01_06_425584	416	216	N.	N.	NNP
10_1101-2021_01_06_425584	416	217	,	,	,
10_1101-2021_01_06_425584	416	218	Sharing	sharing	NN
10_1101-2021_01_06_425584	416	219	and	and	CC
10_1101-2021_01_06_425584	416	220	community	community	NN
10_1101-2021_01_06_425584	416	221	677	677	CD
10_1101-2021_01_06_425584	416	222	.CC	.CC	,
10_1101-2021_01_06_425584	416	223	-	-	HYPH
10_1101-2021_01_06_425584	416	224	BY	by	IN
10_1101-2021_01_06_425584	416	225	-	-	HYPH
10_1101-2021_01_06_425584	416	226	NC	NC	NNP
10_1101-2021_01_06_425584	416	227	-	-	HYPH
10_1101-2021_01_06_425584	416	228	ND	ND	NNP
10_1101-2021_01_06_425584	416	229	4.0	4.0	CD
10_1101-2021_01_06_425584	416	230	International	International	NNP
10_1101-2021_01_06_425584	416	231	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	416	232	under	under	IN
10_1101-2021_01_06_425584	416	233	a	a	DT
10_1101-2021_01_06_425584	416	234	(	(	-LRB-
10_1101-2021_01_06_425584	416	235	which	which	WDT
10_1101-2021_01_06_425584	416	236	was	be	VBD
10_1101-2021_01_06_425584	416	237	not	not	RB
10_1101-2021_01_06_425584	416	238	certified	certify	VBN
10_1101-2021_01_06_425584	416	239	by	by	IN
10_1101-2021_01_06_425584	416	240	peer	peer	NN
10_1101-2021_01_06_425584	416	241	review	review	NN
10_1101-2021_01_06_425584	416	242	)	)	-RRB-
10_1101-2021_01_06_425584	416	243	is	be	VBZ
10_1101-2021_01_06_425584	416	244	the	the	DT
10_1101-2021_01_06_425584	416	245	author	author	NN
10_1101-2021_01_06_425584	416	246	/	/	SYM
10_1101-2021_01_06_425584	416	247	funder	funder	NN
10_1101-2021_01_06_425584	416	248	,	,	,
10_1101-2021_01_06_425584	416	249	who	who	WP
10_1101-2021_01_06_425584	416	250	has	have	VBZ
10_1101-2021_01_06_425584	416	251	granted	grant	VBN
10_1101-2021_01_06_425584	416	252	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	416	253	a	a	DT
10_1101-2021_01_06_425584	416	254	license	license	NN
10_1101-2021_01_06_425584	416	255	to	to	TO
10_1101-2021_01_06_425584	416	256	display	display	VB
10_1101-2021_01_06_425584	416	257	the	the	DT
10_1101-2021_01_06_425584	416	258	preprint	preprint	NN
10_1101-2021_01_06_425584	416	259	in	in	IN
10_1101-2021_01_06_425584	416	260	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	416	261	.	.	.
10_1101-2021_01_06_425584	417	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	417	2	is	be	VBZ
10_1101-2021_01_06_425584	417	3	made	make	VBN
10_1101-2021_01_06_425584	417	4	The	the	DT
10_1101-2021_01_06_425584	417	5	copyright	copyright	NN
10_1101-2021_01_06_425584	417	6	holder	holder	NN
10_1101-2021_01_06_425584	417	7	for	for	IN
10_1101-2021_01_06_425584	417	8	this	this	DT
10_1101-2021_01_06_425584	417	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	417	10	version	version	NN
10_1101-2021_01_06_425584	417	11	posted	post	VBD
10_1101-2021_01_06_425584	417	12	January	January	NNP
10_1101-2021_01_06_425584	417	13	8	8	CD
10_1101-2021_01_06_425584	417	14	,	,	,
10_1101-2021_01_06_425584	417	15	2021	2021	CD
10_1101-2021_01_06_425584	417	16	.	.	.
10_1101-2021_01_06_425584	417	17	;	;	:
10_1101-2021_01_06_425584	417	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	417	19	:	:	:
10_1101-2021_01_06_425584	417	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	417	21	preprint	preprint	NN
10_1101-2021_01_06_425584	417	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	417	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	417	24	24	24	CD
10_1101-2021_01_06_425584	417	25	curation	curation	NN
10_1101-2021_01_06_425584	417	26	of	of	IN
10_1101-2021_01_06_425584	417	27	mass	mass	JJ
10_1101-2021_01_06_425584	417	28	spectrometry	spectrometry	NN
10_1101-2021_01_06_425584	417	29	data	datum	NNS
10_1101-2021_01_06_425584	417	30	with	with	IN
10_1101-2021_01_06_425584	417	31	Global	Global	NNP
10_1101-2021_01_06_425584	417	32	Natural	Natural	NNP
10_1101-2021_01_06_425584	417	33	Products	Products	NNPS
10_1101-2021_01_06_425584	417	34	Social	Social	NNP
10_1101-2021_01_06_425584	417	35	Molecular	Molecular	NNP
10_1101-2021_01_06_425584	417	36	Networking	Networking	NNP
10_1101-2021_01_06_425584	417	37	.	.	.
10_1101-2021_01_06_425584	418	1	678	678	CD
10_1101-2021_01_06_425584	418	2	Nat	Nat	NNP
10_1101-2021_01_06_425584	418	3	Biotechnol	Biotechnol	NNP
10_1101-2021_01_06_425584	418	4	2016	2016	CD
10_1101-2021_01_06_425584	418	5	,	,	,
10_1101-2021_01_06_425584	418	6	34	34	CD
10_1101-2021_01_06_425584	418	7	,	,	,
10_1101-2021_01_06_425584	418	8	(	(	-LRB-
10_1101-2021_01_06_425584	418	9	8)	8)	CD
10_1101-2021_01_06_425584	418	10	,	,	,
10_1101-2021_01_06_425584	418	11	828	828	CD
10_1101-2021_01_06_425584	418	12	-	-	SYM
10_1101-2021_01_06_425584	418	13	837	837	CD
10_1101-2021_01_06_425584	418	14	.	.	.
10_1101-2021_01_06_425584	419	1	679	679	CD
10_1101-2021_01_06_425584	419	2	39	39	CD
10_1101-2021_01_06_425584	419	3	.	.	.
10_1101-2021_01_06_425584	420	1	Bender	Bender	NNP
10_1101-2021_01_06_425584	420	2	,	,	,
10_1101-2021_01_06_425584	420	3	D.	D.	NNP
10_1101-2021_01_06_425584	420	4	A.	A.	NNP
10_1101-2021_01_06_425584	420	5	,	,	,
10_1101-2021_01_06_425584	420	6	Biochemistry	Biochemistry	NNP
10_1101-2021_01_06_425584	420	7	of	of	IN
10_1101-2021_01_06_425584	420	8	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	420	9	in	in	IN
10_1101-2021_01_06_425584	420	10	health	health	NNP
10_1101-2021_01_06_425584	420	11	and	and	CC
10_1101-2021_01_06_425584	420	12	disease	disease	NN
10_1101-2021_01_06_425584	420	13	.	.	.
10_1101-2021_01_06_425584	421	1	Mol	Mol	NNP
10_1101-2021_01_06_425584	421	2	Aspects	Aspects	NNP
10_1101-2021_01_06_425584	421	3	Med	Med	NNP
10_1101-2021_01_06_425584	421	4	1983	1983	CD
10_1101-2021_01_06_425584	421	5	,	,	,
10_1101-2021_01_06_425584	421	6	680	680	CD
10_1101-2021_01_06_425584	421	7	6	6	CD
10_1101-2021_01_06_425584	421	8	,	,	,
10_1101-2021_01_06_425584	421	9	(	(	-LRB-
10_1101-2021_01_06_425584	421	10	2	2	CD
10_1101-2021_01_06_425584	421	11	)	)	-RRB-
10_1101-2021_01_06_425584	421	12	,	,	,
10_1101-2021_01_06_425584	421	13	101	101	CD
10_1101-2021_01_06_425584	421	14	-	-	SYM
10_1101-2021_01_06_425584	421	15	97	97	CD
10_1101-2021_01_06_425584	421	16	.	.	.
10_1101-2021_01_06_425584	422	1	681	681	CD
10_1101-2021_01_06_425584	422	2	40	40	CD
10_1101-2021_01_06_425584	422	3	.	.	.
10_1101-2021_01_06_425584	423	1	Poyatos	Poyatos	NNP
10_1101-2021_01_06_425584	423	2	,	,	,
10_1101-2021_01_06_425584	423	3	J.	J.	NNP
10_1101-2021_01_06_425584	423	4	F.	F.	NNP
10_1101-2021_01_06_425584	423	5	;	;	:
10_1101-2021_01_06_425584	423	6	Hurst	Hurst	NNP
10_1101-2021_01_06_425584	423	7	,	,	,
10_1101-2021_01_06_425584	423	8	L.	L.	NNP
10_1101-2021_01_06_425584	423	9	D.	D.	NNP
10_1101-2021_01_06_425584	423	10	,	,	,
10_1101-2021_01_06_425584	423	11	How	how	WRB
10_1101-2021_01_06_425584	423	12	biologically	biologically	RB
10_1101-2021_01_06_425584	423	13	relevant	relevant	JJ
10_1101-2021_01_06_425584	423	14	are	be	VBP
10_1101-2021_01_06_425584	423	15	interaction	interaction	NN
10_1101-2021_01_06_425584	423	16	-	-	HYPH
10_1101-2021_01_06_425584	423	17	based	base	VBN
10_1101-2021_01_06_425584	423	18	modules	module	NNS
10_1101-2021_01_06_425584	423	19	in	in	IN
10_1101-2021_01_06_425584	423	20	682	682	CD
10_1101-2021_01_06_425584	423	21	protein	protein	NN
10_1101-2021_01_06_425584	423	22	networks	network	NNS
10_1101-2021_01_06_425584	423	23	?	?	.
10_1101-2021_01_06_425584	424	1	Genome	Genome	NNP
10_1101-2021_01_06_425584	424	2	Biol	Biol	NNP
10_1101-2021_01_06_425584	424	3	2004	2004	CD
10_1101-2021_01_06_425584	424	4	,	,	,
10_1101-2021_01_06_425584	424	5	5	5	CD
10_1101-2021_01_06_425584	424	6	,	,	,
10_1101-2021_01_06_425584	424	7	(	(	-LRB-
10_1101-2021_01_06_425584	424	8	11	11	CD
10_1101-2021_01_06_425584	424	9	)	)	-RRB-
10_1101-2021_01_06_425584	424	10	,	,	,
10_1101-2021_01_06_425584	424	11	R93	R93	NNP
10_1101-2021_01_06_425584	424	12	.	.	.
10_1101-2021_01_06_425584	425	1	683	683	CD
10_1101-2021_01_06_425584	425	2	41	41	CD
10_1101-2021_01_06_425584	425	3	.	.	.
10_1101-2021_01_06_425584	426	1	Muller	Muller	NNP
10_1101-2021_01_06_425584	426	2	,	,	,
10_1101-2021_01_06_425584	426	3	A.	a.	NN
10_1101-2021_01_06_425584	426	4	M.	M.	NNP
10_1101-2021_01_06_425584	426	5	;	;	:
10_1101-2021_01_06_425584	426	6	Hermanns	Hermanns	NNP
10_1101-2021_01_06_425584	426	7	,	,	,
10_1101-2021_01_06_425584	426	8	M.	M.	NNP
10_1101-2021_01_06_425584	426	9	I.	I.	NNP
10_1101-2021_01_06_425584	426	10	;	;	:
10_1101-2021_01_06_425584	426	11	Skrzynski	Skrzynski	NNP
10_1101-2021_01_06_425584	426	12	,	,	,
10_1101-2021_01_06_425584	426	13	C.	C.	NNP
10_1101-2021_01_06_425584	426	14	;	;	:
10_1101-2021_01_06_425584	426	15	Nesslinger	Nesslinger	NNP
10_1101-2021_01_06_425584	426	16	,	,	,
10_1101-2021_01_06_425584	426	17	M.	M.	NNP
10_1101-2021_01_06_425584	426	18	;	;	:
10_1101-2021_01_06_425584	426	19	Muller	Muller	NNP
10_1101-2021_01_06_425584	426	20	,	,	,
10_1101-2021_01_06_425584	426	21	K.	K.	NNP
10_1101-2021_01_06_425584	426	22	M.	M.	NNP
10_1101-2021_01_06_425584	426	23	;	;	:
10_1101-2021_01_06_425584	426	24	Kirkpatrick	Kirkpatrick	NNP
10_1101-2021_01_06_425584	426	25	,	,	,
10_1101-2021_01_06_425584	426	26	684	684	CD
10_1101-2021_01_06_425584	426	27	C.	C.	NNP
10_1101-2021_01_06_425584	426	28	J.	J.	NNP
10_1101-2021_01_06_425584	426	29	,	,	,
10_1101-2021_01_06_425584	426	30	Expression	Expression	NNP
10_1101-2021_01_06_425584	426	31	of	of	IN
10_1101-2021_01_06_425584	426	32	the	the	DT
10_1101-2021_01_06_425584	426	33	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	426	34	markers	marker	NNS
10_1101-2021_01_06_425584	426	35	PECAM-1	PECAM-1	NNS
10_1101-2021_01_06_425584	426	36	,	,	,
10_1101-2021_01_06_425584	426	37	vWf	vWf	NNS
10_1101-2021_01_06_425584	426	38	,	,	,
10_1101-2021_01_06_425584	426	39	and	and	CC
10_1101-2021_01_06_425584	426	40	CD34	CD34	NNP
10_1101-2021_01_06_425584	426	41	in	in	IN
10_1101-2021_01_06_425584	426	42	vivo	vivo	NNP
10_1101-2021_01_06_425584	426	43	and	and	CC
10_1101-2021_01_06_425584	426	44	in	in	FW
10_1101-2021_01_06_425584	426	45	vitro	vitro	FW
10_1101-2021_01_06_425584	426	46	.	.	.
10_1101-2021_01_06_425584	427	1	Exp	Exp	NNP
10_1101-2021_01_06_425584	427	2	685	685	CD
10_1101-2021_01_06_425584	427	3	Mol	Mol	NNP
10_1101-2021_01_06_425584	427	4	Pathol	Pathol	NNP
10_1101-2021_01_06_425584	427	5	2002	2002	CD
10_1101-2021_01_06_425584	427	6	,	,	,
10_1101-2021_01_06_425584	427	7	72	72	CD
10_1101-2021_01_06_425584	427	8	,	,	,
10_1101-2021_01_06_425584	427	9	(	(	-LRB-
10_1101-2021_01_06_425584	427	10	3	3	CD
10_1101-2021_01_06_425584	427	11	)	)	-RRB-
10_1101-2021_01_06_425584	427	12	,	,	,
10_1101-2021_01_06_425584	427	13	221	221	CD
10_1101-2021_01_06_425584	427	14	-	-	SYM
10_1101-2021_01_06_425584	427	15	9	9	CD
10_1101-2021_01_06_425584	427	16	.	.	.
10_1101-2021_01_06_425584	428	1	686	686	CD
10_1101-2021_01_06_425584	428	2	42	42	CD
10_1101-2021_01_06_425584	428	3	.	.	.
10_1101-2021_01_06_425584	429	1	Aird	Aird	NNP
10_1101-2021_01_06_425584	429	2	,	,	,
10_1101-2021_01_06_425584	429	3	W.	W.	NNP
10_1101-2021_01_06_425584	429	4	C.	C.	NNP
10_1101-2021_01_06_425584	429	5	,	,	,
10_1101-2021_01_06_425584	429	6	Phenotypic	Phenotypic	NNP
10_1101-2021_01_06_425584	429	7	heterogeneity	heterogeneity	NN
10_1101-2021_01_06_425584	429	8	of	of	IN
10_1101-2021_01_06_425584	429	9	the	the	DT
10_1101-2021_01_06_425584	429	10	endothelium	endothelium	NN
10_1101-2021_01_06_425584	429	11	:	:	:
10_1101-2021_01_06_425584	429	12	II	ii	CD
10_1101-2021_01_06_425584	429	13	.	.	.
10_1101-2021_01_06_425584	430	1	Representative	representative	JJ
10_1101-2021_01_06_425584	430	2	vascular	vascular	JJ
10_1101-2021_01_06_425584	430	3	687	687	CD
10_1101-2021_01_06_425584	430	4	beds	bed	NNS
10_1101-2021_01_06_425584	430	5	.	.	.
10_1101-2021_01_06_425584	431	1	Circ	Circ	NNP
10_1101-2021_01_06_425584	431	2	Res	Res	NNP
10_1101-2021_01_06_425584	431	3	2007	2007	CD
10_1101-2021_01_06_425584	431	4	,	,	,
10_1101-2021_01_06_425584	431	5	100	100	CD
10_1101-2021_01_06_425584	431	6	,	,	,
10_1101-2021_01_06_425584	431	7	(	(	-LRB-
10_1101-2021_01_06_425584	431	8	2	2	CD
10_1101-2021_01_06_425584	431	9	)	)	-RRB-
10_1101-2021_01_06_425584	431	10	,	,	,
10_1101-2021_01_06_425584	431	11	174	174	CD
10_1101-2021_01_06_425584	431	12	-	-	SYM
10_1101-2021_01_06_425584	431	13	90	90	CD
10_1101-2021_01_06_425584	431	14	.	.	.
10_1101-2021_01_06_425584	432	1	688	688	CD
10_1101-2021_01_06_425584	432	2	43	43	CD
10_1101-2021_01_06_425584	432	3	.	.	.
10_1101-2021_01_06_425584	433	1	Aird	Aird	NNP
10_1101-2021_01_06_425584	433	2	,	,	,
10_1101-2021_01_06_425584	433	3	W.	W.	NNP
10_1101-2021_01_06_425584	433	4	C.	C.	NNP
10_1101-2021_01_06_425584	433	5	,	,	,
10_1101-2021_01_06_425584	433	6	Endothelial	endothelial	JJ
10_1101-2021_01_06_425584	433	7	cell	cell	NN
10_1101-2021_01_06_425584	433	8	heterogeneity	heterogeneity	NN
10_1101-2021_01_06_425584	433	9	.	.	.
10_1101-2021_01_06_425584	434	1	Cold	Cold	NNP
10_1101-2021_01_06_425584	434	2	Spring	Spring	NNP
10_1101-2021_01_06_425584	434	3	Harb	Harb	NNP
10_1101-2021_01_06_425584	434	4	Perspect	Perspect	NNP
10_1101-2021_01_06_425584	434	5	Med	Med	NNP
10_1101-2021_01_06_425584	434	6	2012	2012	CD
10_1101-2021_01_06_425584	434	7	,	,	,
10_1101-2021_01_06_425584	434	8	2	2	CD
10_1101-2021_01_06_425584	434	9	,	,	,
10_1101-2021_01_06_425584	434	10	(	(	-LRB-
10_1101-2021_01_06_425584	434	11	1	1	CD
10_1101-2021_01_06_425584	434	12	)	)	-RRB-
10_1101-2021_01_06_425584	434	13	,	,	,
10_1101-2021_01_06_425584	434	14	689	689	CD
10_1101-2021_01_06_425584	434	15	a006429	a006429	NN
10_1101-2021_01_06_425584	434	16	.	.	.
10_1101-2021_01_06_425584	435	1	690	690	CD
10_1101-2021_01_06_425584	435	2	44	44	CD
10_1101-2021_01_06_425584	435	3	.	.	.
10_1101-2021_01_06_425584	436	1	Widlansky	Widlansky	NNP
10_1101-2021_01_06_425584	436	2	,	,	,
10_1101-2021_01_06_425584	436	3	M.	M.	NNP
10_1101-2021_01_06_425584	436	4	E.	E.	NNP
10_1101-2021_01_06_425584	436	5	;	;	:
10_1101-2021_01_06_425584	436	6	Gokce	Gokce	NNP
10_1101-2021_01_06_425584	436	7	,	,	,
10_1101-2021_01_06_425584	436	8	N.	N.	NNP
10_1101-2021_01_06_425584	436	9	;	;	:
10_1101-2021_01_06_425584	436	10	Keaney	Keaney	NNP
10_1101-2021_01_06_425584	436	11	,	,	,
10_1101-2021_01_06_425584	436	12	J.	J.	NNP
10_1101-2021_01_06_425584	436	13	F.	F.	NNP
10_1101-2021_01_06_425584	436	14	,	,	,
10_1101-2021_01_06_425584	436	15	Jr.	Jr.	NNP
10_1101-2021_01_06_425584	436	16	;	;	:
10_1101-2021_01_06_425584	436	17	Vita	Vita	NNP
10_1101-2021_01_06_425584	436	18	,	,	,
10_1101-2021_01_06_425584	436	19	J.	J.	NNP
10_1101-2021_01_06_425584	437	1	A.	A.	NNP
10_1101-2021_01_06_425584	437	2	,	,	,
10_1101-2021_01_06_425584	437	3	The	the	DT
10_1101-2021_01_06_425584	437	4	clinical	clinical	JJ
10_1101-2021_01_06_425584	437	5	implications	implication	NNS
10_1101-2021_01_06_425584	437	6	of	of	IN
10_1101-2021_01_06_425584	437	7	691	691	CD
10_1101-2021_01_06_425584	437	8	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	437	9	dysfunction	dysfunction	NN
10_1101-2021_01_06_425584	437	10	.	.	.
10_1101-2021_01_06_425584	438	1	J	J	NNP
10_1101-2021_01_06_425584	438	2	Am	Am	NNP
10_1101-2021_01_06_425584	438	3	Coll	Coll	NNP
10_1101-2021_01_06_425584	438	4	Cardiol	Cardiol	NNP
10_1101-2021_01_06_425584	438	5	2003	2003	CD
10_1101-2021_01_06_425584	438	6	,	,	,
10_1101-2021_01_06_425584	438	7	42	42	CD
10_1101-2021_01_06_425584	438	8	,	,	,
10_1101-2021_01_06_425584	438	9	(	(	-LRB-
10_1101-2021_01_06_425584	438	10	7	7	CD
10_1101-2021_01_06_425584	438	11	)	)	-RRB-
10_1101-2021_01_06_425584	438	12	,	,	,
10_1101-2021_01_06_425584	438	13	1149	1149	CD
10_1101-2021_01_06_425584	438	14	-	-	SYM
10_1101-2021_01_06_425584	438	15	60	60	CD
10_1101-2021_01_06_425584	438	16	.	.	.
10_1101-2021_01_06_425584	439	1	692	692	CD
10_1101-2021_01_06_425584	439	2	45	45	CD
10_1101-2021_01_06_425584	439	3	.	.	.
10_1101-2021_01_06_425584	440	1	Ganz	Ganz	NNP
10_1101-2021_01_06_425584	440	2	,	,	,
10_1101-2021_01_06_425584	440	3	P.	P.	NNP
10_1101-2021_01_06_425584	440	4	;	;	:
10_1101-2021_01_06_425584	440	5	Vita	Vita	NNP
10_1101-2021_01_06_425584	440	6	,	,	,
10_1101-2021_01_06_425584	440	7	J.	J.	NNP
10_1101-2021_01_06_425584	441	1	A.	A.	NNP
10_1101-2021_01_06_425584	441	2	,	,	,
10_1101-2021_01_06_425584	441	3	Testing	test	VBG
10_1101-2021_01_06_425584	441	4	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	441	5	vasomotor	vasomotor	NN
10_1101-2021_01_06_425584	441	6	function	function	NN
10_1101-2021_01_06_425584	441	7	:	:	:
10_1101-2021_01_06_425584	441	8	nitric	nitric	JJ
10_1101-2021_01_06_425584	441	9	oxide	oxide	NN
10_1101-2021_01_06_425584	441	10	,	,	,
10_1101-2021_01_06_425584	441	11	a	a	DT
10_1101-2021_01_06_425584	441	12	multipotent	multipotent	NN
10_1101-2021_01_06_425584	441	13	693	693	CD
10_1101-2021_01_06_425584	441	14	molecule	molecule	NN
10_1101-2021_01_06_425584	441	15	.	.	.
10_1101-2021_01_06_425584	442	1	Circulation	circulation	NN
10_1101-2021_01_06_425584	442	2	2003	2003	CD
10_1101-2021_01_06_425584	442	3	,	,	,
10_1101-2021_01_06_425584	442	4	108	108	CD
10_1101-2021_01_06_425584	442	5	,	,	,
10_1101-2021_01_06_425584	442	6	(	(	-LRB-
10_1101-2021_01_06_425584	442	7	17	17	CD
10_1101-2021_01_06_425584	442	8	)	)	-RRB-
10_1101-2021_01_06_425584	442	9	,	,	,
10_1101-2021_01_06_425584	442	10	2049	2049	CD
10_1101-2021_01_06_425584	442	11	-	-	SYM
10_1101-2021_01_06_425584	442	12	53	53	CD
10_1101-2021_01_06_425584	442	13	.	.	.
10_1101-2021_01_06_425584	443	1	694	694	CD
10_1101-2021_01_06_425584	443	2	46	46	CD
10_1101-2021_01_06_425584	443	3	.	.	.
10_1101-2021_01_06_425584	444	1	Paulus	Paulus	NNP
10_1101-2021_01_06_425584	444	2	,	,	,
10_1101-2021_01_06_425584	444	3	W.	W.	NNP
10_1101-2021_01_06_425584	444	4	J.	J.	NNP
10_1101-2021_01_06_425584	444	5	;	;	:
10_1101-2021_01_06_425584	444	6	Vantrimpont	Vantrimpont	NNP
10_1101-2021_01_06_425584	444	7	,	,	,
10_1101-2021_01_06_425584	444	8	P.	P.	NNP
10_1101-2021_01_06_425584	444	9	J.	J.	NNP
10_1101-2021_01_06_425584	444	10	;	;	:
10_1101-2021_01_06_425584	444	11	Shah	Shah	NNP
10_1101-2021_01_06_425584	444	12	,	,	,
10_1101-2021_01_06_425584	444	13	A.	a.	NN
10_1101-2021_01_06_425584	444	14	M.	M.	NNP
10_1101-2021_01_06_425584	444	15	,	,	,
10_1101-2021_01_06_425584	444	16	Paracrine	Paracrine	NNP
10_1101-2021_01_06_425584	444	17	coronary	coronary	JJ
10_1101-2021_01_06_425584	444	18	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	444	19	control	control	NN
10_1101-2021_01_06_425584	444	20	of	of	IN
10_1101-2021_01_06_425584	444	21	695	695	CD
10_1101-2021_01_06_425584	444	22	left	left	JJ
10_1101-2021_01_06_425584	444	23	ventricular	ventricular	JJ
10_1101-2021_01_06_425584	444	24	function	function	NN
10_1101-2021_01_06_425584	444	25	in	in	IN
10_1101-2021_01_06_425584	444	26	humans	human	NNS
10_1101-2021_01_06_425584	444	27	.	.	.
10_1101-2021_01_06_425584	445	1	Circulation	circulation	NN
10_1101-2021_01_06_425584	445	2	1995	1995	CD
10_1101-2021_01_06_425584	445	3	,	,	,
10_1101-2021_01_06_425584	445	4	92	92	CD
10_1101-2021_01_06_425584	445	5	,	,	,
10_1101-2021_01_06_425584	445	6	(	(	-LRB-
10_1101-2021_01_06_425584	445	7	8)	8)	CD
10_1101-2021_01_06_425584	445	8	,	,	,
10_1101-2021_01_06_425584	445	9	2119	2119	CD
10_1101-2021_01_06_425584	445	10	-	-	SYM
10_1101-2021_01_06_425584	445	11	26	26	CD
10_1101-2021_01_06_425584	445	12	.	.	.
10_1101-2021_01_06_425584	446	1	696	696	CD
10_1101-2021_01_06_425584	446	2	47	47	CD
10_1101-2021_01_06_425584	446	3	.	.	.
10_1101-2021_01_06_425584	447	1	Abe	Abe	NNP
10_1101-2021_01_06_425584	447	2	,	,	,
10_1101-2021_01_06_425584	447	3	M.	M.	NNP
10_1101-2021_01_06_425584	447	4	;	;	:
10_1101-2021_01_06_425584	447	5	Ono	Ono	NNP
10_1101-2021_01_06_425584	447	6	,	,	,
10_1101-2021_01_06_425584	447	7	J.	J.	NNP
10_1101-2021_01_06_425584	447	8	;	;	:
10_1101-2021_01_06_425584	447	9	Sato	Sato	NNP
10_1101-2021_01_06_425584	447	10	,	,	,
10_1101-2021_01_06_425584	447	11	Y.	Y.	NNP
10_1101-2021_01_06_425584	447	12	;	;	:
10_1101-2021_01_06_425584	447	13	Okeda	Okeda	NNP
10_1101-2021_01_06_425584	447	14	,	,	,
10_1101-2021_01_06_425584	447	15	T.	T.	NNP
10_1101-2021_01_06_425584	447	16	;	;	:
10_1101-2021_01_06_425584	447	17	Takaki	Takaki	NNP
10_1101-2021_01_06_425584	447	18	,	,	,
10_1101-2021_01_06_425584	447	19	R.	R.	NNP
10_1101-2021_01_06_425584	447	20	,	,	,
10_1101-2021_01_06_425584	447	21	Effects	Effects	NNPS
10_1101-2021_01_06_425584	447	22	of	of	IN
10_1101-2021_01_06_425584	447	23	glucose	glucose	NN
10_1101-2021_01_06_425584	447	24	and	and	CC
10_1101-2021_01_06_425584	447	25	insulin	insulin	NN
10_1101-2021_01_06_425584	447	26	on	on	IN
10_1101-2021_01_06_425584	447	27	697	697	CD
10_1101-2021_01_06_425584	447	28	cultured	cultured	JJ
10_1101-2021_01_06_425584	447	29	human	human	JJ
10_1101-2021_01_06_425584	447	30	microvascular	microvascular	JJ
10_1101-2021_01_06_425584	447	31	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	447	32	cells	cell	NNS
10_1101-2021_01_06_425584	447	33	.	.	.
10_1101-2021_01_06_425584	448	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	448	2	Res	res	VBP
10_1101-2021_01_06_425584	448	3	Clin	Clin	NNP
10_1101-2021_01_06_425584	448	4	Pract	Pract	NNP
10_1101-2021_01_06_425584	448	5	1990	1990	CD
10_1101-2021_01_06_425584	448	6	,	,	,
10_1101-2021_01_06_425584	448	7	9	9	CD
10_1101-2021_01_06_425584	448	8	,	,	,
10_1101-2021_01_06_425584	448	9	(	(	-LRB-
10_1101-2021_01_06_425584	448	10	3	3	CD
10_1101-2021_01_06_425584	448	11	)	)	-RRB-
10_1101-2021_01_06_425584	448	12	,	,	,
10_1101-2021_01_06_425584	448	13	287	287	CD
10_1101-2021_01_06_425584	448	14	-	-	SYM
10_1101-2021_01_06_425584	448	15	95	95	CD
10_1101-2021_01_06_425584	448	16	.	.	.
10_1101-2021_01_06_425584	449	1	698	698	CD
10_1101-2021_01_06_425584	449	2	48	48	CD
10_1101-2021_01_06_425584	449	3	.	.	.
10_1101-2021_01_06_425584	450	1	Du	Du	NNP
10_1101-2021_01_06_425584	450	2	,	,	,
10_1101-2021_01_06_425584	450	3	X.	X.	NNP
10_1101-2021_01_06_425584	450	4	L.	L.	NNP
10_1101-2021_01_06_425584	450	5	;	;	:
10_1101-2021_01_06_425584	450	6	Sui	Sui	NNP
10_1101-2021_01_06_425584	450	7	,	,	,
10_1101-2021_01_06_425584	450	8	G.	G.	NNP
10_1101-2021_01_06_425584	450	9	Z.	Z.	NNP
10_1101-2021_01_06_425584	450	10	;	;	:
10_1101-2021_01_06_425584	450	11	Stockklauser	Stockklauser	NNP
10_1101-2021_01_06_425584	450	12	-	-	HYPH
10_1101-2021_01_06_425584	450	13	Farber	Farber	NNP
10_1101-2021_01_06_425584	450	14	,	,	,
10_1101-2021_01_06_425584	450	15	K.	K.	NNP
10_1101-2021_01_06_425584	450	16	;	;	:
10_1101-2021_01_06_425584	450	17	Weiss	Weiss	NNP
10_1101-2021_01_06_425584	450	18	,	,	,
10_1101-2021_01_06_425584	450	19	J.	J.	NNP
10_1101-2021_01_06_425584	450	20	;	;	:
10_1101-2021_01_06_425584	450	21	Zink	Zink	NNP
10_1101-2021_01_06_425584	450	22	,	,	,
10_1101-2021_01_06_425584	450	23	S.	S.	NNP
10_1101-2021_01_06_425584	450	24	;	;	:
10_1101-2021_01_06_425584	450	25	Schwippert	Schwippert	NNP
10_1101-2021_01_06_425584	450	26	,	,	,
10_1101-2021_01_06_425584	450	27	B.	B.	NNP
10_1101-2021_01_06_425584	450	28	;	;	:
10_1101-2021_01_06_425584	450	29	Wu	Wu	NNP
10_1101-2021_01_06_425584	450	30	,	,	,
10_1101-2021_01_06_425584	450	31	Q.	Q.	NNP
10_1101-2021_01_06_425584	451	1	699	699	CD
10_1101-2021_01_06_425584	451	2	X.	X.	NNP
10_1101-2021_01_06_425584	451	3	;	;	:
10_1101-2021_01_06_425584	451	4	Tschope	Tschope	NNP
10_1101-2021_01_06_425584	451	5	,	,	,
10_1101-2021_01_06_425584	451	6	D.	D.	NNP
10_1101-2021_01_06_425584	451	7	;	;	:
10_1101-2021_01_06_425584	451	8	Rosen	Rosen	NNP
10_1101-2021_01_06_425584	451	9	,	,	,
10_1101-2021_01_06_425584	451	10	P.	P.	NNP
10_1101-2021_01_06_425584	451	11	,	,	,
10_1101-2021_01_06_425584	451	12	Introduction	introduction	NN
10_1101-2021_01_06_425584	451	13	of	of	IN
10_1101-2021_01_06_425584	451	14	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	451	15	by	by	IN
10_1101-2021_01_06_425584	451	16	high	high	JJ
10_1101-2021_01_06_425584	451	17	proinsulin	proinsulin	NN
10_1101-2021_01_06_425584	451	18	and	and	CC
10_1101-2021_01_06_425584	451	19	glucose	glucose	NN
10_1101-2021_01_06_425584	451	20	in	in	RP
10_1101-2021_01_06_425584	451	21	cultured	cultured	JJ
10_1101-2021_01_06_425584	451	22	700	700	CD
10_1101-2021_01_06_425584	451	23	human	human	JJ
10_1101-2021_01_06_425584	451	24	umbilical	umbilical	JJ
10_1101-2021_01_06_425584	451	25	vein	vein	NN
10_1101-2021_01_06_425584	451	26	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	451	27	cells	cell	NNS
10_1101-2021_01_06_425584	451	28	is	be	VBZ
10_1101-2021_01_06_425584	451	29	mediated	mediate	VBN
10_1101-2021_01_06_425584	451	30	by	by	IN
10_1101-2021_01_06_425584	451	31	reactive	reactive	JJ
10_1101-2021_01_06_425584	451	32	oxygen	oxygen	NN
10_1101-2021_01_06_425584	451	33	species	specie	NNS
10_1101-2021_01_06_425584	451	34	.	.	.
10_1101-2021_01_06_425584	452	1	Diabetologia	Diabetologia	NNP
10_1101-2021_01_06_425584	452	2	701	701	CD
10_1101-2021_01_06_425584	452	3	1998	1998	CD
10_1101-2021_01_06_425584	452	4	,	,	,
10_1101-2021_01_06_425584	452	5	41	41	CD
10_1101-2021_01_06_425584	452	6	,	,	,
10_1101-2021_01_06_425584	452	7	(	(	-LRB-
10_1101-2021_01_06_425584	452	8	3	3	CD
10_1101-2021_01_06_425584	452	9	)	)	-RRB-
10_1101-2021_01_06_425584	452	10	,	,	,
10_1101-2021_01_06_425584	452	11	249	249	CD
10_1101-2021_01_06_425584	452	12	-	-	SYM
10_1101-2021_01_06_425584	452	13	56	56	CD
10_1101-2021_01_06_425584	452	14	.	.	.
10_1101-2021_01_06_425584	453	1	702	702	CD
10_1101-2021_01_06_425584	453	2	49	49	CD
10_1101-2021_01_06_425584	453	3	.	.	.
10_1101-2021_01_06_425584	454	1	Graier	Graier	NNP
10_1101-2021_01_06_425584	454	2	,	,	,
10_1101-2021_01_06_425584	454	3	W.	W.	NNP
10_1101-2021_01_06_425584	454	4	F.	F.	NNP
10_1101-2021_01_06_425584	454	5	;	;	:
10_1101-2021_01_06_425584	454	6	Grubenthal	Grubenthal	NNP
10_1101-2021_01_06_425584	454	7	,	,	,
10_1101-2021_01_06_425584	454	8	I.	I.	NNP
10_1101-2021_01_06_425584	454	9	;	;	:
10_1101-2021_01_06_425584	454	10	Dittrich	Dittrich	NNP
10_1101-2021_01_06_425584	454	11	,	,	,
10_1101-2021_01_06_425584	454	12	P.	P.	NNP
10_1101-2021_01_06_425584	454	13	;	;	:
10_1101-2021_01_06_425584	454	14	Wascher	Wascher	NNP
10_1101-2021_01_06_425584	454	15	,	,	,
10_1101-2021_01_06_425584	454	16	T.	T.	NNP
10_1101-2021_01_06_425584	454	17	C.	C.	NNP
10_1101-2021_01_06_425584	454	18	;	;	:
10_1101-2021_01_06_425584	454	19	Kostner	Kostner	NNP
10_1101-2021_01_06_425584	454	20	,	,	,
10_1101-2021_01_06_425584	454	21	G.	G.	NNP
10_1101-2021_01_06_425584	454	22	M.	M.	NNP
10_1101-2021_01_06_425584	454	23	,	,	,
10_1101-2021_01_06_425584	454	24	Intracellular	Intracellular	NNP
10_1101-2021_01_06_425584	454	25	703	703	CD
10_1101-2021_01_06_425584	454	26	mechanism	mechanism	NN
10_1101-2021_01_06_425584	454	27	of	of	IN
10_1101-2021_01_06_425584	454	28	high	high	JJ
10_1101-2021_01_06_425584	454	29	D	d	NN
10_1101-2021_01_06_425584	454	30	-	-	HYPH
10_1101-2021_01_06_425584	454	31	glucose	glucose	NN
10_1101-2021_01_06_425584	454	32	-	-	HYPH
10_1101-2021_01_06_425584	454	33	induced	induce	VBN
10_1101-2021_01_06_425584	454	34	modulation	modulation	NN
10_1101-2021_01_06_425584	454	35	of	of	IN
10_1101-2021_01_06_425584	454	36	vascular	vascular	JJ
10_1101-2021_01_06_425584	454	37	cell	cell	NN
10_1101-2021_01_06_425584	454	38	proliferation	proliferation	NN
10_1101-2021_01_06_425584	454	39	.	.	.
10_1101-2021_01_06_425584	455	1	Eur	Eur	NNP
10_1101-2021_01_06_425584	455	2	J	J	NNP
10_1101-2021_01_06_425584	455	3	Pharmacol	Pharmacol	NNP
10_1101-2021_01_06_425584	455	4	704	704	CD
10_1101-2021_01_06_425584	455	5	1995	1995	CD
10_1101-2021_01_06_425584	455	6	,	,	,
10_1101-2021_01_06_425584	455	7	294	294	CD
10_1101-2021_01_06_425584	455	8	,	,	,
10_1101-2021_01_06_425584	455	9	(	(	-LRB-
10_1101-2021_01_06_425584	455	10	1	1	CD
10_1101-2021_01_06_425584	455	11	)	)	-RRB-
10_1101-2021_01_06_425584	455	12	,	,	,
10_1101-2021_01_06_425584	455	13	221	221	CD
10_1101-2021_01_06_425584	455	14	-	-	SYM
10_1101-2021_01_06_425584	455	15	9	9	CD
10_1101-2021_01_06_425584	455	16	.	.	.
10_1101-2021_01_06_425584	456	1	705	705	CD
10_1101-2021_01_06_425584	456	2	50	50	CD
10_1101-2021_01_06_425584	456	3	.	.	.
10_1101-2021_01_06_425584	457	1	Kamal	Kamal	NNP
10_1101-2021_01_06_425584	457	2	,	,	,
10_1101-2021_01_06_425584	457	3	K.	K.	NNP
10_1101-2021_01_06_425584	457	4	;	;	:
10_1101-2021_01_06_425584	457	5	Du	Du	NNP
10_1101-2021_01_06_425584	457	6	,	,	,
10_1101-2021_01_06_425584	457	7	W.	W.	NNP
10_1101-2021_01_06_425584	457	8	;	;	:
10_1101-2021_01_06_425584	457	9	Mills	Mills	NNP
10_1101-2021_01_06_425584	457	10	,	,	,
10_1101-2021_01_06_425584	457	11	I.	i.	NN
10_1101-2021_01_06_425584	457	12	;	;	:
10_1101-2021_01_06_425584	457	13	Sumpio	Sumpio	NNP
10_1101-2021_01_06_425584	457	14	,	,	,
10_1101-2021_01_06_425584	457	15	B.	B.	NNP
10_1101-2021_01_06_425584	457	16	E.	E.	NNP
10_1101-2021_01_06_425584	457	17	,	,	,
10_1101-2021_01_06_425584	457	18	Antiproliferative	antiproliferative	JJ
10_1101-2021_01_06_425584	457	19	effect	effect	NN
10_1101-2021_01_06_425584	457	20	of	of	IN
10_1101-2021_01_06_425584	457	21	elevated	elevated	JJ
10_1101-2021_01_06_425584	457	22	glucose	glucose	NN
10_1101-2021_01_06_425584	457	23	in	in	IN
10_1101-2021_01_06_425584	457	24	706	706	CD
10_1101-2021_01_06_425584	457	25	human	human	JJ
10_1101-2021_01_06_425584	457	26	microvascular	microvascular	JJ
10_1101-2021_01_06_425584	457	27	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	457	28	cells	cell	NNS
10_1101-2021_01_06_425584	457	29	.	.	.
10_1101-2021_01_06_425584	458	1	J	J	NNP
10_1101-2021_01_06_425584	458	2	Cell	Cell	NNP
10_1101-2021_01_06_425584	458	3	Biochem	Biochem	NNP
10_1101-2021_01_06_425584	458	4	1998	1998	CD
10_1101-2021_01_06_425584	458	5	,	,	,
10_1101-2021_01_06_425584	458	6	71	71	CD
10_1101-2021_01_06_425584	458	7	,	,	,
10_1101-2021_01_06_425584	458	8	(	(	-LRB-
10_1101-2021_01_06_425584	458	9	4	4	CD
10_1101-2021_01_06_425584	458	10	)	)	-RRB-
10_1101-2021_01_06_425584	458	11	,	,	,
10_1101-2021_01_06_425584	458	12	491	491	CD
10_1101-2021_01_06_425584	458	13	-	-	SYM
10_1101-2021_01_06_425584	458	14	501	501	CD
10_1101-2021_01_06_425584	458	15	.	.	.
10_1101-2021_01_06_425584	459	1	707	707	CD
10_1101-2021_01_06_425584	459	2	51	51	CD
10_1101-2021_01_06_425584	459	3	.	.	.
10_1101-2021_01_06_425584	460	1	Lorenzi	Lorenzi	NNP
10_1101-2021_01_06_425584	460	2	,	,	,
10_1101-2021_01_06_425584	460	3	M.	M.	NNP
10_1101-2021_01_06_425584	460	4	;	;	:
10_1101-2021_01_06_425584	460	5	Nordberg	Nordberg	NNP
10_1101-2021_01_06_425584	460	6	,	,	,
10_1101-2021_01_06_425584	460	7	J.	J.	NNP
10_1101-2021_01_06_425584	461	1	A.	a.	LS
10_1101-2021_01_06_425584	461	2	;	;	:
10_1101-2021_01_06_425584	461	3	Toledo	Toledo	NNP
10_1101-2021_01_06_425584	461	4	,	,	,
10_1101-2021_01_06_425584	461	5	S.	S.	NNP
10_1101-2021_01_06_425584	461	6	,	,	,
10_1101-2021_01_06_425584	461	7	High	High	NNP
10_1101-2021_01_06_425584	461	8	glucose	glucose	NN
10_1101-2021_01_06_425584	461	9	prolongs	prolong	NNS
10_1101-2021_01_06_425584	461	10	cell	cell	NN
10_1101-2021_01_06_425584	461	11	-	-	HYPH
10_1101-2021_01_06_425584	461	12	cycle	cycle	NN
10_1101-2021_01_06_425584	461	13	traversal	traversal	NN
10_1101-2021_01_06_425584	461	14	of	of	IN
10_1101-2021_01_06_425584	461	15	708	708	CD
10_1101-2021_01_06_425584	461	16	cultured	cultured	JJ
10_1101-2021_01_06_425584	461	17	human	human	JJ
10_1101-2021_01_06_425584	461	18	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	461	19	cells	cell	NNS
10_1101-2021_01_06_425584	461	20	.	.	.
10_1101-2021_01_06_425584	462	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	462	2	1987	1987	CD
10_1101-2021_01_06_425584	462	3	,	,	,
10_1101-2021_01_06_425584	462	4	36	36	CD
10_1101-2021_01_06_425584	462	5	,	,	,
10_1101-2021_01_06_425584	462	6	(	(	-LRB-
10_1101-2021_01_06_425584	462	7	11	11	CD
10_1101-2021_01_06_425584	462	8	)	)	-RRB-
10_1101-2021_01_06_425584	462	9	,	,	,
10_1101-2021_01_06_425584	462	10	1261	1261	CD
10_1101-2021_01_06_425584	462	11	-	-	SYM
10_1101-2021_01_06_425584	462	12	7	7	CD
10_1101-2021_01_06_425584	462	13	.	.	.
10_1101-2021_01_06_425584	463	1	709	709	CD
10_1101-2021_01_06_425584	463	2	52	52	CD
10_1101-2021_01_06_425584	463	3	.	.	.
10_1101-2021_01_06_425584	464	1	Quagliaro	Quagliaro	NNP
10_1101-2021_01_06_425584	464	2	,	,	,
10_1101-2021_01_06_425584	464	3	L.	L.	NNP
10_1101-2021_01_06_425584	464	4	;	;	:
10_1101-2021_01_06_425584	464	5	Piconi	Piconi	NNP
10_1101-2021_01_06_425584	464	6	,	,	,
10_1101-2021_01_06_425584	464	7	L.	L.	NNP
10_1101-2021_01_06_425584	464	8	;	;	:
10_1101-2021_01_06_425584	464	9	Assaloni	Assaloni	NNP
10_1101-2021_01_06_425584	464	10	,	,	,
10_1101-2021_01_06_425584	464	11	R.	R.	NNP
10_1101-2021_01_06_425584	464	12	;	;	:
10_1101-2021_01_06_425584	464	13	Martinelli	Martinelli	NNP
10_1101-2021_01_06_425584	464	14	,	,	,
10_1101-2021_01_06_425584	464	15	L.	L.	NNP
10_1101-2021_01_06_425584	464	16	;	;	:
10_1101-2021_01_06_425584	464	17	Motz	Motz	NNP
10_1101-2021_01_06_425584	464	18	,	,	,
10_1101-2021_01_06_425584	464	19	E.	E.	NNP
10_1101-2021_01_06_425584	464	20	;	;	:
10_1101-2021_01_06_425584	464	21	Ceriello	Ceriello	NNP
10_1101-2021_01_06_425584	464	22	,	,	,
10_1101-2021_01_06_425584	464	23	A.	a.	NN
10_1101-2021_01_06_425584	464	24	,	,	,
10_1101-2021_01_06_425584	464	25	Intermittent	Intermittent	NNP
10_1101-2021_01_06_425584	464	26	710	710	CD
10_1101-2021_01_06_425584	464	27	high	high	JJ
10_1101-2021_01_06_425584	464	28	glucose	glucose	NN
10_1101-2021_01_06_425584	464	29	enhances	enhance	VBZ
10_1101-2021_01_06_425584	464	30	apoptosis	apoptosis	NN
10_1101-2021_01_06_425584	464	31	related	relate	VBN
10_1101-2021_01_06_425584	464	32	to	to	IN
10_1101-2021_01_06_425584	464	33	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	464	34	stress	stress	NN
10_1101-2021_01_06_425584	464	35	in	in	IN
10_1101-2021_01_06_425584	464	36	human	human	JJ
10_1101-2021_01_06_425584	464	37	umbilical	umbilical	JJ
10_1101-2021_01_06_425584	464	38	vein	vein	NN
10_1101-2021_01_06_425584	464	39	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	464	40	711	711	CD
10_1101-2021_01_06_425584	464	41	cells	cell	NNS
10_1101-2021_01_06_425584	464	42	:	:	:
10_1101-2021_01_06_425584	464	43	the	the	DT
10_1101-2021_01_06_425584	464	44	role	role	NN
10_1101-2021_01_06_425584	464	45	of	of	IN
10_1101-2021_01_06_425584	464	46	protein	protein	NN
10_1101-2021_01_06_425584	464	47	kinase	kinase	VBD
10_1101-2021_01_06_425584	464	48	C	C	NNP
10_1101-2021_01_06_425584	464	49	and	and	CC
10_1101-2021_01_06_425584	464	50	NAD(P)H	NAD(P)H	NNP
10_1101-2021_01_06_425584	464	51	-	-	HYPH
10_1101-2021_01_06_425584	464	52	oxidase	oxidase	NN
10_1101-2021_01_06_425584	464	53	activation	activation	NN
10_1101-2021_01_06_425584	464	54	.	.	.
10_1101-2021_01_06_425584	465	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	465	2	2003	2003	CD
10_1101-2021_01_06_425584	465	3	,	,	,
10_1101-2021_01_06_425584	465	4	52	52	CD
10_1101-2021_01_06_425584	465	5	,	,	,
10_1101-2021_01_06_425584	465	6	(	(	-LRB-
10_1101-2021_01_06_425584	465	7	11	11	CD
10_1101-2021_01_06_425584	465	8	)	)	-RRB-
10_1101-2021_01_06_425584	465	9	,	,	,
10_1101-2021_01_06_425584	465	10	712	712	CD
10_1101-2021_01_06_425584	465	11	2795	2795	CD
10_1101-2021_01_06_425584	465	12	-	-	SYM
10_1101-2021_01_06_425584	465	13	804	804	CD
10_1101-2021_01_06_425584	465	14	.	.	.
10_1101-2021_01_06_425584	466	1	713	713	CD
10_1101-2021_01_06_425584	466	2	53	53	CD
10_1101-2021_01_06_425584	466	3	.	.	.
10_1101-2021_01_06_425584	467	1	McGinn	McGinn	NNP
10_1101-2021_01_06_425584	467	2	,	,	,
10_1101-2021_01_06_425584	467	3	S.	S.	NNP
10_1101-2021_01_06_425584	467	4	;	;	:
10_1101-2021_01_06_425584	467	5	Poronnik	Poronnik	NNP
10_1101-2021_01_06_425584	467	6	,	,	,
10_1101-2021_01_06_425584	467	7	P.	P.	NNP
10_1101-2021_01_06_425584	467	8	;	;	:
10_1101-2021_01_06_425584	467	9	King	King	NNP
10_1101-2021_01_06_425584	467	10	,	,	,
10_1101-2021_01_06_425584	467	11	M.	M.	NNP
10_1101-2021_01_06_425584	467	12	;	;	:
10_1101-2021_01_06_425584	467	13	Gallery	Gallery	NNP
10_1101-2021_01_06_425584	467	14	,	,	,
10_1101-2021_01_06_425584	467	15	E.	E.	NNP
10_1101-2021_01_06_425584	467	16	D.	D.	NNP
10_1101-2021_01_06_425584	467	17	;	;	:
10_1101-2021_01_06_425584	467	18	Pollock	Pollock	NNP
10_1101-2021_01_06_425584	467	19	,	,	,
10_1101-2021_01_06_425584	467	20	C.	C.	NNP
10_1101-2021_01_06_425584	467	21	A.	A.	NNP
10_1101-2021_01_06_425584	467	22	,	,	,
10_1101-2021_01_06_425584	467	23	High	high	JJ
10_1101-2021_01_06_425584	467	24	glucose	glucose	NN
10_1101-2021_01_06_425584	467	25	and	and	CC
10_1101-2021_01_06_425584	467	26	714	714	CD
10_1101-2021_01_06_425584	467	27	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	467	28	cell	cell	NN
10_1101-2021_01_06_425584	467	29	growth	growth	NN
10_1101-2021_01_06_425584	467	30	:	:	:
10_1101-2021_01_06_425584	467	31	novel	novel	JJ
10_1101-2021_01_06_425584	467	32	effects	effect	NNS
10_1101-2021_01_06_425584	467	33	independent	independent	JJ
10_1101-2021_01_06_425584	467	34	of	of	IN
10_1101-2021_01_06_425584	467	35	autocrine	autocrine	NN
10_1101-2021_01_06_425584	467	36	TGF	TGF	NNP
10_1101-2021_01_06_425584	467	37	-	-	HYPH
10_1101-2021_01_06_425584	467	38	beta	beta	NNP
10_1101-2021_01_06_425584	467	39	1	1	CD
10_1101-2021_01_06_425584	467	40	and	and	CC
10_1101-2021_01_06_425584	467	41	hyperosmolarity	hyperosmolarity	NN
10_1101-2021_01_06_425584	467	42	.	.	.
10_1101-2021_01_06_425584	468	1	715	715	CD
10_1101-2021_01_06_425584	468	2	Am	Am	NNP
10_1101-2021_01_06_425584	468	3	J	J	NNP
10_1101-2021_01_06_425584	468	4	Physiol	Physiol	NNP
10_1101-2021_01_06_425584	468	5	Cell	Cell	NNP
10_1101-2021_01_06_425584	468	6	Physiol	Physiol	NNP
10_1101-2021_01_06_425584	468	7	2003	2003	CD
10_1101-2021_01_06_425584	468	8	,	,	,
10_1101-2021_01_06_425584	468	9	284	284	CD
10_1101-2021_01_06_425584	468	10	,	,	,
10_1101-2021_01_06_425584	468	11	(	(	-LRB-
10_1101-2021_01_06_425584	468	12	6	6	CD
10_1101-2021_01_06_425584	468	13	)	)	-RRB-
10_1101-2021_01_06_425584	468	14	,	,	,
10_1101-2021_01_06_425584	468	15	C1374	C1374	NNP
10_1101-2021_01_06_425584	468	16	-	-	HYPH
10_1101-2021_01_06_425584	468	17	86	86	CD
10_1101-2021_01_06_425584	468	18	.	.	.
10_1101-2021_01_06_425584	469	1	716	716	CD
10_1101-2021_01_06_425584	469	2	54	54	CD
10_1101-2021_01_06_425584	469	3	.	.	.
10_1101-2021_01_06_425584	470	1	Yuan	Yuan	NNP
10_1101-2021_01_06_425584	470	2	,	,	,
10_1101-2021_01_06_425584	470	3	W.	W.	NNP
10_1101-2021_01_06_425584	470	4	;	;	:
10_1101-2021_01_06_425584	470	5	Zhang	Zhang	NNP
10_1101-2021_01_06_425584	470	6	,	,	,
10_1101-2021_01_06_425584	470	7	J.	J.	NNP
10_1101-2021_01_06_425584	470	8	;	;	:
10_1101-2021_01_06_425584	470	9	Li	Li	NNP
10_1101-2021_01_06_425584	470	10	,	,	,
10_1101-2021_01_06_425584	470	11	S.	S.	NNP
10_1101-2021_01_06_425584	470	12	;	;	:
10_1101-2021_01_06_425584	470	13	Edwards	Edwards	NNP
10_1101-2021_01_06_425584	470	14	,	,	,
10_1101-2021_01_06_425584	470	15	J.	J.	NNP
10_1101-2021_01_06_425584	470	16	L.	L.	NNP
10_1101-2021_01_06_425584	470	17	,	,	,
10_1101-2021_01_06_425584	470	18	Amine	Amine	NNP
10_1101-2021_01_06_425584	470	19	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	470	20	of	of	IN
10_1101-2021_01_06_425584	470	21	hyperglycemic	hyperglycemic	JJ
10_1101-2021_01_06_425584	470	22	717	717	CD
10_1101-2021_01_06_425584	470	23	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	470	24	cells	cell	NNS
10_1101-2021_01_06_425584	470	25	using	use	VBG
10_1101-2021_01_06_425584	470	26	capillary	capillary	JJ
10_1101-2021_01_06_425584	470	27	LC	LC	NNP
10_1101-2021_01_06_425584	470	28	-	-	HYPH
10_1101-2021_01_06_425584	470	29	MS	MS	NNP
10_1101-2021_01_06_425584	470	30	with	with	IN
10_1101-2021_01_06_425584	470	31	isobaric	isobaric	JJ
10_1101-2021_01_06_425584	470	32	tagging	tagging	NN
10_1101-2021_01_06_425584	470	33	.	.	.
10_1101-2021_01_06_425584	471	1	J	J	NNP
10_1101-2021_01_06_425584	471	2	Proteome	Proteome	NNP
10_1101-2021_01_06_425584	471	3	Res	Res	NNP
10_1101-2021_01_06_425584	471	4	2011	2011	CD
10_1101-2021_01_06_425584	471	5	,	,	,
10_1101-2021_01_06_425584	471	6	10	10	CD
10_1101-2021_01_06_425584	471	7	,	,	,
10_1101-2021_01_06_425584	471	8	(	(	-LRB-
10_1101-2021_01_06_425584	471	9	11	11	CD
10_1101-2021_01_06_425584	471	10	)	)	-RRB-
10_1101-2021_01_06_425584	471	11	,	,	,
10_1101-2021_01_06_425584	471	12	718	718	CD
10_1101-2021_01_06_425584	471	13	5242	5242	CD
10_1101-2021_01_06_425584	471	14	-	-	SYM
10_1101-2021_01_06_425584	471	15	50	50	CD
10_1101-2021_01_06_425584	471	16	.	.	.
10_1101-2021_01_06_425584	472	1	719	719	CD
10_1101-2021_01_06_425584	472	2	55	55	CD
10_1101-2021_01_06_425584	472	3	.	.	.
10_1101-2021_01_06_425584	473	1	Chen	Chen	NNP
10_1101-2021_01_06_425584	473	2	,	,	,
10_1101-2021_01_06_425584	473	3	S.	S.	NNP
10_1101-2021_01_06_425584	473	4	;	;	:
10_1101-2021_01_06_425584	473	5	Akter	Akter	NNP
10_1101-2021_01_06_425584	473	6	,	,	,
10_1101-2021_01_06_425584	473	7	S.	S.	NNP
10_1101-2021_01_06_425584	473	8	;	;	:
10_1101-2021_01_06_425584	473	9	Kuwahara	Kuwahara	NNP
10_1101-2021_01_06_425584	473	10	,	,	,
10_1101-2021_01_06_425584	473	11	K.	K.	NNP
10_1101-2021_01_06_425584	473	12	;	;	:
10_1101-2021_01_06_425584	473	13	Matsushita	Matsushita	NNP
10_1101-2021_01_06_425584	473	14	,	,	,
10_1101-2021_01_06_425584	473	15	Y.	Y.	NNP
10_1101-2021_01_06_425584	473	16	;	;	:
10_1101-2021_01_06_425584	473	17	Nakagawa	Nakagawa	NNP
10_1101-2021_01_06_425584	473	18	,	,	,
10_1101-2021_01_06_425584	473	19	T.	T.	NNP
10_1101-2021_01_06_425584	473	20	;	;	:
10_1101-2021_01_06_425584	473	21	Konishi	Konishi	NNP
10_1101-2021_01_06_425584	473	22	,	,	,
10_1101-2021_01_06_425584	473	23	M.	M.	NNP
10_1101-2021_01_06_425584	473	24	;	;	:
10_1101-2021_01_06_425584	473	25	Honda	Honda	NNP
10_1101-2021_01_06_425584	473	26	,	,	,
10_1101-2021_01_06_425584	473	27	T.	t.	NN
10_1101-2021_01_06_425584	473	28	;	;	:
10_1101-2021_01_06_425584	473	29	720	720	CD
10_1101-2021_01_06_425584	473	30	Yamamoto	Yamamoto	NNP
10_1101-2021_01_06_425584	473	31	,	,	,
10_1101-2021_01_06_425584	473	32	S.	S.	NNP
10_1101-2021_01_06_425584	473	33	;	;	:
10_1101-2021_01_06_425584	473	34	Hayashi	Hayashi	NNP
10_1101-2021_01_06_425584	473	35	,	,	,
10_1101-2021_01_06_425584	473	36	T.	T.	NNP
10_1101-2021_01_06_425584	473	37	;	;	:
10_1101-2021_01_06_425584	473	38	Noda	Noda	NNP
10_1101-2021_01_06_425584	473	39	,	,	,
10_1101-2021_01_06_425584	473	40	M.	M.	NNP
10_1101-2021_01_06_425584	473	41	;	;	:
10_1101-2021_01_06_425584	473	42	Mizoue	Mizoue	NNP
10_1101-2021_01_06_425584	473	43	,	,	,
10_1101-2021_01_06_425584	473	44	T.	T.	NNP
10_1101-2021_01_06_425584	473	45	,	,	,
10_1101-2021_01_06_425584	473	46	Serum	Serum	NNP
10_1101-2021_01_06_425584	473	47	amino	amino	NN
10_1101-2021_01_06_425584	473	48	acid	acid	NN
10_1101-2021_01_06_425584	473	49	profiles	profile	NNS
10_1101-2021_01_06_425584	473	50	and	and	CC
10_1101-2021_01_06_425584	473	51	risk	risk	NN
10_1101-2021_01_06_425584	473	52	of	of	IN
10_1101-2021_01_06_425584	473	53	type	type	NN
10_1101-2021_01_06_425584	473	54	2	2	CD
10_1101-2021_01_06_425584	473	55	721	721	CD
10_1101-2021_01_06_425584	473	56	diabetes	diabete	NNS
10_1101-2021_01_06_425584	473	57	among	among	IN
10_1101-2021_01_06_425584	473	58	Japanese	japanese	JJ
10_1101-2021_01_06_425584	473	59	adults	adult	NNS
10_1101-2021_01_06_425584	473	60	in	in	IN
10_1101-2021_01_06_425584	473	61	the	the	DT
10_1101-2021_01_06_425584	473	62	Hitachi	Hitachi	NNP
10_1101-2021_01_06_425584	473	63	Health	Health	NNP
10_1101-2021_01_06_425584	473	64	Study	Study	NNP
10_1101-2021_01_06_425584	473	65	.	.	.
10_1101-2021_01_06_425584	474	1	Sci	Sci	NNP
10_1101-2021_01_06_425584	474	2	Rep	Rep	NNP
10_1101-2021_01_06_425584	474	3	2019	2019	CD
10_1101-2021_01_06_425584	474	4	,	,	,
10_1101-2021_01_06_425584	474	5	9	9	CD
10_1101-2021_01_06_425584	474	6	,	,	,
10_1101-2021_01_06_425584	474	7	(	(	-LRB-
10_1101-2021_01_06_425584	474	8	1	1	CD
10_1101-2021_01_06_425584	474	9	)	)	-RRB-
10_1101-2021_01_06_425584	474	10	,	,	,
10_1101-2021_01_06_425584	474	11	7010	7010	CD
10_1101-2021_01_06_425584	474	12	.	.	.
10_1101-2021_01_06_425584	475	1	722	722	CD
10_1101-2021_01_06_425584	475	2	56	56	CD
10_1101-2021_01_06_425584	475	3	.	.	.
10_1101-2021_01_06_425584	476	1	Lai	Lai	NNP
10_1101-2021_01_06_425584	476	2	,	,	,
10_1101-2021_01_06_425584	476	3	M.	M.	NNP
10_1101-2021_01_06_425584	476	4	;	;	:
10_1101-2021_01_06_425584	476	5	Liu	Liu	NNP
10_1101-2021_01_06_425584	476	6	,	,	,
10_1101-2021_01_06_425584	476	7	Y.	Y.	NNP
10_1101-2021_01_06_425584	476	8	;	;	:
10_1101-2021_01_06_425584	476	9	Ronnett	Ronnett	NNP
10_1101-2021_01_06_425584	476	10	,	,	,
10_1101-2021_01_06_425584	476	11	G.	G.	NNP
10_1101-2021_01_06_425584	476	12	V.	V.	NNP
10_1101-2021_01_06_425584	476	13	;	;	:
10_1101-2021_01_06_425584	476	14	Wu	Wu	NNP
10_1101-2021_01_06_425584	476	15	,	,	,
10_1101-2021_01_06_425584	476	16	A.	a.	NN
10_1101-2021_01_06_425584	476	17	;	;	:
10_1101-2021_01_06_425584	476	18	Cox	Cox	NNP
10_1101-2021_01_06_425584	476	19	,	,	,
10_1101-2021_01_06_425584	476	20	B.	B.	NNP
10_1101-2021_01_06_425584	476	21	J.	J.	NNP
10_1101-2021_01_06_425584	476	22	;	;	:
10_1101-2021_01_06_425584	476	23	Dai	Dai	NNP
10_1101-2021_01_06_425584	476	24	,	,	,
10_1101-2021_01_06_425584	476	25	F.	F.	NNP
10_1101-2021_01_06_425584	476	26	F.	F.	NNP
10_1101-2021_01_06_425584	476	27	;	;	:
10_1101-2021_01_06_425584	476	28	Rost	Rost	NNP
10_1101-2021_01_06_425584	476	29	,	,	,
10_1101-2021_01_06_425584	476	30	H.	H.	NNP
10_1101-2021_01_06_425584	476	31	L.	L.	NNP
10_1101-2021_01_06_425584	476	32	;	;	:
10_1101-2021_01_06_425584	476	33	Gunderson	Gunderson	NNP
10_1101-2021_01_06_425584	476	34	,	,	,
10_1101-2021_01_06_425584	476	35	E.	E.	NNP
10_1101-2021_01_06_425584	476	36	723	723	CD
10_1101-2021_01_06_425584	476	37	P.	P.	NNP
10_1101-2021_01_06_425584	476	38	;	;	:
10_1101-2021_01_06_425584	476	39	Wheeler	Wheeler	NNP
10_1101-2021_01_06_425584	476	40	,	,	,
10_1101-2021_01_06_425584	476	41	M.	M.	NNP
10_1101-2021_01_06_425584	476	42	B.	B.	NNP
10_1101-2021_01_06_425584	476	43	,	,	,
10_1101-2021_01_06_425584	476	44	Amino	Amino	NNP
10_1101-2021_01_06_425584	476	45	acid	acid	NN
10_1101-2021_01_06_425584	476	46	and	and	CC
10_1101-2021_01_06_425584	476	47	lipid	lipid	NN
10_1101-2021_01_06_425584	476	48	metabolism	metabolism	NN
10_1101-2021_01_06_425584	476	49	in	in	IN
10_1101-2021_01_06_425584	476	50	post	post	JJ
10_1101-2021_01_06_425584	476	51	-	-	JJ
10_1101-2021_01_06_425584	476	52	gestational	gestational	JJ
10_1101-2021_01_06_425584	476	53	diabetes	diabetes	NN
10_1101-2021_01_06_425584	476	54	and	and	CC
10_1101-2021_01_06_425584	476	55	724	724	CD
10_1101-2021_01_06_425584	476	56	progression	progression	NN
10_1101-2021_01_06_425584	476	57	to	to	TO
10_1101-2021_01_06_425584	476	58	type	type	VB
10_1101-2021_01_06_425584	476	59	2	2	CD
10_1101-2021_01_06_425584	476	60	diabetes	diabetes	NN
10_1101-2021_01_06_425584	476	61	:	:	:
10_1101-2021_01_06_425584	476	62	A	a	DT
10_1101-2021_01_06_425584	476	63	metabolic	metabolic	JJ
10_1101-2021_01_06_425584	476	64	profiling	profiling	NN
10_1101-2021_01_06_425584	476	65	study	study	NN
10_1101-2021_01_06_425584	476	66	.	.	.
10_1101-2021_01_06_425584	477	1	PLoS	plos	ADD
10_1101-2021_01_06_425584	477	2	Med	Med	NNP
10_1101-2021_01_06_425584	477	3	2020	2020	CD
10_1101-2021_01_06_425584	477	4	,	,	,
10_1101-2021_01_06_425584	477	5	17	17	CD
10_1101-2021_01_06_425584	477	6	,	,	,
10_1101-2021_01_06_425584	477	7	(	(	-LRB-
10_1101-2021_01_06_425584	477	8	5	5	CD
10_1101-2021_01_06_425584	477	9	)	)	-RRB-
10_1101-2021_01_06_425584	477	10	,	,	,
10_1101-2021_01_06_425584	477	11	e1003112	e1003112	NN
10_1101-2021_01_06_425584	477	12	.	.	.
10_1101-2021_01_06_425584	478	1	725	725	CD
10_1101-2021_01_06_425584	478	2	.CC	.CC	:
10_1101-2021_01_06_425584	478	3	-	-	HYPH
10_1101-2021_01_06_425584	478	4	BY	by	IN
10_1101-2021_01_06_425584	478	5	-	-	HYPH
10_1101-2021_01_06_425584	478	6	NC	NC	NNP
10_1101-2021_01_06_425584	478	7	-	-	HYPH
10_1101-2021_01_06_425584	478	8	ND	ND	NNP
10_1101-2021_01_06_425584	478	9	4.0	4.0	CD
10_1101-2021_01_06_425584	478	10	International	International	NNP
10_1101-2021_01_06_425584	478	11	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	478	12	under	under	IN
10_1101-2021_01_06_425584	478	13	a	a	DT
10_1101-2021_01_06_425584	478	14	(	(	-LRB-
10_1101-2021_01_06_425584	478	15	which	which	WDT
10_1101-2021_01_06_425584	478	16	was	be	VBD
10_1101-2021_01_06_425584	478	17	not	not	RB
10_1101-2021_01_06_425584	478	18	certified	certify	VBN
10_1101-2021_01_06_425584	478	19	by	by	IN
10_1101-2021_01_06_425584	478	20	peer	peer	NN
10_1101-2021_01_06_425584	478	21	review	review	NN
10_1101-2021_01_06_425584	478	22	)	)	-RRB-
10_1101-2021_01_06_425584	478	23	is	be	VBZ
10_1101-2021_01_06_425584	478	24	the	the	DT
10_1101-2021_01_06_425584	478	25	author	author	NN
10_1101-2021_01_06_425584	478	26	/	/	SYM
10_1101-2021_01_06_425584	478	27	funder	funder	NN
10_1101-2021_01_06_425584	478	28	,	,	,
10_1101-2021_01_06_425584	478	29	who	who	WP
10_1101-2021_01_06_425584	478	30	has	have	VBZ
10_1101-2021_01_06_425584	478	31	granted	grant	VBN
10_1101-2021_01_06_425584	478	32	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	478	33	a	a	DT
10_1101-2021_01_06_425584	478	34	license	license	NN
10_1101-2021_01_06_425584	478	35	to	to	TO
10_1101-2021_01_06_425584	478	36	display	display	VB
10_1101-2021_01_06_425584	478	37	the	the	DT
10_1101-2021_01_06_425584	478	38	preprint	preprint	NN
10_1101-2021_01_06_425584	478	39	in	in	IN
10_1101-2021_01_06_425584	478	40	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	478	41	.	.	.
10_1101-2021_01_06_425584	479	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	479	2	is	be	VBZ
10_1101-2021_01_06_425584	479	3	made	make	VBN
10_1101-2021_01_06_425584	479	4	The	the	DT
10_1101-2021_01_06_425584	479	5	copyright	copyright	NN
10_1101-2021_01_06_425584	479	6	holder	holder	NN
10_1101-2021_01_06_425584	479	7	for	for	IN
10_1101-2021_01_06_425584	479	8	this	this	DT
10_1101-2021_01_06_425584	479	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	479	10	version	version	NN
10_1101-2021_01_06_425584	479	11	posted	post	VBD
10_1101-2021_01_06_425584	479	12	January	January	NNP
10_1101-2021_01_06_425584	479	13	8	8	CD
10_1101-2021_01_06_425584	479	14	,	,	,
10_1101-2021_01_06_425584	479	15	2021	2021	CD
10_1101-2021_01_06_425584	479	16	.	.	.
10_1101-2021_01_06_425584	479	17	;	;	:
10_1101-2021_01_06_425584	479	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	479	19	:	:	:
10_1101-2021_01_06_425584	479	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	479	21	preprint	preprint	NN
10_1101-2021_01_06_425584	479	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	479	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	479	24	25	25	CD
10_1101-2021_01_06_425584	479	25	57	57	CD
10_1101-2021_01_06_425584	479	26	.	.	.
10_1101-2021_01_06_425584	480	1	Lu	Lu	NNP
10_1101-2021_01_06_425584	480	2	,	,	,
10_1101-2021_01_06_425584	480	3	Y.	Y.	NNP
10_1101-2021_01_06_425584	480	4	;	;	:
10_1101-2021_01_06_425584	480	5	Wang	Wang	NNP
10_1101-2021_01_06_425584	480	6	,	,	,
10_1101-2021_01_06_425584	480	7	Y.	Y.	NNP
10_1101-2021_01_06_425584	480	8	;	;	:
10_1101-2021_01_06_425584	480	9	Liang	Liang	NNP
10_1101-2021_01_06_425584	480	10	,	,	,
10_1101-2021_01_06_425584	480	11	X.	X.	NNP
10_1101-2021_01_06_425584	480	12	;	;	:
10_1101-2021_01_06_425584	480	13	Zou	Zou	NNP
10_1101-2021_01_06_425584	480	14	,	,	,
10_1101-2021_01_06_425584	480	15	L.	L.	NNP
10_1101-2021_01_06_425584	480	16	;	;	:
10_1101-2021_01_06_425584	480	17	Ong	Ong	NNP
10_1101-2021_01_06_425584	480	18	,	,	,
10_1101-2021_01_06_425584	480	19	C.	C.	NNP
10_1101-2021_01_06_425584	480	20	N.	N.	NNP
10_1101-2021_01_06_425584	480	21	;	;	:
10_1101-2021_01_06_425584	480	22	Yuan	Yuan	NNP
10_1101-2021_01_06_425584	480	23	,	,	,
10_1101-2021_01_06_425584	480	24	J.	J.	NNP
10_1101-2021_01_06_425584	480	25	M.	M.	NNP
10_1101-2021_01_06_425584	480	26	;	;	:
10_1101-2021_01_06_425584	480	27	Koh	Koh	NNP
10_1101-2021_01_06_425584	480	28	,	,	,
10_1101-2021_01_06_425584	480	29	W.	W.	NNP
10_1101-2021_01_06_425584	480	30	P.	P.	NNP
10_1101-2021_01_06_425584	480	31	;	;	:
10_1101-2021_01_06_425584	480	32	Pan	Pan	NNP
10_1101-2021_01_06_425584	480	33	,	,	,
10_1101-2021_01_06_425584	480	34	A.	a.	NN
10_1101-2021_01_06_425584	480	35	,	,	,
10_1101-2021_01_06_425584	480	36	Serum	Serum	NNP
10_1101-2021_01_06_425584	480	37	726	726	CD
10_1101-2021_01_06_425584	480	38	Amino	Amino	NNP
10_1101-2021_01_06_425584	480	39	Acids	Acids	NNPS
10_1101-2021_01_06_425584	480	40	in	in	IN
10_1101-2021_01_06_425584	480	41	Association	Association	NNP
10_1101-2021_01_06_425584	480	42	with	with	IN
10_1101-2021_01_06_425584	480	43	Prevalent	Prevalent	NNP
10_1101-2021_01_06_425584	480	44	and	and	CC
10_1101-2021_01_06_425584	480	45	Incident	Incident	NNP
10_1101-2021_01_06_425584	480	46	Type	Type	NNP
10_1101-2021_01_06_425584	480	47	2	2	CD
10_1101-2021_01_06_425584	480	48	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	480	49	in	in	IN
10_1101-2021_01_06_425584	480	50	A	a	DT
10_1101-2021_01_06_425584	480	51	Chinese	chinese	JJ
10_1101-2021_01_06_425584	480	52	727	727	CD
10_1101-2021_01_06_425584	480	53	Population	population	NN
10_1101-2021_01_06_425584	480	54	.	.	.
10_1101-2021_01_06_425584	481	1	Metabolites	metabolite	NNS
10_1101-2021_01_06_425584	481	2	2019	2019	CD
10_1101-2021_01_06_425584	481	3	,	,	,
10_1101-2021_01_06_425584	481	4	9	9	CD
10_1101-2021_01_06_425584	481	5	,	,	,
10_1101-2021_01_06_425584	481	6	(	(	-LRB-
10_1101-2021_01_06_425584	481	7	1	1	CD
10_1101-2021_01_06_425584	481	8	)	)	-RRB-
10_1101-2021_01_06_425584	481	9	.	.	.
10_1101-2021_01_06_425584	482	1	728	728	CD
10_1101-2021_01_06_425584	482	2	58	58	CD
10_1101-2021_01_06_425584	482	3	.	.	.
10_1101-2021_01_06_425584	483	1	Menni	Menni	NNP
10_1101-2021_01_06_425584	483	2	,	,	,
10_1101-2021_01_06_425584	483	3	C.	C.	NNP
10_1101-2021_01_06_425584	483	4	;	;	:
10_1101-2021_01_06_425584	483	5	Fauman	Fauman	NNP
10_1101-2021_01_06_425584	483	6	,	,	,
10_1101-2021_01_06_425584	483	7	E.	E.	NNP
10_1101-2021_01_06_425584	483	8	;	;	:
10_1101-2021_01_06_425584	483	9	Erte	Erte	NNP
10_1101-2021_01_06_425584	483	10	,	,	,
10_1101-2021_01_06_425584	483	11	I.	i.	NN
10_1101-2021_01_06_425584	483	12	;	;	:
10_1101-2021_01_06_425584	483	13	Perry	Perry	NNP
10_1101-2021_01_06_425584	483	14	,	,	,
10_1101-2021_01_06_425584	483	15	J.	J.	NNP
10_1101-2021_01_06_425584	483	16	R.	R.	NNP
10_1101-2021_01_06_425584	483	17	;	;	:
10_1101-2021_01_06_425584	483	18	Kastenmuller	Kastenmuller	NNP
10_1101-2021_01_06_425584	483	19	,	,	,
10_1101-2021_01_06_425584	483	20	G.	G.	NNP
10_1101-2021_01_06_425584	483	21	;	;	:
10_1101-2021_01_06_425584	483	22	Shin	Shin	NNP
10_1101-2021_01_06_425584	483	23	,	,	,
10_1101-2021_01_06_425584	483	24	S.	S.	NNP
10_1101-2021_01_06_425584	483	25	Y.	Y.	NNP
10_1101-2021_01_06_425584	483	26	;	;	:
10_1101-2021_01_06_425584	483	27	Petersen	Petersen	NNP
10_1101-2021_01_06_425584	483	28	,	,	,
10_1101-2021_01_06_425584	483	29	A.	a.	NN
10_1101-2021_01_06_425584	484	1	729	729	CD
10_1101-2021_01_06_425584	484	2	K.	K.	NNP
10_1101-2021_01_06_425584	484	3	;	;	:
10_1101-2021_01_06_425584	484	4	Hyde	Hyde	NNP
10_1101-2021_01_06_425584	484	5	,	,	,
10_1101-2021_01_06_425584	484	6	C.	C.	NNP
10_1101-2021_01_06_425584	484	7	;	;	:
10_1101-2021_01_06_425584	484	8	Psatha	Psatha	NNP
10_1101-2021_01_06_425584	484	9	,	,	,
10_1101-2021_01_06_425584	484	10	M.	M.	NNP
10_1101-2021_01_06_425584	484	11	;	;	:
10_1101-2021_01_06_425584	484	12	Ward	Ward	NNP
10_1101-2021_01_06_425584	484	13	,	,	,
10_1101-2021_01_06_425584	484	14	K.	K.	NNP
10_1101-2021_01_06_425584	484	15	J.	J.	NNP
10_1101-2021_01_06_425584	484	16	;	;	:
10_1101-2021_01_06_425584	484	17	Yuan	Yuan	NNP
10_1101-2021_01_06_425584	484	18	,	,	,
10_1101-2021_01_06_425584	484	19	W.	W.	NNP
10_1101-2021_01_06_425584	484	20	;	;	:
10_1101-2021_01_06_425584	484	21	Milburn	Milburn	NNP
10_1101-2021_01_06_425584	484	22	,	,	,
10_1101-2021_01_06_425584	484	23	M.	M.	NNP
10_1101-2021_01_06_425584	484	24	;	;	:
10_1101-2021_01_06_425584	484	25	Palmer	Palmer	NNP
10_1101-2021_01_06_425584	484	26	,	,	,
10_1101-2021_01_06_425584	484	27	C.	C.	NNP
10_1101-2021_01_06_425584	484	28	N.	N.	NNP
10_1101-2021_01_06_425584	484	29	;	;	:
10_1101-2021_01_06_425584	484	30	Frayling	frayling	NN
10_1101-2021_01_06_425584	484	31	,	,	,
10_1101-2021_01_06_425584	484	32	T.	T.	NNP
10_1101-2021_01_06_425584	484	33	M.	M.	NNP
10_1101-2021_01_06_425584	484	34	;	;	:
10_1101-2021_01_06_425584	484	35	730	730	CD
10_1101-2021_01_06_425584	484	36	Trimmer	Trimmer	NNP
10_1101-2021_01_06_425584	484	37	,	,	,
10_1101-2021_01_06_425584	484	38	J.	J.	NNP
10_1101-2021_01_06_425584	484	39	;	;	:
10_1101-2021_01_06_425584	484	40	Bell	Bell	NNP
10_1101-2021_01_06_425584	484	41	,	,	,
10_1101-2021_01_06_425584	484	42	J.	J.	NNP
10_1101-2021_01_06_425584	484	43	T.	T.	NNP
10_1101-2021_01_06_425584	484	44	;	;	:
10_1101-2021_01_06_425584	484	45	Gieger	Gieger	NNP
10_1101-2021_01_06_425584	484	46	,	,	,
10_1101-2021_01_06_425584	484	47	C.	C.	NNP
10_1101-2021_01_06_425584	484	48	;	;	:
10_1101-2021_01_06_425584	484	49	Mohney	Mohney	NNP
10_1101-2021_01_06_425584	484	50	,	,	,
10_1101-2021_01_06_425584	484	51	R.	R.	NNP
10_1101-2021_01_06_425584	484	52	P.	P.	NNP
10_1101-2021_01_06_425584	484	53	;	;	:
10_1101-2021_01_06_425584	484	54	Brosnan	Brosnan	NNP
10_1101-2021_01_06_425584	484	55	,	,	,
10_1101-2021_01_06_425584	484	56	M.	M.	NNP
10_1101-2021_01_06_425584	484	57	J.	J.	NNP
10_1101-2021_01_06_425584	484	58	;	;	:
10_1101-2021_01_06_425584	484	59	Suhre	Suhre	NNP
10_1101-2021_01_06_425584	484	60	,	,	,
10_1101-2021_01_06_425584	484	61	K.	K.	NNP
10_1101-2021_01_06_425584	484	62	;	;	:
10_1101-2021_01_06_425584	484	63	Soranzo	Soranzo	NNP
10_1101-2021_01_06_425584	484	64	,	,	,
10_1101-2021_01_06_425584	484	65	N.	N.	NNP
10_1101-2021_01_06_425584	484	66	;	;	:
10_1101-2021_01_06_425584	484	67	731	731	CD
10_1101-2021_01_06_425584	484	68	Spector	Spector	NNP
10_1101-2021_01_06_425584	484	69	,	,	,
10_1101-2021_01_06_425584	484	70	T.	T.	NNP
10_1101-2021_01_06_425584	484	71	D.	D.	NNP
10_1101-2021_01_06_425584	484	72	,	,	,
10_1101-2021_01_06_425584	484	73	Biomarkers	Biomarkers	NNP
10_1101-2021_01_06_425584	484	74	for	for	IN
10_1101-2021_01_06_425584	484	75	type	type	NN
10_1101-2021_01_06_425584	484	76	2	2	CD
10_1101-2021_01_06_425584	484	77	diabetes	diabetes	NN
10_1101-2021_01_06_425584	484	78	and	and	CC
10_1101-2021_01_06_425584	484	79	impaired	impair	VBN
10_1101-2021_01_06_425584	484	80	fasting	fasting	NN
10_1101-2021_01_06_425584	484	81	glucose	glucose	NN
10_1101-2021_01_06_425584	484	82	using	use	VBG
10_1101-2021_01_06_425584	484	83	a	a	DT
10_1101-2021_01_06_425584	484	84	nontargeted	nontargete	VBN
10_1101-2021_01_06_425584	484	85	732	732	CD
10_1101-2021_01_06_425584	484	86	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	484	87	approach	approach	NN
10_1101-2021_01_06_425584	484	88	.	.	.
10_1101-2021_01_06_425584	485	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	485	2	2013	2013	CD
10_1101-2021_01_06_425584	485	3	,	,	,
10_1101-2021_01_06_425584	485	4	62	62	CD
10_1101-2021_01_06_425584	485	5	,	,	,
10_1101-2021_01_06_425584	485	6	(	(	-LRB-
10_1101-2021_01_06_425584	485	7	12	12	CD
10_1101-2021_01_06_425584	485	8	)	)	-RRB-
10_1101-2021_01_06_425584	485	9	,	,	,
10_1101-2021_01_06_425584	485	10	4270	4270	CD
10_1101-2021_01_06_425584	485	11	-	-	SYM
10_1101-2021_01_06_425584	485	12	6	6	CD
10_1101-2021_01_06_425584	485	13	.	.	.
10_1101-2021_01_06_425584	486	1	733	733	CD
10_1101-2021_01_06_425584	486	2	59	59	CD
10_1101-2021_01_06_425584	486	3	.	.	.
10_1101-2021_01_06_425584	487	1	Wang	Wang	NNP
10_1101-2021_01_06_425584	487	2	,	,	,
10_1101-2021_01_06_425584	487	3	T.	T.	NNP
10_1101-2021_01_06_425584	487	4	J.	J.	NNP
10_1101-2021_01_06_425584	487	5	;	;	:
10_1101-2021_01_06_425584	487	6	Larson	Larson	NNP
10_1101-2021_01_06_425584	487	7	,	,	,
10_1101-2021_01_06_425584	487	8	M.	M.	NNP
10_1101-2021_01_06_425584	487	9	G.	G.	NNP
10_1101-2021_01_06_425584	487	10	;	;	:
10_1101-2021_01_06_425584	487	11	Vasan	Vasan	NNP
10_1101-2021_01_06_425584	487	12	,	,	,
10_1101-2021_01_06_425584	487	13	R.	R.	NNP
10_1101-2021_01_06_425584	487	14	S.	S.	NNP
10_1101-2021_01_06_425584	487	15	;	;	:
10_1101-2021_01_06_425584	487	16	Cheng	Cheng	NNP
10_1101-2021_01_06_425584	487	17	,	,	,
10_1101-2021_01_06_425584	487	18	S.	S.	NNP
10_1101-2021_01_06_425584	487	19	;	;	:
10_1101-2021_01_06_425584	487	20	Rhee	Rhee	NNP
10_1101-2021_01_06_425584	487	21	,	,	,
10_1101-2021_01_06_425584	487	22	E.	E.	NNP
10_1101-2021_01_06_425584	487	23	P.	P.	NNP
10_1101-2021_01_06_425584	487	24	;	;	:
10_1101-2021_01_06_425584	487	25	McCabe	McCabe	NNP
10_1101-2021_01_06_425584	487	26	,	,	,
10_1101-2021_01_06_425584	487	27	E.	E.	NNP
10_1101-2021_01_06_425584	487	28	;	;	:
10_1101-2021_01_06_425584	487	29	Lewis	Lewis	NNP
10_1101-2021_01_06_425584	487	30	,	,	,
10_1101-2021_01_06_425584	487	31	G.	G.	NNP
10_1101-2021_01_06_425584	487	32	734	734	CD
10_1101-2021_01_06_425584	487	33	D.	D.	NNP
10_1101-2021_01_06_425584	487	34	;	;	:
10_1101-2021_01_06_425584	487	35	Fox	Fox	NNP
10_1101-2021_01_06_425584	487	36	,	,	,
10_1101-2021_01_06_425584	487	37	C.	C.	NNP
10_1101-2021_01_06_425584	487	38	S.	S.	NNP
10_1101-2021_01_06_425584	487	39	;	;	:
10_1101-2021_01_06_425584	487	40	Jacques	Jacques	NNP
10_1101-2021_01_06_425584	487	41	,	,	,
10_1101-2021_01_06_425584	487	42	P.	P.	NNP
10_1101-2021_01_06_425584	487	43	F.	F.	NNP
10_1101-2021_01_06_425584	487	44	;	;	:
10_1101-2021_01_06_425584	487	45	Fernandez	Fernandez	NNP
10_1101-2021_01_06_425584	487	46	,	,	,
10_1101-2021_01_06_425584	487	47	C.	C.	NNP
10_1101-2021_01_06_425584	487	48	;	;	:
10_1101-2021_01_06_425584	487	49	O'Donnell	O'Donnell	NNP
10_1101-2021_01_06_425584	487	50	,	,	,
10_1101-2021_01_06_425584	487	51	C.	C.	NNP
10_1101-2021_01_06_425584	487	52	J.	J.	NNP
10_1101-2021_01_06_425584	487	53	;	;	:
10_1101-2021_01_06_425584	487	54	Carr	Carr	NNP
10_1101-2021_01_06_425584	487	55	,	,	,
10_1101-2021_01_06_425584	487	56	S.	S.	NNP
10_1101-2021_01_06_425584	487	57	A.	A.	NNP
10_1101-2021_01_06_425584	487	58	;	;	:
10_1101-2021_01_06_425584	487	59	Mootha	Mootha	NNP
10_1101-2021_01_06_425584	487	60	,	,	,
10_1101-2021_01_06_425584	487	61	V.	V.	NNP
10_1101-2021_01_06_425584	487	62	K.	K.	NNP
10_1101-2021_01_06_425584	487	63	;	;	:
10_1101-2021_01_06_425584	487	64	735	735	CD
10_1101-2021_01_06_425584	487	65	Florez	Florez	NNP
10_1101-2021_01_06_425584	487	66	,	,	,
10_1101-2021_01_06_425584	487	67	J.	J.	NNP
10_1101-2021_01_06_425584	487	68	C.	C.	NNP
10_1101-2021_01_06_425584	487	69	;	;	:
10_1101-2021_01_06_425584	487	70	Souza	Souza	NNP
10_1101-2021_01_06_425584	487	71	,	,	,
10_1101-2021_01_06_425584	487	72	A.	a.	NN
10_1101-2021_01_06_425584	487	73	;	;	:
10_1101-2021_01_06_425584	487	74	Melander	Melander	NNP
10_1101-2021_01_06_425584	487	75	,	,	,
10_1101-2021_01_06_425584	487	76	O.	O.	NNP
10_1101-2021_01_06_425584	487	77	;	;	:
10_1101-2021_01_06_425584	487	78	Clish	Clish	NNP
10_1101-2021_01_06_425584	487	79	,	,	,
10_1101-2021_01_06_425584	487	80	C.	C.	NNP
10_1101-2021_01_06_425584	487	81	B.	B.	NNP
10_1101-2021_01_06_425584	487	82	;	;	:
10_1101-2021_01_06_425584	487	83	Gerszten	Gerszten	NNP
10_1101-2021_01_06_425584	487	84	,	,	,
10_1101-2021_01_06_425584	487	85	R.	R.	NNP
10_1101-2021_01_06_425584	487	86	E.	E.	NNP
10_1101-2021_01_06_425584	487	87	,	,	,
10_1101-2021_01_06_425584	487	88	Metabolite	Metabolite	NNP
10_1101-2021_01_06_425584	487	89	profiles	profile	NNS
10_1101-2021_01_06_425584	487	90	and	and	CC
10_1101-2021_01_06_425584	487	91	the	the	DT
10_1101-2021_01_06_425584	487	92	736	736	CD
10_1101-2021_01_06_425584	487	93	risk	risk	NN
10_1101-2021_01_06_425584	487	94	of	of	IN
10_1101-2021_01_06_425584	487	95	developing	develop	VBG
10_1101-2021_01_06_425584	487	96	diabetes	diabete	NNS
10_1101-2021_01_06_425584	487	97	.	.	.
10_1101-2021_01_06_425584	488	1	Nat	Nat	NNP
10_1101-2021_01_06_425584	488	2	Med	Med	NNP
10_1101-2021_01_06_425584	488	3	2011	2011	CD
10_1101-2021_01_06_425584	488	4	,	,	,
10_1101-2021_01_06_425584	488	5	17	17	CD
10_1101-2021_01_06_425584	488	6	,	,	,
10_1101-2021_01_06_425584	488	7	(	(	-LRB-
10_1101-2021_01_06_425584	488	8	4	4	CD
10_1101-2021_01_06_425584	488	9	)	)	-RRB-
10_1101-2021_01_06_425584	488	10	,	,	,
10_1101-2021_01_06_425584	488	11	448	448	CD
10_1101-2021_01_06_425584	488	12	-	-	SYM
10_1101-2021_01_06_425584	488	13	53	53	CD
10_1101-2021_01_06_425584	488	14	.	.	.
10_1101-2021_01_06_425584	489	1	737	737	CD
10_1101-2021_01_06_425584	489	2	60	60	CD
10_1101-2021_01_06_425584	489	3	.	.	.
10_1101-2021_01_06_425584	490	1	Koziel	Koziel	NNP
10_1101-2021_01_06_425584	490	2	,	,	,
10_1101-2021_01_06_425584	490	3	A.	A.	NNP
10_1101-2021_01_06_425584	490	4	;	;	:
10_1101-2021_01_06_425584	490	5	Woyda	Woyda	NNP
10_1101-2021_01_06_425584	490	6	-	-	HYPH
10_1101-2021_01_06_425584	490	7	Ploszczyca	Ploszczyca	NNP
10_1101-2021_01_06_425584	490	8	,	,	,
10_1101-2021_01_06_425584	490	9	A.	a.	NN
10_1101-2021_01_06_425584	490	10	;	;	:
10_1101-2021_01_06_425584	490	11	Kicinska	Kicinska	NNP
10_1101-2021_01_06_425584	490	12	,	,	,
10_1101-2021_01_06_425584	490	13	A.	a.	NN
10_1101-2021_01_06_425584	490	14	;	;	:
10_1101-2021_01_06_425584	490	15	Jarmuszkiewicz	Jarmuszkiewicz	NNP
10_1101-2021_01_06_425584	490	16	,	,	,
10_1101-2021_01_06_425584	490	17	W.	W.	NNP
10_1101-2021_01_06_425584	490	18	,	,	,
10_1101-2021_01_06_425584	490	19	The	the	DT
10_1101-2021_01_06_425584	490	20	influence	influence	NN
10_1101-2021_01_06_425584	490	21	of	of	IN
10_1101-2021_01_06_425584	490	22	738	738	CD
10_1101-2021_01_06_425584	490	23	high	high	JJ
10_1101-2021_01_06_425584	490	24	glucose	glucose	NN
10_1101-2021_01_06_425584	490	25	on	on	IN
10_1101-2021_01_06_425584	490	26	the	the	DT
10_1101-2021_01_06_425584	490	27	aerobic	aerobic	JJ
10_1101-2021_01_06_425584	490	28	metabolism	metabolism	NN
10_1101-2021_01_06_425584	490	29	of	of	IN
10_1101-2021_01_06_425584	490	30	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	490	31	EA.hy926	ea.hy926	JJ
10_1101-2021_01_06_425584	490	32	cells	cell	NNS
10_1101-2021_01_06_425584	490	33	.	.	.
10_1101-2021_01_06_425584	491	1	Pflugers	Pflugers	NNP
10_1101-2021_01_06_425584	491	2	Arch	Arch	NNP
10_1101-2021_01_06_425584	491	3	2012	2012	CD
10_1101-2021_01_06_425584	491	4	,	,	,
10_1101-2021_01_06_425584	491	5	464	464	CD
10_1101-2021_01_06_425584	491	6	,	,	,
10_1101-2021_01_06_425584	491	7	739	739	CD
10_1101-2021_01_06_425584	491	8	(	(	-LRB-
10_1101-2021_01_06_425584	491	9	6	6	CD
10_1101-2021_01_06_425584	491	10	)	)	-RRB-
10_1101-2021_01_06_425584	491	11	,	,	,
10_1101-2021_01_06_425584	491	12	657	657	CD
10_1101-2021_01_06_425584	491	13	-	-	SYM
10_1101-2021_01_06_425584	491	14	69	69	CD
10_1101-2021_01_06_425584	491	15	.	.	.
10_1101-2021_01_06_425584	492	1	740	740	CD
10_1101-2021_01_06_425584	492	2	61	61	CD
10_1101-2021_01_06_425584	492	3	.	.	.
10_1101-2021_01_06_425584	493	1	Badawy	Badawy	NNP
10_1101-2021_01_06_425584	493	2	,	,	,
10_1101-2021_01_06_425584	493	3	A.	a.	NN
10_1101-2021_01_06_425584	494	1	A.	A.	NNP
10_1101-2021_01_06_425584	494	2	,	,	,
10_1101-2021_01_06_425584	494	3	Kynurenine	Kynurenine	NNP
10_1101-2021_01_06_425584	494	4	Pathway	Pathway	NNP
10_1101-2021_01_06_425584	494	5	of	of	IN
10_1101-2021_01_06_425584	494	6	Tryptophan	Tryptophan	NNP
10_1101-2021_01_06_425584	494	7	Metabolism	Metabolism	NNP
10_1101-2021_01_06_425584	494	8	:	:	:
10_1101-2021_01_06_425584	494	9	Regulatory	regulatory	JJ
10_1101-2021_01_06_425584	494	10	and	and	CC
10_1101-2021_01_06_425584	494	11	741	741	CD
10_1101-2021_01_06_425584	494	12	Functional	Functional	NNP
10_1101-2021_01_06_425584	494	13	Aspects	Aspects	NNPS
10_1101-2021_01_06_425584	494	14	.	.	.
10_1101-2021_01_06_425584	495	1	Int	Int	NNP
10_1101-2021_01_06_425584	495	2	J	J	NNP
10_1101-2021_01_06_425584	495	3	Tryptophan	Tryptophan	NNP
10_1101-2021_01_06_425584	495	4	Res	Res	NNP
10_1101-2021_01_06_425584	495	5	2017	2017	CD
10_1101-2021_01_06_425584	495	6	,	,	,
10_1101-2021_01_06_425584	495	7	10	10	CD
10_1101-2021_01_06_425584	495	8	,	,	,
10_1101-2021_01_06_425584	495	9	1178646917691938	1178646917691938	CD
10_1101-2021_01_06_425584	495	10	.	.	.
10_1101-2021_01_06_425584	496	1	742	742	CD
10_1101-2021_01_06_425584	496	2	62	62	CD
10_1101-2021_01_06_425584	496	3	.	.	.
10_1101-2021_01_06_425584	497	1	Pedersen	Pedersen	NNP
10_1101-2021_01_06_425584	497	2	,	,	,
10_1101-2021_01_06_425584	497	3	E.	E.	NNP
10_1101-2021_01_06_425584	497	4	R.	R.	NNP
10_1101-2021_01_06_425584	497	5	;	;	:
10_1101-2021_01_06_425584	497	6	Tuseth	Tuseth	NNP
10_1101-2021_01_06_425584	497	7	,	,	,
10_1101-2021_01_06_425584	497	8	N.	N.	NNP
10_1101-2021_01_06_425584	497	9	;	;	:
10_1101-2021_01_06_425584	497	10	Eussen	Eussen	NNP
10_1101-2021_01_06_425584	497	11	,	,	,
10_1101-2021_01_06_425584	497	12	S.	S.	NNP
10_1101-2021_01_06_425584	497	13	J.	J.	NNP
10_1101-2021_01_06_425584	497	14	;	;	:
10_1101-2021_01_06_425584	497	15	Ueland	Ueland	NNP
10_1101-2021_01_06_425584	497	16	,	,	,
10_1101-2021_01_06_425584	497	17	P.	P.	NNP
10_1101-2021_01_06_425584	497	18	M.	M.	NNP
10_1101-2021_01_06_425584	497	19	;	;	:
10_1101-2021_01_06_425584	497	20	Strand	Strand	NNP
10_1101-2021_01_06_425584	497	21	,	,	,
10_1101-2021_01_06_425584	497	22	E.	E.	NNP
10_1101-2021_01_06_425584	497	23	;	;	:
10_1101-2021_01_06_425584	497	24	Svingen	Svingen	NNP
10_1101-2021_01_06_425584	497	25	,	,	,
10_1101-2021_01_06_425584	497	26	G.	G.	NNP
10_1101-2021_01_06_425584	497	27	F.	F.	NNP
10_1101-2021_01_06_425584	497	28	;	;	:
10_1101-2021_01_06_425584	497	29	743	743	CD
10_1101-2021_01_06_425584	497	30	Midttun	Midttun	NNP
10_1101-2021_01_06_425584	497	31	,	,	,
10_1101-2021_01_06_425584	497	32	O.	O.	NNP
10_1101-2021_01_06_425584	497	33	;	;	:
10_1101-2021_01_06_425584	497	34	Meyer	Meyer	NNP
10_1101-2021_01_06_425584	497	35	,	,	,
10_1101-2021_01_06_425584	497	36	K.	K.	NNP
10_1101-2021_01_06_425584	497	37	;	;	:
10_1101-2021_01_06_425584	497	38	Mellgren	Mellgren	NNP
10_1101-2021_01_06_425584	497	39	,	,	,
10_1101-2021_01_06_425584	497	40	G.	G.	NNP
10_1101-2021_01_06_425584	497	41	;	;	:
10_1101-2021_01_06_425584	497	42	Ulvik	Ulvik	NNP
10_1101-2021_01_06_425584	497	43	,	,	,
10_1101-2021_01_06_425584	497	44	A.	a.	NN
10_1101-2021_01_06_425584	497	45	;	;	:
10_1101-2021_01_06_425584	497	46	Nordrehaug	Nordrehaug	NNP
10_1101-2021_01_06_425584	497	47	,	,	,
10_1101-2021_01_06_425584	497	48	J.	J.	NNP
10_1101-2021_01_06_425584	497	49	E.	E.	NNP
10_1101-2021_01_06_425584	497	50	;	;	:
10_1101-2021_01_06_425584	497	51	Nilsen	Nilsen	NNP
10_1101-2021_01_06_425584	497	52	,	,	,
10_1101-2021_01_06_425584	497	53	D.	D.	NNP
10_1101-2021_01_06_425584	497	54	W.	W.	NNP
10_1101-2021_01_06_425584	497	55	;	;	:
10_1101-2021_01_06_425584	497	56	Nygard	Nygard	NNP
10_1101-2021_01_06_425584	497	57	,	,	,
10_1101-2021_01_06_425584	497	58	O.	O.	NNP
10_1101-2021_01_06_425584	497	59	,	,	,
10_1101-2021_01_06_425584	497	60	744	744	CD
10_1101-2021_01_06_425584	497	61	Associations	Associations	NNPS
10_1101-2021_01_06_425584	497	62	of	of	IN
10_1101-2021_01_06_425584	497	63	plasma	plasma	NN
10_1101-2021_01_06_425584	497	64	kynurenines	kynurenine	NNS
10_1101-2021_01_06_425584	497	65	with	with	IN
10_1101-2021_01_06_425584	497	66	risk	risk	NN
10_1101-2021_01_06_425584	497	67	of	of	IN
10_1101-2021_01_06_425584	497	68	acute	acute	JJ
10_1101-2021_01_06_425584	497	69	myocardial	myocardial	JJ
10_1101-2021_01_06_425584	497	70	infarction	infarction	NN
10_1101-2021_01_06_425584	497	71	in	in	IN
10_1101-2021_01_06_425584	497	72	patients	patient	NNS
10_1101-2021_01_06_425584	497	73	with	with	IN
10_1101-2021_01_06_425584	497	74	745	745	CD
10_1101-2021_01_06_425584	497	75	stable	stable	JJ
10_1101-2021_01_06_425584	497	76	angina	angina	NN
10_1101-2021_01_06_425584	497	77	pectoris	pectoris	NN
10_1101-2021_01_06_425584	497	78	.	.	.
10_1101-2021_01_06_425584	498	1	Arterioscler	Arterioscler	NNP
10_1101-2021_01_06_425584	498	2	Thromb	Thromb	NNP
10_1101-2021_01_06_425584	498	3	Vasc	Vasc	NNP
10_1101-2021_01_06_425584	498	4	Biol	Biol	NNP
10_1101-2021_01_06_425584	498	5	2015	2015	CD
10_1101-2021_01_06_425584	498	6	,	,	,
10_1101-2021_01_06_425584	498	7	35	35	CD
10_1101-2021_01_06_425584	498	8	,	,	,
10_1101-2021_01_06_425584	498	9	(	(	-LRB-
10_1101-2021_01_06_425584	498	10	2	2	CD
10_1101-2021_01_06_425584	498	11	)	)	-RRB-
10_1101-2021_01_06_425584	498	12	,	,	,
10_1101-2021_01_06_425584	498	13	455	455	CD
10_1101-2021_01_06_425584	498	14	-	-	SYM
10_1101-2021_01_06_425584	498	15	62	62	CD
10_1101-2021_01_06_425584	498	16	.	.	.
10_1101-2021_01_06_425584	499	1	746	746	CD
10_1101-2021_01_06_425584	499	2	63	63	CD
10_1101-2021_01_06_425584	499	3	.	.	.
10_1101-2021_01_06_425584	500	1	Sulo	sulo	VB
10_1101-2021_01_06_425584	500	2	,	,	,
10_1101-2021_01_06_425584	500	3	G.	G.	NNP
10_1101-2021_01_06_425584	500	4	;	;	:
10_1101-2021_01_06_425584	500	5	Vollset	Vollset	NNP
10_1101-2021_01_06_425584	500	6	,	,	,
10_1101-2021_01_06_425584	500	7	S.	S.	NNP
10_1101-2021_01_06_425584	500	8	E.	E.	NNP
10_1101-2021_01_06_425584	500	9	;	;	:
10_1101-2021_01_06_425584	500	10	Nygard	Nygard	NNP
10_1101-2021_01_06_425584	500	11	,	,	,
10_1101-2021_01_06_425584	500	12	O.	O.	NNP
10_1101-2021_01_06_425584	500	13	;	;	:
10_1101-2021_01_06_425584	500	14	Midttun	Midttun	NNP
10_1101-2021_01_06_425584	500	15	,	,	,
10_1101-2021_01_06_425584	500	16	O.	O.	NNP
10_1101-2021_01_06_425584	500	17	;	;	:
10_1101-2021_01_06_425584	500	18	Ueland	Ueland	NNP
10_1101-2021_01_06_425584	500	19	,	,	,
10_1101-2021_01_06_425584	500	20	P.	P.	NNP
10_1101-2021_01_06_425584	500	21	M.	M.	NNP
10_1101-2021_01_06_425584	500	22	;	;	:
10_1101-2021_01_06_425584	500	23	Eussen	Eussen	NNP
10_1101-2021_01_06_425584	500	24	,	,	,
10_1101-2021_01_06_425584	500	25	S.	S.	NNP
10_1101-2021_01_06_425584	500	26	J.	J.	NNP
10_1101-2021_01_06_425584	500	27	;	;	:
10_1101-2021_01_06_425584	500	28	Pedersen	Pedersen	NNP
10_1101-2021_01_06_425584	500	29	,	,	,
10_1101-2021_01_06_425584	500	30	747	747	CD
10_1101-2021_01_06_425584	500	31	E.	E.	NNP
10_1101-2021_01_06_425584	500	32	R.	R.	NNP
10_1101-2021_01_06_425584	500	33	;	;	:
10_1101-2021_01_06_425584	500	34	Tell	Tell	NNP
10_1101-2021_01_06_425584	500	35	,	,	,
10_1101-2021_01_06_425584	500	36	G.	G.	NNP
10_1101-2021_01_06_425584	500	37	S.	S.	NNP
10_1101-2021_01_06_425584	500	38	,	,	,
10_1101-2021_01_06_425584	500	39	Neopterin	Neopterin	NNP
10_1101-2021_01_06_425584	500	40	and	and	CC
10_1101-2021_01_06_425584	500	41	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	500	42	-	-	HYPH
10_1101-2021_01_06_425584	500	43	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	500	44	ratio	ratio	NN
10_1101-2021_01_06_425584	500	45	as	as	IN
10_1101-2021_01_06_425584	500	46	predictors	predictor	NNS
10_1101-2021_01_06_425584	500	47	of	of	IN
10_1101-2021_01_06_425584	500	48	coronary	coronary	JJ
10_1101-2021_01_06_425584	500	49	events	event	NNS
10_1101-2021_01_06_425584	500	50	in	in	IN
10_1101-2021_01_06_425584	500	51	748	748	CD
10_1101-2021_01_06_425584	500	52	older	old	JJR
10_1101-2021_01_06_425584	500	53	adults	adult	NNS
10_1101-2021_01_06_425584	500	54	,	,	,
10_1101-2021_01_06_425584	500	55	the	the	DT
10_1101-2021_01_06_425584	500	56	Hordaland	Hordaland	NNP
10_1101-2021_01_06_425584	500	57	Health	Health	NNP
10_1101-2021_01_06_425584	500	58	Study	Study	NNP
10_1101-2021_01_06_425584	500	59	.	.	.
10_1101-2021_01_06_425584	501	1	Int	Int	NNP
10_1101-2021_01_06_425584	501	2	J	J	NNP
10_1101-2021_01_06_425584	501	3	Cardiol	Cardiol	NNP
10_1101-2021_01_06_425584	501	4	2013	2013	CD
10_1101-2021_01_06_425584	501	5	,	,	,
10_1101-2021_01_06_425584	501	6	168	168	CD
10_1101-2021_01_06_425584	501	7	,	,	,
10_1101-2021_01_06_425584	501	8	(	(	-LRB-
10_1101-2021_01_06_425584	501	9	2	2	CD
10_1101-2021_01_06_425584	501	10	)	)	-RRB-
10_1101-2021_01_06_425584	501	11	,	,	,
10_1101-2021_01_06_425584	501	12	1435	1435	CD
10_1101-2021_01_06_425584	501	13	-	-	SYM
10_1101-2021_01_06_425584	501	14	40	40	CD
10_1101-2021_01_06_425584	501	15	.	.	.
10_1101-2021_01_06_425584	502	1	749	749	CD
10_1101-2021_01_06_425584	502	2	64	64	CD
10_1101-2021_01_06_425584	502	3	.	.	.
10_1101-2021_01_06_425584	503	1	Polyzos	Polyzos	NNP
10_1101-2021_01_06_425584	503	2	,	,	,
10_1101-2021_01_06_425584	503	3	K.	K.	NNP
10_1101-2021_01_06_425584	503	4	A.	A.	NNP
10_1101-2021_01_06_425584	503	5	;	;	:
10_1101-2021_01_06_425584	503	6	Ketelhuth	Ketelhuth	NNP
10_1101-2021_01_06_425584	503	7	,	,	,
10_1101-2021_01_06_425584	503	8	D.	D.	NNP
10_1101-2021_01_06_425584	503	9	F.	F.	NNP
10_1101-2021_01_06_425584	503	10	,	,	,
10_1101-2021_01_06_425584	503	11	The	the	DT
10_1101-2021_01_06_425584	503	12	role	role	NN
10_1101-2021_01_06_425584	503	13	of	of	IN
10_1101-2021_01_06_425584	503	14	the	the	DT
10_1101-2021_01_06_425584	503	15	kynurenine	kynurenine	NNP
10_1101-2021_01_06_425584	503	16	pathway	pathway	NN
10_1101-2021_01_06_425584	503	17	of	of	IN
10_1101-2021_01_06_425584	503	18	tryptophan	tryptophan	NNP
10_1101-2021_01_06_425584	503	19	750	750	CD
10_1101-2021_01_06_425584	503	20	metabolism	metabolism	NN
10_1101-2021_01_06_425584	503	21	in	in	IN
10_1101-2021_01_06_425584	503	22	cardiovascular	cardiovascular	JJ
10_1101-2021_01_06_425584	503	23	disease	disease	NN
10_1101-2021_01_06_425584	503	24	.	.	.
10_1101-2021_01_06_425584	504	1	An	an	DT
10_1101-2021_01_06_425584	504	2	emerging	emerge	VBG
10_1101-2021_01_06_425584	504	3	field	field	NN
10_1101-2021_01_06_425584	504	4	.	.	.
10_1101-2021_01_06_425584	505	1	Hamostaseologie	Hamostaseologie	NNP
10_1101-2021_01_06_425584	505	2	2015	2015	CD
10_1101-2021_01_06_425584	505	3	,	,	,
10_1101-2021_01_06_425584	505	4	35	35	CD
10_1101-2021_01_06_425584	505	5	,	,	,
10_1101-2021_01_06_425584	505	6	(	(	-LRB-
10_1101-2021_01_06_425584	505	7	2	2	CD
10_1101-2021_01_06_425584	505	8	)	)	-RRB-
10_1101-2021_01_06_425584	505	9	,	,	,
10_1101-2021_01_06_425584	505	10	128	128	CD
10_1101-2021_01_06_425584	505	11	-	-	SYM
10_1101-2021_01_06_425584	505	12	751	751	CD
10_1101-2021_01_06_425584	505	13	36	36	CD
10_1101-2021_01_06_425584	505	14	.	.	.
10_1101-2021_01_06_425584	506	1	752	752	CD
10_1101-2021_01_06_425584	506	2	65	65	CD
10_1101-2021_01_06_425584	506	3	.	.	.
10_1101-2021_01_06_425584	507	1	Aquilano	Aquilano	NNP
10_1101-2021_01_06_425584	507	2	,	,	,
10_1101-2021_01_06_425584	507	3	K.	K.	NNP
10_1101-2021_01_06_425584	507	4	;	;	:
10_1101-2021_01_06_425584	507	5	Baldelli	Baldelli	NNP
10_1101-2021_01_06_425584	507	6	,	,	,
10_1101-2021_01_06_425584	507	7	S.	S.	NNP
10_1101-2021_01_06_425584	507	8	;	;	:
10_1101-2021_01_06_425584	507	9	Ciriolo	Ciriolo	NNP
10_1101-2021_01_06_425584	507	10	,	,	,
10_1101-2021_01_06_425584	507	11	M.	M.	NNP
10_1101-2021_01_06_425584	507	12	R.	R.	NNP
10_1101-2021_01_06_425584	507	13	,	,	,
10_1101-2021_01_06_425584	507	14	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	507	15	:	:	:
10_1101-2021_01_06_425584	507	16	new	new	JJ
10_1101-2021_01_06_425584	507	17	roles	role	NNS
10_1101-2021_01_06_425584	507	18	in	in	IN
10_1101-2021_01_06_425584	507	19	redox	redox	NN
10_1101-2021_01_06_425584	507	20	signaling	signaling	NN
10_1101-2021_01_06_425584	507	21	for	for	IN
10_1101-2021_01_06_425584	507	22	an	an	DT
10_1101-2021_01_06_425584	507	23	753	753	CD
10_1101-2021_01_06_425584	507	24	old	old	JJ
10_1101-2021_01_06_425584	507	25	antioxidant	antioxidant	NN
10_1101-2021_01_06_425584	507	26	.	.	.
10_1101-2021_01_06_425584	508	1	Front	Front	NNP
10_1101-2021_01_06_425584	508	2	Pharmacol	Pharmacol	NNP
10_1101-2021_01_06_425584	508	3	2014	2014	CD
10_1101-2021_01_06_425584	508	4	,	,	,
10_1101-2021_01_06_425584	508	5	5	5	CD
10_1101-2021_01_06_425584	508	6	,	,	,
10_1101-2021_01_06_425584	508	7	196	196	CD
10_1101-2021_01_06_425584	508	8	.	.	.
10_1101-2021_01_06_425584	509	1	754	754	CD
10_1101-2021_01_06_425584	509	2	66	66	CD
10_1101-2021_01_06_425584	509	3	.	.	.
10_1101-2021_01_06_425584	510	1	Yuan	Yuan	NNP
10_1101-2021_01_06_425584	510	2	,	,	,
10_1101-2021_01_06_425584	510	3	W.	W.	NNP
10_1101-2021_01_06_425584	510	4	;	;	:
10_1101-2021_01_06_425584	510	5	Edwards	Edwards	NNP
10_1101-2021_01_06_425584	510	6	,	,	,
10_1101-2021_01_06_425584	510	7	J.	J.	NNP
10_1101-2021_01_06_425584	510	8	L.	L.	NNP
10_1101-2021_01_06_425584	510	9	,	,	,
10_1101-2021_01_06_425584	510	10	Thiol	Thiol	NNP
10_1101-2021_01_06_425584	510	11	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	510	12	of	of	IN
10_1101-2021_01_06_425584	510	13	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	510	14	cells	cell	NNS
10_1101-2021_01_06_425584	510	15	using	use	VBG
10_1101-2021_01_06_425584	510	16	capillary	capillary	JJ
10_1101-2021_01_06_425584	510	17	liquid	liquid	NN
10_1101-2021_01_06_425584	510	18	755	755	CD
10_1101-2021_01_06_425584	510	19	chromatography	chromatography	NN
10_1101-2021_01_06_425584	510	20	mass	mass	NN
10_1101-2021_01_06_425584	510	21	spectrometry	spectrometry	NN
10_1101-2021_01_06_425584	510	22	with	with	IN
10_1101-2021_01_06_425584	510	23	isotope	isotope	NN
10_1101-2021_01_06_425584	510	24	coded	code	VBN
10_1101-2021_01_06_425584	510	25	affinity	affinity	NN
10_1101-2021_01_06_425584	510	26	tags	tag	NNS
10_1101-2021_01_06_425584	510	27	.	.	.
10_1101-2021_01_06_425584	511	1	J	J	NNP
10_1101-2021_01_06_425584	511	2	Chromatogr	Chromatogr	NNP
10_1101-2021_01_06_425584	511	3	A	a	DT
10_1101-2021_01_06_425584	511	4	2011	2011	CD
10_1101-2021_01_06_425584	511	5	,	,	,
10_1101-2021_01_06_425584	511	6	756	756	CD
10_1101-2021_01_06_425584	511	7	1218	1218	CD
10_1101-2021_01_06_425584	511	8	,	,	,
10_1101-2021_01_06_425584	511	9	(	(	-LRB-
10_1101-2021_01_06_425584	511	10	18	18	CD
10_1101-2021_01_06_425584	511	11	)	)	-RRB-
10_1101-2021_01_06_425584	511	12	,	,	,
10_1101-2021_01_06_425584	511	13	2561	2561	CD
10_1101-2021_01_06_425584	511	14	-	-	SYM
10_1101-2021_01_06_425584	511	15	8	8	CD
10_1101-2021_01_06_425584	511	16	.	.	.
10_1101-2021_01_06_425584	512	1	757	757	CD
10_1101-2021_01_06_425584	512	2	67	67	CD
10_1101-2021_01_06_425584	512	3	.	.	.
10_1101-2021_01_06_425584	513	1	Weidig	Weidig	NNP
10_1101-2021_01_06_425584	513	2	,	,	,
10_1101-2021_01_06_425584	513	3	P.	P.	NNP
10_1101-2021_01_06_425584	513	4	;	;	:
10_1101-2021_01_06_425584	513	5	McMaster	McMaster	NNP
10_1101-2021_01_06_425584	513	6	,	,	,
10_1101-2021_01_06_425584	513	7	D.	D.	NNP
10_1101-2021_01_06_425584	513	8	;	;	:
10_1101-2021_01_06_425584	513	9	Bayraktutan	Bayraktutan	NNP
10_1101-2021_01_06_425584	513	10	,	,	,
10_1101-2021_01_06_425584	513	11	U.	U.	NNP
10_1101-2021_01_06_425584	513	12	,	,	,
10_1101-2021_01_06_425584	513	13	High	high	JJ
10_1101-2021_01_06_425584	513	14	glucose	glucose	NN
10_1101-2021_01_06_425584	513	15	mediates	mediate	VBZ
10_1101-2021_01_06_425584	513	16	pro	pro	JJ
10_1101-2021_01_06_425584	513	17	-	-	JJ
10_1101-2021_01_06_425584	513	18	oxidant	oxidant	JJ
10_1101-2021_01_06_425584	513	19	and	and	CC
10_1101-2021_01_06_425584	513	20	758	758	CD
10_1101-2021_01_06_425584	513	21	antioxidant	antioxidant	JJ
10_1101-2021_01_06_425584	513	22	enzyme	enzyme	NNS
10_1101-2021_01_06_425584	513	23	activities	activity	NNS
10_1101-2021_01_06_425584	513	24	in	in	IN
10_1101-2021_01_06_425584	513	25	coronary	coronary	JJ
10_1101-2021_01_06_425584	513	26	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	513	27	cells	cell	NNS
10_1101-2021_01_06_425584	513	28	.	.	.
10_1101-2021_01_06_425584	514	1	Diabetes	diabetes	NN
10_1101-2021_01_06_425584	514	2	Obes	Obes	NNP
10_1101-2021_01_06_425584	514	3	Metab	Metab	NNP
10_1101-2021_01_06_425584	514	4	2004	2004	CD
10_1101-2021_01_06_425584	514	5	,	,	,
10_1101-2021_01_06_425584	514	6	6	6	CD
10_1101-2021_01_06_425584	514	7	,	,	,
10_1101-2021_01_06_425584	514	8	(	(	-LRB-
10_1101-2021_01_06_425584	514	9	6	6	CD
10_1101-2021_01_06_425584	514	10	)	)	-RRB-
10_1101-2021_01_06_425584	514	11	,	,	,
10_1101-2021_01_06_425584	514	12	759	759	CD
10_1101-2021_01_06_425584	514	13	432	432	CD
10_1101-2021_01_06_425584	514	14	-	-	SYM
10_1101-2021_01_06_425584	514	15	41	41	CD
10_1101-2021_01_06_425584	514	16	.	.	.
10_1101-2021_01_06_425584	515	1	760	760	CD
10_1101-2021_01_06_425584	515	2	68	68	CD
10_1101-2021_01_06_425584	515	3	.	.	.
10_1101-2021_01_06_425584	516	1	Felice	Felice	NNP
10_1101-2021_01_06_425584	516	2	,	,	,
10_1101-2021_01_06_425584	516	3	F.	F.	NNP
10_1101-2021_01_06_425584	516	4	;	;	:
10_1101-2021_01_06_425584	516	5	Lucchesi	Lucchesi	NNP
10_1101-2021_01_06_425584	516	6	,	,	,
10_1101-2021_01_06_425584	516	7	D.	D.	NNP
10_1101-2021_01_06_425584	516	8	;	;	:
10_1101-2021_01_06_425584	516	9	di	di	NNP
10_1101-2021_01_06_425584	516	10	Stefano	Stefano	NNP
10_1101-2021_01_06_425584	516	11	,	,	,
10_1101-2021_01_06_425584	516	12	R.	R.	NNP
10_1101-2021_01_06_425584	516	13	;	;	:
10_1101-2021_01_06_425584	516	14	Barsotti	Barsotti	NNP
10_1101-2021_01_06_425584	516	15	,	,	,
10_1101-2021_01_06_425584	516	16	M.	M.	NNP
10_1101-2021_01_06_425584	516	17	C.	C.	NNP
10_1101-2021_01_06_425584	516	18	;	;	:
10_1101-2021_01_06_425584	516	19	Storti	Storti	NNP
10_1101-2021_01_06_425584	516	20	,	,	,
10_1101-2021_01_06_425584	516	21	E.	E.	NNP
10_1101-2021_01_06_425584	516	22	;	;	:
10_1101-2021_01_06_425584	516	23	Penno	Penno	NNP
10_1101-2021_01_06_425584	516	24	,	,	,
10_1101-2021_01_06_425584	516	25	G.	G.	NNP
10_1101-2021_01_06_425584	516	26	;	;	:
10_1101-2021_01_06_425584	516	27	Balbarini	Balbarini	NNP
10_1101-2021_01_06_425584	516	28	,	,	,
10_1101-2021_01_06_425584	516	29	761	761	CD
10_1101-2021_01_06_425584	516	30	A.	a.	NN
10_1101-2021_01_06_425584	516	31	;	;	:
10_1101-2021_01_06_425584	516	32	Del	Del	NNP
10_1101-2021_01_06_425584	516	33	Prato	Prato	NNP
10_1101-2021_01_06_425584	516	34	,	,	,
10_1101-2021_01_06_425584	516	35	S.	S.	NNP
10_1101-2021_01_06_425584	516	36	;	;	:
10_1101-2021_01_06_425584	516	37	Pucci	Pucci	NNP
10_1101-2021_01_06_425584	516	38	,	,	,
10_1101-2021_01_06_425584	516	39	L.	L.	NNP
10_1101-2021_01_06_425584	516	40	,	,	,
10_1101-2021_01_06_425584	516	41	Oxidative	Oxidative	NNP
10_1101-2021_01_06_425584	516	42	stress	stress	NN
10_1101-2021_01_06_425584	516	43	in	in	IN
10_1101-2021_01_06_425584	516	44	response	response	NN
10_1101-2021_01_06_425584	516	45	to	to	IN
10_1101-2021_01_06_425584	516	46	high	high	JJ
10_1101-2021_01_06_425584	516	47	glucose	glucose	NN
10_1101-2021_01_06_425584	516	48	levels	level	NNS
10_1101-2021_01_06_425584	516	49	in	in	IN
10_1101-2021_01_06_425584	516	50	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	516	51	762	762	CD
10_1101-2021_01_06_425584	516	52	cells	cell	NNS
10_1101-2021_01_06_425584	516	53	and	and	CC
10_1101-2021_01_06_425584	516	54	in	in	IN
10_1101-2021_01_06_425584	516	55	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	516	56	progenitor	progenitor	NN
10_1101-2021_01_06_425584	516	57	cells	cell	NNS
10_1101-2021_01_06_425584	516	58	:	:	:
10_1101-2021_01_06_425584	516	59	evidence	evidence	NN
10_1101-2021_01_06_425584	516	60	for	for	IN
10_1101-2021_01_06_425584	516	61	differential	differential	NN
10_1101-2021_01_06_425584	516	62	glutathione	glutathione	NN
10_1101-2021_01_06_425584	516	63	peroxidase-1	peroxidase-1	NNP
10_1101-2021_01_06_425584	516	64	763	763	CD
10_1101-2021_01_06_425584	516	65	expression	expression	NN
10_1101-2021_01_06_425584	516	66	.	.	.
10_1101-2021_01_06_425584	517	1	Microvasc	Microvasc	NNP
10_1101-2021_01_06_425584	517	2	Res	Res	NNP
10_1101-2021_01_06_425584	517	3	2010	2010	CD
10_1101-2021_01_06_425584	517	4	,	,	,
10_1101-2021_01_06_425584	517	5	80	80	CD
10_1101-2021_01_06_425584	517	6	,	,	,
10_1101-2021_01_06_425584	517	7	(	(	-LRB-
10_1101-2021_01_06_425584	517	8	3	3	CD
10_1101-2021_01_06_425584	517	9	)	)	-RRB-
10_1101-2021_01_06_425584	517	10	,	,	,
10_1101-2021_01_06_425584	517	11	332	332	CD
10_1101-2021_01_06_425584	517	12	-	-	SYM
10_1101-2021_01_06_425584	517	13	8	8	CD
10_1101-2021_01_06_425584	517	14	.	.	.
10_1101-2021_01_06_425584	518	1	764	764	CD
10_1101-2021_01_06_425584	518	2	69	69	CD
10_1101-2021_01_06_425584	518	3	.	.	.
10_1101-2021_01_06_425584	519	1	Kashiwagi	Kashiwagi	NNP
10_1101-2021_01_06_425584	519	2	,	,	,
10_1101-2021_01_06_425584	519	3	A.	a.	NN
10_1101-2021_01_06_425584	519	4	;	;	:
10_1101-2021_01_06_425584	519	5	Asahina	Asahina	NNP
10_1101-2021_01_06_425584	519	6	,	,	,
10_1101-2021_01_06_425584	519	7	T.	T.	NNP
10_1101-2021_01_06_425584	519	8	;	;	:
10_1101-2021_01_06_425584	519	9	Ikebuchi	Ikebuchi	NNP
10_1101-2021_01_06_425584	519	10	,	,	,
10_1101-2021_01_06_425584	519	11	M.	M.	NNP
10_1101-2021_01_06_425584	519	12	;	;	:
10_1101-2021_01_06_425584	519	13	Tanaka	Tanaka	NNP
10_1101-2021_01_06_425584	519	14	,	,	,
10_1101-2021_01_06_425584	519	15	Y.	Y.	NNP
10_1101-2021_01_06_425584	519	16	;	;	:
10_1101-2021_01_06_425584	519	17	Takagi	Takagi	NNP
10_1101-2021_01_06_425584	519	18	,	,	,
10_1101-2021_01_06_425584	519	19	Y.	Y.	NNP
10_1101-2021_01_06_425584	519	20	;	;	:
10_1101-2021_01_06_425584	519	21	Nishio	Nishio	NNP
10_1101-2021_01_06_425584	519	22	,	,	,
10_1101-2021_01_06_425584	519	23	Y.	Y.	NNP
10_1101-2021_01_06_425584	519	24	;	;	:
10_1101-2021_01_06_425584	519	25	Kikkawa	Kikkawa	NNP
10_1101-2021_01_06_425584	519	26	,	,	,
10_1101-2021_01_06_425584	519	27	R.	R.	NNP
10_1101-2021_01_06_425584	519	28	;	;	:
10_1101-2021_01_06_425584	519	29	765	765	CD
10_1101-2021_01_06_425584	519	30	Shigeta	Shigeta	NNP
10_1101-2021_01_06_425584	519	31	,	,	,
10_1101-2021_01_06_425584	519	32	Y.	Y.	NNP
10_1101-2021_01_06_425584	519	33	,	,	,
10_1101-2021_01_06_425584	519	34	Abnormal	Abnormal	NNP
10_1101-2021_01_06_425584	519	35	glutathione	glutathione	VBD
10_1101-2021_01_06_425584	519	36	metabolism	metabolism	NN
10_1101-2021_01_06_425584	519	37	and	and	CC
10_1101-2021_01_06_425584	519	38	increased	increase	VBN
10_1101-2021_01_06_425584	519	39	cytotoxicity	cytotoxicity	NN
10_1101-2021_01_06_425584	519	40	caused	cause	VBN
10_1101-2021_01_06_425584	519	41	by	by	IN
10_1101-2021_01_06_425584	519	42	H2O2	H2O2	NNP
10_1101-2021_01_06_425584	519	43	in	in	IN
10_1101-2021_01_06_425584	519	44	766	766	CD
10_1101-2021_01_06_425584	519	45	human	human	JJ
10_1101-2021_01_06_425584	519	46	umbilical	umbilical	JJ
10_1101-2021_01_06_425584	519	47	vein	vein	NN
10_1101-2021_01_06_425584	519	48	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	519	49	cells	cell	NNS
10_1101-2021_01_06_425584	519	50	cultured	culture	VBN
10_1101-2021_01_06_425584	519	51	in	in	IN
10_1101-2021_01_06_425584	519	52	high	high	JJ
10_1101-2021_01_06_425584	519	53	glucose	glucose	NN
10_1101-2021_01_06_425584	519	54	medium	medium	NN
10_1101-2021_01_06_425584	519	55	.	.	.
10_1101-2021_01_06_425584	520	1	Diabetologia	diabetologia	NN
10_1101-2021_01_06_425584	520	2	1994	1994	CD
10_1101-2021_01_06_425584	520	3	,	,	,
10_1101-2021_01_06_425584	520	4	37	37	CD
10_1101-2021_01_06_425584	520	5	,	,	,
10_1101-2021_01_06_425584	520	6	767	767	CD
10_1101-2021_01_06_425584	520	7	(	(	-LRB-
10_1101-2021_01_06_425584	520	8	3	3	CD
10_1101-2021_01_06_425584	520	9	)	)	-RRB-
10_1101-2021_01_06_425584	520	10	,	,	,
10_1101-2021_01_06_425584	520	11	264	264	CD
10_1101-2021_01_06_425584	520	12	-	-	SYM
10_1101-2021_01_06_425584	520	13	9	9	CD
10_1101-2021_01_06_425584	520	14	.	.	.
10_1101-2021_01_06_425584	521	1	768	768	CD
10_1101-2021_01_06_425584	521	2	70	70	CD
10_1101-2021_01_06_425584	521	3	.	.	.
10_1101-2021_01_06_425584	522	1	Hanschmann	Hanschmann	NNP
10_1101-2021_01_06_425584	522	2	,	,	,
10_1101-2021_01_06_425584	522	3	E.	E.	NNP
10_1101-2021_01_06_425584	522	4	M.	M.	NNP
10_1101-2021_01_06_425584	522	5	;	;	:
10_1101-2021_01_06_425584	522	6	Godoy	Godoy	NNP
10_1101-2021_01_06_425584	522	7	,	,	,
10_1101-2021_01_06_425584	522	8	J.	J.	NNP
10_1101-2021_01_06_425584	522	9	R.	R.	NNP
10_1101-2021_01_06_425584	522	10	;	;	:
10_1101-2021_01_06_425584	522	11	Berndt	Berndt	NNP
10_1101-2021_01_06_425584	522	12	,	,	,
10_1101-2021_01_06_425584	522	13	C.	C.	NNP
10_1101-2021_01_06_425584	522	14	;	;	:
10_1101-2021_01_06_425584	522	15	Hudemann	Hudemann	NNP
10_1101-2021_01_06_425584	522	16	,	,	,
10_1101-2021_01_06_425584	522	17	C.	C.	NNP
10_1101-2021_01_06_425584	522	18	;	;	:
10_1101-2021_01_06_425584	522	19	Lillig	Lillig	NNP
10_1101-2021_01_06_425584	522	20	,	,	,
10_1101-2021_01_06_425584	522	21	C.	C.	NNP
10_1101-2021_01_06_425584	522	22	H.	H.	NNP
10_1101-2021_01_06_425584	522	23	,	,	,
10_1101-2021_01_06_425584	522	24	Thioredoxins	Thioredoxins	NNP
10_1101-2021_01_06_425584	522	25	,	,	,
10_1101-2021_01_06_425584	522	26	769	769	CD
10_1101-2021_01_06_425584	522	27	glutaredoxins	glutaredoxin	NNS
10_1101-2021_01_06_425584	522	28	,	,	,
10_1101-2021_01_06_425584	522	29	and	and	CC
10_1101-2021_01_06_425584	522	30	peroxiredoxins	peroxiredoxin	NNS
10_1101-2021_01_06_425584	522	31	--	--	:
10_1101-2021_01_06_425584	522	32	molecular	molecular	JJ
10_1101-2021_01_06_425584	522	33	mechanisms	mechanism	NNS
10_1101-2021_01_06_425584	522	34	and	and	CC
10_1101-2021_01_06_425584	522	35	health	health	NN
10_1101-2021_01_06_425584	522	36	significance	significance	NN
10_1101-2021_01_06_425584	522	37	:	:	:
10_1101-2021_01_06_425584	522	38	from	from	IN
10_1101-2021_01_06_425584	522	39	770	770	CD
10_1101-2021_01_06_425584	522	40	cofactors	cofactor	NNS
10_1101-2021_01_06_425584	522	41	to	to	IN
10_1101-2021_01_06_425584	522	42	antioxidants	antioxidant	NNS
10_1101-2021_01_06_425584	522	43	to	to	IN
10_1101-2021_01_06_425584	522	44	redox	redox	NN
10_1101-2021_01_06_425584	522	45	signaling	signaling	NN
10_1101-2021_01_06_425584	522	46	.	.	.
10_1101-2021_01_06_425584	523	1	Antioxid	Antioxid	NNP
10_1101-2021_01_06_425584	523	2	Redox	Redox	NNP
10_1101-2021_01_06_425584	523	3	Signal	Signal	NNP
10_1101-2021_01_06_425584	523	4	2013	2013	CD
10_1101-2021_01_06_425584	523	5	,	,	,
10_1101-2021_01_06_425584	523	6	19	19	CD
10_1101-2021_01_06_425584	523	7	,	,	,
10_1101-2021_01_06_425584	523	8	(	(	-LRB-
10_1101-2021_01_06_425584	523	9	13	13	CD
10_1101-2021_01_06_425584	523	10	)	)	-RRB-
10_1101-2021_01_06_425584	523	11	,	,	,
10_1101-2021_01_06_425584	523	12	1539	1539	CD
10_1101-2021_01_06_425584	523	13	-	-	SYM
10_1101-2021_01_06_425584	523	14	605	605	CD
10_1101-2021_01_06_425584	523	15	.	.	.
10_1101-2021_01_06_425584	524	1	771	771	CD
10_1101-2021_01_06_425584	524	2	71	71	CD
10_1101-2021_01_06_425584	524	3	.	.	.
10_1101-2021_01_06_425584	525	1	Scocchi	Scocchi	NNP
10_1101-2021_01_06_425584	525	2	,	,	,
10_1101-2021_01_06_425584	525	3	M.	M.	NNP
10_1101-2021_01_06_425584	525	4	;	;	:
10_1101-2021_01_06_425584	525	5	Tossi	Tossi	NNP
10_1101-2021_01_06_425584	525	6	,	,	,
10_1101-2021_01_06_425584	525	7	A.	a.	NN
10_1101-2021_01_06_425584	525	8	;	;	:
10_1101-2021_01_06_425584	525	9	Gennaro	Gennaro	NNP
10_1101-2021_01_06_425584	525	10	,	,	,
10_1101-2021_01_06_425584	525	11	R.	R.	NNP
10_1101-2021_01_06_425584	525	12	,	,	,
10_1101-2021_01_06_425584	525	13	Proline	Proline	NNP
10_1101-2021_01_06_425584	525	14	-	-	HYPH
10_1101-2021_01_06_425584	525	15	rich	rich	JJ
10_1101-2021_01_06_425584	525	16	antimicrobial	antimicrobial	JJ
10_1101-2021_01_06_425584	525	17	peptides	peptide	NNS
10_1101-2021_01_06_425584	525	18	:	:	:
10_1101-2021_01_06_425584	525	19	converging	converge	VBG
10_1101-2021_01_06_425584	525	20	to	to	IN
10_1101-2021_01_06_425584	525	21	a	a	DT
10_1101-2021_01_06_425584	525	22	772	772	CD
10_1101-2021_01_06_425584	525	23	non	non	JJ
10_1101-2021_01_06_425584	525	24	-	-	JJ
10_1101-2021_01_06_425584	525	25	lytic	lytic	JJ
10_1101-2021_01_06_425584	525	26	mechanism	mechanism	NN
10_1101-2021_01_06_425584	525	27	of	of	IN
10_1101-2021_01_06_425584	525	28	action	action	NN
10_1101-2021_01_06_425584	525	29	.	.	.
10_1101-2021_01_06_425584	526	1	Cell	Cell	NNP
10_1101-2021_01_06_425584	526	2	Mol	Mol	NNP
10_1101-2021_01_06_425584	526	3	Life	Life	NNP
10_1101-2021_01_06_425584	526	4	Sci	Sci	NNP
10_1101-2021_01_06_425584	526	5	2011	2011	CD
10_1101-2021_01_06_425584	526	6	,	,	,
10_1101-2021_01_06_425584	526	7	68	68	CD
10_1101-2021_01_06_425584	526	8	,	,	,
10_1101-2021_01_06_425584	526	9	(	(	-LRB-
10_1101-2021_01_06_425584	526	10	13	13	CD
10_1101-2021_01_06_425584	526	11	)	)	-RRB-
10_1101-2021_01_06_425584	526	12	,	,	,
10_1101-2021_01_06_425584	526	13	2317	2317	CD
10_1101-2021_01_06_425584	526	14	-	-	SYM
10_1101-2021_01_06_425584	526	15	30	30	CD
10_1101-2021_01_06_425584	526	16	.	.	.
10_1101-2021_01_06_425584	527	1	773	773	CD
10_1101-2021_01_06_425584	527	2	.CC	.CC	:
10_1101-2021_01_06_425584	527	3	-	-	HYPH
10_1101-2021_01_06_425584	527	4	BY	by	IN
10_1101-2021_01_06_425584	527	5	-	-	HYPH
10_1101-2021_01_06_425584	527	6	NC	NC	NNP
10_1101-2021_01_06_425584	527	7	-	-	HYPH
10_1101-2021_01_06_425584	527	8	ND	ND	NNP
10_1101-2021_01_06_425584	527	9	4.0	4.0	CD
10_1101-2021_01_06_425584	527	10	International	International	NNP
10_1101-2021_01_06_425584	527	11	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	527	12	under	under	IN
10_1101-2021_01_06_425584	527	13	a	a	DT
10_1101-2021_01_06_425584	527	14	(	(	-LRB-
10_1101-2021_01_06_425584	527	15	which	which	WDT
10_1101-2021_01_06_425584	527	16	was	be	VBD
10_1101-2021_01_06_425584	527	17	not	not	RB
10_1101-2021_01_06_425584	527	18	certified	certify	VBN
10_1101-2021_01_06_425584	527	19	by	by	IN
10_1101-2021_01_06_425584	527	20	peer	peer	NN
10_1101-2021_01_06_425584	527	21	review	review	NN
10_1101-2021_01_06_425584	527	22	)	)	-RRB-
10_1101-2021_01_06_425584	527	23	is	be	VBZ
10_1101-2021_01_06_425584	527	24	the	the	DT
10_1101-2021_01_06_425584	527	25	author	author	NN
10_1101-2021_01_06_425584	527	26	/	/	SYM
10_1101-2021_01_06_425584	527	27	funder	funder	NN
10_1101-2021_01_06_425584	527	28	,	,	,
10_1101-2021_01_06_425584	527	29	who	who	WP
10_1101-2021_01_06_425584	527	30	has	have	VBZ
10_1101-2021_01_06_425584	527	31	granted	grant	VBN
10_1101-2021_01_06_425584	527	32	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	527	33	a	a	DT
10_1101-2021_01_06_425584	527	34	license	license	NN
10_1101-2021_01_06_425584	527	35	to	to	TO
10_1101-2021_01_06_425584	527	36	display	display	VB
10_1101-2021_01_06_425584	527	37	the	the	DT
10_1101-2021_01_06_425584	527	38	preprint	preprint	NN
10_1101-2021_01_06_425584	527	39	in	in	IN
10_1101-2021_01_06_425584	527	40	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	527	41	.	.	.
10_1101-2021_01_06_425584	528	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	528	2	is	be	VBZ
10_1101-2021_01_06_425584	528	3	made	make	VBN
10_1101-2021_01_06_425584	528	4	The	the	DT
10_1101-2021_01_06_425584	528	5	copyright	copyright	NN
10_1101-2021_01_06_425584	528	6	holder	holder	NN
10_1101-2021_01_06_425584	528	7	for	for	IN
10_1101-2021_01_06_425584	528	8	this	this	DT
10_1101-2021_01_06_425584	528	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	528	10	version	version	NN
10_1101-2021_01_06_425584	528	11	posted	post	VBD
10_1101-2021_01_06_425584	528	12	January	January	NNP
10_1101-2021_01_06_425584	528	13	8	8	CD
10_1101-2021_01_06_425584	528	14	,	,	,
10_1101-2021_01_06_425584	528	15	2021	2021	CD
10_1101-2021_01_06_425584	528	16	.	.	.
10_1101-2021_01_06_425584	528	17	;	;	:
10_1101-2021_01_06_425584	528	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	528	19	:	:	:
10_1101-2021_01_06_425584	528	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	528	21	preprint	preprint	NN
10_1101-2021_01_06_425584	528	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	528	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	528	24	26	26	CD
10_1101-2021_01_06_425584	528	25	72	72	CD
10_1101-2021_01_06_425584	528	26	.	.	.
10_1101-2021_01_06_425584	529	1	Migliaccio	Migliaccio	NNP
10_1101-2021_01_06_425584	529	2	,	,	,
10_1101-2021_01_06_425584	529	3	A.	a.	NN
10_1101-2021_01_06_425584	529	4	;	;	:
10_1101-2021_01_06_425584	529	5	Castoria	Castoria	NNP
10_1101-2021_01_06_425584	529	6	,	,	,
10_1101-2021_01_06_425584	529	7	G.	G.	NNP
10_1101-2021_01_06_425584	529	8	;	;	:
10_1101-2021_01_06_425584	529	9	de	de	NNP
10_1101-2021_01_06_425584	529	10	Falco	Falco	NNP
10_1101-2021_01_06_425584	529	11	,	,	,
10_1101-2021_01_06_425584	529	12	A.	a.	NN
10_1101-2021_01_06_425584	529	13	;	;	:
10_1101-2021_01_06_425584	529	14	Bilancio	Bilancio	NNP
10_1101-2021_01_06_425584	529	15	,	,	,
10_1101-2021_01_06_425584	529	16	A.	a.	NN
10_1101-2021_01_06_425584	529	17	;	;	:
10_1101-2021_01_06_425584	529	18	Giovannelli	Giovannelli	NNP
10_1101-2021_01_06_425584	529	19	,	,	,
10_1101-2021_01_06_425584	529	20	P.	P.	NNP
10_1101-2021_01_06_425584	529	21	;	;	:
10_1101-2021_01_06_425584	529	22	Di	Di	NNP
10_1101-2021_01_06_425584	529	23	Donato	Donato	NNP
10_1101-2021_01_06_425584	529	24	,	,	,
10_1101-2021_01_06_425584	529	25	M.	M.	NNP
10_1101-2021_01_06_425584	529	26	;	;	:
10_1101-2021_01_06_425584	529	27	774	774	CD
10_1101-2021_01_06_425584	529	28	Marino	Marino	NNP
10_1101-2021_01_06_425584	529	29	,	,	,
10_1101-2021_01_06_425584	529	30	I.	i.	NN
10_1101-2021_01_06_425584	529	31	;	;	:
10_1101-2021_01_06_425584	529	32	Yamaguchi	Yamaguchi	NNP
10_1101-2021_01_06_425584	529	33	,	,	,
10_1101-2021_01_06_425584	529	34	H.	H.	NNP
10_1101-2021_01_06_425584	529	35	;	;	:
10_1101-2021_01_06_425584	529	36	Appella	Appella	NNP
10_1101-2021_01_06_425584	529	37	,	,	,
10_1101-2021_01_06_425584	529	38	E.	E.	NNP
10_1101-2021_01_06_425584	529	39	;	;	:
10_1101-2021_01_06_425584	529	40	Auricchio	Auricchio	NNP
10_1101-2021_01_06_425584	529	41	,	,	,
10_1101-2021_01_06_425584	529	42	F.	F.	NNP
10_1101-2021_01_06_425584	529	43	,	,	,
10_1101-2021_01_06_425584	529	44	Polyproline	Polyproline	NNP
10_1101-2021_01_06_425584	529	45	and	and	CC
10_1101-2021_01_06_425584	529	46	Tat	Tat	NNP
10_1101-2021_01_06_425584	529	47	transduction	transduction	NN
10_1101-2021_01_06_425584	529	48	peptides	peptide	VBZ
10_1101-2021_01_06_425584	529	49	775	775	CD
10_1101-2021_01_06_425584	529	50	in	in	IN
10_1101-2021_01_06_425584	529	51	the	the	DT
10_1101-2021_01_06_425584	529	52	study	study	NN
10_1101-2021_01_06_425584	529	53	of	of	IN
10_1101-2021_01_06_425584	529	54	the	the	DT
10_1101-2021_01_06_425584	529	55	rapid	rapid	JJ
10_1101-2021_01_06_425584	529	56	actions	action	NNS
10_1101-2021_01_06_425584	529	57	of	of	IN
10_1101-2021_01_06_425584	529	58	steroid	steroid	NN
10_1101-2021_01_06_425584	529	59	receptors	receptor	NNS
10_1101-2021_01_06_425584	529	60	.	.	.
10_1101-2021_01_06_425584	530	1	Steroids	steroid	NNS
10_1101-2021_01_06_425584	530	2	2012	2012	CD
10_1101-2021_01_06_425584	530	3	,	,	,
10_1101-2021_01_06_425584	530	4	77	77	CD
10_1101-2021_01_06_425584	530	5	,	,	,
10_1101-2021_01_06_425584	530	6	(	(	-LRB-
10_1101-2021_01_06_425584	530	7	10	10	CD
10_1101-2021_01_06_425584	530	8	)	)	-RRB-
10_1101-2021_01_06_425584	530	9	,	,	,
10_1101-2021_01_06_425584	530	10	974	974	CD
10_1101-2021_01_06_425584	530	11	-	-	SYM
10_1101-2021_01_06_425584	530	12	8	8	CD
10_1101-2021_01_06_425584	530	13	.	.	.
10_1101-2021_01_06_425584	531	1	776	776	CD
10_1101-2021_01_06_425584	531	2	73	73	CD
10_1101-2021_01_06_425584	531	3	.	.	.
10_1101-2021_01_06_425584	532	1	Radicioni	Radicioni	NNP
10_1101-2021_01_06_425584	532	2	,	,	,
10_1101-2021_01_06_425584	532	3	G.	G.	NNP
10_1101-2021_01_06_425584	532	4	;	;	:
10_1101-2021_01_06_425584	532	5	Stringaro	Stringaro	NNP
10_1101-2021_01_06_425584	532	6	,	,	,
10_1101-2021_01_06_425584	532	7	A.	a.	NN
10_1101-2021_01_06_425584	532	8	;	;	:
10_1101-2021_01_06_425584	532	9	Molinari	Molinari	NNP
10_1101-2021_01_06_425584	532	10	,	,	,
10_1101-2021_01_06_425584	532	11	A.	a.	NN
10_1101-2021_01_06_425584	532	12	;	;	:
10_1101-2021_01_06_425584	532	13	Nocca	Nocca	NNP
10_1101-2021_01_06_425584	532	14	,	,	,
10_1101-2021_01_06_425584	532	15	G.	G.	NNP
10_1101-2021_01_06_425584	532	16	;	;	:
10_1101-2021_01_06_425584	532	17	Longhi	Longhi	NNP
10_1101-2021_01_06_425584	532	18	,	,	,
10_1101-2021_01_06_425584	532	19	R.	R.	NNP
10_1101-2021_01_06_425584	532	20	;	;	:
10_1101-2021_01_06_425584	532	21	Pirolli	Pirolli	NNP
10_1101-2021_01_06_425584	532	22	,	,	,
10_1101-2021_01_06_425584	532	23	D.	D.	NNP
10_1101-2021_01_06_425584	532	24	;	;	:
10_1101-2021_01_06_425584	532	25	Scarano	Scarano	NNP
10_1101-2021_01_06_425584	532	26	,	,	,
10_1101-2021_01_06_425584	532	27	E.	E.	NNP
10_1101-2021_01_06_425584	532	28	;	;	:
10_1101-2021_01_06_425584	532	29	777	777	CD
10_1101-2021_01_06_425584	532	30	Iavarone	Iavarone	NNP
10_1101-2021_01_06_425584	532	31	,	,	,
10_1101-2021_01_06_425584	532	32	F.	F.	NNP
10_1101-2021_01_06_425584	532	33	;	;	:
10_1101-2021_01_06_425584	532	34	Manconi	Manconi	NNP
10_1101-2021_01_06_425584	532	35	,	,	,
10_1101-2021_01_06_425584	532	36	B.	B.	NNP
10_1101-2021_01_06_425584	532	37	;	;	:
10_1101-2021_01_06_425584	532	38	Cabras	Cabras	NNP
10_1101-2021_01_06_425584	532	39	,	,	,
10_1101-2021_01_06_425584	532	40	T.	T.	NNP
10_1101-2021_01_06_425584	532	41	;	;	:
10_1101-2021_01_06_425584	532	42	Messana	Messana	NNP
10_1101-2021_01_06_425584	532	43	,	,	,
10_1101-2021_01_06_425584	532	44	I.	i.	NN
10_1101-2021_01_06_425584	532	45	;	;	:
10_1101-2021_01_06_425584	532	46	Castagnola	Castagnola	NNP
10_1101-2021_01_06_425584	532	47	,	,	,
10_1101-2021_01_06_425584	532	48	M.	M.	NNP
10_1101-2021_01_06_425584	532	49	;	;	:
10_1101-2021_01_06_425584	532	50	Vitali	Vitali	NNP
10_1101-2021_01_06_425584	532	51	,	,	,
10_1101-2021_01_06_425584	532	52	A.	A.	NNP
10_1101-2021_01_06_425584	532	53	,	,	,
10_1101-2021_01_06_425584	532	54	Characterization	Characterization	NNP
10_1101-2021_01_06_425584	532	55	778	778	CD
10_1101-2021_01_06_425584	532	56	of	of	IN
10_1101-2021_01_06_425584	532	57	the	the	DT
10_1101-2021_01_06_425584	532	58	cell	cell	NN
10_1101-2021_01_06_425584	532	59	penetrating	penetrating	NN
10_1101-2021_01_06_425584	532	60	properties	property	NNS
10_1101-2021_01_06_425584	532	61	of	of	IN
10_1101-2021_01_06_425584	532	62	a	a	DT
10_1101-2021_01_06_425584	532	63	human	human	JJ
10_1101-2021_01_06_425584	532	64	salivary	salivary	JJ
10_1101-2021_01_06_425584	532	65	proline	proline	NN
10_1101-2021_01_06_425584	532	66	-	-	HYPH
10_1101-2021_01_06_425584	532	67	rich	rich	JJ
10_1101-2021_01_06_425584	532	68	peptide	peptide	NN
10_1101-2021_01_06_425584	532	69	.	.	.
10_1101-2021_01_06_425584	533	1	Biochim	Biochim	NNP
10_1101-2021_01_06_425584	533	2	Biophys	Biophys	NNP
10_1101-2021_01_06_425584	533	3	Acta	Acta	NNP
10_1101-2021_01_06_425584	533	4	779	779	CD
10_1101-2021_01_06_425584	533	5	2015	2015	CD
10_1101-2021_01_06_425584	533	6	,	,	,
10_1101-2021_01_06_425584	533	7	1848	1848	CD
10_1101-2021_01_06_425584	533	8	,	,	,
10_1101-2021_01_06_425584	533	9	(	(	-LRB-
10_1101-2021_01_06_425584	533	10	11	11	CD
10_1101-2021_01_06_425584	533	11	Pt	Pt	NNP
10_1101-2021_01_06_425584	533	12	A	A	NNP
10_1101-2021_01_06_425584	533	13	)	)	-RRB-
10_1101-2021_01_06_425584	533	14	,	,	,
10_1101-2021_01_06_425584	533	15	2868	2868	CD
10_1101-2021_01_06_425584	533	16	-	-	SYM
10_1101-2021_01_06_425584	533	17	77	77	CD
10_1101-2021_01_06_425584	533	18	.	.	.
10_1101-2021_01_06_425584	534	1	780	780	CD
10_1101-2021_01_06_425584	534	2	74	74	CD
10_1101-2021_01_06_425584	534	3	.	.	.
10_1101-2021_01_06_425584	535	1	Vanhoof	Vanhoof	NNP
10_1101-2021_01_06_425584	535	2	,	,	,
10_1101-2021_01_06_425584	535	3	G.	G.	NNP
10_1101-2021_01_06_425584	535	4	;	;	:
10_1101-2021_01_06_425584	535	5	Goossens	Goossens	NNP
10_1101-2021_01_06_425584	535	6	,	,	,
10_1101-2021_01_06_425584	535	7	F.	F.	NNP
10_1101-2021_01_06_425584	535	8	;	;	:
10_1101-2021_01_06_425584	535	9	De	De	NNP
10_1101-2021_01_06_425584	535	10	Meester	Meester	NNP
10_1101-2021_01_06_425584	535	11	,	,	,
10_1101-2021_01_06_425584	535	12	I.	I.	NNP
10_1101-2021_01_06_425584	535	13	;	;	:
10_1101-2021_01_06_425584	535	14	Hendriks	Hendriks	NNP
10_1101-2021_01_06_425584	535	15	,	,	,
10_1101-2021_01_06_425584	535	16	D.	D.	NNP
10_1101-2021_01_06_425584	535	17	;	;	:
10_1101-2021_01_06_425584	535	18	Scharpe	Scharpe	NNP
10_1101-2021_01_06_425584	535	19	,	,	,
10_1101-2021_01_06_425584	535	20	S.	S.	NNP
10_1101-2021_01_06_425584	535	21	,	,	,
10_1101-2021_01_06_425584	535	22	Proline	Proline	NNP
10_1101-2021_01_06_425584	535	23	motifs	motif	VBZ
10_1101-2021_01_06_425584	535	24	in	in	IN
10_1101-2021_01_06_425584	535	25	781	781	CD
10_1101-2021_01_06_425584	535	26	peptides	peptide	NNS
10_1101-2021_01_06_425584	535	27	and	and	CC
10_1101-2021_01_06_425584	535	28	their	-PRON-	PRP$
10_1101-2021_01_06_425584	535	29	biological	biological	JJ
10_1101-2021_01_06_425584	535	30	processing	processing	NN
10_1101-2021_01_06_425584	535	31	.	.	.
10_1101-2021_01_06_425584	536	1	FASEB	FASEB	NNP
10_1101-2021_01_06_425584	536	2	J	J	NNP
10_1101-2021_01_06_425584	536	3	1995	1995	CD
10_1101-2021_01_06_425584	536	4	,	,	,
10_1101-2021_01_06_425584	536	5	9	9	CD
10_1101-2021_01_06_425584	536	6	,	,	,
10_1101-2021_01_06_425584	536	7	(	(	-LRB-
10_1101-2021_01_06_425584	536	8	9	9	CD
10_1101-2021_01_06_425584	536	9	)	)	-RRB-
10_1101-2021_01_06_425584	536	10	,	,	,
10_1101-2021_01_06_425584	536	11	736	736	CD
10_1101-2021_01_06_425584	536	12	-	-	SYM
10_1101-2021_01_06_425584	536	13	44	44	CD
10_1101-2021_01_06_425584	536	14	.	.	.
10_1101-2021_01_06_425584	537	1	782	782	CD
10_1101-2021_01_06_425584	537	2	75	75	CD
10_1101-2021_01_06_425584	537	3	.	.	.
10_1101-2021_01_06_425584	538	1	Colombo	Colombo	NNP
10_1101-2021_01_06_425584	538	2	,	,	,
10_1101-2021_01_06_425584	538	3	S.	S.	NNP
10_1101-2021_01_06_425584	538	4	;	;	:
10_1101-2021_01_06_425584	538	5	Melo	Melo	NNP
10_1101-2021_01_06_425584	538	6	,	,	,
10_1101-2021_01_06_425584	538	7	T.	t.	NN
10_1101-2021_01_06_425584	538	8	;	;	:
10_1101-2021_01_06_425584	538	9	Martinez	Martinez	NNP
10_1101-2021_01_06_425584	538	10	-	-	HYPH
10_1101-2021_01_06_425584	538	11	Lopez	Lopez	NNP
10_1101-2021_01_06_425584	538	12	,	,	,
10_1101-2021_01_06_425584	538	13	M.	M.	NNP
10_1101-2021_01_06_425584	538	14	;	;	:
10_1101-2021_01_06_425584	538	15	Carrasco	Carrasco	NNP
10_1101-2021_01_06_425584	538	16	,	,	,
10_1101-2021_01_06_425584	538	17	M.	M.	NNP
10_1101-2021_01_06_425584	538	18	J.	J.	NNP
10_1101-2021_01_06_425584	538	19	;	;	:
10_1101-2021_01_06_425584	538	20	Domingues	Domingues	NNP
10_1101-2021_01_06_425584	538	21	,	,	,
10_1101-2021_01_06_425584	538	22	M.	M.	NNP
10_1101-2021_01_06_425584	538	23	R.	R.	NNP
10_1101-2021_01_06_425584	538	24	;	;	:
10_1101-2021_01_06_425584	538	25	Perez-783	Perez-783	.
10_1101-2021_01_06_425584	538	26	Sala	Sala	NNP
10_1101-2021_01_06_425584	538	27	,	,	,
10_1101-2021_01_06_425584	538	28	D.	D.	NNP
10_1101-2021_01_06_425584	538	29	;	;	:
10_1101-2021_01_06_425584	538	30	Domingues	Domingues	NNP
10_1101-2021_01_06_425584	538	31	,	,	,
10_1101-2021_01_06_425584	538	32	P.	P.	NNP
10_1101-2021_01_06_425584	538	33	,	,	,
10_1101-2021_01_06_425584	538	34	Phospholipidome	Phospholipidome	NNP
10_1101-2021_01_06_425584	538	35	of	of	IN
10_1101-2021_01_06_425584	538	36	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	538	37	cells	cell	NNS
10_1101-2021_01_06_425584	538	38	shows	show	VBZ
10_1101-2021_01_06_425584	538	39	a	a	DT
10_1101-2021_01_06_425584	538	40	different	different	JJ
10_1101-2021_01_06_425584	538	41	adaptation	adaptation	NN
10_1101-2021_01_06_425584	538	42	784	784	CD
10_1101-2021_01_06_425584	538	43	response	response	NN
10_1101-2021_01_06_425584	538	44	upon	upon	IN
10_1101-2021_01_06_425584	538	45	oxidative	oxidative	JJ
10_1101-2021_01_06_425584	538	46	,	,	,
10_1101-2021_01_06_425584	538	47	glycative	glycative	JJ
10_1101-2021_01_06_425584	538	48	and	and	CC
10_1101-2021_01_06_425584	538	49	lipoxidative	lipoxidative	JJ
10_1101-2021_01_06_425584	538	50	stress	stress	NN
10_1101-2021_01_06_425584	538	51	.	.	.
10_1101-2021_01_06_425584	539	1	Sci	Sci	NNP
10_1101-2021_01_06_425584	539	2	Rep	Rep	NNP
10_1101-2021_01_06_425584	539	3	2018	2018	CD
10_1101-2021_01_06_425584	539	4	,	,	,
10_1101-2021_01_06_425584	539	5	8	8	CD
10_1101-2021_01_06_425584	539	6	,	,	,
10_1101-2021_01_06_425584	539	7	(	(	-LRB-
10_1101-2021_01_06_425584	539	8	1	1	CD
10_1101-2021_01_06_425584	539	9	)	)	-RRB-
10_1101-2021_01_06_425584	539	10	,	,	,
10_1101-2021_01_06_425584	539	11	12365	12365	CD
10_1101-2021_01_06_425584	539	12	.	.	.
10_1101-2021_01_06_425584	540	1	785	785	CD
10_1101-2021_01_06_425584	540	2	76	76	CD
10_1101-2021_01_06_425584	540	3	.	.	.
10_1101-2021_01_06_425584	541	1	De	De	NNP
10_1101-2021_01_06_425584	541	2	Keyzer	Keyzer	NNP
10_1101-2021_01_06_425584	541	3	,	,	,
10_1101-2021_01_06_425584	541	4	D.	D.	NNP
10_1101-2021_01_06_425584	541	5	;	;	:
10_1101-2021_01_06_425584	541	6	Karabina	Karabina	NNP
10_1101-2021_01_06_425584	541	7	,	,	,
10_1101-2021_01_06_425584	541	8	S.	S.	NNP
10_1101-2021_01_06_425584	541	9	A.	A.	NNP
10_1101-2021_01_06_425584	541	10	;	;	:
10_1101-2021_01_06_425584	541	11	Wei	Wei	NNP
10_1101-2021_01_06_425584	541	12	,	,	,
10_1101-2021_01_06_425584	541	13	W.	W.	NNP
10_1101-2021_01_06_425584	541	14	;	;	:
10_1101-2021_01_06_425584	541	15	Geeraert	Geeraert	NNP
10_1101-2021_01_06_425584	541	16	,	,	,
10_1101-2021_01_06_425584	541	17	B.	B.	NNP
10_1101-2021_01_06_425584	541	18	;	;	:
10_1101-2021_01_06_425584	541	19	Stengel	Stengel	NNP
10_1101-2021_01_06_425584	541	20	,	,	,
10_1101-2021_01_06_425584	541	21	D.	D.	NNP
10_1101-2021_01_06_425584	541	22	;	;	:
10_1101-2021_01_06_425584	541	23	Marsillach	Marsillach	NNP
10_1101-2021_01_06_425584	541	24	,	,	,
10_1101-2021_01_06_425584	541	25	J.	J.	NNP
10_1101-2021_01_06_425584	541	26	;	;	:
10_1101-2021_01_06_425584	541	27	786	786	CD
10_1101-2021_01_06_425584	541	28	Camps	Camps	NNPS
10_1101-2021_01_06_425584	541	29	,	,	,
10_1101-2021_01_06_425584	541	30	J.	J.	NNP
10_1101-2021_01_06_425584	541	31	;	;	:
10_1101-2021_01_06_425584	541	32	Holvoet	Holvoet	NNP
10_1101-2021_01_06_425584	541	33	,	,	,
10_1101-2021_01_06_425584	541	34	P.	P.	NNP
10_1101-2021_01_06_425584	541	35	;	;	:
10_1101-2021_01_06_425584	541	36	Ninio	Ninio	NNP
10_1101-2021_01_06_425584	541	37	,	,	,
10_1101-2021_01_06_425584	541	38	E.	E.	NNP
10_1101-2021_01_06_425584	541	39	,	,	,
10_1101-2021_01_06_425584	541	40	Increased	Increased	NNP
10_1101-2021_01_06_425584	541	41	PAFAH	PAFAH	NNP
10_1101-2021_01_06_425584	541	42	and	and	CC
10_1101-2021_01_06_425584	541	43	oxidized	oxidize	VBN
10_1101-2021_01_06_425584	541	44	lipids	lipid	NNS
10_1101-2021_01_06_425584	541	45	are	be	VBP
10_1101-2021_01_06_425584	541	46	associated	associate	VBN
10_1101-2021_01_06_425584	541	47	with	with	IN
10_1101-2021_01_06_425584	541	48	787	787	CD
10_1101-2021_01_06_425584	541	49	inflammation	inflammation	NN
10_1101-2021_01_06_425584	541	50	and	and	CC
10_1101-2021_01_06_425584	541	51	atherosclerosis	atherosclerosis	NN
10_1101-2021_01_06_425584	541	52	in	in	IN
10_1101-2021_01_06_425584	541	53	hypercholesterolemic	hypercholesterolemic	JJ
10_1101-2021_01_06_425584	541	54	pigs	pig	NNS
10_1101-2021_01_06_425584	541	55	.	.	.
10_1101-2021_01_06_425584	542	1	Arterioscler	Arterioscler	NNP
10_1101-2021_01_06_425584	542	2	Thromb	Thromb	NNP
10_1101-2021_01_06_425584	542	3	Vasc	Vasc	NNP
10_1101-2021_01_06_425584	542	4	Biol	Biol	NNP
10_1101-2021_01_06_425584	542	5	788	788	CD
10_1101-2021_01_06_425584	542	6	2009	2009	CD
10_1101-2021_01_06_425584	542	7	,	,	,
10_1101-2021_01_06_425584	542	8	29	29	CD
10_1101-2021_01_06_425584	542	9	,	,	,
10_1101-2021_01_06_425584	542	10	(	(	-LRB-
10_1101-2021_01_06_425584	542	11	12	12	CD
10_1101-2021_01_06_425584	542	12	)	)	-RRB-
10_1101-2021_01_06_425584	542	13	,	,	,
10_1101-2021_01_06_425584	542	14	2041	2041	CD
10_1101-2021_01_06_425584	542	15	-	-	SYM
10_1101-2021_01_06_425584	542	16	6	6	CD
10_1101-2021_01_06_425584	542	17	.	.	.
10_1101-2021_01_06_425584	543	1	789	789	CD
10_1101-2021_01_06_425584	543	2	77	77	CD
10_1101-2021_01_06_425584	543	3	.	.	.
10_1101-2021_01_06_425584	544	1	Tselepis	tselepis	NN
10_1101-2021_01_06_425584	544	2	,	,	,
10_1101-2021_01_06_425584	544	3	A.	A.	NNP
10_1101-2021_01_06_425584	544	4	D.	D.	NNP
10_1101-2021_01_06_425584	544	5	;	;	:
10_1101-2021_01_06_425584	544	6	John	John	NNP
10_1101-2021_01_06_425584	544	7	Chapman	Chapman	NNP
10_1101-2021_01_06_425584	544	8	,	,	,
10_1101-2021_01_06_425584	544	9	M.	M.	NNP
10_1101-2021_01_06_425584	544	10	,	,	,
10_1101-2021_01_06_425584	544	11	Inflammation	Inflammation	NNP
10_1101-2021_01_06_425584	544	12	,	,	,
10_1101-2021_01_06_425584	544	13	bioactive	bioactive	JJ
10_1101-2021_01_06_425584	544	14	lipids	lipid	NNS
10_1101-2021_01_06_425584	544	15	and	and	CC
10_1101-2021_01_06_425584	544	16	atherosclerosis	atherosclerosis	NN
10_1101-2021_01_06_425584	544	17	:	:	:
10_1101-2021_01_06_425584	544	18	790	790	CD
10_1101-2021_01_06_425584	544	19	potential	potential	JJ
10_1101-2021_01_06_425584	544	20	roles	role	NNS
10_1101-2021_01_06_425584	544	21	of	of	IN
10_1101-2021_01_06_425584	544	22	a	a	DT
10_1101-2021_01_06_425584	544	23	lipoprotein	lipoprotein	RB
10_1101-2021_01_06_425584	544	24	-	-	HYPH
10_1101-2021_01_06_425584	544	25	associated	associated	JJ
10_1101-2021_01_06_425584	544	26	phospholipase	phospholipase	NN
10_1101-2021_01_06_425584	544	27	A2	a2	NN
10_1101-2021_01_06_425584	544	28	,	,	,
10_1101-2021_01_06_425584	544	29	platelet	platelet	RB
10_1101-2021_01_06_425584	544	30	activating	activate	VBG
10_1101-2021_01_06_425584	544	31	factor-791	factor-791	NNP
10_1101-2021_01_06_425584	544	32	acetylhydrolase	acetylhydrolase	NN
10_1101-2021_01_06_425584	544	33	.	.	.
10_1101-2021_01_06_425584	545	1	Atheroscler	Atheroscler	NNP
10_1101-2021_01_06_425584	545	2	Suppl	Suppl	NNP
10_1101-2021_01_06_425584	545	3	2002	2002	CD
10_1101-2021_01_06_425584	545	4	,	,	,
10_1101-2021_01_06_425584	545	5	3	3	CD
10_1101-2021_01_06_425584	545	6	,	,	,
10_1101-2021_01_06_425584	545	7	(	(	-LRB-
10_1101-2021_01_06_425584	545	8	4	4	CD
10_1101-2021_01_06_425584	545	9	)	)	-RRB-
10_1101-2021_01_06_425584	545	10	,	,	,
10_1101-2021_01_06_425584	545	11	57	57	CD
10_1101-2021_01_06_425584	545	12	-	-	SYM
10_1101-2021_01_06_425584	545	13	68	68	CD
10_1101-2021_01_06_425584	545	14	.	.	.
10_1101-2021_01_06_425584	546	1	792	792	CD
10_1101-2021_01_06_425584	546	2	78	78	CD
10_1101-2021_01_06_425584	546	3	.	.	.
10_1101-2021_01_06_425584	547	1	Wang	Wang	NNP
10_1101-2021_01_06_425584	547	2	,	,	,
10_1101-2021_01_06_425584	547	3	A.	A.	NNP
10_1101-2021_01_06_425584	547	4	;	;	:
10_1101-2021_01_06_425584	547	5	Dennis	Dennis	NNP
10_1101-2021_01_06_425584	547	6	,	,	,
10_1101-2021_01_06_425584	547	7	E.	E.	NNP
10_1101-2021_01_06_425584	547	8	A.	A.	NNP
10_1101-2021_01_06_425584	547	9	,	,	,
10_1101-2021_01_06_425584	547	10	Mammalian	mammalian	JJ
10_1101-2021_01_06_425584	547	11	lysophospholipases	lysophospholipase	NNS
10_1101-2021_01_06_425584	547	12	.	.	.
10_1101-2021_01_06_425584	548	1	Biochim	Biochim	NNP
10_1101-2021_01_06_425584	548	2	Biophys	Biophys	NNP
10_1101-2021_01_06_425584	548	3	Acta	Acta	NNP
10_1101-2021_01_06_425584	548	4	1999	1999	CD
10_1101-2021_01_06_425584	548	5	,	,	,
10_1101-2021_01_06_425584	548	6	793	793	CD
10_1101-2021_01_06_425584	548	7	1439	1439	CD
10_1101-2021_01_06_425584	548	8	,	,	,
10_1101-2021_01_06_425584	548	9	(	(	-LRB-
10_1101-2021_01_06_425584	548	10	1	1	CD
10_1101-2021_01_06_425584	548	11	)	)	-RRB-
10_1101-2021_01_06_425584	548	12	,	,	,
10_1101-2021_01_06_425584	548	13	1	1	CD
10_1101-2021_01_06_425584	548	14	-	-	SYM
10_1101-2021_01_06_425584	548	15	16	16	CD
10_1101-2021_01_06_425584	548	16	.	.	.
10_1101-2021_01_06_425584	549	1	794	794	CD
10_1101-2021_01_06_425584	549	2	79	79	CD
10_1101-2021_01_06_425584	549	3	.	.	.
10_1101-2021_01_06_425584	550	1	Marco	Marco	NNP
10_1101-2021_01_06_425584	550	2	-	-	HYPH
10_1101-2021_01_06_425584	550	3	Ramell	Ramell	NNP
10_1101-2021_01_06_425584	550	4	,	,	,
10_1101-2021_01_06_425584	550	5	A.	a.	NN
10_1101-2021_01_06_425584	550	6	;	;	:
10_1101-2021_01_06_425584	550	7	Palau	Palau	NNP
10_1101-2021_01_06_425584	550	8	-	-	HYPH
10_1101-2021_01_06_425584	550	9	Rodriguez	Rodriguez	NNP
10_1101-2021_01_06_425584	550	10	,	,	,
10_1101-2021_01_06_425584	550	11	M.	M.	NNP
10_1101-2021_01_06_425584	550	12	;	;	:
10_1101-2021_01_06_425584	550	13	Alay	Alay	NNP
10_1101-2021_01_06_425584	550	14	,	,	,
10_1101-2021_01_06_425584	550	15	A.	a.	NN
10_1101-2021_01_06_425584	550	16	;	;	:
10_1101-2021_01_06_425584	550	17	Tulipani	Tulipani	NNP
10_1101-2021_01_06_425584	550	18	,	,	,
10_1101-2021_01_06_425584	550	19	S.	S.	NNP
10_1101-2021_01_06_425584	550	20	;	;	:
10_1101-2021_01_06_425584	550	21	Urpi	Urpi	NNP
10_1101-2021_01_06_425584	550	22	-	-	HYPH
10_1101-2021_01_06_425584	550	23	Sarda	Sarda	NNP
10_1101-2021_01_06_425584	550	24	,	,	,
10_1101-2021_01_06_425584	550	25	M.	M.	NNP
10_1101-2021_01_06_425584	550	26	;	;	:
10_1101-2021_01_06_425584	550	27	Sanchez-795	Sanchez-795	.
10_1101-2021_01_06_425584	550	28	Pla	Pla	NNP
10_1101-2021_01_06_425584	550	29	,	,	,
10_1101-2021_01_06_425584	550	30	A.	a.	NN
10_1101-2021_01_06_425584	550	31	;	;	:
10_1101-2021_01_06_425584	550	32	Andres	Andres	NNP
10_1101-2021_01_06_425584	550	33	-	-	HYPH
10_1101-2021_01_06_425584	550	34	Lacueva	Lacueva	NNP
10_1101-2021_01_06_425584	550	35	,	,	,
10_1101-2021_01_06_425584	550	36	C.	C.	NNP
10_1101-2021_01_06_425584	550	37	,	,	,
10_1101-2021_01_06_425584	550	38	Evaluation	Evaluation	NNP
10_1101-2021_01_06_425584	550	39	and	and	CC
10_1101-2021_01_06_425584	550	40	comparison	comparison	NN
10_1101-2021_01_06_425584	550	41	of	of	IN
10_1101-2021_01_06_425584	550	42	bioinformatic	bioinformatic	JJ
10_1101-2021_01_06_425584	550	43	tools	tool	NNS
10_1101-2021_01_06_425584	550	44	for	for	IN
10_1101-2021_01_06_425584	550	45	the	the	DT
10_1101-2021_01_06_425584	550	46	796	796	CD
10_1101-2021_01_06_425584	550	47	enrichment	enrichment	NN
10_1101-2021_01_06_425584	550	48	analysis	analysis	NN
10_1101-2021_01_06_425584	550	49	of	of	IN
10_1101-2021_01_06_425584	550	50	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	550	51	data	datum	NNS
10_1101-2021_01_06_425584	550	52	.	.	.
10_1101-2021_01_06_425584	551	1	BMC	BMC	NNP
10_1101-2021_01_06_425584	551	2	Bioinformatics	Bioinformatics	NNP
10_1101-2021_01_06_425584	551	3	2018	2018	CD
10_1101-2021_01_06_425584	551	4	,	,	,
10_1101-2021_01_06_425584	551	5	19	19	CD
10_1101-2021_01_06_425584	551	6	,	,	,
10_1101-2021_01_06_425584	551	7	(	(	-LRB-
10_1101-2021_01_06_425584	551	8	1	1	CD
10_1101-2021_01_06_425584	551	9	)	)	-RRB-
10_1101-2021_01_06_425584	551	10	,	,	,
10_1101-2021_01_06_425584	551	11	1	1	CD
10_1101-2021_01_06_425584	551	12	.	.	.
10_1101-2021_01_06_425584	552	1	797	797	CD
10_1101-2021_01_06_425584	552	2	80	80	CD
10_1101-2021_01_06_425584	552	3	.	.	.
10_1101-2021_01_06_425584	553	1	Zhou	Zhou	NNP
10_1101-2021_01_06_425584	553	2	,	,	,
10_1101-2021_01_06_425584	553	3	X.	X.	NNP
10_1101-2021_01_06_425584	553	4	;	;	:
10_1101-2021_01_06_425584	553	5	Liao	Liao	NNP
10_1101-2021_01_06_425584	553	6	,	,	,
10_1101-2021_01_06_425584	553	7	W.	W.	NNP
10_1101-2021_01_06_425584	553	8	J.	J.	NNP
10_1101-2021_01_06_425584	553	9	;	;	:
10_1101-2021_01_06_425584	553	10	Liao	Liao	NNP
10_1101-2021_01_06_425584	553	11	,	,	,
10_1101-2021_01_06_425584	553	12	J.	J.	NNP
10_1101-2021_01_06_425584	553	13	M.	M.	NNP
10_1101-2021_01_06_425584	553	14	;	;	:
10_1101-2021_01_06_425584	553	15	Liao	Liao	NNP
10_1101-2021_01_06_425584	553	16	,	,	,
10_1101-2021_01_06_425584	553	17	P.	P.	NNP
10_1101-2021_01_06_425584	553	18	;	;	:
10_1101-2021_01_06_425584	553	19	Lu	Lu	NNP
10_1101-2021_01_06_425584	553	20	,	,	,
10_1101-2021_01_06_425584	553	21	H.	H.	NNP
10_1101-2021_01_06_425584	553	22	,	,	,
10_1101-2021_01_06_425584	553	23	Ribosomal	Ribosomal	NNP
10_1101-2021_01_06_425584	553	24	proteins	protein	NNS
10_1101-2021_01_06_425584	553	25	:	:	:
10_1101-2021_01_06_425584	553	26	functions	function	NNS
10_1101-2021_01_06_425584	553	27	beyond	beyond	IN
10_1101-2021_01_06_425584	553	28	798	798	CD
10_1101-2021_01_06_425584	553	29	the	the	DT
10_1101-2021_01_06_425584	553	30	ribosome	ribosome	NN
10_1101-2021_01_06_425584	553	31	.	.	.
10_1101-2021_01_06_425584	554	1	J	J	NNP
10_1101-2021_01_06_425584	554	2	Mol	Mol	NNP
10_1101-2021_01_06_425584	554	3	Cell	Cell	NNP
10_1101-2021_01_06_425584	554	4	Biol	Biol	NNP
10_1101-2021_01_06_425584	554	5	2015	2015	CD
10_1101-2021_01_06_425584	554	6	,	,	,
10_1101-2021_01_06_425584	554	7	7	7	CD
10_1101-2021_01_06_425584	554	8	,	,	,
10_1101-2021_01_06_425584	554	9	(	(	-LRB-
10_1101-2021_01_06_425584	554	10	2	2	CD
10_1101-2021_01_06_425584	554	11	)	)	-RRB-
10_1101-2021_01_06_425584	554	12	,	,	,
10_1101-2021_01_06_425584	554	13	92	92	CD
10_1101-2021_01_06_425584	554	14	-	-	HYPH
10_1101-2021_01_06_425584	554	15	104	104	CD
10_1101-2021_01_06_425584	554	16	.	.	.
10_1101-2021_01_06_425584	555	1	799	799	CD
10_1101-2021_01_06_425584	555	2	81	81	CD
10_1101-2021_01_06_425584	555	3	.	.	.
10_1101-2021_01_06_425584	556	1	Goldberg	Goldberg	NNP
10_1101-2021_01_06_425584	556	2	,	,	,
10_1101-2021_01_06_425584	556	3	A.	A.	NNP
10_1101-2021_01_06_425584	556	4	L.	L.	NNP
10_1101-2021_01_06_425584	556	5	,	,	,
10_1101-2021_01_06_425584	556	6	Protein	Protein	NNP
10_1101-2021_01_06_425584	556	7	degradation	degradation	NN
10_1101-2021_01_06_425584	556	8	and	and	CC
10_1101-2021_01_06_425584	556	9	protection	protection	NN
10_1101-2021_01_06_425584	556	10	against	against	IN
10_1101-2021_01_06_425584	556	11	misfolded	misfolde	VBN
10_1101-2021_01_06_425584	556	12	or	or	CC
10_1101-2021_01_06_425584	556	13	damaged	damage	VBN
10_1101-2021_01_06_425584	556	14	800	800	CD
10_1101-2021_01_06_425584	556	15	proteins	protein	NNS
10_1101-2021_01_06_425584	556	16	.	.	.
10_1101-2021_01_06_425584	557	1	Nature	nature	NN
10_1101-2021_01_06_425584	557	2	2003	2003	CD
10_1101-2021_01_06_425584	557	3	,	,	,
10_1101-2021_01_06_425584	557	4	426	426	CD
10_1101-2021_01_06_425584	557	5	,	,	,
10_1101-2021_01_06_425584	557	6	(	(	-LRB-
10_1101-2021_01_06_425584	557	7	6968	6968	CD
10_1101-2021_01_06_425584	557	8	)	)	-RRB-
10_1101-2021_01_06_425584	557	9	,	,	,
10_1101-2021_01_06_425584	557	10	895	895	CD
10_1101-2021_01_06_425584	557	11	-	-	SYM
10_1101-2021_01_06_425584	557	12	9	9	CD
10_1101-2021_01_06_425584	557	13	.	.	.
10_1101-2021_01_06_425584	558	1	801	801	CD
10_1101-2021_01_06_425584	558	2	82	82	CD
10_1101-2021_01_06_425584	558	3	.	.	.
10_1101-2021_01_06_425584	559	1	Vinals	vinal	NNS
10_1101-2021_01_06_425584	559	2	,	,	,
10_1101-2021_01_06_425584	559	3	F.	F.	NNP
10_1101-2021_01_06_425584	559	4	;	;	:
10_1101-2021_01_06_425584	559	5	Pouyssegur	Pouyssegur	NNP
10_1101-2021_01_06_425584	559	6	,	,	,
10_1101-2021_01_06_425584	559	7	J.	J.	NNP
10_1101-2021_01_06_425584	559	8	,	,	,
10_1101-2021_01_06_425584	559	9	Confluence	Confluence	NNP
10_1101-2021_01_06_425584	559	10	of	of	IN
10_1101-2021_01_06_425584	559	11	vascular	vascular	JJ
10_1101-2021_01_06_425584	559	12	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	559	13	cells	cell	NNS
10_1101-2021_01_06_425584	559	14	induces	induce	VBZ
10_1101-2021_01_06_425584	559	15	cell	cell	NN
10_1101-2021_01_06_425584	559	16	cycle	cycle	NN
10_1101-2021_01_06_425584	559	17	802	802	CD
10_1101-2021_01_06_425584	559	18	exit	exit	NN
10_1101-2021_01_06_425584	559	19	by	by	IN
10_1101-2021_01_06_425584	559	20	inhibiting	inhibit	VBG
10_1101-2021_01_06_425584	559	21	p42	p42	NN
10_1101-2021_01_06_425584	559	22	/	/	SYM
10_1101-2021_01_06_425584	559	23	p44	p44	NNP
10_1101-2021_01_06_425584	559	24	mitogen	mitogen	NN
10_1101-2021_01_06_425584	559	25	-	-	HYPH
10_1101-2021_01_06_425584	559	26	activated	activate	VBN
10_1101-2021_01_06_425584	559	27	protein	protein	NN
10_1101-2021_01_06_425584	559	28	kinase	kinase	NN
10_1101-2021_01_06_425584	559	29	activity	activity	NN
10_1101-2021_01_06_425584	559	30	.	.	.
10_1101-2021_01_06_425584	560	1	Mol	Mol	NNP
10_1101-2021_01_06_425584	560	2	Cell	Cell	NNP
10_1101-2021_01_06_425584	560	3	Biol	Biol	NNP
10_1101-2021_01_06_425584	560	4	1999	1999	CD
10_1101-2021_01_06_425584	560	5	,	,	,
10_1101-2021_01_06_425584	560	6	19	19	CD
10_1101-2021_01_06_425584	560	7	,	,	,
10_1101-2021_01_06_425584	560	8	(	(	-LRB-
10_1101-2021_01_06_425584	560	9	4	4	CD
10_1101-2021_01_06_425584	560	10	)	)	-RRB-
10_1101-2021_01_06_425584	560	11	,	,	,
10_1101-2021_01_06_425584	560	12	803	803	CD
10_1101-2021_01_06_425584	560	13	2763	2763	CD
10_1101-2021_01_06_425584	560	14	-	-	SYM
10_1101-2021_01_06_425584	560	15	72	72	CD
10_1101-2021_01_06_425584	560	16	.	.	.
10_1101-2021_01_06_425584	561	1	804	804	CD
10_1101-2021_01_06_425584	561	2	83	83	CD
10_1101-2021_01_06_425584	561	3	.	.	.
10_1101-2021_01_06_425584	562	1	Yu	Yu	NNP
10_1101-2021_01_06_425584	562	2	,	,	,
10_1101-2021_01_06_425584	562	3	Y.	Y.	NNP
10_1101-2021_01_06_425584	562	4	;	;	:
10_1101-2021_01_06_425584	562	5	Moulton	Moulton	NNP
10_1101-2021_01_06_425584	562	6	,	,	,
10_1101-2021_01_06_425584	562	7	K.	K.	NNP
10_1101-2021_01_06_425584	562	8	S.	S.	NNP
10_1101-2021_01_06_425584	562	9	;	;	:
10_1101-2021_01_06_425584	562	10	Khan	Khan	NNP
10_1101-2021_01_06_425584	562	11	,	,	,
10_1101-2021_01_06_425584	562	12	M.	M.	NNP
10_1101-2021_01_06_425584	562	13	K.	K.	NNP
10_1101-2021_01_06_425584	562	14	;	;	:
10_1101-2021_01_06_425584	562	15	Vineberg	Vineberg	NNP
10_1101-2021_01_06_425584	562	16	,	,	,
10_1101-2021_01_06_425584	562	17	S.	S.	NNP
10_1101-2021_01_06_425584	562	18	;	;	:
10_1101-2021_01_06_425584	562	19	Boye	Boye	NNP
10_1101-2021_01_06_425584	562	20	,	,	,
10_1101-2021_01_06_425584	562	21	E.	E.	NNP
10_1101-2021_01_06_425584	562	22	;	;	:
10_1101-2021_01_06_425584	562	23	Davis	Davis	NNP
10_1101-2021_01_06_425584	562	24	,	,	,
10_1101-2021_01_06_425584	562	25	V.	V.	NNP
10_1101-2021_01_06_425584	562	26	M.	M.	NNP
10_1101-2021_01_06_425584	562	27	;	;	:
10_1101-2021_01_06_425584	562	28	O'Donnell	O'Donnell	NNP
10_1101-2021_01_06_425584	562	29	,	,	,
10_1101-2021_01_06_425584	562	30	P.	P.	NNP
10_1101-2021_01_06_425584	562	31	805	805	CD
10_1101-2021_01_06_425584	562	32	E.	E.	NNP
10_1101-2021_01_06_425584	562	33	;	;	:
10_1101-2021_01_06_425584	562	34	Bischoff	Bischoff	NNP
10_1101-2021_01_06_425584	562	35	,	,	,
10_1101-2021_01_06_425584	562	36	J.	J.	NNP
10_1101-2021_01_06_425584	562	37	;	;	:
10_1101-2021_01_06_425584	562	38	Milstone	Milstone	NNP
10_1101-2021_01_06_425584	562	39	,	,	,
10_1101-2021_01_06_425584	562	40	D.	D.	NNP
10_1101-2021_01_06_425584	562	41	S.	S.	NNP
10_1101-2021_01_06_425584	562	42	,	,	,
10_1101-2021_01_06_425584	562	43	E	E	NNP
10_1101-2021_01_06_425584	562	44	-	-	NN
10_1101-2021_01_06_425584	562	45	selectin	selectin	NN
10_1101-2021_01_06_425584	562	46	is	be	VBZ
10_1101-2021_01_06_425584	562	47	required	require	VBN
10_1101-2021_01_06_425584	562	48	for	for	IN
10_1101-2021_01_06_425584	562	49	the	the	DT
10_1101-2021_01_06_425584	562	50	antiangiogenic	antiangiogenic	JJ
10_1101-2021_01_06_425584	562	51	activity	activity	NN
10_1101-2021_01_06_425584	562	52	of	of	IN
10_1101-2021_01_06_425584	562	53	806	806	CD
10_1101-2021_01_06_425584	562	54	endostatin	endostatin	NNS
10_1101-2021_01_06_425584	562	55	.	.	.
10_1101-2021_01_06_425584	563	1	Proc	Proc	NNP
10_1101-2021_01_06_425584	563	2	Natl	Natl	NNP
10_1101-2021_01_06_425584	563	3	Acad	Acad	NNP
10_1101-2021_01_06_425584	563	4	Sci	Sci	NNP
10_1101-2021_01_06_425584	563	5	U	U	NNP
10_1101-2021_01_06_425584	563	6	S	S	NNP
10_1101-2021_01_06_425584	563	7	A	A	NNP
10_1101-2021_01_06_425584	563	8	2004	2004	CD
10_1101-2021_01_06_425584	563	9	,	,	,
10_1101-2021_01_06_425584	563	10	101	101	CD
10_1101-2021_01_06_425584	563	11	,	,	,
10_1101-2021_01_06_425584	563	12	(	(	-LRB-
10_1101-2021_01_06_425584	563	13	21	21	CD
10_1101-2021_01_06_425584	563	14	)	)	-RRB-
10_1101-2021_01_06_425584	563	15	,	,	,
10_1101-2021_01_06_425584	563	16	8005	8005	CD
10_1101-2021_01_06_425584	563	17	-	-	SYM
10_1101-2021_01_06_425584	563	18	10	10	CD
10_1101-2021_01_06_425584	563	19	.	.	.
10_1101-2021_01_06_425584	564	1	807	807	CD
10_1101-2021_01_06_425584	564	2	84	84	CD
10_1101-2021_01_06_425584	564	3	.	.	.
10_1101-2021_01_06_425584	565	1	Brigstock	Brigstock	NNP
10_1101-2021_01_06_425584	565	2	,	,	,
10_1101-2021_01_06_425584	565	3	D.	D.	NNP
10_1101-2021_01_06_425584	565	4	R.	R.	NNP
10_1101-2021_01_06_425584	565	5	,	,	,
10_1101-2021_01_06_425584	565	6	Regulation	Regulation	NNP
10_1101-2021_01_06_425584	565	7	of	of	IN
10_1101-2021_01_06_425584	565	8	angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	565	9	and	and	CC
10_1101-2021_01_06_425584	565	10	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	565	11	cell	cell	NN
10_1101-2021_01_06_425584	565	12	function	function	NN
10_1101-2021_01_06_425584	565	13	by	by	IN
10_1101-2021_01_06_425584	565	14	connective	connective	JJ
10_1101-2021_01_06_425584	565	15	808	808	CD
10_1101-2021_01_06_425584	565	16	tissue	tissue	NN
10_1101-2021_01_06_425584	565	17	growth	growth	NN
10_1101-2021_01_06_425584	565	18	factor	factor	NN
10_1101-2021_01_06_425584	565	19	(	(	-LRB-
10_1101-2021_01_06_425584	565	20	CTGF	CTGF	NNP
10_1101-2021_01_06_425584	565	21	)	)	-RRB-
10_1101-2021_01_06_425584	565	22	and	and	CC
10_1101-2021_01_06_425584	565	23	cysteine	cysteine	NN
10_1101-2021_01_06_425584	565	24	-	-	HYPH
10_1101-2021_01_06_425584	565	25	rich	rich	JJ
10_1101-2021_01_06_425584	565	26	61	61	CD
10_1101-2021_01_06_425584	565	27	(	(	-LRB-
10_1101-2021_01_06_425584	565	28	CYR61	CYR61	NNP
10_1101-2021_01_06_425584	565	29	)	)	-RRB-
10_1101-2021_01_06_425584	565	30	.	.	.
10_1101-2021_01_06_425584	566	1	Angiogenesis	Angiogenesis	NNP
10_1101-2021_01_06_425584	566	2	2002	2002	CD
10_1101-2021_01_06_425584	566	3	,	,	,
10_1101-2021_01_06_425584	566	4	5	5	CD
10_1101-2021_01_06_425584	566	5	,	,	,
10_1101-2021_01_06_425584	566	6	(	(	-LRB-
10_1101-2021_01_06_425584	566	7	3	3	CD
10_1101-2021_01_06_425584	566	8	)	)	-RRB-
10_1101-2021_01_06_425584	566	9	,	,	,
10_1101-2021_01_06_425584	566	10	153	153	CD
10_1101-2021_01_06_425584	566	11	-	-	SYM
10_1101-2021_01_06_425584	566	12	65	65	CD
10_1101-2021_01_06_425584	566	13	.	.	.
10_1101-2021_01_06_425584	567	1	809	809	CD
10_1101-2021_01_06_425584	567	2	85	85	CD
10_1101-2021_01_06_425584	567	3	.	.	.
10_1101-2021_01_06_425584	568	1	Elmasri	Elmasri	NNP
10_1101-2021_01_06_425584	568	2	,	,	,
10_1101-2021_01_06_425584	568	3	H.	H.	NNP
10_1101-2021_01_06_425584	568	4	;	;	:
10_1101-2021_01_06_425584	568	5	Ghelfi	Ghelfi	NNP
10_1101-2021_01_06_425584	568	6	,	,	,
10_1101-2021_01_06_425584	568	7	E.	E.	NNP
10_1101-2021_01_06_425584	568	8	;	;	:
10_1101-2021_01_06_425584	568	9	Yu	Yu	NNP
10_1101-2021_01_06_425584	568	10	,	,	,
10_1101-2021_01_06_425584	568	11	C.	C.	NNP
10_1101-2021_01_06_425584	568	12	W.	W.	NNP
10_1101-2021_01_06_425584	568	13	;	;	:
10_1101-2021_01_06_425584	568	14	Traphagen	Traphagen	NNP
10_1101-2021_01_06_425584	568	15	,	,	,
10_1101-2021_01_06_425584	568	16	S.	S.	NNP
10_1101-2021_01_06_425584	568	17	;	;	:
10_1101-2021_01_06_425584	568	18	Cernadas	Cernadas	NNP
10_1101-2021_01_06_425584	568	19	,	,	,
10_1101-2021_01_06_425584	568	20	M.	M.	NNP
10_1101-2021_01_06_425584	568	21	;	;	:
10_1101-2021_01_06_425584	568	22	Cao	Cao	NNP
10_1101-2021_01_06_425584	568	23	,	,	,
10_1101-2021_01_06_425584	568	24	H.	H.	NNP
10_1101-2021_01_06_425584	568	25	;	;	:
10_1101-2021_01_06_425584	568	26	Shi	Shi	NNP
10_1101-2021_01_06_425584	568	27	,	,	,
10_1101-2021_01_06_425584	568	28	G.	G.	NNP
10_1101-2021_01_06_425584	568	29	P.	P.	NNP
10_1101-2021_01_06_425584	568	30	;	;	:
10_1101-2021_01_06_425584	568	31	810	810	CD
10_1101-2021_01_06_425584	568	32	Plutzky	Plutzky	NNP
10_1101-2021_01_06_425584	568	33	,	,	,
10_1101-2021_01_06_425584	568	34	J.	J.	NNP
10_1101-2021_01_06_425584	568	35	;	;	:
10_1101-2021_01_06_425584	568	36	Sahin	Sahin	NNP
10_1101-2021_01_06_425584	568	37	,	,	,
10_1101-2021_01_06_425584	568	38	M.	M.	NNP
10_1101-2021_01_06_425584	568	39	;	;	:
10_1101-2021_01_06_425584	568	40	Hotamisligil	Hotamisligil	NNP
10_1101-2021_01_06_425584	568	41	,	,	,
10_1101-2021_01_06_425584	568	42	G.	G.	NNP
10_1101-2021_01_06_425584	568	43	;	;	:
10_1101-2021_01_06_425584	568	44	Cataltepe	Cataltepe	NNP
10_1101-2021_01_06_425584	568	45	,	,	,
10_1101-2021_01_06_425584	568	46	S.	S.	NNP
10_1101-2021_01_06_425584	568	47	,	,	,
10_1101-2021_01_06_425584	568	48	Endothelial	endothelial	JJ
10_1101-2021_01_06_425584	568	49	cell	cell	NN
10_1101-2021_01_06_425584	568	50	-	-	HYPH
10_1101-2021_01_06_425584	568	51	fatty	fatty	NN
10_1101-2021_01_06_425584	568	52	acid	acid	NN
10_1101-2021_01_06_425584	568	53	binding	bind	VBG
10_1101-2021_01_06_425584	568	54	protein	protein	NN
10_1101-2021_01_06_425584	568	55	4	4	CD
10_1101-2021_01_06_425584	568	56	811	811	CD
10_1101-2021_01_06_425584	568	57	promotes	promote	NNS
10_1101-2021_01_06_425584	568	58	angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	568	59	:	:	:
10_1101-2021_01_06_425584	568	60	role	role	NN
10_1101-2021_01_06_425584	568	61	of	of	IN
10_1101-2021_01_06_425584	568	62	stem	stem	NN
10_1101-2021_01_06_425584	568	63	cell	cell	NN
10_1101-2021_01_06_425584	568	64	factor	factor	NN
10_1101-2021_01_06_425584	568	65	/	/	SYM
10_1101-2021_01_06_425584	568	66	c	c	NNP
10_1101-2021_01_06_425584	568	67	-	-	HYPH
10_1101-2021_01_06_425584	568	68	kit	kit	NN
10_1101-2021_01_06_425584	568	69	pathway	pathway	NN
10_1101-2021_01_06_425584	568	70	.	.	.
10_1101-2021_01_06_425584	569	1	Angiogenesis	Angiogenesis	NNP
10_1101-2021_01_06_425584	569	2	2012	2012	CD
10_1101-2021_01_06_425584	569	3	,	,	,
10_1101-2021_01_06_425584	569	4	15	15	CD
10_1101-2021_01_06_425584	569	5	,	,	,
10_1101-2021_01_06_425584	569	6	(	(	-LRB-
10_1101-2021_01_06_425584	569	7	3	3	CD
10_1101-2021_01_06_425584	569	8	)	)	-RRB-
10_1101-2021_01_06_425584	569	9	,	,	,
10_1101-2021_01_06_425584	569	10	457	457	CD
10_1101-2021_01_06_425584	569	11	-	-	SYM
10_1101-2021_01_06_425584	569	12	812	812	CD
10_1101-2021_01_06_425584	569	13	68	68	CD
10_1101-2021_01_06_425584	569	14	.	.	.
10_1101-2021_01_06_425584	570	1	813	813	CD
10_1101-2021_01_06_425584	570	2	86	86	CD
10_1101-2021_01_06_425584	570	3	.	.	.
10_1101-2021_01_06_425584	571	1	Quinn	Quinn	NNP
10_1101-2021_01_06_425584	571	2	,	,	,
10_1101-2021_01_06_425584	571	3	M.	M.	NNP
10_1101-2021_01_06_425584	571	4	T.	T.	NNP
10_1101-2021_01_06_425584	571	5	;	;	:
10_1101-2021_01_06_425584	571	6	Schepetkin	Schepetkin	NNP
10_1101-2021_01_06_425584	571	7	,	,	,
10_1101-2021_01_06_425584	571	8	I.	i.	NN
10_1101-2021_01_06_425584	572	1	A.	A.	NNP
10_1101-2021_01_06_425584	572	2	,	,	,
10_1101-2021_01_06_425584	572	3	Role	Role	NNP
10_1101-2021_01_06_425584	572	4	of	of	IN
10_1101-2021_01_06_425584	572	5	NADPH	NADPH	NNP
10_1101-2021_01_06_425584	572	6	oxidase	oxidase	NN
10_1101-2021_01_06_425584	572	7	in	in	IN
10_1101-2021_01_06_425584	572	8	formation	formation	NN
10_1101-2021_01_06_425584	572	9	and	and	CC
10_1101-2021_01_06_425584	572	10	function	function	NN
10_1101-2021_01_06_425584	572	11	of	of	IN
10_1101-2021_01_06_425584	572	12	814	814	CD
10_1101-2021_01_06_425584	572	13	multinucleated	multinucleated	JJ
10_1101-2021_01_06_425584	572	14	giant	giant	JJ
10_1101-2021_01_06_425584	572	15	cells	cell	NNS
10_1101-2021_01_06_425584	572	16	.	.	.
10_1101-2021_01_06_425584	573	1	J	J	NNP
10_1101-2021_01_06_425584	573	2	Innate	Innate	NNP
10_1101-2021_01_06_425584	573	3	Immun	Immun	NNP
10_1101-2021_01_06_425584	573	4	2009	2009	CD
10_1101-2021_01_06_425584	573	5	,	,	,
10_1101-2021_01_06_425584	573	6	1	1	CD
10_1101-2021_01_06_425584	573	7	,	,	,
10_1101-2021_01_06_425584	573	8	(	(	-LRB-
10_1101-2021_01_06_425584	573	9	6	6	CD
10_1101-2021_01_06_425584	573	10	)	)	-RRB-
10_1101-2021_01_06_425584	573	11	,	,	,
10_1101-2021_01_06_425584	573	12	509	509	CD
10_1101-2021_01_06_425584	573	13	-	-	SYM
10_1101-2021_01_06_425584	573	14	26	26	CD
10_1101-2021_01_06_425584	573	15	.	.	.
10_1101-2021_01_06_425584	574	1	815	815	CD
10_1101-2021_01_06_425584	574	2	87	87	CD
10_1101-2021_01_06_425584	574	3	.	.	.
10_1101-2021_01_06_425584	575	1	Holt	Holt	NNP
10_1101-2021_01_06_425584	575	2	,	,	,
10_1101-2021_01_06_425584	575	3	D.	D.	NNP
10_1101-2021_01_06_425584	575	4	J.	J.	NNP
10_1101-2021_01_06_425584	575	5	;	;	:
10_1101-2021_01_06_425584	575	6	Grainger	Grainger	NNP
10_1101-2021_01_06_425584	575	7	,	,	,
10_1101-2021_01_06_425584	575	8	D.	D.	NNP
10_1101-2021_01_06_425584	575	9	W.	W.	NNP
10_1101-2021_01_06_425584	575	10	,	,	,
10_1101-2021_01_06_425584	575	11	Multinucleated	multinucleated	JJ
10_1101-2021_01_06_425584	575	12	giant	giant	JJ
10_1101-2021_01_06_425584	575	13	cells	cell	NNS
10_1101-2021_01_06_425584	575	14	from	from	IN
10_1101-2021_01_06_425584	575	15	fibroblast	fibroblast	NN
10_1101-2021_01_06_425584	575	16	cultures	culture	NNS
10_1101-2021_01_06_425584	575	17	.	.	.
10_1101-2021_01_06_425584	576	1	816	816	CD
10_1101-2021_01_06_425584	576	2	Biomaterials	Biomaterials	NNP
10_1101-2021_01_06_425584	576	3	2011	2011	CD
10_1101-2021_01_06_425584	576	4	,	,	,
10_1101-2021_01_06_425584	576	5	32	32	CD
10_1101-2021_01_06_425584	576	6	,	,	,
10_1101-2021_01_06_425584	576	7	(	(	-LRB-
10_1101-2021_01_06_425584	576	8	16	16	CD
10_1101-2021_01_06_425584	576	9	)	)	-RRB-
10_1101-2021_01_06_425584	576	10	,	,	,
10_1101-2021_01_06_425584	576	11	3977	3977	CD
10_1101-2021_01_06_425584	576	12	-	-	SYM
10_1101-2021_01_06_425584	576	13	87	87	CD
10_1101-2021_01_06_425584	576	14	.	.	.
10_1101-2021_01_06_425584	577	1	817	817	CD
10_1101-2021_01_06_425584	577	2	88	88	CD
10_1101-2021_01_06_425584	577	3	.	.	.
10_1101-2021_01_06_425584	578	1	Tse	Tse	NNP
10_1101-2021_01_06_425584	578	2	,	,	,
10_1101-2021_01_06_425584	578	3	G.	G.	NNP
10_1101-2021_01_06_425584	578	4	M.	M.	NNP
10_1101-2021_01_06_425584	578	5	;	;	:
10_1101-2021_01_06_425584	578	6	Law	Law	NNP
10_1101-2021_01_06_425584	578	7	,	,	,
10_1101-2021_01_06_425584	578	8	B.	B.	NNP
10_1101-2021_01_06_425584	578	9	K.	K.	NNP
10_1101-2021_01_06_425584	578	10	;	;	:
10_1101-2021_01_06_425584	578	11	Chan	Chan	NNP
10_1101-2021_01_06_425584	578	12	,	,	,
10_1101-2021_01_06_425584	578	13	K.	K.	NNP
10_1101-2021_01_06_425584	578	14	F.	F.	NNP
10_1101-2021_01_06_425584	578	15	;	;	:
10_1101-2021_01_06_425584	578	16	Mas	Mas	NNP
10_1101-2021_01_06_425584	578	17	,	,	,
10_1101-2021_01_06_425584	578	18	T.	T.	NNP
10_1101-2021_01_06_425584	578	19	K.	K.	NNP
10_1101-2021_01_06_425584	578	20	,	,	,
10_1101-2021_01_06_425584	578	21	Multinucleated	Multinucleated	NNP
10_1101-2021_01_06_425584	578	22	stromal	stromal	VBP
10_1101-2021_01_06_425584	578	23	giant	giant	JJ
10_1101-2021_01_06_425584	578	24	cells	cell	NNS
10_1101-2021_01_06_425584	578	25	in	in	IN
10_1101-2021_01_06_425584	578	26	818	818	CD
10_1101-2021_01_06_425584	578	27	mammary	mammary	JJ
10_1101-2021_01_06_425584	578	28	phyllodes	phyllode	NNS
10_1101-2021_01_06_425584	578	29	tumours	tumour	NNS
10_1101-2021_01_06_425584	578	30	.	.	.
10_1101-2021_01_06_425584	579	1	Pathology	pathology	NN
10_1101-2021_01_06_425584	579	2	2001	2001	CD
10_1101-2021_01_06_425584	579	3	,	,	,
10_1101-2021_01_06_425584	579	4	33	33	CD
10_1101-2021_01_06_425584	579	5	,	,	,
10_1101-2021_01_06_425584	579	6	(	(	-LRB-
10_1101-2021_01_06_425584	579	7	2	2	CD
10_1101-2021_01_06_425584	579	8	)	)	-RRB-
10_1101-2021_01_06_425584	579	9	,	,	,
10_1101-2021_01_06_425584	579	10	153	153	CD
10_1101-2021_01_06_425584	579	11	-	-	SYM
10_1101-2021_01_06_425584	579	12	6	6	CD
10_1101-2021_01_06_425584	579	13	.	.	.
10_1101-2021_01_06_425584	580	1	819	819	CD
10_1101-2021_01_06_425584	580	2	89	89	CD
10_1101-2021_01_06_425584	580	3	.	.	.
10_1101-2021_01_06_425584	581	1	Celton	Celton	NNP
10_1101-2021_01_06_425584	581	2	-	-	HYPH
10_1101-2021_01_06_425584	581	3	Morizur	Morizur	NNP
10_1101-2021_01_06_425584	581	4	,	,	,
10_1101-2021_01_06_425584	581	5	S.	S.	NNP
10_1101-2021_01_06_425584	581	6	;	;	:
10_1101-2021_01_06_425584	581	7	Merlen	Merlen	NNP
10_1101-2021_01_06_425584	581	8	,	,	,
10_1101-2021_01_06_425584	581	9	G.	G.	NNP
10_1101-2021_01_06_425584	581	10	;	;	:
10_1101-2021_01_06_425584	581	11	Couton	Couton	NNP
10_1101-2021_01_06_425584	581	12	,	,	,
10_1101-2021_01_06_425584	581	13	D.	D.	NNP
10_1101-2021_01_06_425584	581	14	;	;	:
10_1101-2021_01_06_425584	581	15	Desdouets	Desdouets	NNP
10_1101-2021_01_06_425584	581	16	,	,	,
10_1101-2021_01_06_425584	581	17	C.	C.	NNP
10_1101-2021_01_06_425584	581	18	,	,	,
10_1101-2021_01_06_425584	581	19	Polyploidy	Polyploidy	NNP
10_1101-2021_01_06_425584	581	20	and	and	CC
10_1101-2021_01_06_425584	581	21	liver	liver	NN
10_1101-2021_01_06_425584	581	22	820	820	CD
10_1101-2021_01_06_425584	581	23	proliferation	proliferation	NN
10_1101-2021_01_06_425584	581	24	:	:	:
10_1101-2021_01_06_425584	581	25	central	central	JJ
10_1101-2021_01_06_425584	581	26	role	role	NN
10_1101-2021_01_06_425584	581	27	of	of	IN
10_1101-2021_01_06_425584	581	28	insulin	insulin	NN
10_1101-2021_01_06_425584	581	29	signaling	signal	VBG
10_1101-2021_01_06_425584	581	30	.	.	.
10_1101-2021_01_06_425584	582	1	Cell	Cell	NNP
10_1101-2021_01_06_425584	582	2	Cycle	Cycle	NNP
10_1101-2021_01_06_425584	582	3	2010	2010	CD
10_1101-2021_01_06_425584	582	4	,	,	,
10_1101-2021_01_06_425584	582	5	9	9	CD
10_1101-2021_01_06_425584	582	6	,	,	,
10_1101-2021_01_06_425584	582	7	(	(	-LRB-
10_1101-2021_01_06_425584	582	8	3	3	CD
10_1101-2021_01_06_425584	582	9	)	)	-RRB-
10_1101-2021_01_06_425584	582	10	,	,	,
10_1101-2021_01_06_425584	582	11	460	460	CD
10_1101-2021_01_06_425584	582	12	-	-	SYM
10_1101-2021_01_06_425584	582	13	6	6	CD
10_1101-2021_01_06_425584	582	14	.	.	.
10_1101-2021_01_06_425584	583	1	821	821	CD
10_1101-2021_01_06_425584	583	2	822	822	CD
10_1101-2021_01_06_425584	583	3	.CC	.CC	:
10_1101-2021_01_06_425584	583	4	-	-	HYPH
10_1101-2021_01_06_425584	583	5	BY	by	IN
10_1101-2021_01_06_425584	583	6	-	-	HYPH
10_1101-2021_01_06_425584	583	7	NC	NC	NNP
10_1101-2021_01_06_425584	583	8	-	-	HYPH
10_1101-2021_01_06_425584	583	9	ND	ND	NNP
10_1101-2021_01_06_425584	583	10	4.0	4.0	CD
10_1101-2021_01_06_425584	583	11	International	International	NNP
10_1101-2021_01_06_425584	583	12	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	583	13	under	under	IN
10_1101-2021_01_06_425584	583	14	a	a	DT
10_1101-2021_01_06_425584	583	15	(	(	-LRB-
10_1101-2021_01_06_425584	583	16	which	which	WDT
10_1101-2021_01_06_425584	583	17	was	be	VBD
10_1101-2021_01_06_425584	583	18	not	not	RB
10_1101-2021_01_06_425584	583	19	certified	certify	VBN
10_1101-2021_01_06_425584	583	20	by	by	IN
10_1101-2021_01_06_425584	583	21	peer	peer	NN
10_1101-2021_01_06_425584	583	22	review	review	NN
10_1101-2021_01_06_425584	583	23	)	)	-RRB-
10_1101-2021_01_06_425584	583	24	is	be	VBZ
10_1101-2021_01_06_425584	583	25	the	the	DT
10_1101-2021_01_06_425584	583	26	author	author	NN
10_1101-2021_01_06_425584	583	27	/	/	SYM
10_1101-2021_01_06_425584	583	28	funder	funder	NN
10_1101-2021_01_06_425584	583	29	,	,	,
10_1101-2021_01_06_425584	583	30	who	who	WP
10_1101-2021_01_06_425584	583	31	has	have	VBZ
10_1101-2021_01_06_425584	583	32	granted	grant	VBN
10_1101-2021_01_06_425584	583	33	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	583	34	a	a	DT
10_1101-2021_01_06_425584	583	35	license	license	NN
10_1101-2021_01_06_425584	583	36	to	to	TO
10_1101-2021_01_06_425584	583	37	display	display	VB
10_1101-2021_01_06_425584	583	38	the	the	DT
10_1101-2021_01_06_425584	583	39	preprint	preprint	NN
10_1101-2021_01_06_425584	583	40	in	in	IN
10_1101-2021_01_06_425584	583	41	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	583	42	.	.	.
10_1101-2021_01_06_425584	584	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	584	2	is	be	VBZ
10_1101-2021_01_06_425584	584	3	made	make	VBN
10_1101-2021_01_06_425584	584	4	The	the	DT
10_1101-2021_01_06_425584	584	5	copyright	copyright	NN
10_1101-2021_01_06_425584	584	6	holder	holder	NN
10_1101-2021_01_06_425584	584	7	for	for	IN
10_1101-2021_01_06_425584	584	8	this	this	DT
10_1101-2021_01_06_425584	584	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	584	10	version	version	NN
10_1101-2021_01_06_425584	584	11	posted	post	VBD
10_1101-2021_01_06_425584	584	12	January	January	NNP
10_1101-2021_01_06_425584	584	13	8	8	CD
10_1101-2021_01_06_425584	584	14	,	,	,
10_1101-2021_01_06_425584	584	15	2021	2021	CD
10_1101-2021_01_06_425584	584	16	.	.	.
10_1101-2021_01_06_425584	584	17	;	;	:
10_1101-2021_01_06_425584	584	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	584	19	:	:	:
10_1101-2021_01_06_425584	584	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	584	21	preprint	preprint	NN
10_1101-2021_01_06_425584	584	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	584	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	584	24	27	27	CD
10_1101-2021_01_06_425584	584	25	Figure	figure	NN
10_1101-2021_01_06_425584	584	26	legends	legend	VBZ
10_1101-2021_01_06_425584	584	27	823	823	CD
10_1101-2021_01_06_425584	584	28	824	824	CD
10_1101-2021_01_06_425584	584	29	Figure	figure	NN
10_1101-2021_01_06_425584	584	30	1	1	CD
10_1101-2021_01_06_425584	584	31	.	.	.
10_1101-2021_01_06_425584	585	1	Illustration	illustration	NN
10_1101-2021_01_06_425584	585	2	of	of	IN
10_1101-2021_01_06_425584	585	3	the	the	DT
10_1101-2021_01_06_425584	585	4	methodology	methodology	NN
10_1101-2021_01_06_425584	585	5	followed	follow	VBN
10_1101-2021_01_06_425584	585	6	in	in	IN
10_1101-2021_01_06_425584	585	7	this	this	DT
10_1101-2021_01_06_425584	585	8	study	study	NN
10_1101-2021_01_06_425584	585	9	.	.	.
10_1101-2021_01_06_425584	586	1	825	825	CD
10_1101-2021_01_06_425584	586	2	826	826	CD
10_1101-2021_01_06_425584	586	3	Figure	Figure	NNP
10_1101-2021_01_06_425584	586	4	2	2	CD
10_1101-2021_01_06_425584	586	5	.	.	.
10_1101-2021_01_06_425584	587	1	Simulated	simulate	VBN
10_1101-2021_01_06_425584	587	2	diabetes	diabete	NNS
10_1101-2021_01_06_425584	587	3	induced	induce	VBD
10_1101-2021_01_06_425584	587	4	changes	change	NNS
10_1101-2021_01_06_425584	587	5	in	in	IN
10_1101-2021_01_06_425584	587	6	the	the	DT
10_1101-2021_01_06_425584	587	7	metabolome	metabolome	NN
10_1101-2021_01_06_425584	587	8	of	of	IN
10_1101-2021_01_06_425584	587	9	bovine	bovine	JJ
10_1101-2021_01_06_425584	587	10	coronary	coronary	JJ
10_1101-2021_01_06_425584	587	11	827	827	CD
10_1101-2021_01_06_425584	587	12	artery	artery	NN
10_1101-2021_01_06_425584	587	13	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	587	14	cells	cell	NNS
10_1101-2021_01_06_425584	587	15	(	(	-LRB-
10_1101-2021_01_06_425584	587	16	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	587	17	)	)	-RRB-
10_1101-2021_01_06_425584	587	18	.	.	.
10_1101-2021_01_06_425584	588	1	(	(	-LRB-
10_1101-2021_01_06_425584	588	2	A	a	DT
10_1101-2021_01_06_425584	588	3	)	)	-RRB-
10_1101-2021_01_06_425584	588	4	Venn	Venn	NNP
10_1101-2021_01_06_425584	588	5	diagram	diagram	NN
10_1101-2021_01_06_425584	588	6	of	of	IN
10_1101-2021_01_06_425584	588	7	features	feature	NNS
10_1101-2021_01_06_425584	588	8	identified	identify	VBN
10_1101-2021_01_06_425584	588	9	among	among	IN
10_1101-2021_01_06_425584	588	10	MZmine	MZmine	NNP
10_1101-2021_01_06_425584	588	11	and	and	CC
10_1101-2021_01_06_425584	588	12	828	828	CD
10_1101-2021_01_06_425584	588	13	XCMS	XCMS	NNP
10_1101-2021_01_06_425584	588	14	software	software	NN
10_1101-2021_01_06_425584	588	15	(	(	-LRB-
10_1101-2021_01_06_425584	588	16	0.01	0.01	CD
10_1101-2021_01_06_425584	588	17	Da	Da	NNP
10_1101-2021_01_06_425584	588	18	and	and	CC
10_1101-2021_01_06_425584	588	19	1	1	CD
10_1101-2021_01_06_425584	588	20	min	min	NNP
10_1101-2021_01_06_425584	588	21	retention	retention	NN
10_1101-2021_01_06_425584	588	22	time	time	NN
10_1101-2021_01_06_425584	588	23	,	,	,
10_1101-2021_01_06_425584	588	24	thresholds	threshold	NNS
10_1101-2021_01_06_425584	588	25	)	)	-RRB-
10_1101-2021_01_06_425584	588	26	on	on	IN
10_1101-2021_01_06_425584	588	27	LC	LC	NNP
10_1101-2021_01_06_425584	588	28	-	-	HYPH
10_1101-2021_01_06_425584	588	29	MS2	MS2	NNP
10_1101-2021_01_06_425584	588	30	datasets	dataset	NNS
10_1101-2021_01_06_425584	588	31	.	.	.
10_1101-2021_01_06_425584	589	1	(	(	-LRB-
10_1101-2021_01_06_425584	589	2	B	b	NN
10_1101-2021_01_06_425584	589	3	)	)	-RRB-
10_1101-2021_01_06_425584	589	4	Volcano	volcano	NN
10_1101-2021_01_06_425584	589	5	829	829	CD
10_1101-2021_01_06_425584	589	6	plot	plot	NN
10_1101-2021_01_06_425584	589	7	of	of	IN
10_1101-2021_01_06_425584	589	8	all	all	DT
10_1101-2021_01_06_425584	589	9	quantified	quantify	VBN
10_1101-2021_01_06_425584	589	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	589	11	displaying	display	VBG
10_1101-2021_01_06_425584	589	12	differences	difference	NNS
10_1101-2021_01_06_425584	589	13	in	in	IN
10_1101-2021_01_06_425584	589	14	relative	relative	JJ
10_1101-2021_01_06_425584	589	15	abundance	abundance	NN
10_1101-2021_01_06_425584	589	16	(	(	-LRB-
10_1101-2021_01_06_425584	589	17	>	>	XX
10_1101-2021_01_06_425584	589	18	+	+	SYM
10_1101-2021_01_06_425584	589	19	/-30	/-30	CD
10_1101-2021_01_06_425584	589	20	%	%	NN
10_1101-2021_01_06_425584	589	21	change	change	NN
10_1101-2021_01_06_425584	589	22	,	,	,
10_1101-2021_01_06_425584	589	23	830	830	CD
10_1101-2021_01_06_425584	589	24	<	<	XX
10_1101-2021_01_06_425584	589	25	0.05	0.05	CD
10_1101-2021_01_06_425584	589	26	p	p	NN
10_1101-2021_01_06_425584	589	27	-	-	HYPH
10_1101-2021_01_06_425584	589	28	value	value	NN
10_1101-2021_01_06_425584	589	29	cut	cut	NN
10_1101-2021_01_06_425584	589	30	-	-	HYPH
10_1101-2021_01_06_425584	589	31	offs	off	NNS
10_1101-2021_01_06_425584	589	32	)	)	-RRB-
10_1101-2021_01_06_425584	589	33	between	between	IN
10_1101-2021_01_06_425584	589	34	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	589	35	cultured	cultured	JJ
10_1101-2021_01_06_425584	589	36	in	in	IN
10_1101-2021_01_06_425584	589	37	control	control	NN
10_1101-2021_01_06_425584	589	38	(	(	-LRB-
10_1101-2021_01_06_425584	589	39	NG	NG	NNP
10_1101-2021_01_06_425584	589	40	)	)	-RRB-
10_1101-2021_01_06_425584	589	41	media	medium	NNS
10_1101-2021_01_06_425584	589	42	and	and	CC
10_1101-2021_01_06_425584	589	43	simulated	simulate	VBN
10_1101-2021_01_06_425584	589	44	diabetes	diabetes	NN
10_1101-2021_01_06_425584	589	45	831	831	CD
10_1101-2021_01_06_425584	589	46	(	(	-LRB-
10_1101-2021_01_06_425584	589	47	HG+	HG+	NNP
10_1101-2021_01_06_425584	589	48	HI	HI	NNP
10_1101-2021_01_06_425584	589	49	)	)	-RRB-
10_1101-2021_01_06_425584	589	50	for	for	IN
10_1101-2021_01_06_425584	589	51	twelve	twelve	CD
10_1101-2021_01_06_425584	589	52	days	day	NNS
10_1101-2021_01_06_425584	589	53	.	.	.
10_1101-2021_01_06_425584	590	1	Values	value	NNS
10_1101-2021_01_06_425584	590	2	(	(	-LRB-
10_1101-2021_01_06_425584	590	3	dots	dot	NNS
10_1101-2021_01_06_425584	590	4	)	)	-RRB-
10_1101-2021_01_06_425584	590	5	represent	represent	VBP
10_1101-2021_01_06_425584	590	6	the	the	DT
10_1101-2021_01_06_425584	590	7	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	590	8	/	/	SYM
10_1101-2021_01_06_425584	590	9	NG	NG	NNP
10_1101-2021_01_06_425584	590	10	ratio	ratio	NN
10_1101-2021_01_06_425584	590	11	for	for	IN
10_1101-2021_01_06_425584	590	12	all	all	DT
10_1101-2021_01_06_425584	590	13	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	590	14	.	.	.
10_1101-2021_01_06_425584	591	1	Red	Red	NNP
10_1101-2021_01_06_425584	591	2	832	832	CD
10_1101-2021_01_06_425584	591	3	and	and	CC
10_1101-2021_01_06_425584	591	4	blue	blue	JJ
10_1101-2021_01_06_425584	591	5	dots	dot	NNS
10_1101-2021_01_06_425584	591	6	denote	denote	VBP
10_1101-2021_01_06_425584	591	7	downregulated	downregulated	JJ
10_1101-2021_01_06_425584	591	8	and	and	CC
10_1101-2021_01_06_425584	591	9	upregulated	upregulated	JJ
10_1101-2021_01_06_425584	591	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	591	11	in	in	IN
10_1101-2021_01_06_425584	591	12	the	the	DT
10_1101-2021_01_06_425584	591	13	HG	HG	NNP
10_1101-2021_01_06_425584	591	14	+	+	CC
10_1101-2021_01_06_425584	591	15	HI	HI	NNP
10_1101-2021_01_06_425584	591	16	group	group	NN
10_1101-2021_01_06_425584	591	17	vs.	vs.	IN
10_1101-2021_01_06_425584	591	18	NG	NG	NNP
10_1101-2021_01_06_425584	591	19	833	833	CD
10_1101-2021_01_06_425584	591	20	group	group	NN
10_1101-2021_01_06_425584	591	21	,	,	,
10_1101-2021_01_06_425584	591	22	respectively	respectively	RB
10_1101-2021_01_06_425584	591	23	.	.	.
10_1101-2021_01_06_425584	592	1	(	(	-LRB-
10_1101-2021_01_06_425584	592	2	C	C	NNP
10_1101-2021_01_06_425584	592	3	)	)	-RRB-
10_1101-2021_01_06_425584	592	4	Principal	Principal	NNP
10_1101-2021_01_06_425584	592	5	Component	Component	NNP
10_1101-2021_01_06_425584	592	6	Analysis	Analysis	NNP
10_1101-2021_01_06_425584	592	7	(	(	-LRB-
10_1101-2021_01_06_425584	592	8	PCA	PCA	NNP
10_1101-2021_01_06_425584	592	9	)	)	-RRB-
10_1101-2021_01_06_425584	592	10	of	of	IN
10_1101-2021_01_06_425584	592	11	LC	LC	NNP
10_1101-2021_01_06_425584	592	12	-	-	HYPH
10_1101-2021_01_06_425584	592	13	MS2	MS2	NNP
10_1101-2021_01_06_425584	592	14	datasets	dataset	NNS
10_1101-2021_01_06_425584	592	15	.	.	.
10_1101-2021_01_06_425584	593	1	Data	datum	NNS
10_1101-2021_01_06_425584	593	2	was	be	VBD
10_1101-2021_01_06_425584	593	3	log	log	NN
10_1101-2021_01_06_425584	593	4	834	834	CD
10_1101-2021_01_06_425584	593	5	transformed	transform	VBD
10_1101-2021_01_06_425584	593	6	without	without	IN
10_1101-2021_01_06_425584	593	7	scaling	scale	VBG
10_1101-2021_01_06_425584	593	8	.	.	.
10_1101-2021_01_06_425584	594	1	Shade	shade	NN
10_1101-2021_01_06_425584	594	2	areas	area	NNS
10_1101-2021_01_06_425584	594	3	depict	depict	VBP
10_1101-2021_01_06_425584	594	4	the	the	DT
10_1101-2021_01_06_425584	594	5	95	95	CD
10_1101-2021_01_06_425584	594	6	%	%	NN
10_1101-2021_01_06_425584	594	7	confidence	confidence	NN
10_1101-2021_01_06_425584	594	8	intervals	interval	NNS
10_1101-2021_01_06_425584	594	9	.	.	.
10_1101-2021_01_06_425584	595	1	(	(	-LRB-
10_1101-2021_01_06_425584	595	2	C	C	NNP
10_1101-2021_01_06_425584	595	3	)	)	-RRB-
10_1101-2021_01_06_425584	595	4	HeatMap	HeatMap	NNP
10_1101-2021_01_06_425584	595	5	of	of	IN
10_1101-2021_01_06_425584	595	6	835	835	CD
10_1101-2021_01_06_425584	595	7	the	the	DT
10_1101-2021_01_06_425584	595	8	top	top	JJ
10_1101-2021_01_06_425584	595	9	100	100	CD
10_1101-2021_01_06_425584	595	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	595	11	ranked	rank	VBN
10_1101-2021_01_06_425584	595	12	by	by	IN
10_1101-2021_01_06_425584	595	13	t	t	NN
10_1101-2021_01_06_425584	595	14	-	-	HYPH
10_1101-2021_01_06_425584	595	15	test	test	NN
10_1101-2021_01_06_425584	595	16	.	.	.
10_1101-2021_01_06_425584	596	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	596	2	:	:	:
10_1101-2021_01_06_425584	596	3	NG	NG	NNP
10_1101-2021_01_06_425584	596	4	,	,	,
10_1101-2021_01_06_425584	596	5	normal	normal	JJ
10_1101-2021_01_06_425584	596	6	glucose	glucose	NN
10_1101-2021_01_06_425584	596	7	;	;	:
10_1101-2021_01_06_425584	596	8	HG	HG	NNP
10_1101-2021_01_06_425584	596	9	,	,	,
10_1101-2021_01_06_425584	596	10	high	high	JJ
10_1101-2021_01_06_425584	596	11	glucose	glucose	NN
10_1101-2021_01_06_425584	596	12	;	;	:
10_1101-2021_01_06_425584	596	13	836	836	CD
10_1101-2021_01_06_425584	596	14	HI	HI	NNP
10_1101-2021_01_06_425584	596	15	,	,	,
10_1101-2021_01_06_425584	596	16	high	high	JJ
10_1101-2021_01_06_425584	596	17	insulin	insulin	NN
10_1101-2021_01_06_425584	596	18	;	;	:
10_1101-2021_01_06_425584	596	19	QC	QC	NNP
10_1101-2021_01_06_425584	596	20	,	,	,
10_1101-2021_01_06_425584	596	21	quality	quality	NN
10_1101-2021_01_06_425584	596	22	control	control	NN
10_1101-2021_01_06_425584	596	23	.	.	.
10_1101-2021_01_06_425584	597	1	837	837	CD
10_1101-2021_01_06_425584	597	2	838	838	CD
10_1101-2021_01_06_425584	597	3	Figure	figure	NN
10_1101-2021_01_06_425584	597	4	3	3	CD
10_1101-2021_01_06_425584	597	5	.	.	.
10_1101-2021_01_06_425584	598	1	Bovine	bovine	JJ
10_1101-2021_01_06_425584	598	2	coronary	coronary	JJ
10_1101-2021_01_06_425584	598	3	artery	artery	NN
10_1101-2021_01_06_425584	598	4	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	598	5	cells	cell	NNS
10_1101-2021_01_06_425584	598	6	(	(	-LRB-
10_1101-2021_01_06_425584	598	7	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	598	8	)	)	-RRB-
10_1101-2021_01_06_425584	598	9	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	598	10	molecular	molecular	JJ
10_1101-2021_01_06_425584	598	11	network	network	NN
10_1101-2021_01_06_425584	598	12	.	.	.
10_1101-2021_01_06_425584	599	1	839	839	CD
10_1101-2021_01_06_425584	599	2	(	(	-LRB-
10_1101-2021_01_06_425584	599	3	A	a	NN
10_1101-2021_01_06_425584	599	4	)	)	-RRB-
10_1101-2021_01_06_425584	599	5	Molecular	molecular	JJ
10_1101-2021_01_06_425584	599	6	classes	class	NNS
10_1101-2021_01_06_425584	599	7	(	(	-LRB-
10_1101-2021_01_06_425584	599	8	according	accord	VBG
10_1101-2021_01_06_425584	599	9	to	to	IN
10_1101-2021_01_06_425584	599	10	Classyfire	Classyfire	NNP
10_1101-2021_01_06_425584	599	11	)	)	-RRB-
10_1101-2021_01_06_425584	599	12	of	of	IN
10_1101-2021_01_06_425584	599	13	the	the	DT
10_1101-2021_01_06_425584	599	14	metabolome	metabolome	NN
10_1101-2021_01_06_425584	599	15	identified	identify	VBN
10_1101-2021_01_06_425584	599	16	by	by	IN
10_1101-2021_01_06_425584	599	17	the	the	DT
10_1101-2021_01_06_425584	599	18	840	840	CD
10_1101-2021_01_06_425584	599	19	MolNetEnhancer	MolNetEnhancer	NNP
10_1101-2021_01_06_425584	599	20	workflow	workflow	NN
10_1101-2021_01_06_425584	599	21	and	and	CC
10_1101-2021_01_06_425584	599	22	visualized	visualize	VBN
10_1101-2021_01_06_425584	599	23	by	by	IN
10_1101-2021_01_06_425584	599	24	Cytoscape	Cytoscape	NNP
10_1101-2021_01_06_425584	599	25	version	version	NN
10_1101-2021_01_06_425584	599	26	3.8.2	3.8.2	CD
10_1101-2021_01_06_425584	599	27	.	.	.
10_1101-2021_01_06_425584	600	1	Each	each	DT
10_1101-2021_01_06_425584	600	2	node	node	NN
10_1101-2021_01_06_425584	600	3	represents	represent	VBZ
10_1101-2021_01_06_425584	600	4	a	a	DT
10_1101-2021_01_06_425584	600	5	841	841	CD
10_1101-2021_01_06_425584	600	6	unique	unique	JJ
10_1101-2021_01_06_425584	600	7	feature	feature	NN
10_1101-2021_01_06_425584	600	8	and	and	CC
10_1101-2021_01_06_425584	600	9	the	the	DT
10_1101-2021_01_06_425584	600	10	color	color	NN
10_1101-2021_01_06_425584	600	11	of	of	IN
10_1101-2021_01_06_425584	600	12	the	the	DT
10_1101-2021_01_06_425584	600	13	node	node	NN
10_1101-2021_01_06_425584	600	14	denotes	denote	VBZ
10_1101-2021_01_06_425584	600	15	the	the	DT
10_1101-2021_01_06_425584	600	16	associated	associated	NNP
10_1101-2021_01_06_425584	600	17	chemical	chemical	NNP
10_1101-2021_01_06_425584	600	18	class	class	NNP
10_1101-2021_01_06_425584	600	19	.	.	.
10_1101-2021_01_06_425584	601	1	The	the	DT
10_1101-2021_01_06_425584	601	2	thickness	thickness	NN
10_1101-2021_01_06_425584	601	3	of	of	IN
10_1101-2021_01_06_425584	601	4	842	842	CD
10_1101-2021_01_06_425584	601	5	the	the	DT
10_1101-2021_01_06_425584	601	6	edge	edge	NN
10_1101-2021_01_06_425584	601	7	(	(	-LRB-
10_1101-2021_01_06_425584	601	8	connectivity	connectivity	NN
10_1101-2021_01_06_425584	601	9	)	)	-RRB-
10_1101-2021_01_06_425584	601	10	indicates	indicate	VBZ
10_1101-2021_01_06_425584	601	11	the	the	DT
10_1101-2021_01_06_425584	601	12	MS2	MS2	NNP
10_1101-2021_01_06_425584	601	13	similarity	similarity	NN
10_1101-2021_01_06_425584	601	14	(	(	-LRB-
10_1101-2021_01_06_425584	601	15	Cosine	Cosine	NNP
10_1101-2021_01_06_425584	601	16	score	score	NN
10_1101-2021_01_06_425584	601	17	)	)	-RRB-
10_1101-2021_01_06_425584	601	18	among	among	IN
10_1101-2021_01_06_425584	601	19	features	feature	NNS
10_1101-2021_01_06_425584	601	20	.	.	.
10_1101-2021_01_06_425584	602	1	The	the	DT
10_1101-2021_01_06_425584	602	2	m	m	NNP
10_1101-2021_01_06_425584	602	3	/	/	SYM
10_1101-2021_01_06_425584	602	4	z	z	NNP
10_1101-2021_01_06_425584	602	5	value	value	NN
10_1101-2021_01_06_425584	602	6	843	843	CD
10_1101-2021_01_06_425584	602	7	of	of	IN
10_1101-2021_01_06_425584	602	8	the	the	DT
10_1101-2021_01_06_425584	602	9	feature	feature	NN
10_1101-2021_01_06_425584	602	10	is	be	VBZ
10_1101-2021_01_06_425584	602	11	shown	show	VBN
10_1101-2021_01_06_425584	602	12	inside	inside	IN
10_1101-2021_01_06_425584	602	13	the	the	DT
10_1101-2021_01_06_425584	602	14	node	node	NN
10_1101-2021_01_06_425584	602	15	and	and	CC
10_1101-2021_01_06_425584	602	16	is	be	VBZ
10_1101-2021_01_06_425584	602	17	proportional	proportional	JJ
10_1101-2021_01_06_425584	602	18	to	to	IN
10_1101-2021_01_06_425584	602	19	the	the	DT
10_1101-2021_01_06_425584	602	20	size	size	NN
10_1101-2021_01_06_425584	602	21	of	of	IN
10_1101-2021_01_06_425584	602	22	the	the	DT
10_1101-2021_01_06_425584	602	23	node	node	NN
10_1101-2021_01_06_425584	602	24	.	.	.
10_1101-2021_01_06_425584	603	1	Three	three	CD
10_1101-2021_01_06_425584	603	2	selected	select	VBD
10_1101-2021_01_06_425584	603	3	844	844	CD
10_1101-2021_01_06_425584	603	4	clusters	cluster	NNS
10_1101-2021_01_06_425584	603	5	or	or	CC
10_1101-2021_01_06_425584	603	6	connected	connect	VBN
10_1101-2021_01_06_425584	603	7	features	feature	NNS
10_1101-2021_01_06_425584	603	8	as	as	IN
10_1101-2021_01_06_425584	603	9	relevant	relevant	JJ
10_1101-2021_01_06_425584	603	10	are	be	VBP
10_1101-2021_01_06_425584	603	11	shown	show	VBN
10_1101-2021_01_06_425584	603	12	.	.	.
10_1101-2021_01_06_425584	604	1	(	(	-LRB-
10_1101-2021_01_06_425584	604	2	B	b	NN
10_1101-2021_01_06_425584	604	3	)	)	-RRB-
10_1101-2021_01_06_425584	604	4	Inset	Inset	NNP
10_1101-2021_01_06_425584	604	5	of	of	IN
10_1101-2021_01_06_425584	604	6	cluster	cluster	NN
10_1101-2021_01_06_425584	604	7	1	1	CD
10_1101-2021_01_06_425584	604	8	denoting	denote	VBG
10_1101-2021_01_06_425584	604	9	the	the	DT
10_1101-2021_01_06_425584	604	10	presence	presence	NN
10_1101-2021_01_06_425584	604	11	845	845	CD
10_1101-2021_01_06_425584	604	12	of	of	IN
10_1101-2021_01_06_425584	604	13	phosphocholine	phosphocholine	NN
10_1101-2021_01_06_425584	604	14	(	(	-LRB-
10_1101-2021_01_06_425584	604	15	PC)-containing	pc)-containe	VBG
10_1101-2021_01_06_425584	604	16	lipids	lipid	NNS
10_1101-2021_01_06_425584	604	17	.	.	.
10_1101-2021_01_06_425584	605	1	Significant	significant	JJ
10_1101-2021_01_06_425584	605	2	differential	differential	NN
10_1101-2021_01_06_425584	605	3	abundant	abundant	JJ
10_1101-2021_01_06_425584	605	4	features	feature	NNS
10_1101-2021_01_06_425584	605	5	among	among	IN
10_1101-2021_01_06_425584	605	6	846	846	CD
10_1101-2021_01_06_425584	605	7	simulated	simulate	VBN
10_1101-2021_01_06_425584	605	8	diabetes	diabete	NNS
10_1101-2021_01_06_425584	605	9	(	(	-LRB-
10_1101-2021_01_06_425584	605	10	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	605	11	)	)	-RRB-
10_1101-2021_01_06_425584	605	12	and	and	CC
10_1101-2021_01_06_425584	605	13	control	control	NN
10_1101-2021_01_06_425584	605	14	(	(	-LRB-
10_1101-2021_01_06_425584	605	15	NG	NG	NNP
10_1101-2021_01_06_425584	605	16	)	)	-RRB-
10_1101-2021_01_06_425584	605	17	groups	group	NNS
10_1101-2021_01_06_425584	605	18	are	be	VBP
10_1101-2021_01_06_425584	605	19	indicated	indicate	VBN
10_1101-2021_01_06_425584	605	20	with	with	IN
10_1101-2021_01_06_425584	605	21	an	an	DT
10_1101-2021_01_06_425584	605	22	asterisk	asterisk	NN
10_1101-2021_01_06_425584	605	23	(	(	-LRB-
10_1101-2021_01_06_425584	605	24	p	p	NN
10_1101-2021_01_06_425584	605	25	-	-	HYPH
10_1101-2021_01_06_425584	605	26	value	value	NN
10_1101-2021_01_06_425584	605	27	847	847	CD
10_1101-2021_01_06_425584	605	28	<	<	XX
10_1101-2021_01_06_425584	605	29	0.05	0.05	CD
10_1101-2021_01_06_425584	605	30	)	)	-RRB-
10_1101-2021_01_06_425584	605	31	.	.	.
10_1101-2021_01_06_425584	606	1	(	(	-LRB-
10_1101-2021_01_06_425584	606	2	C	C	NNP
10_1101-2021_01_06_425584	606	3	)	)	-RRB-
10_1101-2021_01_06_425584	606	4	Characterization	characterization	NN
10_1101-2021_01_06_425584	606	5	of	of	IN
10_1101-2021_01_06_425584	606	6	features	feature	NNS
10_1101-2021_01_06_425584	606	7	in	in	IN
10_1101-2021_01_06_425584	606	8	(	(	-LRB-
10_1101-2021_01_06_425584	606	9	B	b	NN
10_1101-2021_01_06_425584	606	10	)	)	-RRB-
10_1101-2021_01_06_425584	606	11	aided	aid	VBN
10_1101-2021_01_06_425584	606	12	by	by	IN
10_1101-2021_01_06_425584	606	13	substructure	substructure	NN
10_1101-2021_01_06_425584	606	14	recognition	recognition	NN
10_1101-2021_01_06_425584	606	15	by	by	IN
10_1101-2021_01_06_425584	606	16	MSLDA	MSLDA	NNP
10_1101-2021_01_06_425584	606	17	848	848	CD
10_1101-2021_01_06_425584	606	18	software	software	NN
10_1101-2021_01_06_425584	606	19	using	use	VBG
10_1101-2021_01_06_425584	606	20	MS1	MS1	NNP
10_1101-2021_01_06_425584	606	21	visualization	visualization	NN
10_1101-2021_01_06_425584	606	22	in	in	IN
10_1101-2021_01_06_425584	606	23	www.ms2lda.org	www.ms2lda.org	NN
10_1101-2021_01_06_425584	606	24	.	.	.
10_1101-2021_01_06_425584	607	1	Fragment	fragment	NN
10_1101-2021_01_06_425584	607	2	at	at	IN
10_1101-2021_01_06_425584	607	3	m	m	NN
10_1101-2021_01_06_425584	607	4	/	/	SYM
10_1101-2021_01_06_425584	607	5	z	z	NNP
10_1101-2021_01_06_425584	607	6	184.0725	184.0725	NN
10_1101-2021_01_06_425584	607	7	linked	link	VBN
10_1101-2021_01_06_425584	607	8	to	to	IN
10_1101-2021_01_06_425584	607	9	a	a	DT
10_1101-2021_01_06_425584	607	10	PC	pc	NN
10_1101-2021_01_06_425584	607	11	849	849	CD
10_1101-2021_01_06_425584	607	12	head	head	NN
10_1101-2021_01_06_425584	607	13	group	group	NN
10_1101-2021_01_06_425584	607	14	by	by	IN
10_1101-2021_01_06_425584	607	15	mzCloud	mzCloud	NNP
10_1101-2021_01_06_425584	607	16	in	in	IN
10_1101-2021_01_06_425584	607	17	silico	silico	NNP
10_1101-2021_01_06_425584	607	18	prediction	prediction	NN
10_1101-2021_01_06_425584	607	19	(	(	-LRB-
10_1101-2021_01_06_425584	607	20	www.mzCloud.org	www.mzcloud.org	UH
10_1101-2021_01_06_425584	607	21	)	)	-RRB-
10_1101-2021_01_06_425584	607	22	.	.	.
10_1101-2021_01_06_425584	608	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	608	2	:	:	:
10_1101-2021_01_06_425584	608	3	M2	M2	NNP
10_1101-2021_01_06_425584	608	4	M	M	NNP
10_1101-2021_01_06_425584	608	5	,	,	,
10_1101-2021_01_06_425584	608	6	mass2motif	mass2motif	NNP
10_1101-2021_01_06_425584	608	7	;	;	:
10_1101-2021_01_06_425584	608	8	850	850	CD
10_1101-2021_01_06_425584	608	9	FC	FC	NNP
10_1101-2021_01_06_425584	608	10	,	,	,
10_1101-2021_01_06_425584	608	11	fold	fold	VB
10_1101-2021_01_06_425584	608	12	change	change	NN
10_1101-2021_01_06_425584	608	13	;	;	:
10_1101-2021_01_06_425584	608	14	NG	NG	NNP
10_1101-2021_01_06_425584	608	15	,	,	,
10_1101-2021_01_06_425584	608	16	normal	normal	JJ
10_1101-2021_01_06_425584	608	17	glucose	glucose	NN
10_1101-2021_01_06_425584	608	18	;	;	:
10_1101-2021_01_06_425584	608	19	HG	HG	NNP
10_1101-2021_01_06_425584	608	20	,	,	,
10_1101-2021_01_06_425584	608	21	high	high	JJ
10_1101-2021_01_06_425584	608	22	glucose	glucose	NN
10_1101-2021_01_06_425584	608	23	;	;	:
10_1101-2021_01_06_425584	608	24	HI	hi	UH
10_1101-2021_01_06_425584	608	25	,	,	,
10_1101-2021_01_06_425584	608	26	high	high	JJ
10_1101-2021_01_06_425584	608	27	insulin	insulin	NN
10_1101-2021_01_06_425584	608	28	.	.	.
10_1101-2021_01_06_425584	609	1	Chemical	chemical	JJ
10_1101-2021_01_06_425584	609	2	structures	structure	NNS
10_1101-2021_01_06_425584	609	3	851	851	CD
10_1101-2021_01_06_425584	609	4	were	be	VBD
10_1101-2021_01_06_425584	609	5	drawn	draw	VBN
10_1101-2021_01_06_425584	609	6	by	by	IN
10_1101-2021_01_06_425584	609	7	ChemDraw	ChemDraw	NNP
10_1101-2021_01_06_425584	609	8	Professional	Professional	NNP
10_1101-2021_01_06_425584	609	9	version	version	NN
10_1101-2021_01_06_425584	609	10	16.0.1.4	16.0.1.4	NN
10_1101-2021_01_06_425584	609	11	.	.	.
10_1101-2021_01_06_425584	610	1	852	852	CD
10_1101-2021_01_06_425584	610	2	853	853	CD
10_1101-2021_01_06_425584	610	3	Figure	figure	NN
10_1101-2021_01_06_425584	610	4	4	4	CD
10_1101-2021_01_06_425584	610	5	.	.	.
10_1101-2021_01_06_425584	611	1	Peptide	peptide	JJ
10_1101-2021_01_06_425584	611	2	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	611	3	modulated	modulate	VBN
10_1101-2021_01_06_425584	611	4	by	by	IN
10_1101-2021_01_06_425584	611	5	simulated	simulated	JJ
10_1101-2021_01_06_425584	611	6	diabetes	diabete	NNS
10_1101-2021_01_06_425584	611	7	in	in	IN
10_1101-2021_01_06_425584	611	8	bovine	bovine	JJ
10_1101-2021_01_06_425584	611	9	coronary	coronary	JJ
10_1101-2021_01_06_425584	611	10	artery	artery	NN
10_1101-2021_01_06_425584	611	11	854	854	CD
10_1101-2021_01_06_425584	611	12	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	611	13	cells	cell	NNS
10_1101-2021_01_06_425584	611	14	(	(	-LRB-
10_1101-2021_01_06_425584	611	15	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	611	16	)	)	-RRB-
10_1101-2021_01_06_425584	611	17	.	.	.
10_1101-2021_01_06_425584	612	1	(	(	-LRB-
10_1101-2021_01_06_425584	612	2	A	a	DT
10_1101-2021_01_06_425584	612	3	)	)	-RRB-
10_1101-2021_01_06_425584	612	4	Cluster	cluster	NN
10_1101-2021_01_06_425584	612	5	2	2	CD
10_1101-2021_01_06_425584	612	6	retrieved	retrieve	VBN
10_1101-2021_01_06_425584	612	7	from	from	IN
10_1101-2021_01_06_425584	612	8	the	the	DT
10_1101-2021_01_06_425584	612	9	main	main	JJ
10_1101-2021_01_06_425584	612	10	molecular	molecular	JJ
10_1101-2021_01_06_425584	612	11	network	network	NN
10_1101-2021_01_06_425584	612	12	linked	link	VBN
10_1101-2021_01_06_425584	612	13	to	to	IN
10_1101-2021_01_06_425584	612	14	855	855	CD
10_1101-2021_01_06_425584	612	15	glutathione	glutathione	NN
10_1101-2021_01_06_425584	612	16	and	and	CC
10_1101-2021_01_06_425584	612	17	derivatives	derivative	NNS
10_1101-2021_01_06_425584	612	18	.	.	.
10_1101-2021_01_06_425584	613	1	The	the	DT
10_1101-2021_01_06_425584	613	2	fragments	fragment	NNS
10_1101-2021_01_06_425584	613	3	of	of	IN
10_1101-2021_01_06_425584	613	4	mass-2-motif	mass-2-motif	NNP
10_1101-2021_01_06_425584	613	5	(	(	-LRB-
10_1101-2021_01_06_425584	613	6	M2M)_453	m2m)_453	RB
10_1101-2021_01_06_425584	613	7	colored	color	VBN
10_1101-2021_01_06_425584	613	8	in	in	IN
10_1101-2021_01_06_425584	613	9	red	red	NNP
10_1101-2021_01_06_425584	613	10	are	be	VBP
10_1101-2021_01_06_425584	613	11	856	856	CD
10_1101-2021_01_06_425584	613	12	.CC	.CC	:
10_1101-2021_01_06_425584	613	13	-	-	HYPH
10_1101-2021_01_06_425584	613	14	BY	by	IN
10_1101-2021_01_06_425584	613	15	-	-	HYPH
10_1101-2021_01_06_425584	613	16	NC	NC	NNP
10_1101-2021_01_06_425584	613	17	-	-	HYPH
10_1101-2021_01_06_425584	613	18	ND	ND	NNP
10_1101-2021_01_06_425584	613	19	4.0	4.0	CD
10_1101-2021_01_06_425584	613	20	International	International	NNP
10_1101-2021_01_06_425584	613	21	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	613	22	under	under	IN
10_1101-2021_01_06_425584	613	23	a	a	DT
10_1101-2021_01_06_425584	613	24	(	(	-LRB-
10_1101-2021_01_06_425584	613	25	which	which	WDT
10_1101-2021_01_06_425584	613	26	was	be	VBD
10_1101-2021_01_06_425584	613	27	not	not	RB
10_1101-2021_01_06_425584	613	28	certified	certify	VBN
10_1101-2021_01_06_425584	613	29	by	by	IN
10_1101-2021_01_06_425584	613	30	peer	peer	NN
10_1101-2021_01_06_425584	613	31	review	review	NN
10_1101-2021_01_06_425584	613	32	)	)	-RRB-
10_1101-2021_01_06_425584	613	33	is	be	VBZ
10_1101-2021_01_06_425584	613	34	the	the	DT
10_1101-2021_01_06_425584	613	35	author	author	NN
10_1101-2021_01_06_425584	613	36	/	/	SYM
10_1101-2021_01_06_425584	613	37	funder	funder	NN
10_1101-2021_01_06_425584	613	38	,	,	,
10_1101-2021_01_06_425584	613	39	who	who	WP
10_1101-2021_01_06_425584	613	40	has	have	VBZ
10_1101-2021_01_06_425584	613	41	granted	grant	VBN
10_1101-2021_01_06_425584	613	42	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	613	43	a	a	DT
10_1101-2021_01_06_425584	613	44	license	license	NN
10_1101-2021_01_06_425584	613	45	to	to	TO
10_1101-2021_01_06_425584	613	46	display	display	VB
10_1101-2021_01_06_425584	613	47	the	the	DT
10_1101-2021_01_06_425584	613	48	preprint	preprint	NN
10_1101-2021_01_06_425584	613	49	in	in	IN
10_1101-2021_01_06_425584	613	50	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	613	51	.	.	.
10_1101-2021_01_06_425584	614	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	614	2	is	be	VBZ
10_1101-2021_01_06_425584	614	3	made	make	VBN
10_1101-2021_01_06_425584	614	4	The	the	DT
10_1101-2021_01_06_425584	614	5	copyright	copyright	NN
10_1101-2021_01_06_425584	614	6	holder	holder	NN
10_1101-2021_01_06_425584	614	7	for	for	IN
10_1101-2021_01_06_425584	614	8	this	this	DT
10_1101-2021_01_06_425584	614	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	614	10	version	version	NN
10_1101-2021_01_06_425584	614	11	posted	post	VBD
10_1101-2021_01_06_425584	614	12	January	January	NNP
10_1101-2021_01_06_425584	614	13	8	8	CD
10_1101-2021_01_06_425584	614	14	,	,	,
10_1101-2021_01_06_425584	614	15	2021	2021	CD
10_1101-2021_01_06_425584	614	16	.	.	.
10_1101-2021_01_06_425584	614	17	;	;	:
10_1101-2021_01_06_425584	614	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	614	19	:	:	:
10_1101-2021_01_06_425584	614	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	614	21	preprint	preprint	NN
10_1101-2021_01_06_425584	614	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	614	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2021_01_06_425584	614	24	28	28	CD
10_1101-2021_01_06_425584	614	25	characteristic	characteristic	NN
10_1101-2021_01_06_425584	614	26	of	of	IN
10_1101-2021_01_06_425584	614	27	a	a	DT
10_1101-2021_01_06_425584	614	28	glutathione	glutathione	JJ
10_1101-2021_01_06_425584	614	29	core	core	NN
10_1101-2021_01_06_425584	614	30	and	and	CC
10_1101-2021_01_06_425584	614	31	the	the	DT
10_1101-2021_01_06_425584	614	32	fragments	fragment	NNS
10_1101-2021_01_06_425584	614	33	are	be	VBP
10_1101-2021_01_06_425584	614	34	shown	show	VBN
10_1101-2021_01_06_425584	614	35	in	in	IN
10_1101-2021_01_06_425584	614	36	red	red	NN
10_1101-2021_01_06_425584	614	37	.	.	.
10_1101-2021_01_06_425584	615	1	(	(	-LRB-
10_1101-2021_01_06_425584	615	2	B	b	NN
10_1101-2021_01_06_425584	615	3	)	)	-RRB-
10_1101-2021_01_06_425584	615	4	Features	feature	NNS
10_1101-2021_01_06_425584	615	5	associated	associate	VBD
10_1101-2021_01_06_425584	615	6	857	857	CD
10_1101-2021_01_06_425584	615	7	with	with	IN
10_1101-2021_01_06_425584	615	8	M2M_453	M2M_453	NNP
10_1101-2021_01_06_425584	615	9	using	use	VBG
10_1101-2021_01_06_425584	615	10	MS1	MS1	NNP
10_1101-2021_01_06_425584	615	11	visualization	visualization	NN
10_1101-2021_01_06_425584	615	12	in	in	IN
10_1101-2021_01_06_425584	615	13	www.ms2lda.org	www.ms2lda.org	NN
10_1101-2021_01_06_425584	615	14	.	.	.
10_1101-2021_01_06_425584	616	1	(	(	-LRB-
10_1101-2021_01_06_425584	616	2	C	C	NNP
10_1101-2021_01_06_425584	616	3	)	)	-RRB-
10_1101-2021_01_06_425584	616	4	Cluster	Cluster	NNP
10_1101-2021_01_06_425584	616	5	3	3	CD
10_1101-2021_01_06_425584	616	6	retrieved	retrieve	VBD
10_1101-2021_01_06_425584	616	7	from	from	IN
10_1101-2021_01_06_425584	616	8	the	the	DT
10_1101-2021_01_06_425584	616	9	main	main	JJ
10_1101-2021_01_06_425584	616	10	858	858	CD
10_1101-2021_01_06_425584	616	11	molecular	molecular	JJ
10_1101-2021_01_06_425584	616	12	network	network	NN
10_1101-2021_01_06_425584	616	13	linked	link	VBN
10_1101-2021_01_06_425584	616	14	to	to	IN
10_1101-2021_01_06_425584	616	15	phenylalanine	phenylalanine	NN
10_1101-2021_01_06_425584	616	16	-	-	HYPH
10_1101-2021_01_06_425584	616	17	based	base	VBN
10_1101-2021_01_06_425584	616	18	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	616	19	.	.	.
10_1101-2021_01_06_425584	617	1	A	a	DT
10_1101-2021_01_06_425584	617	2	singular	singular	JJ
10_1101-2021_01_06_425584	617	3	node	node	NN
10_1101-2021_01_06_425584	617	4	at	at	IN
10_1101-2021_01_06_425584	617	5	m	m	NNP
10_1101-2021_01_06_425584	617	6	/	/	SYM
10_1101-2021_01_06_425584	617	7	z	z	NNP
10_1101-2021_01_06_425584	617	8	487.1548	487.1548	CD
10_1101-2021_01_06_425584	617	9	859	859	CD
10_1101-2021_01_06_425584	617	10	is	be	VBZ
10_1101-2021_01_06_425584	617	11	also	also	RB
10_1101-2021_01_06_425584	617	12	shown	show	VBN
10_1101-2021_01_06_425584	617	13	.	.	.
10_1101-2021_01_06_425584	618	1	The	the	DT
10_1101-2021_01_06_425584	618	2	fragments	fragment	NNS
10_1101-2021_01_06_425584	618	3	of	of	IN
10_1101-2021_01_06_425584	618	4	M2M_59	M2M_59	NNP
10_1101-2021_01_06_425584	618	5	colored	color	VBN
10_1101-2021_01_06_425584	618	6	in	in	IN
10_1101-2021_01_06_425584	618	7	red	red	NN
10_1101-2021_01_06_425584	618	8	are	be	VBP
10_1101-2021_01_06_425584	618	9	characteristic	characteristic	JJ
10_1101-2021_01_06_425584	618	10	of	of	IN
10_1101-2021_01_06_425584	618	11	a	a	DT
10_1101-2021_01_06_425584	618	12	phenylalanine	phenylalanine	NN
10_1101-2021_01_06_425584	618	13	core	core	NN
10_1101-2021_01_06_425584	618	14	860	860	CD
10_1101-2021_01_06_425584	618	15	(	(	-LRB-
10_1101-2021_01_06_425584	618	16	Heuristic	Heuristic	NNP
10_1101-2021_01_06_425584	618	17	and	and	CC
10_1101-2021_01_06_425584	618	18	Quantum	Quantum	NNP
10_1101-2021_01_06_425584	618	19	Chemical	Chemical	NNP
10_1101-2021_01_06_425584	618	20	predictions	prediction	NNS
10_1101-2021_01_06_425584	618	21	by	by	IN
10_1101-2021_01_06_425584	618	22	www.mzCloud.org	www.mzcloud.org	NN
10_1101-2021_01_06_425584	618	23	)	)	-RRB-
10_1101-2021_01_06_425584	618	24	.	.	.
10_1101-2021_01_06_425584	619	1	(	(	-LRB-
10_1101-2021_01_06_425584	619	2	D	d	NN
10_1101-2021_01_06_425584	619	3	)	)	-RRB-
10_1101-2021_01_06_425584	619	4	Features	feature	NNS
10_1101-2021_01_06_425584	619	5	associated	associate	VBD
10_1101-2021_01_06_425584	619	6	861	861	CD
10_1101-2021_01_06_425584	619	7	with	with	IN
10_1101-2021_01_06_425584	619	8	M2M_59	M2M_59	NNP
10_1101-2021_01_06_425584	619	9	using	use	VBG
10_1101-2021_01_06_425584	619	10	MS1	MS1	NNP
10_1101-2021_01_06_425584	619	11	visualization	visualization	NN
10_1101-2021_01_06_425584	619	12	in	in	IN
10_1101-2021_01_06_425584	619	13	www.ms2lda.org	www.ms2lda.org	NN
10_1101-2021_01_06_425584	619	14	.	.	.
10_1101-2021_01_06_425584	620	1	In	in	IN
10_1101-2021_01_06_425584	620	2	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	620	3	’s	’s	POS
10_1101-2021_01_06_425584	620	4	clusters	cluster	NNS
10_1101-2021_01_06_425584	620	5	(	(	-LRB-
10_1101-2021_01_06_425584	620	6	A	a	NN
10_1101-2021_01_06_425584	620	7	and	and	CC
10_1101-2021_01_06_425584	620	8	C	C	NNP
10_1101-2021_01_06_425584	620	9	)	)	-RRB-
10_1101-2021_01_06_425584	620	10	,	,	,
10_1101-2021_01_06_425584	620	11	the	the	DT
10_1101-2021_01_06_425584	620	12	862	862	CD
10_1101-2021_01_06_425584	620	13	node	node	NN
10_1101-2021_01_06_425584	620	14	’s	’s	POS
10_1101-2021_01_06_425584	620	15	color	color	NN
10_1101-2021_01_06_425584	620	16	denotes	denote	VBZ
10_1101-2021_01_06_425584	620	17	the	the	DT
10_1101-2021_01_06_425584	620	18	chemical	chemical	NN
10_1101-2021_01_06_425584	620	19	class	class	NN
10_1101-2021_01_06_425584	620	20	assigned	assign	VBN
10_1101-2021_01_06_425584	620	21	to	to	IN
10_1101-2021_01_06_425584	620	22	the	the	DT
10_1101-2021_01_06_425584	620	23	cluster	cluster	NN
10_1101-2021_01_06_425584	620	24	.	.	.
10_1101-2021_01_06_425584	621	1	The	the	DT
10_1101-2021_01_06_425584	621	2	thickness	thickness	NN
10_1101-2021_01_06_425584	621	3	of	of	IN
10_1101-2021_01_06_425584	621	4	the	the	DT
10_1101-2021_01_06_425584	621	5	edge	edge	NN
10_1101-2021_01_06_425584	621	6	863	863	CD
10_1101-2021_01_06_425584	621	7	(	(	-LRB-
10_1101-2021_01_06_425584	621	8	connectivity	connectivity	NN
10_1101-2021_01_06_425584	621	9	)	)	-RRB-
10_1101-2021_01_06_425584	621	10	indicates	indicate	VBZ
10_1101-2021_01_06_425584	621	11	the	the	DT
10_1101-2021_01_06_425584	621	12	cosine	cosine	NN
10_1101-2021_01_06_425584	621	13	score	score	NN
10_1101-2021_01_06_425584	621	14	(	(	-LRB-
10_1101-2021_01_06_425584	621	15	MS2	MS2	NNP
10_1101-2021_01_06_425584	621	16	similarity	similarity	NN
10_1101-2021_01_06_425584	621	17	)	)	-RRB-
10_1101-2021_01_06_425584	621	18	.	.	.
10_1101-2021_01_06_425584	622	1	The	the	DT
10_1101-2021_01_06_425584	622	2	m	m	NNP
10_1101-2021_01_06_425584	622	3	/	/	SYM
10_1101-2021_01_06_425584	622	4	z	z	NN
10_1101-2021_01_06_425584	622	5	value	value	NN
10_1101-2021_01_06_425584	622	6	of	of	IN
10_1101-2021_01_06_425584	622	7	the	the	DT
10_1101-2021_01_06_425584	622	8	feature	feature	NN
10_1101-2021_01_06_425584	622	9	is	be	VBZ
10_1101-2021_01_06_425584	622	10	shown	show	VBN
10_1101-2021_01_06_425584	622	11	864	864	CD
10_1101-2021_01_06_425584	622	12	inside	inside	IN
10_1101-2021_01_06_425584	622	13	the	the	DT
10_1101-2021_01_06_425584	622	14	node	node	NN
10_1101-2021_01_06_425584	622	15	and	and	CC
10_1101-2021_01_06_425584	622	16	is	be	VBZ
10_1101-2021_01_06_425584	622	17	proportional	proportional	JJ
10_1101-2021_01_06_425584	622	18	to	to	IN
10_1101-2021_01_06_425584	622	19	the	the	DT
10_1101-2021_01_06_425584	622	20	size	size	NN
10_1101-2021_01_06_425584	622	21	of	of	IN
10_1101-2021_01_06_425584	622	22	the	the	DT
10_1101-2021_01_06_425584	622	23	node	node	NN
10_1101-2021_01_06_425584	622	24	.	.	.
10_1101-2021_01_06_425584	623	1	Significant	significant	JJ
10_1101-2021_01_06_425584	623	2	differential	differential	NN
10_1101-2021_01_06_425584	623	3	abundant	abundant	JJ
10_1101-2021_01_06_425584	623	4	865	865	CD
10_1101-2021_01_06_425584	623	5	features	feature	NNS
10_1101-2021_01_06_425584	623	6	among	among	IN
10_1101-2021_01_06_425584	623	7	simulated	simulated	JJ
10_1101-2021_01_06_425584	623	8	diabetes	diabete	NNS
10_1101-2021_01_06_425584	623	9	(	(	-LRB-
10_1101-2021_01_06_425584	623	10	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	623	11	)	)	-RRB-
10_1101-2021_01_06_425584	623	12	and	and	CC
10_1101-2021_01_06_425584	623	13	control	control	NN
10_1101-2021_01_06_425584	623	14	(	(	-LRB-
10_1101-2021_01_06_425584	623	15	NG	NG	NNP
10_1101-2021_01_06_425584	623	16	)	)	-RRB-
10_1101-2021_01_06_425584	623	17	groups	group	NNS
10_1101-2021_01_06_425584	623	18	are	be	VBP
10_1101-2021_01_06_425584	623	19	indicated	indicate	VBN
10_1101-2021_01_06_425584	623	20	with	with	IN
10_1101-2021_01_06_425584	623	21	an	an	DT
10_1101-2021_01_06_425584	623	22	866	866	CD
10_1101-2021_01_06_425584	623	23	asterisk	asterisk	NN
10_1101-2021_01_06_425584	623	24	(	(	-LRB-
10_1101-2021_01_06_425584	623	25	p	p	NN
10_1101-2021_01_06_425584	623	26	-	-	HYPH
10_1101-2021_01_06_425584	623	27	value	value	NN
10_1101-2021_01_06_425584	623	28	<	<	XX
10_1101-2021_01_06_425584	623	29	0.05	0.05	CD
10_1101-2021_01_06_425584	623	30	)	)	-RRB-
10_1101-2021_01_06_425584	623	31	.	.	.
10_1101-2021_01_06_425584	624	1	In	in	IN
10_1101-2021_01_06_425584	624	2	MS2LDA	MS2LDA	NNP
10_1101-2021_01_06_425584	624	3	’s	’s	POS
10_1101-2021_01_06_425584	624	4	nodes	node	NNS
10_1101-2021_01_06_425584	624	5	(	(	-LRB-
10_1101-2021_01_06_425584	624	6	B	b	NN
10_1101-2021_01_06_425584	624	7	and	and	CC
10_1101-2021_01_06_425584	624	8	D	D	NNP
10_1101-2021_01_06_425584	624	9	)	)	-RRB-
10_1101-2021_01_06_425584	624	10	,	,	,
10_1101-2021_01_06_425584	624	11	the	the	DT
10_1101-2021_01_06_425584	624	12	green	green	NNP
10_1101-2021_01_06_425584	624	13	node	node	RB
10_1101-2021_01_06_425584	624	14	represents	represent	VBZ
10_1101-2021_01_06_425584	624	15	the	the	DT
10_1101-2021_01_06_425584	624	16	M2	M2	NNP
10_1101-2021_01_06_425584	624	17	M	M	NNP
10_1101-2021_01_06_425584	624	18	and	and	CC
10_1101-2021_01_06_425584	624	19	867	867	CD
10_1101-2021_01_06_425584	624	20	squares	square	NNS
10_1101-2021_01_06_425584	624	21	indicate	indicate	VBP
10_1101-2021_01_06_425584	624	22	individual	individual	JJ
10_1101-2021_01_06_425584	624	23	features	feature	NNS
10_1101-2021_01_06_425584	624	24	.	.	.
10_1101-2021_01_06_425584	625	1	Edges	edge	NNS
10_1101-2021_01_06_425584	625	2	represent	represent	VBP
10_1101-2021_01_06_425584	625	3	connections	connection	NNS
10_1101-2021_01_06_425584	625	4	to	to	IN
10_1101-2021_01_06_425584	625	5	M2M.	m2m.	VB
10_1101-2021_01_06_425584	626	1	Significant	significant	JJ
10_1101-2021_01_06_425584	626	2	differential	differential	NN
10_1101-2021_01_06_425584	626	3	868	868	CD
10_1101-2021_01_06_425584	626	4	abundant	abundant	JJ
10_1101-2021_01_06_425584	626	5	features	feature	NNS
10_1101-2021_01_06_425584	626	6	among	among	IN
10_1101-2021_01_06_425584	626	7	groups	group	NNS
10_1101-2021_01_06_425584	626	8	are	be	VBP
10_1101-2021_01_06_425584	626	9	indicated	indicate	VBN
10_1101-2021_01_06_425584	626	10	with	with	IN
10_1101-2021_01_06_425584	626	11	an	an	DT
10_1101-2021_01_06_425584	626	12	asterisk	asterisk	NN
10_1101-2021_01_06_425584	626	13	(	(	-LRB-
10_1101-2021_01_06_425584	626	14	p	p	NN
10_1101-2021_01_06_425584	626	15	-	-	HYPH
10_1101-2021_01_06_425584	626	16	value	value	NN
10_1101-2021_01_06_425584	626	17	<	<	XX
10_1101-2021_01_06_425584	626	18	0.05	0.05	CD
10_1101-2021_01_06_425584	626	19	)	)	-RRB-
10_1101-2021_01_06_425584	626	20	.	.	.
10_1101-2021_01_06_425584	627	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	627	2	:	:	:
10_1101-2021_01_06_425584	627	3	869	869	CD
10_1101-2021_01_06_425584	627	4	M2	M2	NNP
10_1101-2021_01_06_425584	627	5	M	M	NNP
10_1101-2021_01_06_425584	627	6	,	,	,
10_1101-2021_01_06_425584	627	7	mass2motif	mass2motif	NNP
10_1101-2021_01_06_425584	627	8	;	;	:
10_1101-2021_01_06_425584	627	9	FC	fc	NN
10_1101-2021_01_06_425584	627	10	,	,	,
10_1101-2021_01_06_425584	627	11	fold	fold	VB
10_1101-2021_01_06_425584	627	12	change	change	NN
10_1101-2021_01_06_425584	627	13	;	;	:
10_1101-2021_01_06_425584	627	14	NG	NG	NNP
10_1101-2021_01_06_425584	627	15	,	,	,
10_1101-2021_01_06_425584	627	16	normal	normal	JJ
10_1101-2021_01_06_425584	627	17	glucose	glucose	NN
10_1101-2021_01_06_425584	627	18	;	;	:
10_1101-2021_01_06_425584	627	19	HG	HG	NNP
10_1101-2021_01_06_425584	627	20	,	,	,
10_1101-2021_01_06_425584	627	21	high	high	JJ
10_1101-2021_01_06_425584	627	22	glucose	glucose	NN
10_1101-2021_01_06_425584	627	23	;	;	:
10_1101-2021_01_06_425584	627	24	HI	hi	UH
10_1101-2021_01_06_425584	627	25	,	,	,
10_1101-2021_01_06_425584	627	26	high	high	JJ
10_1101-2021_01_06_425584	627	27	insulin	insulin	NN
10_1101-2021_01_06_425584	627	28	.	.	.
10_1101-2021_01_06_425584	628	1	870	870	CD
10_1101-2021_01_06_425584	628	2	Chemical	Chemical	NNP
10_1101-2021_01_06_425584	628	3	structures	structure	NNS
10_1101-2021_01_06_425584	628	4	were	be	VBD
10_1101-2021_01_06_425584	628	5	drawn	draw	VBN
10_1101-2021_01_06_425584	628	6	by	by	IN
10_1101-2021_01_06_425584	628	7	ChemDraw	ChemDraw	NNP
10_1101-2021_01_06_425584	628	8	Professional	Professional	NNP
10_1101-2021_01_06_425584	628	9	version	version	NN
10_1101-2021_01_06_425584	628	10	16.0.1.4	16.0.1.4	NN
10_1101-2021_01_06_425584	628	11	.	.	.
10_1101-2021_01_06_425584	629	1	871	871	CD
10_1101-2021_01_06_425584	629	2	872	872	CD
10_1101-2021_01_06_425584	629	3	Figure	figure	NN
10_1101-2021_01_06_425584	629	4	5	5	CD
10_1101-2021_01_06_425584	629	5	.	.	.
10_1101-2021_01_06_425584	630	1	Simulated	simulate	VBN
10_1101-2021_01_06_425584	630	2	diabetes	diabete	NNS
10_1101-2021_01_06_425584	630	3	induced	induce	VBD
10_1101-2021_01_06_425584	630	4	changes	change	NNS
10_1101-2021_01_06_425584	630	5	in	in	IN
10_1101-2021_01_06_425584	630	6	the	the	DT
10_1101-2021_01_06_425584	630	7	proteome	proteome	NN
10_1101-2021_01_06_425584	630	8	of	of	IN
10_1101-2021_01_06_425584	630	9	bovine	bovine	JJ
10_1101-2021_01_06_425584	630	10	coronary	coronary	JJ
10_1101-2021_01_06_425584	630	11	artery	artery	NN
10_1101-2021_01_06_425584	630	12	873	873	CD
10_1101-2021_01_06_425584	630	13	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	630	14	cells	cell	NNS
10_1101-2021_01_06_425584	630	15	(	(	-LRB-
10_1101-2021_01_06_425584	630	16	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	630	17	)	)	-RRB-
10_1101-2021_01_06_425584	630	18	.	.	.
10_1101-2021_01_06_425584	631	1	(	(	-LRB-
10_1101-2021_01_06_425584	631	2	A	a	DT
10_1101-2021_01_06_425584	631	3	)	)	-RRB-
10_1101-2021_01_06_425584	631	4	Principal	Principal	NNP
10_1101-2021_01_06_425584	631	5	Component	Component	NNP
10_1101-2021_01_06_425584	631	6	Analysis	Analysis	NNP
10_1101-2021_01_06_425584	631	7	(	(	-LRB-
10_1101-2021_01_06_425584	631	8	PCA	PCA	NNP
10_1101-2021_01_06_425584	631	9	)	)	-RRB-
10_1101-2021_01_06_425584	631	10	of	of	IN
10_1101-2021_01_06_425584	631	11	LC	LC	NNP
10_1101-2021_01_06_425584	631	12	-	-	HYPH
10_1101-2021_01_06_425584	631	13	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	631	14	-	-	HYPH
10_1101-2021_01_06_425584	631	15	MS2	MS2	NNP
10_1101-2021_01_06_425584	631	16	874	874	CD
10_1101-2021_01_06_425584	631	17	datasets	dataset	NNS
10_1101-2021_01_06_425584	631	18	.	.	.
10_1101-2021_01_06_425584	632	1	Data	datum	NNS
10_1101-2021_01_06_425584	632	2	was	be	VBD
10_1101-2021_01_06_425584	632	3	log	log	NN
10_1101-2021_01_06_425584	632	4	transformed	transform	VBN
10_1101-2021_01_06_425584	632	5	without	without	IN
10_1101-2021_01_06_425584	632	6	scaling	scale	VBG
10_1101-2021_01_06_425584	632	7	.	.	.
10_1101-2021_01_06_425584	633	1	Shade	shade	NN
10_1101-2021_01_06_425584	633	2	areas	area	NNS
10_1101-2021_01_06_425584	633	3	depict	depict	VBP
10_1101-2021_01_06_425584	633	4	the	the	DT
10_1101-2021_01_06_425584	633	5	95	95	CD
10_1101-2021_01_06_425584	633	6	%	%	NN
10_1101-2021_01_06_425584	633	7	confidence	confidence	NN
10_1101-2021_01_06_425584	633	8	875	875	CD
10_1101-2021_01_06_425584	633	9	intervals	interval	NNS
10_1101-2021_01_06_425584	633	10	.	.	.
10_1101-2021_01_06_425584	634	1	No	no	DT
10_1101-2021_01_06_425584	634	2	scaling	scaling	NN
10_1101-2021_01_06_425584	634	3	was	be	VBD
10_1101-2021_01_06_425584	634	4	used	use	VBN
10_1101-2021_01_06_425584	634	5	.	.	.
10_1101-2021_01_06_425584	635	1	(	(	-LRB-
10_1101-2021_01_06_425584	635	2	B	b	NN
10_1101-2021_01_06_425584	635	3	)	)	-RRB-
10_1101-2021_01_06_425584	635	4	Volcano	Volcano	NNP
10_1101-2021_01_06_425584	635	5	plot	plot	NN
10_1101-2021_01_06_425584	635	6	of	of	IN
10_1101-2021_01_06_425584	635	7	all	all	DT
10_1101-2021_01_06_425584	635	8	quantified	quantify	VBN
10_1101-2021_01_06_425584	635	9	proteins	protein	NNS
10_1101-2021_01_06_425584	635	10	(	(	-LRB-
10_1101-2021_01_06_425584	635	11	Quantile	Quantile	NNP
10_1101-2021_01_06_425584	635	12	normalization	normalization	NN
10_1101-2021_01_06_425584	635	13	)	)	-RRB-
10_1101-2021_01_06_425584	635	14	876	876	CD
10_1101-2021_01_06_425584	635	15	displaying	display	VBG
10_1101-2021_01_06_425584	635	16	differences	difference	NNS
10_1101-2021_01_06_425584	635	17	in	in	IN
10_1101-2021_01_06_425584	635	18	relative	relative	JJ
10_1101-2021_01_06_425584	635	19	abundance	abundance	NN
10_1101-2021_01_06_425584	635	20	(	(	-LRB-
10_1101-2021_01_06_425584	635	21	>	>	XX
10_1101-2021_01_06_425584	635	22	+	+	SYM
10_1101-2021_01_06_425584	635	23	/-20	/-20	CD
10_1101-2021_01_06_425584	635	24	%	%	NN
10_1101-2021_01_06_425584	635	25	change	change	NN
10_1101-2021_01_06_425584	635	26	,	,	,
10_1101-2021_01_06_425584	635	27	<	<	XX
10_1101-2021_01_06_425584	635	28	0.05	0.05	CD
10_1101-2021_01_06_425584	635	29	p	p	NN
10_1101-2021_01_06_425584	635	30	-	-	HYPH
10_1101-2021_01_06_425584	635	31	value	value	NN
10_1101-2021_01_06_425584	635	32	cut	cut	NN
10_1101-2021_01_06_425584	635	33	-	-	HYPH
10_1101-2021_01_06_425584	635	34	offs	off	NNS
10_1101-2021_01_06_425584	635	35	)	)	-RRB-
10_1101-2021_01_06_425584	635	36	between	between	IN
10_1101-2021_01_06_425584	635	37	877	877	CD
10_1101-2021_01_06_425584	635	38	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	635	39	cultured	cultured	JJ
10_1101-2021_01_06_425584	635	40	in	in	IN
10_1101-2021_01_06_425584	635	41	control	control	NN
10_1101-2021_01_06_425584	635	42	(	(	-LRB-
10_1101-2021_01_06_425584	635	43	NG	NG	NNP
10_1101-2021_01_06_425584	635	44	)	)	-RRB-
10_1101-2021_01_06_425584	635	45	media	medium	NNS
10_1101-2021_01_06_425584	635	46	and	and	CC
10_1101-2021_01_06_425584	635	47	simulated	simulate	VBN
10_1101-2021_01_06_425584	635	48	diabetes	diabetes	NN
10_1101-2021_01_06_425584	635	49	(	(	-LRB-
10_1101-2021_01_06_425584	635	50	HG+	HG+	NNP
10_1101-2021_01_06_425584	635	51	HI	HI	NNP
10_1101-2021_01_06_425584	635	52	)	)	-RRB-
10_1101-2021_01_06_425584	635	53	for	for	IN
10_1101-2021_01_06_425584	635	54	twelve	twelve	CD
10_1101-2021_01_06_425584	635	55	days	day	NNS
10_1101-2021_01_06_425584	635	56	.	.	.
10_1101-2021_01_06_425584	636	1	Values	value	NNS
10_1101-2021_01_06_425584	636	2	878	878	CD
10_1101-2021_01_06_425584	636	3	(	(	-LRB-
10_1101-2021_01_06_425584	636	4	dots	dot	NNS
10_1101-2021_01_06_425584	636	5	)	)	-RRB-
10_1101-2021_01_06_425584	636	6	represent	represent	VBP
10_1101-2021_01_06_425584	636	7	the	the	DT
10_1101-2021_01_06_425584	636	8	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	636	9	/	/	SYM
10_1101-2021_01_06_425584	636	10	NG	NG	NNP
10_1101-2021_01_06_425584	636	11	ratio	ratio	NN
10_1101-2021_01_06_425584	636	12	for	for	IN
10_1101-2021_01_06_425584	636	13	all	all	DT
10_1101-2021_01_06_425584	636	14	proteins	protein	NNS
10_1101-2021_01_06_425584	636	15	.	.	.
10_1101-2021_01_06_425584	637	1	Red	red	JJ
10_1101-2021_01_06_425584	637	2	and	and	CC
10_1101-2021_01_06_425584	637	3	blue	blue	JJ
10_1101-2021_01_06_425584	637	4	dots	dot	NNS
10_1101-2021_01_06_425584	637	5	denote	denote	VBP
10_1101-2021_01_06_425584	637	6	downregulated	downregulate	VBD
10_1101-2021_01_06_425584	637	7	879	879	CD
10_1101-2021_01_06_425584	637	8	and	and	CC
10_1101-2021_01_06_425584	637	9	upregulated	upregulated	JJ
10_1101-2021_01_06_425584	637	10	proteins	protein	NNS
10_1101-2021_01_06_425584	637	11	in	in	IN
10_1101-2021_01_06_425584	637	12	the	the	DT
10_1101-2021_01_06_425584	637	13	HG	HG	NNP
10_1101-2021_01_06_425584	637	14	+	+	CC
10_1101-2021_01_06_425584	637	15	HI	HI	NNP
10_1101-2021_01_06_425584	637	16	group	group	NN
10_1101-2021_01_06_425584	637	17	vs.	vs.	IN
10_1101-2021_01_06_425584	637	18	NG	NG	NNP
10_1101-2021_01_06_425584	637	19	group	group	NN
10_1101-2021_01_06_425584	637	20	,	,	,
10_1101-2021_01_06_425584	637	21	respectively	respectively	RB
10_1101-2021_01_06_425584	637	22	.	.	.
10_1101-2021_01_06_425584	638	1	(	(	-LRB-
10_1101-2021_01_06_425584	638	2	C	C	NNP
10_1101-2021_01_06_425584	638	3	)	)	-RRB-
10_1101-2021_01_06_425584	638	4	HeatMap	HeatMap	NNP
10_1101-2021_01_06_425584	638	5	of	of	IN
10_1101-2021_01_06_425584	638	6	the	the	DT
10_1101-2021_01_06_425584	638	7	880	880	CD
10_1101-2021_01_06_425584	638	8	top	top	JJ
10_1101-2021_01_06_425584	638	9	50	50	CD
10_1101-2021_01_06_425584	638	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	638	11	ranked	rank	VBN
10_1101-2021_01_06_425584	638	12	by	by	IN
10_1101-2021_01_06_425584	638	13	t	t	NN
10_1101-2021_01_06_425584	638	14	-	-	HYPH
10_1101-2021_01_06_425584	638	15	test	test	NN
10_1101-2021_01_06_425584	638	16	.	.	.
10_1101-2021_01_06_425584	639	1	Protein	Protein	NNP
10_1101-2021_01_06_425584	639	2	-	-	HYPH
10_1101-2021_01_06_425584	639	3	Protein	Protein	NNP
10_1101-2021_01_06_425584	639	4	interactome	interactome	NN
10_1101-2021_01_06_425584	639	5	(	(	-LRB-
10_1101-2021_01_06_425584	639	6	>	>	XX
10_1101-2021_01_06_425584	639	7	0.9	0.9	CD
10_1101-2021_01_06_425584	639	8	confidence	confidence	NN
10_1101-2021_01_06_425584	639	9	)	)	-RRB-
10_1101-2021_01_06_425584	639	10	using	use	VBG
10_1101-2021_01_06_425584	639	11	the	the	DT
10_1101-2021_01_06_425584	639	12	list	list	NN
10_1101-2021_01_06_425584	639	13	881	881	CD
10_1101-2021_01_06_425584	639	14	of	of	IN
10_1101-2021_01_06_425584	639	15	proteins	protein	NNS
10_1101-2021_01_06_425584	639	16	with	with	IN
10_1101-2021_01_06_425584	639	17	increased	increase	VBN
10_1101-2021_01_06_425584	639	18	abundance	abundance	NN
10_1101-2021_01_06_425584	639	19	(	(	-LRB-
10_1101-2021_01_06_425584	639	20	D	D	NNP
10_1101-2021_01_06_425584	639	21	)	)	-RRB-
10_1101-2021_01_06_425584	639	22	and	and	CC
10_1101-2021_01_06_425584	639	23	reduced	reduce	VBN
10_1101-2021_01_06_425584	639	24	abundance	abundance	NN
10_1101-2021_01_06_425584	639	25	(	(	-LRB-
10_1101-2021_01_06_425584	639	26	E	e	NN
10_1101-2021_01_06_425584	639	27	)	)	-RRB-
10_1101-2021_01_06_425584	639	28	in	in	IN
10_1101-2021_01_06_425584	639	29	the	the	DT
10_1101-2021_01_06_425584	639	30	HG	HG	NNP
10_1101-2021_01_06_425584	639	31	+	+	CC
10_1101-2021_01_06_425584	639	32	HI	HI	NNP
10_1101-2021_01_06_425584	639	33	group	group	NN
10_1101-2021_01_06_425584	639	34	.	.	.
10_1101-2021_01_06_425584	640	1	882	882	CD
10_1101-2021_01_06_425584	640	2	Colored	colored	JJ
10_1101-2021_01_06_425584	640	3	circles	circle	NNS
10_1101-2021_01_06_425584	640	4	denote	denote	NN
10_1101-2021_01_06_425584	640	5	modules	module	NNS
10_1101-2021_01_06_425584	640	6	or	or	CC
10_1101-2021_01_06_425584	640	7	clusters	cluster	NNS
10_1101-2021_01_06_425584	640	8	which	which	WDT
10_1101-2021_01_06_425584	640	9	may	may	MD
10_1101-2021_01_06_425584	640	10	represent	represent	VB
10_1101-2021_01_06_425584	640	11	relevant	relevant	JJ
10_1101-2021_01_06_425584	640	12	complexes	complex	NNS
10_1101-2021_01_06_425584	640	13	or	or	CC
10_1101-2021_01_06_425584	640	14	functional	functional	JJ
10_1101-2021_01_06_425584	640	15	883	883	CD
10_1101-2021_01_06_425584	640	16	units	unit	NNS
10_1101-2021_01_06_425584	640	17	.	.	.
10_1101-2021_01_06_425584	641	1	The	the	DT
10_1101-2021_01_06_425584	641	2	input	input	NN
10_1101-2021_01_06_425584	641	3	proteins	protein	NNS
10_1101-2021_01_06_425584	641	4	are	be	VBP
10_1101-2021_01_06_425584	641	5	illustrated	illustrate	VBN
10_1101-2021_01_06_425584	641	6	with	with	IN
10_1101-2021_01_06_425584	641	7	a	a	DT
10_1101-2021_01_06_425584	641	8	blue	blue	JJ
10_1101-2021_01_06_425584	641	9	shade	shade	NN
10_1101-2021_01_06_425584	641	10	and	and	CC
10_1101-2021_01_06_425584	641	11	the	the	DT
10_1101-2021_01_06_425584	641	12	gene	gene	NN
10_1101-2021_01_06_425584	641	13	ID	ID	NNP
10_1101-2021_01_06_425584	641	14	is	be	VBZ
10_1101-2021_01_06_425584	641	15	also	also	RB
10_1101-2021_01_06_425584	641	16	shown	show	VBN
10_1101-2021_01_06_425584	641	17	.	.	.
10_1101-2021_01_06_425584	642	1	The	the	DT
10_1101-2021_01_06_425584	642	2	884	884	CD
10_1101-2021_01_06_425584	642	3	most	most	RBS
10_1101-2021_01_06_425584	642	4	representative	representative	JJ
10_1101-2021_01_06_425584	642	5	pathway	pathway	NN
10_1101-2021_01_06_425584	642	6	(	(	-LRB-
10_1101-2021_01_06_425584	642	7	containing	contain	VBG
10_1101-2021_01_06_425584	642	8	more	more	JJR
10_1101-2021_01_06_425584	642	9	input	input	NN
10_1101-2021_01_06_425584	642	10	proteins	protein	NNS
10_1101-2021_01_06_425584	642	11	)	)	-RRB-
10_1101-2021_01_06_425584	642	12	for	for	IN
10_1101-2021_01_06_425584	642	13	all	all	DT
10_1101-2021_01_06_425584	642	14	modules	module	NNS
10_1101-2021_01_06_425584	642	15	is	be	VBZ
10_1101-2021_01_06_425584	642	16	indicated	indicate	VBN
10_1101-2021_01_06_425584	642	17	in	in	IN
10_1101-2021_01_06_425584	642	18	blue	blue	JJ
10_1101-2021_01_06_425584	642	19	885	885	CD
10_1101-2021_01_06_425584	642	20	letters	letter	NNS
10_1101-2021_01_06_425584	642	21	.	.	.
10_1101-2021_01_06_425584	643	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	643	2	:	:	:
10_1101-2021_01_06_425584	643	3	NG	NG	NNP
10_1101-2021_01_06_425584	643	4	,	,	,
10_1101-2021_01_06_425584	643	5	normal	normal	JJ
10_1101-2021_01_06_425584	643	6	glucose	glucose	NN
10_1101-2021_01_06_425584	643	7	;	;	:
10_1101-2021_01_06_425584	643	8	HG	HG	NNP
10_1101-2021_01_06_425584	643	9	,	,	,
10_1101-2021_01_06_425584	643	10	high	high	JJ
10_1101-2021_01_06_425584	643	11	glucose	glucose	NN
10_1101-2021_01_06_425584	643	12	;	;	:
10_1101-2021_01_06_425584	643	13	HI	hi	UH
10_1101-2021_01_06_425584	643	14	,	,	,
10_1101-2021_01_06_425584	643	15	high	high	JJ
10_1101-2021_01_06_425584	643	16	insulin	insulin	NN
10_1101-2021_01_06_425584	643	17	.	.	.
10_1101-2021_01_06_425584	644	1	886	886	CD
10_1101-2021_01_06_425584	644	2	887	887	CD
10_1101-2021_01_06_425584	644	3	Figure	figure	NN
10_1101-2021_01_06_425584	644	4	6	6	CD
10_1101-2021_01_06_425584	644	5	.	.	.
10_1101-2021_01_06_425584	645	1	3D	3d	JJ
10_1101-2021_01_06_425584	645	2	Integrative	integrative	JJ
10_1101-2021_01_06_425584	645	3	network	network	NN
10_1101-2021_01_06_425584	645	4	of	of	IN
10_1101-2021_01_06_425584	645	5	the	the	DT
10_1101-2021_01_06_425584	645	6	proteomic	proteomic	JJ
10_1101-2021_01_06_425584	645	7	and	and	CC
10_1101-2021_01_06_425584	645	8	metabolomic	metabolomic	JJ
10_1101-2021_01_06_425584	645	9	perturbations	perturbation	NNS
10_1101-2021_01_06_425584	645	10	caused	cause	VBD
10_1101-2021_01_06_425584	645	11	888	888	CD
10_1101-2021_01_06_425584	645	12	by	by	IN
10_1101-2021_01_06_425584	645	13	simulated	simulated	JJ
10_1101-2021_01_06_425584	645	14	diabetes	diabete	NNS
10_1101-2021_01_06_425584	645	15	in	in	IN
10_1101-2021_01_06_425584	645	16	bovine	bovine	JJ
10_1101-2021_01_06_425584	645	17	coronary	coronary	JJ
10_1101-2021_01_06_425584	645	18	artery	artery	NN
10_1101-2021_01_06_425584	645	19	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	645	20	cells	cell	NNS
10_1101-2021_01_06_425584	645	21	(	(	-LRB-
10_1101-2021_01_06_425584	645	22	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	645	23	)	)	-RRB-
10_1101-2021_01_06_425584	645	24	.	.	.
10_1101-2021_01_06_425584	646	1	Composite	composite	JJ
10_1101-2021_01_06_425584	646	2	889	889	CD
10_1101-2021_01_06_425584	646	3	protein	protein	NN
10_1101-2021_01_06_425584	646	4	-	-	HYPH
10_1101-2021_01_06_425584	646	5	metabolite	metabolite	JJ
10_1101-2021_01_06_425584	646	6	network	network	NN
10_1101-2021_01_06_425584	646	7	created	create	VBN
10_1101-2021_01_06_425584	646	8	by	by	IN
10_1101-2021_01_06_425584	646	9	OmicsNet	OmicsNet	NNP
10_1101-2021_01_06_425584	646	10	using	use	VBG
10_1101-2021_01_06_425584	646	11	the	the	DT
10_1101-2021_01_06_425584	646	12	up	up	RB
10_1101-2021_01_06_425584	646	13	-	-	HYPH
10_1101-2021_01_06_425584	646	14	regulated	regulated	JJ
10_1101-2021_01_06_425584	646	15	proteins	protein	NNS
10_1101-2021_01_06_425584	646	16	(	(	-LRB-
10_1101-2021_01_06_425584	646	17	red	red	JJ
10_1101-2021_01_06_425584	646	18	nodes	node	NNS
10_1101-2021_01_06_425584	646	19	)	)	-RRB-
10_1101-2021_01_06_425584	646	20	and	and	CC
10_1101-2021_01_06_425584	646	21	890	890	CD
10_1101-2021_01_06_425584	646	22	.CC	.CC	:
10_1101-2021_01_06_425584	646	23	-	-	HYPH
10_1101-2021_01_06_425584	646	24	BY	by	IN
10_1101-2021_01_06_425584	646	25	-	-	HYPH
10_1101-2021_01_06_425584	646	26	NC	NC	NNP
10_1101-2021_01_06_425584	646	27	-	-	HYPH
10_1101-2021_01_06_425584	646	28	ND	ND	NNP
10_1101-2021_01_06_425584	646	29	4.0	4.0	CD
10_1101-2021_01_06_425584	646	30	International	International	NNP
10_1101-2021_01_06_425584	646	31	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	646	32	under	under	IN
10_1101-2021_01_06_425584	646	33	a	a	DT
10_1101-2021_01_06_425584	646	34	(	(	-LRB-
10_1101-2021_01_06_425584	646	35	which	which	WDT
10_1101-2021_01_06_425584	646	36	was	be	VBD
10_1101-2021_01_06_425584	646	37	not	not	RB
10_1101-2021_01_06_425584	646	38	certified	certify	VBN
10_1101-2021_01_06_425584	646	39	by	by	IN
10_1101-2021_01_06_425584	646	40	peer	peer	NN
10_1101-2021_01_06_425584	646	41	review	review	NN
10_1101-2021_01_06_425584	646	42	)	)	-RRB-
10_1101-2021_01_06_425584	646	43	is	be	VBZ
10_1101-2021_01_06_425584	646	44	the	the	DT
10_1101-2021_01_06_425584	646	45	author	author	NN
10_1101-2021_01_06_425584	646	46	/	/	SYM
10_1101-2021_01_06_425584	646	47	funder	funder	NN
10_1101-2021_01_06_425584	646	48	,	,	,
10_1101-2021_01_06_425584	646	49	who	who	WP
10_1101-2021_01_06_425584	646	50	has	have	VBZ
10_1101-2021_01_06_425584	646	51	granted	grant	VBN
10_1101-2021_01_06_425584	646	52	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	646	53	a	a	DT
10_1101-2021_01_06_425584	646	54	license	license	NN
10_1101-2021_01_06_425584	646	55	to	to	TO
10_1101-2021_01_06_425584	646	56	display	display	VB
10_1101-2021_01_06_425584	646	57	the	the	DT
10_1101-2021_01_06_425584	646	58	preprint	preprint	NN
10_1101-2021_01_06_425584	646	59	in	in	IN
10_1101-2021_01_06_425584	646	60	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	646	61	.	.	.
10_1101-2021_01_06_425584	647	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	647	2	is	be	VBZ
10_1101-2021_01_06_425584	647	3	made	make	VBN
10_1101-2021_01_06_425584	647	4	The	the	DT
10_1101-2021_01_06_425584	647	5	copyright	copyright	NN
10_1101-2021_01_06_425584	647	6	holder	holder	NN
10_1101-2021_01_06_425584	647	7	for	for	IN
10_1101-2021_01_06_425584	647	8	this	this	DT
10_1101-2021_01_06_425584	647	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	647	10	version	version	NN
10_1101-2021_01_06_425584	647	11	posted	post	VBD
10_1101-2021_01_06_425584	647	12	January	January	NNP
10_1101-2021_01_06_425584	647	13	8	8	CD
10_1101-2021_01_06_425584	647	14	,	,	,
10_1101-2021_01_06_425584	647	15	2021	2021	CD
10_1101-2021_01_06_425584	647	16	.	.	.
10_1101-2021_01_06_425584	647	17	;	;	:
10_1101-2021_01_06_425584	647	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	647	19	:	:	:
10_1101-2021_01_06_425584	647	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	647	21	preprint	preprint	NN
10_1101-2021_01_06_425584	647	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	647	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	647	24	29	29	CD
10_1101-2021_01_06_425584	647	25	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	647	26	(	(	-LRB-
10_1101-2021_01_06_425584	647	27	magenta	magenta	NNP
10_1101-2021_01_06_425584	647	28	nodes	node	NNS
10_1101-2021_01_06_425584	647	29	)	)	-RRB-
10_1101-2021_01_06_425584	647	30	in	in	IN
10_1101-2021_01_06_425584	647	31	the	the	DT
10_1101-2021_01_06_425584	647	32	HG	HG	NNP
10_1101-2021_01_06_425584	647	33	+	+	CC
10_1101-2021_01_06_425584	647	34	HI	HI	NNP
10_1101-2021_01_06_425584	647	35	group	group	NN
10_1101-2021_01_06_425584	647	36	(	(	-LRB-
10_1101-2021_01_06_425584	647	37	simulated	simulate	VBN
10_1101-2021_01_06_425584	647	38	diabetes	diabetes	NN
10_1101-2021_01_06_425584	647	39	)	)	-RRB-
10_1101-2021_01_06_425584	647	40	.	.	.
10_1101-2021_01_06_425584	648	1	Interacting	interact	VBG
10_1101-2021_01_06_425584	648	2	proteins	protein	NNS
10_1101-2021_01_06_425584	648	3	(	(	-LRB-
10_1101-2021_01_06_425584	648	4	<	<	XX
10_1101-2021_01_06_425584	648	5	0.9	0.9	CD
10_1101-2021_01_06_425584	648	6	891	891	CD
10_1101-2021_01_06_425584	648	7	confidence	confidence	NN
10_1101-2021_01_06_425584	648	8	)	)	-RRB-
10_1101-2021_01_06_425584	648	9	were	be	VBD
10_1101-2021_01_06_425584	648	10	retrieved	retrieve	VBN
10_1101-2021_01_06_425584	648	11	from	from	IN
10_1101-2021_01_06_425584	648	12	STRING	STRING	NNP
10_1101-2021_01_06_425584	648	13	Database	Database	NNP
10_1101-2021_01_06_425584	648	14	and	and	CC
10_1101-2021_01_06_425584	648	15	are	be	VBP
10_1101-2021_01_06_425584	648	16	shown	show	VBN
10_1101-2021_01_06_425584	648	17	as	as	IN
10_1101-2021_01_06_425584	648	18	gray	gray	JJ
10_1101-2021_01_06_425584	648	19	nodes	node	NNS
10_1101-2021_01_06_425584	648	20	.	.	.
10_1101-2021_01_06_425584	649	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	649	2	:	:	:
10_1101-2021_01_06_425584	649	3	892	892	CD
10_1101-2021_01_06_425584	649	4	NG	NG	NNP
10_1101-2021_01_06_425584	649	5	,	,	,
10_1101-2021_01_06_425584	649	6	normal	normal	JJ
10_1101-2021_01_06_425584	649	7	glucose	glucose	NN
10_1101-2021_01_06_425584	649	8	;	;	:
10_1101-2021_01_06_425584	649	9	HG	HG	NNP
10_1101-2021_01_06_425584	649	10	,	,	,
10_1101-2021_01_06_425584	649	11	high	high	JJ
10_1101-2021_01_06_425584	649	12	glucose	glucose	NN
10_1101-2021_01_06_425584	649	13	;	;	:
10_1101-2021_01_06_425584	649	14	HI	hi	UH
10_1101-2021_01_06_425584	649	15	,	,	,
10_1101-2021_01_06_425584	649	16	high	high	JJ
10_1101-2021_01_06_425584	649	17	insulin	insulin	NN
10_1101-2021_01_06_425584	649	18	.	.	.
10_1101-2021_01_06_425584	650	1	893	893	CD
10_1101-2021_01_06_425584	650	2	894	894	CD
10_1101-2021_01_06_425584	650	3	Figure	Figure	NNP
10_1101-2021_01_06_425584	650	4	7	7	CD
10_1101-2021_01_06_425584	650	5	.	.	.
10_1101-2021_01_06_425584	651	1	Increased	increase	VBN
10_1101-2021_01_06_425584	651	2	cellular	cellular	JJ
10_1101-2021_01_06_425584	651	3	binucleation	binucleation	NN
10_1101-2021_01_06_425584	651	4	by	by	IN
10_1101-2021_01_06_425584	651	5	simulated	simulate	VBN
10_1101-2021_01_06_425584	651	6	diabetes	diabete	NNS
10_1101-2021_01_06_425584	651	7	in	in	IN
10_1101-2021_01_06_425584	651	8	bovine	bovine	JJ
10_1101-2021_01_06_425584	651	9	coronary	coronary	JJ
10_1101-2021_01_06_425584	651	10	artery	artery	NN
10_1101-2021_01_06_425584	651	11	895	895	CD
10_1101-2021_01_06_425584	651	12	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	651	13	cells	cell	NNS
10_1101-2021_01_06_425584	651	14	(	(	-LRB-
10_1101-2021_01_06_425584	651	15	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	651	16	)	)	-RRB-
10_1101-2021_01_06_425584	651	17	and	and	CC
10_1101-2021_01_06_425584	651	18	human	human	JJ
10_1101-2021_01_06_425584	651	19	coronary	coronary	JJ
10_1101-2021_01_06_425584	651	20	artery	artery	NN
10_1101-2021_01_06_425584	651	21	endothelial	endothelial	JJ
10_1101-2021_01_06_425584	651	22	cells	cell	NNS
10_1101-2021_01_06_425584	651	23	(	(	-LRB-
10_1101-2021_01_06_425584	651	24	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	651	25	)	)	-RRB-
10_1101-2021_01_06_425584	651	26	.	.	.
10_1101-2021_01_06_425584	652	1	(	(	-LRB-
10_1101-2021_01_06_425584	652	2	A	a	NN
10_1101-2021_01_06_425584	652	3	)	)	-RRB-
10_1101-2021_01_06_425584	652	4	896	896	CD
10_1101-2021_01_06_425584	652	5	Representative	representative	JJ
10_1101-2021_01_06_425584	652	6	immunofluorescence	immunofluorescence	NN
10_1101-2021_01_06_425584	652	7	micrographs	micrograph	NNS
10_1101-2021_01_06_425584	652	8	showing	show	VBG
10_1101-2021_01_06_425584	652	9	the	the	DT
10_1101-2021_01_06_425584	652	10	localization	localization	NN
10_1101-2021_01_06_425584	652	11	of	of	IN
10_1101-2021_01_06_425584	652	12	the	the	DT
10_1101-2021_01_06_425584	652	13	von	von	NNP
10_1101-2021_01_06_425584	652	14	-	-	HYPH
10_1101-2021_01_06_425584	652	15	Willebrand	Willebrand	NNP
10_1101-2021_01_06_425584	652	16	897	897	CD
10_1101-2021_01_06_425584	652	17	factor	factor	NN
10_1101-2021_01_06_425584	652	18	(	(	-LRB-
10_1101-2021_01_06_425584	652	19	vWf	vWf	NNS
10_1101-2021_01_06_425584	652	20	,	,	,
10_1101-2021_01_06_425584	652	21	1:400	1:400	CD
10_1101-2021_01_06_425584	652	22	,	,	,
10_1101-2021_01_06_425584	652	23	3	3	CD
10_1101-2021_01_06_425584	652	24	%	%	NN
10_1101-2021_01_06_425584	652	25	BSA	BSA	NNP
10_1101-2021_01_06_425584	652	26	in	in	IN
10_1101-2021_01_06_425584	652	27	PBS	PBS	NNP
10_1101-2021_01_06_425584	652	28	)	)	-RRB-
10_1101-2021_01_06_425584	652	29	in	in	IN
10_1101-2021_01_06_425584	652	30	fixed	fix	VBN
10_1101-2021_01_06_425584	652	31	and	and	CC
10_1101-2021_01_06_425584	652	32	permeabilized	permeabilized	JJ
10_1101-2021_01_06_425584	652	33	cells	cell	NNS
10_1101-2021_01_06_425584	652	34	.	.	.
10_1101-2021_01_06_425584	653	1	The	the	DT
10_1101-2021_01_06_425584	653	2	nuclei	nucleus	NNS
10_1101-2021_01_06_425584	653	3	were	be	VBD
10_1101-2021_01_06_425584	653	4	stained	stain	VBN
10_1101-2021_01_06_425584	653	5	898	898	CD
10_1101-2021_01_06_425584	653	6	using	use	VBG
10_1101-2021_01_06_425584	653	7	the	the	DT
10_1101-2021_01_06_425584	653	8	dye	dye	NN
10_1101-2021_01_06_425584	653	9	Hoechst	Hoechst	NNP
10_1101-2021_01_06_425584	653	10	33258	33258	CD
10_1101-2021_01_06_425584	653	11	(	(	-LRB-
10_1101-2021_01_06_425584	653	12	2	2	CD
10_1101-2021_01_06_425584	653	13	µg	µg	NN
10_1101-2021_01_06_425584	653	14	/	/	SYM
10_1101-2021_01_06_425584	653	15	ml	ml	NN
10_1101-2021_01_06_425584	653	16	in	in	IN
10_1101-2021_01_06_425584	653	17	HBSS	HBSS	NNP
10_1101-2021_01_06_425584	653	18	)	)	-RRB-
10_1101-2021_01_06_425584	653	19	.	.	.
10_1101-2021_01_06_425584	654	1	White	white	JJ
10_1101-2021_01_06_425584	654	2	arrows	arrow	NNS
10_1101-2021_01_06_425584	654	3	indicate	indicate	VBP
10_1101-2021_01_06_425584	654	4	binucleated	binucleated	JJ
10_1101-2021_01_06_425584	654	5	cells	cell	NNS
10_1101-2021_01_06_425584	654	6	.	.	.
10_1101-2021_01_06_425584	655	1	(	(	-LRB-
10_1101-2021_01_06_425584	655	2	B	b	NN
10_1101-2021_01_06_425584	655	3	)	)	-RRB-
10_1101-2021_01_06_425584	655	4	899	899	CD
10_1101-2021_01_06_425584	655	5	Quantification	quantification	NN
10_1101-2021_01_06_425584	655	6	of	of	IN
10_1101-2021_01_06_425584	655	7	binucleated	binucleated	JJ
10_1101-2021_01_06_425584	655	8	cells	cell	NNS
10_1101-2021_01_06_425584	655	9	in	in	IN
10_1101-2021_01_06_425584	655	10	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	655	11	and	and	CC
10_1101-2021_01_06_425584	655	12	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	655	13	under	under	IN
10_1101-2021_01_06_425584	655	14	simulated	simulate	VBN
10_1101-2021_01_06_425584	655	15	diabetes	diabetes	NN
10_1101-2021_01_06_425584	655	16	(	(	-LRB-
10_1101-2021_01_06_425584	655	17	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	655	18	)	)	-RRB-
10_1101-2021_01_06_425584	655	19	vs.	vs.	IN
10_1101-2021_01_06_425584	655	20	900	900	CD
10_1101-2021_01_06_425584	655	21	control	control	NN
10_1101-2021_01_06_425584	655	22	(	(	-LRB-
10_1101-2021_01_06_425584	655	23	NG	NG	NNP
10_1101-2021_01_06_425584	655	24	)	)	-RRB-
10_1101-2021_01_06_425584	655	25	group	group	NN
10_1101-2021_01_06_425584	655	26	.	.	.
10_1101-2021_01_06_425584	656	1	Fluorescence	fluorescence	NN
10_1101-2021_01_06_425584	656	2	images	image	NNS
10_1101-2021_01_06_425584	656	3	were	be	VBD
10_1101-2021_01_06_425584	656	4	taken	take	VBN
10_1101-2021_01_06_425584	656	5	in	in	RP
10_1101-2021_01_06_425584	656	6	at	at	RB
10_1101-2021_01_06_425584	656	7	least	least	RBS
10_1101-2021_01_06_425584	656	8	three	three	CD
10_1101-2021_01_06_425584	656	9	random	random	JJ
10_1101-2021_01_06_425584	656	10	fields	field	NNS
10_1101-2021_01_06_425584	656	11	per	per	IN
10_1101-2021_01_06_425584	656	12	condition	condition	NN
10_1101-2021_01_06_425584	656	13	901	901	CD
10_1101-2021_01_06_425584	656	14	using	use	VBG
10_1101-2021_01_06_425584	656	15	an	an	DT
10_1101-2021_01_06_425584	656	16	EVOS	evos	NN
10_1101-2021_01_06_425584	656	17	®	®	.
10_1101-2021_01_06_425584	656	18	FLoid	floid	NN
10_1101-2021_01_06_425584	656	19	®	®	:
10_1101-2021_01_06_425584	656	20	Cell	Cell	NNP
10_1101-2021_01_06_425584	656	21	Imaging	Imaging	NNP
10_1101-2021_01_06_425584	656	22	Station	Station	NNP
10_1101-2021_01_06_425584	656	23	with	with	IN
10_1101-2021_01_06_425584	656	24	a	a	DT
10_1101-2021_01_06_425584	656	25	fixed	fix	VBN
10_1101-2021_01_06_425584	656	26	20x	20x	NNS
10_1101-2021_01_06_425584	656	27	air	air	NN
10_1101-2021_01_06_425584	656	28	objective	objective	NN
10_1101-2021_01_06_425584	656	29	.	.	.
10_1101-2021_01_06_425584	657	1	Image	image	NN
10_1101-2021_01_06_425584	657	2	analysis	analysis	NN
10_1101-2021_01_06_425584	657	3	was	be	VBD
10_1101-2021_01_06_425584	657	4	902	902	CD
10_1101-2021_01_06_425584	657	5	performed	perform	VBN
10_1101-2021_01_06_425584	657	6	by	by	IN
10_1101-2021_01_06_425584	657	7	ImageJ	ImageJ	NNP
10_1101-2021_01_06_425584	657	8	software	software	NN
10_1101-2021_01_06_425584	657	9	(	(	-LRB-
10_1101-2021_01_06_425584	657	10	version	version	NN
10_1101-2021_01_06_425584	657	11	2.0.0	2.0.0	CD
10_1101-2021_01_06_425584	657	12	)	)	-RRB-
10_1101-2021_01_06_425584	657	13	.	.	.
10_1101-2021_01_06_425584	658	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	658	2	:	:	:
10_1101-2021_01_06_425584	658	3	NG	NG	NNP
10_1101-2021_01_06_425584	658	4	,	,	,
10_1101-2021_01_06_425584	658	5	normal	normal	JJ
10_1101-2021_01_06_425584	658	6	glucose	glucose	NN
10_1101-2021_01_06_425584	658	7	;	;	:
10_1101-2021_01_06_425584	658	8	HG	HG	NNP
10_1101-2021_01_06_425584	658	9	,	,	,
10_1101-2021_01_06_425584	658	10	high	high	JJ
10_1101-2021_01_06_425584	658	11	903	903	CD
10_1101-2021_01_06_425584	658	12	glucose	glucose	NN
10_1101-2021_01_06_425584	658	13	;	;	:
10_1101-2021_01_06_425584	658	14	HI	hi	UH
10_1101-2021_01_06_425584	658	15	,	,	,
10_1101-2021_01_06_425584	658	16	high	high	JJ
10_1101-2021_01_06_425584	658	17	insulin	insulin	NN
10_1101-2021_01_06_425584	658	18	.	.	.
10_1101-2021_01_06_425584	659	1	904	904	CD
10_1101-2021_01_06_425584	659	2	905	905	CD
10_1101-2021_01_06_425584	659	3	Figure	figure	NN
10_1101-2021_01_06_425584	659	4	8	8	CD
10_1101-2021_01_06_425584	659	5	.	.	.
10_1101-2021_01_06_425584	660	1	Summary	summary	JJ
10_1101-2021_01_06_425584	660	2	illustration	illustration	NN
10_1101-2021_01_06_425584	660	3	of	of	IN
10_1101-2021_01_06_425584	660	4	study	study	NN
10_1101-2021_01_06_425584	660	5	findings	finding	NNS
10_1101-2021_01_06_425584	660	6	.	.	.
10_1101-2021_01_06_425584	661	1	Cellular	cellular	JJ
10_1101-2021_01_06_425584	661	2	structures	structure	NNS
10_1101-2021_01_06_425584	661	3	were	be	VBD
10_1101-2021_01_06_425584	661	4	created	create	VBN
10_1101-2021_01_06_425584	661	5	using	use	VBG
10_1101-2021_01_06_425584	661	6	906	906	CD
10_1101-2021_01_06_425584	661	7	Servier	servier	JJ
10_1101-2021_01_06_425584	661	8	Medical	medical	JJ
10_1101-2021_01_06_425584	661	9	Art	art	NN
10_1101-2021_01_06_425584	661	10	templates	template	NNS
10_1101-2021_01_06_425584	661	11	,	,	,
10_1101-2021_01_06_425584	661	12	which	which	WDT
10_1101-2021_01_06_425584	661	13	are	be	VBP
10_1101-2021_01_06_425584	661	14	licensed	license	VBN
10_1101-2021_01_06_425584	661	15	under	under	IN
10_1101-2021_01_06_425584	661	16	a	a	DT
10_1101-2021_01_06_425584	661	17	Creative	Creative	NNP
10_1101-2021_01_06_425584	661	18	Commons	Commons	NNP
10_1101-2021_01_06_425584	661	19	Attribution	Attribution	NNP
10_1101-2021_01_06_425584	661	20	3.0	3.0	CD
10_1101-2021_01_06_425584	661	21	907	907	CD
10_1101-2021_01_06_425584	661	22	Unported	Unported	NNP
10_1101-2021_01_06_425584	661	23	License	License	NNP
10_1101-2021_01_06_425584	661	24	;	;	:
10_1101-2021_01_06_425584	661	25	https://smart.servier.com	https://smart.servier.com	ADD
10_1101-2021_01_06_425584	661	26	.	.	.
10_1101-2021_01_06_425584	662	1	Chemical	chemical	JJ
10_1101-2021_01_06_425584	662	2	structures	structure	NNS
10_1101-2021_01_06_425584	662	3	were	be	VBD
10_1101-2021_01_06_425584	662	4	drawn	draw	VBN
10_1101-2021_01_06_425584	662	5	by	by	IN
10_1101-2021_01_06_425584	662	6	ChemDraw	ChemDraw	NNP
10_1101-2021_01_06_425584	662	7	908	908	CD
10_1101-2021_01_06_425584	662	8	Professional	Professional	NNP
10_1101-2021_01_06_425584	662	9	version	version	NN
10_1101-2021_01_06_425584	662	10	16.0.1.4	16.0.1.4	CD
10_1101-2021_01_06_425584	662	11	.	.	.
10_1101-2021_01_06_425584	663	1	909	909	CD
10_1101-2021_01_06_425584	663	2	910	910	CD
10_1101-2021_01_06_425584	663	3	911	911	CD
10_1101-2021_01_06_425584	663	4	912	912	CD
10_1101-2021_01_06_425584	663	5	.CC	.CC	:
10_1101-2021_01_06_425584	663	6	-	-	HYPH
10_1101-2021_01_06_425584	663	7	BY	by	IN
10_1101-2021_01_06_425584	663	8	-	-	HYPH
10_1101-2021_01_06_425584	663	9	NC	NC	NNP
10_1101-2021_01_06_425584	663	10	-	-	HYPH
10_1101-2021_01_06_425584	663	11	ND	ND	NNP
10_1101-2021_01_06_425584	663	12	4.0	4.0	CD
10_1101-2021_01_06_425584	663	13	International	International	NNP
10_1101-2021_01_06_425584	663	14	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	663	15	under	under	IN
10_1101-2021_01_06_425584	663	16	a	a	DT
10_1101-2021_01_06_425584	663	17	(	(	-LRB-
10_1101-2021_01_06_425584	663	18	which	which	WDT
10_1101-2021_01_06_425584	663	19	was	be	VBD
10_1101-2021_01_06_425584	663	20	not	not	RB
10_1101-2021_01_06_425584	663	21	certified	certify	VBN
10_1101-2021_01_06_425584	663	22	by	by	IN
10_1101-2021_01_06_425584	663	23	peer	peer	NN
10_1101-2021_01_06_425584	663	24	review	review	NN
10_1101-2021_01_06_425584	663	25	)	)	-RRB-
10_1101-2021_01_06_425584	663	26	is	be	VBZ
10_1101-2021_01_06_425584	663	27	the	the	DT
10_1101-2021_01_06_425584	663	28	author	author	NN
10_1101-2021_01_06_425584	663	29	/	/	SYM
10_1101-2021_01_06_425584	663	30	funder	funder	NN
10_1101-2021_01_06_425584	663	31	,	,	,
10_1101-2021_01_06_425584	663	32	who	who	WP
10_1101-2021_01_06_425584	663	33	has	have	VBZ
10_1101-2021_01_06_425584	663	34	granted	grant	VBN
10_1101-2021_01_06_425584	663	35	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	663	36	a	a	DT
10_1101-2021_01_06_425584	663	37	license	license	NN
10_1101-2021_01_06_425584	663	38	to	to	TO
10_1101-2021_01_06_425584	663	39	display	display	VB
10_1101-2021_01_06_425584	663	40	the	the	DT
10_1101-2021_01_06_425584	663	41	preprint	preprint	NN
10_1101-2021_01_06_425584	663	42	in	in	IN
10_1101-2021_01_06_425584	663	43	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	663	44	.	.	.
10_1101-2021_01_06_425584	664	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	664	2	is	be	VBZ
10_1101-2021_01_06_425584	664	3	made	make	VBN
10_1101-2021_01_06_425584	664	4	The	the	DT
10_1101-2021_01_06_425584	664	5	copyright	copyright	NN
10_1101-2021_01_06_425584	664	6	holder	holder	NN
10_1101-2021_01_06_425584	664	7	for	for	IN
10_1101-2021_01_06_425584	664	8	this	this	DT
10_1101-2021_01_06_425584	664	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	664	10	version	version	NN
10_1101-2021_01_06_425584	664	11	posted	post	VBD
10_1101-2021_01_06_425584	664	12	January	January	NNP
10_1101-2021_01_06_425584	664	13	8	8	CD
10_1101-2021_01_06_425584	664	14	,	,	,
10_1101-2021_01_06_425584	664	15	2021	2021	CD
10_1101-2021_01_06_425584	664	16	.	.	.
10_1101-2021_01_06_425584	664	17	;	;	:
10_1101-2021_01_06_425584	664	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	664	19	:	:	:
10_1101-2021_01_06_425584	664	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	664	21	preprint	preprint	NN
10_1101-2021_01_06_425584	664	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	664	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2021_01_06_425584	664	24	30	30	CD
10_1101-2021_01_06_425584	664	25	Supporting	support	VBG
10_1101-2021_01_06_425584	664	26	information	information	NN
10_1101-2021_01_06_425584	664	27	913	913	CD
10_1101-2021_01_06_425584	664	28	914	914	CD
10_1101-2021_01_06_425584	664	29	Table	table	NN
10_1101-2021_01_06_425584	664	30	S1	S1	NNS
10_1101-2021_01_06_425584	664	31	.	.	.
10_1101-2021_01_06_425584	665	1	List	list	NN
10_1101-2021_01_06_425584	665	2	of	of	IN
10_1101-2021_01_06_425584	665	3	all	all	PDT
10_1101-2021_01_06_425584	665	4	the	the	DT
10_1101-2021_01_06_425584	665	5	putatively	putatively	RB
10_1101-2021_01_06_425584	665	6	annotated	annotate	VBN
10_1101-2021_01_06_425584	665	7	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	665	8	by	by	IN
10_1101-2021_01_06_425584	665	9	MS2	MS2	NNP
10_1101-2021_01_06_425584	665	10	spectral	spectral	JJ
10_1101-2021_01_06_425584	665	11	matching	matching	NN
10_1101-2021_01_06_425584	665	12	against	against	IN
10_1101-2021_01_06_425584	665	13	GNPS	GNPS	NNP
10_1101-2021_01_06_425584	665	14	915	915	CD
10_1101-2021_01_06_425584	665	15	public	public	JJ
10_1101-2021_01_06_425584	665	16	spectral	spectral	JJ
10_1101-2021_01_06_425584	665	17	libraries	library	NNS
10_1101-2021_01_06_425584	665	18	.	.	.
10_1101-2021_01_06_425584	666	1	916	916	CD
10_1101-2021_01_06_425584	666	2	917	917	CD
10_1101-2021_01_06_425584	666	3	Table	table	NN
10_1101-2021_01_06_425584	666	4	S2	s2	NN
10_1101-2021_01_06_425584	666	5	.	.	.
10_1101-2021_01_06_425584	667	1	List	list	NN
10_1101-2021_01_06_425584	667	2	of	of	IN
10_1101-2021_01_06_425584	667	3	putatively	putatively	RB
10_1101-2021_01_06_425584	667	4	annotated	annotate	VBN
10_1101-2021_01_06_425584	667	5	(	(	-LRB-
10_1101-2021_01_06_425584	667	6	MS2	MS2	NNP
10_1101-2021_01_06_425584	667	7	spectral	spectral	JJ
10_1101-2021_01_06_425584	667	8	matching	matching	NN
10_1101-2021_01_06_425584	667	9	)	)	-RRB-
10_1101-2021_01_06_425584	667	10	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	667	11	modulated	modulate	VBN
10_1101-2021_01_06_425584	667	12	by	by	IN
10_1101-2021_01_06_425584	667	13	918	918	CD
10_1101-2021_01_06_425584	667	14	simulated	simulated	JJ
10_1101-2021_01_06_425584	667	15	diabetes	diabete	NNS
10_1101-2021_01_06_425584	667	16	.	.	.
10_1101-2021_01_06_425584	668	1	919	919	CD
10_1101-2021_01_06_425584	668	2	920	920	CD
10_1101-2021_01_06_425584	668	3	Table	table	NN
10_1101-2021_01_06_425584	668	4	S3	S3	NNP
10_1101-2021_01_06_425584	668	5	.	.	.
10_1101-2021_01_06_425584	669	1	List	list	NN
10_1101-2021_01_06_425584	669	2	of	of	IN
10_1101-2021_01_06_425584	669	3	all	all	DT
10_1101-2021_01_06_425584	669	4	detected	detect	VBN
10_1101-2021_01_06_425584	669	5	peptides	peptide	NNS
10_1101-2021_01_06_425584	669	6	by	by	IN
10_1101-2021_01_06_425584	669	7	ProteinPilot	ProteinPilot	NNP
10_1101-2021_01_06_425584	669	8	Software	Software	NNP
10_1101-2021_01_06_425584	669	9	using	use	VBG
10_1101-2021_01_06_425584	669	10	the	the	DT
10_1101-2021_01_06_425584	669	11	metabolomics	metabolomic	NNS
10_1101-2021_01_06_425584	669	12	datasets	dataset	NNS
10_1101-2021_01_06_425584	669	13	.	.	.
10_1101-2021_01_06_425584	670	1	921	921	CD
10_1101-2021_01_06_425584	670	2	922	922	CD
10_1101-2021_01_06_425584	670	3	Table	table	NN
10_1101-2021_01_06_425584	670	4	S4	s4	NN
10_1101-2021_01_06_425584	670	5	Putative	Putative	NNP
10_1101-2021_01_06_425584	670	6	annotated	annotate	VBD
10_1101-2021_01_06_425584	670	7	proline	proline	NN
10_1101-2021_01_06_425584	670	8	-	-	HYPH
10_1101-2021_01_06_425584	670	9	peptides	peptide	NNS
10_1101-2021_01_06_425584	670	10	altered	alter	VBN
10_1101-2021_01_06_425584	670	11	by	by	IN
10_1101-2021_01_06_425584	670	12	simulated	simulated	JJ
10_1101-2021_01_06_425584	670	13	diabetes	diabete	NNS
10_1101-2021_01_06_425584	670	14	in	in	IN
10_1101-2021_01_06_425584	670	15	Bovine	Bovine	NNP
10_1101-2021_01_06_425584	670	16	Coronary	Coronary	NNP
10_1101-2021_01_06_425584	670	17	923	923	CD
10_1101-2021_01_06_425584	670	18	Artery	Artery	NNP
10_1101-2021_01_06_425584	670	19	Endothelial	Endothelial	NNP
10_1101-2021_01_06_425584	670	20	Cells	Cells	NNPS
10_1101-2021_01_06_425584	670	21	by	by	IN
10_1101-2021_01_06_425584	670	22	ProteinPilot	ProteinPilot	NNP
10_1101-2021_01_06_425584	670	23	Software	Software	NNP
10_1101-2021_01_06_425584	670	24	and	and	CC
10_1101-2021_01_06_425584	670	25	manual	manual	JJ
10_1101-2021_01_06_425584	670	26	inspection	inspection	NN
10_1101-2021_01_06_425584	670	27	.	.	.
10_1101-2021_01_06_425584	671	1	924	924	CD
10_1101-2021_01_06_425584	671	2	925	925	CD
10_1101-2021_01_06_425584	671	3	Table	table	NN
10_1101-2021_01_06_425584	671	4	S5	s5	NN
10_1101-2021_01_06_425584	671	5	.	.	.
10_1101-2021_01_06_425584	672	1	List	list	NN
10_1101-2021_01_06_425584	672	2	of	of	IN
10_1101-2021_01_06_425584	672	3	the	the	DT
10_1101-2021_01_06_425584	672	4	detected	detect	VBN
10_1101-2021_01_06_425584	672	5	peptides	peptide	NNS
10_1101-2021_01_06_425584	672	6	and	and	CC
10_1101-2021_01_06_425584	672	7	proteins	protein	NNS
10_1101-2021_01_06_425584	672	8	in	in	IN
10_1101-2021_01_06_425584	672	9	all	all	DT
10_1101-2021_01_06_425584	672	10	conditions	condition	NNS
10_1101-2021_01_06_425584	672	11	for	for	IN
10_1101-2021_01_06_425584	672	12	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	672	13	-	-	HYPH
10_1101-2021_01_06_425584	672	14	based	base	VBN
10_1101-2021_01_06_425584	672	15	926	926	CD
10_1101-2021_01_06_425584	672	16	quantification	quantification	NN
10_1101-2021_01_06_425584	672	17	.	.	.
10_1101-2021_01_06_425584	673	1	927	927	CD
10_1101-2021_01_06_425584	673	2	928	928	CD
10_1101-2021_01_06_425584	673	3	Figure	figure	NN
10_1101-2021_01_06_425584	673	4	S1	S1	NNS
10_1101-2021_01_06_425584	673	5	.	.	.
10_1101-2021_01_06_425584	674	1	Proteomics	Proteomics	NNP
10_1101-2021_01_06_425584	674	2	data	data	NN
10_1101-2021_01_06_425584	674	3	normalization	normalization	NN
10_1101-2021_01_06_425584	674	4	results	result	NNS
10_1101-2021_01_06_425584	674	5	using	use	VBG
10_1101-2021_01_06_425584	674	6	NormalyzerDE	NormalyzerDE	NNP
10_1101-2021_01_06_425584	674	7	.	.	.
10_1101-2021_01_06_425584	675	1	(	(	-LRB-
10_1101-2021_01_06_425584	675	2	A	a	DT
10_1101-2021_01_06_425584	675	3	)	)	-RRB-
10_1101-2021_01_06_425584	675	4	Total	total	JJ
10_1101-2021_01_06_425584	675	5	intensity	intensity	NN
10_1101-2021_01_06_425584	675	6	of	of	IN
10_1101-2021_01_06_425584	675	7	raw	raw	JJ
10_1101-2021_01_06_425584	675	8	929	929	CD
10_1101-2021_01_06_425584	675	9	data	datum	NNS
10_1101-2021_01_06_425584	675	10	before	before	IN
10_1101-2021_01_06_425584	675	11	normalization	normalization	NN
10_1101-2021_01_06_425584	675	12	.	.	.
10_1101-2021_01_06_425584	676	1	(	(	-LRB-
10_1101-2021_01_06_425584	676	2	B	b	NN
10_1101-2021_01_06_425584	676	3	)	)	-RRB-
10_1101-2021_01_06_425584	676	4	Quantitative	quantitative	JJ
10_1101-2021_01_06_425584	676	5	parameters	parameter	NNS
10_1101-2021_01_06_425584	676	6	of	of	IN
10_1101-2021_01_06_425584	676	7	normalization	normalization	NN
10_1101-2021_01_06_425584	676	8	algorithms	algorithm	NNS
10_1101-2021_01_06_425584	676	9	(	(	-LRB-
10_1101-2021_01_06_425584	676	10	pooled	pool	VBN
10_1101-2021_01_06_425584	676	11	930	930	CD
10_1101-2021_01_06_425584	676	12	intragroup	intragroup	JJ
10_1101-2021_01_06_425584	676	13	coefficient	coefficient	NN
10_1101-2021_01_06_425584	676	14	of	of	IN
10_1101-2021_01_06_425584	676	15	variation	variation	NN
10_1101-2021_01_06_425584	676	16	[	[	-LRB-
10_1101-2021_01_06_425584	676	17	PCV	PCV	NNP
10_1101-2021_01_06_425584	676	18	]	]	-RRB-
10_1101-2021_01_06_425584	676	19	,	,	,
10_1101-2021_01_06_425584	676	20	median	median	JJ
10_1101-2021_01_06_425584	676	21	absolute	absolute	JJ
10_1101-2021_01_06_425584	676	22	deviation	deviation	NN
10_1101-2021_01_06_425584	676	23	[	[	-LRB-
10_1101-2021_01_06_425584	676	24	PMAD	PMAD	NNP
10_1101-2021_01_06_425584	676	25	]	]	-RRB-
10_1101-2021_01_06_425584	676	26	,	,	,
10_1101-2021_01_06_425584	676	27	estimate	estimate	NN
10_1101-2021_01_06_425584	676	28	of	of	IN
10_1101-2021_01_06_425584	676	29	variance	variance	NN
10_1101-2021_01_06_425584	676	30	931	931	CD
10_1101-2021_01_06_425584	676	31	[	[	-LRB-
10_1101-2021_01_06_425584	676	32	PEV	PEV	NNP
10_1101-2021_01_06_425584	676	33	]	]	-RRB-
10_1101-2021_01_06_425584	676	34	)	)	-RRB-
10_1101-2021_01_06_425584	676	35	.	.	.
10_1101-2021_01_06_425584	677	1	Qualitative	qualitative	JJ
10_1101-2021_01_06_425584	677	2	parameters	parameter	NNS
10_1101-2021_01_06_425584	677	3	of	of	IN
10_1101-2021_01_06_425584	677	4	normalization	normalization	NN
10_1101-2021_01_06_425584	677	5	algorithms	algorithm	NNS
10_1101-2021_01_06_425584	677	6	;	;	:
10_1101-2021_01_06_425584	677	7	(	(	-LRB-
10_1101-2021_01_06_425584	677	8	C	C	NNP
10_1101-2021_01_06_425584	677	9	)	)	-RRB-
10_1101-2021_01_06_425584	677	10	Box	Box	NNP
10_1101-2021_01_06_425584	677	11	plots	plot	NNS
10_1101-2021_01_06_425584	677	12	(	(	-LRB-
10_1101-2021_01_06_425584	677	13	D	D	NNP
10_1101-2021_01_06_425584	677	14	)	)	-RRB-
10_1101-2021_01_06_425584	677	15	MA	MA	NNP
10_1101-2021_01_06_425584	677	16	plots	plot	NNS
10_1101-2021_01_06_425584	677	17	,	,	,
10_1101-2021_01_06_425584	677	18	and	and	CC
10_1101-2021_01_06_425584	677	19	(	(	-LRB-
10_1101-2021_01_06_425584	677	20	E	e	NN
10_1101-2021_01_06_425584	677	21	)	)	-RRB-
10_1101-2021_01_06_425584	677	22	932	932	CD
10_1101-2021_01_06_425584	677	23	Density	density	NN
10_1101-2021_01_06_425584	677	24	plots	plot	NNS
10_1101-2021_01_06_425584	677	25	.	.	.
10_1101-2021_01_06_425584	678	1	933	933	CD
10_1101-2021_01_06_425584	678	2	934	934	CD
10_1101-2021_01_06_425584	678	3	Figure	figure	NN
10_1101-2021_01_06_425584	678	4	S2	s2	NN
10_1101-2021_01_06_425584	678	5	.	.	.
10_1101-2021_01_06_425584	679	1	Cellular	cellular	JJ
10_1101-2021_01_06_425584	679	2	confluence	confluence	NN
10_1101-2021_01_06_425584	679	3	in	in	IN
10_1101-2021_01_06_425584	679	4	control	control	NN
10_1101-2021_01_06_425584	679	5	and	and	CC
10_1101-2021_01_06_425584	679	6	experimental	experimental	JJ
10_1101-2021_01_06_425584	679	7	group	group	NN
10_1101-2021_01_06_425584	679	8	.	.	.
10_1101-2021_01_06_425584	680	1	Representative	representative	NN
10_1101-2021_01_06_425584	680	2	935	935	CD
10_1101-2021_01_06_425584	680	3	micrographs	micrograph	NNS
10_1101-2021_01_06_425584	680	4	of	of	IN
10_1101-2021_01_06_425584	680	5	Bovine	Bovine	NNP
10_1101-2021_01_06_425584	680	6	Coronary	Coronary	NNP
10_1101-2021_01_06_425584	680	7	Artery	Artery	NNP
10_1101-2021_01_06_425584	680	8	Endothelial	Endothelial	NNP
10_1101-2021_01_06_425584	680	9	Cells	Cells	NNPS
10_1101-2021_01_06_425584	680	10	(	(	-LRB-
10_1101-2021_01_06_425584	680	11	BCAEC	BCAEC	NNP
10_1101-2021_01_06_425584	680	12	)	)	-RRB-
10_1101-2021_01_06_425584	680	13	cultured	culture	VBD
10_1101-2021_01_06_425584	680	14	for	for	IN
10_1101-2021_01_06_425584	680	15	9	9	CD
10_1101-2021_01_06_425584	680	16	days	day	NNS
10_1101-2021_01_06_425584	680	17	with	with	IN
10_1101-2021_01_06_425584	680	18	5.5	5.5	CD
10_1101-2021_01_06_425584	680	19	936	936	CD
10_1101-2021_01_06_425584	680	20	mmol	mmol	NN
10_1101-2021_01_06_425584	680	21	/	/	SYM
10_1101-2021_01_06_425584	680	22	L	l	NN
10_1101-2021_01_06_425584	680	23	glucose	glucose	NN
10_1101-2021_01_06_425584	680	24	(	(	-LRB-
10_1101-2021_01_06_425584	680	25	control	control	NNP
10_1101-2021_01_06_425584	680	26	group	group	NN
10_1101-2021_01_06_425584	680	27	)	)	-RRB-
10_1101-2021_01_06_425584	680	28	and	and	CC
10_1101-2021_01_06_425584	680	29	20	20	CD
10_1101-2021_01_06_425584	680	30	mmol	mmol	NN
10_1101-2021_01_06_425584	680	31	/	/	SYM
10_1101-2021_01_06_425584	680	32	L	L	NNP
10_1101-2021_01_06_425584	680	33	glucose+100	glucose+100	NNP
10_1101-2021_01_06_425584	680	34	nmol	nmol	NNP
10_1101-2021_01_06_425584	680	35	/	/	SYM
10_1101-2021_01_06_425584	680	36	L	L	NNP
10_1101-2021_01_06_425584	680	37	insulin	insulin	NN
10_1101-2021_01_06_425584	680	38	(	(	-LRB-
10_1101-2021_01_06_425584	680	39	simulated	simulate	VBN
10_1101-2021_01_06_425584	680	40	diabetes	diabetes	NN
10_1101-2021_01_06_425584	680	41	937	937	CD
10_1101-2021_01_06_425584	680	42	or	or	CC
10_1101-2021_01_06_425584	680	43	experimental	experimental	JJ
10_1101-2021_01_06_425584	680	44	group	group	NN
10_1101-2021_01_06_425584	680	45	)	)	-RRB-
10_1101-2021_01_06_425584	680	46	.	.	.
10_1101-2021_01_06_425584	681	1	Images	image	NNS
10_1101-2021_01_06_425584	681	2	were	be	VBD
10_1101-2021_01_06_425584	681	3	taken	take	VBN
10_1101-2021_01_06_425584	681	4	using	use	VBG
10_1101-2021_01_06_425584	681	5	an	an	DT
10_1101-2021_01_06_425584	681	6	EVOS	evos	NN
10_1101-2021_01_06_425584	681	7	®	®	.
10_1101-2021_01_06_425584	681	8	FLoid	floid	NN
10_1101-2021_01_06_425584	681	9	®	®	:
10_1101-2021_01_06_425584	681	10	Cell	Cell	NNP
10_1101-2021_01_06_425584	681	11	Imaging	Imaging	NNP
10_1101-2021_01_06_425584	681	12	Station	Station	NNP
10_1101-2021_01_06_425584	681	13	with	with	IN
10_1101-2021_01_06_425584	681	14	a	a	DT
10_1101-2021_01_06_425584	681	15	938	938	CD
10_1101-2021_01_06_425584	681	16	fixed	fix	VBN
10_1101-2021_01_06_425584	681	17	20x	20x	NNS
10_1101-2021_01_06_425584	681	18	air	air	NN
10_1101-2021_01_06_425584	681	19	objective	objective	NN
10_1101-2021_01_06_425584	681	20	.	.	.
10_1101-2021_01_06_425584	682	1	Abbreviations	abbreviation	NNS
10_1101-2021_01_06_425584	682	2	:	:	:
10_1101-2021_01_06_425584	682	3	NG	NG	NNP
10_1101-2021_01_06_425584	682	4	,	,	,
10_1101-2021_01_06_425584	682	5	normal	normal	JJ
10_1101-2021_01_06_425584	682	6	glucose	glucose	NN
10_1101-2021_01_06_425584	682	7	;	;	:
10_1101-2021_01_06_425584	682	8	HG	HG	NNP
10_1101-2021_01_06_425584	682	9	,	,	,
10_1101-2021_01_06_425584	682	10	high	high	JJ
10_1101-2021_01_06_425584	682	11	glucose	glucose	NN
10_1101-2021_01_06_425584	682	12	;	;	:
10_1101-2021_01_06_425584	682	13	HI	hi	UH
10_1101-2021_01_06_425584	682	14	,	,	,
10_1101-2021_01_06_425584	682	15	high	high	JJ
10_1101-2021_01_06_425584	682	16	insulin	insulin	NN
10_1101-2021_01_06_425584	682	17	.	.	.
10_1101-2021_01_06_425584	683	1	939	939	CD
10_1101-2021_01_06_425584	683	2	940	940	CD
10_1101-2021_01_06_425584	683	3	941	941	CD
10_1101-2021_01_06_425584	683	4	942	942	CD
10_1101-2021_01_06_425584	683	5	.CC	.CC	:
10_1101-2021_01_06_425584	683	6	-	-	HYPH
10_1101-2021_01_06_425584	683	7	BY	by	IN
10_1101-2021_01_06_425584	683	8	-	-	HYPH
10_1101-2021_01_06_425584	683	9	NC	NC	NNP
10_1101-2021_01_06_425584	683	10	-	-	HYPH
10_1101-2021_01_06_425584	683	11	ND	ND	NNP
10_1101-2021_01_06_425584	683	12	4.0	4.0	CD
10_1101-2021_01_06_425584	683	13	International	International	NNP
10_1101-2021_01_06_425584	683	14	licenseavailable	licenseavailable	NN
10_1101-2021_01_06_425584	683	15	under	under	IN
10_1101-2021_01_06_425584	683	16	a	a	DT
10_1101-2021_01_06_425584	683	17	(	(	-LRB-
10_1101-2021_01_06_425584	683	18	which	which	WDT
10_1101-2021_01_06_425584	683	19	was	be	VBD
10_1101-2021_01_06_425584	683	20	not	not	RB
10_1101-2021_01_06_425584	683	21	certified	certify	VBN
10_1101-2021_01_06_425584	683	22	by	by	IN
10_1101-2021_01_06_425584	683	23	peer	peer	NN
10_1101-2021_01_06_425584	683	24	review	review	NN
10_1101-2021_01_06_425584	683	25	)	)	-RRB-
10_1101-2021_01_06_425584	683	26	is	be	VBZ
10_1101-2021_01_06_425584	683	27	the	the	DT
10_1101-2021_01_06_425584	683	28	author	author	NN
10_1101-2021_01_06_425584	683	29	/	/	SYM
10_1101-2021_01_06_425584	683	30	funder	funder	NN
10_1101-2021_01_06_425584	683	31	,	,	,
10_1101-2021_01_06_425584	683	32	who	who	WP
10_1101-2021_01_06_425584	683	33	has	have	VBZ
10_1101-2021_01_06_425584	683	34	granted	grant	VBN
10_1101-2021_01_06_425584	683	35	bioRxiv	biorxiv	IN
10_1101-2021_01_06_425584	683	36	a	a	DT
10_1101-2021_01_06_425584	683	37	license	license	NN
10_1101-2021_01_06_425584	683	38	to	to	TO
10_1101-2021_01_06_425584	683	39	display	display	VB
10_1101-2021_01_06_425584	683	40	the	the	DT
10_1101-2021_01_06_425584	683	41	preprint	preprint	NN
10_1101-2021_01_06_425584	683	42	in	in	IN
10_1101-2021_01_06_425584	683	43	perpetuity	perpetuity	NN
10_1101-2021_01_06_425584	683	44	.	.	.
10_1101-2021_01_06_425584	684	1	It	-PRON-	PRP
10_1101-2021_01_06_425584	684	2	is	be	VBZ
10_1101-2021_01_06_425584	684	3	made	make	VBN
10_1101-2021_01_06_425584	684	4	The	the	DT
10_1101-2021_01_06_425584	684	5	copyright	copyright	NN
10_1101-2021_01_06_425584	684	6	holder	holder	NN
10_1101-2021_01_06_425584	684	7	for	for	IN
10_1101-2021_01_06_425584	684	8	this	this	DT
10_1101-2021_01_06_425584	684	9	preprintthis	preprintthis	NN
10_1101-2021_01_06_425584	684	10	version	version	NN
10_1101-2021_01_06_425584	684	11	posted	post	VBD
10_1101-2021_01_06_425584	684	12	January	January	NNP
10_1101-2021_01_06_425584	684	13	8	8	CD
10_1101-2021_01_06_425584	684	14	,	,	,
10_1101-2021_01_06_425584	684	15	2021	2021	CD
10_1101-2021_01_06_425584	684	16	.	.	.
10_1101-2021_01_06_425584	684	17	;	;	:
10_1101-2021_01_06_425584	684	18	https://doi.org/10.1101/2021.01.06.425584doi	https://doi.org/10.1101/2021.01.06.425584doi	DT
10_1101-2021_01_06_425584	684	19	:	:	:
10_1101-2021_01_06_425584	684	20	bioRxiv	biorxiv	VB
10_1101-2021_01_06_425584	684	21	preprint	preprint	NN
10_1101-2021_01_06_425584	684	22	https://doi.org/10.1101/2021.01.06.425584	https://doi.org/10.1101/2021.01.06.425584	UH
10_1101-2021_01_06_425584	684	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2021_01_06_425584	684	24	Metabolites	Metabolites	NNP
10_1101-2021_01_06_425584	684	25	DDA	DDA	NNP
10_1101-2021_01_06_425584	684	26	Omics	Omics	NNPS
10_1101-2021_01_06_425584	684	27	Integration	Integration	NNP
10_1101-2021_01_06_425584	684	28	GO	GO	NNP
10_1101-2021_01_06_425584	684	29	analysis	analysis	NN
10_1101-2021_01_06_425584	684	30	ProteomeXchange	ProteomeXchange	NNP
10_1101-2021_01_06_425584	684	31	PXD013643	PXD013643	NNP
10_1101-2021_01_06_425584	684	32	`	`	''
10_1101-2021_01_06_425584	684	33	`	`	''
10_1101-2021_01_06_425584	684	34	SWATH	SWATH	NNP
10_1101-2021_01_06_425584	684	35	-	-	HYPH
10_1101-2021_01_06_425584	684	36	based	base	VBN
10_1101-2021_01_06_425584	684	37	Proteomics	proteomic	NNS
10_1101-2021_01_06_425584	684	38	`	`	''
10_1101-2021_01_06_425584	684	39	`	`	''
10_1101-2021_01_06_425584	684	40	Untargeted	Untargeted	NNP
10_1101-2021_01_06_425584	684	41	Metabolomics	Metabolomics	NNPS
10_1101-2021_01_06_425584	684	42	MeOH	MeOH	NNP
10_1101-2021_01_06_425584	684	43	/	/	SYM
10_1101-2021_01_06_425584	684	44	EtOH	EtOH	NNP
10_1101-2021_01_06_425584	684	45	(	(	-LRB-
10_1101-2021_01_06_425584	684	46	50:50	50:50	CD
10_1101-2021_01_06_425584	684	47	,	,	,
10_1101-2021_01_06_425584	684	48	v	v	NN
10_1101-2021_01_06_425584	684	49	:	:	:
10_1101-2021_01_06_425584	684	50	v	v	LS
10_1101-2021_01_06_425584	684	51	)	)	-RRB-
10_1101-2021_01_06_425584	684	52	0	0	CD
10_1101-2021_01_06_425584	684	53	1	1	CD
10_1101-2021_01_06_425584	684	54	2	2	CD
10_1101-2021_01_06_425584	684	55	3	3	CD
10_1101-2021_01_06_425584	684	56	4	4	CD
10_1101-2021_01_06_425584	684	57	5	5	CD
10_1101-2021_01_06_425584	684	58	6	6	CD
10_1101-2021_01_06_425584	684	59	7	7	CD
10_1101-2021_01_06_425584	684	60	8	8	CD
10_1101-2021_01_06_425584	684	61	9	9	CD
10_1101-2021_01_06_425584	684	62	10	10	CD
10_1101-2021_01_06_425584	684	63	11	11	CD
10_1101-2021_01_06_425584	684	64	12	12	CD
10_1101-2021_01_06_425584	684	65	Insulin	Insulin	NNP
10_1101-2021_01_06_425584	684	66	100	100	CD
10_1101-2021_01_06_425584	684	67	nmol	nmol	JJ
10_1101-2021_01_06_425584	684	68	/	/	SYM
10_1101-2021_01_06_425584	684	69	L	L	NNP
10_1101-2021_01_06_425584	684	70	Glucose	Glucose	NNP
10_1101-2021_01_06_425584	684	71	20	20	CD
10_1101-2021_01_06_425584	684	72	mmol	mmol	NN
10_1101-2021_01_06_425584	684	73	/	/	SYM
10_1101-2021_01_06_425584	684	74	L	L	NNP
10_1101-2021_01_06_425584	684	75	Days	Days	NNPS
10_1101-2021_01_06_425584	684	76	Glucose	Glucose	NNP
10_1101-2021_01_06_425584	684	77	5.5	5.5	CD
10_1101-2021_01_06_425584	684	78	mmol	mmol	NN
10_1101-2021_01_06_425584	684	79	/	/	SYM
10_1101-2021_01_06_425584	684	80	L	L	NNP
10_1101-2021_01_06_425584	684	81	Control	Control	NNP
10_1101-2021_01_06_425584	684	82	Substructure	substructure	NN
10_1101-2021_01_06_425584	684	83	annotation	annotation	NN
10_1101-2021_01_06_425584	684	84	Ry	Ry	NNP
10_1101-2021_01_06_425584	684	85	Metabolite	metabolite	JJ
10_1101-2021_01_06_425584	684	86	annotation	annotation	NN
10_1101-2021_01_06_425584	684	87	COOH	COOH	NNP
10_1101-2021_01_06_425584	684	88	`	`	''
10_1101-2021_01_06_425584	684	89	`	`	''
10_1101-2021_01_06_425584	684	90	m	m	NN
10_1101-2021_01_06_425584	684	91	/	/	SYM
10_1101-2021_01_06_425584	684	92	z	z	NNP
10_1101-2021_01_06_425584	684	93	m	m	NNP
10_1101-2021_01_06_425584	684	94	/	/	SYM
10_1101-2021_01_06_425584	684	95	z	z	NNP
10_1101-2021_01_06_425584	684	96	RT	RT	NNP
10_1101-2021_01_06_425584	684	97	In	in	IN
10_1101-2021_01_06_425584	684	98	te	te	NNP
10_1101-2021_01_06_425584	684	99	ns	ns	IN
10_1101-2021_01_06_425584	684	100	it	-PRON-	PRP
10_1101-2021_01_06_425584	684	101	y	y	VBZ
10_1101-2021_01_06_425584	684	102	In	in	IN
10_1101-2021_01_06_425584	684	103	te	te	NNP
10_1101-2021_01_06_425584	684	104	ns	ns	IN
10_1101-2021_01_06_425584	684	105	it	-PRON-	PRP
10_1101-2021_01_06_425584	684	106	y	y	VBZ
10_1101-2021_01_06_425584	684	107	In	in	IN
10_1101-2021_01_06_425584	684	108	te	te	NNP
10_1101-2021_01_06_425584	684	109	ns	ns	IN
10_1101-2021_01_06_425584	684	110	it	-PRON-	PRP
10_1101-2021_01_06_425584	684	111	y	y	VBZ
10_1101-2021_01_06_425584	684	112	MS1	MS1	NNP
10_1101-2021_01_06_425584	684	113	MS2	MS2	NNP
10_1101-2021_01_06_425584	684	114	A	A	NNP
10_1101-2021_01_06_425584	684	115	B	B	NNP
10_1101-2021_01_06_425584	684	116	SC	SC	NNP
10_1101-2021_01_06_425584	684	117	IEX	IEX	NNP
10_1101-2021_01_06_425584	684	118	Trip	Trip	NNP
10_1101-2021_01_06_425584	684	119	le	le	VBP
10_1101-2021_01_06_425584	684	120	TO	to	IN
10_1101-2021_01_06_425584	684	121	F	F	NNP
10_1101-2021_01_06_425584	684	122	5	5	CD
10_1101-2021_01_06_425584	684	123	6	6	CD
10_1101-2021_01_06_425584	684	124	0	0	CD
10_1101-2021_01_06_425584	684	125	0	0	CD
10_1101-2021_01_06_425584	684	126	LC	LC	NNP
10_1101-2021_01_06_425584	684	127	-	-	HYPH
10_1101-2021_01_06_425584	684	128	MS	MS	NNP
10_1101-2021_01_06_425584	684	129	/	/	SYM
10_1101-2021_01_06_425584	684	130	MS	MS	NNP
10_1101-2021_01_06_425584	684	131	Triple	Triple	NNP
10_1101-2021_01_06_425584	684	132	®	®	NNPS
10_1101-2021_01_06_425584	684	133	TOF	TOF	NNP
10_1101-2021_01_06_425584	684	134	5600	5600	CD
10_1101-2021_01_06_425584	684	135	+	+	CC
10_1101-2021_01_06_425584	684	136	A	a	DT
10_1101-2021_01_06_425584	684	137	957	957	CD
10_1101-2021_01_06_425584	684	138	(	(	-LRB-
10_1101-2021_01_06_425584	684	139	17.18	17.18	CD
10_1101-2021_01_06_425584	684	140	%	%	NN
10_1101-2021_01_06_425584	684	141	)	)	-RRB-
10_1101-2021_01_06_425584	684	142	Total	total	JJ
10_1101-2021_01_06_425584	684	143	features	feature	NNS
10_1101-2021_01_06_425584	684	144	detected	detect	VBD
10_1101-2021_01_06_425584	684	145	:	:	:
10_1101-2021_01_06_425584	684	146	5571	5571	CD
10_1101-2021_01_06_425584	684	147	2194	2194	CD
10_1101-2021_01_06_425584	684	148	(	(	-LRB-
10_1101-2021_01_06_425584	684	149	39.96	39.96	CD
10_1101-2021_01_06_425584	684	150	%	%	NN
10_1101-2021_01_06_425584	684	151	)	)	-RRB-
10_1101-2021_01_06_425584	684	152	2420	2420	CD
10_1101-2021_01_06_425584	684	153	(	(	-LRB-
10_1101-2021_01_06_425584	684	154	43.44	43.44	CD
10_1101-2021_01_06_425584	684	155	%	%	NN
10_1101-2021_01_06_425584	684	156	)	)	-RRB-
10_1101-2021_01_06_425584	684	157	n=82n=140	n=82n=140	VBP
10_1101-2021_01_06_425584	684	158	B	b	NN
10_1101-2021_01_06_425584	684	159	C	c	NN
10_1101-2021_01_06_425584	684	160	D	d	NN
10_1101-2021_01_06_425584	684	161	N	n	CD
10_1101-2021_01_06_425584	684	162	orm	orm	NN
10_1101-2021_01_06_425584	684	163	alized	alize	VBN
10_1101-2021_01_06_425584	684	164	m	m	NN
10_1101-2021_01_06_425584	684	165	etabolite	etabolite	NN
10_1101-2021_01_06_425584	684	166	abundance	abundance	NN
10_1101-2021_01_06_425584	684	167	PC1	PC1	NNP
10_1101-2021_01_06_425584	684	168	P	P	NNP
10_1101-2021_01_06_425584	684	169	C	c	NN
10_1101-2021_01_06_425584	684	170	2	2	CD
10_1101-2021_01_06_425584	684	171	NG	NG	NNP
10_1101-2021_01_06_425584	684	172	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	684	173	QC	QC	NNP
10_1101-2021_01_06_425584	684	174	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	684	175	NG	NG	NNP
10_1101-2021_01_06_425584	684	176	QC	QC	NNP
10_1101-2021_01_06_425584	684	177	Glycerophospholipids	Glycerophospholipids	NNP
10_1101-2021_01_06_425584	684	178	Organooxygen	Organooxygen	NNP
10_1101-2021_01_06_425584	684	179	compounds	compound	VBZ
10_1101-2021_01_06_425584	684	180	Fatty	Fatty	NNP
10_1101-2021_01_06_425584	684	181	acyls	acyls	NN
10_1101-2021_01_06_425584	684	182	Steroids	Steroids	NNP
10_1101-2021_01_06_425584	684	183	and	and	CC
10_1101-2021_01_06_425584	684	184	derivatives	derivative	VBZ
10_1101-2021_01_06_425584	684	185	Glycerolipids	Glycerolipids	NNP
10_1101-2021_01_06_425584	684	186	Chemical	Chemical	NNP
10_1101-2021_01_06_425584	684	187	class	class	NN
10_1101-2021_01_06_425584	684	188	Indoles	indole	NNS
10_1101-2021_01_06_425584	684	189	and	and	CC
10_1101-2021_01_06_425584	684	190	derivatives	derivative	VBZ
10_1101-2021_01_06_425584	684	191	Organonitrogen	Organonitrogen	NNP
10_1101-2021_01_06_425584	684	192	compounds	compound	VBZ
10_1101-2021_01_06_425584	684	193	Coumarins	coumarin	NNS
10_1101-2021_01_06_425584	684	194	and	and	CC
10_1101-2021_01_06_425584	684	195	derivatives	derivative	VBZ
10_1101-2021_01_06_425584	684	196	Connectivity	Connectivity	NNP
10_1101-2021_01_06_425584	684	197	(	(	-LRB-
10_1101-2021_01_06_425584	684	198	Cosine	Cosine	NNP
10_1101-2021_01_06_425584	684	199	Score	Score	NNP
10_1101-2021_01_06_425584	684	200	)	)	-RRB-
10_1101-2021_01_06_425584	684	201	Precursor	Precursor	NNP
10_1101-2021_01_06_425584	684	202	ion	ion	NN
10_1101-2021_01_06_425584	684	203	m	m	NN
10_1101-2021_01_06_425584	684	204	/	/	SYM
10_1101-2021_01_06_425584	684	205	z	z	NNP
10_1101-2021_01_06_425584	684	206	value	value	NN
10_1101-2021_01_06_425584	684	207	Carboxylic	carboxylic	JJ
10_1101-2021_01_06_425584	684	208	acids	acid	NNS
10_1101-2021_01_06_425584	684	209	and	and	CC
10_1101-2021_01_06_425584	684	210	derivatives	derivative	NNS
10_1101-2021_01_06_425584	684	211	Benzene	Benzene	NNP
10_1101-2021_01_06_425584	684	212	and	and	CC
10_1101-2021_01_06_425584	684	213	substituted	substitute	VBD
10_1101-2021_01_06_425584	684	214	derivatives	derivative	NNS
10_1101-2021_01_06_425584	684	215	Unknown	unknown	JJ
10_1101-2021_01_06_425584	684	216	522.3415	522.3415	NN
10_1101-2021_01_06_425584	684	217	194.1019	194.1019	IN
10_1101-2021_01_06_425584	684	218	210.1343	210.1343	CD
10_1101-2021_01_06_425584	684	219	286.0574	286.0574	CD
10_1101-2021_01_06_425584	684	220	703.5731	703.5731	NN
10_1101-2021_01_06_425584	684	221	376.259	376.259	CD
10_1101-2021_01_06_425584	684	222	376.2327	376.2327	CD
10_1101-2021_01_06_425584	684	223	546.2845	546.2845	RB
10_1101-2021_01_06_425584	684	224	575.2753	575.2753	RB
10_1101-2021_01_06_425584	684	225	467.1657	467.1657	NN
10_1101-2021_01_06_425584	684	226	786.5972	786.5972	NN
10_1101-2021_01_06_425584	684	227	264.2317	264.2317	CD
10_1101-2021_01_06_425584	684	228	393.2856	393.2856	CD
10_1101-2021_01_06_425584	684	229	522.355	522.355	CD
10_1101-2021_01_06_425584	684	230	184.1104	184.1104	NNP
10_1101-2021_01_06_425584	684	231	238.1764	238.1764	CD
10_1101-2021_01_06_425584	684	232	530.2946	530.2946	CD
10_1101-2021_01_06_425584	684	233	413.6366	413.6366	CD
10_1101-2021_01_06_425584	684	234	227.0673425.1357	227.0673425.1357	CD
10_1101-2021_01_06_425584	684	235	307.0978	307.0978	CD
10_1101-2021_01_06_425584	684	236	701.5589	701.5589	NNP
10_1101-2021_01_06_425584	684	237	760.5815	760.5815	CD
10_1101-2021_01_06_425584	684	238	327.0837	327.0837	NN
10_1101-2021_01_06_425584	684	239	367.3351	367.3351	CD
10_1101-2021_01_06_425584	684	240	507.1058	507.1058	RB
10_1101-2021_01_06_425584	684	241	390.0094	390.0094	IN
10_1101-2021_01_06_425584	684	242	448.2113	448.2113	NNS
10_1101-2021_01_06_425584	684	243	418.3511	418.3511	CD
10_1101-2021_01_06_425584	684	244	291.0476	291.0476	CD
10_1101-2021_01_06_425584	684	245	538.2512	538.2512	NNP
10_1101-2021_01_06_425584	684	246	472.2715	472.2715	CD
10_1101-2021_01_06_425584	684	247	505.105	505.105	CD
10_1101-2021_01_06_425584	684	248	161.096	161.096	CD
10_1101-2021_01_06_425584	684	249	246.0794	246.0794	CD
10_1101-2021_01_06_425584	684	250	376.2308	376.2308	XX
10_1101-2021_01_06_425584	684	251	283.0944	283.0944	CD
10_1101-2021_01_06_425584	684	252	575.2728	575.2728	RB
10_1101-2021_01_06_425584	684	253	264.0784	264.0784	CD
10_1101-2021_01_06_425584	684	254	675.5421	675.5421	CD
10_1101-2021_01_06_425584	684	255	283.1171	283.1171	CD
10_1101-2021_01_06_425584	684	256	440.2142	440.2142	NNP
10_1101-2021_01_06_425584	684	257	699.612	699.612	CD
10_1101-2021_01_06_425584	684	258	*	*	NFP
10_1101-2021_01_06_425584	684	259	*	*	NFP
10_1101-2021_01_06_425584	684	260	PC(18:0/18:2(9Z,12Z	PC(18:0/18:2(9Z,12Z	NNP
10_1101-2021_01_06_425584	684	261	)	)	-RRB-
10_1101-2021_01_06_425584	684	262	)	)	-RRB-
10_1101-2021_01_06_425584	684	263	O	o	UH
10_1101-2021_01_06_425584	684	264	P	p	NN
10_1101-2021_01_06_425584	684	265	O	o	NN
10_1101-2021_01_06_425584	684	266	OO	oo	NN
10_1101-2021_01_06_425584	684	267	N+	n+	JJ
10_1101-2021_01_06_425584	684	268	O	o	NN
10_1101-2021_01_06_425584	684	269	O	o	NN
10_1101-2021_01_06_425584	684	270	O	o	NN
10_1101-2021_01_06_425584	684	271	O	o	NN
10_1101-2021_01_06_425584	684	272	PC(16:0/18:1(9Z	pc(16:0/18:1(9z	NN
10_1101-2021_01_06_425584	684	273	)	)	-RRB-
10_1101-2021_01_06_425584	684	274	)	)	-RRB-
10_1101-2021_01_06_425584	684	275	O	o	UH
10_1101-2021_01_06_425584	684	276	P	p	NN
10_1101-2021_01_06_425584	684	277	O	o	NN
10_1101-2021_01_06_425584	684	278	OO	oo	NN
10_1101-2021_01_06_425584	684	279	N+	n+	JJ
10_1101-2021_01_06_425584	684	280	O	o	NN
10_1101-2021_01_06_425584	684	281	O	o	NN
10_1101-2021_01_06_425584	684	282	O	o	NN
10_1101-2021_01_06_425584	684	283	O	o	NN
10_1101-2021_01_06_425584	684	284	Cluster	cluster	NN
10_1101-2021_01_06_425584	684	285	1	1	CD
10_1101-2021_01_06_425584	684	286	588.3571	588.3571	NN
10_1101-2021_01_06_425584	684	287	403.2539	403.2539	NN
10_1101-2021_01_06_425584	684	288	522.3415	522.3415	XX
10_1101-2021_01_06_425584	684	289	289.0601	289.0601	CD
10_1101-2021_01_06_425584	684	290	443.112	443.112	CD
10_1101-2021_01_06_425584	684	291	884.5907	884.5907	NNP
10_1101-2021_01_06_425584	684	292	413.1411	413.1411	NNP
10_1101-2021_01_06_425584	684	293	295.1284	295.1284	VBZ
10_1101-2021_01_06_425584	684	294	367.2373	367.2373	NN
10_1101-2021_01_06_425584	684	295	429.1976	429.1976	CD
10_1101-2021_01_06_425584	684	296	194.1019	194.1019	CD
10_1101-2021_01_06_425584	684	297	399.349	399.349	CD
10_1101-2021_01_06_425584	684	298	277.1856	277.1856	CD
10_1101-2021_01_06_425584	684	299	514.128	514.128	CD
10_1101-2021_01_06_425584	684	300	414.6985	414.6985	CD
10_1101-2021_01_06_425584	684	301	600.2445	600.2445	IN
10_1101-2021_01_06_425584	684	302	181.6122	181.6122	CD
10_1101-2021_01_06_425584	684	303	118.086	118.086	CD
10_1101-2021_01_06_425584	684	304	212.1178	212.1178	CD
10_1101-2021_01_06_425584	684	305	386.2386	386.2386	JJ
10_1101-2021_01_06_425584	684	306	545.1027	545.1027	IN
10_1101-2021_01_06_425584	684	307	271.0785	271.0785	CD
10_1101-2021_01_06_425584	684	308	540.1645	540.1645	JJ
10_1101-2021_01_06_425584	684	309	664.4615	664.4615	CD
10_1101-2021_01_06_425584	684	310	713.4423	713.4423	CD
10_1101-2021_01_06_425584	684	311	404.2208	404.2208	NNS
10_1101-2021_01_06_425584	684	312	413.2847	413.2847	NNP
10_1101-2021_01_06_425584	684	313	455.1888	455.1888	CD
10_1101-2021_01_06_425584	684	314	212.1424	212.1424	CD
10_1101-2021_01_06_425584	684	315	345.1096	345.1096	NNP
10_1101-2021_01_06_425584	684	316	481.2106	481.2106	NNP
10_1101-2021_01_06_425584	684	317	401.3451386.3258	401.3451386.3258	CD
10_1101-2021_01_06_425584	684	318	623.364	623.364	CD
10_1101-2021_01_06_425584	684	319	460.311	460.311	CD
10_1101-2021_01_06_425584	684	320	615.1719	615.1719	CD
10_1101-2021_01_06_425584	684	321	462.2474	462.2474	CD
10_1101-2021_01_06_425584	684	322	658.375	658.375	CD
10_1101-2021_01_06_425584	684	323	423.2506	423.2506	CD
10_1101-2021_01_06_425584	684	324	301.169	301.169	CD
10_1101-2021_01_06_425584	684	325	475.3242	475.3242	CD
10_1101-2021_01_06_425584	684	326	436.3157	436.3157	CD
10_1101-2021_01_06_425584	684	327	133.0648	133.0648	CD
10_1101-2021_01_06_425584	684	328	507.1667	507.1667	CD
10_1101-2021_01_06_425584	684	329	369.3511	369.3511	IN
10_1101-2021_01_06_425584	684	330	360.2117	360.2117	NN
10_1101-2021_01_06_425584	684	331	550.1585	550.1585	CD
10_1101-2021_01_06_425584	684	332	210.1343	210.1343	CD
10_1101-2021_01_06_425584	684	333	391.1352	391.1352	NN
10_1101-2021_01_06_425584	684	334	309.1828	309.1828	NNP
10_1101-2021_01_06_425584	684	335	462.2255	462.2255	NN
10_1101-2021_01_06_425584	684	336	516.3869	516.3869	UH
10_1101-2021_01_06_425584	684	337	567.2984	567.2984	JJ
10_1101-2021_01_06_425584	684	338	562.1643	562.1643	NNP
10_1101-2021_01_06_425584	684	339	299.1096	299.1096	NNP
10_1101-2021_01_06_425584	684	340	382.2582	382.2582	NN
10_1101-2021_01_06_425584	684	341	238.1065	238.1065	CD
10_1101-2021_01_06_425584	684	342	382.527	382.527	CD
10_1101-2021_01_06_425584	684	343	332.2428	332.2428	NN
10_1101-2021_01_06_425584	684	344	349.1834	349.1834	NN
10_1101-2021_01_06_425584	684	345	642.613	642.613	CD
10_1101-2021_01_06_425584	684	346	299.1441	299.1441	CD
10_1101-2021_01_06_425584	684	347	490.2817	490.2817	CD
10_1101-2021_01_06_425584	684	348	253.2143	253.2143	IN
10_1101-2021_01_06_425584	684	349	500.2991	500.2991	NN
10_1101-2021_01_06_425584	684	350	465.2575	465.2575	JJ
10_1101-2021_01_06_425584	684	351	449.1492	449.1492	NNS
10_1101-2021_01_06_425584	684	352	322.1153	322.1153	CD
10_1101-2021_01_06_425584	684	353	299.0619	299.0619	CD
10_1101-2021_01_06_425584	684	354	337.0757	337.0757	CD
10_1101-2021_01_06_425584	684	355	436.1964	436.1964	CD
10_1101-2021_01_06_425584	684	356	371.1907	371.1907	NNP
10_1101-2021_01_06_425584	684	357	367.1969	367.1969	NNP
10_1101-2021_01_06_425584	684	358	757.4697	757.4697	NNP
10_1101-2021_01_06_425584	684	359	316.2243	316.2243	NNP
10_1101-2021_01_06_425584	684	360	409.2795	409.2795	NNP
10_1101-2021_01_06_425584	684	361	371.0673	371.0673	NNP
10_1101-2021_01_06_425584	684	362	585.2858	585.2858	NNP
10_1101-2021_01_06_425584	684	363	244.1903	244.1903	CD
10_1101-2021_01_06_425584	684	364	344.1112	344.1112	NNP
10_1101-2021_01_06_425584	684	365	360.3446	360.3446	NNP
10_1101-2021_01_06_425584	684	366	217.1478	217.1478	NN
10_1101-2021_01_06_425584	684	367	390.2615	390.2615	POS
10_1101-2021_01_06_425584	684	368	381.1105	381.1105	NNP
10_1101-2021_01_06_425584	684	369	587.2967	587.2967	CD
10_1101-2021_01_06_425584	684	370	345.2034	345.2034	NNP
10_1101-2021_01_06_425584	684	371	301.0599	301.0599	NN
10_1101-2021_01_06_425584	684	372	319.2257	319.2257	NN
10_1101-2021_01_06_425584	684	373	273.0908	273.0908	CD
10_1101-2021_01_06_425584	684	374	343.2142	343.2142	CD
10_1101-2021_01_06_425584	684	375	490.1759	490.1759	NNP
10_1101-2021_01_06_425584	684	376	520.3321	520.3321	NNP
10_1101-2021_01_06_425584	684	377	699.5139	699.5139	NNP
10_1101-2021_01_06_425584	684	378	629.159	629.159	CD
10_1101-2021_01_06_425584	684	379	441.7374	441.7374	CD
10_1101-2021_01_06_425584	684	380	292.1173	292.1173	CD
10_1101-2021_01_06_425584	684	381	456.2792	456.2792	CD
10_1101-2021_01_06_425584	684	382	396.0879	396.0879	NNP
10_1101-2021_01_06_425584	684	383	398.7747	398.7747	NNP
10_1101-2021_01_06_425584	684	384	309.1296	309.1296	NNP
10_1101-2021_01_06_425584	684	385	401.1592	401.1592	NNP
10_1101-2021_01_06_425584	684	386	313.2729	313.2729	NNP
10_1101-2021_01_06_425584	684	387	528.3076	528.3076	UH
10_1101-2021_01_06_425584	684	388	419.1089	419.1089	VBZ
10_1101-2021_01_06_425584	684	389	594.2896	594.2896	VBP
10_1101-2021_01_06_425584	684	390	655.3817	655.3817	UH
10_1101-2021_01_06_425584	684	391	531.2728	531.2728	RB
10_1101-2021_01_06_425584	684	392	477.1781	477.1781	XX
10_1101-2021_01_06_425584	684	393	286.0574	286.0574	CD
10_1101-2021_01_06_425584	684	394	114.0912	114.0912	NNP
10_1101-2021_01_06_425584	684	395	181.1218	181.1218	NNP
10_1101-2021_01_06_425584	684	396	536.1638	536.1638	NNP
10_1101-2021_01_06_425584	684	397	566.3353	566.3353	XX
10_1101-2021_01_06_425584	684	398	789.4651	789.4651	NNS
10_1101-2021_01_06_425584	684	399	229.1418	229.1418	CD
10_1101-2021_01_06_425584	684	400	185.0804	185.0804	IN
10_1101-2021_01_06_425584	684	401	316.2842	316.2842	IN
10_1101-2021_01_06_425584	684	402	349.2379	349.2379	NNP
10_1101-2021_01_06_425584	684	403	331.2598	331.2598	NNP
10_1101-2021_01_06_425584	684	404	258.1688	258.1688	NNP
10_1101-2021_01_06_425584	684	405	422.3033	422.3033	NNP
10_1101-2021_01_06_425584	684	406	495.2392	495.2392	CD
10_1101-2021_01_06_425584	684	407	509.2865	509.2865	NN
10_1101-2021_01_06_425584	684	408	550.2611	550.2611	RB
10_1101-2021_01_06_425584	684	409	306.2272	306.2272	NNP
10_1101-2021_01_06_425584	684	410	378.2235	378.2235	NNP
10_1101-2021_01_06_425584	684	411	358.135	358.135	CD
10_1101-2021_01_06_425584	684	412	230.1749	230.1749	CD
10_1101-2021_01_06_425584	684	413	387.083	387.083	CD
10_1101-2021_01_06_425584	684	414	442.8012	442.8012	CD
10_1101-2021_01_06_425584	684	415	751.5126	751.5126	CD
10_1101-2021_01_06_425584	684	416	305.6453	305.6453	NN
10_1101-2021_01_06_425584	684	417	768.5299	768.5299	NNP
10_1101-2021_01_06_425584	684	418	455.247	455.247	CD
10_1101-2021_01_06_425584	684	419	444.3311	444.3311	JJ
10_1101-2021_01_06_425584	684	420	298.0777	298.0777	CD
10_1101-2021_01_06_425584	684	421	703.5731	703.5731	NNP
10_1101-2021_01_06_425584	684	422	318.2987	318.2987	NNP
10_1101-2021_01_06_425584	684	423	358.1104	358.1104	NNP
10_1101-2021_01_06_425584	684	424	330.0751	330.0751	CD
10_1101-2021_01_06_425584	684	425	632.3741	632.3741	CD
10_1101-2021_01_06_425584	684	426	376.259	376.259	CD
10_1101-2021_01_06_425584	684	427	475.1924	475.1924	NNP
10_1101-2021_01_06_425584	684	428	414.1404	414.1404	CD
10_1101-2021_01_06_425584	684	429	273.2528	273.2528	CD
10_1101-2021_01_06_425584	684	430	273.1396	273.1396	CD
10_1101-2021_01_06_425584	684	431	385.1528	385.1528	NN
10_1101-2021_01_06_425584	684	432	213.1103	213.1103	CD
10_1101-2021_01_06_425584	684	433	398.2412	398.2412	NN
10_1101-2021_01_06_425584	684	434	446.2587	446.2587	CD
10_1101-2021_01_06_425584	684	435	540.2848	540.2848	CD
10_1101-2021_01_06_425584	684	436	801.4936	801.4936	NNP
10_1101-2021_01_06_425584	684	437	353.1448	353.1448	NNP
10_1101-2021_01_06_425584	684	438	283.1749	283.1749	NNP
10_1101-2021_01_06_425584	684	439	304.8924	304.8924	NNP
10_1101-2021_01_06_425584	684	440	504.2723	504.2723	RB
10_1101-2021_01_06_425584	684	441	565.3329	565.3329	IN
10_1101-2021_01_06_425584	684	442	355.1119	355.1119	CD
10_1101-2021_01_06_425584	684	443	279.0797	279.0797	CD
10_1101-2021_01_06_425584	684	444	593.1553	593.1553	XX
10_1101-2021_01_06_425584	684	445	497.2902	497.2902	CD
10_1101-2021_01_06_425584	684	446	202.0859	202.0859	CD
10_1101-2021_01_06_425584	684	447	216.1608	216.1608	CD
10_1101-2021_01_06_425584	684	448	376.2327	376.2327	CD
10_1101-2021_01_06_425584	684	449	359.3151	359.3151	NN
10_1101-2021_01_06_425584	684	450	400.3045	400.3045	CD
10_1101-2021_01_06_425584	684	451	474.1614	474.1614	CD
10_1101-2021_01_06_425584	684	452	711.1412	711.1412	NNP
10_1101-2021_01_06_425584	684	453	319.1052	319.1052	CD
10_1101-2021_01_06_425584	684	454	486.0965	486.0965	NNP
10_1101-2021_01_06_425584	684	455	696.6349	696.6349	NNP
10_1101-2021_01_06_425584	684	456	407.1877	407.1877	NNP
10_1101-2021_01_06_425584	684	457	331.9947	331.9947	NNP
10_1101-2021_01_06_425584	684	458	230.1386	230.1386	UH
10_1101-2021_01_06_425584	684	459	439.2532	439.2532	NNP
10_1101-2021_01_06_425584	684	460	506.2452	506.2452	NNP
10_1101-2021_01_06_425584	684	461	285.1309	285.1309	CD
10_1101-2021_01_06_425584	684	462	504.1222	504.1222	CD
10_1101-2021_01_06_425584	684	463	414.2137	414.2137	CD
10_1101-2021_01_06_425584	684	464	498.4031	498.4031	NN
10_1101-2021_01_06_425584	684	465	546.2845	546.2845	NNP
10_1101-2021_01_06_425584	684	466	509.1202	509.1202	NNP
10_1101-2021_01_06_425584	684	467	867.5631	867.5631	NN
10_1101-2021_01_06_425584	684	468	475.2779	475.2779	CD
10_1101-2021_01_06_425584	684	469	434.2584	434.2584	CD
10_1101-2021_01_06_425584	684	470	817.4667	817.4667	CD
10_1101-2021_01_06_425584	684	471	348.1855	348.1855	IN
10_1101-2021_01_06_425584	684	472	575.2753	575.2753	RB
10_1101-2021_01_06_425584	684	473	200.1057	200.1057	NNP
10_1101-2021_01_06_425584	684	474	407.0865	407.0865	CD
10_1101-2021_01_06_425584	684	475	612.4165	612.4165	CD
10_1101-2021_01_06_425584	684	476	375.0856	375.0856	NN
10_1101-2021_01_06_425584	684	477	467.1657	467.1657	NN
10_1101-2021_01_06_425584	684	478	564.358	564.358	CD
10_1101-2021_01_06_425584	684	479	377.2349	377.2349	NNP
10_1101-2021_01_06_425584	684	480	174.9548	174.9548	CD
10_1101-2021_01_06_425584	684	481	386.2077	386.2077	NNP
10_1101-2021_01_06_425584	684	482	338.1949	338.1949	CD
10_1101-2021_01_06_425584	684	483	314.2003	314.2003	NNP
10_1101-2021_01_06_425584	684	484	786.5972	786.5972	NNP
10_1101-2021_01_06_425584	684	485	415.2237	415.2237	CD
10_1101-2021_01_06_425584	684	486	419.17	419.17	CD
10_1101-2021_01_06_425584	684	487	264.2317	264.2317	CD
10_1101-2021_01_06_425584	684	488	313.2128	313.2128	CD
10_1101-2021_01_06_425584	684	489	225.0906	225.0906	NN
10_1101-2021_01_06_425584	684	490	233.1838	233.1838	CD
10_1101-2021_01_06_425584	684	491	393.2856	393.2856	NN
10_1101-2021_01_06_425584	684	492	257.0585	257.0585	NNP
10_1101-2021_01_06_425584	684	493	276.1806	276.1806	CD
10_1101-2021_01_06_425584	684	494	527.156	527.156	CD
10_1101-2021_01_06_425584	684	495	377.0441	377.0441	NN
10_1101-2021_01_06_425584	684	496	232.6427	232.6427	CD
10_1101-2021_01_06_425584	684	497	297.1442	297.1442	CD
10_1101-2021_01_06_425584	684	498	933.571	933.571	CD
10_1101-2021_01_06_425584	684	499	411.2079	411.2079	CD
10_1101-2021_01_06_425584	684	500	430.2003	430.2003	CD
10_1101-2021_01_06_425584	684	501	437.1154	437.1154	CD
10_1101-2021_01_06_425584	684	502	197.116	197.116	CD
10_1101-2021_01_06_425584	684	503	239.9349	239.9349	CD
10_1101-2021_01_06_425584	684	504	928.6203	928.6203	CD
10_1101-2021_01_06_425584	684	505	261.2528	261.2528	VBD
10_1101-2021_01_06_425584	684	506	522.355	522.355	CD
10_1101-2021_01_06_425584	684	507	319.1367	319.1367	NNP
10_1101-2021_01_06_425584	684	508	328.1327	328.1327	NNP
10_1101-2021_01_06_425584	684	509	420.7869	420.7869	NN
10_1101-2021_01_06_425584	684	510	129.069	129.069	CD
10_1101-2021_01_06_425584	684	511	403.1745	403.1745	CD
10_1101-2021_01_06_425584	684	512	506.2405	506.2405	NNP
10_1101-2021_01_06_425584	684	513	271.0781	271.0781	CD
10_1101-2021_01_06_425584	684	514	232.1639	232.1639	CD
10_1101-2021_01_06_425584	684	515	244.2086	244.2086	CD
10_1101-2021_01_06_425584	684	516	354.2356	354.2356	NN
10_1101-2021_01_06_425584	684	517	889.5489	889.5489	NNP
10_1101-2021_01_06_425584	684	518	390.2321	390.2321	NNP
10_1101-2021_01_06_425584	684	519	544.3316	544.3316	NNP
10_1101-2021_01_06_425584	684	520	107.0795	107.0795	RB
10_1101-2021_01_06_425584	684	521	288.2526	288.2526	CD
10_1101-2021_01_06_425584	684	522	399.222	399.222	CD
10_1101-2021_01_06_425584	684	523	338.0442	338.0442	NNP
10_1101-2021_01_06_425584	684	524	223.0626	223.0626	CD
10_1101-2021_01_06_425584	684	525	439.1149	439.1149	CD
10_1101-2021_01_06_425584	684	526	298.2223	298.2223	CD
10_1101-2021_01_06_425584	684	527	184.1104	184.1104	NNP
10_1101-2021_01_06_425584	684	528	369.0139	369.0139	NNP
10_1101-2021_01_06_425584	684	529	768.5354	768.5354	CD
10_1101-2021_01_06_425584	684	530	294.1536	294.1536	CD
10_1101-2021_01_06_425584	684	531	448.1644	448.1644	CD
10_1101-2021_01_06_425584	684	532	301.1202	301.1202	IN
10_1101-2021_01_06_425584	684	533	404.1451	404.1451	JJ
10_1101-2021_01_06_425584	684	534	242.116	242.116	CD
10_1101-2021_01_06_425584	684	535	304.2111	304.2111	NN
10_1101-2021_01_06_425584	684	536	299.199	299.199	CD
10_1101-2021_01_06_425584	684	537	578.3353	578.3353	CD
10_1101-2021_01_06_425584	684	538	172.1334	172.1334	CD
10_1101-2021_01_06_425584	684	539	277.0957	277.0957	CD
10_1101-2021_01_06_425584	684	540	315.264	315.264	CD
10_1101-2021_01_06_425584	684	541	232.1536	232.1536	NN
10_1101-2021_01_06_425584	684	542	497.2898	497.2898	NNP
10_1101-2021_01_06_425584	684	543	678.5877	678.5877	NNP
10_1101-2021_01_06_425584	684	544	632.4042	632.4042	IN
10_1101-2021_01_06_425584	684	545	567.3284	567.3284	CD
10_1101-2021_01_06_425584	684	546	633.737	633.737	CD
10_1101-2021_01_06_425584	684	547	304.0625	304.0625	NN
10_1101-2021_01_06_425584	684	548	284.1591	284.1591	CD
10_1101-2021_01_06_425584	684	549	203.1064	203.1064	CD
10_1101-2021_01_06_425584	684	550	272.2211	272.2211	CD
10_1101-2021_01_06_425584	684	551	443.2961	443.2961	CD
10_1101-2021_01_06_425584	684	552	238.1764	238.1764	CD
10_1101-2021_01_06_425584	684	553	359.0625	359.0625	NN
10_1101-2021_01_06_425584	684	554	385.2079	385.2079	NNP
10_1101-2021_01_06_425584	684	555	245.1861	245.1861	NNP
10_1101-2021_01_06_425584	684	556	713.1472	713.1472	NNP
10_1101-2021_01_06_425584	684	557	358.2426	358.2426	NNP
10_1101-2021_01_06_425584	684	558	423.136	423.136	CD
10_1101-2021_01_06_425584	684	559	229.1379	229.1379	CD
10_1101-2021_01_06_425584	684	560	327.1659	327.1659	CD
10_1101-2021_01_06_425584	684	561	302.1146	302.1146	CD
10_1101-2021_01_06_425584	684	562	477.2296	477.2296	CD
10_1101-2021_01_06_425584	684	563	297.154	297.154	CD
10_1101-2021_01_06_425584	684	564	548.157	548.157	CD
10_1101-2021_01_06_425584	684	565	502.0925	502.0925	CD
10_1101-2021_01_06_425584	684	566	399.3618	399.3618	NNP
10_1101-2021_01_06_425584	684	567	394.0924	394.0924	NNP
10_1101-2021_01_06_425584	684	568	307.1737	307.1737	NNP
10_1101-2021_01_06_425584	684	569	301.1301	301.1301	NNP
10_1101-2021_01_06_425584	684	570	301.2823	301.2823	NNP
10_1101-2021_01_06_425584	684	571	796.5661	796.5661	NNP
10_1101-2021_01_06_425584	684	572	309.1275	309.1275	CD
10_1101-2021_01_06_425584	684	573	693.2997	693.2997	JJ
10_1101-2021_01_06_425584	684	574	536.1732	536.1732	NNP
10_1101-2021_01_06_425584	684	575	316.2115	316.2115	CD
10_1101-2021_01_06_425584	684	576	388.1274	388.1274	CD
10_1101-2021_01_06_425584	684	577	483.2052	483.2052	CD
10_1101-2021_01_06_425584	684	578	331.1683	331.1683	NNP
10_1101-2021_01_06_425584	684	579	551.3183	551.3183	NNP
10_1101-2021_01_06_425584	684	580	353.1478	353.1478	NNP
10_1101-2021_01_06_425584	684	581	473.2587	473.2587	NNP
10_1101-2021_01_06_425584	684	582	654.3295	654.3295	VBD
10_1101-2021_01_06_425584	684	583	558.7383	558.7383	CD
10_1101-2021_01_06_425584	684	584	530.2946	530.2946	IN
10_1101-2021_01_06_425584	684	585	508.3023	508.3023	CD
10_1101-2021_01_06_425584	684	586	659.359	659.359	CD
10_1101-2021_01_06_425584	684	587	473.234	473.234	CD
10_1101-2021_01_06_425584	684	588	383.2783	383.2783	NN
10_1101-2021_01_06_425584	684	589	443.1717	443.1717	NN
10_1101-2021_01_06_425584	684	590	664.1098	664.1098	XX
10_1101-2021_01_06_425584	684	591	231.1589	231.1589	CD
10_1101-2021_01_06_425584	684	592	267.0061	267.0061	CD
10_1101-2021_01_06_425584	684	593	500.2756	500.2756	CD
10_1101-2021_01_06_425584	684	594	679.4094	679.4094	CD
10_1101-2021_01_06_425584	684	595	433.2468	433.2468	CD
10_1101-2021_01_06_425584	684	596	630.8588	630.8588	CD
10_1101-2021_01_06_425584	684	597	409.1622	409.1622	CD
10_1101-2021_01_06_425584	684	598	319.2253	319.2253	NNP
10_1101-2021_01_06_425584	684	599	250.1779	250.1779	NNP
10_1101-2021_01_06_425584	684	600	247.013	247.013	CD
10_1101-2021_01_06_425584	684	601	329.0054	329.0054	NNP
10_1101-2021_01_06_425584	684	602	691.4994	691.4994	CD
10_1101-2021_01_06_425584	684	603	315.195	315.195	CD
10_1101-2021_01_06_425584	684	604	474.2317	474.2317	CD
10_1101-2021_01_06_425584	684	605	358.2043	358.2043	NNS
10_1101-2021_01_06_425584	684	606	438.2635	438.2635	CD
10_1101-2021_01_06_425584	684	607	239.1529	239.1529	CD
10_1101-2021_01_06_425584	684	608	299.0617	299.0617	CD
10_1101-2021_01_06_425584	684	609	180.1749	180.1749	CD
10_1101-2021_01_06_425584	684	610	433.2028	433.2028	CD
10_1101-2021_01_06_425584	684	611	291.1168	291.1168	CD
10_1101-2021_01_06_425584	684	612	296.2214	296.2214	NNP
10_1101-2021_01_06_425584	684	613	300.0763	300.0763	NNP
10_1101-2021_01_06_425584	684	614	387.1685	387.1685	NNP
10_1101-2021_01_06_425584	684	615	320.1042	320.1042	CD
10_1101-2021_01_06_425584	684	616	716.5212	716.5212	CD
10_1101-2021_01_06_425584	684	617	587.3253	587.3253	NN
10_1101-2021_01_06_425584	684	618	236.0713	236.0713	NNP
10_1101-2021_01_06_425584	684	619	197.0779	197.0779	CD
10_1101-2021_01_06_425584	684	620	151.075	151.075	CD
10_1101-2021_01_06_425584	684	621	413.6366	413.6366	CD
10_1101-2021_01_06_425584	684	622	531.3313	531.3313	NNP
10_1101-2021_01_06_425584	684	623	851.3932	851.3932	NNP
10_1101-2021_01_06_425584	684	624	227.0673	227.0673	CD
10_1101-2021_01_06_425584	684	625	429.2316	429.2316	CD
10_1101-2021_01_06_425584	684	626	246.1521	246.1521	JJ
10_1101-2021_01_06_425584	684	627	453.21	453.21	CD
10_1101-2021_01_06_425584	684	628	329.202	329.202	CD
10_1101-2021_01_06_425584	684	629	652.4089	652.4089	CD
10_1101-2021_01_06_425584	684	630	270.0416	270.0416	MD
10_1101-2021_01_06_425584	684	631	552.1533	552.1533	CD
10_1101-2021_01_06_425584	684	632	371.0477	371.0477	NN
10_1101-2021_01_06_425584	684	633	338.1339	338.1339	NNP
10_1101-2021_01_06_425584	684	634	613.1577	613.1577	NNP
10_1101-2021_01_06_425584	684	635	334.9126	334.9126	NNP
10_1101-2021_01_06_425584	684	636	374.1591	374.1591	NN
10_1101-2021_01_06_425584	684	637	309.1524	309.1524	CD
10_1101-2021_01_06_425584	684	638	522.3083	522.3083	IN
10_1101-2021_01_06_425584	684	639	541.2215	541.2215	NNP
10_1101-2021_01_06_425584	684	640	415.2797	415.2797	NNP
10_1101-2021_01_06_425584	684	641	376.1159	376.1159	NNP
10_1101-2021_01_06_425584	684	642	734.6477	734.6477	NNP
10_1101-2021_01_06_425584	684	643	257.0572	257.0572	CD
10_1101-2021_01_06_425584	684	644	283.6001	283.6001	CD
10_1101-2021_01_06_425584	684	645	331.0834	331.0834	VBZ
10_1101-2021_01_06_425584	684	646	374.0627	374.0627	NNP
10_1101-2021_01_06_425584	684	647	592.3889	592.3889	XX
10_1101-2021_01_06_425584	684	648	246.1016	246.1016	RB
10_1101-2021_01_06_425584	684	649	425.1357	425.1357	NN
10_1101-2021_01_06_425584	684	650	331.2049	331.2049	CD
10_1101-2021_01_06_425584	684	651	575.209	575.209	CD
10_1101-2021_01_06_425584	684	652	404.7346	404.7346	CD
10_1101-2021_01_06_425584	684	653	348.1212	348.1212	NN
10_1101-2021_01_06_425584	684	654	283.1205	283.1205	CD
10_1101-2021_01_06_425584	684	655	242.0992	242.0992	CD
10_1101-2021_01_06_425584	684	656	478.292	478.292	CD
10_1101-2021_01_06_425584	684	657	377.1814	377.1814	CD
10_1101-2021_01_06_425584	684	658	345.1106	345.1106	CD
10_1101-2021_01_06_425584	684	659	285.007	285.007	CD
10_1101-2021_01_06_425584	684	660	640.268	640.268	CD
10_1101-2021_01_06_425584	684	661	307.0978	307.0978	NNP
10_1101-2021_01_06_425584	684	662	240.1799	240.1799	CD
10_1101-2021_01_06_425584	684	663	402.0959	402.0959	NNP
10_1101-2021_01_06_425584	684	664	701.5589	701.5589	NNP
10_1101-2021_01_06_425584	684	665	404.2348	404.2348	CD
10_1101-2021_01_06_425584	684	666	661.5624	661.5624	NNP
10_1101-2021_01_06_425584	684	667	331.1573	331.1573	NNP
10_1101-2021_01_06_425584	684	668	353.2221	353.2221	NNP
10_1101-2021_01_06_425584	684	669	509.2995	509.2995	NNP
10_1101-2021_01_06_425584	684	670	265.1674	265.1674	CD
10_1101-2021_01_06_425584	684	671	283.1263	283.1263	NN
10_1101-2021_01_06_425584	684	672	416.0969	416.0969	CD
10_1101-2021_01_06_425584	684	673	509.2353	509.2353	XX
10_1101-2021_01_06_425584	684	674	487.1958	487.1958	JJ
10_1101-2021_01_06_425584	684	675	620.4355	620.4355	JJ
10_1101-2021_01_06_425584	684	676	332.0995	332.0995	NNP
10_1101-2021_01_06_425584	684	677	190.1434	190.1434	NNP
10_1101-2021_01_06_425584	684	678	263.0813	263.0813	CD
10_1101-2021_01_06_425584	684	679	760.5815	760.5815	NN
10_1101-2021_01_06_425584	684	680	453.2655	453.2655	JJ
10_1101-2021_01_06_425584	684	681	382.2214	382.2214	NNP
10_1101-2021_01_06_425584	684	682	271.1622	271.1622	CD
10_1101-2021_01_06_425584	684	683	210.0494	210.0494	CD
10_1101-2021_01_06_425584	684	684	309.1573	309.1573	JJ
10_1101-2021_01_06_425584	684	685	493.1866	493.1866	CD
10_1101-2021_01_06_425584	684	686	488.2337	488.2337	CD
10_1101-2021_01_06_425584	684	687	295.1274	295.1274	CD
10_1101-2021_01_06_425584	684	688	273.1677	273.1677	CD
10_1101-2021_01_06_425584	684	689	161.1165	161.1165	IN
10_1101-2021_01_06_425584	684	690	349.2384	349.2384	NNP
10_1101-2021_01_06_425584	684	691	187.1435	187.1435	NNP
10_1101-2021_01_06_425584	684	692	398.0898	398.0898	NN
10_1101-2021_01_06_425584	684	693	428.1321	428.1321	CD
10_1101-2021_01_06_425584	684	694	439.2902	439.2902	CD
10_1101-2021_01_06_425584	684	695	321.1474	321.1474	NN
10_1101-2021_01_06_425584	684	696	535.21	535.21	CD
10_1101-2021_01_06_425584	684	697	204.6112	204.6112	NNP
10_1101-2021_01_06_425584	684	698	446.2585	446.2585	NN
10_1101-2021_01_06_425584	684	699	407.1732	407.1732	CD
10_1101-2021_01_06_425584	684	700	654.19	654.19	CD
10_1101-2021_01_06_425584	684	701	455.3344	455.3344	CD
10_1101-2021_01_06_425584	684	702	500.3049	500.3049	JJ
10_1101-2021_01_06_425584	684	703	409.2372	409.2372	CD
10_1101-2021_01_06_425584	684	704	295.1285	295.1285	CD
10_1101-2021_01_06_425584	684	705	547.331	547.331	CD
10_1101-2021_01_06_425584	684	706	625.2796	625.2796	CD
10_1101-2021_01_06_425584	684	707	375.0536	375.0536	NN
10_1101-2021_01_06_425584	684	708	242.1172	242.1172	CD
10_1101-2021_01_06_425584	684	709	376.2281	376.2281	CD
10_1101-2021_01_06_425584	684	710	209.0914	209.0914	NNP
10_1101-2021_01_06_425584	684	711	597.3382	597.3382	NNP
10_1101-2021_01_06_425584	684	712	370.1355	370.1355	NNP
10_1101-2021_01_06_425584	684	713	270.0645	270.0645	NNP
10_1101-2021_01_06_425584	684	714	541.2606	541.2606	NNP
10_1101-2021_01_06_425584	684	715	671.3161	671.3161	NNP
10_1101-2021_01_06_425584	684	716	276.1258	276.1258	CD
10_1101-2021_01_06_425584	684	717	468.9809	468.9809	CD
10_1101-2021_01_06_425584	684	718	287.0473	287.0473	CD
10_1101-2021_01_06_425584	684	719	320.2047	320.2047	CD
10_1101-2021_01_06_425584	684	720	277.1414	277.1414	CD
10_1101-2021_01_06_425584	684	721	177.0627	177.0627	CD
10_1101-2021_01_06_425584	684	722	504.3367	504.3367	NNP
10_1101-2021_01_06_425584	684	723	735.4868	735.4868	CD
10_1101-2021_01_06_425584	684	724	461.2096	461.2096	NNP
10_1101-2021_01_06_425584	684	725	617.3879	617.3879	CD
10_1101-2021_01_06_425584	684	726	589.3121	589.3121	CD
10_1101-2021_01_06_425584	684	727	202.1068	202.1068	CD
10_1101-2021_01_06_425584	684	728	148.0604	148.0604	CD
10_1101-2021_01_06_425584	684	729	520.295	520.295	CD
10_1101-2021_01_06_425584	684	730	327.0837	327.0837	CD
10_1101-2021_01_06_425584	684	731	347.1596	347.1596	NNP
10_1101-2021_01_06_425584	684	732	556.1906	556.1906	CD
10_1101-2021_01_06_425584	684	733	297.1436	297.1436	NN
10_1101-2021_01_06_425584	684	734	334.0427	334.0427	IN
10_1101-2021_01_06_425584	684	735	206.1392	206.1392	CD
10_1101-2021_01_06_425584	684	736	431.0663	431.0663	CD
10_1101-2021_01_06_425584	684	737	911.594	911.594	CD
10_1101-2021_01_06_425584	684	738	336.1909	336.1909	JJ
10_1101-2021_01_06_425584	684	739	329.1818	329.1818	CD
10_1101-2021_01_06_425584	684	740	608.3826	608.3826	CD
10_1101-2021_01_06_425584	684	741	289.2475	289.2475	CD
10_1101-2021_01_06_425584	684	742	367.3351	367.3351	CD
10_1101-2021_01_06_425584	684	743	156.0483	156.0483	CD
10_1101-2021_01_06_425584	684	744	478.1842	478.1842	CD
10_1101-2021_01_06_425584	684	745	619.2416	619.2416	CD
10_1101-2021_01_06_425584	684	746	404.847	404.847	CD
10_1101-2021_01_06_425584	684	747	465.1608	465.1608	CD
10_1101-2021_01_06_425584	684	748	207.0614	207.0614	CD
10_1101-2021_01_06_425584	684	749	605.4416	605.4416	XX
10_1101-2021_01_06_425584	684	750	579.337	579.337	CD
10_1101-2021_01_06_425584	684	751	242.2114	242.2114	CD
10_1101-2021_01_06_425584	684	752	310.0135	310.0135	NNS
10_1101-2021_01_06_425584	684	753	396.1853	396.1853	CD
10_1101-2021_01_06_425584	684	754	341.206	341.206	CD
10_1101-2021_01_06_425584	684	755	397.2156	397.2156	NNP
10_1101-2021_01_06_425584	684	756	344.2247	344.2247	CD
10_1101-2021_01_06_425584	684	757	433.1485	433.1485	CD
10_1101-2021_01_06_425584	684	758	393.2099	393.2099	CD
10_1101-2021_01_06_425584	684	759	346.1958	346.1958	NNP
10_1101-2021_01_06_425584	684	760	434.0664	434.0664	CD
10_1101-2021_01_06_425584	684	761	398.7746	398.7746	CD
10_1101-2021_01_06_425584	684	762	484.137	484.137	CD
10_1101-2021_01_06_425584	684	763	371.2276	371.2276	CD
10_1101-2021_01_06_425584	684	764	216.1954	216.1954	NNP
10_1101-2021_01_06_425584	684	765	318.1811	318.1811	NNP
10_1101-2021_01_06_425584	684	766	399.1987	399.1987	NNP
10_1101-2021_01_06_425584	684	767	708.4868	708.4868	NNP
10_1101-2021_01_06_425584	684	768	435.1311	435.1311	NNP
10_1101-2021_01_06_425584	684	769	474.2324	474.2324	CD
10_1101-2021_01_06_425584	684	770	383.0228	383.0228	NN
10_1101-2021_01_06_425584	684	771	291.1928	291.1928	.
10_1101-2021_01_06_425584	684	772	316.1778	316.1778	NN
10_1101-2021_01_06_425584	684	773	751.5081	751.5081	VBZ
10_1101-2021_01_06_425584	684	774	467.6187	467.6187	CD
10_1101-2021_01_06_425584	684	775	272.1853	272.1853	CD
10_1101-2021_01_06_425584	684	776	739.6026	739.6026	NN
10_1101-2021_01_06_425584	684	777	434.1648	434.1648	CD
10_1101-2021_01_06_425584	684	778	269.0628	269.0628	CD
10_1101-2021_01_06_425584	684	779	293.6761	293.6761	CD
10_1101-2021_01_06_425584	684	780	744.5533	744.5533	JJ
10_1101-2021_01_06_425584	684	781	302.1702	302.1702	NN
10_1101-2021_01_06_425584	684	782	637.1514	637.1514	CD
10_1101-2021_01_06_425584	684	783	331.109	331.109	CD
10_1101-2021_01_06_425584	684	784	507.1058	507.1058	RB
10_1101-2021_01_06_425584	684	785	416.158	416.158	CD
10_1101-2021_01_06_425584	684	786	369.1843	369.1843	CD
10_1101-2021_01_06_425584	684	787	489.1045	489.1045	NNP
10_1101-2021_01_06_425584	684	788	233.0772	233.0772	CD
10_1101-2021_01_06_425584	684	789	507.1304	507.1304	XX
10_1101-2021_01_06_425584	684	790	407.1706	407.1706	NNP
10_1101-2021_01_06_425584	684	791	298.1856	298.1856	CD
10_1101-2021_01_06_425584	684	792	404.1482	404.1482	CD
10_1101-2021_01_06_425584	684	793	427.305	427.305	CD
10_1101-2021_01_06_425584	684	794	210.1843	210.1843	NNP
10_1101-2021_01_06_425584	684	795	857.3778	857.3778	CD
10_1101-2021_01_06_425584	684	796	729.4168	729.4168	NN
10_1101-2021_01_06_425584	684	797	348.2378	348.2378	CD
10_1101-2021_01_06_425584	684	798	477.2335	477.2335	CD
10_1101-2021_01_06_425584	684	799	409.1764	409.1764	CD
10_1101-2021_01_06_425584	684	800	735.4996	735.4996	CD
10_1101-2021_01_06_425584	684	801	779.5132	779.5132	NNP
10_1101-2021_01_06_425584	684	802	388.2532	388.2532	NNP
10_1101-2021_01_06_425584	684	803	478.2635	478.2635	CD
10_1101-2021_01_06_425584	684	804	431.2514	431.2514	CD
10_1101-2021_01_06_425584	684	805	208.1812	208.1812	CD
10_1101-2021_01_06_425584	684	806	449.2862	449.2862	NNP
10_1101-2021_01_06_425584	684	807	576.4091	576.4091	NNP
10_1101-2021_01_06_425584	684	808	474.2906	474.2906	NNP
10_1101-2021_01_06_425584	684	809	594.1326	594.1326	VBZ
10_1101-2021_01_06_425584	684	810	336.3255	336.3255	NNP
10_1101-2021_01_06_425584	684	811	637.8139	637.8139	JJ
10_1101-2021_01_06_425584	684	812	627.095	627.095	CD
10_1101-2021_01_06_425584	684	813	403.2751	403.2751	CD
10_1101-2021_01_06_425584	684	814	353.2653	353.2653	CD
10_1101-2021_01_06_425584	684	815	683.345	683.345	CD
10_1101-2021_01_06_425584	684	816	325.0998	325.0998	CD
10_1101-2021_01_06_425584	684	817	331.2087	331.2087	CD
10_1101-2021_01_06_425584	684	818	242.2836	242.2836	CD
10_1101-2021_01_06_425584	684	819	450.2319	450.2319	CD
10_1101-2021_01_06_425584	684	820	342.1657	342.1657	NNP
10_1101-2021_01_06_425584	684	821	188.066	188.066	CD
10_1101-2021_01_06_425584	684	822	339.2526	339.2526	CD
10_1101-2021_01_06_425584	684	823	335.158	335.158	CD
10_1101-2021_01_06_425584	684	824	300.2013	300.2013	CD
10_1101-2021_01_06_425584	684	825	659.2866	659.2866	CD
10_1101-2021_01_06_425584	684	826	591.358	591.358	CD
10_1101-2021_01_06_425584	684	827	214.2521	214.2521	CD
10_1101-2021_01_06_425584	684	828	686.4674	686.4674	NN
10_1101-2021_01_06_425584	684	829	545.2051	545.2051	RB
10_1101-2021_01_06_425584	684	830	348.2012	348.2012	NNP
10_1101-2021_01_06_425584	684	831	314.1799	314.1799	NNP
10_1101-2021_01_06_425584	684	832	231.1164	231.1164	NNP
10_1101-2021_01_06_425584	684	833	209.122	209.122	CD
10_1101-2021_01_06_425584	684	834	503.3049	503.3049	NNP
10_1101-2021_01_06_425584	684	835	297.1802	297.1802	NNP
10_1101-2021_01_06_425584	684	836	360.1322	360.1322	CD
10_1101-2021_01_06_425584	684	837	403.2229	403.2229	CD
10_1101-2021_01_06_425584	684	838	455.107	455.107	CD
10_1101-2021_01_06_425584	684	839	322.0628	322.0628	CD
10_1101-2021_01_06_425584	684	840	229.0386	229.0386	CD
10_1101-2021_01_06_425584	684	841	311.1988	311.1988	NNP
10_1101-2021_01_06_425584	684	842	316.061	316.061	CD
10_1101-2021_01_06_425584	684	843	300.0013	300.0013	NNP
10_1101-2021_01_06_425584	684	844	520.3407	520.3407	NNP
10_1101-2021_01_06_425584	684	845	250.1462	250.1462	CD
10_1101-2021_01_06_425584	684	846	446.2248	446.2248	CD
10_1101-2021_01_06_425584	684	847	387.1969	387.1969	CD
10_1101-2021_01_06_425584	684	848	436.1368	436.1368	NN
10_1101-2021_01_06_425584	684	849	480.1787	480.1787	NNP
10_1101-2021_01_06_425584	684	850	390.0094	390.0094	NNP
10_1101-2021_01_06_425584	684	851	334.2211	334.2211	CD
10_1101-2021_01_06_425584	684	852	458.2322	458.2322	CD
10_1101-2021_01_06_425584	684	853	399.3568	399.3568	JJ
10_1101-2021_01_06_425584	684	854	506.2726	506.2726	NNP
10_1101-2021_01_06_425584	684	855	235.1782	235.1782	CD
10_1101-2021_01_06_425584	684	856	389.1216	389.1216	NNP
10_1101-2021_01_06_425584	684	857	452.2747	452.2747	NN
10_1101-2021_01_06_425584	684	858	329.0849	329.0849	NNP
10_1101-2021_01_06_425584	684	859	502.2879	502.2879	CD
10_1101-2021_01_06_425584	684	860	654.3297	654.3297	CD
10_1101-2021_01_06_425584	684	861	385.2046	385.2046	NNS
10_1101-2021_01_06_425584	684	862	421.2828	421.2828	NNP
10_1101-2021_01_06_425584	684	863	433.2463	433.2463	CD
10_1101-2021_01_06_425584	684	864	846.4398	846.4398	NNP
10_1101-2021_01_06_425584	684	865	402.2327	402.2327	NNP
10_1101-2021_01_06_425584	684	866	355.1755	355.1755	NNP
10_1101-2021_01_06_425584	684	867	325.0272	325.0272	NNP
10_1101-2021_01_06_425584	684	868	360.2022	360.2022	CD
10_1101-2021_01_06_425584	684	869	263.1492	263.1492	CD
10_1101-2021_01_06_425584	684	870	447.1673	447.1673	CD
10_1101-2021_01_06_425584	684	871	402.1759	402.1759	CD
10_1101-2021_01_06_425584	684	872	316.3205	316.3205	CD
10_1101-2021_01_06_425584	684	873	610.3903	610.3903	JJ
10_1101-2021_01_06_425584	684	874	396.0943	396.0943	NNP
10_1101-2021_01_06_425584	684	875	157.0855	157.0855	NN
10_1101-2021_01_06_425584	684	876	465.1713	465.1713	NN
10_1101-2021_01_06_425584	684	877	256.0605	256.0605	CD
10_1101-2021_01_06_425584	684	878	518.3147	518.3147	JJ
10_1101-2021_01_06_425584	684	879	773.4406	773.4406	NNP
10_1101-2021_01_06_425584	684	880	653.332	653.332	IN
10_1101-2021_01_06_425584	684	881	331.1648	331.1648	CD
10_1101-2021_01_06_425584	684	882	448.2113	448.2113	VBZ
10_1101-2021_01_06_425584	684	883	511.2145	511.2145	CD
10_1101-2021_01_06_425584	684	884	606.138	606.138	CD
10_1101-2021_01_06_425584	684	885	294.2061	294.2061	CD
10_1101-2021_01_06_425584	684	886	409.1837	409.1837	CD
10_1101-2021_01_06_425584	684	887	198.1845	198.1845	RB
10_1101-2021_01_06_425584	684	888	403.22	403.22	CD
10_1101-2021_01_06_425584	684	889	486.2007	486.2007	CD
10_1101-2021_01_06_425584	684	890	740.5427	740.5427	CD
10_1101-2021_01_06_425584	684	891	560.4098	560.4098	NNP
10_1101-2021_01_06_425584	684	892	345.2984	345.2984	NNP
10_1101-2021_01_06_425584	684	893	669.4164	669.4164	NNP
10_1101-2021_01_06_425584	684	894	480.8023	480.8023	NNP
10_1101-2021_01_06_425584	684	895	407.1805	407.1805	CD
10_1101-2021_01_06_425584	684	896	611.3249	611.3249	NNP
10_1101-2021_01_06_425584	684	897	395.2195	395.2195	NNP
10_1101-2021_01_06_425584	684	898	333.1659	333.1659	NNP
10_1101-2021_01_06_425584	684	899	840.5653	840.5653	NNP
10_1101-2021_01_06_425584	684	900	491.1995	491.1995	NNP
10_1101-2021_01_06_425584	684	901	211.0939	211.0939	NNP
10_1101-2021_01_06_425584	684	902	377.1463	377.1463	NNP
10_1101-2021_01_06_425584	684	903	299.1804	299.1804	NNP
10_1101-2021_01_06_425584	684	904	431.1815	431.1815	CD
10_1101-2021_01_06_425584	684	905	459.1706	459.1706	CD
10_1101-2021_01_06_425584	684	906	329.1689	329.1689	NN
10_1101-2021_01_06_425584	684	907	401.2022	401.2022	VBD
10_1101-2021_01_06_425584	684	908	302.1736	302.1736	CD
10_1101-2021_01_06_425584	684	909	248.108	248.108	CD
10_1101-2021_01_06_425584	684	910	482.3244	482.3244	CD
10_1101-2021_01_06_425584	684	911	823.5398	823.5398	NN
10_1101-2021_01_06_425584	684	912	358.1599	358.1599	NN
10_1101-2021_01_06_425584	684	913	228.0157	228.0157	NNP
10_1101-2021_01_06_425584	684	914	441.1515	441.1515	CD
10_1101-2021_01_06_425584	684	915	247.1286	247.1286	CD
10_1101-2021_01_06_425584	684	916	255.0077	255.0077	NN
10_1101-2021_01_06_425584	684	917	385.1619	385.1619	CD
10_1101-2021_01_06_425584	684	918	534.3515	534.3515	CD
10_1101-2021_01_06_425584	684	919	310.0137	310.0137	NN
10_1101-2021_01_06_425584	684	920	601.3545	601.3545	CD
10_1101-2021_01_06_425584	684	921	307.5846	307.5846	NN
10_1101-2021_01_06_425584	684	922	257.1651	257.1651	CD
10_1101-2021_01_06_425584	684	923	682.583	682.583	CD
10_1101-2021_01_06_425584	684	924	205.0968233.128	205.0968233.128	CD
10_1101-2021_01_06_425584	684	925	311.0851	311.0851	CD
10_1101-2021_01_06_425584	684	926	708.4518	708.4518	CD
10_1101-2021_01_06_425584	684	927	208.9943	208.9943	CD
10_1101-2021_01_06_425584	684	928	367.317	367.317	CD
10_1101-2021_01_06_425584	684	929	502.1256	502.1256	CD
10_1101-2021_01_06_425584	684	930	221.117	221.117	CD
10_1101-2021_01_06_425584	684	931	404.2074	404.2074	CD
10_1101-2021_01_06_425584	684	932	293.0018	293.0018	CD
10_1101-2021_01_06_425584	684	933	418.3511	418.3511	CD
10_1101-2021_01_06_425584	684	934	522.2898	522.2898	NNP
10_1101-2021_01_06_425584	684	935	383.0299	383.0299	NNP
10_1101-2021_01_06_425584	684	936	232.0109	232.0109	CD
10_1101-2021_01_06_425584	684	937	187.0257	187.0257	CD
10_1101-2021_01_06_425584	684	938	625.39	625.39	CD
10_1101-2021_01_06_425584	684	939	315.0742	315.0742	NN
10_1101-2021_01_06_425584	684	940	365.157	365.157	CD
10_1101-2021_01_06_425584	684	941	387.3458	387.3458	NN
10_1101-2021_01_06_425584	684	942	528.1033	528.1033	NNP
10_1101-2021_01_06_425584	684	943	363.1622	363.1622	NN
10_1101-2021_01_06_425584	684	944	415.2539	415.2539	NNP
10_1101-2021_01_06_425584	684	945	399.268	399.268	CD
10_1101-2021_01_06_425584	684	946	291.0476	291.0476	CD
10_1101-2021_01_06_425584	684	947	313.0673	313.0673	NN
10_1101-2021_01_06_425584	684	948	288.3147	288.3147	CD
10_1101-2021_01_06_425584	684	949	415.2449	415.2449	NN
10_1101-2021_01_06_425584	684	950	667.3875	667.3875	NN
10_1101-2021_01_06_425584	684	951	480.3075	480.3075	NN
10_1101-2021_01_06_425584	684	952	602.3388	602.3388	NN
10_1101-2021_01_06_425584	684	953	334.0404	334.0404	NNP
10_1101-2021_01_06_425584	684	954	261.1445	261.1445	CD
10_1101-2021_01_06_425584	684	955	433.2063	433.2063	NNP
10_1101-2021_01_06_425584	684	956	331.9939	331.9939	NNP
10_1101-2021_01_06_425584	684	957	331.1366	331.1366	CD
10_1101-2021_01_06_425584	684	958	243.1336	243.1336	CD
10_1101-2021_01_06_425584	684	959	261.1307	261.1307	CD
10_1101-2021_01_06_425584	684	960	313.068	313.068	CD
10_1101-2021_01_06_425584	684	961	543.1052	543.1052	CD
10_1101-2021_01_06_425584	684	962	331.2228	331.2228	CD
10_1101-2021_01_06_425584	684	963	329.1491	329.1491	CD
10_1101-2021_01_06_425584	684	964	224.185	224.185	CD
10_1101-2021_01_06_425584	684	965	284.0988	284.0988	CD
10_1101-2021_01_06_425584	684	966	497.7717	497.7717	CD
10_1101-2021_01_06_425584	684	967	332.604	332.604	CD
10_1101-2021_01_06_425584	684	968	295.1349	295.1349	CD
10_1101-2021_01_06_425584	684	969	538.2512	538.2512	NNP
10_1101-2021_01_06_425584	684	970	284.2213	284.2213	CD
10_1101-2021_01_06_425584	684	971	257.2212	257.2212	CD
10_1101-2021_01_06_425584	684	972	285.1892	285.1892	CD
10_1101-2021_01_06_425584	684	973	260.1854	260.1854	CD
10_1101-2021_01_06_425584	684	974	561.3954	561.3954	CD
10_1101-2021_01_06_425584	684	975	343.1966	343.1966	CD
10_1101-2021_01_06_425584	684	976	385.0872	385.0872	NNP
10_1101-2021_01_06_425584	684	977	544.3215	544.3215	NNP
10_1101-2021_01_06_425584	684	978	318.8867	318.8867	NNP
10_1101-2021_01_06_425584	684	979	301.1419	301.1419	CD
10_1101-2021_01_06_425584	684	980	214.0972	214.0972	CD
10_1101-2021_01_06_425584	684	981	377.2579	377.2579	CD
10_1101-2021_01_06_425584	684	982	306.094	306.094	CD
10_1101-2021_01_06_425584	684	983	356.077	356.077	CD
10_1101-2021_01_06_425584	684	984	669.2021	669.2021	CD
10_1101-2021_01_06_425584	684	985	717.6223	717.6223	NN
10_1101-2021_01_06_425584	684	986	487.3739	487.3739	NN
10_1101-2021_01_06_425584	684	987	402.1677	402.1677	CD
10_1101-2021_01_06_425584	684	988	204.042	204.042	CD
10_1101-2021_01_06_425584	684	989	683.5415	683.5415	CD
10_1101-2021_01_06_425584	684	990	592.1747430.2644	592.1747430.2644	CD
10_1101-2021_01_06_425584	684	991	421.3172	421.3172	CD
10_1101-2021_01_06_425584	684	992	484.1461	484.1461	CD
10_1101-2021_01_06_425584	684	993	243.0875	243.0875	CD
10_1101-2021_01_06_425584	684	994	597.8556	597.8556	XX
10_1101-2021_01_06_425584	684	995	425.1561	425.1561	NNP
10_1101-2021_01_06_425584	684	996	779.5197	779.5197	NNP
10_1101-2021_01_06_425584	684	997	874.4691	874.4691	CD
10_1101-2021_01_06_425584	684	998	610.2815	610.2815	CD
10_1101-2021_01_06_425584	684	999	575.2665	575.2665	NN
10_1101-2021_01_06_425584	684	1000	362.0542	362.0542	JJ
10_1101-2021_01_06_425584	684	1001	472.2715	472.2715	CD
10_1101-2021_01_06_425584	684	1002	504.3064	504.3064	VBP
10_1101-2021_01_06_425584	684	1003	592.3891	592.3891	NN
10_1101-2021_01_06_425584	684	1004	245.137	245.137	CD
10_1101-2021_01_06_425584	684	1005	414.2359	414.2359	NN
10_1101-2021_01_06_425584	684	1006	342.2119	342.2119	JJ
10_1101-2021_01_06_425584	684	1007	305.2105	305.2105	NN
10_1101-2021_01_06_425584	684	1008	651.257	651.257	CD
10_1101-2021_01_06_425584	684	1009	387.2096	387.2096	IN
10_1101-2021_01_06_425584	684	1010	376.3416	376.3416	CD
10_1101-2021_01_06_425584	684	1011	376.762	376.762	CD
10_1101-2021_01_06_425584	684	1012	505.105	505.105	CD
10_1101-2021_01_06_425584	684	1013	653.3624	653.3624	NNP
10_1101-2021_01_06_425584	684	1014	613.3397	613.3397	CD
10_1101-2021_01_06_425584	684	1015	308.8983	308.8983	NN
10_1101-2021_01_06_425584	684	1016	247.132	247.132	CD
10_1101-2021_01_06_425584	684	1017	368.1613	368.1613	CD
10_1101-2021_01_06_425584	684	1018	289.0533	289.0533	CD
10_1101-2021_01_06_425584	684	1019	237.0678	237.0678	CD
10_1101-2021_01_06_425584	684	1020	311.1281	311.1281	NNP
10_1101-2021_01_06_425584	684	1021	790.3776	790.3776	JJ
10_1101-2021_01_06_425584	684	1022	569.3138	569.3138	NN
10_1101-2021_01_06_425584	684	1023	328.2316	328.2316	NN
10_1101-2021_01_06_425584	684	1024	298.1252	298.1252	CD
10_1101-2021_01_06_425584	684	1025	521.1332	521.1332	CD
10_1101-2021_01_06_425584	684	1026	379.2408	379.2408	CD
10_1101-2021_01_06_425584	684	1027	307.5897	307.5897	NNP
10_1101-2021_01_06_425584	684	1028	120.0809	120.0809	CD
10_1101-2021_01_06_425584	684	1029	459.1915	459.1915	NN
10_1101-2021_01_06_425584	684	1030	685.3904	685.3904	NN
10_1101-2021_01_06_425584	684	1031	443.2189	443.2189	CD
10_1101-2021_01_06_425584	684	1032	544.3519	544.3519	NNP
10_1101-2021_01_06_425584	684	1033	348.3105	348.3105	NNP
10_1101-2021_01_06_425584	684	1034	264.0825	264.0825	NNP
10_1101-2021_01_06_425584	684	1035	648.3785	648.3785	CD
10_1101-2021_01_06_425584	684	1036	274.1444	274.1444	CD
10_1101-2021_01_06_425584	684	1037	541.1202	541.1202	CD
10_1101-2021_01_06_425584	684	1038	550.1643	550.1643	XX
10_1101-2021_01_06_425584	684	1039	306.2638	306.2638	UH
10_1101-2021_01_06_425584	684	1040	472.3602	472.3602	CD
10_1101-2021_01_06_425584	684	1041	219.1125	219.1125	CD
10_1101-2021_01_06_425584	684	1042	642.6193	642.6193	NNP
10_1101-2021_01_06_425584	684	1043	290.1934	290.1934	NNP
10_1101-2021_01_06_425584	684	1044	664.1265	664.1265	CD
10_1101-2021_01_06_425584	684	1045	415.2426	415.2426	CD
10_1101-2021_01_06_425584	684	1046	504.1223	504.1223	CD
10_1101-2021_01_06_425584	684	1047	528.1789	528.1789	IN
10_1101-2021_01_06_425584	684	1048	195.1005	195.1005	NNP
10_1101-2021_01_06_425584	684	1049	290.1952	290.1952	NN
10_1101-2021_01_06_425584	684	1050	190.0339	190.0339	NNP
10_1101-2021_01_06_425584	684	1051	471.1366	471.1366	NNP
10_1101-2021_01_06_425584	684	1052	487.1548	487.1548	CD
10_1101-2021_01_06_425584	684	1053	331.1695	331.1695	NNP
10_1101-2021_01_06_425584	684	1054	412.2519	412.2519	NNP
10_1101-2021_01_06_425584	684	1055	416.2854	416.2854	CD
10_1101-2021_01_06_425584	684	1056	321.0536	321.0536	NNP
10_1101-2021_01_06_425584	684	1057	533.4225	533.4225	CD
10_1101-2021_01_06_425584	684	1058	386.0815	386.0815	NN
10_1101-2021_01_06_425584	684	1059	204.1049	204.1049	CD
10_1101-2021_01_06_425584	684	1060	433.2634	433.2634	CD
10_1101-2021_01_06_425584	684	1061	353.0485	353.0485	CD
10_1101-2021_01_06_425584	684	1062	309.6428	309.6428	CD
10_1101-2021_01_06_425584	684	1063	354.0344	354.0344	NN
10_1101-2021_01_06_425584	684	1064	315.215	315.215	CD
10_1101-2021_01_06_425584	684	1065	518.0863	518.0863	CD
10_1101-2021_01_06_425584	684	1066	409.1898	409.1898	NN
10_1101-2021_01_06_425584	684	1067	635.3845	635.3845	NN
10_1101-2021_01_06_425584	684	1068	796.5389	796.5389	NNS
10_1101-2021_01_06_425584	684	1069	537.3384	537.3384	CD
10_1101-2021_01_06_425584	684	1070	227.1646	227.1646	CD
10_1101-2021_01_06_425584	684	1071	353.2061	353.2061	CD
10_1101-2021_01_06_425584	684	1072	480.164	480.164	CD
10_1101-2021_01_06_425584	684	1073	752.5133	752.5133	NNP
10_1101-2021_01_06_425584	684	1074	264.072	264.072	CD
10_1101-2021_01_06_425584	684	1075	488.3571	488.3571	CD
10_1101-2021_01_06_425584	684	1076	308.0629	308.0629	CD
10_1101-2021_01_06_425584	684	1077	130.1588	130.1588	NN
10_1101-2021_01_06_425584	684	1078	603.2672	603.2672	NNP
10_1101-2021_01_06_425584	684	1079	654.1961	654.1961	NNP
10_1101-2021_01_06_425584	684	1080	861.4975	861.4975	NNP
10_1101-2021_01_06_425584	684	1081	452.0319	452.0319	RB
10_1101-2021_01_06_425584	684	1082	293.1149	293.1149	CD
10_1101-2021_01_06_425584	684	1083	222.0541	222.0541	CD
10_1101-2021_01_06_425584	684	1084	266.173	266.173	CD
10_1101-2021_01_06_425584	684	1085	546.1593	546.1593	CD
10_1101-2021_01_06_425584	684	1086	481.2613	481.2613	CD
10_1101-2021_01_06_425584	684	1087	198.0459	198.0459	CD
10_1101-2021_01_06_425584	684	1088	773.4417	773.4417	NNP
10_1101-2021_01_06_425584	684	1089	297.2129	297.2129	CD
10_1101-2021_01_06_425584	684	1090	312.1869	312.1869	NNP
10_1101-2021_01_06_425584	684	1091	161.096	161.096	CD
10_1101-2021_01_06_425584	684	1092	357.0869	357.0869	NNP
10_1101-2021_01_06_425584	684	1093	302.148	302.148	CD
10_1101-2021_01_06_425584	684	1094	493.313	493.313	CD
10_1101-2021_01_06_425584	684	1095	532.3832	532.3832	JJ
10_1101-2021_01_06_425584	684	1096	373.3665	373.3665	UH
10_1101-2021_01_06_425584	684	1097	448.1767	448.1767	NN
10_1101-2021_01_06_425584	684	1098	287.1911	287.1911	NN
10_1101-2021_01_06_425584	684	1099	181.6125	181.6125	CD
10_1101-2021_01_06_425584	684	1100	845.5211	845.5211	NNP
10_1101-2021_01_06_425584	684	1101	335.0784	335.0784	NNP
10_1101-2021_01_06_425584	684	1102	289.1088	289.1088	CD
10_1101-2021_01_06_425584	684	1103	369.154	369.154	CD
10_1101-2021_01_06_425584	684	1104	288.1805	288.1805	NN
10_1101-2021_01_06_425584	684	1105	509.3542	509.3542	JJ
10_1101-2021_01_06_425584	684	1106	773.4915	773.4915	CD
10_1101-2021_01_06_425584	684	1107	641.3634	641.3634	CD
10_1101-2021_01_06_425584	684	1108	289.0603	289.0603	CD
10_1101-2021_01_06_425584	684	1109	277.1275	277.1275	CD
10_1101-2021_01_06_425584	684	1110	202.1436	202.1436	CD
10_1101-2021_01_06_425584	684	1111	320.2765	320.2765	NNP
10_1101-2021_01_06_425584	684	1112	604.3512	604.3512	NNP
10_1101-2021_01_06_425584	684	1113	355.0651	355.0651	NNP
10_1101-2021_01_06_425584	684	1114	445.1738	445.1738	NNP
10_1101-2021_01_06_425584	684	1115	561.3101	561.3101	NNP
10_1101-2021_01_06_425584	684	1116	304.2108	304.2108	NNP
10_1101-2021_01_06_425584	684	1117	439.2092	439.2092	NN
10_1101-2021_01_06_425584	684	1118	582.272	582.272	CD
10_1101-2021_01_06_425584	684	1119	380.1061	380.1061	CD
10_1101-2021_01_06_425584	684	1120	639.3729	639.3729	CD
10_1101-2021_01_06_425584	684	1121	521.1369	521.1369	NN
10_1101-2021_01_06_425584	684	1122	334.0761	334.0761	NN
10_1101-2021_01_06_425584	684	1123	593.2762	593.2762	NNP
10_1101-2021_01_06_425584	684	1124	324.1011	324.1011	CD
10_1101-2021_01_06_425584	684	1125	453.3427	453.3427	CD
10_1101-2021_01_06_425584	684	1126	335.1059	335.1059	NN
10_1101-2021_01_06_425584	684	1127	515.2178	515.2178	NNP
10_1101-2021_01_06_425584	684	1128	540.1005	540.1005	NNP
10_1101-2021_01_06_425584	684	1129	294.2273	294.2273	NNP
10_1101-2021_01_06_425584	684	1130	380.1122	380.1122	NN
10_1101-2021_01_06_425584	684	1131	246.0794	246.0794	MD
10_1101-2021_01_06_425584	684	1132	365.2676	365.2676	PRP
10_1101-2021_01_06_425584	684	1133	462.1453	462.1453	NN
10_1101-2021_01_06_425584	684	1134	376.2308	376.2308	NNP
10_1101-2021_01_06_425584	684	1135	204.045	204.045	CD
10_1101-2021_01_06_425584	684	1136	357.2989	357.2989	CD
10_1101-2021_01_06_425584	684	1137	268.0628	268.0628	CD
10_1101-2021_01_06_425584	684	1138	215.9822	215.9822	CD
10_1101-2021_01_06_425584	684	1139	725.3575	725.3575	NNP
10_1101-2021_01_06_425584	684	1140	530.1589	530.1589	NN
10_1101-2021_01_06_425584	684	1141	184.1328	184.1328	CD
10_1101-2021_01_06_425584	684	1142	338.0815	338.0815	NN
10_1101-2021_01_06_425584	684	1143	385.1971	385.1971	RB
10_1101-2021_01_06_425584	684	1144	268.1542	268.1542	CD
10_1101-2021_01_06_425584	684	1145	343.2955	343.2955	CD
10_1101-2021_01_06_425584	684	1146	645.3443	645.3443	NNP
10_1101-2021_01_06_425584	684	1147	283.0944	283.0944	JJ
10_1101-2021_01_06_425584	684	1148	559.3043	559.3043	NNS
10_1101-2021_01_06_425584	684	1149	462.248	462.248	CD
10_1101-2021_01_06_425584	684	1150	313.1461	313.1461	CD
10_1101-2021_01_06_425584	684	1151	477.3414	477.3414	CD
10_1101-2021_01_06_425584	684	1152	529.3357	529.3357	NN
10_1101-2021_01_06_425584	684	1153	609.3057	609.3057	NNP
10_1101-2021_01_06_425584	684	1154	373.1514	373.1514	NNP
10_1101-2021_01_06_425584	684	1155	405.2599	405.2599	NNP
10_1101-2021_01_06_425584	684	1156	545.1545	545.1545	XX
10_1101-2021_01_06_425584	684	1157	394.1956	394.1956	CD
10_1101-2021_01_06_425584	684	1158	385.1877	385.1877	NNP
10_1101-2021_01_06_425584	684	1159	423.1984	423.1984	CD
10_1101-2021_01_06_425584	684	1160	592.1777	592.1777	NNP
10_1101-2021_01_06_425584	684	1161	409.2473	409.2473	NNP
10_1101-2021_01_06_425584	684	1162	325.2274	325.2274	NN
10_1101-2021_01_06_425584	684	1163	276.0625	276.0625	CD
10_1101-2021_01_06_425584	684	1164	436.062	436.062	CD
10_1101-2021_01_06_425584	684	1165	320.1688	320.1688	NNP
10_1101-2021_01_06_425584	684	1166	228.1955	228.1955	CD
10_1101-2021_01_06_425584	684	1167	867.3655	867.3655	JJ
10_1101-2021_01_06_425584	684	1168	317.21	317.21	CD
10_1101-2021_01_06_425584	684	1169	344.2278	344.2278	CD
10_1101-2021_01_06_425584	684	1170	509.2845	509.2845	JJ
10_1101-2021_01_06_425584	684	1171	517.2837	517.2837	JJ
10_1101-2021_01_06_425584	684	1172	584.2047	584.2047	NN
10_1101-2021_01_06_425584	684	1173	328.9155	328.9155	CD
10_1101-2021_01_06_425584	684	1174	341.1805	341.1805	IN
10_1101-2021_01_06_425584	684	1175	434.0686	434.0686	CD
10_1101-2021_01_06_425584	684	1176	287.2105	287.2105	CD
10_1101-2021_01_06_425584	684	1177	242.1159	242.1159	CD
10_1101-2021_01_06_425584	684	1178	221.1114	221.1114	CD
10_1101-2021_01_06_425584	684	1179	575.2728	575.2728	RB
10_1101-2021_01_06_425584	684	1180	597.2364	597.2364	JJ
10_1101-2021_01_06_425584	684	1181	198.1485	198.1485	NN
10_1101-2021_01_06_425584	684	1182	362.3622	362.3622	NN
10_1101-2021_01_06_425584	684	1183	312.3253	312.3253	NNP
10_1101-2021_01_06_425584	684	1184	543.2987	543.2987	NN
10_1101-2021_01_06_425584	684	1185	345.3354	345.3354	NNP
10_1101-2021_01_06_425584	684	1186	315.2268	315.2268	NNP
10_1101-2021_01_06_425584	684	1187	713.3509	713.3509	NNP
10_1101-2021_01_06_425584	684	1188	478.0851	478.0851	NNP
10_1101-2021_01_06_425584	684	1189	357.2366	357.2366	CD
10_1101-2021_01_06_425584	684	1190	610.367	610.367	CD
10_1101-2021_01_06_425584	684	1191	264.0784	264.0784	CD
10_1101-2021_01_06_425584	684	1192	476.3052	476.3052	CD
10_1101-2021_01_06_425584	684	1193	340.0767	340.0767	CD
10_1101-2021_01_06_425584	684	1194	286.1397	286.1397	CD
10_1101-2021_01_06_425584	684	1195	636.4161	636.4161	CD
10_1101-2021_01_06_425584	684	1196	475.2773	475.2773	CD
10_1101-2021_01_06_425584	684	1197	652.1914	652.1914	NN
10_1101-2021_01_06_425584	684	1198	166.0861	166.0861	CD
10_1101-2021_01_06_425584	684	1199	675.5421	675.5421	NNP
10_1101-2021_01_06_425584	684	1200	546.1562	546.1562	NNP
10_1101-2021_01_06_425584	684	1201	271.181	271.181	CD
10_1101-2021_01_06_425584	684	1202	387.1935	387.1935	CD
10_1101-2021_01_06_425584	684	1203	192.1223	192.1223	CD
10_1101-2021_01_06_425584	684	1204	331.1899	331.1899	NN
10_1101-2021_01_06_425584	684	1205	351.1808	351.1808	NNP
10_1101-2021_01_06_425584	684	1206	507.2935	507.2935	NNP
10_1101-2021_01_06_425584	684	1207	637.3037	637.3037	IN
10_1101-2021_01_06_425584	684	1208	225.1095	225.1095	NN
10_1101-2021_01_06_425584	684	1209	560.3254	560.3254	NNP
10_1101-2021_01_06_425584	684	1210	631.3504	631.3504	IN
10_1101-2021_01_06_425584	684	1211	359.1477	359.1477	RB
10_1101-2021_01_06_425584	684	1212	269.0883	269.0883	CD
10_1101-2021_01_06_425584	684	1213	619.2691	619.2691	CD
10_1101-2021_01_06_425584	684	1214	164.1065	164.1065	CD
10_1101-2021_01_06_425584	684	1215	218.1383	218.1383	CD
10_1101-2021_01_06_425584	684	1216	283.1171	283.1171	CD
10_1101-2021_01_06_425584	684	1217	259.0201	259.0201	NN
10_1101-2021_01_06_425584	684	1218	434.2585	434.2585	CD
10_1101-2021_01_06_425584	684	1219	188.1999	188.1999	CD
10_1101-2021_01_06_425584	684	1220	385.2071	385.2071	NN
10_1101-2021_01_06_425584	684	1221	635.1389	635.1389	VB
10_1101-2021_01_06_425584	684	1222	493.2815	493.2815	IN
10_1101-2021_01_06_425584	684	1223	479.0776	479.0776	JJ
10_1101-2021_01_06_425584	684	1224	526.2914	526.2914	JJ
10_1101-2021_01_06_425584	684	1225	223.0963	223.0963	NN
10_1101-2021_01_06_425584	684	1226	429.3016	429.3016	RB
10_1101-2021_01_06_425584	684	1227	639.2251	639.2251	VB
10_1101-2021_01_06_425584	684	1228	534.3094	534.3094	RB
10_1101-2021_01_06_425584	684	1229	298.095	298.095	CD
10_1101-2021_01_06_425584	684	1230	486.226	486.226	CD
10_1101-2021_01_06_425584	684	1231	697.3627	697.3627	CD
10_1101-2021_01_06_425584	684	1232	513.3387	513.3387	NN
10_1101-2021_01_06_425584	684	1233	373.0739	373.0739	RB
10_1101-2021_01_06_425584	684	1234	277.0958	277.0958	CD
10_1101-2021_01_06_425584	684	1235	440.2142	440.2142	NNP
10_1101-2021_01_06_425584	684	1236	711.1232	711.1232	NNP
10_1101-2021_01_06_425584	684	1237	297.0668	297.0668	CD
10_1101-2021_01_06_425584	684	1238	285.0076	285.0076	NN
10_1101-2021_01_06_425584	684	1239	420.1996	420.1996	CD
10_1101-2021_01_06_425584	684	1240	246.0252	246.0252	NN
10_1101-2021_01_06_425584	684	1241	486.1428	486.1428	NN
10_1101-2021_01_06_425584	684	1242	516.2999	516.2999	NN
10_1101-2021_01_06_425584	684	1243	325.2119	325.2119	XX
10_1101-2021_01_06_425584	684	1244	455.2416	455.2416	CD
10_1101-2021_01_06_425584	684	1245	581.3643	581.3643	JJ
10_1101-2021_01_06_425584	684	1246	300.2164	300.2164	NNP
10_1101-2021_01_06_425584	684	1247	625.2127	625.2127	NNP
10_1101-2021_01_06_425584	684	1248	421.2334	421.2334	CD
10_1101-2021_01_06_425584	684	1249	241.5671	241.5671	CD
10_1101-2021_01_06_425584	684	1250	239.1269	239.1269	CD
10_1101-2021_01_06_425584	684	1251	301.0709	301.0709	NNP
10_1101-2021_01_06_425584	684	1252	384.1148	384.1148	NNP
10_1101-2021_01_06_425584	684	1253	381.2962	381.2962	NNP
10_1101-2021_01_06_425584	684	1254	299.1163	299.1163	NNP
10_1101-2021_01_06_425584	684	1255	829.4161	829.4161	NN
10_1101-2021_01_06_425584	684	1256	366.1317	366.1317	NNP
10_1101-2021_01_06_425584	684	1257	711.1342	711.1342	NNP
10_1101-2021_01_06_425584	684	1258	362.2528	362.2528	NNP
10_1101-2021_01_06_425584	684	1259	305.1569	305.1569	NNP
10_1101-2021_01_06_425584	684	1260	548.3632	548.3632	RB
10_1101-2021_01_06_425584	684	1261	263.125	263.125	CD
10_1101-2021_01_06_425584	684	1262	526.2574	526.2574	NNP
10_1101-2021_01_06_425584	684	1263	610.1959	610.1959	NNP
10_1101-2021_01_06_425584	684	1264	353.1168	353.1168	NNP
10_1101-2021_01_06_425584	684	1265	337.0808	337.0808	CD
10_1101-2021_01_06_425584	684	1266	580.1723	580.1723	NN
10_1101-2021_01_06_425584	684	1267	282.1469	282.1469	NNP
10_1101-2021_01_06_425584	684	1268	383.2029	383.2029	CD
10_1101-2021_01_06_425584	684	1269	699.612	699.612	CD
10_1101-2021_01_06_425584	684	1270	408.7552	408.7552	CD
10_1101-2021_01_06_425584	684	1271	166.0742	166.0742	CD
10_1101-2021_01_06_425584	684	1272	359.7141	359.7141	CD
10_1101-2021_01_06_425584	684	1273	218.1194	218.1194	NNP
10_1101-2021_01_06_425584	684	1274	283.1332	283.1332	NNP
10_1101-2021_01_06_425584	684	1275	696.4348	696.4348	VB
10_1101-2021_01_06_425584	684	1276	671.3179	671.3179	NNP
10_1101-2021_01_06_425584	684	1277	525.2874	525.2874	UH
10_1101-2021_01_06_425584	684	1278	553.3113	553.3113	IN
10_1101-2021_01_06_425584	684	1279	443.1129	443.1129	CD
10_1101-2021_01_06_425584	684	1280	332.2177	332.2177	CD
10_1101-2021_01_06_425584	684	1281	262.1188	262.1188	NNP
10_1101-2021_01_06_425584	684	1282	539.267	539.267	CD
10_1101-2021_01_06_425584	684	1283	437.2364	437.2364	JJ
10_1101-2021_01_06_425584	684	1284	184.9848	184.9848	CD
10_1101-2021_01_06_425584	684	1285	265.5857	265.5857	CD
10_1101-2021_01_06_425584	684	1286	343.1425	343.1425	CD
10_1101-2021_01_06_425584	684	1287	188.07	188.07	CD
10_1101-2021_01_06_425584	684	1288	292.096	292.096	CD
10_1101-2021_01_06_425584	684	1289	432.2794	432.2794	CD
10_1101-2021_01_06_425584	684	1290	368.1451	368.1451	CD
10_1101-2021_01_06_425584	684	1291	261.1094	261.1094	CD
10_1101-2021_01_06_425584	684	1292	456.2802	456.2802	NNP
10_1101-2021_01_06_425584	684	1293	Cluster	Cluster	NNP
10_1101-2021_01_06_425584	684	1294	1	1	CD
10_1101-2021_01_06_425584	684	1295	Cluster	cluster	NN
10_1101-2021_01_06_425584	684	1296	3	3	CD
10_1101-2021_01_06_425584	684	1297	Cluster	cluster	NN
10_1101-2021_01_06_425584	684	1298	2	2	CD
10_1101-2021_01_06_425584	684	1299	A	a	DT
10_1101-2021_01_06_425584	684	1300	C	c	NN
10_1101-2021_01_06_425584	684	1301	MS2LDA	ms2lda	NN
10_1101-2021_01_06_425584	684	1302	760.5815	760.5815	CD
10_1101-2021_01_06_425584	684	1303	m	m	NN
10_1101-2021_01_06_425584	684	1304	/	/	SYM
10_1101-2021_01_06_425584	684	1305	z	z	NN
10_1101-2021_01_06_425584	684	1306	*	*	NFP
10_1101-2021_01_06_425584	684	1307	B	b	NN
10_1101-2021_01_06_425584	684	1308	M2M_526_Phosphocholine	m2m_526_phosphocholine	NN
10_1101-2021_01_06_425584	684	1309	-	-	HYPH
10_1101-2021_01_06_425584	684	1310	based	base	VBN
10_1101-2021_01_06_425584	684	1311	substructure	substructure	NN
10_1101-2021_01_06_425584	684	1312	0	0	CD
10_1101-2021_01_06_425584	684	1313	100	100	CD
10_1101-2021_01_06_425584	684	1314	200	200	CD
10_1101-2021_01_06_425584	684	1315	300	300	CD
10_1101-2021_01_06_425584	684	1316	400	400	CD
10_1101-2021_01_06_425584	684	1317	0	0	CD
10_1101-2021_01_06_425584	684	1318	25	25	CD
10_1101-2021_01_06_425584	684	1319	50	50	CD
10_1101-2021_01_06_425584	684	1320	75	75	CD
10_1101-2021_01_06_425584	684	1321	100	100	CD
10_1101-2021_01_06_425584	684	1322	m	m	NN
10_1101-2021_01_06_425584	684	1323	/	/	SYM
10_1101-2021_01_06_425584	684	1324	z	z	NNP
10_1101-2021_01_06_425584	684	1325	R	R	NNP
10_1101-2021_01_06_425584	684	1326	el	el	NNP
10_1101-2021_01_06_425584	684	1327	at	at	IN
10_1101-2021_01_06_425584	684	1328	iv	iv	NNP
10_1101-2021_01_06_425584	684	1329	e	e	NNP
10_1101-2021_01_06_425584	684	1330	In	in	IN
10_1101-2021_01_06_425584	684	1331	te	te	NNP
10_1101-2021_01_06_425584	684	1332	ns	ns	IN
10_1101-2021_01_06_425584	684	1333	ity	ity	NNP
10_1101-2021_01_06_425584	684	1334	184.0725	184.0725	NNP
10_1101-2021_01_06_425584	684	1335	OH	OH	NNP
10_1101-2021_01_06_425584	684	1336	P	p	NN
10_1101-2021_01_06_425584	684	1337	O	o	NN
10_1101-2021_01_06_425584	684	1338	OHO	oho	NN
10_1101-2021_01_06_425584	684	1339	N+	N+	VBN
10_1101-2021_01_06_425584	684	1340	Lo	Lo	NNP
10_1101-2021_01_06_425584	684	1341	g2	g2	NNP
10_1101-2021_01_06_425584	684	1342	F	F	NNP
10_1101-2021_01_06_425584	684	1343	C	C	NNP
10_1101-2021_01_06_425584	684	1344	3.6	3.6	CD
10_1101-2021_01_06_425584	684	1345	-2.6	-2.6	CD
10_1101-2021_01_06_425584	684	1346	1	1	CD
10_1101-2021_01_06_425584	684	1347	Peptide	peptide	NN
10_1101-2021_01_06_425584	684	1348	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	684	1349	C	C	NNP
10_1101-2021_01_06_425584	684	1350	A	a	NN
10_1101-2021_01_06_425584	684	1351	162.0225	162.0225	JJ
10_1101-2021_01_06_425584	684	1352	m	m	NN
10_1101-2021_01_06_425584	684	1353	/	/	SYM
10_1101-2021_01_06_425584	684	1354	z	z	NNP
10_1101-2021_01_06_425584	684	1355	M2M_453_Glutathione	M2M_453_Glutathione	NNP
10_1101-2021_01_06_425584	684	1356	-	-	HYPH
10_1101-2021_01_06_425584	684	1357	based	base	VBN
10_1101-2021_01_06_425584	684	1358	substructure	substructure	NN
10_1101-2021_01_06_425584	684	1359	H	h	NN
10_1101-2021_01_06_425584	684	1360	+	+	CC
10_1101-2021_01_06_425584	684	1361	308.0911	308.0911	CD
10_1101-2021_01_06_425584	684	1362	m	m	NN
10_1101-2021_01_06_425584	684	1363	/	/	SYM
10_1101-2021_01_06_425584	684	1364	z	z	NN
10_1101-2021_01_06_425584	684	1365	OH	oh	NN
10_1101-2021_01_06_425584	684	1366	H	h	NN
10_1101-2021_01_06_425584	684	1367	N	n	NN
10_1101-2021_01_06_425584	684	1368	OH	oh	NN
10_1101-2021_01_06_425584	684	1369	O	o	UH
10_1101-2021_01_06_425584	684	1370	SH	sh	NN
10_1101-2021_01_06_425584	684	1371	H2N	h2n	NN
10_1101-2021_01_06_425584	684	1372	O	o	NN
10_1101-2021_01_06_425584	684	1373	H	h	NN
10_1101-2021_01_06_425584	684	1374	N	n	NN
10_1101-2021_01_06_425584	684	1375	OH	oh	NN
10_1101-2021_01_06_425584	684	1376	O	o	UH
10_1101-2021_01_06_425584	684	1377	SH	SH	NNP
10_1101-2021_01_06_425584	684	1378	N	n	NN
10_1101-2021_01_06_425584	684	1379	H	H	NNP
10_1101-2021_01_06_425584	684	1380	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1381	HO	HO	NNP
10_1101-2021_01_06_425584	684	1382	O	o	NN
10_1101-2021_01_06_425584	684	1383	O	o	NN
10_1101-2021_01_06_425584	684	1384	O	o	NN
10_1101-2021_01_06_425584	684	1385	H2	h2	NN
10_1101-2021_01_06_425584	684	1386	N	n	NN
10_1101-2021_01_06_425584	684	1387	OH	oh	NN
10_1101-2021_01_06_425584	684	1388	O	o	UH
10_1101-2021_01_06_425584	684	1389	SH	sh	NN
10_1101-2021_01_06_425584	684	1390	O	o	NN
10_1101-2021_01_06_425584	684	1391	H	h	NN
10_1101-2021_01_06_425584	684	1392	N	n	NN
10_1101-2021_01_06_425584	684	1393	OH	oh	NN
10_1101-2021_01_06_425584	684	1394	O	o	UH
10_1101-2021_01_06_425584	684	1395	SH	sh	NN
10_1101-2021_01_06_425584	684	1396	N	n	NN
10_1101-2021_01_06_425584	684	1397	H	h	NN
10_1101-2021_01_06_425584	684	1398	O	o	NN
10_1101-2021_01_06_425584	684	1399	233.059	233.059	CD
10_1101-2021_01_06_425584	684	1400	m	m	NN
10_1101-2021_01_06_425584	684	1401	/	/	SYM
10_1101-2021_01_06_425584	684	1402	z	z	NNP
10_1101-2021_01_06_425584	684	1403	162.0219	162.0219	CD
10_1101-2021_01_06_425584	684	1404	m	m	NNP
10_1101-2021_01_06_425584	684	1405	/	/	SYM
10_1101-2021_01_06_425584	684	1406	z	z	NNP
10_1101-2021_01_06_425584	684	1407	179.0484	179.0484	CD
10_1101-2021_01_06_425584	684	1408	m	m	NNP
10_1101-2021_01_06_425584	684	1409	/	/	SYM
10_1101-2021_01_06_425584	684	1410	z	z	NNP
10_1101-2021_01_06_425584	684	1411	M2M_59_Phenylalanine	M2M_59_Phenylalanine	NNP
10_1101-2021_01_06_425584	684	1412	-	-	HYPH
10_1101-2021_01_06_425584	684	1413	based	base	VBN
10_1101-2021_01_06_425584	684	1414	substructure	substructure	NN
10_1101-2021_01_06_425584	684	1415	166.0875	166.0875	CD
10_1101-2021_01_06_425584	684	1416	m	m	NN
10_1101-2021_01_06_425584	684	1417	/	/	SYM
10_1101-2021_01_06_425584	684	1418	z	z	NNP
10_1101-2021_01_06_425584	684	1419	166.0875	166.0875	CD
10_1101-2021_01_06_425584	684	1420	m	m	NNP
10_1101-2021_01_06_425584	684	1421	/	/	SYM
10_1101-2021_01_06_425584	684	1422	z	z	NNP
10_1101-2021_01_06_425584	684	1423	166.0875	166.0875	CD
10_1101-2021_01_06_425584	684	1424	m	m	NNP
10_1101-2021_01_06_425584	684	1425	/	/	SYM
10_1101-2021_01_06_425584	684	1426	z	z	NNP
10_1101-2021_01_06_425584	684	1427	166.0875	166.0875	CD
10_1101-2021_01_06_425584	684	1428	m	m	NNP
10_1101-2021_01_06_425584	684	1429	/	/	SYM
10_1101-2021_01_06_425584	684	1430	z	z	NNP
10_1101-2021_01_06_425584	684	1431	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1432	OH	OH	NNP
10_1101-2021_01_06_425584	684	1433	OH	OH	NNP
10_1101-2021_01_06_425584	684	1434	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1435	120.0825	120.0825	CD
10_1101-2021_01_06_425584	684	1436	m	m	NNP
10_1101-2021_01_06_425584	684	1437	/	/	SYM
10_1101-2021_01_06_425584	684	1438	z	z	NNP
10_1101-2021_01_06_425584	684	1439	120.0825	120.0825	CD
10_1101-2021_01_06_425584	684	1440	m	m	NNP
10_1101-2021_01_06_425584	684	1441	/	/	SYM
10_1101-2021_01_06_425584	684	1442	z	z	NNP
10_1101-2021_01_06_425584	684	1443	120.0825	120.0825	CD
10_1101-2021_01_06_425584	684	1444	m	m	NNP
10_1101-2021_01_06_425584	684	1445	/	/	SYM
10_1101-2021_01_06_425584	684	1446	z	z	NNP
10_1101-2021_01_06_425584	684	1447	120.0825	120.0825	CD
10_1101-2021_01_06_425584	684	1448	m	m	NN
10_1101-2021_01_06_425584	684	1449	/	/	SYM
10_1101-2021_01_06_425584	684	1450	z	z	NNP
10_1101-2021_01_06_425584	684	1451	[	[	-LRB-
10_1101-2021_01_06_425584	684	1452	M+H]+	M+H]+	NNP
10_1101-2021_01_06_425584	684	1453	[	[	-LRB-
10_1101-2021_01_06_425584	684	1454	M+H]+	M+H]+	NNP
10_1101-2021_01_06_425584	684	1455	MS2LDA	ms2lda	NN
10_1101-2021_01_06_425584	684	1456	M2M_453	m2m_453	NN
10_1101-2021_01_06_425584	684	1457	B	b	NN
10_1101-2021_01_06_425584	684	1458	*	*	NFP
10_1101-2021_01_06_425584	684	1459	615.1719	615.1719	CD
10_1101-2021_01_06_425584	684	1460	m	m	NN
10_1101-2021_01_06_425584	684	1461	/	/	SYM
10_1101-2021_01_06_425584	684	1462	z	z	NNP
10_1101-2021_01_06_425584	684	1463	D	D	NNP
10_1101-2021_01_06_425584	684	1464	MS2LDA	ms2lda	NN
10_1101-2021_01_06_425584	684	1465	M2M_59	M2M_59	NNP
10_1101-2021_01_06_425584	684	1466	*	*	NFP
10_1101-2021_01_06_425584	684	1467	297.1802	297.1802	CD
10_1101-2021_01_06_425584	684	1468	m	m	NNP
10_1101-2021_01_06_425584	684	1469	/	/	SYM
10_1101-2021_01_06_425584	684	1470	z	z	NNP
10_1101-2021_01_06_425584	684	1471	487.1548	487.1548	CD
10_1101-2021_01_06_425584	684	1472	m	m	NNP
10_1101-2021_01_06_425584	684	1473	/	/	SYM
10_1101-2021_01_06_425584	684	1474	z	z	NN
10_1101-2021_01_06_425584	684	1475	*	*	NFP
10_1101-2021_01_06_425584	684	1476	*	*	NFP
10_1101-2021_01_06_425584	684	1477	295.1285	295.1285	CD
10_1101-2021_01_06_425584	684	1478	m	m	NN
10_1101-2021_01_06_425584	684	1479	/	/	SYM
10_1101-2021_01_06_425584	684	1480	z	z	NNP
10_1101-2021_01_06_425584	684	1481	277.1856	277.1856	CD
10_1101-2021_01_06_425584	684	1482	382.2582	382.2582	NN
10_1101-2021_01_06_425584	684	1483	382.527	382.527	CD
10_1101-2021_01_06_425584	684	1484	371.1907	371.1907	NNP
10_1101-2021_01_06_425584	684	1485	371.0673	371.0673	NNP
10_1101-2021_01_06_425584	684	1486	306.2272	306.2272	NNP
10_1101-2021_01_06_425584	684	1487	230.1749	230.1749	NNP
10_1101-2021_01_06_425584	684	1488	442.8012	442.8012	NN
10_1101-2021_01_06_425584	684	1489	509.1202	509.1202	NNP
10_1101-2021_01_06_425584	684	1490	403.1745	403.1745	CD
10_1101-2021_01_06_425584	684	1491	244.2086	244.2086	CD
10_1101-2021_01_06_425584	684	1492	385.2079	385.2079	NNP
10_1101-2021_01_06_425584	684	1493	358.2426	358.2426	NNP
10_1101-2021_01_06_425584	684	1494	477.2296	477.2296	CD
10_1101-2021_01_06_425584	684	1495	371.0477	371.0477	NNP
10_1101-2021_01_06_425584	684	1496	331.1573	331.1573	NNP
10_1101-2021_01_06_425584	684	1497	190.1434	190.1434	NNP
10_1101-2021_01_06_425584	684	1498	295.1285	295.1285	NNP
10_1101-2021_01_06_425584	684	1499	461.2096	461.2096	NNP
10_1101-2021_01_06_425584	684	1500	347.1596	347.1596	NNP
10_1101-2021_01_06_425584	684	1501	329.1818	329.1818	NNP
10_1101-2021_01_06_425584	684	1502	371.2276	371.2276	NNP
10_1101-2021_01_06_425584	684	1503	216.1954	216.1954	NNP
10_1101-2021_01_06_425584	684	1504	318.1811	318.1811	NNP
10_1101-2021_01_06_425584	684	1505	348.2378	348.2378	NNP
10_1101-2021_01_06_425584	684	1506	477.2335	477.2335	NNP
10_1101-2021_01_06_425584	684	1507	208.1812	208.1812	NNP
10_1101-2021_01_06_425584	684	1508	297.1802	297.1802	NNP
10_1101-2021_01_06_425584	684	1509	355.1755	355.1755	NNP
10_1101-2021_01_06_425584	684	1510	331.1648	331.1648	NNP
10_1101-2021_01_06_425584	684	1511	261.1445	261.1445	CD
10_1101-2021_01_06_425584	684	1512	331.1366	331.1366	CD
10_1101-2021_01_06_425584	684	1513	295.1349	295.1349	CD
10_1101-2021_01_06_425584	684	1514	257.2212	257.2212	CD
10_1101-2021_01_06_425584	684	1515	331.1695	331.1695	NNP
10_1101-2021_01_06_425584	684	1516	264.072	264.072	CD
10_1101-2021_01_06_425584	684	1517	302.148	302.148	CD
10_1101-2021_01_06_425584	684	1518	509.3542	509.3542	JJ
10_1101-2021_01_06_425584	684	1519	202.1436	202.1436	CD
10_1101-2021_01_06_425584	684	1520	334.0761	334.0761	NN
10_1101-2021_01_06_425584	684	1521	313.1461	313.1461	CD
10_1101-2021_01_06_425584	684	1522	320.1688	320.1688	NN
10_1101-2021_01_06_425584	684	1523	188.1999	188.1999	NN
10_1101-2021_01_06_425584	684	1524	610.1959	610.1959	VBD
10_1101-2021_01_06_425584	684	1525	261.1094	261.1094	CD
10_1101-2021_01_06_425584	684	1526	N	n	NN
10_1101-2021_01_06_425584	684	1527	H	h	NN
10_1101-2021_01_06_425584	684	1528	O	o	NN
10_1101-2021_01_06_425584	684	1529	OH	oh	NN
10_1101-2021_01_06_425584	684	1530	O	o	UH
10_1101-2021_01_06_425584	684	1531	HO	HO	NNP
10_1101-2021_01_06_425584	684	1532	O	o	NN
10_1101-2021_01_06_425584	684	1533	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1534	Glutamyl	Glutamyl	NNP
10_1101-2021_01_06_425584	684	1535	-	-	HYPH
10_1101-2021_01_06_425584	684	1536	phenylalanine	phenylalanine	NNP
10_1101-2021_01_06_425584	684	1537	[	[	-LRB-
10_1101-2021_01_06_425584	684	1538	M+H]+	M+H]+	NNP
10_1101-2021_01_06_425584	684	1539	Unknown	unknown	JJ
10_1101-2021_01_06_425584	684	1540	118.086	118.086	CD
10_1101-2021_01_06_425584	684	1541	481.2106	481.2106	CD
10_1101-2021_01_06_425584	684	1542	386.3258	386.3258	CD
10_1101-2021_01_06_425584	684	1543	615.1719	615.1719	CD
10_1101-2021_01_06_425584	684	1544	409.2795	409.2795	NNP
10_1101-2021_01_06_425584	684	1545	217.1478	217.1478	NNP
10_1101-2021_01_06_425584	684	1546	490.1759	490.1759	CD
10_1101-2021_01_06_425584	684	1547	629.159	629.159	CD
10_1101-2021_01_06_425584	684	1548	358.1104	358.1104	NNP
10_1101-2021_01_06_425584	684	1549	398.2412	398.2412	NN
10_1101-2021_01_06_425584	684	1550	313.2128	313.2128	JJ
10_1101-2021_01_06_425584	684	1551	197.116	197.116	CD
10_1101-2021_01_06_425584	684	1552	242.116	242.116	CD
10_1101-2021_01_06_425584	684	1553	299.199	299.199	CD
10_1101-2021_01_06_425584	684	1554	713.1472	713.1472	CD
10_1101-2021_01_06_425584	684	1555	502.0925	502.0925	NNP
10_1101-2021_01_06_425584	684	1556	508.3023	508.3023	NNP
10_1101-2021_01_06_425584	684	1557	679.4094	679.4094	NNP
10_1101-2021_01_06_425584	684	1558	409.1622	409.1622	CD
10_1101-2021_01_06_425584	684	1559	716.5212	716.5212	NNP
10_1101-2021_01_06_425584	684	1560	197.0779	197.0779	CD
10_1101-2021_01_06_425584	684	1561	338.1339	338.1339	VBZ
10_1101-2021_01_06_425584	684	1562	246.1016	246.1016	NNP
10_1101-2021_01_06_425584	684	1563	210.0494	210.0494	NNP
10_1101-2021_01_06_425584	684	1564	242.1172	242.1172	CD
10_1101-2021_01_06_425584	684	1565	291.1928	291.1928	CD
10_1101-2021_01_06_425584	684	1566	637.1514	637.1514	CD
10_1101-2021_01_06_425584	684	1567	311.1988	311.1988	NNP
10_1101-2021_01_06_425584	684	1568	256.0605	256.0605	NN
10_1101-2021_01_06_425584	684	1569	294.2061	294.2061	IN
10_1101-2021_01_06_425584	684	1570	307.5846	307.5846	NN
10_1101-2021_01_06_425584	684	1571	285.1892	285.1892	CD
10_1101-2021_01_06_425584	684	1572	421.3172	421.3172	CD
10_1101-2021_01_06_425584	684	1573	305.2105	305.2105	CD
10_1101-2021_01_06_425584	684	1574	308.8983	308.8983	CD
10_1101-2021_01_06_425584	684	1575	307.5897	307.5897	NNP
10_1101-2021_01_06_425584	684	1576	321.0536	321.0536	NN
10_1101-2021_01_06_425584	684	1577	308.0629	308.0629	NNP
10_1101-2021_01_06_425584	684	1578	222.0541	222.0541	CD
10_1101-2021_01_06_425584	684	1579	266.173	266.173	CD
10_1101-2021_01_06_425584	684	1580	277.1275	277.1275	CD
10_1101-2021_01_06_425584	684	1581	268.1542	268.1542	CD
10_1101-2021_01_06_425584	684	1582	343.2955	343.2955	CD
10_1101-2021_01_06_425584	684	1583	242.1159	242.1159	CD
10_1101-2021_01_06_425584	684	1584	513.3387	513.3387	NNP
10_1101-2021_01_06_425584	684	1585	277.0958	277.0958	CD
10_1101-2021_01_06_425584	684	1586	301.0709	301.0709	NNP
10_1101-2021_01_06_425584	684	1587	526.2574	526.2574	NNP
10_1101-2021_01_06_425584	684	1588	580.1723	580.1723	NNP
10_1101-2021_01_06_425584	684	1589	359.7141	359.7141	CD
10_1101-2021_01_06_425584	684	1590	283.1332	283.1332	CD
10_1101-2021_01_06_425584	684	1591	265.5857	265.5857	CD
10_1101-2021_01_06_425584	684	1592	*	*	NFP
10_1101-2021_01_06_425584	684	1593	308.0925	308.0925	NNP
10_1101-2021_01_06_425584	684	1594	m	m	NNP
10_1101-2021_01_06_425584	684	1595	/	/	SYM
10_1101-2021_01_06_425584	684	1596	z	z	NNP
10_1101-2021_01_06_425584	684	1597	179.0475	179.0475	NNP
10_1101-2021_01_06_425584	684	1598	m	m	NNP
10_1101-2021_01_06_425584	684	1599	/	/	SYM
10_1101-2021_01_06_425584	684	1600	z	z	NNP
10_1101-2021_01_06_425584	684	1601	233.0575	233.0575	CD
10_1101-2021_01_06_425584	684	1602	m	m	NNP
10_1101-2021_01_06_425584	684	1603	/	/	SYM
10_1101-2021_01_06_425584	684	1604	z	z	NNP
10_1101-2021_01_06_425584	684	1605	162.0225	162.0225	NNP
10_1101-2021_01_06_425584	684	1606	m	m	NNP
10_1101-2021_01_06_425584	684	1607	/	/	SYM
10_1101-2021_01_06_425584	684	1608	z	z	NNP
10_1101-2021_01_06_425584	684	1609	179.0475	179.0475	NNP
10_1101-2021_01_06_425584	684	1610	m	m	NNP
10_1101-2021_01_06_425584	684	1611	/	/	SYM
10_1101-2021_01_06_425584	684	1612	z	z	NNP
10_1101-2021_01_06_425584	684	1613	308.0925	308.0925	NNP
10_1101-2021_01_06_425584	684	1614	m	m	NNP
10_1101-2021_01_06_425584	684	1615	/	/	SYM
10_1101-2021_01_06_425584	684	1616	z	z	NNP
10_1101-2021_01_06_425584	684	1617	308.0925	308.0925	NNP
10_1101-2021_01_06_425584	684	1618	m	m	NNP
10_1101-2021_01_06_425584	684	1619	/	/	SYM
10_1101-2021_01_06_425584	684	1620	z	z	NNP
10_1101-2021_01_06_425584	684	1621	179.0475	179.0475	NNP
10_1101-2021_01_06_425584	684	1622	m	m	NNP
10_1101-2021_01_06_425584	684	1623	/	/	SYM
10_1101-2021_01_06_425584	684	1624	z	z	NNP
10_1101-2021_01_06_425584	684	1625	Precursor	Precursor	NNP
10_1101-2021_01_06_425584	684	1626	ion	ion	NN
10_1101-2021_01_06_425584	684	1627	629.159	629.159	CD
10_1101-2021_01_06_425584	684	1628	m	m	NNP
10_1101-2021_01_06_425584	684	1629	/z	/z	NNP
10_1101-2021_01_06_425584	684	1630	Precursor	Precursor	NNP
10_1101-2021_01_06_425584	684	1631	ion	ion	NN
10_1101-2021_01_06_425584	684	1632	713.1472	713.1472	NNP
10_1101-2021_01_06_425584	684	1633	m	m	NNP
10_1101-2021_01_06_425584	684	1634	/z	/z	NNP
10_1101-2021_01_06_425584	684	1635	Precursor	Precursor	NNP
10_1101-2021_01_06_425584	684	1636	ion	ion	NN
10_1101-2021_01_06_425584	684	1637	615.1719	615.1719	NN
10_1101-2021_01_06_425584	684	1638	m	m	NN
10_1101-2021_01_06_425584	684	1639	/z	/z	.
10_1101-2021_01_06_425584	684	1640	[	[	-LRB-
10_1101-2021_01_06_425584	684	1641	M+H]+	M+H]+	NNP
10_1101-2021_01_06_425584	684	1642	*	*	NFP
10_1101-2021_01_06_425584	684	1643	[	[	-LRB-
10_1101-2021_01_06_425584	684	1644	M+H]+	M+H]+	NNP
10_1101-2021_01_06_425584	684	1645	535.21233.0772	535.21233.0772	CD
10_1101-2021_01_06_425584	684	1646	487.1548	487.1548	CD
10_1101-2021_01_06_425584	684	1647	Unknown	unknown	JJ
10_1101-2021_01_06_425584	684	1648	*	*	NFP
10_1101-2021_01_06_425584	684	1649	*	*	NFP
10_1101-2021_01_06_425584	684	1650	[	[	-LRB-
10_1101-2021_01_06_425584	684	1651	2M+H]+	2m+h]+	CD
10_1101-2021_01_06_425584	684	1652	Lo	Lo	NNP
10_1101-2021_01_06_425584	684	1653	g2	g2	NNP
10_1101-2021_01_06_425584	684	1654	F	F	NNP
10_1101-2021_01_06_425584	684	1655	C	C	NNP
10_1101-2021_01_06_425584	684	1656	-0.8	-0.8	:
10_1101-2021_01_06_425584	684	1657	3.1	3.1	CD
10_1101-2021_01_06_425584	684	1658	0	0	CD
10_1101-2021_01_06_425584	684	1659	Lo	Lo	NNP
10_1101-2021_01_06_425584	684	1660	g2	g2	NNP
10_1101-2021_01_06_425584	684	1661	F	F	NNP
10_1101-2021_01_06_425584	684	1662	C	C	NNP
10_1101-2021_01_06_425584	684	1663	-1.1	-1.1	.
10_1101-2021_01_06_425584	684	1664	1.3	1.3	CD
10_1101-2021_01_06_425584	684	1665	0	0	CD
10_1101-2021_01_06_425584	684	1666	Interacting	interact	VBG
10_1101-2021_01_06_425584	684	1667	protein	protein	NN
10_1101-2021_01_06_425584	684	1668	Seed	seed	NN
10_1101-2021_01_06_425584	684	1669	/	/	SYM
10_1101-2021_01_06_425584	684	1670	input	input	NN
10_1101-2021_01_06_425584	684	1671	protein	protein	NN
10_1101-2021_01_06_425584	684	1672	Connectivity	connectivity	NN
10_1101-2021_01_06_425584	684	1673	E	e	NN
10_1101-2021_01_06_425584	684	1674	B	B	NNP
10_1101-2021_01_06_425584	684	1675	n=32n=33	n=32n=33	NNP
10_1101-2021_01_06_425584	684	1676	A	A	NNP
10_1101-2021_01_06_425584	684	1677	Protein	protein	NN
10_1101-2021_01_06_425584	684	1678	-	-	HYPH
10_1101-2021_01_06_425584	684	1679	protein	protein	NN
10_1101-2021_01_06_425584	684	1680	interaction	interaction	NN
10_1101-2021_01_06_425584	684	1681	network	network	NN
10_1101-2021_01_06_425584	684	1682	symbology	symbology	NN
10_1101-2021_01_06_425584	684	1683	Mitochondrial	Mitochondrial	NNP
10_1101-2021_01_06_425584	684	1684	function	function	NN
10_1101-2021_01_06_425584	684	1685	PSMD3	PSMD3	.
10_1101-2021_01_06_425584	684	1686	PSMA4	PSMA4	''
10_1101-2021_01_06_425584	684	1687	RPS13	RPS13	NNP
10_1101-2021_01_06_425584	684	1688	RPL9	RPL9	NNP
10_1101-2021_01_06_425584	684	1689	RPS7	RPS7	NNP
10_1101-2021_01_06_425584	684	1690	MCM3	MCM3	NNP
10_1101-2021_01_06_425584	684	1691	PPP2R2B	PPP2R2B	NNP
10_1101-2021_01_06_425584	684	1692	YWHAQ	YWHAQ	NNP
10_1101-2021_01_06_425584	684	1693	UBE2N	ube2n	JJ
10_1101-2021_01_06_425584	684	1694	PRMT5	PRMT5	NNS
10_1101-2021_01_06_425584	684	1695	PRDX2	PRDX2	NNS
10_1101-2021_01_06_425584	684	1696	PRDX6	prdx6	NN
10_1101-2021_01_06_425584	684	1697	COPG1	COPG1	NNP
10_1101-2021_01_06_425584	684	1698	DNA	DNA	NNP
10_1101-2021_01_06_425584	684	1699	/	/	SYM
10_1101-2021_01_06_425584	684	1700	RNA	RNA	NNP
10_1101-2021_01_06_425584	684	1701	metabolism	metabolism	NN
10_1101-2021_01_06_425584	684	1702	APRT	APRT	NNP
10_1101-2021_01_06_425584	684	1703	DDX1	DDX1	NNP
10_1101-2021_01_06_425584	684	1704	FIS1	FIS1	NNP
10_1101-2021_01_06_425584	684	1705	MX1	MX1	NNP
10_1101-2021_01_06_425584	684	1706	H2AFV	H2AFV	NNP
10_1101-2021_01_06_425584	684	1707	DHX9	DHX9	NNP
10_1101-2021_01_06_425584	684	1708	CAV1	CAV1	NNP
10_1101-2021_01_06_425584	684	1709	APEX1	apex1	NN
10_1101-2021_01_06_425584	684	1710	DYNLL1	dynll1	VBP
10_1101-2021_01_06_425584	684	1711	MYH10	MYH10	NNP
10_1101-2021_01_06_425584	684	1712	RDX	rdx	NN
10_1101-2021_01_06_425584	684	1713	YWHAB	YWHAB	NNP
10_1101-2021_01_06_425584	684	1714	GABARAPL2	gabarapl2	JJ
10_1101-2021_01_06_425584	684	1715	RPL18A	rpl18a	NN
10_1101-2021_01_06_425584	684	1716	COX4I1	COX4I1	:
10_1101-2021_01_06_425584	684	1717	UQCRC1	uqcrc1	NN
10_1101-2021_01_06_425584	684	1718	CTGF	CTGF	NNP
10_1101-2021_01_06_425584	684	1719	LAMP1	LAMP1	VBZ
10_1101-2021_01_06_425584	684	1720	CPSF6	CPSF6	NNP
10_1101-2021_01_06_425584	684	1721	B2	b2	NN
10_1101-2021_01_06_425584	684	1722	M	M	NNP
10_1101-2021_01_06_425584	684	1723	PDIA4	pdia4	NN
10_1101-2021_01_06_425584	684	1724	D	d	NN
10_1101-2021_01_06_425584	684	1725	C	c	NN
10_1101-2021_01_06_425584	684	1726	N	n	NN
10_1101-2021_01_06_425584	684	1727	orm	orm	NN
10_1101-2021_01_06_425584	684	1728	alized	alize	VBN
10_1101-2021_01_06_425584	684	1729	protein	protein	NN
10_1101-2021_01_06_425584	684	1730	abundance	abundance	NN
10_1101-2021_01_06_425584	684	1731	Protein	Protein	NNP
10_1101-2021_01_06_425584	684	1732	metabolism-20	metabolism-20	NN
10_1101-2021_01_06_425584	684	1733	-10	-10	NNP
10_1101-2021_01_06_425584	684	1734	0	0	CD
10_1101-2021_01_06_425584	684	1735	10	10	CD
10_1101-2021_01_06_425584	684	1736	20	20	CD
10_1101-2021_01_06_425584	684	1737	-4	-4	SYM
10_1101-2021_01_06_425584	684	1738	0	0	NFP
10_1101-2021_01_06_425584	684	1739	-2	-2	NFP
10_1101-2021_01_06_425584	684	1740	0	0	CD
10_1101-2021_01_06_425584	684	1741	0	0	CD
10_1101-2021_01_06_425584	684	1742	20	20	CD
10_1101-2021_01_06_425584	684	1743	40	40	CD
10_1101-2021_01_06_425584	684	1744	Scores	Scores	NNPS
10_1101-2021_01_06_425584	684	1745	Plot	Plot	NNP
10_1101-2021_01_06_425584	684	1746	PC	pc	NN
10_1101-2021_01_06_425584	684	1747	4	4	CD
10_1101-2021_01_06_425584	684	1748	(	(	-LRB-
10_1101-2021_01_06_425584	684	1749	14.8	14.8	CD
10_1101-2021_01_06_425584	684	1750	%	%	NN
10_1101-2021_01_06_425584	684	1751	)	)	-RRB-
10_1101-2021_01_06_425584	684	1752	P	p	NN
10_1101-2021_01_06_425584	684	1753	C	c	NN
10_1101-2021_01_06_425584	684	1754	1	1	CD
10_1101-2021_01_06_425584	684	1755	(	(	-LRB-
10_1101-2021_01_06_425584	684	1756	36	36	CD
10_1101-2021_01_06_425584	684	1757	.6	.6	CD
10_1101-2021_01_06_425584	684	1758	%	%	NN
10_1101-2021_01_06_425584	684	1759	)	)	-RRB-
10_1101-2021_01_06_425584	684	1760	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	684	1761	NG	NG	NNP
10_1101-2021_01_06_425584	684	1762	PC4	PC4	NNP
10_1101-2021_01_06_425584	684	1763	P	P	NNP
10_1101-2021_01_06_425584	684	1764	C	c	NN
10_1101-2021_01_06_425584	684	1765	1	1	CD
10_1101-2021_01_06_425584	684	1766	NG	NG	NNP
10_1101-2021_01_06_425584	684	1767	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	684	1768	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	684	1769	NG	NG	NNP
10_1101-2021_01_06_425584	684	1770	PRDX6	prdx6	NN
10_1101-2021_01_06_425584	684	1771	TXN2	txn2	VBP
10_1101-2021_01_06_425584	684	1772	APRT	APRT	NNP
10_1101-2021_01_06_425584	684	1773	Metabolites	Metabolites	NNP
10_1101-2021_01_06_425584	684	1774	Proteins	Proteins	NNPS
10_1101-2021_01_06_425584	684	1775	PRDX2	PRDX2	NNS
10_1101-2021_01_06_425584	684	1776	Glutamate	Glutamate	NNP
10_1101-2021_01_06_425584	684	1777	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	684	1778	Proline	Proline	NNP
10_1101-2021_01_06_425584	684	1779	Leucine	Leucine	NNP
10_1101-2021_01_06_425584	684	1780	Tyrosine	Tyrosine	NNP
10_1101-2021_01_06_425584	684	1781	2-AminoadipateKynurenine	2-aminoadipatekynurenine	CD
10_1101-2021_01_06_425584	684	1782	Serine	Serine	NNP
10_1101-2021_01_06_425584	684	1783	Methionine	Methionine	NNP
10_1101-2021_01_06_425584	684	1784	Threonine	Threonine	NNP
10_1101-2021_01_06_425584	684	1785	OAT	OAT	NNP
10_1101-2021_01_06_425584	684	1786	HG+HING	HG+HING	NNP
10_1101-2021_01_06_425584	684	1787	Nuclei	Nuclei	NNP
10_1101-2021_01_06_425584	684	1788	vWF	vWF	VBD
10_1101-2021_01_06_425584	684	1789	Nuclei	Nuclei	NNP
10_1101-2021_01_06_425584	684	1790	vWF	vwf	IN
10_1101-2021_01_06_425584	684	1791	HG+HING	hg+hing	NN
10_1101-2021_01_06_425584	684	1792	B	B	NNP
10_1101-2021_01_06_425584	684	1793	A	a	DT
10_1101-2021_01_06_425584	684	1794	HCAEC	HCAEC	NNP
10_1101-2021_01_06_425584	684	1795	BCAEC	bcaec	JJ
10_1101-2021_01_06_425584	684	1796	≈	≈	NN
10_1101-2021_01_06_425584	684	1797	30	30	CD
10_1101-2021_01_06_425584	684	1798	%	%	NN
10_1101-2021_01_06_425584	684	1799	≈	≈	NNP
10_1101-2021_01_06_425584	684	1800	58	58	CD
10_1101-2021_01_06_425584	684	1801	%	%	NN
10_1101-2021_01_06_425584	684	1802	Binucleation	Binucleation	NNP
10_1101-2021_01_06_425584	684	1803	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	684	1804	BINUCLEATION	BINUCLEATION	NNP
10_1101-2021_01_06_425584	684	1805	Translation	translation	NN
10_1101-2021_01_06_425584	684	1806	Nuclei	Nuclei	NNP
10_1101-2021_01_06_425584	684	1807	Up	up	RP
10_1101-2021_01_06_425584	684	1808	-	-	HYPH
10_1101-2021_01_06_425584	684	1809	regulated	regulate	VBN
10_1101-2021_01_06_425584	684	1810	Down	down	RP
10_1101-2021_01_06_425584	684	1811	-	-	HYPH
10_1101-2021_01_06_425584	684	1812	regulated	regulate	VBN
10_1101-2021_01_06_425584	684	1813	Angiogenesis	angiogenesis	NN
10_1101-2021_01_06_425584	684	1814	or	or	CC
10_1101-2021_01_06_425584	684	1815	cell	cell	NN
10_1101-2021_01_06_425584	684	1816	proliferation	proliferation	NN
10_1101-2021_01_06_425584	684	1817	CTGF	CTGF	NNP
10_1101-2021_01_06_425584	684	1818	AFABP	AFABP	VBD
10_1101-2021_01_06_425584	684	1819	CD62	CD62	NNP
10_1101-2021_01_06_425584	684	1820	CAV-1	CAV-1	NNP
10_1101-2021_01_06_425584	684	1821	RPS7	RPS7	NNP
10_1101-2021_01_06_425584	684	1822	RPS13	RPS13	NNP
10_1101-2021_01_06_425584	684	1823	RPL9	RPL9	NNP
10_1101-2021_01_06_425584	684	1824	PSMA4	PSMA4	''
10_1101-2021_01_06_425584	684	1825	PSMD3	PSMD3	.
10_1101-2021_01_06_425584	684	1826	Integrated	Integrated	NNP
10_1101-2021_01_06_425584	684	1827	Analysis	Analysis	NNP
10_1101-2021_01_06_425584	684	1828	COX4I1	COX4I1	NNP
10_1101-2021_01_06_425584	684	1829	UQCRC1	uqcrc1	XX
10_1101-2021_01_06_425584	684	1830	NDUFB3	ndufb3	CD
10_1101-2021_01_06_425584	684	1831	NDUFA7	NDUFA7	NNP
10_1101-2021_01_06_425584	684	1832	Mitochondrial	Mitochondrial	NNP
10_1101-2021_01_06_425584	684	1833	inner	inner	JJ
10_1101-2021_01_06_425584	684	1834	mas	mas	NN
10_1101-2021_01_06_425584	684	1835	CAVIN3	CAVIN3	NNP
10_1101-2021_01_06_425584	684	1836	Caveolae	Caveolae	NNP
10_1101-2021_01_06_425584	684	1837	DNA	DNA	NNP
10_1101-2021_01_06_425584	684	1838	and	and	CC
10_1101-2021_01_06_425584	684	1839	RNA	RNA	NNP
10_1101-2021_01_06_425584	684	1840	metabolism	metabolism	NN
10_1101-2021_01_06_425584	684	1841	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1842	H	H	NNP
10_1101-2021_01_06_425584	684	1843	N	n	NN
10_1101-2021_01_06_425584	684	1844	O	o	NN
10_1101-2021_01_06_425584	684	1845	OH	oh	UH
10_1101-2021_01_06_425584	684	1846	NH2O	nh2o	UH
10_1101-2021_01_06_425584	684	1847	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1848	O	O	NNP
10_1101-2021_01_06_425584	684	1849	OH	oh	NN
10_1101-2021_01_06_425584	684	1850	Tryptophan	Tryptophan	NNP
10_1101-2021_01_06_425584	684	1851	SerotoninKynurenine	SerotoninKynurenine	NNP
10_1101-2021_01_06_425584	684	1852	Catabolism	Catabolism	NNP
10_1101-2021_01_06_425584	684	1853	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1854	H	H	NNP
10_1101-2021_01_06_425584	684	1855	N	N	NNP
10_1101-2021_01_06_425584	684	1856	HO	HO	NNP
10_1101-2021_01_06_425584	684	1857	N	n	NN
10_1101-2021_01_06_425584	684	1858	H	h	NN
10_1101-2021_01_06_425584	684	1859	O	o	NN
10_1101-2021_01_06_425584	684	1860	OH	oh	NN
10_1101-2021_01_06_425584	684	1861	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1862	O	o	UH
10_1101-2021_01_06_425584	684	1863	HO	ho	NN
10_1101-2021_01_06_425584	684	1864	O	o	NN
10_1101-2021_01_06_425584	684	1865	H2N	h2n	NN
10_1101-2021_01_06_425584	684	1866	O	o	UH
10_1101-2021_01_06_425584	684	1867	OH	OH	NNP
10_1101-2021_01_06_425584	684	1868	Glutamyl	Glutamyl	NNP
10_1101-2021_01_06_425584	684	1869	-	-	HYPH
10_1101-2021_01_06_425584	684	1870	phenylalanine	phenylalanine	NNP
10_1101-2021_01_06_425584	684	1871	Phenylalanine	Phenylalanine	NNP
10_1101-2021_01_06_425584	684	1872	-	-	HYPH
10_1101-2021_01_06_425584	684	1873	based	base	VBN
10_1101-2021_01_06_425584	684	1874	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	684	1875	Phenylalanine	Phenylalanine	NNP
10_1101-2021_01_06_425584	684	1876	O	O	NNP
10_1101-2021_01_06_425584	684	1877	P	p	NN
10_1101-2021_01_06_425584	684	1878	O	o	NN
10_1101-2021_01_06_425584	684	1879	OO	oo	NN
10_1101-2021_01_06_425584	684	1880	N+	N+	VBN
10_1101-2021_01_06_425584	684	1881	O	o	NN
10_1101-2021_01_06_425584	684	1882	O	o	NN
10_1101-2021_01_06_425584	684	1883	H	h	NN
10_1101-2021_01_06_425584	684	1884	R1	r1	NN
10_1101-2021_01_06_425584	684	1885	PAFAH1B2	PAFAH1B2	NNP
10_1101-2021_01_06_425584	684	1886	Deacylation	Deacylation	NNP
10_1101-2021_01_06_425584	684	1887	LysoPC	LysoPC	NNP
10_1101-2021_01_06_425584	684	1888	lipids	lipid	VBZ
10_1101-2021_01_06_425584	684	1889	PC	pc	NN
10_1101-2021_01_06_425584	684	1890	lipids	lipid	NNS
10_1101-2021_01_06_425584	684	1891	OH	oh	NN
10_1101-2021_01_06_425584	684	1892	P	p	NN
10_1101-2021_01_06_425584	684	1893	O	o	NN
10_1101-2021_01_06_425584	684	1894	OHO	oho	NN
10_1101-2021_01_06_425584	684	1895	N+	N+	VBN
10_1101-2021_01_06_425584	684	1896	Phosphocholine	Phosphocholine	NNP
10_1101-2021_01_06_425584	684	1897	O	O	NNP
10_1101-2021_01_06_425584	684	1898	P	p	NN
10_1101-2021_01_06_425584	684	1899	O	o	NN
10_1101-2021_01_06_425584	684	1900	OO	oo	NN
10_1101-2021_01_06_425584	684	1901	N+	N+	VBN
10_1101-2021_01_06_425584	684	1902	O	o	NN
10_1101-2021_01_06_425584	684	1903	O	o	NN
10_1101-2021_01_06_425584	684	1904	R2	r2	NN
10_1101-2021_01_06_425584	684	1905	R1	r1	NN
10_1101-2021_01_06_425584	684	1906	LYPLA1	lypla1	NN
10_1101-2021_01_06_425584	684	1907	Degradation	Degradation	NNP
10_1101-2021_01_06_425584	684	1908	Inflammation	Inflammation	NNP
10_1101-2021_01_06_425584	684	1909	Catabolism	Catabolism	NNP
10_1101-2021_01_06_425584	684	1910	Oxidative	Oxidative	NNP
10_1101-2021_01_06_425584	684	1911	stress	stress	NN
10_1101-2021_01_06_425584	684	1912	Peptides	Peptides	NNPS
10_1101-2021_01_06_425584	684	1913	NH2	NH2	NNP
10_1101-2021_01_06_425584	684	1914	O	o	UH
10_1101-2021_01_06_425584	684	1915	HO	ho	NN
10_1101-2021_01_06_425584	684	1916	O	o	NN
10_1101-2021_01_06_425584	684	1917	OHOrnitine	ohornitine	NN
10_1101-2021_01_06_425584	684	1918	OAT	OAT	NNP
10_1101-2021_01_06_425584	684	1919	Glutamic	Glutamic	NNP
10_1101-2021_01_06_425584	684	1920	acid	acid	NN
10_1101-2021_01_06_425584	684	1921	NH	NH	NNP
10_1101-2021_01_06_425584	684	1922	O	o	NN
10_1101-2021_01_06_425584	684	1923	OH	oh	NN
10_1101-2021_01_06_425584	684	1924	O	o	NN
10_1101-2021_01_06_425584	684	1925	H	h	NN
10_1101-2021_01_06_425584	684	1926	N	n	NN
10_1101-2021_01_06_425584	684	1927	OH	oh	NN
10_1101-2021_01_06_425584	684	1928	OSH	OSH	NNP
10_1101-2021_01_06_425584	684	1929	N	N	NNP
10_1101-2021_01_06_425584	684	1930	HNH2	HNH2	NNP
10_1101-2021_01_06_425584	684	1931	HO	HO	NNP
10_1101-2021_01_06_425584	684	1932	O	o	NN
10_1101-2021_01_06_425584	684	1933	O	o	NN
10_1101-2021_01_06_425584	684	1934	Ox	Ox	NNP
10_1101-2021_01_06_425584	684	1935	-	-	HYPH
10_1101-2021_01_06_425584	684	1936	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	684	1937	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	684	1938	-	-	HYPH
10_1101-2021_01_06_425584	684	1939	based	base	VBN
10_1101-2021_01_06_425584	684	1940	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	684	1941	PRDX2	prdx2	DT
10_1101-2021_01_06_425584	684	1942	PRDX6	prdx6	NN
10_1101-2021_01_06_425584	684	1943	TXN2	TXN2	NNP
10_1101-2021_01_06_425584	684	1944	ROS	ROS	NNP
10_1101-2021_01_06_425584	684	1945	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	684	1946	Proline	Proline	NNP
10_1101-2021_01_06_425584	684	1947	Mitochondria	Mitochondria	NNP
10_1101-2021_01_06_425584	684	1948	Table	Table	NNP
10_1101-2021_01_06_425584	684	1949	1	1	CD
10_1101-2021_01_06_425584	684	1950	.	.	.
10_1101-2021_01_06_425584	685	1	Pathway	pathway	JJ
10_1101-2021_01_06_425584	685	2	enrichment	enrichment	NN
10_1101-2021_01_06_425584	685	3	analysis	analysis	NN
10_1101-2021_01_06_425584	685	4	of	of	IN
10_1101-2021_01_06_425584	685	5	up	up	RB
10_1101-2021_01_06_425584	685	6	-	-	HYPH
10_1101-2021_01_06_425584	685	7	regulated	regulated	JJ
10_1101-2021_01_06_425584	685	8	and	and	CC
10_1101-2021_01_06_425584	685	9	down	down	RB
10_1101-2021_01_06_425584	685	10	-	-	HYPH
10_1101-2021_01_06_425584	685	11	regulated	regulate	VBN
10_1101-2021_01_06_425584	685	12	proteins	protein	NNS
10_1101-2021_01_06_425584	685	13	in	in	IN
10_1101-2021_01_06_425584	685	14	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	685	15	group	group	NN
10_1101-2021_01_06_425584	685	16	REACTOME	REACTOME	NNP
10_1101-2021_01_06_425584	685	17	Database	Database	NNP
10_1101-2021_01_06_425584	685	18	Total	Total	NNP
10_1101-2021_01_06_425584	685	19	Hits	Hits	NNP
10_1101-2021_01_06_425584	685	20	FDR	FDR	NNP
10_1101-2021_01_06_425584	685	21	Total	Total	NNP
10_1101-2021_01_06_425584	685	22	Hits	Hits	NNP
10_1101-2021_01_06_425584	685	23	FDR	FDR	NNP
10_1101-2021_01_06_425584	685	24	Up	up	RP
10_1101-2021_01_06_425584	685	25	-	-	HYPH
10_1101-2021_01_06_425584	685	26	regulated	regulate	VBN
10_1101-2021_01_06_425584	685	27	Down	down	RP
10_1101-2021_01_06_425584	685	28	-	-	HYPH
10_1101-2021_01_06_425584	685	29	regulated	regulated	JJ
10_1101-2021_01_06_425584	685	30	Metabolism	Metabolism	NNP
10_1101-2021_01_06_425584	685	31	of	of	IN
10_1101-2021_01_06_425584	685	32	RNA	RNA	NNP
10_1101-2021_01_06_425584	685	33	339	339	CD
10_1101-2021_01_06_425584	685	34	142	142	CD
10_1101-2021_01_06_425584	685	35	1.26E-	1.26e-	CD
10_1101-2021_01_06_425584	685	36	100	100	CD
10_1101-2021_01_06_425584	685	37	Peptide	peptide	NN
10_1101-2021_01_06_425584	685	38	chain	chain	NN
10_1101-2021_01_06_425584	685	39	elongation	elongation	NN
10_1101-2021_01_06_425584	685	40	178	178	CD
10_1101-2021_01_06_425584	685	41	77	77	CD
10_1101-2021_01_06_425584	685	42	5.81E-	5.81e-	CD
10_1101-2021_01_06_425584	685	43	48	48	CD
10_1101-2021_01_06_425584	685	44	Metabolism	metabolism	NN
10_1101-2021_01_06_425584	685	45	of	of	IN
10_1101-2021_01_06_425584	685	46	mRNA	mrna	$
10_1101-2021_01_06_425584	685	47	317	317	CD
10_1101-2021_01_06_425584	685	48	136	136	CD
10_1101-2021_01_06_425584	685	49	1.04E-97	1.04e-97	CD
10_1101-2021_01_06_425584	685	50	Influenza	Influenza	NNP
10_1101-2021_01_06_425584	685	51	Infection	Infection	NNP
10_1101-2021_01_06_425584	685	52	185	185	CD
10_1101-2021_01_06_425584	685	53	78	78	CD
10_1101-2021_01_06_425584	685	54	6.52E-	6.52e-	CD
10_1101-2021_01_06_425584	685	55	48	48	CD
10_1101-2021_01_06_425584	685	56	Synthesis	Synthesis	NNP
10_1101-2021_01_06_425584	685	57	of	of	IN
10_1101-2021_01_06_425584	685	58	DNA	dna	NN
10_1101-2021_01_06_425584	685	59	95	95	CD
10_1101-2021_01_06_425584	685	60	75	75	CD
10_1101-2021_01_06_425584	685	61	2.37E-79	2.37e-79	CD
10_1101-2021_01_06_425584	685	62	Nonsense	Nonsense	NNP
10_1101-2021_01_06_425584	685	63	Mediated	mediate	VBN
10_1101-2021_01_06_425584	685	64	Decay	Decay	NNP
10_1101-2021_01_06_425584	685	65	Independent	Independent	NNP
10_1101-2021_01_06_425584	685	66	of	of	IN
10_1101-2021_01_06_425584	685	67	the	the	DT
10_1101-2021_01_06_425584	685	68	Exon	Exon	NNP
10_1101-2021_01_06_425584	685	69	Junction	Junction	NNP
10_1101-2021_01_06_425584	685	70	Complex	Complex	NNP
10_1101-2021_01_06_425584	685	71	184	184	CD
10_1101-2021_01_06_425584	685	72	77	77	CD
10_1101-2021_01_06_425584	685	73	4.04E-	4.04e-	CD
10_1101-2021_01_06_425584	685	74	47	47	CD
10_1101-2021_01_06_425584	685	75	DNA	DNA	NNP
10_1101-2021_01_06_425584	685	76	Replication	Replication	NNP
10_1101-2021_01_06_425584	685	77	102	102	CD
10_1101-2021_01_06_425584	685	78	77	77	CD
10_1101-2021_01_06_425584	685	79	5.67E-79	5.67e-79	CD
10_1101-2021_01_06_425584	685	80	Influenza	Influenza	NNP
10_1101-2021_01_06_425584	685	81	Life	Life	NNP
10_1101-2021_01_06_425584	685	82	Cycle	Cycle	NNP
10_1101-2021_01_06_425584	685	83	180	180	CD
10_1101-2021_01_06_425584	685	84	76	76	CD
10_1101-2021_01_06_425584	685	85	4.63E-	4.63e-	CD
10_1101-2021_01_06_425584	685	86	47	47	CD
10_1101-2021_01_06_425584	685	87	DNA	dna	NN
10_1101-2021_01_06_425584	685	88	Replication	Replication	NNP
10_1101-2021_01_06_425584	685	89	Pre	Pre	NNP
10_1101-2021_01_06_425584	685	90	-	-	HYPH
10_1101-2021_01_06_425584	685	91	Initiation	Initiation	NNP
10_1101-2021_01_06_425584	685	92	80	80	CD
10_1101-2021_01_06_425584	685	93	68	68	CD
10_1101-2021_01_06_425584	685	94	3.49E-76	3.49e-76	CD
10_1101-2021_01_06_425584	685	95	Eukaryotic	Eukaryotic	NNP
10_1101-2021_01_06_425584	685	96	Translation	Translation	NNP
10_1101-2021_01_06_425584	685	97	Elongation	Elongation	NNP
10_1101-2021_01_06_425584	685	98	186	186	CD
10_1101-2021_01_06_425584	685	99	77	77	CD
10_1101-2021_01_06_425584	685	100	4.63E-	4.63e-	CD
10_1101-2021_01_06_425584	685	101	47	47	CD
10_1101-2021_01_06_425584	685	102	M	M	NNP
10_1101-2021_01_06_425584	685	103	/	/	SYM
10_1101-2021_01_06_425584	685	104	G1	G1	NNP
10_1101-2021_01_06_425584	685	105	Transition	Transition	NNP
10_1101-2021_01_06_425584	685	106	80	80	CD
10_1101-2021_01_06_425584	685	107	68	68	CD
10_1101-2021_01_06_425584	685	108	3.49E-76	3.49e-76	CD
10_1101-2021_01_06_425584	685	109	Nonsense	nonsense	NN
10_1101-2021_01_06_425584	685	110	Mediated	mediate	VBN
10_1101-2021_01_06_425584	685	111	Decay	Decay	NNP
10_1101-2021_01_06_425584	685	112	Enhanced	enhance	VBN
10_1101-2021_01_06_425584	685	113	by	by	IN
10_1101-2021_01_06_425584	685	114	the	the	DT
10_1101-2021_01_06_425584	685	115	Exon	Exon	NNP
10_1101-2021_01_06_425584	685	116	Junction	Junction	NNP
10_1101-2021_01_06_425584	685	117	Complex	Complex	NNP
10_1101-2021_01_06_425584	685	118	203	203	CD
10_1101-2021_01_06_425584	685	119	80	80	CD
10_1101-2021_01_06_425584	685	120	4.63E-	4.63e-	CD
10_1101-2021_01_06_425584	685	121	47	47	CD
10_1101-2021_01_06_425584	685	122	S	S	NNP
10_1101-2021_01_06_425584	685	123	Phase	Phase	NNP
10_1101-2021_01_06_425584	685	124	122	122	CD
10_1101-2021_01_06_425584	685	125	78	78	CD
10_1101-2021_01_06_425584	685	126	4.62E-71	4.62e-71	CD
10_1101-2021_01_06_425584	685	127	Nonsense	Nonsense	NNP
10_1101-2021_01_06_425584	685	128	-	-	HYPH
10_1101-2021_01_06_425584	685	129	Mediated	Mediated	NNP
10_1101-2021_01_06_425584	685	130	Decay	Decay	NNP
10_1101-2021_01_06_425584	685	131	203	203	CD
10_1101-2021_01_06_425584	685	132	80	80	CD
10_1101-2021_01_06_425584	685	133	4.63E-	4.63e-	CD
10_1101-2021_01_06_425584	685	134	47	47	CD
10_1101-2021_01_06_425584	685	135	G1	g1	NN
10_1101-2021_01_06_425584	685	136	/	/	SYM
10_1101-2021_01_06_425584	685	137	S	S	NNP
10_1101-2021_01_06_425584	685	138	Transition	Transition	NNP
10_1101-2021_01_06_425584	685	139	113	113	CD
10_1101-2021_01_06_425584	685	140	75	75	CD
10_1101-2021_01_06_425584	685	141	4.37E-70	4.37e-70	CD
10_1101-2021_01_06_425584	685	142	Influenza	Influenza	NNP
10_1101-2021_01_06_425584	685	143	Viral	Viral	NNP
10_1101-2021_01_06_425584	685	144	RNA	RNA	NNP
10_1101-2021_01_06_425584	685	145	Transcription	Transcription	NNP
10_1101-2021_01_06_425584	685	146	and	and	CC
10_1101-2021_01_06_425584	685	147	Replication	Replication	NNP
10_1101-2021_01_06_425584	685	148	176	176	CD
10_1101-2021_01_06_425584	685	149	75	75	CD
10_1101-2021_01_06_425584	685	150	5.77E-	5.77e-	CD
10_1101-2021_01_06_425584	685	151	47	47	CD
10_1101-2021_01_06_425584	685	152	Assembly	assembly	NN
10_1101-2021_01_06_425584	685	153	of	of	IN
10_1101-2021_01_06_425584	685	154	the	the	DT
10_1101-2021_01_06_425584	685	155	pre-	pre-	NN
10_1101-2021_01_06_425584	685	156	replicative	replicative	JJ
10_1101-2021_01_06_425584	685	157	complex	complex	NNP
10_1101-2021_01_06_425584	685	158	63	63	CD
10_1101-2021_01_06_425584	685	159	57	57	CD
10_1101-2021_01_06_425584	685	160	5.61E-67	5.61e-67	CD
10_1101-2021_01_06_425584	685	161	Viral	Viral	NNP
10_1101-2021_01_06_425584	685	162	mRNA	mrna	NN
10_1101-2021_01_06_425584	685	163	Translation	translation	NN
10_1101-2021_01_06_425584	685	164	176	176	CD
10_1101-2021_01_06_425584	685	165	75	75	CD
10_1101-2021_01_06_425584	685	166	5.77E-	5.77e-	CD
10_1101-2021_01_06_425584	685	167	47	47	CD
10_1101-2021_01_06_425584	685	168	Metabolism	metabolism	NN
10_1101-2021_01_06_425584	685	169	of	of	IN
10_1101-2021_01_06_425584	685	170	RNA	RNA	NNP
10_1101-2021_01_06_425584	685	171	339	339	CD
10_1101-2021_01_06_425584	685	172	142	142	CD
10_1101-2021_01_06_425584	685	173	1.26E-	1.26e-	CD
10_1101-2021_01_06_425584	685	174	100	100	CD
10_1101-2021_01_06_425584	685	175	Eukaryotic	Eukaryotic	NNP
10_1101-2021_01_06_425584	685	176	Translation	Translation	NNP
10_1101-2021_01_06_425584	685	177	Termination	Termination	NNP
10_1101-2021_01_06_425584	685	178	178	178	CD
10_1101-2021_01_06_425584	685	179	75	75	CD
10_1101-2021_01_06_425584	685	180	1.42E-	1.42e-	CD
10_1101-2021_01_06_425584	685	181	46	46	CD
10_1101-2021_01_06_425584	685	182	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	685	183	Database	Database	NNP
10_1101-2021_01_06_425584	685	184	Up	up	RP
10_1101-2021_01_06_425584	685	185	-	-	HYPH
10_1101-2021_01_06_425584	685	186	regulated	regulate	VBN
10_1101-2021_01_06_425584	685	187	Down	down	RP
10_1101-2021_01_06_425584	685	188	-	-	HYPH
10_1101-2021_01_06_425584	685	189	regulated	regulate	VBN
10_1101-2021_01_06_425584	685	190	Basal	Basal	NNP
10_1101-2021_01_06_425584	685	191	transcription	transcription	NN
10_1101-2021_01_06_425584	685	192	factors	factor	VBZ
10_1101-2021_01_06_425584	685	193	153	153	CD
10_1101-2021_01_06_425584	685	194	111	111	CD
10_1101-2021_01_06_425584	685	195	2.17E-	2.17e-	CD
10_1101-2021_01_06_425584	685	196	115	115	CD
10_1101-2021_01_06_425584	685	197	Basal	Basal	NNP
10_1101-2021_01_06_425584	685	198	transcription	transcription	NN
10_1101-2021_01_06_425584	685	199	factors	factor	NNS
10_1101-2021_01_06_425584	685	200	153	153	CD
10_1101-2021_01_06_425584	685	201	88	88	CD
10_1101-2021_01_06_425584	685	202	8.15E-	8.15e-	CD
10_1101-2021_01_06_425584	685	203	73	73	CD
10_1101-2021_01_06_425584	685	204	Mismatch	Mismatch	NNP
10_1101-2021_01_06_425584	685	205	repair	repair	NN
10_1101-2021_01_06_425584	685	206	45	45	CD
10_1101-2021_01_06_425584	685	207	43	43	CD
10_1101-2021_01_06_425584	685	208	1.68E-53	1.68e-53	CD
10_1101-2021_01_06_425584	685	209	Nucleotide	nucleotide	JJ
10_1101-2021_01_06_425584	685	210	excision	excision	NN
10_1101-2021_01_06_425584	685	211	repair	repair	NN
10_1101-2021_01_06_425584	685	212	135	135	CD
10_1101-2021_01_06_425584	685	213	46	46	CD
10_1101-2021_01_06_425584	685	214	3.62E-	3.62e-	CD
10_1101-2021_01_06_425584	685	215	24	24	CD
10_1101-2021_01_06_425584	685	216	SNARE	SNARE	NNP
10_1101-2021_01_06_425584	685	217	interactions	interaction	NNS
10_1101-2021_01_06_425584	685	218	in	in	IN
10_1101-2021_01_06_425584	685	219	vesicular	vesicular	JJ
10_1101-2021_01_06_425584	685	220	transport	transport	NN
10_1101-2021_01_06_425584	685	221	124	124	CD
10_1101-2021_01_06_425584	685	222	41	41	CD
10_1101-2021_01_06_425584	685	223	2.28E-22	2.28e-22	CD
10_1101-2021_01_06_425584	685	224	Renal	renal	JJ
10_1101-2021_01_06_425584	685	225	cell	cell	NN
10_1101-2021_01_06_425584	685	226	carcinoma	carcinoma	NN
10_1101-2021_01_06_425584	685	227	201	201	CD
10_1101-2021_01_06_425584	685	228	46	46	CD
10_1101-2021_01_06_425584	685	229	2.26E-	2.26e-	CD
10_1101-2021_01_06_425584	685	230	16	16	CD
10_1101-2021_01_06_425584	685	231	Base	Base	NNP
10_1101-2021_01_06_425584	685	232	excision	excision	NN
10_1101-2021_01_06_425584	685	233	repair	repair	NN
10_1101-2021_01_06_425584	685	234	36	36	CD
10_1101-2021_01_06_425584	685	235	18	18	CD
10_1101-2021_01_06_425584	685	236	3.46E-13	3.46e-13	CD
10_1101-2021_01_06_425584	685	237	Endometrial	Endometrial	NNP
10_1101-2021_01_06_425584	685	238	cancer	cancer	NN
10_1101-2021_01_06_425584	685	239	204	204	CD
10_1101-2021_01_06_425584	685	240	45	45	CD
10_1101-2021_01_06_425584	685	241	1.88E-	1.88e-	CD
10_1101-2021_01_06_425584	685	242	15	15	CD
10_1101-2021_01_06_425584	685	243	Human	human	NN
10_1101-2021_01_06_425584	685	244	papillomavirus	papillomavirus	NN
10_1101-2021_01_06_425584	685	245	infection	infection	NN
10_1101-2021_01_06_425584	685	246	155	155	CD
10_1101-2021_01_06_425584	685	247	34	34	CD
10_1101-2021_01_06_425584	685	248	1.62E-12	1.62e-12	CD
10_1101-2021_01_06_425584	685	249	Peroxisome	peroxisome	NN
10_1101-2021_01_06_425584	685	250	137	137	CD
10_1101-2021_01_06_425584	685	251	35	35	CD
10_1101-2021_01_06_425584	685	252	5.32E-	5.32e-	CD
10_1101-2021_01_06_425584	685	253	14	14	CD
10_1101-2021_01_06_425584	685	254	Chemical	Chemical	NNP
10_1101-2021_01_06_425584	685	255	carcinogenesis	carcinogenesis	NN
10_1101-2021_01_06_425584	685	256	201	201	CD
10_1101-2021_01_06_425584	685	257	36	36	CD
10_1101-2021_01_06_425584	685	258	1.50E-10	1.50e-10	CD
10_1101-2021_01_06_425584	685	259	Nicotine	Nicotine	NNP
10_1101-2021_01_06_425584	685	260	addiction	addiction	NN
10_1101-2021_01_06_425584	685	261	193	193	CD
10_1101-2021_01_06_425584	685	262	41	41	CD
10_1101-2021_01_06_425584	685	263	1.48E-	1.48e-	CD
10_1101-2021_01_06_425584	685	264	13	13	CD
10_1101-2021_01_06_425584	685	265	Hepatocellular	Hepatocellular	NNP
10_1101-2021_01_06_425584	685	266	carcinoma	carcinoma	NN
10_1101-2021_01_06_425584	685	267	76	76	CD
10_1101-2021_01_06_425584	685	268	18	18	CD
10_1101-2021_01_06_425584	685	269	4.74E-07	4.74e-07	CD
10_1101-2021_01_06_425584	685	270	Ribosome	Ribosome	NNP
10_1101-2021_01_06_425584	685	271	biogenesis	biogenesis	NN
10_1101-2021_01_06_425584	685	272	in	in	IN
10_1101-2021_01_06_425584	685	273	eukaryotes	eukaryote	NNS
10_1101-2021_01_06_425584	685	274	79	79	CD
10_1101-2021_01_06_425584	685	275	26	26	CD
10_1101-2021_01_06_425584	685	276	2.92E-	2.92e-	CD
10_1101-2021_01_06_425584	685	277	13	13	CD
10_1101-2021_01_06_425584	685	278	Human	Human	NNP
10_1101-2021_01_06_425584	685	279	T	T	NNP
10_1101-2021_01_06_425584	685	280	-	-	HYPH
10_1101-2021_01_06_425584	685	281	cell	cell	NN
10_1101-2021_01_06_425584	685	282	leukemia	leukemia	NN
10_1101-2021_01_06_425584	685	283	virus	virus	NN
10_1101-2021_01_06_425584	685	284	1	1	CD
10_1101-2021_01_06_425584	685	285	infection	infection	NN
10_1101-2021_01_06_425584	685	286	162	162	CD
10_1101-2021_01_06_425584	685	287	26	26	CD
10_1101-2021_01_06_425584	685	288	1.49E-06	1.49e-06	CD
10_1101-2021_01_06_425584	685	289	Gap	Gap	NNP
10_1101-2021_01_06_425584	685	290	junction	junction	NN
10_1101-2021_01_06_425584	685	291	199	199	CD
10_1101-2021_01_06_425584	685	292	41	41	CD
10_1101-2021_01_06_425584	685	293	3.40E-	3.40e-	CD
10_1101-2021_01_06_425584	685	294	13	13	CD
10_1101-2021_01_06_425584	685	295	Chronic	chronic	NN
10_1101-2021_01_06_425584	685	296	myeloid	myeloid	NN
10_1101-2021_01_06_425584	685	297	leukemia	leukemia	NN
10_1101-2021_01_06_425584	685	298	97	97	CD
10_1101-2021_01_06_425584	685	299	19	19	CD
10_1101-2021_01_06_425584	685	300	3.79E-06	3.79e-06	CD
10_1101-2021_01_06_425584	685	301	Herpes	Herpes	NNP
10_1101-2021_01_06_425584	685	302	simplex	simplex	NN
10_1101-2021_01_06_425584	685	303	virus	virus	NN
10_1101-2021_01_06_425584	685	304	1	1	CD
10_1101-2021_01_06_425584	685	305	infection	infection	NN
10_1101-2021_01_06_425584	685	306	225	225	CD
10_1101-2021_01_06_425584	685	307	42	42	CD
10_1101-2021_01_06_425584	685	308	5.11E-	5.11e-	CD
10_1101-2021_01_06_425584	685	309	12	12	CD
10_1101-2021_01_06_425584	685	310	Notch	Notch	NNP
10_1101-2021_01_06_425584	685	311	signaling	signal	VBG
10_1101-2021_01_06_425584	685	312	pathway	pathway	JJ
10_1101-2021_01_06_425584	685	313	160	160	CD
10_1101-2021_01_06_425584	685	314	25	25	CD
10_1101-2021_01_06_425584	685	315	3.79E-06	3.79e-06	CD
10_1101-2021_01_06_425584	685	316	Glutamatergic	Glutamatergic	NNP
10_1101-2021_01_06_425584	685	317	synapse	synapse	VBD
10_1101-2021_01_06_425584	685	318	231	231	CD
10_1101-2021_01_06_425584	685	319	36	36	CD
10_1101-2021_01_06_425584	685	320	1.02E-	1.02e-	CD
10_1101-2021_01_06_425584	685	321	14	14	CD
10_1101-2021_01_06_425584	685	322	Table	table	NN
10_1101-2021_01_06_425584	685	323	2	2	CD
10_1101-2021_01_06_425584	685	324	.	.	.
10_1101-2021_01_06_425584	686	1	Integrative	integrative	JJ
10_1101-2021_01_06_425584	686	2	pathway	pathway	JJ
10_1101-2021_01_06_425584	686	3	enrichment	enrichment	NN
10_1101-2021_01_06_425584	686	4	analysis	analysis	NN
10_1101-2021_01_06_425584	686	5	of	of	IN
10_1101-2021_01_06_425584	686	6	up	up	RB
10_1101-2021_01_06_425584	686	7	-	-	HYPH
10_1101-2021_01_06_425584	686	8	regulated	regulated	JJ
10_1101-2021_01_06_425584	686	9	proteins	protein	NNS
10_1101-2021_01_06_425584	686	10	and	and	CC
10_1101-2021_01_06_425584	686	11	metabolites	metabolite	NNS
10_1101-2021_01_06_425584	686	12	in	in	IN
10_1101-2021_01_06_425584	686	13	HG+HI	HG+HI	NNP
10_1101-2021_01_06_425584	686	14	group	group	NN
10_1101-2021_01_06_425584	686	15	REACTOME	REACTOME	NNP
10_1101-2021_01_06_425584	686	16	Database	Database	NNP
10_1101-2021_01_06_425584	686	17	Total	Total	NNP
10_1101-2021_01_06_425584	686	18	Hits	Hits	NNP
10_1101-2021_01_06_425584	686	19	FDR	FDR	NNP
10_1101-2021_01_06_425584	686	20	KEGG	KEGG	NNP
10_1101-2021_01_06_425584	686	21	Database	Database	NNP
10_1101-2021_01_06_425584	686	22	Total	Total	NNP
10_1101-2021_01_06_425584	686	23	Hits	Hits	NNP
10_1101-2021_01_06_425584	686	24	FDR	FDR	NNP
10_1101-2021_01_06_425584	686	25	Metabolism	Metabolism	NNP
10_1101-2021_01_06_425584	686	26	of	of	IN
10_1101-2021_01_06_425584	686	27	amino	amino	JJ
10_1101-2021_01_06_425584	686	28	acids	acid	NNS
10_1101-2021_01_06_425584	686	29	and	and	CC
10_1101-2021_01_06_425584	686	30	derivatives	derivative	NNS
10_1101-2021_01_06_425584	686	31	190	190	CD
10_1101-2021_01_06_425584	686	32	44	44	CD
10_1101-2021_01_06_425584	686	33	8.74E-39	8.74e-39	CD
10_1101-2021_01_06_425584	686	34	EGFR	EGFR	NNP
10_1101-2021_01_06_425584	686	35	tyrosine	tyrosine	JJ
10_1101-2021_01_06_425584	686	36	kinase	kinase	NN
10_1101-2021_01_06_425584	686	37	inhibitor	inhibitor	NN
10_1101-2021_01_06_425584	686	38	resistance	resistance	NN
10_1101-2021_01_06_425584	686	39	1490	1490	CD
10_1101-2021_01_06_425584	686	40	129	129	CD
10_1101-2021_01_06_425584	686	41	1.01E-	1.01e-	CD
10_1101-2021_01_06_425584	686	42	72	72	CD
10_1101-2021_01_06_425584	686	43	Metabolism	Metabolism	NNP
10_1101-2021_01_06_425584	686	44	1490	1490	CD
10_1101-2021_01_06_425584	686	45	85	85	CD
10_1101-2021_01_06_425584	686	46	1.33E-35	1.33e-35	CD
10_1101-2021_01_06_425584	686	47	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	686	48	metabolism	metabolism	NN
10_1101-2021_01_06_425584	686	49	56	56	CD
10_1101-2021_01_06_425584	686	50	39	39	CD
10_1101-2021_01_06_425584	686	51	1.63E-	1.63e-	CD
10_1101-2021_01_06_425584	686	52	54	54	CD
10_1101-2021_01_06_425584	686	53	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	686	54	conjugation	conjugation	NN
10_1101-2021_01_06_425584	686	55	25	25	CD
10_1101-2021_01_06_425584	686	56	21	21	CD
10_1101-2021_01_06_425584	686	57	7.33E-33	7.33e-33	CD
10_1101-2021_01_06_425584	686	58	Alanine	Alanine	NNP
10_1101-2021_01_06_425584	686	59	,	,	,
10_1101-2021_01_06_425584	686	60	aspartate	aspartate	NN
10_1101-2021_01_06_425584	686	61	and	and	CC
10_1101-2021_01_06_425584	686	62	glutamate	glutamate	VB
10_1101-2021_01_06_425584	686	63	metabolism	metabolism	NN
10_1101-2021_01_06_425584	686	64	36	36	CD
10_1101-2021_01_06_425584	686	65	24	24	CD
10_1101-2021_01_06_425584	686	66	4.57E-	4.57e-	CD
10_1101-2021_01_06_425584	686	67	32	32	CD
10_1101-2021_01_06_425584	686	68	Phase	phase	NN
10_1101-2021_01_06_425584	686	69	II	ii	CD
10_1101-2021_01_06_425584	686	70	conjugation	conjugation	NN
10_1101-2021_01_06_425584	686	71	74	74	CD
10_1101-2021_01_06_425584	686	72	25	25	CD
10_1101-2021_01_06_425584	686	73	2.04E-25	2.04e-25	CD
10_1101-2021_01_06_425584	686	74	ABC	ABC	NNP
10_1101-2021_01_06_425584	686	75	transporters	transporter	NNS
10_1101-2021_01_06_425584	686	76	75	75	CD
10_1101-2021_01_06_425584	686	77	27	27	CD
10_1101-2021_01_06_425584	686	78	1.09E-	1.09e-	CD
10_1101-2021_01_06_425584	686	79	26	26	CD
10_1101-2021_01_06_425584	686	80	Amino	amino	JJ
10_1101-2021_01_06_425584	686	81	acid	acid	JJ
10_1101-2021_01_06_425584	686	82	synthesis	synthesis	NN
10_1101-2021_01_06_425584	686	83	and	and	CC
10_1101-2021_01_06_425584	686	84	interconversion	interconversion	NN
10_1101-2021_01_06_425584	686	85	(	(	-LRB-
10_1101-2021_01_06_425584	686	86	transamination	transamination	NN
10_1101-2021_01_06_425584	686	87	)	)	-RRB-
10_1101-2021_01_06_425584	686	88	18	18	CD
10_1101-2021_01_06_425584	686	89	15	15	CD
10_1101-2021_01_06_425584	686	90	5.97E-23	5.97e-23	CD
10_1101-2021_01_06_425584	686	91	Cysteine	Cysteine	NNP
10_1101-2021_01_06_425584	686	92	and	and	CC
10_1101-2021_01_06_425584	686	93	methionine	methionine	NNP
10_1101-2021_01_06_425584	686	94	metabolism	metabolism	NN
10_1101-2021_01_06_425584	686	95	49	49	CD
10_1101-2021_01_06_425584	686	96	22	22	CD
10_1101-2021_01_06_425584	686	97	3.48E-	3.48e-	CD
10_1101-2021_01_06_425584	686	98	24	24	CD
10_1101-2021_01_06_425584	686	99	Biological	biological	JJ
10_1101-2021_01_06_425584	686	100	oxidations	oxidation	NNS
10_1101-2021_01_06_425584	686	101	142	142	CD
10_1101-2021_01_06_425584	686	102	25	25	CD
10_1101-2021_01_06_425584	686	103	7.73E-18	7.73e-18	CD
10_1101-2021_01_06_425584	686	104	Pancreatic	pancreatic	JJ
10_1101-2021_01_06_425584	686	105	cancer	cancer	NN
10_1101-2021_01_06_425584	686	106	82	82	CD
10_1101-2021_01_06_425584	686	107	23	23	CD
10_1101-2021_01_06_425584	686	108	7.55E-	7.55e-	CD
10_1101-2021_01_06_425584	686	109	20	20	CD
10_1101-2021_01_06_425584	686	110	tRNA	trna	CD
10_1101-2021_01_06_425584	686	111	Aminoacylation	Aminoacylation	NNP
10_1101-2021_01_06_425584	686	112	42	42	CD
10_1101-2021_01_06_425584	686	113	13	13	CD
10_1101-2021_01_06_425584	686	114	5.19E-12	5.19e-12	CD
10_1101-2021_01_06_425584	686	115	Drug	drug	NN
10_1101-2021_01_06_425584	686	116	metabolism	metabolism	NN
10_1101-2021_01_06_425584	686	117	-	-	HYPH
10_1101-2021_01_06_425584	686	118	cytochrome	cytochrome	VBN
10_1101-2021_01_06_425584	686	119	P450	P450	NNP
10_1101-2021_01_06_425584	686	120	72	72	CD
10_1101-2021_01_06_425584	686	121	21	21	CD
10_1101-2021_01_06_425584	686	122	1.67E-	1.67e-	CD
10_1101-2021_01_06_425584	686	123	18	18	CD
10_1101-2021_01_06_425584	686	124	Glutathione	Glutathione	NNP
10_1101-2021_01_06_425584	686	125	synthesis	synthesis	NN
10_1101-2021_01_06_425584	686	126	and	and	CC
10_1101-2021_01_06_425584	686	127	recycling	recycle	VBG
10_1101-2021_01_06_425584	686	128	10	10	CD
10_1101-2021_01_06_425584	686	129	7	7	CD
10_1101-2021_01_06_425584	686	130	3.67E-09	3.67e-09	CD
10_1101-2021_01_06_425584	686	131	Metabolism	metabolism	NN
10_1101-2021_01_06_425584	686	132	of	of	IN
10_1101-2021_01_06_425584	686	133	xenobiotics	xenobiotic	NNS
10_1101-2021_01_06_425584	686	134	by	by	IN
10_1101-2021_01_06_425584	686	135	cytochrome	cytochrome	NNP
10_1101-2021_01_06_425584	686	136	P450	P450	NNP
10_1101-2021_01_06_425584	686	137	76	76	CD
10_1101-2021_01_06_425584	686	138	21	21	CD
10_1101-2021_01_06_425584	686	139	5.18E-	5.18e-	CD
10_1101-2021_01_06_425584	686	140	18	18	CD
10_1101-2021_01_06_425584	686	141	Sulfur	Sulfur	NNP
10_1101-2021_01_06_425584	686	142	amino	amino	NN
10_1101-2021_01_06_425584	686	143	acid	acid	NN
10_1101-2021_01_06_425584	686	144	metabolism	metabolism	VBG
10_1101-2021_01_06_425584	686	145	25	25	CD
10_1101-2021_01_06_425584	686	146	9	9	CD
10_1101-2021_01_06_425584	686	147	9.84E-09	9.84e-09	CD
10_1101-2021_01_06_425584	686	148	Drug	Drug	NNP
10_1101-2021_01_06_425584	686	149	metabolism	metabolism	NN
10_1101-2021_01_06_425584	686	150	-	-	HYPH
10_1101-2021_01_06_425584	686	151	other	other	JJ
10_1101-2021_01_06_425584	686	152	enzymes	enzyme	NNS
10_1101-2021_01_06_425584	686	153	79	79	CD
10_1101-2021_01_06_425584	686	154	20	20	CD
10_1101-2021_01_06_425584	686	155	2.45E-	2.45e-	CD
10_1101-2021_01_06_425584	686	156	16	16	CD
10_1101-2021_01_06_425584	686	157	Tryptophan	Tryptophan	NNP
10_1101-2021_01_06_425584	686	158	catabolism	catabolism	NN
10_1101-2021_01_06_425584	686	159	11	11	CD
10_1101-2021_01_06_425584	686	160	6	6	CD
10_1101-2021_01_06_425584	686	161	7.51E-07	7.51e-07	CD
10_1101-2021_01_06_425584	686	162	mRNA	mrna	NN
10_1101-2021_01_06_425584	686	163	surveillance	surveillance	NN
10_1101-2021_01_06_425584	686	164	pathway	pathway	VBD
10_1101-2021_01_06_425584	686	165	73	73	CD
10_1101-2021_01_06_425584	686	166	19	19	CD
10_1101-2021_01_06_425584	686	167	8.78E-	8.78e-	CD
10_1101-2021_01_06_425584	686	168	16	16	CD